Tissue thickness compensators for surgical staplers

Information

  • Patent Grant
  • 10363031
  • Patent Number
    10,363,031
  • Date Filed
    Monday, June 13, 2016
    8 years ago
  • Date Issued
    Tuesday, July 30, 2019
    5 years ago
Abstract
Tissue thickness compensators for use with circular surgical staplers. Various tissue thickness compensators are disclosed for deployment between a stapler head of a surgical circular stapler and an anvil attached thereto to accommodate variances in tissue thickness during stapling. Some tissue thickness compensator arrangements include means and configurations for deploying healing agents for enhancing the healing process.
Description
BACKGROUND

The present invention relates to surgical instruments and, in various embodiments, to surgical cutting and stapling instruments and staple cartridges therefor that are designed to cut and staple tissue.





BRIEF DESCRIPTION OF THE DRAWINGS

The features and advantages of this invention, and the manner of attaining them, will become more apparent and the invention itself will be better understood by reference to the following description of embodiments of the invention taken in conjunction with the accompanying drawings, wherein:



FIG. 1 is a cross-sectional view of a surgical instrument embodiment;



FIG. 1A is a perspective view of one embodiment of an implantable staple cartridge;



FIGS. 1B-1E illustrate portions of an end effector clamping and stapling tissue with an implantable staple cartridge;



FIG. 2 is a partial cross-sectional side view of another end effector coupled to a portion of a surgical instrument with the end effector supporting a surgical staple cartridge and with the anvil thereof in an open position;



FIG. 3 is another partial cross-sectional side view of the end effector of FIG. 2 in a closed position;



FIG. 4 is another partial cross-sectional side view of the end effector of FIGS. 2 and 3 as the knife bar is starting to advance through the end effector;



FIG. 5 is another partial cross-sectional side view of the end effector of FIGS. 2-4 with the knife bar partially advanced therethrough;



FIG. 6 is a perspective view of an alternative staple cartridge embodiment installed in a surgical cutting and stapling device;



FIG. 7 is a top view of the surgical staple cartridge and elongated channel of the device depicted in FIG. 6;



FIG. 8 is a top view of another surgical staple cartridge embodiment installed in an elongated channel of an end effector;



FIG. 9 is a bottom view of an anvil;



FIG. 10 is a partial perspective view of a plurality of staples forming a portion of a staple line;



FIG. 11 is another partial perspective view of the staple line of FIG. 10 with the staples thereof after being formed by being contacted by the anvil of the surgical cutting and stapling device;



FIG. 12 is a partial perspective view of alternative staples forming a portion of another staple line;



FIG. 13 is a partial perspective view of alternative staples forming a portion of another staple line;



FIG. 14 is a partial perspective view of alternative staples forming a portion of another staple line embodiment;



FIG. 15 is a cross-sectional view of an end effector supporting a staple cartridge;



FIG. 16 is a cross-sectional view of the elongated channel portion of the end effector of FIG. 15 after the implantable staple cartridge body portion and staples have been removed therefrom;



FIG. 17 is a cross-sectional view of an end effector supporting another staple cartridge;



FIGS. 18A-18D diagram the deformation of a surgical staple positioned within a collapsible staple cartridge body in accordance with at least one embodiment;



FIG. 19A is a diagram illustrating a staple positioned in a crushable staple cartridge body;



FIG. 19B is a diagram illustrating the crushable staple cartridge body of FIG. 19A being crushed by an anvil;



FIG. 19C is a diagram illustrating the crushable staple cartridge body of FIG. 19A being further crushed by the anvil;



FIG. 19D is a diagram illustrating the staple of FIG. 19A in a fully formed configuration and the crushable staple cartridge of FIG. 19A in a fully crushed condition;



FIG. 20 is a diagram depicting a staple positioned against a staple cartridge support surface and illustrating potential relative movement therebetween;



FIG. 21 is a cross-sectional view of a staple cartridge support surface comprising a slot, or trough, configured to stabilize the base of the staple of FIG. 20;



FIG. 22 is a cross-sectional view of a staple comprising an overmolded crown and a slot, or trough, configured to receive a portion of the crown in accordance with at least one alternative embodiment;



FIG. 23 is a top view of a staple cartridge in accordance with at least one embodiment comprising staples embedded in a collapsible staple cartridge body;



FIG. 24 is an elevational view of the staple cartridge of FIG. 23;



FIG. 25 is an elevational view of a staple cartridge in accordance with at least one embodiment comprising a protective layer surrounding staples positioned within a collapsible staple cartridge body;



FIG. 26 is a cross-sectional view of the staple cartridge of FIG. 25 taken along line 26-26 in FIG. 25;



FIG. 27 is an elevational view of a staple cartridge in accordance with at least one embodiment comprising staples at least partially extending outside of a collapsible staple cartridge body and a protective layer surrounding the staple cartridge body;



FIG. 28 is a cross-sectional view of the staple cartridge of FIG. 27 taken along line 28-28 in FIG. 27;



FIG. 29 is a partial break-away view of a staple cartridge in accordance with at least one embodiment comprising staples at least partially embedded in a collapsible staple cartridge body, the staples being at least partially positioned in a staple cavity void in the staple cartridge body;



FIG. 30 is a cross-sectional view of the staple cartridge of FIG. 29 taken along line 30-30 in FIG. 29;



FIG. 31 is a partial break-away view of a staple cartridge in accordance with at least one embodiment;



FIG. 32 is a partial break-away view of a staple cartridge in accordance with at least one embodiment comprising staples at least partially embedded within a collapsible staple cartridge body and an alignment matrix connecting the staples and aligning the staples with respect to each other;



FIG. 33 is a cross-sectional view of the staple cartridge of FIG. 32 taken along line 33-33 in FIG. 32;



FIG. 34 is partial cut-away view of an inner layer of a compressible staple cartridge body;



FIG. 35 is a diagram illustrating the inner layer of FIG. 34 compressed between a transfer plate and a support plate;



FIG. 36 is a diagram illustrating staples being inserted into the compressed inner layer of FIG. 35;



FIG. 37 is a diagram of the support plate of FIG. 35 being removed away from the inner layer;



FIG. 38 is a diagram of a subassembly comprising the inner layer of FIG. 34 and the staples of FIG. 36 being inserted into an outer layer;



FIG. 39 is a diagram illustrating the outer layer of FIG. 38 being sealed to form a sealed staple cartridge;



FIG. 40 is a cross-sectional view of the sealed staple cartridge of FIG. 39;



FIG. 41 is a cross-sectional view of a staple cartridge and staple cartridge channel in accordance with at least one embodiment;



FIG. 42 is a diagram illustrating a portion of the staple cartridge of FIG. 41 in a deformed state;



FIG. 43 is an elevational view of an end effector of a surgical stapler comprising an anvil in an open position and a staple cartridge positioned within a staple cartridge channel;



FIG. 44 is an elevational view of the end effector of FIG. 43 illustrating the anvil in a closed position and the staple cartridge compressed between the anvil and the staple cartridge channel;



FIG. 45 is an elevational view of the end effector of FIG. 43 illustrating the staple cartridge of FIG. 43 positioned within the staple cartridge channel in an alternative manner;



FIG. 46 is a cross-sectional view of an end effector of a surgical stapler comprising a compressible staple cartridge positioned within a staple cartridge channel and a piece of buttress material attached to an anvil;



FIG. 47 is a cross-sectional view of the end effector of FIG. 46 illustrating the anvil in a closed position;



FIG. 48 is a cross-sectional view of an alternative embodiment of an end effector of a surgical stapler comprising a staple cartridge comprising a water impermeable layer;



FIG. 49 is a cross-sectional view of another alternative embodiment of an end effector of a surgical stapler;



FIG. 50 is a cross-sectional view of an alternative embodiment of an end effector of a surgical stapler comprising a stepped anvil and a staple cartridge comprising a stepped cartridge body;



FIG. 51 is a cross-sectional view of another alternative embodiment of an end effector of a surgical stapler;



FIG. 52 is a cross-sectional view of an alternative embodiment of an end effector of a surgical stapler comprising inclined tissue-contacting surfaces;



FIG. 53 is a cross-sectional view of another alternative embodiment of an end effector of a surgical stapler comprising inclined tissue-contacting surfaces;



FIG. 54 is a cross-sectional view of an alternative embodiment of an end effector of a surgical stapler comprising a support insert configured to support a staple cartridge;



FIG. 55 is a cross-sectional view of an alternative embodiment of an end effector of a surgical stapler comprising a staple cartridge comprising a plurality of compressible layers;



FIG. 56 is a cross-sectional view of an alternative embodiment of an end effector of a surgical stapler comprising a staple cartridge comprising a stepped compressible cartridge body;



FIG. 57 is a cross-sectional view of another alternative embodiment of an end effector of a surgical stapler comprising a staple cartridge comprising a stepped compressible cartridge body;



FIG. 58 is a cross-sectional view of an alternative embodiment of an end effector of a surgical stapler comprising a staple cartridge comprising a curved tissue-contacting surface;



FIG. 59 is a cross-sectional view of an alternative embodiment of an end effector of a surgical stapler comprising a staple cartridge having an inclined tissue-contacting surface;



FIG. 60 is a cross-sectional view of a compressible staple cartridge comprising staples and at least one medicament stored therein;



FIG. 61 is a diagram illustrating the compressible staple cartridge of FIG. 60 after it has been compressed and the staples contained therein have been deformed;



FIG. 62 is a partial cut-away view of a staple cartridge in accordance with at least one embodiment;



FIG. 63 is a cross-sectional view of the staple cartridge of FIG. 62;



FIG. 64 is a perspective view of an implanted staple cartridge in accordance with at least one alternative embodiment;



FIG. 65 is a cross-sectional view of the implanted staple cartridge of FIG. 64;



FIG. 66 is a perspective view of an alternative embodiment of a staple cartridge comprising deformable members extending from an outer layer of the staple cartridge;



FIG. 67 is a perspective view of an alternative embodiment of a staple cartridge comprising an outer layer of the staple cartridge being assembled to an inner layer;



FIG. 68 is a cross-sectional view of an alternative embodiment of a staple cartridge comprising a plurality of staples, a compressible layer, and a pledget layer;



FIG. 69 is a perspective view of the pledget layer of FIG. 68;



FIG. 70 is a perspective view of a pledget singulated from the pledget layer of FIG. 68 and a staple aligned with a groove in the pledget;



FIG. 71 is a perspective view of two connected pledgets from the pledget layer of FIG. 68;



FIG. 72 is a perspective view of a pledget support frame of the pledget layer of FIG. 68 being removed from the singulated pledgets;



FIG. 73 is an exploded perspective view of an alternative embodiment of a compressible staple cartridge comprising staples therein and a system for driving the staples against an anvil;



FIG. 73A is a partial cut-away view of an alternative embodiment of the staple cartridge of FIG. 73;



FIG. 74 is a cross-sectional view of the staple cartridge of FIG. 73;



FIG. 75 is an elevational view of a sled configured to traverse the staple cartridge of FIG. 73 and move the staples to toward the anvil;



FIG. 76 is a diagram of a staple driver which can be lifted toward the anvil by the sled of FIG. 75;



FIG. 77 is a break-away view of a staple cartridge in accordance with at least one alternative embodiment comprising staples positioned within staple drivers;



FIG. 78 is a cross-sectional view of the staple cartridge of FIG. 77 positioned within a staple cartridge channel;



FIG. 79 is a cross-sectional view of the staple cartridge of FIG. 77 illustrating an anvil moved into a closed position and staples contained within the staple cartridge deformed by the anvil;



FIG. 80 is a cross-sectional view of the staple cartridge of FIG. 77 illustrating the staples moved upwardly toward the anvil;



FIG. 81 is a perspective view of an alternative embodiment of a staple cartridge comprising straps connecting the flexible sides of the staple cartridge;



FIG. 82 is a perspective view of a sled and cutting member assembly;



FIG. 83 is a diagram of the sled and cutting member assembly of FIG. 82 being used to lift the staples of the staple cartridge of FIG. 77;



FIG. 84 is a diagram illustrating a sled configured to engage and lift staples toward an anvil and a lock-out system configured to selectively permit the sled to move distally;



FIGS. 85A-85C illustrate the progression of a staple being inserted into a staple crown;



FIG. 86 is a cross-sectional view of a staple cartridge comprising a support pan or retainer;



FIG. 87 is a partial cross-sectional view of a compressible staple cartridge in accordance with at least one alternative embodiment;



FIG. 88 is a diagram illustrating the staple cartridge of FIG. 87 in an implanted condition;



FIG. 89 is a partial cut-away view of a compressible staple cartridge in accordance with at least one alternative embodiment;



FIG. 90 is a partial cross-sectional view of the staple cartridge of FIG. 89;



FIG. 91 is a diagram illustrating the staple cartridge of FIG. 89 in an implanted condition;



FIG. 92 is a partial cross-sectional view of a crushable staple cartridge in accordance with at least one alternative embodiment;



FIG. 93 is a partial cut-away view of a collapsible staple cartridge in accordance with at least one embodiment comprising a plurality of collapsible elements;



FIG. 94 is a perspective view of a collapsible element of FIG. 93 in an uncollapsed state;



FIG. 95 is a perspective view of the collapsible element of FIG. 94 in a collapsed state;



FIG. 96A is a partial cross-sectional view of an end effector of a surgical stapling instrument comprising a jaw, a staple cartridge channel positioned opposite the jaw, and a staple cartridge positioned within the staple cartridge channel, wherein the jaw comprises a retention matrix attached thereto;



FIG. 96B is a partial cross-sectional view of the end effector of FIG. 96A illustrating the jaw being moved toward the staple cartridge channel, the staple cartridge being compressed by the anvil and the retention matrix, and a staple at least partially extending through tissue positioned intermediate the retention matrix and the staple cartridge;



FIG. 96C is a partial cross-sectional view of the end effector of FIG. 96A illustrating the jaw in a final position and the retention matrix engaged with the staple of FIG. 96B;



FIG. 96D is a partial cross-sectional view of the end effector of FIG. 96A illustrating the jaw and the staple cartridge channel being moved away from the implanted staple cartridge and retention matrix;



FIG. 97 is a perspective view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment comprising a plurality of retention members configured to engage a fastener leg extending therethrough;



FIG. 98 is a perspective view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment comprising six retention members;



FIG. 99 is a perspective view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment comprising eight retention members;



FIG. 100 is a perspective view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment comprising a plurality of retention members configured to engage a fastener leg extending therethrough;



FIG. 101 is a perspective view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment comprising six retention members;



FIG. 102 is a perspective view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment comprising eight retention members;



FIG. 103 is a perspective view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment comprising a plurality of retention members that have been stamped from a sheet of metal;



FIG. 104 is a perspective view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment comprising a plurality of apertures extending around the perimeter of the retention aperture;



FIG. 105 is a top view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment;



FIG. 106 is a top view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment;



FIG. 107 is a top view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment;



FIG. 108 is a top view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment;



FIG. 109 is a top view of a retention aperture of a retention matrix in accordance with at least one alternative embodiment;



FIG. 110 is a top view of a retention aperture of a retention matrix comprising a retention tab extending into the retention aperture in accordance with at least one embodiment;



FIG. 111 is a top view of a retention aperture of a retention matrix comprising a retention tab extending into the retention aperture in accordance with at least one alternative embodiment;



FIG. 112 is a perspective view of a fastening system comprising a plurality of staples, a retention matrix engaged with the staples, and an alignment matrix configured to align the staples;



FIG. 113 is a perspective view of the retention matrix of FIG. 112;



FIG. 114 is a perspective view of the alignment matrix of FIG. 112;



FIG. 115 is a partial top view of the retention matrix of FIG. 112 engaged with the staples of FIG. 112;



FIG. 116 is a partial bottom view of the retention matrix of FIG. 112 engaged with the staples of FIG. 112;



FIG. 117 is a partial elevational view of the fastening system of FIG. 112;



FIG. 118 is a partial perspective view of the fastening system of FIG. 112;



FIG. 119 is a partial cross-sectional view of the retention matrix of FIG. 112 engaged with the staples of FIG. 112;



FIG. 120 is a partial cross-sectional view of the fastening system of FIG. 112;



FIG. 121 is a perspective view of the fastening system of FIG. 112 further comprising protective caps assembled to the legs of the staples;



FIG. 122 is a bottom perspective view of the fastening system arrangement of FIG. 121;



FIG. 123 is a partial perspective view of the fastening system arrangement of FIG. 121;



FIG. 124 is a partial cross-sectional view of the fastening system arrangement of FIG. 121;



FIG. 125 is an elevational view of an end effector in accordance with at least one embodiment comprising a jaw in an open position, a retention matrix and a plurality of protective caps positioned in the jaw, and a staple cartridge positioned in a staple cartridge channel;



FIG. 126 is an elevational view of the end effector of FIG. 125 in a closed position;



FIG. 127 is an elevational view of the end effector of FIG. 125 in a fired position;



FIG. 128 is an elevational view of the retention matrix and protective caps of FIG. 125 assembled to the staple cartridge of FIG. 125;



FIG. 129 is a detail view of the arrangement of FIG. 128;



FIG. 130 is an elevational view of the end effector of FIG. 125 illustrating the jaw in an open position with thinner tissue positioned between the retention matrix and the staple cartridge;



FIG. 131 is an elevational view of the end effector of FIG. 125 illustrating the jaw in a closed position against the thinner tissue of FIG. 130;



FIG. 132 is an elevational view of the end effector of FIG. 125 illustrating the jaw in a fired position to capture the thinner tissue of FIG. 130 between the retention matrix and the staple cartridge;



FIG. 133 is an elevational view of the retention matrix and the protective caps of FIG. 125 assembled to the staple cartridge of FIG. 125 with the thin tissue of FIG. 130 positioned therebetween;



FIG. 134 is a detail view of the arrangement of FIG. 133;



FIG. 135 is a cross-sectional view of a protective cap positioned on the tip of a staple leg in accordance with at least one alternative embodiment;



FIG. 136 is a perspective view of a plurality of protective caps embedded within a sheet of material;



FIG. 137 is a perspective view of a jaw comprising a plurality of recesses configured to receive a plurality of protective caps therein;



FIG. 138 is a detail view of a portion of a jaw comprising a sheet covering the protective caps positioned within the jaw of FIG. 137;



FIG. 139 is a cross-sectional view of a protective cap positioned on a tip of a staple leg in accordance with at least one alternative embodiment wherein the protective cap comprises an interior forming surface;



FIG. 140 is another cross-sectional view of the protective cap of FIG. 139 illustrating the staple leg being deformed against the forming surface;



FIG. 141 is a top view of an alternative embodiment of a retention matrix comprising a plurality of connected matrix elements;



FIG. 142 is a top view of an alternative embodiment of a retention matrix comprising a plurality of connected matrix elements;



FIG. 143 is a top view of an alternative embodiment of a retention matrix comprising a plurality of connected matrix elements;



FIG. 144 is a top view of an alternative embodiment of an array of retention matrices comprising a plurality of connected matrix elements;



FIG. 145 is a top view of an alternative embodiment of a retention matrix comprising a plurality of connected matrix elements;



FIG. 146 is a partial exploded view of a jaw comprising a retention matrix including a compressible cover;



FIG. 147 is a detail view of the retention matrix of FIG. 146;



FIG. 148 is a partial cross-sectional view of a fastening system comprising a retention matrix including a compressible layer and a plurality of cells encapsulating one or more medicaments;



FIG. 149 is a diagram illustrating staple legs which have pierced the cells of FIG. 148 as they are being engaged with the retention matrix;



FIG. 150 is a partial cross-sectional view of a fastening system comprising a retention matrix including a compressible layer;



FIG. 151 is an elevational view of a fastener cartridge insertion assembly comprising a holder, a first fastener cartridge, and a second fastener cartridge;



FIG. 152 is an elevational view of an end effector of a surgical stapler comprising a first jaw and a second jaw, the second jaw being illustrated in an open configuration;



FIG. 153 is an elevational view of the end effector of FIG. 152 illustrating the second jaw in a closed configuration and the fastener cartridge insertion assembly of FIG. 151 being used to load the first jaw with the first cartridge and the second jaw with the second cartridge;



FIG. 154 is an elevational view of the loaded end effector of FIG. 153 illustrating the cartridge insertion assembly removed from the end effector, the second jaw in an open configuration once again, and tissue positioned intermediate the first jaw and the second jaw;



FIG. 155 is an elevational view of the loaded end effector of FIG. 154 in a fired configuration;



FIG. 156 is an elevational view of the first cartridge and the second cartridge in an implanted condition;



FIG. 157 is an elevational view of the end effector of FIG. 152 illustrating a portion of the first cartridge still engaged with the first jaw in accordance with at least one embodiment;



FIG. 158 is an elevational view of an alternative embodiment of a fastener cartridge insertion assembly comprising a holder, a first fastener cartridge, and a second fastener cartridge;



FIG. 159 is an elevational view of the fastener cartridge insertion assembly of FIG. 158 being used to load a first jaw of an end effector with the first cartridge and a second jaw with the second cartridge;



FIG. 160 is a cross-sectional view of the loaded end effector of FIG. 159;



FIG. 161 is a perspective view of a surgical stapler comprising a bottom jaw and a top jaw in accordance with at least one embodiment illustrated with portions of the surgical stapler removed;



FIG. 162 is a perspective view of the surgical stapler of FIG. 161 with the top jaw removed;



FIG. 163 is a perspective view of a slidable anvil system of the top jaw of the surgical stapler of FIG. 161 comprising a first slidable anvil and a second slidable anvil;



FIG. 164 is an end view of the slidable anvil system of FIG. 163;



FIG. 165 is a top view of the slidable anvil system of FIG. 163;



FIG. 166 is a diagram illustrating the slidable anvil system of FIG. 163 in an unfired condition;



FIG. 167 is a diagram illustrating the first slidable anvil of the slidable anvil system of FIG. 163 in an unfired position and staples positioned within the bottom jaw in an undeployed position;



FIG. 168 is a diagram illustrating the staples in the bottom jaw in a deployed configuration and the first slidable anvil of FIG. 167 being pulled proximally to deform a first group of staple legs of the staples;



FIG. 169 is a diagram illustrating the first group of staples of FIG. 168 deformed to a fully deformed state;



FIG. 170 is a diagram illustrating the second slidable anvil of the slidable anvil system of FIG. 163 being pushed distally to deform a second group of staple legs;



FIG. 171 is a partial perspective view of an anvil comprising a plurality of forming pockets in at least one embodiment;



FIG. 172 is a cross-sectional end view of the anvil of FIG. 171;



FIG. 173 is a diagram illustrating a first step in manufacturing the forming pockets of FIG. 171;



FIG. 174 is a diagram illustrating a second step in manufacturing the forming pockets of FIG. 171;



FIG. 175 is a top view of the forming pocket arrangement of the anvil of FIG. 171;



FIG. 176 is a diagram illustrating a first step of a manufacturing process for producing an anvil;



FIG. 177 is a diagram illustrating a second step in the manufacturing process of FIG. 176;



FIG. 178 is a diagram illustrating a third step in the manufacturing process of FIG. 176;



FIG. 179 is a left front perspective view of a surgical stapling and severing instrument with a handle portion including a link triggered automatic retraction and a ratcheting manual retraction mechanism;



FIG. 180 is a right aft perspective view of the surgical stapling and severing instrument of FIG. 179 with a portion of an elongate shaft cut away and a right half shell of a handle housing removed to expose an automatic end-of-firing travel retraction mechanism and a manual firing retraction mechanism;



FIG. 181 is a right aft perspective disassembled view of the handle portion and an elongate shaft of the surgical stapling and severing instrument of FIG. 179;



FIG. 182 is a right aft perspective view of the surgical stapling and severing instrument of FIG. 31 with a right half shell and outer portions of the implement portion removed to expose the closure and firing mechanisms in an initial state;



FIG. 183 is a right side view in elevation of the partially disassembled surgical stapling and severing instrument of FIG. 182;



FIG. 184 is a right aft perspective view of the partially disassembled surgical stapling and severing instrument of FIG. 182 with a closure mechanism closed and clamped and the side pawl firing mechanism completing a first stroke and with a manual retraction mechanism removed to expose a distal link of the linked rack that triggers automatic retraction of the firing mechanism;



FIG. 185 is a right aft perspective view of the partially disassembled surgical stapling and severing instrument of FIG. 183 with the side pawl firing mechanism disengaged and the distal link approaching automatic retraction;



FIG. 186 is left side view in elevation of the partially disassembled surgical stapling and severing instrument of FIG. 183 in an initial state of end effector open and anti-backup mechanism engaged;



FIG. 187 is a left side detail view of the right half shell and an anti-backup release lever of the handle portion of FIG. 186;



FIG. 188 is a left side detail view in elevation of the disassembled surgical stapling and severing instrument of FIG. 179 with the closure trigger clamped, the firing trigger performing a final stroke and the distal link positioned to trip automatic retraction;



FIG. 189 is a left side detail in elevation of the disassembled surgical stapling and severing instrument of FIG. 188 immediately after the distal link has actuated and locked forward the anti-backup release lever, allowing the linked rack to retract;



FIG. 190 is a right disassembled perspective view of the idler and aft gears and manual retraction lever and ratcheting pawl of a manual retraction mechanism of the surgical stapling and severing instrument of FIG. 179;



FIG. 191 is a right perspective view of the manual retraction mechanism of FIG. 190 with the manual retraction lever partially cut away to expose a smaller diameter ratchet gear on the aft gear engaging the ratcheting pawl;



FIG. 192 is a partially disassembled left side view in elevation of a surgical stapling and severing instrument of FIG. 179 with the anti-backup mechanism engaged to a fully fired linked rack that is disconnected from a combination tension/compression spring prior to actuation of the manual retraction lever of FIG. 190;



FIG. 193 is a partially disassembled left side view in elevation of the surgical stapling and severing instrument of FIG. 192 with hidden portions of the anti-backup release lever, aft gear, and manual firing release lever shown in phantom;



FIG. 194 is a partially disassembled left side view in elevation of the surgical stapling and severing instrument of FIG. 193 after actuation of the manual firing release lever has manually retracted the link rack;



FIG. 195 is a partially disassembled left side view in elevation of the surgical stapling and severing instrument of FIG. 194 with the linked rack omitted depicting the manual firing release lever disengaging the anti-backup mechanism;



FIG. 196 is a left side detail view of an alternative anti-backup release lever and handle housing for the surgical stapling and severing instrument of FIG. 179;



FIG. 197 is a left perspective disassembled view of the alternative anti-backup release lever, aft gear axle, and automatic retraction cam wheel of FIG. 196;



FIG. 198 is a right side view in elevation of the alternative anti-backup release mechanism of FIG. 196 with the linked rack in a retracted position and the anti-backup release lever proximally positioned with the anti-backup plate engaged to the firing rod;



FIG. 198A is a right detail side view in elevation of the aft gear, automatic retraction cam wheel and distal-most link of FIG. 198;



FIG. 199 is a right side view in elevation of the anti-backup release mechanism of FIG. 198 after a first firing stroke;



FIG. 199A is a right detail side view in elevation of the aft gear, automatic retraction cam wheel and a second link of FIG. 199;



FIG. 200 is a right side view in elevation of the anti-backup release mechanism of FIG. 199 after a second firing stroke;



FIG. 200A is a right detail side view in elevation of the aft gear, automatic retraction cam wheel and third link of FIG. 200;



FIG. 201 is a right detail side view in elevation of the anti-backup release mechanism of FIG. 200 after a third firing and final stroke;



FIG. 201A is a right detail side view in elevation of the aft gear, automatic retraction cam wheel and proximal-most fourth link of FIG. 201;



FIG. 202 is a right side view in elevation of the automatic release mechanism of FIG. 201 after a further firing stroke causes the automatic retraction cam wheel to distally slide and lock the anti-backup release lever, disengaging the anti-backup mechanism;



FIG. 203 is a left, front perspective view of an open staple applying assembly with a right half portion of a replaceable staple cartridge included in a staple channel;



FIG. 204 is an exploded perspective view of the staple applying assembly of FIG. 203 with a complete replaceable staple cartridge and an nonarticulating shaft configuration;



FIG. 205 is a perspective view of a two-piece knife and firing bar (“E-beam”) of the staple applying assembly of FIG. 203;



FIG. 206 is a perspective view of a wedge sled of a staple cartridge of a staple applying assembly;



FIG. 207 is a left side view in elevation taken in longitudinal cross section along a centerline line 207-207 of the staple applying assembly of FIG. 203;



FIG. 208 is a perspective view of the open staple applying assembly of FIG. 203 without the replaceable staple cartridge, a portion of the staple channel proximate to a middle pin of two-piece knife and firing bar, and without a distal portion of a staple channel;



FIG. 209 is a front view in elevation taken in cross section along line 209-209 of the staple applying assembly of FIG. 203 depicting internal staple drivers of the staple cartridge and portions of the two-piece knife and firing bar;



FIG. 210 is a left side view in elevation taken generally along the longitudinal axis of line 207-207 of a closed staple applying assembly of FIG. 203 to include center contact points between the two-piece knife and wedge sled but also laterally offset to show staples and staple drivers within the staple cartridge;



FIG. 211 is a left side detail view in elevation of the staple applying assembly of FIG. 210 with the two-piece knife retracted slightly more as typical for staple cartridge replacement;



FIG. 212 is a left side detail view in elevation of the staple applying assembly of FIG. 211 with the two-piece knife beginning to fire, corresponding to the configuration depicted in FIG. 210;



FIG. 213 is a left side cross-sectional view in elevation of the closed staple applying assembly of FIG. 210 after the two-piece knife and firing bar has distally fired;



FIG. 214 is a left side cross-sectional view in elevation of the closed staple applying assembly of FIG. 213 after firing of the staple cartridge and retraction of the two-piece knife;



FIG. 215 is a left side cross-sectional detail view in elevation of the staple applying assembly of FIG. 214 with the two-piece knife allowed to drop into a lockout position;



FIG. 216 is a perspective view of a staple cartridge comprising a rigid support portion and a compressible tissue thickness compensator for use with a surgical stapling instrument in accordance with at least one embodiment of the invention;



FIG. 217 is a partially exploded view of the staple cartridge of FIG. 216;



FIG. 218 is a fully exploded view of the staple cartridge of FIG. 216;



FIG. 219 is another exploded view of the staple cartridge of FIG. 216 without a warp covering the tissue thickness compensator;



FIG. 220 is a perspective view of a cartridge body, or support portion, of the staple cartridge of FIG. 216;



FIG. 221 is a top perspective view of a sled movable within the staple cartridge of FIG. 216 to deploy staples from the staple cartridge;



FIG. 222 is a bottom perspective view of the sled of FIG. 221;



FIG. 223 is an elevational view of the sled of FIG. 221;



FIG. 224 is a top perspective view of a driver configured to support one or more staples and to be lifted upwardly by the sled of FIG. 221 to eject the staples from the staple cartridge;



FIG. 225 is a bottom perspective view of the driver of FIG. 224;



FIG. 226 is a wrap configured to at least partially surround a compressible tissue thickness compensator of a staple cartridge;



FIG. 227 is a partial cut away view of a staple cartridge comprising a rigid support portion and a compressible tissue thickness compensator illustrated with staples being moved from an unfired position to a fired position during a first sequence;



FIG. 228 is an elevational view of the staple cartridge of FIG. 227;



FIG. 229 is a detail elevational view of the staple cartridge of FIG. 227;



FIG. 230 is a cross-sectional end view of the staple cartridge of FIG. 227;



FIG. 231 is a bottom view of the staple cartridge of FIG. 227;



FIG. 232 is a detail bottom view of the staple cartridge of FIG. 227;



FIG. 233 is a longitudinal cross-sectional view of an anvil in a closed position and a staple cartridge comprising a rigid support portion and a compressible tissue thickness compensator illustrated with staples being moved from an unfired position to a fired position during a first sequence;



FIG. 234 is another cross-sectional view of the anvil and the staple cartridge of FIG. 233 illustrating the anvil in an open position after the firing sequence has been completed;



FIG. 235 is a partial detail view of the staple cartridge of FIG. 233 illustrating the staples in an unfired position;



FIG. 236 is a cross-sectional elevational view of a staple cartridge comprising a rigid support portion and a compressible tissue thickness compensator illustrating the staples in an unfired position;



FIG. 237 is a detail view of the staple cartridge of FIG. 236;



FIG. 238 is an elevational view of an anvil in an open position and a staple cartridge comprising a rigid support portion and a compressible tissue thickness compensator illustrating the staples in an unfired position;



FIG. 239 is an elevational view of an anvil in a closed position and a staple cartridge comprising a rigid support portion and a compressible tissue thickness compensator illustrating the staples in an unfired position and tissue captured between the anvil and the tissue thickness compensator;



FIG. 240 is a detail view of the anvil and staple cartridge of FIG. 239;



FIG. 241 is an elevational view of an anvil in a closed position and a staple cartridge comprising a rigid support portion and a compressible tissue thickness compensator illustrating the staples in an unfired position illustrating thicker tissue positioned between the anvil and the staple cartridge;



FIG. 242 is a detail view of the anvil and staple cartridge of FIG. 241;



FIG. 243 is an elevational view of the anvil and staple cartridge of FIG. 241 illustrating tissue having different thicknesses positioned between the anvil and the staple cartridge;



FIG. 244 is a detail view of the anvil and staple cartridge of FIG. 241 as illustrated in FIG. 243;



FIG. 245 is a diagram illustrating a tissue thickness compensator which is compensating for different tissue thickness captured within different staples;



FIG. 246 is a diagram illustrating a tissue thickness compensator applying a compressive pressure to one or more vessels that have been transected by a staple line;



FIG. 247 is a diagram illustrating a circumstance wherein one or more staples have been improperly formed;



FIG. 248 is a diagram illustrating a tissue thickness compensator which could compensate for improperly formed staples;



FIG. 249 is a diagram illustrating a tissue thickness compensator positioned in a region of tissue in which multiple staples lines have intersected;



FIG. 250 is a diagram illustrating tissue captured within a staple;



FIG. 251 is a diagram illustrating tissue and a tissue thickness compensator captured within a staple;



FIG. 252 is a diagram illustrating tissue captured within a staple;



FIG. 253 is a diagram illustrating thick tissue and a tissue thickness compensator captured within a staple;



FIG. 254 is a diagram illustrating thin tissue and a tissue thickness compensator captured within a staple;



FIG. 255 is a diagram illustrating tissue having an intermediate thickness and a tissue thickness compensator captured within a staple;



FIG. 256 is a diagram illustrating tissue having another intermediate thickness and a tissue thickness compensator captured within a staple;



FIG. 257 is a diagram illustrating thick tissue and a tissue thickness compensator captured within a staple;



FIG. 258 is a partial cross-sectional view of an end effector of a surgical stapling instrument illustrating a firing bar and staple-firing sled in a retracted, unfired position;



FIG. 259 is another partial cross-sectional view of the end effector of FIG. 258 illustrating the firing bar and the staple-firing sled in a partially advanced position;



FIG. 260 is a cross-sectional view of the end effector of FIG. 258 illustrating the firing bar in a fully advanced, or fired, position;



FIG. 261 is a cross-sectional view of the end effector of FIG. 258 illustrating the firing bar in a retracted position after being fired and the staple-firing sled left in its fully fired position;



FIG. 262 is a detail view of the firing bar in the retracted position of FIG. 261;



FIG. 263 is a partial cross-sectional view of an end effector of a surgical stapling instrument including a staple cartridge comprising a tissue thickness compensator and staples at least partially positioned therein;



FIG. 264 is another partial cross-sectional view of the end effector of FIG. 263 illustrating the staples at least partially moved and/or rotated relative to an anvil positioned opposite the staple cartridge;



FIG. 265 is a partial cross-sectional view of an end effector of a surgical stapling instrument in accordance with at least one embodiment;



FIG. 266 is a partial cross-sectional view of an end effector in accordance with at least one alternative embodiment;



FIG. 267 is a partial cross-sectional view of an end effector in accordance with another alternative embodiment;



FIG. 268 is a perspective view of an end effector of a surgical stapling instrument in accordance with at least one embodiment;



FIG. 269 is a partial cross-sectional view of the end effector of FIG. 268 illustrated in a flexed condition;



FIG. 270 is a partial cross-sectional view of the end effector of FIG. 269 in a released condition;



FIG. 271 is a perspective view of an end effector comprising a tissue thickness compensator sock;



FIG. 272 is a rear perspective of the tissue thickness compensator sock in FIG. 271;



FIG. 273 is a perspective view of an end effector comprising a plurality of rails extending from a support portion and a tissue thickness compensator having a longitudinal cavity defined therein;



FIG. 274 is a perspective view of the tissue thickness compensator of FIG. 273;



FIG. 275 is a perspective view of an end effector comprising a plurality of teeth extending from a support portion and a tissue thickness compensator engaged therewith;



FIG. 276 is a perspective view of an anvil comprising a pocket array in accordance with at least one embodiment;



FIG. 277 is a partial detail view of the anvil of FIG. 276;



FIG. 278 is a partial longitudinal cross-sectional view of the anvil of FIG. 276;



FIG. 279 is a transverse cross-sectional view of the anvil of FIG. 276;



FIG. 280 is an elevational view of a fired staple comprising a substantially B-shaped configuration;



FIG. 281 is an elevational view of a fired staple comprising one leg deformed inwardly and one leg deformed outwardly;



FIG. 282 is an elevational view of a fired staple comprising both legs formed outwardly;



FIG. 283 is a partial perspective view of a support portion of a staple cartridge comprising detachable and/or displaceable staple leg guides;



FIG. 284 is a partial cross-sectional view of the staple cartridge of FIG. 283 illustrating staples being deployed from the staple cartridge;



FIG. 285 is a detail view of the cross-sectional view of FIG. 284 after the staple cartridge has been fired;



FIG. 286 is an exploded view of a staple cartridge including a tissue thickness compensator comprising voids defined therein;



FIG. 287 is a diagram illustrating the tissue thickness compensator of FIG. 286 implanted against tissue;



FIG. 288 is another diagram illustrating the tissue thickness compensator of FIG. 286 implanted against tissue;



FIG. 289 is a cross-sectional perspective view of a staple cartridge comprising lateral retention members extending from a support portion thereof configured to hold a tissue thickness compensator in position;



FIG. 290 is a cross-sectional view of the staple cartridge of FIG. 289 being utilized to staple tissue;



FIG. 291 is another cross-sectional view of the staple cartridge of FIG. 289 illustrating the support portion being moved away from the implanted tissue thickness compensator;



FIG. 292 is a cross-sectional perspective view of a staple cartridge comprising lateral retention members configured to hold a tissue thickness compensator to a support portion;



FIG. 293 is a cross-sectional view of the staple cartridge of FIG. 292 being utilized to staple tissue;



FIG. 294 is another cross-sectional view of the staple cartridge of FIG. 292 illustrating the support portion being moved away from the implanted tissue thickness compensator;



FIG. 295 is a cross-sectional detail view of a retainer holding a tissue thickness compensator to a support portion of a staple cartridge in accordance with at least one embodiment;



FIG. 296 is partial cut-away view of a staple cartridge comprising staple drivers having different heights in accordance with at least one embodiment;



FIG. 296A is a diagram illustrating the staple drivers of FIG. 296 and staples having different unfired heights supported thereon;



FIG. 297 is a diagram illustrating a tissue thickness compensator comprising a varying thickness, staple drivers having different heights, and staples having different unformed heights;



FIG. 298 is a diagram illustrating the staples and the tissue thickness compensator of FIG. 297 implanted to tissue;



FIG. 299 is a partial cross-sectional view of a staple cartridge comprising a tissue thickness compensator comprising a varying thickness in accordance with at least one embodiment;



FIG. 300 is a cross-sectional view of an end effector of a surgical stapling instrument in an open configuration;



FIG. 301 is cross-sectional view of the end effector of FIG. 300 illustrated in a partially-fired configuration;



FIG. 302 is a cross-sectional view of the end effector of FIG. 300 illustrated in a re-opened configuration;



FIG. 303 is a cross-sectional view of an end effector of a surgical stapling instrument comprising staple drivers having different heights and a contoured deck surface in accordance with at least one embodiment;



FIG. 304 is a cross-sectional view of an end effector of a surgical stapling instrument comprising staple drivers having different heights and a stepped deck surface in accordance with at least one embodiment;



FIG. 305 is a perspective view of a staple cartridge being loaded into an effector of a surgical stapling instrument utilizing a staple cartridge applicator;



FIG. 306 is a bottom perspective view of the staple cartridge applicator of FIG. 305;



FIG. 307 is a side view of the staple cartridge applicator of FIG. 305 assembled to a staple cartridge;



FIG. 308 is a cross-sectional view of the assembly of FIG. 307;



FIG. 309 is a perspective view of a staple cartridge applicator assembly further including an upper tissue thickness compensator positioned on the top surface of the staple cartridge applicator in accordance with at least one embodiment;



FIG. 310 is an exploded view of the upper tissue thickness compensator and the staple cartridge applicator of FIG. 309;



FIG. 310A is an exploded view of a staple cartridge applicator assembly comprising a pull member configured to detach an upper tissue thickness compensator adhered to the staple cartridge applicator;



FIG. 311 is a partial exploded view of a staple cartridge applicator assembly in accordance with at least one alternative embodiment;



FIG. 312 is a perspective view of a staple cartridge applicator assembly comprising an upper tissue thickness compensator including a plurality of retention features extending therefrom and a staple cartridge comprising a lower tissue thickness compensator;



FIG. 313 is an elevational view of the staple cartridge applicator assembly of FIG. 312 positioned within a staple cartridge channel and an anvil being closed onto the staple cartridge applicator assembly;



FIG. 314 is an elevational view of the anvil of FIG. 313 in a re-opened position and the staple cartridge applicator of FIG. 312 being removed from the end effector;



FIG. 314A is a cross-sectional view of tissue positioned intermediate the upper tissue thickness compensator and the lower tissue thickness compensator of FIG. 312;



FIG. 314B is a cross-sectional view illustrating the upper tissue thickness compensator and the lower tissue thickness compensator stapled to the tissue and severed by a cutting member;



FIG. 315 is a diagram illustrating a tissue thickness compensator being inserted into an anvil in accordance with at least one embodiment;



FIG. 316 is a cross-sectional view of the tissue thickness compensator of FIG. 315;



FIG. 317 is an exploded view of a tissue thickness compensator and an anvil in accordance with at least one alternative embodiment;



FIG. 318 is a perspective view of staple cartridge applicator assembly comprising an upper tissue thickness compensator configured to be attached to an anvil in accordance with at least one embodiment;



FIG. 319 is an elevational view of the staple cartridge applicator assembly of FIG. 318 positioned within a staple cartridge channel and an anvil being moved toward the upper tissue thickness compensator;



FIG. 320 illustrates the staple cartridge applicator of FIG. 318 being removed from the end effector after the upper tissue thickness compensator has been engaged with the anvil;



FIG. 321 is a cross-sectional end view of the anvil being moved toward the upper tissue thickness compensator of FIG. 318;



FIG. 322 is a cross-sectional end view of the anvil engaged with the upper tissue thickness compensator;



FIG. 323 is a cross-sectional view of an end effector of a surgical stapling instrument comprising a staple cartridge including a segmentable tissue thickness compensator attached to a support portion of the staple cartridge by a plurality of fasteners;



FIG. 324 is a cross-sectional view of the end effector of FIG. 323 illustrating a firing member in a partially-fired position;



FIG. 325 is a cross-sectional view of the end effector of FIG. 323 illustrating the support portion being moved away from the partially-implanted tissue thickness compensator;



FIG. 326 is a partial perspective view of the support portion of FIG. 323;



FIG. 327 is a perspective view of a staple-deploying sled in accordance with at least one embodiment;



FIG. 328 is an elevational view of the sled of FIG. 327;



FIG. 329 is a perspective view of an end effector of a surgical stapling instrument comprising a staple cartridge including a tissue thickness compensator and a plurality of staple guides positioned on the tissue thickness compensator;



FIG. 330 is a partial cross-sectional view of the tissue thickness compensator and the staple guides of FIG. 329 in an unfired configuration;



FIG. 331 is a partial cross-sectional view of the tissue thickness compensator and the staple guides of FIG. 329 in a fired configuration;



FIG. 332 is a cross-sectional view of a staple cartridge comprising a tissue thickness compensator and a support portion in accordance with at least one embodiment;



FIG. 333 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position;



FIG. 334 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position in accordance with at least one alternative embodiment;



FIG. 335 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position in accordance with at least one alternative embodiment;



FIG. 336 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position in accordance with at least one alternative embodiment;



FIG. 337 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position in accordance with at least one alternative embodiment;



FIG. 338 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position in accordance with at least one alternative embodiment;



FIG. 339 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position in accordance with at least one alternative embodiment;



FIG. 340 is a detail view of a region surrounding a tip of the staple of FIG. 339;



FIG. 341 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position in accordance with at least one alternative embodiment;



FIG. 342 is a detail view of a region surrounding a tip of the staple of FIG. 341;



FIG. 343 is a partial cross-sectional view of a tissue thickness compensator, a staple guide layer, and a staple in an unfired position in accordance with at least one alternative embodiment;



FIG. 344 is a perspective view of a staple guide layer and a plurality of staples in an unfired position in accordance with at least one alternative embodiment;



FIG. 345 is an end view of a tissue thickness compensator configured to be used with a circular surgical stapler;



FIG. 346 is a perspective view of the tissue thickness compensator and the circular surgical stapler of FIG. 345;



FIG. 347 is an end view of a tissue thickness compensator configured to be used with a circular surgical stapler in accordance with at least one alternative embodiment;



FIG. 348 is a perspective view of the tissue thickness compensator and the circular surgical stapler of FIG. 347;



FIG. 349 is an end view of a tissue thickness compensator configured to be used with a circular surgical stapler;



FIG. 350 is an end view of the tissue thickness compensator of FIG. 349 in a partially expanded configuration;



FIG. 351 is an elevational view of a surgical stapling instrument comprising a staple cartridge in accordance with at least one embodiment;



FIG. 352 is an end view of the surgical stapling instrument of FIG. 351 positioned relative to tissue;



FIG. 353 is an end view of the surgical stapling instrument of FIG. 351 further comprising a tissue thickness compensator positioned between the staple cartridge and the tissue;



FIG. 354 is a partial perspective view of staples deployed into tissue from the surgical stapling instrument of FIG. 351 without a tissue thickness compensator;



FIG. 355 is a partial perspective view of staples deployed into tissue from the surgical stapling instrument of FIG. 351 with a tissue thickness compensator;



FIG. 356 is a partial cross-sectional view of the end effector of the surgical stapling instrument of FIG. 351 comprising an anvil plate in a first position;



FIG. 357 is a partial cross-sectional view of the end effector of the surgical stapling instrument of FIG. 351 illustrating the anvil plate of FIG. 356 in a second position;



FIG. 358 is a cross-sectional view of an end effector of a surgical stapling instrument comprising a staple cartridge including a gap setting element;



FIG. 359 is a perspective view illustrating a firing member cutting the gap setting element of FIG. 358 at the end of firing stroke of the firing member;



FIG. 360 is a cross-sectional view of an end effector of a surgical stapling instrument comprising a staple cartridge including a flexible nose;



FIG. 361 is a cross-sectional view of the end effector of FIG. 360 illustrating the nose in a flexed configuration;



FIG. 362 is a cross-sectional view of an end effector of a surgical stapling instrument comprising a staple cartridge including a slidable portion;



FIG. 363 is a cross-sectional view of the end effector of FIG. 362 illustrating the slidable portion slid distally;



FIG. 364 is a cross-sectional view of an end effector of a surgical stapling instrument comprising a support portion comprising an inclined deck surface and a tissue thickness compensator comprising a varying thickness;



FIG. 365 is a cross-sectional view of an end effector of a surgical stapling instrument comprising a support portion comprising an inclined deck surface and a tissue thickness compensator comprising a uniform thickness;



FIG. 366 is a perspective view of a staple cartridge comprising a tissue thickness compensator having a varying thickness;



FIG. 367 is an end view of the staple cartridge of FIG. 366;



FIG. 368 is a cross-sectional perspective view of a tissue thickness compensator comprising longitudinal layers;



FIG. 369 is a cross-sectional perspective view of a tissue thickness compensator comprising a plurality of layers in accordance with at least one alternative embodiment;



FIG. 370 is a perspective view of a disposable loading unit comprising retention members configured to releasably hold a tissue thickness compensator thereto;



FIG. 371 is a perspective view of a tissue thickness compensator including retention members configured to releasably hold the tissue thickness compensator to a disposable loading unit;



FIG. 372 is a perspective view of the tissue thickness compensator of FIG. 371 attached to a disposable loading unit;



FIG. 373 is an end view of the disposable loading unit of FIG. 372;



FIG. 374 is a perspective view of a tissue thickness compensator including retention members configured to releasably hold the tissue thickness compensator to a disposable loading unit;



FIG. 375 is a perspective view of the tissue thickness compensator of FIG. 374 attached to a disposable loading unit;



FIG. 376 is an end view of the disposable loading unit of FIG. 375;



FIG. 377 is a perspective view of a tissue thickness compensator including a retention member configured to releasably hold the tissue thickness compensator to a disposable loading unit;



FIG. 378 is a perspective view of the tissue thickness compensator of FIG. 377 attached to a disposable loading unit;



FIG. 379 is a perspective view of a tissue thickness compensator applicator positioned within an effector of a disposable loading unit;



FIG. 380 is a top perspective view of the tissue thickness compensator applicator of FIG. 379;



FIG. 381 is a bottom perspective view of the tissue thickness compensator applicator of FIG. 379;



FIG. 382 is a perspective view of a tissue thickness compensator applicator positioned within an effector of a disposable loading unit in accordance with at least one alternative embodiment;



FIG. 383 is a top perspective view of the tissue thickness compensator applicator of FIG. 382;



FIG. 384 is a bottom perspective view of the tissue thickness compensator applicator of FIG. 382;



FIG. 385 is an elevational view of a disposable loading unit including a pivotable jaw configured to support a staple cartridge;



FIG. 386 is a cross-sectional view of a staple cartridge comprising a tissue thickness compensator attached to a support portion of the staple cartridge in accordance with at least one embodiment;



FIG. 387 is a cross-sectional view of a staple cartridge comprising a tissue thickness compensator attached to a support portion of the staple cartridge in accordance with at least one embodiment;



FIG. 388 is a cross-sectional view of a staple cartridge comprising a tissue thickness compensator attached to a support portion of the staple cartridge in accordance with at least one embodiment;



FIG. 389 is a perspective view of the tissue thickness compensator of FIG. 387;



FIG. 390 is a perspective view of a circular surgical stapling device;



FIG. 391 is a cross-sectional view of a circular surgical stapling device with a tissue thickness compensator embodiment supported between a proximal colon portion and a distal colon portion;



FIG. 392 is an enlarged cross-sectional view of the circular surgical stapling device depicted in FIG. 391 in a clamped orientation;



FIG. 393 is another enlarged cross-sectional view of the circular surgical stapling device of FIGS. 391 and 392 after being fired;



FIG. 394 is an enlarged cross-sectional view of a circular stapler anvil with a tissue thickness compensator embodiment attached thereto;



FIG. 395 is a cross-sectional view of a portion of tissue with a tissue thickness compensator embodiment stapled thereto;



FIG. 396 is a cross-sectional view of a circular surgical stapling device with another tissue thickness compensator embodiment supported between a proximal colon portion and a distal colon portion;



FIG. 397 is an enlarged cross-sectional view of the circular surgical stapling device depicted in FIG. 396 in a clamped orientation;



FIG. 398 is a cross-sectional view of a circular surgical stapling device with another tissue thickness compensator embodiment supported between a proximal colon portion and a distal colon portion;



FIG. 399 is an enlarged cross-sectional view of the circular surgical stapling device depicted in FIG. 398 in a clamped orientation;



FIG. 400 is a partial exploded perspective view of a circular surgical stapling device and anvil with another tissue thickness compensator embodiment;



FIG. 401 is a top view of a tissue thickness compensator embodiment;



FIG. 402 is a top view of another tissue thickness compensator embodiment;



FIG. 403 is a cross-sectional exploded view of a circular surgical stapling device and the tissue thickness compensator of FIG. 403;



FIG. 404 is a cross-sectional exploded view of the circular surgical stapling device and the tissue thickness compensator of FIG. 403 inserted into the proximal and distal portions of a colon;



FIG. 405 is another cross-sectional exploded view of the circular surgical stapling device and the tissue thickness compensator of FIGS. 403 and 404 inserted into the proximal and distal portions of a colon;



FIG. 406 is another cross-sectional exploded view of the circular surgical stapling device and the tissue thickness compensator of FIGS. 403-405 inserted into the proximal and distal portions of a colon wherein the stapling device is in a clamped orientation;



FIG. 407 is another cross-sectional exploded view of the circular surgical stapling device and the tissue thickness compensator of FIGS. 403-406 inserted into the proximal and distal portions of a colon after the stapling device has been fired;



FIG. 408 is a partial cross-sectional view of the proximal and distal portions of the colon after being stapled;



FIG. 409 is another partial cross-sectional view of the proximal and distal portions of the colon after one staple line has sloughed off into the colon;



FIG. 410 is another partial cross-sectional view of the proximal and distal portions of the colon after the other staple line has sloughed off into the colon;



FIG. 411 is a top view of a tissue thickness compensator embodiment;



FIG. 412 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 411 taken along line 412-412 in FIG. 411;



FIG. 413 is a top view of another tissue thickness compensator embodiment;



FIG. 414 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 413 taken along line 414-414 in FIG. 413;



FIG. 415 is a partial cross-sectional view of the proximal and distal portions of the colon after being stapled;



FIG. 416 is another partial cross-sectional view of the proximal and distal portions of the colon after being stapled;



FIG. 417 is another partial cross-sectional view of the proximal and distal portions of the colon after one staple line has sloughed off into the colon;



FIG. 418 is another partial cross-sectional view of the proximal and distal portions of the colon after the other staple line has sloughed off into the colon;



FIG. 419 is a partial cross-sectional view of a circular surgical stapling device inserted into the proximal and distal portions of the colon wherein three tissue thickness compensator embodiments are supported on the device;



FIG. 420 is a top view of another tissue thickness compensator embodiment;



FIG. 421 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 420 taken along line 421-421 in FIG. 420;



FIG. 422 is a top view of another tissue thickness compensator embodiment;



FIG. 423 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 422 taken along line 423-423 in FIG. 422;



FIG. 424 is a top view of another tissue thickness compensator embodiment;



FIG. 425 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 424 taken along line 425-425 in FIG. 424;



FIG. 426 is a top view of another tissue thickness compensator embodiment;



FIG. 427 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 426 taken along line 427-427 in FIG. 426;



FIG. 428 is a top view of another tissue thickness compensator embodiment;



FIG. 429 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 428 taken along line 429-429 in FIG. 428;



FIG. 430 is a partial cross-sectional view of the proximal and distal portions of the colon after being stapled;



FIG. 431 is another partial cross-sectional view of the proximal and distal portions of the colon after being stapled;



FIG. 432 is another partial cross-sectional view of the proximal and distal portions of the colon after one staple line has sloughed off into the colon;



FIG. 433 is another partial cross-sectional view of the proximal and distal portions of the colon after the other staple line has sloughed off into the colon;



FIG. 434 is a top view of another tissue thickness compensator embodiment;



FIG. 435 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 434 taken along line 435-435 in FIG. 434;



FIG. 436 is a partial cross-sectional view of the proximal and distal portions of the colon after being stapled with the tissue thickness compensator of FIGS. 434 and 435;



FIG. 437 is a top view of another tissue thickness compensator embodiment;



FIG. 438 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 437 taken along line 438-438 in FIG. 437;



FIG. 439 is a top view of another tissue thickness compensator embodiment;



FIG. 440 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 439 taken along line 440-440 in FIG. 439;



FIG. 441 is a top view of another tissue thickness compensator embodiment;



FIG. 442 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 441 taken along line 442-442 in FIG. 441;



FIG. 443 is a top view of another tissue thickness compensator embodiment;



FIG. 444 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIG. 443 taken along line 444-444 in FIG. 443;



FIG. 445 is a top view of another tissue thickness compensator embodiment;



FIG. 446 is a perspective view of the tissue thickness compensator of FIG. 445;



FIG. 447 is a bottom view of the tissue thickness compensator of FIGS. 445 and 446;



FIG. 448 is a partial cross-sectional view of the tissue thickness compensator embodiment of FIGS. 445-447 taken along line 448-448 in FIG. 445;



FIG. 449 is a partial top view of one bioabsorbable material arrangement;



FIG. 450 is a partial top view of another bioabsorbable material arrangement;



FIG. 451 is a partial top view of another bioabsorbable material arrangement;



FIG. 452 is a partial perspective view of another tissue thickness compensator embodiment;



FIG. 453 is a side view of the tissue thickness compensator of FIG. 452;



FIG. 454 is another partial perspective view of another tissue thickness compensator embodiment;



FIG. 455 illustrates alternate fin arrangements that may be employed in the tissue thickness embodiment depicted in FIGS. 452-454;



FIG. 456 is a partial cross-sectional view of a circular surgical stapling device inserted into the proximal and distal portions of the colon wherein the tissue thickness compensator embodiment of FIGS. 452-454 is supported on the device;



FIG. 457 is another partial cross-sectional view of a circular surgical stapling device of FIG. 455 after being fired;



FIG. 458 is a perspective view of a portion of another tissue thickness compensator embodiment;



FIG. 459 is a side view of the tissue thickness compensator of FIG. 458;



FIG. 460 is a partial cross-sectional view of a circular surgical stapling device inserted into the proximal and distal portions of the colon wherein the tissue thickness compensator embodiment of FIGS. 458 and 459 is supported on the device;



FIG. 461 is another partial cross-sectional view of a circular surgical stapling device of FIG. 460 after being fired;



FIG. 462 is a top view of a bioabsorbable material arrangement;



FIG. 463 is a partial cross-sectional view of a distal colon portion and a proximal colon portion being stapled with a tissue thickness compensator comprising the material composition of FIG. 462;



FIG. 464 is a partial enlarged view showing the tissue thickness compensator and colon tissue of FIG. 463;



FIG. 465 is another partial enlarged view showing the tissue thickness compensator and colon tissue of FIG. 463;



FIG. 466 is another partial cross-sectional showing the tissue thickness compensator and colon portions of tissue of FIG. 463;



FIG. 467 is a partial cross-sectional view of a distal colon portion and a proximal colon portion being stapled with another tissue thickness compensator embodiment;



FIG. 468 is a partial cross-sectional view of a distal colon portion and a proximal colon portion being stapled with another tissue thickness compensator embodiment;



FIG. 469 is an enlarged view of the material comprising the tissue thickness compensator of FIG. 468;



FIG. 470 is a top view of a tissue thickness compensator embodiment;



FIG. 471 is a cross-sectional side view of the tissue thickness compensator embodiment of FIG. 470;



FIG. 472 is a top view of a circular stapler introducer embodiment with a portion thereof cutaway for clarity;



FIG. 473 is a side view of the circular stapler introducer embodiment of FIG. 472;



FIG. 474 is a side view of a circular stapler being inserted into the circular stapler introducer of FIGS. 472 and 473;



FIG. 475 is a partial cross-sectional view of the distal end of the circular stapler introducer embodiment illustrating the seating of the circular stapler head therein;



FIG. 476 is another partial cross-sectional view of the distal end of the circular stapler introducer after the circular stapler head has been seated therein;



FIG. 477 is another partial cross-sectional view of the distal end of the circular stapler introducer with a portion of the circular stapler head shown in cross-section; and



FIG. 478 is another partial cross-sectional view of the distal end of the circular stapler introducer with the circular stapler head advanced through the distal end portion of the introducer.





Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate certain embodiments of the invention, in one form, and such exemplifications are not to be construed as limiting the scope of the invention in any manner.


DETAILED DESCRIPTION

The Applicant of the present application also owns the U.S. Patent Applications identified below which are each herein incorporated by reference in their respective entirety:


U.S. patent application Ser. No. 12/894,311, entitled SURGICAL INSTRUMENTS WITH RECONFIGURABLE SHAFT SEGMENTS, now U.S. Pat. No. 8,763,877;


U.S. patent application Ser. No. 12/894,340, entitled SURGICAL STAPLE CARTRIDGES SUPPORTING NON-LINEARLY ARRANGED STAPLES AND SURGICAL STAPLING INSTRUMENTS WITH COMMON STAPLE-FORMING POCKETS, now U.S. Pat. No. 8,899,463;


U.S. patent application Ser. No. 12/894,327, entitled JAW CLOSURE ARRANGEMENTS FOR SURGICAL INSTRUMENTS, now U.S. Pat. No. 8,978,956;


U.S. patent application Ser. No. 12/894,351, entitled SURGICAL CUTTING AND FASTENING INSTRUMENTS WITH SEPARATE AND DISTINCT FASTENER DEPLOYMENT AND TISSUE CUTTING SYSTEMS, now U.S. Pat. No. 9,113,864;


U.S. patent application Ser. No. 12/894,338, entitled IMPLANTABLE FASTENER CARTRIDGE HAVING A NON-UNIFORM ARRANGEMENT, now U.S. Pat. No. 8,864,007;


U.S. patent application Ser. No. 12/894,369, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING A SUPPORT RETAINER, now U.S. Patent Application Publication No. 2012/0080344;


U.S. patent application Ser. No. 12/894,312, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING MULTIPLE LAYERS, now U.S. Pat. No. 8,925,782;


U.S. patent application Ser. No. 12/894,377, entitled SELECTIVELY ORIENTABLE IMPLANTABLE FASTENER CARTRIDGE, now U.S. Pat. No. 8,393,514;


U.S. patent application Ser. No. 12/894,339, entitled SURGICAL STAPLING INSTRUMENT WITH COMPACT ARTICULATION CONTROL ARRANGEMENT, now U.S. Pat. No. 8,840,003;


U.S. patent application Ser. No. 12/894,360, entitled SURGICAL STAPLING INSTRUMENT WITH A VARIABLE STAPLE FORMING SYSTEM, now U.S. Pat. No. 9,113,862;


U.S. patent application Ser. No. 12/894,322, entitled SURGICAL STAPLING INSTRUMENT WITH INTERCHANGEABLE STAPLE CARTRIDGE ARRANGEMENTS, now U.S. Pat. No. 8,740,034;


U.S. patent application Ser. No. 12/894,350, entitled SURGICAL STAPLE CARTRIDGES WITH DETACHABLE SUPPORT STRUCTURES AND SURGICAL STAPLING INSTRUMENTS WITH SYSTEMS FOR PREVENTING ACTUATION MOTIONS WHEN A CARTRIDGE IS NOT PRESENT, now U.S. Patent Application Publication No. 2012/0080478;


U.S. patent application Ser. No. 12/894,383, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING BIOABSORBABLE LAYERS, now U.S. Pat. No. 8,752,699;


U.S. patent application Ser. No. 12/894,389, entitled COMPRESSIBLE FASTENER CARTRIDGE, now U.S. Pat. No. 8,740,037;


U.S. patent application Ser. No. 12/894,345, entitled FASTENERS SUPPORTED BY A FASTENER CARTRIDGE SUPPORT, now U.S. Pat. No. 8,783,542;


U.S. patent application Ser. No. 12/894,306, entitled COLLAPSIBLE FASTENER CARTRIDGE, now U.S. Pat. No. 9,044,227;


U.S. patent application Ser. No. 12/894,318, entitled FASTENER SYSTEM COMPRISING A PLURALITY OF CONNECTED RETENTION MATRIX ELEMENTS, now U.S. Pat. No. 8,814,024;


U.S. patent application Ser. No. 12/894,330, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX AND AN ALIGNMENT MATRIX, now U.S. Pat. No. 8,757,465;


U.S. patent application Ser. No. 12/894,361, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX, now U.S. Pat. No. 8,529,600;


U.S. patent application Ser. No. 12/894,367, entitled FASTENING INSTRUMENT FOR DEPLOYING A FASTENER SYSTEM COMPRISING A RETENTION MATRIX, now U.S. Pat. No. 9,033,203;


U.S. patent application Ser. No. 12/894,388, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX AND A COVER, now U.S. Pat. No. 8,474,677;


U.S. patent application Ser. No. 12/894,376, entitled FASTENER SYSTEM COMPRISING A PLURALITY OF FASTENER CARTRIDGES, now U.S. Pat. No. 9,044,228;


U.S. patent application Ser. No. 13/097,865, entitled SURGICAL STAPLER ANVIL COMPRISING A PLURALITY OF FORMING POCKETS, now U.S. Pat. No. 9,295,464;


U.S. patent application Ser. No. 13/097,936, entitled TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER, now U.S. Pat. No. 8,657,176;


U.S. patent application Ser. No. 13/097,954, entitled STAPLE CARTRIDGE COMPRISING A VARIABLE THICKNESS COMPRESSIBLE PORTION, now U.S. Patent Application Publication No. 2012/0080340;


U.S. patent application Ser. No. 13/097,856, entitled STAPLE CARTRIDGE COMPRISING STAPLES POSITIONED WITHIN A COMPRESSIBLE PORTION THEREOF, now U.S. Patent Application Publication No. 2012/0080336;


U.S. patent application Ser. No. 13/097,928, entitled TISSUE THICKNESS COMPENSATOR COMPRISING DETACHABLE PORTIONS, now U.S. Pat. No. 8,746,535;


U.S. patent application Ser. No. 13/097,891, entitled TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER COMPRISING AN ADJUSTABLE ANVIL, now U.S. Pat. No. 8,864,009;


U.S. patent application Ser. No. 13/097,948, entitled STAPLE CARTRIDGE COMPRISING AN ADJUSTABLE DISTAL PORTION, now U.S. Pat. No. 8,978,954;


U.S. patent application Ser. No. 13/097,907, entitled COMPRESSIBLE STAPLE CARTRIDGE ASSEMBLY, now U.S. Pat. No. 9,301,755;


U.S. patent application Ser. No. 13/097,861, entitled TISSUE THICKNESS COMPENSATOR COMPRISING PORTIONS HAVING DIFFERENT PROPERTIES, now U.S. Pat. No. 9,113,865;


U.S. patent application Ser. No. 13/097,869, entitled STAPLE CARTRIDGE LOADING ASSEMBLY, now U.S. Pat. No. 8,857,694;


U.S. patent application Ser. No. 13/097,917, entitled COMPRESSIBLE STAPLE CARTRIDGE COMPRISING ALIGNMENT MEMBERS, now U.S. Pat. No. 8,777,004;


U.S. patent application Ser. No. 13/097,873, entitled STAPLE CARTRIDGE COMPRISING A RELEASABLE PORTION, now U.S. Pat. No. 8,740,038;


U.S. patent application Ser. No. 13/097,938, entitled STAPLE CARTRIDGE COMPRISING COMPRESSIBLE DISTORTION RESISTANT COMPONENTS, now U.S. Pat. No. 9,016,542;


U.S. patent application Ser. No. 13/097,924, entitled STAPLE CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,168,038;


U.S. patent application Ser. No. 13/242,029, entitled SURGICAL STAPLER WITH FLOATING ANVIL, now U.S. Pat. No. 8,893,949;


U.S. patent application Ser. No. 13/242,066, entitled CURVED END EFFECTOR FOR A STAPLING INSTRUMENT, now U.S. Patent Application Publication No. 2012/0080498;


U.S. patent application Ser. No. 13/242,086, entitled STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK, now U.S. Pat. No. 9,055,941;


U.S. patent application Ser. No. 13/241,912, entitled STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK ARRANGEMENT, now U.S. Pat. No. 9,050,084;


U.S. patent application Ser. No. 13/241,922, entitled SURGICAL STAPLER WITH STATIONARY STAPLE DRIVERS, now U.S. Pat. No. 9,216,019;


U.S. patent application Ser. No. 13/241,637, entitled SURGICAL INSTRUMENT WITH TRIGGER ASSEMBLY FOR GENERATING MULTIPLE ACTUATION MOTIONS, now U.S. Pat. No. 8,789,741; and


U.S. patent application Ser. No. 13/241,629, entitled SURGICAL INSTRUMENT WITH SELECTIVELY ARTICULATABLE END EFFECTOR, now U.S. Patent Application Publication No. 2012/0074200.


The Applicant of the present application also owns the U.S. Patent Applications identified below which were filed on Mar. 28, 2012 and which are each herein incorporated by reference in their respective entirety:


U.S. patent application Ser. No. 13/433,096, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF CAPSULES, now U.S. Pat. No. 9,301,752;


U.S. patent application Ser. No. 13/433,103, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF LAYERS, now U.S. Patent Application Publication No. 2012/0241498;


U.S. patent application Ser. No. 13/433,098, entitled EXPANDABLE TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,301,753.


U.S. patent application Ser. No. 13/433,102, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A RESERVOIR, now U.S. Pat. No. 9,232,941;


U.S. patent application Ser. No. 13/433,114, entitled RETAINER ASSEMBLY INCLUDING A TISSUE THICKNESS COMPENSATOR, now U.S. Patent Application Publication No. 2012/0241499;


U.S. patent application Ser. No. 13/433,136, entitled TISSUE THICKNESS COMPENSATOR COMPRISING AT LEAST ONE MEDICAMENT, now U.S. Patent Application Publication No. 2012/0241492;


U.S. patent application Ser. No. 13/433,141, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CONTROLLED RELEASE AND EXPANSION, now U.S. Patent Application Publication No. 2012/0241493;


U.S. patent application Ser. No. 13/433,144, entitled TISSUE THICKNESS COMPENSATOR COMPRISING FIBERS TO PRODUCE A RESILIENT LOAD, now U.S. Pat. No. 9,277,919;


U.S. patent application Ser. No. 13/433,148, entitled TISSUE THICKNESS COMPENSATOR COMPRISING STRUCTURE TO PRODUCE A RESILIENT LOAD, now U.S. Pat. No. 9,220,500;


U.S. patent application Ser. No. 13/433,155, entitled TISSUE THICKNESS COMPENSATOR COMPRISING RESILIENT MEMBERS, now U.S. Patent Application Publication No. 2012/0241502;


U.S. patent application Ser. No. 13/433,163, entitled METHODS FOR FORMING TISSUE THICKNESS COMPENSATOR ARRANGEMENTS FOR SURGICAL STAPLERS, now U.S. Patent Application Publication No. 2012/0248169;


U.S. patent application Ser. No. 13/433,167, entitled TISSUE THICKNESS COMPENSATORS, now U.S. Pat. No. 9,220,501;


U.S. patent application Ser. No. 13/433,175, entitled LAYERED TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,332,974;


U.S. patent application Ser. No. 13/433,115, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CAPSULES DEFINING A LOW PRESSURE ENVIRONMENT, now U.S. Pat. No. 9,204,880;


U.S. patent application Ser. No. 13/433,118, entitled TISSUE THICKNESS COMPENSATOR COMPRISED OF A PLURALITY OF MATERIALS, now U.S. Patent Application Publication No. 2013/0256365;


U.S. patent application Ser. No. 13/433,135, entitled MOVABLE MEMBER FOR USE WITH A TISSUE THICKNESS COMPENSATOR, now U.S. Patent Application Publication No. 2013/0256382;


U.S. patent application Ser. No. 13/433,129, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF MEDICAMENTS, now U.S. Pat. No. 9,211,120;


U.S. patent application Ser. No. 13/433,140, entitled TISSUE THICKNESS COMPENSATOR AND METHOD FOR MAKING THE SAME, now U.S. Pat. No. 9,241,714;


U.S. patent application Ser. No. 13/433,147, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CHANNELS, now U.S. Pat. No. 9,351,730;


U.S. patent application Ser. No. 13/433,126, entitled TISSUE THICKNESS COMPENSATOR COMPRISING TISSUE INGROWTH FEATURES, now U.S. Pat. No. 9,320,523; and


U.S. patent application Ser. No. 13/433,132, entitled DEVICES AND METHODS FOR ATTACHING TISSUE THICKNESS COMPENSATING MATERIALS TO SURGICAL STAPLING INSTRUMENTS, now U.S. Patent Application Publication No. 2013/0256373.


Certain exemplary embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those of ordinary skill in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments and that the scope of the various embodiments of the present invention is defined solely by the claims. The features illustrated or described in connection with one exemplary embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the present invention.


Reference throughout the specification to “various embodiments,” “some embodiments,” “one embodiment,” or “an embodiment”, or the like, means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in various embodiments,” “in some embodiments,” “in one embodiment”, or “in an embodiment”, or the like, in places throughout the specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. Thus, the particular features, structures, or characteristics illustrated or described in connection with one embodiment may be combined, in whole or in part, with the features structures, or characteristics of one or more other embodiments without limitation Such modifications and variations are intended to be included within the scope of the present invention.


The terms “proximal” and “distal” are used herein with reference to a clinician manipulating the handle portion of the surgical instrument. The term “proximal” referring to the portion closest to the clinician and the term “distal” referring to the portion located away from the clinician. It will be further appreciated that, for convenience and clarity, spatial terms such as “vertical”, “horizontal”, “up”, and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and/or absolute.


Various exemplary devices and methods are provided for performing laparoscopic and minimally invasive surgical procedures. However, the person of ordinary skill in the art will readily appreciate that the various methods and devices disclosed herein can be used in numerous surgical procedures and applications including, for example, in connection with open surgical procedures. As the present Detailed Description proceeds, those of ordinary skill in the art will further appreciate that the various instruments disclosed herein can be inserted into a body in any way, such as through a natural orifice, through an incision or puncture hole formed in tissue, etc. The working portions or end effector portions of the instruments can be inserted directly into a patient's body or can be inserted through an access device that has a working channel through which the end effector and elongated shaft of a surgical instrument can be advanced.


Turning to the Drawings wherein like numerals denote like components throughout the several views, FIG. 1 depicts a surgical instrument 10 that is capable of practicing several unique benefits. The surgical stapling instrument 10 is designed to manipulate and/or actuate various forms and sizes of end effectors 12 that are operably attached thereto. In the embodiment depicted in FIGS. 1-1E, for example, the end effector 12 includes an elongated channel 14 that forms a lower jaw 13 of the end effector 12. The elongated channel 14 is configured to support an “implantable” staple cartridge 30 and also movably support an anvil 20 that functions as an upper jaw 15 of the end effector 12.


In various embodiments, the elongated channel 14 may be fabricated from, for example, 300 & 400 Series, 17-4 & 17-7 stainless steel, titanium, etc. and be formed with spaced side walls 16. The anvil 20 may be fabricated from, for example, 300 & 400 Series, 17-4 & 17-7 stainless steel, titanium, etc. and have a staple forming undersurface, generally labeled as 22 that has a plurality of staple forming pockets 23 formed therein. See FIGS. 1B-1E. In addition, the anvil 20 has a bifurcated ramp assembly 24 that protrudes proximally therefrom. An anvil pin 26 protrudes from each lateral side of the ramp assembly 24 to be received within a corresponding slot or opening 18 in the side walls 16 of the elongated channel 14 to facilitate its movable or pivotable attachment thereto.


Various forms of implantable staple cartridges may be employed with the various embodiments of the surgical instruments disclosed herein. Specific staple cartridge configurations and constructions will be discussed in further detail below. However, in the embodiment depicted in FIG. 1A, an implantable staple cartridge 30 is shown. In at least one embodiment, the staple cartridge 30 has a body that consists of a compressible hemostat material such as, for example, oxidized regenerated cellulose (“ORC”) or a bio-absorbable foam in which lines of unformed metal staples 32 are supported. In at least some embodiments, in order to prevent the staple from being affected and the hemostat material from being activated during the introduction and positioning process, the entire cartridge may be coated or wrapped in a biodegradable film 38 such as a polydioxanon film sold under the trademark PDS® or with a Polyglycerol sebacate (PGS) film or other biodegradable films formed from PGA (Polyglycolic acid, marketed under the trade mark Vicryl), PCL (Polycaprolactone), PLA or PLLA (Polylactic acid), PHA (polyhydroxyalkanoate), PGCL (poliglecaprone 25, sold under the trademark Monocryl) or a composite of PGA, PCL, PLA, PDS that would be impermeable until ruptured. The body 31 of staple cartridge 30 is sized to be removably supported within the elongated channel 14 as shown such that each staple 32 therein is aligned with corresponding staple forming pockets 23 in the anvil when the anvil 20 is driven into forming contact with the staple cartridge 30.


In use, once the end effector 12 has been positioned adjacent the target tissue, the end effector 12 is manipulated to capture or clamp the target tissue between an upper face 36 of the staple cartridge 30 and the staple forming surface 22 of the anvil 20. The staples 32 are formed by moving the anvil 20 in a path that is substantially parallel to the elongated channel 14 to bring the staple forming surface 22 and, more particularly, the staple forming pockets 23 therein into substantially simultaneous contact with the upper face 36 of the staple cartridge 30. As the anvil 20 continues to move into the staple cartridge 30, the legs 34 of the staples 32 contact a corresponding staple forming pocket 23 in anvil 20 which serves to bend the staple legs 34 over to form the staples 32 into a “B shape”. Further movement of the anvil 20 toward the elongated channel 14 will further compress and form the staples 32 to a desired final formed height “FF”.


The above-described staple forming process is generally depicted in FIGS. 1B-1E. For example, FIG. 1B illustrates the end effector 12 with target tissue “T” between the anvil 20 and the upper face 36 of the implantable staple cartridge 30. FIG. 1C illustrates the initial clamping position of the anvil 20 wherein the anvil has 20 been closed onto the target tissue “T” to clamp the target tissue “T” between the anvil 20 and the upper face 36 of the staple cartridge 30. FIG. 1D illustrates the initial staple formation wherein the anvil 20 has started to compress the staple cartridge 30 such that the legs 34 of the staples 32 are starting to be formed by the staple forming pockets 23 in the anvil 20. FIG. 1E illustrates the staple 32 in its final formed condition through the target tissue “T” with the anvil 20 removed for clarity purposes. Once the staples 32 have been formed and fastened to the target tissue “T”, the surgeon will move the anvil 20 to the open position to enable the cartridge body 31 and the staples 32 to remain affixed to the target tissue while the end effector 12 is being withdrawn from the patient. The end effector 12 forms all of the staples simultaneously as the two jaws 13, 15 are clamped together. The remaining “crushed” body materials 31 act as both a hemostat (the ORC) and a staple line reinforcement (PGA, PDS or any of the other film compositions mentioned above 38). Also, since the staples 32 never have to leave the cartridge body 31 during forming, the likelihood of the staples 32 being malformed during forming is minimized. As used herein the term “implantable” means that, in addition to the staples, the cartridge body materials that support the staples will also remain in the patient and may eventually be absorbed by the patient's body. Such implantable staple cartridges are distinguishable from prior cartridge arrangements that remain positioned within the end effector in their entirety after they have been fired.


In various implementations, the end effector 12 is configured to be coupled to an elongated shaft assembly 40 that protrudes from a handle assembly 100. The end effector 12 (when closed) and the elongated shaft assembly 40 may have similar cross-sectional shapes and be sized to operably pass through a trocar tube or working channel in another form of access instrument. As used herein, the term “operably pass” means that the end effector and at least a portion of the elongated shaft assembly may be inserted through or passed through the channel or tube opening and can be manipulated therein as needed to complete the surgical stapling procedure. In some embodiments, when in a closed position, the jaws 13 and 15 of the end effector 12 may provide the end effector with a roughly circular cross-sectional shape that facilitates its passage through a circular passage/opening. However, the end effectors of various embodiments of the present invention, as well as the elongated shaft assembly embodiments, could conceivably be provided with other cross-sectional shapes that could otherwise pass through access passages and openings that have non-circular cross-sectional shapes. Thus, an overall size of a cross-section of a closed end effector will be related to the size of the passage or opening through which it is intended to pass. Thus, one end effector for example, may be referred to as a “5 mm” end effector which means it can operably pass through an opening that is at least approximately 5 mm in diameter.


In various embodiments, the elongated shaft assembly 40 may have an outer diameter that is substantially the same as the outer diameter of the end effector 12 when in a closed position. For example, a 5 mm end effector may be coupled to an elongated shaft assembly 40 that has 5 mm cross-sectional diameter. However, as the present Detailed Description proceeds, it will become apparent that various embodiments of the present may be effectively used in connection with different sizes of end effectors. For example, a 10 mm end effector may be attached to an elongated shaft that has a 5 mm cross-sectional diameter. Conversely, for those applications wherein a 10 mm or larger access opening or passage is provided, the elongated shaft assembly 40 may have a 10 mm (or larger) cross-sectional diameter, but may also be able to actuate a 5 mm or 10 mm end effector. Accordingly, the outer shaft 40 may have an outer diameter that is the same as or is different from the outer diameter of a closed end effector 12 attached thereto.


As depicted, the elongated shaft assembly 40 extends distally from the handle assembly 100 in a generally straight line to define a longitudinal axis A-A. In various embodiments, for example, the elongated shaft assembly 40 may be approximately 9-16 inches (229-406 mm) long. However, the elongated shaft assembly 40 may be provided in other lengths and, in other embodiments, may have joints therein or be otherwise configured to facilitate articulation of the end effector 12 relative to other portions of the shaft or handle assembly as will be discussed in further detail below. In various embodiments, the elongated shaft assembly 40 includes a spine member 50 that extends from the handle assembly 100 to the end effector 12. The proximal end of the elongated channel 14 of the end effector 12 has a pair of retention trunnions 17 protruding therefrom that are sized to be received within corresponding trunnion openings or cradles 52 that are provided in a distal end of the spine member 50 to enable the end effector 12 to be removably coupled the elongated shaft assembly 40. The spine member 50 may be fabricated from, for example, 6061 or 7075 aluminum, stainless steel, titanium, etc.


In various embodiments, the handle assembly 100 comprises a pistol grip-type housing that may be fabricated in two or more pieces for assembly purposes. For example, the handle assembly 100 as shown comprises a right hand case member 102 and a left hand case member (not illustrated) that are molded or otherwise fabricated from a polymer or plastic material and are designed to mate together. Such case members may be attached together by snap features, pegs and sockets molded or otherwise formed therein and/or by adhesive, screws, etc. The spine member 50 has a proximal end 54 that has a flange 56 formed thereon. The flange 56 is configured to be rotatably supported within a groove 106 formed by mating ribs 108 that protrude inwardly from each of the case members 102, 104. Such arrangement facilitates the attachment of the spine member 50 to the handle assembly 100 while enabling the spine member 50 to be rotated relative to the handle assembly 100 about the longitudinal axis A-A in a 360° path.


As can be further seen in FIG. 1, the spine member 50 passes through and is supported by a mounting bushing 60 that is rotatably affixed to the handle assembly 100. The mounting bushing 60 has a proximal flange 62 and a distal flange 64 that define a rotational groove 65 that is configured to rotatably receive a nose portion 101 of the handle assembly 100 therebetween. Such arrangement enables the mounting bushing 60 to rotate about longitudinal axis A-A relative to the handle assembly 100. The spine member 50 is non-rotatably pinned to the mounting bushing 60 by a spine pin 66. In addition, a rotation knob 70 is attached to the mounting bushing 60. In one embodiment, for example, the rotation knob 70 has a hollow mounting flange portion 72 that is sized to receive a portion of the mounting bushing 60 therein. In various embodiments, the rotation knob 70 may be fabricated from, for example, glass or carbon filled Nylon, polycarbonate, Ultem®, etc. and is affixed to the mounting bushing 60 by the spine pin 66 as well. In addition, an inwardly protruding retention flange 74 is formed on the mounting flange portion 72 and is configured to extend into a radial groove 68 formed in the mounting bushing 60. Thus, the surgeon may rotate the spine member 50 (and the end effector 12 attached thereto) about longitudinal axis A-A in a 360° path by grasping the rotation knob 70 and rotating it relative to the handle assembly 100.


In various embodiments, the anvil 20 is retained in an open position by an anvil spring 21 and/or another biasing arrangement. The anvil 20 is selectively movable from the open position to various closed or clamping and firing positions by a firing system, generally designated as 109. The firing system 109 includes a “firing member” 110 which, in various embodiments, comprises a hollow firing tube 110. The hollow firing tube 110 is axially movable on the spine member 50 and thus forms the outer portion of the elongated shaft assembly 40. The firing tube 110 may be fabricated from a polymer or other suitable material and have a proximal end that is attached to a firing yoke 114 of the firing system 109. In various embodiments for example, the firing yoke 114 may be over-molded to the proximal end of the firing tube 110. However, other fastener arrangements may be employed.


As can be seen in FIG. 1, the firing yoke 114 may be rotatably supported within a support collar 120 that is configured to move axially within the handle assembly 100. In various embodiments, the support collar 120 has a pair of laterally extending fins that are sized to be slidably received within fin slots formed in the right and left hand case members. Thus, the support collar 120 may slide axially within the handle housing 100 while enabling the firing yoke 114 and firing tube 110 to rotate relative thereto about the longitudinal axis A-A. In various embodiments, a longitudinal slot is provided through the firing tube 110 to enable the spine pin 66 to extend therethrough into the spine member 50 while facilitating the axial travel of the firing tube 110 on the spine member 50.


The firing system 109 further comprises a firing trigger 130 which serves to control the axial travel of the firing tube 110 on the spine member 50. See FIG. 1. Such axial movement in the distal direction of the firing tube 110 into firing interaction with the anvil 20 is referred to herein as “firing motion”. As can be seen in FIG. 1, the firing trigger 130 is movably or pivotally coupled to the handle assembly 100 by a pivot pin 132. A torsion spring 135 is employed to bias the firing trigger 130 away from the pistol grip portion 107 of the handle assembly 100 to an un-actuated “open” or starting position. As can be seen in FIG. 1, the firing trigger 130 has an upper portion 134 that is movably attached to (pinned) firing links 136 that are movably attached to (pinned) the support collar 120. Thus, movement of the firing trigger 130 from the starting position (FIG. 1) toward an ending position adjacent the pistol grip portion 107 of the handle assembly 100 will cause the firing yoke 114 and the firing tube 110 to move in the distal direction “DD”. Movement of the firing trigger 130 away from the pistol grip portion 107 of the handle assembly 100 (under the bias of the torsion spring 135) will cause the firing yoke 114 and firing tube 110 to move in the proximal direction “PD” on the spine member 50.


Various embodiments of the present invention may be employed with different sizes and configurations of implantable staple cartridges. For example, the surgical instrument 10, when used in connection with a first firing adapter 140, may be used with a 5 mm end effector 12 that is approximately 20 mm long (or in other lengths) which supports an implantable staple cartridge 30. Such end effector size may be particularly well-suited, for example, to complete relatively fine dissection and vascular transactions. However, as will be discussed in further detail below, the surgical instrument 10 may also be employed, for example, in connection with other sizes of end effectors and staple cartridges by replacing the first firing adapter 140 with a second firing adapter. In still other embodiments, the elongated shaft assembly 40 may configured to be attached to only one form or size of end effector.


One method of removably coupling the end effector 12 to the spine member 50 will now be explained. The coupling process is commenced by inserting the retention trunnions 17 on the elongated channel 14 into the trunnion cradles 52 in the spine member 50. Thereafter, the surgeon advances the firing trigger 130 toward the pistol grip 107 of the housing assembly 100 to distally advance the firing tube 110 and the first firing adapter 140 over a proximal end portion 47 of the elongated channel 14 to thereby retain the trunnions 17 in their respective cradles 52. Such position of the first firing adapter 140 over the trunnions 17 is referred to herein as the “coupled position”. Various embodiments of the present invention may also have an end effector locking assembly for locking the firing trigger 130 in position after an end effector 12 has been attached to the spine member 50.


More specifically, one embodiment of the end effector locking assembly 160 includes a retention pin 162 that is movably supported in the upper portion 134 of the firing trigger 130. As discussed above, the firing tube 110 must initially be advanced distally to the coupled position wherein the first firing adapter 140 retains the retention trunnions 17 of the end effector 12 in the trunnion cradles 52 in the spine member 50. The surgeon advances the firing adapter 140 distally to the coupled position by pulling the firing trigger 130 from the starting position toward the pistol grip 107. As the firing trigger 130 is initially actuated, the retention pin 162 is moved distally until the firing tube 110 has advanced the first firing adapter 140 to the coupled position at which point the retention pin 162 is biased into a locking cavity 164 formed in the case member. In various embodiments, when the retention pin 162 enters into the locking cavity 164, the pin 162 may make an audible “click” or other sound, as well as provide a tactile indication to the surgeon that the end effector 12 has been “locked” onto the spine member 50. In addition, the surgeon cannot inadvertently continue to actuate the firing trigger 130 to start to form staples 32 in the end effector 12 without intentionally biasing the retention pin 162 out of the locking cavity 164. Similarly, if the surgeon releases the firing trigger 130 when in the coupled position, it is retained in that position by the retention pin 162 to prevent the firing trigger 130 from returning to the starting position and thereby releasing the end effector 12 from the spine member 50.


Various embodiments of the present invention may further include a firing system lock button 137 that is pivotally attached to the handle assembly 100. In one form, the firing system lock button 137 has a latch 138 formed on a distal end thereof that is oriented to engage the firing yoke 114 when the firing release button is in a first latching position. As can be seen in FIG. 1, a latch spring 139 serves to bias the firing system lock button 137 to the first latching position. In various circumstances, the latch 138 serves to engage the firing yoke 114 at a point where the position of the firing yoke 114 on the spine member 50 corresponds to a point wherein the first firing adapter 140 is about to distally advance up the clamping ramp 28 on the anvil 20. It will be understood that, as the first firing adapter 140 advances axially up the clamping ramp 28, the anvil 20 will move in a path such that its staple forming surface portion 22 is substantially parallel to the upper face 36 of the staple cartridge 30.


After the end effector 12 has been coupled to the spine member 50, the staple forming process is commenced by first depressing the firing system lock button 137 to enable the firing yoke 114 to be further moved distally on the spine member 50 and ultimately compress the anvil 20 into the staple cartridge 30. After depressing the firing system lock button 137, the surgeon continues to actuate the firing trigger 130 towards the pistol grip 107 thereby driving the first staple collar 140 up the corresponding staple forming ramp 29 to force the anvil 20 into forming contact with the staples 32 in the staple cartridge 30. The firing system lock button 137 prevents the inadvertent forming of the staples 32 until the surgeon is ready to start that process. In this embodiment, the surgeon must depress the firing system lock button 137 before the firing trigger 130 may be further actuated to begin the staple forming process.


The surgical instrument 10 may be solely used as a tissue stapling device if so desired. However, various embodiments of the present invention may also include a tissue cutting system, generally designated as 170. In at least one form, the tissue cutting system 170 comprises a knife member 172 that may be selectively advanced from an un-actuated position adjacent the proximal end of the end effector 12 to an actuated position by actuating a knife advancement trigger 200. The knife member 172 is movably supported within the spine member 50 and is attached or otherwise protrudes from a knife rod 180. The knife member 172 may be fabricated from, for example, 420 or 440 stainless steel with a hardness of greater than 38 HRC (Rockwell Hardness C-scale) and have a tissue cutting edge 176 formed on the distal end 174 thereof and be configured to slidably extend through a slot in the anvil 20 and a centrally disposed slot 33 in the staple cartridge 30 to cut through tissue that is clamped in the end effector 12. In various embodiments, the knife rod 180 extends through the spine member 50 and has a proximal end portion which drivingly interfaces with a knife transmission that is operably attached to the knife advance trigger 200. In various embodiments, the knife advance trigger 200 is attached to pivot pin 132 such that it may be pivoted or otherwise actuated without actuating the firing trigger 130. In various embodiments, a first knife gear 192 is also attached to the pivot pin 132 such that actuation of the knife advance trigger 200 also pivots the first knife gear 192. A firing return spring 202 is attached between the first knife gear 192 and the handle housing 100 to bias the knife advancement trigger 200 to a starting or un-actuated position.


Various embodiments of the knife transmission also include a second knife gear 194 that is rotatably supported on a second gear spindle and in meshing engagement with the first knife gear 192. The second knife gear 194 is in meshing engagement with a third knife gear 196 that is supported on a third gear spindle. Also supported on the third gear spindle 195 is a fourth knife gear 198. The fourth knife gear 198 is adapted to drivingly engage a series of annular gear teeth or rings on a proximal end of the knife rod 180. Thus, such arrangement enables the fourth knife gear 198 to axially drive the knife rod 180 in the distal direction “DD” or proximal direction “PD” while enabling the firing rod 180 to rotate about longitudinal axis A-A with respect to the fourth knife gear 198. Accordingly, the surgeon may axially advance the firing rod 180 and ultimately the knife member 172 distally by pulling the knife advancement trigger 200 towards the pistol grip 107 of the handle assembly 100.


Various embodiments of the present invention further include a knife lockout system 210 that prevents the advancement of the knife member 172 unless the firing trigger 130 has been pulled to the fully fired position. Such feature will therefore prevent the activation of the knife advancement system 170 unless the staples have first been fired or formed into the tissue. As can be seen in FIG. 1, various implementations of the knife lockout system 210 comprise a knife lockout bar 211 that is pivotally supported within the pistol grip portion 107 of the handle assembly 100. The knife lockout bar 211 has an activation end 212 that is adapted to be engaged by the firing trigger 130 when the firing trigger 130 is in the fully fired position. In addition, the knife lockout bar 211 has a retaining hook 214 on its other end that is adapted to hookingly engage a latch rod 216 on the first cut gear 192. A knife lock spring 218 is employed to bias the knife lockout bar 211 to a “locked” position wherein the retaining hook 214 is retained in engagement with the latch rod 216 to thereby prevent actuation of the knife advancement trigger 200 unless the firing trigger 130 is in the fully fired position.


After the staples have been “fired” (formed) into the target tissue, the surgeon may depress the firing trigger release button 167 to enable the firing trigger 130 to return to the starting position under the bias of the torsion spring 135 which enables the anvil 20 to be biased to an open position under the bias of spring 21. When in the open position, the surgeon may withdraw the end effector 12 leaving the implantable staple cartridge 30 and staples 32 behind. In applications wherein the end effector was inserted through a passage, working channel, etc. the surgeon will return the anvil 20 to the closed position by activating the firing trigger 130 to enable the end effector 12 to be withdrawn out through the passage or working channel. If, however, the surgeon desires to cut the target tissue after firing the staples, the surgeon activates the knife advancement trigger 200 in the above-described manner to drive the knife bar 172 through the target tissue to the end of the end effector. Thereafter, the surgeon may release the knife advancement trigger 200 to enable the firing return spring 202 to cause the firing transmission to return the knife bar 172 to the starting (un-actuated) position. Once the knife bar 172 has been returned to the starting position, the surgeon may open the end effector jaws 13, 15 to release the implantable cartridge 30 within the patient and then withdraw the end effector 12 from the patient. Thus, such surgical instruments facilitate the use of small implantable staple cartridges that may be inserted through relatively smaller working channels and passages, while providing the surgeon with the option to fire the staples without cutting tissue or if desired to also cut tissue after the staples have been fired.


Various unique and novel embodiments of the present invention employ a compressible staple cartridge that supports staples in a substantially stationary position for forming contact by the anvil. In various embodiments, the anvil is driven into the unformed staples wherein, in at least one such embodiment, the degree of staple formation attained is dependent upon how far the anvil is driven into the staples. Such an arrangement provides the surgeon with the ability to adjust the amount of forming or firing pressure applied to the staples and thereby alter the final formed height of the staples. In other various embodiments of the present invention, surgical stapling arrangements can employ staple driving elements which can lift the staples toward the anvil. Such embodiments are described in greater detail further below.


In various embodiments, with regard to the embodiments described in detail above, the amount of firing motion that is applied to the movable anvil is dependent upon the degree of actuation of the firing trigger. For example, if the surgeon desires to attain only partially formed staples, then the firing trigger is only partially depressed inward towards the pistol grip 107. To attain more staple formation, the surgeon simply compresses the firing trigger further which results in the anvil being further driven into forming contact with the staples. As used herein, the term “forming contact” means that the staple forming surface or staple forming pockets have contacted the ends of the staple legs and have started to form or bend the legs over into a formed position. The degree of staple formation refers to how far the staple legs have been folded over and ultimately relates to the forming height of the staple as referenced above. Those of ordinary skill in the art will further understand that, because the anvil 20 moves in a substantially parallel relationship with respect to the staple cartridge as the firing motions are applied thereto, the staples are formed substantially simultaneously with substantially the same formed heights.



FIGS. 2 and 3 illustrate an alternative end effector 12″ that is similar to the end effector 12′ described above, except with the following differences that are configured to accommodate a knife bar 172′. The knife bar 172′ is coupled to or protrudes from a knife rod 180 and is otherwise operated in the above described manner with respect to the knife bar 172. However, in this embodiment, the knife bar 172′ is long enough to traverse the entire length of the end effector 12″ and therefore, a separate distal knife member is not employed in the end effector 12″. The knife bar 172′ has an upper transverse member 173′ and a lower transverse member 175′ formed thereon. The upper transverse member 173′ is oriented to slidably transverse a corresponding elongated slot 250 in anvil 20″ and the lower transverse member 175′ is oriented to traverse an elongated slot 252 in the elongated channel 14″ of the end effector 12″. A disengagement slot (not shown) is also provided in the anvil 20″ such that when the knife bar 172′ has been driven to an ending position within end effector 12″, the upper transverse member 173′ drops through the corresponding slot to enable the anvil 20″ to move to the open position to disengage the stapled and cut tissue. The anvil 20″ may be otherwise identical to anvil 20 described above and the elongated channel 14″ may be otherwise identical to elongated channel 14 described above.


In these embodiments, the anvil 20″ is biased to a fully open position (FIG. 2) by a spring or other opening arrangement (not shown). The anvil 20″ is moved between the open and fully clamped positions by the axial travel of the firing adapter 150 in the manner described above. Once the firing adapter 150 has been advanced to the fully clamped position (FIG. 3), the surgeon may then advance the knife bar 172″ distally in the manner described above. If the surgeon desires to use the end effector as a grasping device to manipulate tissue, the firing adapter may be moved proximally to allow the anvil 20″ to move away from the elongated channel 14″ as represented in FIG. 4 in broken lines. In this embodiment, as the knife bar 172″ moves distally, the upper transverse member 173′ and the lower transverse member 175′ draw the anvil 20″ and elongated channel 14″ together to achieve the desired staple formation as the knife bar 172″ is advanced distally through the end effector 12″. See FIG. 5. Thus, in this embodiment, staple formation occurs simultaneously with tissue cutting, but the staples themselves may be sequentially formed as the knife bar 172″ is driven distally.


The unique and novel features of the various surgical staple cartridges and the surgical instruments of the present invention enable the staples in those cartridges to be arranged in one or more linear or non-linear lines. A plurality of such staple lines may be provided on each side of an elongated slot that is centrally disposed within the staple cartridge for receiving the tissue cutting member therethrough. In one arrangement, for example, the staples in one line may be substantially parallel with the staples in adjacent line(s) of staples, but offset therefrom. In still other embodiments, one or more lines of staples may be non-linear in nature. That is, the base of at least one staple in a line of staples may extend along an axis that is substantially transverse to the bases of other staples in the same staple line. For example, as will be discussed in further detail below, in alternative embodiments, the lines of staples on each side of the elongated slot may have a zigzag appearance. Such non-linear staple arrangements may attain better tissue fastening results with less staples than various linear staple arrangements employed in prior staple cartridges.



FIG. 6 illustrates use of a surgical staple cartridge embodiment 900 in an end effector embodiment 612′. As can be seen in FIGS. 6 and 7, an embodiment of the surgical staple cartridge 900 has a cartridge body 902 that has a centrally disposed elongated slot 904 extending through a proximal end 903 to an area adjacent a distal end 905. The elongated slot 904 is configured to permit a knife body to axially move therethrough during a tissue cutting operation in the manner described above. In at least one embodiment, the cartridge body 902 consists of a compressible hemostat material such as, for example, oxidized regenerated cellulose (“ORC”) or a bio-absorbable foam fabricated from, for example, PGA (Polyglycolic acid, sold under the trademark Vicryl), PCL (polycaprolactone), PLA or PLLA (Polyactic acid), PDS, (Polydioxanone), PHA (polyhydroxyalkanoate), PGCL (poliglecaprone 25, sold under the trademark Monocryl) or a composite of PGA, PCL, PLA and PDS in which lines 920, 930 of unformed staples 922 are supported. However, the cartridge body 902 may be fabricated from other materials that serve to support the unformed staples 922 in a desired orientation such that they may be compressed as the anvil 910′ is brought into contact therewith. As with various other embodiments described above, the staple cartridge 900 is implantable and is left attached to the stapled tissue after the stapling procedure has been completed. In at least some embodiments, in order to prevent the staples 922 from being affected and the hemostat material from being activated during the introduction and positioning process, the entire cartridge 900 may be coated or wrapped in a biodegradable film 906 such as a polydioxanon film sold under the trademark PDS® or with a Polyglycerol sebacate (PGS) film or other biodegradable films fabricated from, for example, PGA (Polyglycolic acid, marketed under the trade mark Vicryl), PCL (Polycaprolactone), PLA or PLLA (Polylactic acid), PHA (polyhydroxyalkanoate), PGCL (poliglecaprone 25, sold under the trademark Monocryl) or a composite of PGA, PCL, PLA, PDS that would be impermeable until ruptured. The cartridge body 902 of staple cartridge 900 is sized to be removably supported within the elongated channel of the end effector 612′.


In the embodiment depicted in FIGS. 6, 10, and 11, the surgical staple cartridge 900 operably supports a first line 920 of staples 922 on one lateral side 907 of the elongated slot 904 and a second line 930 of staples 922 on the other lateral side 909 of the elongated slot 904. In various embodiments, the staples 922 may be fabricated from a metal material such as, for example, Titanium, Titanium alloys (e.g., 6Al-4V Titanium, 3al-2.5V Titanium), Stainless Steel, etc. and have a staple base 924 and two upstanding staple legs 926 protruding therefrom. Each staple leg 926 may have a tissue-piercing tip 928 formed thereon. In the first line 920 of staples 922, the staple base 924 of at least one staple 922 overlaps the staple base of another staple 922. In a preferred embodiment, the staple base 924 of each staple 922 overlaps the staple bases 924 of two adjacent staples 922, except for the base 924 of the last staple 922 on each end of the first staple line 920. See FIG. 10. Thus, the first staple line 920 has a substantially non-linear shape. More particularly, when viewed from above, the first staple line 920 has a substantially zigzag appearance.


As can be seen in FIG. 9, the anvil 90 has two sequential longitudinal staple forming pockets 912 that each has a substantial zigzag shape that corresponds to the shape of the first line 920 of staples 922 such that, when the anvil 910 is brought into forming contact with the staples 922, the legs 926 thereof are formed as shown in FIG. 11. Thus, the distal leg of one staple shares the same pocket as the proximal leg of the next staple longitudinally. Such arrangement allows for a denser pocket pattern, even to a point where the staples themselves interact (e.g., are folded over one another). In prior staple pocket arrangements, in general, there has to be between 0.005 and 0.015 inches of metal/space from one set of pockets to the next. This embodiment of the present invention, however, has a spacing arrangement from 0 to 0.02 inches of interference/overlap (essentially a −0.020″) because one staple mates with the next staple, for example. Such arrangements allow for 15-30% more staples in the same space. Furthermore, when the staples interlock, there is less need for multiple lateral rows of staples. Prior arrangements commonly employ three rows on each side of the tissue cut line to prevent the existing of an open path through which blood may pass. Lines of interlocking staples are less likely to leave paths through which blood may pass. Another distinct advantage provided by the various interlocking staple arrangements of the present invention relates to improved “burst strength” which relates to the amount of force required to tear a staple line open.


Another staple forming pocket arrangement may comprise a common staple forming pocket. As used herein, the term “common staple forming pocket” means that one forming pocket can form all of the staples in a single line of staples as opposed to prior anvil designs wherein a discrete forming pocket is provided for each leg of each staple to be formed.



FIG. 12 illustrates yet another staple embodiment 922′ wherein the base 924′ has an offset portion 929 to facilitate a tighter overlap of the bases 924′. As indicated above, the staple cartridge 900 has a second line 930 of staples 922 supported on a second lateral side 909 of the elongated slot 904. The second line 930 of staples 922 is substantially identical to the first line 920 of staples 922. Thus, the anvil 910 has a second common staple forming pocket 912 that corresponds to the second line of staples 930 for forming contact therewith. In alternative embodiments, however, the second line 930 of staples 922 may differ from the first line 920 of staples in shape and, perhaps, number of staples.



FIG. 8 illustrates a surgical staple cartridge 900′ that is substantially identical to the staple cartridge 900 described above, with the exception of the lines 920′, 930′ of staples 922 supported therein. For example, in this embodiment, the line 920′ of staples 922 are arranged relative to each other such that a base axis S-S of at least one staple base 924 is substantially transverse to the base axis S-S of the staple base 924 of at least one other adjacent staple 922. Such predetermined pattern of staples, when viewed from above, comprises a substantially zigzag arrangement. In the embodiment depicted in FIG. 13, the respective bases 924 of staples 922 may additionally have a base support member 927 overmolded thereon as shown. In various embodiments, the base support member 927 may be fabricated from, for example, non-absorbable plastic such as Polyether ether ketone “PEEK” or absorbable plastic such as, for example, Polyglycolic acid “PGA”, Polylactic acid “PLA” or “PLLA”, Polydioxanone “PDS”, PCL (polycaprolactone), PHA (polyhydroxyalkanoate), PGCL (poliglecaprone 25, sold under the trademark Monocryl) or various composite mixes if PGS, PDS, PLA, PGA, and PCL. The base support members 927 facilitate interlocking between the staples without making the staples themselves overlap. Thus, such arrangements could form staples with “B” shapes or inverted “W” shapes without the legs of the staples themselves overlapping. However, the crowns are connected by the base support members so they act like overlapping staples. Such arrangements allow the combined pockets to have two discrete paths for each leg.


The embodiment depicted in FIG. 14 employs a staple line 920″ wherein the legs 926 of adjacent staples 922 are coupled together by a coupler portion 929 molded or otherwise attached thereto. Each coupler portion 929 may be fabricated from, for example, Polyether ether ketone “PEEK” or absorbable plastic such as, for example, Polyglycolic acid “PGA”, Polylactic acid “PLA” or “PLLA”, Polydioxanone “PDS”, PCL (polycaprolactone), PHA (polyhydroxyalkanoate), PGCL (poliglecaprone 25, sold under the trademark Monocryl) or various composite mixes if PGS, PDS, PLA, PGA, and PCL. Such staple line 920″ has substantial zigzag appearance when viewed from above. While the various surgical staple cartridge embodiments 900, 900′ have been explained with reference to use with the end effector 612′, it will be understood that the staple cartridges 900, 900′ may be effectively employed with the various other end effectors and surgical instruments described hereinabove, with appropriate staple forming pocket arrangements being provided in the anvils of those instruments in order to achieved the desired amount of staple formation upon movement of the anvils into forming contact with the staples.



FIGS. 15 and 16 illustrate another surgical staple cartridge 940 embodiment supported in an elongated channel 14 of a surgical instrument 10. In at least one embodiment, the surgical staple cartridge 940 includes a cartridge body 942 that has a centrally disposed elongated slot 944 extending at least partially therethrough. The elongated slot 944 is configured to permit a knife body of the surgical instrument 10 to axially move therethrough during a tissue cutting operation in the manner described above. In various embodiments, the cartridge body 942 consists of a compressible hemostat material such as, for example, oxidized regenerated cellulose (“ORC”) or a bio-absorbable foam of the types described above or below in which lines 946, 948, 950, 952 of unformed staples 922 are supported. In at least some embodiments, in order to prevent the staples 922 from being affected and the hemostat material from being activated during the introduction and positioning process, the entire cartridge 940 may be coated or wrapped in a biodegradable film 954 such as a polydioxanon film sold under the trademark PDS® or with a Polyglycerol sebacate (PGS) film or other biodegradable films fabricated from, for example, PGA (Polyglycolic acid, marketed under the trade mark Vicryl), PCL (Polycaprolactone), PLA or PLLA (Polylactic acid), PHA (polyhydroxyalkanoate), PGCL (poliglecaprone 25, sold under the trademark Monocryl) or a composite of PGA, PCL, PLA, PDS that would be impermeable until ruptured.


In the embodiment depicted in FIG. 15, the cartridge 940 further includes a cartridge support member 960 that is coupled to the cartridge body 942. In various embodiments, the cartridge support member 960 may be fabricated from a rigid material such as, for example, Titanium, Stainless Steel, Aluminum, any alloy of the foregoing, etc. and may be partially embedded within the cartridge body 942. In various embodiments, the cartridge support member 960 may be held in place by, for example, film 954. In still other embodiments wherein a limited bond is desired, sporadic use of cyanoacylate could be used to “glue” the two components together. In yet other embodiments, the cartridge body 942 may be heated and “welded” or “fused” to the cartridge support member 960. In various embodiments, the cartridge support member 960 forms at least a portion of the bottom surface of the cartridge body 942 for mating with the elongated channel 14. In at least one embodiment, the cartridge support member 960 has one or more snap features 962 protruding therefrom for releasably coupling the cartridge support member 960 to the elongated channel 14. Other forms of snap features/fastener arrangements may be employed for releasably coupling the cartridge support member 960 to the elongated channel 14.


In various embodiments, the cartridge support member 960 has a series of support ridges 964, 966, 968, 970, 972, 974, 976 formed thereon to provide some lateral support to the bases 924 of the staples 922 in the staple lines 946, 948, 950, 952 as shown in FIG. 15. Thus, in at least some embodiments, the support ridges are substantially coextensive with the staple lines. FIG. 17 illustrates an alternative staple cartridge embodiment 940′ that is substantially identical to cartridge 940, except for the inclusion of upstanding fin portions 978, 979, 980, 981, 982, 983 that protrude from the support ridges 964, 966, 968, 970, 972, 976, respectively to provide additional lateral support to the staples 922. In various embodiments, the fin portions may be integrally formed with the cartridge support member 960 and have a height that is about ½ or less of the height of the cartridge. Thus, in various embodiments, for example, any standing features supporting the foam cannot extend above the maximum compression height of the foam. Thus, if the cartridge is designed, for example, to compress to ⅓ of its original height when fired, the fins would between 66% of the uncompressed height, all the way down to 10% of uncompressed height.


In use, once the staples 922 have been formed through contact with the anvil 20 in the manner described above, the anvil 20 is opened and the end effector 12 is pulled away from the stapled tissue. As the end effector 12 is pulled away from the stapled tissue, the cartridge body 942 remains fastened to the stapled tissue and is then separated from the cartridge support member 960 which remains coupled to the elongated channel 14. In various embodiments, the cartridge support member 960 is provided with a color that differs from the color of the material comprising the cartridge body 942 as well as the color of the elongated channel 14. Such arrangement provides the surgeon with an easily recognizable indication that no staple cartridge is present within the end effector. Thus, the surgeon will not inadvertently attempt to reinsert/use the end effector without first installing a new staple cartridge therein. To do so, the surgeon simply disconnects the snap features of the cartridge support member 960 from the elongated channel 14 to enable the cartridge support member 960 of a new staple cartridge 940 to be placed therein. While the staple cartridges 940, 940′ have been explained with reference to surgical instrument 10, it will be understood that those cartridges may be effectively employed with many of the other surgical instrument embodiments disclosed herein without departing from the spirit and scope of the present invention.


In various embodiments, a staple cartridge can comprise a cartridge body and a plurality of staples stored within the cartridge body. In use, the staple cartridge can be introduced into a surgical site and positioned on a side of the tissue being treated. In addition, a staple-forming anvil can be positioned on the opposite side of the tissue. In various embodiments, the anvil can be carried by a first jaw and the staple cartridge can be carried by a second jaw, wherein the first jaw and/or the second jaw can be moved toward the other. Once the staple cartridge and the anvil have been positioned relative to the tissue, the staples can be ejected from the staple cartridge body such that the staples can pierce the tissue and contact the staple-forming anvil. Once the staples have been deployed from the staple cartridge body, the staple cartridge body can then be removed from the surgical site. In various embodiments disclosed herein, a staple cartridge, or at least a portion of a staple cartridge, can be implanted with the staples. In at least one such embodiment, as described in greater detail further below, a staple cartridge can comprise a cartridge body which can be compressed, crushed, and/or collapsed by the anvil when the anvil is moved from an open position into a closed position. When the cartridge body is compressed, crushed, and/or collapsed, the staples positioned within the cartridge body can be deformed by the anvil. Alternatively, the jaw supporting the staple cartridge can be moved toward the anvil into a closed position. In either event, in various embodiments, the staples can be deformed while they are at least partially positioned within the cartridge body. In certain embodiments, the staples may not be ejected from the staple cartridge while, in some embodiments, the staples can be ejected from the staple cartridge along with a portion of the cartridge body.


Referring now to FIGS. 18A-18D, a compressible staple cartridge, such as staple cartridge 1000, for example, can comprise a compressible, implantable cartridge body 1010 and, in addition, a plurality of staples 1020 positioned in the compressible cartridge body 1010, although only one staple 1020 is depicted in FIGS. 18A-18D. FIG. 18A illustrates the staple cartridge 1000 supported by a staple cartridge support, or staple cartridge channel, 1030, wherein the staple cartridge 1000 is illustrated in an uncompressed condition. In such an uncompressed condition, the anvil 1040 may or may not be in contact with the tissue T. In use, the anvil 1040 can be moved from an open position into contact with the tissue T as illustrated in FIG. 18B and position the tissue T against the cartridge body 1010. Even though the anvil 1040 can position the tissue T against a tissue-contacting surface 1019 of staple cartridge body 1010, referring again to FIG. 18B, the staple cartridge body 1010 may be subjected to little, if any, compressive force or pressure at such point and the staples 1020 may remain in an unformed, or unfired, condition. As illustrated in FIGS. 18A and 18B, the staple cartridge body 1010 can comprise one or more layers and the staple legs 1021 of staples 1020 can extend upwardly through these layers. In various embodiments, the cartridge body 1010 can comprise a first layer 1011, a second layer 1012, a third layer 1013, wherein the second layer 1012 can be positioned intermediate the first layer 1011 and the third layer 1013, and a fourth layer 1014, wherein the third layer 1013 can be positioned intermediate the second layer 1012 and the fourth layer 1014. In at least one embodiment, the bases 1022 of the staples 1020 can be positioned within cavities 1015 in the fourth layer 1014 and the staple legs 1021 can extend upwardly from the bases 1022 and through the fourth layer 1014, the third layer 1013, and the second layer 1012, for example. In various embodiments, each deformable leg 1021 can comprise a tip, such as sharp tip 1023, for example, which can be positioned in the second layer 1012, for example, when the staple cartridge 1000 is in an uncompressed condition. In at least one such embodiment, the tips 1023 may not extend into and/or through the first layer 1011, wherein, in at least one embodiment, the tips 1023 may not protrude through the tissue-contacting surface 1019 when the staple cartridge 1000 is in an uncompressed condition. In certain other embodiments, the sharp tips 1023 may be positioned in the third layer 1013, and/or any other suitable layer, when the staple cartridge is in an uncompressed condition. In various alternative embodiments, a cartridge body of a staple cartridge may have any suitable number of layers such as less than four layers or more than four layers, for example.


In various embodiments, as described in greater detail below, the first layer 1011 can be comprised of a buttress material and/or plastic material, such as polydioxanone (PDS) and/or polyglycolic acid (PGA), for example, and the second layer 1012 can be comprised of a bioabsorbable foam material and/or a compressible hemostatic material, such as oxidized regenerated cellulose (ORC), for example. In various embodiments, one or more of the first layer 1011, the second layer 1012, the third layer 1013, and the fourth layer 1014 may hold the staples 1020 within the staple cartridge body 1010 and, in addition, maintain the staples 1020 in alignment with one another. In various embodiments, the third layer 1013 can be comprised of a buttress material, or a fairly incompressible or inelastic material, which can be configured to hold the staple legs 1021 of the staples 1020 in position relative to one another. Furthermore, the second layer 1012 and the fourth layer 1014, which are positioned on opposite sides of the third layer 1013, can stabilize, or reduce the movement of, the staples 1020 even though the second layer 1012 and the fourth layer 1014 can be comprised of a compressible foam or elastic material. In certain embodiments, the staple tips 1023 of the staple legs 1021 can be at least partially embedded in the first layer 1011. In at least one such embodiment, the first layer 1011 and the third layer 1013 can be configured to co-operatively and firmly hold the staple legs 1021 in position. In at least one embodiment, the first layer 1011 and the third layer 1013 can each be comprised of a sheet of bioabsorbable plastic, such as polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example, and the second layer 1012 and the fourth layer 1014 can each be comprised of at least one hemostatic material or agent.


Although the first layer 1011 can be compressible, the second layer 1012 can be substantially more compressible than the first layer 1011. For example, the second layer 1012 can be about twice as compressible, about three times as compressible, about four times as compressible, about five times as compressible, and/or about ten times as compressible, for example, as the first layer 1011. Stated another way, the second layer 1012 may compress about two times, about three times, about four times, about five times, and/or about ten times as much as first layer 1011, for a given force. In certain embodiments, the second layer 1012 can be between about twice as compressible and about ten times as compressible, for example, as the first layer 1011. In at least one embodiment, the second layer 1012 can comprise a plurality of air voids defined therein, wherein the amount and/or size of the air voids in the second layer 1012 can be controlled in order to provide a desired compressibility of the second layer 1012. Similar to the above, although the third layer 1013 can be compressible, the fourth layer 1014 can be substantially more compressible than the third layer 1013. For example, the fourth layer 1014 can be about twice as compressible, about three times as compressible, about four times as compressible, about five times as compressible, and/or about ten times as compressible, for example, as the third layer 1013. Stated another way, the fourth layer 1014 may compress about two times, about three times, about four times, about five times, and/or about ten times as much as third layer 1013, for a given force. In certain embodiments, the fourth layer 1014 can be between about twice as compressible and about ten times as compressible, for example, as the third layer 1013. In at least one embodiment, the fourth layer 1014 can comprise a plurality of air voids defined therein, wherein the amount and/or size of the air voids in the fourth layer 1014 can be controlled in order to provide a desired compressibility of the fourth layer 1014. In various circumstances, the compressibility of a cartridge body, or cartridge body layer, can be expressed in terms of a compression rate, i.e., a distance in which a layer is compressed for a given amount of force. For example, a layer having a high compression rate will compress a larger distance for a given amount of compressive force applied to the layer as compared to a layer having a lower compression rate. This being said, the second layer 1012 can have a higher compression rate than the first layer 1011 and, similarly, the fourth layer 1014 can have a higher compression rate than the third layer 1013. In various embodiments, the second layer 1012 and the fourth layer 1014 can be comprised of the same material and can comprise the same compression rate. In various embodiments, the second layer 1012 and the fourth layer 1014 can be comprised of materials having different compression rates. Similarly, the first layer 1011 and the third layer 1013 can be comprised of the same material and can comprise the same compression rate. In certain embodiments, the first layer 1011 and the third layer 1013 can be comprised of materials having different compression rates.


As the anvil 1040 is moved toward its closed position, the anvil 1040 can contact tissue T and apply a compressive force to the tissue T and the staple cartridge 1000, as illustrated in FIG. 18C. In such circumstances, the anvil 1040 can push the top surface, or tissue-contacting surface 1019, of the cartridge body 1010 downwardly toward the staple cartridge support 1030. In various embodiments, the staple cartridge support 1030 can comprise a cartridge support surface 1031 which can be configured to support the staple cartridge 1000 as the staple cartridge 1000 is compressed between the cartridge support surface 1031 and the tissue-contacting surface 1041 of anvil 1040. Owing to the pressure applied by the anvil 1040, the cartridge body 1010 can be compressed and the anvil 1040 can come into contact with the staples 1020. More particularly, in various embodiments, the compression of the cartridge body 1010 and the downward movement of the tissue-contacting surface 1019 can cause the tips 1023 of the staple legs 1021 to pierce the first layer 1011 of cartridge body 1010, pierce the tissue T, and enter into forming pockets 1042 in the anvil 1040. As the cartridge body 1010 is further compressed by the anvil 1040, the tips 1023 can contact the walls defining the forming pockets 1042 and, as a result, the legs 1021 can be deformed or curled inwardly, for example, as illustrated in FIG. 18C. As the staple legs 1021 are being deformed, as also illustrated in FIG. 18C, the bases 1022 of the staples 1020 can be in contact with or supported by the staple cartridge support 1030. In various embodiments, as described in greater detail below, the staple cartridge support 1030 can comprise a plurality of support features, such as staple support grooves, slots, or troughs 1032, for example, which can be configured to support the staples 1020, or at least the bases 1022 of the staples 1020, as the staples 1020 are being deformed. As also illustrated in FIG. 18C, the cavities 1015 in the fourth layer 1014 can collapse as a result of the compressive force applied to the staple cartridge body 1010. In addition to the cavities 1015, the staple cartridge body 1010 can further comprise one or more voids, such as voids 1016, for example, which may or may not comprise a portion of a staple positioned therein, that can be configured to allow the cartridge body 1010 to collapse. In various embodiments, the cavities 1015 and/or the voids 1016 can be configured to collapse such that the walls defining the cavities and/or walls deflect downwardly and contact the cartridge support surface 1031 and/or contact a layer of the cartridge body 1010 positioned underneath the cavities and/or voids.


Upon comparing FIG. 18B and FIG. 18C, it is evident that the second layer 1012 and the fourth layer 1014 have been substantially compressed by the compressive pressure applied by the anvil 1040. It may also be noted that the first layer 1011 and the third layer 1013 have been compressed as well. As the anvil 1040 is moved into its closed position, the anvil 1040 may continue to further compress the cartridge body 1010 by pushing the tissue-contacting surface 1019 downwardly toward the staple cartridge support 1030. As the cartridge body 1010 is further compressed, the anvil 1040 can deform the staples 1020 into their completely-formed shape as illustrated in FIG. 18D. Referring to FIG. 18D, the legs 1021 of each staple 1020 can be deformed downwardly toward the base 1022 of each staple 1020 in order to capture at least a portion of the tissue T, the first layer 1011, the second layer 1012, the third layer 1013, and the fourth layer 1014 between the deformable legs 1021 and the base 1022. Upon comparing FIGS. 18C and 18D, it is further evident that the second layer 1012 and the fourth layer 1014 have been further substantially compressed by the compressive pressure applied by the anvil 1040. It may also be noted upon comparing FIGS. 18C and 18D that the first layer 1011 and the third layer 1013 have been further compressed as well. After the staples 1020 have been completely, or at least sufficiently, formed, the anvil 1040 can be lifted away from the tissue T and the staple cartridge support 1030 can be moved away, and/or detached from, the staple cartridge 1000. As depicted in FIG. 18D, and as a result of the above, the cartridge body 1010 can be implanted with the staples 1020. In various circumstances, the implanted cartridge body 1010 can support the tissue along the staple line. In some circumstances, a hemostatic agent, and/or any other suitable therapeutic medicament, contained within the implanted cartridge body 1010 can treat the tissue over time. A hemostatic agent, as mentioned above, can reduce the bleeding of the stapled and/or incised tissue while a bonding agent or tissue adhesive can provide strength to the tissue over time. The implanted cartridge body 1010 can be comprised of materials such as ORC (oxidized regenerated cellulous), protein matrix, polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In certain circumstances, the cartridge body 1010 can comprise an antibiotic and/or anti-microbial material, such as colloidal silver and/or triclosan, for example, which can reduce the possibility of infection in the surgical site.


In various embodiments, the layers of the cartridge body 1010 can be connected to one another. In at least one embodiment, the second layer 1012 can be adhered to the first layer 1011, the third layer 1013 can be adhered to the second layer 1012, and the fourth layer 1014 can be adhered to the third layer 1013 utilizing at least one adhesive, such as fibrin and/or protein hydrogel, for example. In certain embodiments, although not illustrated, the layers of the cartridge body 1010 can be connected together by interlocking mechanical features. In at least one such embodiment, the first layer 1011 and the second layer 1012 can each comprise corresponding interlocking features, such as a tongue and groove arrangement and/or a dovetail joint arrangement, for example. Similarly, the second layer 1012 and the third layer 1013 can each comprise corresponding interlocking features while the third layer 1013 and the fourth layer 1014 can each comprise corresponding interlocking features. In certain embodiments, although not illustrated, the staple cartridge 1000 can comprise one or more rivets, for example, which can extend through one or more layers of the cartridge body 1010. In at least one such embodiment, each rivet can comprise a first end, or head, positioned adjacent to the first layer 1011 and a second head positioned adjacent to the fourth layer 1014 which can be either assembled to or formed by a second end of the rivet. Owing to the compressible nature of the cartridge body 1010, in at least one embodiment, the rivets can compress the cartridge body 1010 such that the heads of the rivets can be recessed relative to the tissue-contacting surface 1019 and/or the bottom surface 1018 of the cartridge body 1010, for example. In at least one such embodiment, the rivets can be comprised of a bioabsorbable material, such as polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In certain embodiments, the layers of the cartridge body 1010 may not be connected to one another other than by the staples 1020 contained therein. In at least one such embodiment, the frictional engagement between the staple legs 1021 and the cartridge body 1010, for example, can hold the layers of the cartridge body 1010 together and, once the staples have been formed, the layers can be captured within the staples 1020. In certain embodiments, at least a portion of the staple legs 1021 can comprise a roughened surface or rough coating which can increase the friction forces between the staples 1020 and the cartridge body 1010.


As described above, a surgical instrument can comprise a first jaw including the staple cartridge support 1030 and a second jaw including the anvil 1040. In various embodiments, as described in greater detail further below, the staple cartridge 1000 can comprise one or more retention features which can be configured to engage the staple cartridge support 1030 and, as a result, releasably retain the staple cartridge 1000 to the staple cartridge support 1030. In certain embodiments, the staple cartridge 1000 can be adhered to the staple cartridge support 1030 by at least one adhesive, such as fibrin and/or protein hydrogel, for example. In use, in at least one circumstance, especially in laparoscopic and/or endoscopic surgery, the second jaw can be moved into a closed position opposite the first jaw, for example, such that the first and second jaws can be inserted through a trocar into a surgical site. In at least one such embodiment, the trocar can define an approximately 5 mm aperture, or cannula, through which the first and second jaws can be inserted. In certain embodiments, the second jaw can be moved into a partially-closed position intermediate the open position and the closed position which can allow the first and second jaws to be inserted through the trocar without deforming the staples 1020 contained in the staple cartridge body 1010. In at least one such embodiment, the anvil 1040 may not apply a compressive force to the staple cartridge body 1010 when the second jaw is in its partially-closed intermediate position while, in certain other embodiments, the anvil 1040 can compress the staple cartridge body 1010 when the second jaw is in its partially-closed intermediate position. Even though the anvil 1040 can compress the staple cartridge body 1010 when it is in such an intermediate position, the anvil 1040 may not sufficiently compress the staple cartridge body 1010 such that the anvil 1040 comes into contact with the staples 1020 and/or such that the staples 1020 are deformed by the anvil 1040. Once the first and second jaws have been inserted through the trocar into the surgical site, the second jaw can be opened once again and the anvil 1040 and the staple cartridge 1000 can be positioned relative to the targeted tissue as described above.


In various embodiments, referring now to FIGS. 19A-19D, an end effector of a surgical stapler can comprise an implantable staple cartridge 1100 positioned intermediate an anvil 1140 and a staple cartridge support 1130. Similar to the above, the anvil 1140 can comprise a tissue-contacting surface 1141, the staple cartridge 1100 can comprise a tissue-contacting surface 1119, and the staple cartridge support 1130 can comprise a support surface 1131 which can be configured to support the staple cartridge 1100. Referring to FIG. 19A, the anvil 1140 can be utilized to position the tissue T against the tissue contacting surface 1119 of staple cartridge 1100 without deforming the staple cartridge 1100 and, when the anvil 1140 is in such a position, the tissue-contacting surface 1141 can be positioned a distance 1101a away from the staple cartridge support surface 1131 and the tissue-contacting surface 1119 can be positioned a distance 1102a away from the staple cartridge support surface 1131. Thereafter, as the anvil 1140 is moved toward the staple cartridge support 1130, referring now to FIG. 19B, the anvil 1140 can push the top surface, or tissue-contacting surface 1119, of staple cartridge 1100 downwardly and compress the first layer 1111 and the second layer 1112 of cartridge body 1110. As the layers 1111 and 1112 are compressed, referring again to FIG. 19B, the second layer 1112 can be crushed and the legs 1121 of staples 1120 can pierce the first layer 1111 and enter into the tissue T. In at least one such embodiment, the staples 1120 can be at least partially positioned within staple cavities, or voids, 1115 in the second layer 1112 and, when the second layer 1112 is compressed, the staple cavities 1115 can collapse and, as a result, allow the second layer 1112 to collapse around the staples 1120. In various embodiments, the second layer 1112 can comprise cover portions 1116 which can extend over the staple cavities 1115 and enclose, or at least partially enclose, the staple cavities 1115. FIG. 19B illustrates the cover portions 1116 being crushed downwardly into the staple cavities 1115. In certain embodiments, the second layer 1112 can comprise one or more weakened portions which can facilitate the collapse of the second layer 1112. In various embodiments, such weakened portions can comprise score marks, perforations, and/or thin cross-sections, for example, which can facilitate a controlled collapse of the cartridge body 1110. In at least one embodiment, the first layer 1111 can comprise one or more weakened portions which can facilitate the penetration of the staple legs 1121 through the first layer 1111. In various embodiments, such weakened portions can comprise score marks, perforations, and/or thin cross-sections, for example, which can be aligned, or at least substantially aligned, with the staple legs 1121.


When the anvil 1140 is in a partially closed, unfired position, referring again to FIG. 19A, the anvil 1140 can be positioned a distance 1101a away from the cartridge support surface 1131 such that a gap is defined therebetween. This gap can be filled by the staple cartridge 1100, having a staple cartridge height 1102a, and the tissue T. As the anvil 1140 is moved downwardly to compress the staple cartridge 1100, referring again to FIG. 19B, the distance between the tissue contacting surface 1141 and the cartridge support surface 1131 can be defined by a distance 1101b which is shorter than the distance 1101a. In various circumstances, the gap between the tissue-contacting surface 1141 of anvil 1140 and the cartridge support surface 1131, defined by distance 1101b, may be larger than the original, undeformed staple cartridge height 1102a. As the anvil 1140 is moved closer to the cartridge support surface 1131, referring now to FIG. 19C, the second layer 1112 can continue to collapse and the distance between the staple legs 1121 and the forming pockets 1142 can decrease. Similarly, the distance between the tissue-contacting surface 1141 and the cartridge support surface 1131 can decrease to a distance 1101c which, in various embodiments, may be greater than, equal to, or less than the original, undeformed cartridge height 1102a. Referring now to FIG. 19D, the anvil 1140 can be moved into a final, fired position in which the staples 1120 have been fully formed, or at least formed to a desired height. In such a position, the tissue-contacting surface 1141 of anvil 1140 can be a distance 1101d away from the cartridge support surface 1131, wherein the distance 1101d can be shorter than the original, undeformed cartridge height 1102a. As also illustrated in FIG. 19D, the staple cavities 1115 may be fully, or at least substantially, collapsed and the staples 1120 may be completely, or at least substantially, surrounded by the collapsed second layer 1112. In various circumstances, the anvil 1140 can be thereafter moved away from the staple cartridge 1100. Once the anvil 1140 has been disengaged from the staple cartridge 1100, the cartridge body 1110 can at least partially re-expand in various locations, i.e., locations intermediate adjacent staples 1120, for example. In at least one embodiment, the crushed cartridge body 1110 may not resiliently re-expand. In various embodiments, the formed staples 1120 and, in addition, the cartridge body 1110 positioned intermediate adjacent staples 1120 may apply pressure, or compressive forces, to the tissue T which may provide various therapeutic benefits.


As discussed above, referring again to the embodiment illustrated in FIG. 19A, each staple 1120 can comprise staple legs 1121 extending therefrom. Although staples 1120 are depicted as comprising two staple legs 1121, various staples can be utilized which can comprise one staple leg or, alternatively, more than two staple legs, such as three staple legs or four staple legs, for example. As illustrated in FIG. 19A, each staple leg 1121 can be embedded in the second layer 1112 of the cartridge body 1110 such that the staples 1120 are secured within the second layer 1112. In various embodiments, the staples 1120 can be inserted into the staple cavities 1115 in cartridge body 1110 such that the tips 1123 of the staple legs 1121 enter into the cavities 1115 before the bases 1122. After the tips 1123 have been inserted into the cavities 1115, in various embodiments, the tips 1123 can be pressed into the cover portions 1116 and incise the second layer 1112. In various embodiments, the staples 1120 can be seated to a sufficient depth within the second layer 1112 such that the staples 1120 do not move, or at least substantially move, relative to the second layer 1112. In certain embodiments, the staples 1120 can be seated to a sufficient depth within the second layer 1112 such that the bases 1122 are positioned or embedded within the staple cavities 1115. In various other embodiments, the bases 1122 may not be positioned or embedded within the second layer 1112. In certain embodiments, referring again to FIG. 19A, the bases 1122 may extend below the bottom surface 1118 of the cartridge body 1110. In certain embodiments, the bases 1122 can rest on, or can be directly positioned against, the cartridge support surface 1130. In various embodiments, the cartridge support surface 1130 can comprise support features extending therefrom and/or defined therein wherein, in at least one such embodiment, the bases 1122 of the staples 1120 may be positioned within and supported by one or more support grooves, slots, or troughs, 1132, for example, in the staple cartridge support 1130, as described in greater detail further below.


Further to the above, referring now to FIG. 20, the bases 1122 of the staples 1120 can be positioned directly against the support surface 1131 of staple cartridge support 1130. In various embodiments, including embodiments where the staple bases 1122 comprise circular or arcuate bottom surfaces 1124, for example, the staple bases 1122 may move or slide along the staple cartridge support surface 1131. Such sliding can occur when the anvil 1140 is pressed against the tips 1123 of the staple legs 1121 during the staple forming process. In certain embodiments, as described above and referring now to FIG. 21, the staple cartridge support 1130 can comprise one or more support slots 1132 therein which can be configured to eliminate, or at least reduce, the relative movement between the staple bases 1122 and the cartridge support surface 1131. In at least one such embodiment, each support slot 1132 can be defined by a surface contour which matches, or at least substantially matches, the contour of the bottom surface of the staple positioned therein. For example, the bottom surface 1124 of the base 1122 depicted in FIG. 21 can comprise a circular, or at least substantially circular, surface and the support slot 1132 can also comprise a circular, or at least substantially circular, surface. In at least one such embodiment, the surface defining the slot 1132 can be defined by a radius of curvature which is greater than or equal to a radius of curvature which defines bottom surface 1124. Although the slots 1132 may assist in preventing or reducing relative sliding movement between the staples 1120 and the staple cartridge support 1130, the slots 1132 may also be configured to prevent or reduce relative rotational movement between the staples 1120 and the staple cartridge support 1130. More particularly, in at least one embodiment, the slots 1132 can be configured to closely receive the bases 1122 in order to prevent or reduce the rotation of the staples 1120 about axes 1129, for example, such that the staples 1120 do not rotate or twist when they are being deformed.


In various embodiments, further to the above, each staple 1120 can be formed from a round, or an at least substantially round, wire. In certain embodiments, the legs and the base of each staple can be formed from a wire having a non-circular cross-section, such as a rectangular cross-section, for example. In at least one such embodiment, the staple cartridge support 1130 can comprise corresponding non-circular slots, such as rectangular slots, for example, configured to receive the bases of such staples. In various embodiments, referring now to FIG. 22, each staple 1120 can comprise a crown, such as a crown 1125, for example, overmolded onto a base 1122 wherein each crown 1125 can be positioned within a support slot in the staple cartridge support 1130. In at least one such embodiment, each crown 1125 can comprise a square and/or rectangular cross-section, for example, which can be configured to be received within square and/or rectangular slots 1134, for example, in the staple cartridge support 1130. In various embodiments, the crowns 1125 can be comprised of a bioabsorbable plastic, such as polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example, and can be formed around the bases 1122 of the staples 1120 by an injection molding process, for example. Various crowns and methods for forming various crowns are disclosed in U.S. patent application Ser. No. 11/541,123, entitled SURGICAL STAPLES HAVING COMPRESSIBLE OR CRUSHABLE MEMBERS FOR SECURING TISSUE THEREIN AND STAPLING INSTRUMENTS FOR DEPLOYING THE SAME, filed on Sep. 29, 2006, now U.S. Pat. No. 7,794,475, the entire disclosure of which is incorporated be reference herein. Referring again to FIG. 22, the slots 1134 can further comprise lead-ins, or bevels, 1135 which can be configured to facilitate the insertion of the crowns 1125 into the slots 1134. In various embodiments, the bases and/or crowns of the staples 1120 may be positioned within the slots 1134 when the staple cartridge 1100 is assembled to the staple cartridge support 1130. In certain embodiments, the crowns 1125 of the staples 1120 may be aligned with the slots 1134 when the staple cartridge 1100 is assembled to the staple cartridge support 1130. In at least one such embodiment, the crowns 1125 may not enter into the slots 1134 until a compressive force is applied to the staple legs 1121 and the bases and/or crowns of the staples 1120 are pushed downwardly into the slots 1134.


In various embodiments, referring now to FIGS. 23 and 24, a staple cartridge, such as staple cartridge 1200, for example, can comprise a compressible, implantable cartridge body 1210 comprising an outer layer 1211 and an inner layer 1212. Similar to the above, the staple cartridge 1200 can comprise a plurality of staples 1220 positioned within the cartridge body 1210. In various embodiments, each staple 1220 can comprise a base 1222 and one or more staple legs 1221 extending therefrom. In at least one such embodiment, the staple legs 1221 can be inserted into the inner layer 1212 and seated to a depth in which the bases 1222 of the staples 1220 abut and/or are positioned adjacent to the bottom surface 1218 of the inner layer 1212, for example. In the embodiment depicted in FIGS. 23 and 24, the inner layer 1212 does not comprise staple cavities configured to receive a portion of the staples 1220 while, in other embodiments, the inner layer 1212 can comprise such staple cavities. In various embodiments, further to the above, the inner layer 1212 can be comprised of a compressible material, such as bioabsorbable foam and/or oxidized regenerated cellulose (ORC), for example, which can be configured to allow the cartridge body 1210 to collapse when a compressive load is applied thereto. In various embodiments, the inner layer 1212 can be comprised of a lyophilized foam comprising polylactic acid (PLA) and/or polyglycolic acid (PGA), for example. The ORC may be commercially available under the trade name Surgicel and can comprise a loose woven fabric (like a surgical sponge), loose fibers (like a cotton ball), and/or a foam. In at least one embodiment, the inner layer 1212 can be comprised of a material including medicaments, such as freeze-dried thrombin and/or fibrin, for example, contained therein and/or coated thereon which can be water-activated and/or activated by fluids within the patient's body, for example. In at least one such embodiment, the freeze-dried thrombin and/or fibrin can be held on a Vicryl (PGA) matrix, for example. In certain circumstances, however, the activatable medicaments can be unintentionally activated when the staple cartridge 1200 is inserted into a surgical site within the patient, for example. In various embodiments, referring again to FIGS. 23 and 24, the outer layer 1211 can be comprised of a water impermeable, or at least substantially water impermeable, material such that liquids do not come into contact with, or at least substantially contact, the inner layer 1212 until after the cartridge body 1210 has been compressed and the staple legs have penetrated the outer layer 1211 and/or after the outer layer 1211 has been incised in some fashion. In various embodiments, the outer layer 1211 can be comprised of a buttress material and/or plastic material, such as polydioxanone (PDS) and/or polyglycolic acid (PGA), for example. In certain embodiments, the outer layer 1211 can comprise a wrap which surrounds the inner layer 1212 and the staples 1220. More particularly, in at least one embodiment, the staples 1220 can be inserted into the inner layer 1212 and the outer layer 1211 can be wrapped around the sub-assembly comprising the inner layer 1212 and the staples 1220 and then sealed.


In various embodiments, referring now to FIGS. 25 and 26, a staple cartridge, such as staple cartridge 1300, for example, can comprise a compressible, implantable cartridge body 1310 including an outer layer 1311 and an inner layer 1312. Similar to the above, the staple cartridge 1300 can further comprise staples 1320 positioned within the cartridge body 1310 wherein each staple 1320 can comprise a base 1322 and one or more legs 1321 extending therefrom Similar to staple cartridge 1200, the bases 1322 of staples 1320 can extend below the bottom surface 1318 of the inner layer 1312 and the outer layer 1311 can surround the bases 1322. In at least one such embodiment, the outer layer 1311 can be sufficiently flexible so as to envelop each staple base 1322 such that the outer layer 1311 conforms to the contour of the bases 1322. In at least one alternative embodiment, referring again to FIG. 24, the outer layer 1211 can be sufficiently rigid such that it extends around the bases 1222 without conforming to each base 1222. In any event, in various embodiments, the outer layer 1311 can be positioned intermediate the bases 1322 of staples 1320 and a staple cartridge support surface, such as support surfaces 1031 or 1131, for example, supporting the staple cartridge 1300. In at least one such embodiment, the outer layer 1311 can be positioned intermediate the bases 1322 and support slots, such as slots 1032 or 1132, for example, defined in the staple cartridge support surface. In at least one such embodiment, further to the above, the outer layer 1311 can be configured to limit the movement of the bases 1322 and/or increase the coefficient of friction between the bases 1322 and the staple cartridge support surface and/or support slots in order to reduce relative movement therebetween. In various alternative embodiments, referring now to FIGS. 27 and 28, the outer layer of a staple cartridge, such as staple cartridge 1400, for example, may not entirely surround the staples positioned therein. In at least one such embodiment, an outer layer 1411 of a compressible, implantable cartridge body 1410 may be assembled to the inner layer 1412 before the staple legs 1421 of staples 1420 are inserted into the cartridge body 1410. As a result of the above, the bases 1422 of staples 1420 may extend outside of the outer layer 1411 and, in at least one such embodiment, the bases 1422 may be positioned directly into the support slots 1032 or 1132 within the staple cartridge support surfaces 1031 or 1131, for example. In various embodiments, the staple legs 1421 may incise the outer layer 1411 when they are inserted therethrough. In various circumstances, the holes created by the staple legs 1421 may closely surround the staple legs 1421 such that very little, if any, fluid can leak between the staple legs 1421 and the outer layer 1411 which can reduce the possibility of, or prevent, the medicament contained within the staple cartridge body 1410 from being activated and/or leaking out of the cartridge body 1410 prematurely.


As discussed above, referring again to FIGS. 23 and 24, the legs 1221 of the staples 1220 can be embedded within the cartridge body 1210 and the bases 1222 of staples 1220 may extend outwardly from the bottom surface 1218 of the inner layer 1212. In various embodiments, further to the above, the inner layer 1212 may not comprise staple cavities configured to receive the staples 1220. In various other embodiments, referring now to FIGS. 29 and 30, a staple cartridge, such as staple cartridge 1500, for example, may comprise a compressible, implantable cartridge body 1510 comprising staple cavities 1515 which can be configured to receive at least a portion of the staples 1520 therein. In at least one such embodiment, a top portion of the staple legs 1521 of the staples 1520 may be embedded in the inner layer 1512 while a bottom portion of the staple legs 1521, and the bases 1522, may be positioned within the staple cavities 1515. In certain embodiments, the bases 1522 may be entirely positioned in the staple cavities 1515 while, in some embodiments, the bases 1522 may at least partially extend below the bottom surface 1518 of the inner layer 1512. Similar to the above, the outer layer 1511 may enclose the inner layer 1512 and the staples 1520 positioned therein. In certain other embodiments, referring now to FIG. 31, a staple cartridge 1600 may comprise staples 1620 positioned within staple cavities 1615 in a compressible, implantable cartridge body 1610 wherein at least a portion of the staples 1620 are not enclosed by the outer layer 1611. In at least one such embodiment, each staple 1620 can comprise staple legs 1621 which are at least partially embedded in the inner layer 1612 and, in addition, bases 1622 which extend outwardly around the outer layer 1611.


In various embodiments, referring now to FIGS. 32 and 33, a staple cartridge, such as staple cartridge 1700, for example, can comprise a compressible, implantable cartridge body 1710 and a plurality of staples 1720 at least partially positioned within the cartridge body 1710. The cartridge body 1710 can comprise an outer layer 1711, an inner layer 1712, and, in addition, an alignment matrix 1740 which can be configured to align and/or retain the staples 1720 in position within the cartridge body 1710. In at least one embodiment, the inner layer 1712 can comprise a recess 1741 which can be configured to receive the alignment matrix 1740 therein. In various embodiments, the alignment matrix 1140 can be press-fit within the recess 1741 and/or otherwise suitably secured to the inner layer 1712 utilizing at least one adhesive, such as fibrin and/or protein hydrogel, for example. In at least one embodiment, the recess 1741 can be configured such that the bottom surface 1742 of alignment matrix 1740 is aligned, or at least substantially aligned, with the bottom surface 1718 of the inner layer 1712. In certain embodiments, the bottom surface 1742 of the alignment matrix can be recessed with respect to and/or extend from the bottom surface 1718 of the second layer 1712. In various embodiments, each staple 1720 can comprise a base 1722 and one or more legs 1721 extending from the base 1722, wherein at least a portion of the staple legs 1721 can extend through the alignment matrix 1740. The alignment matrix 1740 can further comprise a plurality of apertures and/or slots, for example, extending therethrough which can be configured to receive the staple legs 1721 therein. In at least one such embodiment, each aperture can be configured to closely receive a staple leg 1721 such that there is little, if any, relative movement between the staple leg 1721 and the sidewalls of the aperture. In certain embodiments, the alignment matrix apertures may not extend entirely through the alignment matrix 1740 and the staple legs 1721 may be required to incise the alignment matrix 1740 as the staple legs 1721 are pushed therethrough.


In various embodiments, the alignment matrix 1740 can be comprised of a molded plastic body which, in at least one embodiment, can be stiffer or less compressible than the inner layer 1712 and/or the outer layer 1711. In at least one such embodiment, the alignment matrix 1740 can be comprised of a plastic material and/or any other suitable material, such as polydioxanone (PDS) and/or polyglycolic acid (PGA), for example. In certain embodiments, the alignment matrix 1740 can be assembled to the inner layer 1712 and the staple legs 1721 can thereafter be inserted through the alignment matrix 1740 and embedded into the inner layer 1712. In various embodiments, the bottom surface 1742 of the alignment matrix 1740 can comprise one or more grooves, slots, or troughs, for example, which can be configured to at least partially receive the bases 1722 of the staples 1720. Similar to the above, the outer layer 1711 can then be placed around the subassembly comprising the inner layer 1712, the alignment matrix 1740, and the staples 1720. Alternatively, the outer layer 1711 can be placed around a subassembly comprising the inner layer 1712 and the alignment matrix 1740 wherein the staples 1720 can be thereafter inserted through the outer layer 1711, the alignment matrix 1740, and the inner layer 1712. In any event, as a result of the above, the inner layer 1712, the alignment matrix 1740, and/or the outer layer 1711 can be configured to retain the staples 1720 in position until and/or after they are deformed by an anvil as described above. In at least one such embodiment, the alignment matrix 1740 can serve to hold the staples 1720 in place before the staple cartridge 1700 is implanted within a patient and, in addition, secure the tissue along the staple line after the staple cartridge 1700 has been implanted. In at least one embodiment, the staples 1720 may be secured within the alignment matrix 1740 without being embedded in the inner layer 1712 and/or the outer layer 1711, for example.


In various embodiments, referring now to FIGS. 34-40, a staple cartridge, such as staple cartridge 1800, for example, can be assembled by compressing an inner layer 1812, inserting staples, such as staples 1820, for example, into the inner layer 1812, and wrapping the inner layer 1812 with an outer layer 1811. Referring primarily to FIG. 34, a compressible inner layer 1812 is illustrated as comprising a plurality of staple cavities 1815 defined therein, although other embodiments are envisioned in which the inner layer 1812 does not comprise staple cavities, as described above. Referring now to FIG. 35, the compressible inner layer 1812 can be positioned intermediate a transfer plate 1850 and a support plate 1860 and compressed between the compression surfaces 1852 and 1862 thereof, respectively. As illustrated in FIG. 35, the top and bottom surfaces of the inner layer 1812 can be compressed toward one another and, in response thereto, the inner layer 1812 can bulge outwardly in the lateral directions. In certain embodiments, the inner layer 1812 can be compressed to a height which is approximately one-third of its original height, for example, and can have a height or thickness between approximately 0.06″ and approximately 0.08″ in its compressed state, for example. As also illustrated in FIG. 35, the transfer plate 1850 can further comprise a plurality of staples, such as staples 1820, for example, positioned within a plurality of staple wells 1853. In addition, the transfer plate 1850 can further comprise a plurality of drivers 1851 which can be configured to push the staples 1820 upwardly and out of the staple wells 1853. Referring now to FIG. 36, the drivers 1851 can be utilized to push the staple legs 1821 of the staples 1820 into and through the compressed inner layer 1812. In various embodiments, the drivers 1851 can be configured such that the top surfaces thereof are positioned flush, or at least nearly flush, with the compression surface 1852 of the transfer plate 1850 when the staples 1820 have been fully deployed from the staple wells 1853 of transfer plate 1850. In certain embodiments, as also illustrated in FIG. 36, the support plate 1860 can comprise a plurality of receiving apertures 1861 which can be configured to receive the staple legs 1821, or at least the tips of the staple legs 1821, after they are pushed through the inner layer 1812. The receiving apertures 1861, or the like, may be necessitated in embodiments where the inner layer 1812 has been compressed to a height which is shorter than the height of the staples 1820 and, thus, when the staples 1820 have been fully ejected from the staple wells 1853, the staple legs 1821 may protrude from the top surface of the compressed inner layer 1812. In certain other embodiments, the inner layer 1812 may be compressed to a height which is taller than the height of the staples 1820 and, as a result, the receiving apertures 1861 in support plate 1860 may be unnecessary.


After the staples 1820 have been inserted into the inner layer 1812, referring now to FIG. 37, the support plate 1860 can be moved away from the transfer plate 1850 in order to allow the inner layer 1812 to decompress. In such circumstances, the inner layer 1812 can resiliently re-expand to its original, or at least near-original, uncompressed height. As the inner layer 1812 re-expands, the height of the inner layer 1812 can increase such that it exceeds the height of the staples 1820 and such that the staple legs 1821 of the staples 1820 no longer protrude from the top surface of the inner layer 1812. In various circumstances, the receiving apertures 1861 can be configured to hold the staple legs 1821 in position at least until the support plate 1860 has been sufficiently moved away such that the legs 1821 are no longer positioned within the receiving apertures 1861. In such circumstances, the receiving apertures 1861 can assist in maintaining the relative alignment of the staples 1820 within the inner layer 1812 as it re-expands. In various circumstances, the inner layer 1812 and the staples 1820 positioned therein can comprise a subassembly 1801 which, referring now to FIG. 38, can be inserted into an outer layer 1811, for example. In at least one such embodiment, the outer layer 1811 can comprise a cavity 1802 defined therein which can be configured to receive the subassembly 1801 therein. In various circumstances, a tool, such as pliers 1855, for example, can be utilized to pull the outer layer 1811 onto the subassembly 1801. Once the subassembly 1801 has been sufficiently positioned within the outer layer 1811, referring now to FIG. 39, the outer layer 1811 can be sealed. In various embodiments, the outer layer 1811 can be sealed utilizing the application of heat energy to a portion thereof. More particularly, in at least one embodiment, the outer layer 1811 can be comprised of a plastic material wherein the open end of the outer layer 1811 can be heat-staked by one or more heated elements, or irons, 1856 in order to bond and/or seal the perimeter of the open end of the outer layer 1811 together. In at least one such embodiment, referring now to FIG. 40, an excess portion 1857 of the outer layer 1811 can be removed and the staple cartridge 1800 can then be used as described herein.


As described above, a staple cartridge can be positioned within and/or secured to a staple cartridge attachment portion. In various embodiments, referring now to FIGS. 41 and 42, a staple cartridge attachment portion can comprise a staple cartridge channel, such as staple cartridge channel 1930, for example, which can be configured to receive at least a portion of a staple cartridge, such as staple cartridge 1900, for example, therein. In at least one embodiment, the staple cartridge channel 1930 can comprise a bottom support surface 1931, a first lateral support wall 1940, and a second lateral support wall 1941. In use, the staple cartridge 1900 can be positioned within the staple cartridge channel 1930 such that the staple cartridge 1900 is positioned against and/or adjacent to the bottom support surface 1931 and positioned intermediate the first lateral support wall 1940 and the second lateral support wall 1941. In certain embodiments, the first lateral support wall 1940 and the second lateral support wall 1941 can define a lateral gap therebetween. In at least one such embodiment, the staple cartridge 1900 can comprise a lateral width 1903 which is the same as and/or wider than the lateral gap defined between the support walls 1940 and 1941 such that a compressible, implantable cartridge body 1910 of the staple cartridge 1900 can fit securely between the walls 1940 and 1941. In certain other embodiments, the lateral width 1903 of the staple cartridge 1900 can be shorter than the gap defined between the first and second side walls 1940 and 1941. In various embodiments, at least a portion of the walls 1940 and 1941 and the bottom support surface 1931 can be defined by a stamped metal channel while, in at least one embodiment, at least a portion of the lateral support wall 1940 and/or lateral support wall 1941 can be comprised of a flexible material, such as an elastomeric material, for example. Referring primarily to FIG. 41, the first side wall 1940 and the second side wall 1941 of the staple cartridge channel 1930 can each be comprised of a rigid portion 1933 extending upwardly from the bottom support surface 1931 and a flexible portion 1934 extending upwardly from the rigid portions 1933.


In various embodiments, further to the above, the cartridge body 1910 of staple cartridge 1900 can be comprised of one or more compressible layers, such as first layer 1911 and second layer 1912, for example. When the cartridge body 1910 is compressed against the bottom support surface 1931 by an anvil, as described above, the side portions of the cartridge body 1910 can expand laterally. In embodiments where the staple cartridge 1930 is comprised of rigid side walls, the lateral expansion of the cartridge body 1910 can be prevented, or at least limited, by the rigid side walls and, as a result, a significant amount of internal pressure, or stress, can be developed within the cartridge body 1910. In embodiments where at least a portion of the staple cartridge 1930 is comprised of flexible side walls, the flexible side walls can be configured to flex laterally and permit the side portions of the cartridge body 1910 to expand laterally, thereby reducing the internal pressure, or stress, generated within the cartridge body 1910. In embodiments where the cartridge channel does not comprise lateral side walls, or comprises lateral sidewalls which are relatively shorter than the staple cartridge, the side portions of the staple cartridge may expand laterally uninhibited, or at least substantially uninhibited. In any event, referring now to FIG. 42, a staple cartridge channel 2030 can comprise lateral sidewalls 2040 and 2041 which can be entirely comprised of a flexible material, such as an elastomeric material, for example. The staple cartridge channel 2030 can further comprise lateral slots 2033 extending along the sides of the bottom support surface 2031 of the staple cartridge channel 2030 which can be configured to receive and secure at least a portion of the lateral sidewalls 2040 and 2041 therein. In certain embodiments, the lateral side walls 2040 and 2041 can be secured in the slots 2033 via a snap-fit and/or press-fit arrangement while, in at least some embodiments, the lateral side walls 2040 and 2041 can be secured in the slots 2033 by one or more adhesives. In at least one embodiment, the sidewalls 2040 and 2041 may be detachable from the bottom support surface 2031 during use. In any event, a compressible, implantable cartridge body 2010 can be detached and/or disengaged from the lateral side walls 2040 and 2041 when the cartridge body 2010 is implanted with the staples 2020.


In various embodiments, referring now to FIG. 43, a surgical instrument can comprise a shaft 2150 and an end effector extending from the distal end of the shaft 2150. The end effector can comprise, similar to the above, a staple cartridge channel 2130, an anvil 2140 movable between an open position and a closed position, and a staple cartridge 2100 positioned intermediate the staple cartridge channel 2130 and the anvil 2140. Also similar to the above, the staple cartridge 2100 can comprise a compressible, implantable cartridge body 2110 and a plurality of staples 2120 positioned in the cartridge body 2110. In various embodiments, the staple cartridge channel 2130 can comprise, one, a bottom support surface 2131 against which the staple cartridge 2100 can be positioned, two, a distal end 2135 and, three, a proximal end 2136. In at least one embodiment, as illustrated in FIG. 43, the staple cartridge 2100 can comprise a first end 2105 which can be positionable in the distal end 2135 of the staple cartridge channel 2130 and a second end 2106 which can be positionable in the proximal end 2136 of the staple cartridge channel 2130. In various embodiments, the distal end 2135 of the staple cartridge channel 2130 can comprise at least one distal retention feature, such as a retention wall 2137, for example, and, similarly, the proximal end 2136 can comprise at least one proximal retention feature, such as a retention wall 2138, for example. In at least one such embodiment, the distal retention wall 2137 and the proximal retention wall 2138 can define a gap therebetween which can be equal to or less than the length of the staple cartridge 2100 such that the staple cartridge 2100 can fit securely within the staple cartridge channel 2130 when the staple cartridge 2100 is inserted therein.


In various embodiments, referring again to FIGS. 23 and 24, a staple cartridge, such as staple cartridge 1200, for example, can comprise a flat, or at least substantially flat, tissue-contacting surface 1219. In at least one such embodiment, the staple cartridge body 1210 of staple cartridge 1200 can comprise a first end 1205 which can be defined by a first height, or thickness, 1207 and a second end 1206 which can be defined by a second height, or thickness, 1208, wherein the first height 1207 can be equal to, or at least substantially equal to, the second height 1208. In certain embodiments, the cartridge body 1210 can comprise a constant, or at least substantially constant, height, or thickness, between the first end 1205 and the second end 1206. In at least one such embodiment, the tissue-contacting surface 1219 can be parallel, or at least substantially parallel, to the bottom surface 1218 of the cartridge body 1210. In various embodiments, referring once again to FIG. 43, the first end 2105 of the cartridge body 2110 of staple cartridge 2100 can be defined by a first height 2107 which is different than a second height 2108 of the second end 2106. In the illustrated embodiment, the first height 2107 is larger than the second height 2108, although the second height 2108 could be larger than the first height 2107 in alternative embodiments. In various embodiments, the height of the cartridge body 2110 can decrease linearly and/or geometrically between the first end 2105 and the second end 2106. In at least one such embodiment, the tissue-contacting surface 2119, which extends between the first end 2105 and the second end 2106, can be oriented along an angle defined therebetween. In at least one such embodiment, the tissue-contacting surface 2119 may not be parallel to the bottom surface 2118 of the cartridge body 2110 and/or parallel to the support surface 2131 of the staple cartridge channel 2130.


In various embodiments, referring again to FIGS. 43 and 44, the anvil 2140 can comprise a tissue-contacting surface 2141 which can be parallel, or at least substantially parallel, to the support surface 2131 of the staple cartridge channel 2130 when the anvil 2140 is in a closed position, as illustrated in FIG. 44. When the anvil 2140 is in a closed position, the anvil 2140 can be configured to compress the first end 2105 of the staple cartridge 2100 more than the second end 2106 owing to the taller height of the first end 2105 and the shorter height of the second end 2106. In some circumstances, including circumstances where the tissue T positioned intermediate the tissue contacting surfaces 2119 and 2141 has a constant, or at least substantially constant, thickness, the pressure generated within the tissue T and the cartridge 2100 can be greater at the distal end of the end effector than the proximal end of the end effector. More particularly, when the tissue T between the anvil 2140 and the staple cartridge 2100 has a substantially constant thickness, the tissue T positioned intermediate the distal end 2145 of the anvil 2140 and the first end 2105 of the staple cartridge 2100 can be more compressed than the tissue T positioned intermediate the proximal end 2146 of the anvil 2140 and the second end 2106 of the staple cartridge 2100. In various embodiments, a pressure gradient can be generated within the tissue T between the proximal end and the distal end of the end effector. More particularly, in at least one embodiment, when the tissue T between the anvil 2140 and the staple cartridge 2100 has a substantially constant thickness and the height of the staple cartridge 2100 decreases linearly from the distal end to the proximal end of the end effector, the pressure within the tissue T can decrease linearly from the distal end of the end effector to the proximal end of the end effector. Similarly, in at least one embodiment, when the tissue T between the anvil 2140 and the staple cartridge 2100 has a substantially constant thickness and the height of the staple cartridge 2100 decreases geometrically from the distal end to the proximal end of the end effector, the pressure within the tissue T can decrease geometrically from the distal end of the end effector to the proximal end of the end effector.


In various embodiments, referring again to FIG. 43, the tissue T positioned intermediate the staple cartridge 2100 and the anvil 2140 may not have a constant thickness throughout. In at least one such circumstance, the tissue T positioned between the proximal end 2146 of the anvil 2140 and the second end 2106 of the staple cartridge 2100 may be thicker than the tissue T positioned between the distal end 2145 of the anvil 2140 and the first end 2105 of the staple cartridge 2100. In such circumstances, as a result, the thicker tissue T may be generally positioned above the shorter proximal end 2106 of the staple cartridge 2100 and the thinner tissue T may be generally positioned above the taller distal end 2105. In use, the firing collar 2152 of the shaft 2150 can be advanced distally along the shaft spine 2151 such that the firing collar 2152 engages the cam portion 2143 of the anvil 2140 and rotates the anvil 2140 toward the staple cartridge 2100 as illustrated in FIG. 44. Once the anvil 2140 has been rotated into a fully-closed position, the tissue T may be compressed between the tissue-contacting surfaces 2119 and 2141 and, even though the height of the staple cartridge 2100 may not be constant between the proximal and distal ends of the end effector, the pressure or compressive forces applied to the tissue T may be constant, or at least substantially constant, thereacross. More particularly, as the thinner tissue T may be associated with the taller height of the staple cartridge 2100 and the thicker tissue T may be associated with the shorter height of the staple cartridge 2100, the cumulative, or summed, height of the tissue T and the staple cartridge 2100 may be constant, or at least substantially constant, between the proximal and distal ends of the end effector and, as a result, the compression of this cumulative height by the anvil 2140 may be constant, or at least substantially constant, thereacross.


In various embodiments, referring again to FIGS. 43 and 44, the staple cartridge 2100 can comprise an asymmetrical configuration. In at least one such embodiment, for example, the height of the staple cartridge 2100 at the first end 2105 thereof may be higher than the height of the staple cartridge 2100 at the second end 2106 thereof. In certain embodiments, the staple cartridge 2100 and/or the staple cartridge channel 2130 can comprise one or more alignment and/or retention features which can be configured to assure that the staple cartridge 2100 can only be positioned within the staple cartridge channel 2130 in one orientation, i.e., an orientation in which the first end 2105 is positioned in the distal end 2135 of the staple cartridge channel 2130 and the second end 2106 is positioned in the proximal end 2136. In various alternative embodiments, the staple cartridge 2100 and/or the staple cartridge channel 2130 can comprise one or more alignment and/or retention features which can be configured to permit the staple cartridge 2100 to be positioned within the staple cartridge channel 2130 in more than one orientation. Referring now to FIG. 45, for example, the staple cartridge 2100 can be positioned within the staple cartridge channel 2130 such that the first end 2105 of the staple cartridge 2100 can be positioned in the proximal end 2136 of the staple cartridge channel 2130 and the second end 2106 can be positioned in the distal end 2135. In various embodiments, as a result, the shorter height of the staple cartridge 2100 can be positioned proximate the distal retention wall 2137 and the taller height of the staple cartridge 2100 can be positioned proximate to the proximal retention wall 2138. In at least one such embodiment, the staple cartridge 2100 can be suitably arranged to apply a constant, or at least substantially constant, clamping pressure to tissue T having a thicker portion within the distal end of the end effector and a thinner portion within the proximal end of the end effector. In various embodiments, the staple cartridge 2100, for example, can be selectively oriented within the staple cartridge channel 2130. In at least one such embodiment, the alignment and/or retention features of the staple cartridge 2100 can be symmetrical and a surgeon can selectively orient the staple cartridge 2100 within the staple cartridge channel 2130 in the orientations depicted in FIG. 43 and FIG. 45, for example.


Further to the above, the implantable cartridge body 2110 can comprise a longitudinal axis 2109 which, when the staple cartridge 2100 is positioned in the staple cartridge channel 2130, can extend between the proximal and distal ends of the end effector. In various embodiments, the thickness of the cartridge body 2110 can generally decrease and/or generally increase between the first end 2105 and the second end 2106 along the longitudinal axis 2109. In at least one such embodiment, the distance, or height, between the bottom surface 2118 and the tissue-contacting surface 2119 can generally decrease and/or generally increase between the first end 2105 and the second end 2106. In certain embodiments, the thickness of the cartridge body 2110 can both increase and decrease along the longitudinal axis 2109. In at least one such embodiment, the thickness of the cartridge body 2110 can comprise one or more portions which increase in thickness and one or more portions which can decrease in thickness. In various embodiments, the staple cartridge 2100 can comprise a plurality of staples 2120 positioned therein. In use, as described above, the staples 2120 can be deformed when the anvil 2140 is moved into a closed position. In certain embodiments, each staple 2120 can have the same, or at least substantially the same, height. In at least one such embodiment, the height of a staple can be measured from the bottom of the base of the staple to the top, or tip, of the tallest leg of the staple, for example.


In various embodiments, the staples within a staple cartridge can have different staple heights. In at least one such embodiment, a staple cartridge can comprise a first group of staples having a first staple height which are positioned in a first portion of a compressible cartridge body and a second group of staples having a second staple height which are positioned in a second portion of the compressible cartridge body. In at least one embodiment, the first staple height can be taller than the second staple height and the first group of staples can be positioned in the first end 2105 of the staple cartridge 2100 while the second group of staples can be positioned in the second end 2106. Alternatively, the taller first group of staples can be positioned in the second end 2106 of the staple cartridge 2100 while the shorter second group of staples can be positioned in the first end 2105. In certain embodiments, a plurality of staple groups, each group having a different staple height, can be utilized. In at least one such embodiment, a third group having an intermediate staple height can be positioned in the cartridge body 2110 intermediate the first group of staples and the second group of staples. In various embodiments, each staple within a staple row in the staple cartridge can comprise a different staple height. In at least one embodiment, the tallest staple within a staple row can be positioned on a first end of a staple row and the shortest staple can be positioned on an opposite end of the staple row. In at least one such embodiment, the staples positioned intermediate the tallest staple and the shortest staple can be arranged such that the staple heights descend between the tallest staple and the shortest staple, for example.


In various embodiments, referring now to FIG. 46, an end effector of a surgical stapler can comprise an anvil 2240, a staple cartridge channel 2230, and a staple cartridge 2200 supported by the staple cartridge channel 2230. The staple cartridge 2200 can comprise a compressible, implantable cartridge body 2210 and a plurality of staples, such as staples 2220a and staples 2220b, for example, positioned therein. In various embodiments, the staple cartridge channel 2230 can comprise a cartridge support surface 2231 and a plurality of staple support slots, such as support slots 2232a and 2232b, for example, defined therein. In at least one such embodiment, the staple cartridge 2200 can comprise two outer rows of staples 2220a and two inner rows of staples 2220b, wherein the support slots 2232a can be configured to support the staples 2220a and the support slots 2232b can be configured to support the staples 2220b. Referring to FIGS. 46 and 47, the anvil 2240 can comprise a plurality of staple forming pockets 2242 defined therein which can be configured to receive and deform the staples 2220a and 2220b when the anvil 2240 is moved toward the staple cartridge 2200. In at least one such embodiment, the bottom surfaces of the support slots 2232a can be a first distance 2201a away from the top surfaces of the staple forming pockets 2242 while the bottom surfaces of the support slots 2232b can be a second distance 2201b away from the top surfaces of the staple forming pockets 2242. In at least one such embodiment, the support slots 2232b are positioned closer to the anvil 2240 owing to the raised step in the support surface 2231 in which they are defined. Owing to the different distances 2201a and 2201b, in various embodiments, the outer rows of staples 2220a and the inner rows of staples 2220b can be deformed to different formed heights. In various circumstances, staples deformed to different formed heights can apply different clamping pressures or forces to the tissue T being stapled. In addition to the above, the staples can begin with different unformed staple heights. In at least one such embodiment, referring again to FIG. 46, the outer staples 2220a can have an initial, unformed height which is greater than the initial, unformed height of the inner staples 2220b. As illustrated in FIGS. 46 and 47, the inner staples 2220b, which have a shorter unformed height than the outer staples 2220a, can also have a shorter formed height than the outer staples 2220b. In various alternative embodiments, the inner staples 2220b may have a taller unformed height than the outer staples 2220a yet have a shorter deformed staple height than the outer staples 2220a.


In various embodiments, further to the above, the anvil 2240 can be moved into a closed position, as illustrated in FIG. 47, in order to compress the cartridge body 2210 and deform the staples 2220a and 2220b. In certain embodiments, a surgical stapler comprising the end effector depicted in FIGS. 46 and 47, for example, can further comprise a cutting member which can be configured to transect the tissue T positioned intermediate the anvil 2240 and the staple cartridge 2200. In at least one such embodiment, the anvil 2240, the staple cartridge channel 2230 and/or the staple cartridge 2200 can define a slot configured to slidably receive a cutting member therein. More particularly, the anvil 2240 can comprise a slot portion 2249, the staple cartridge channel 2230 can comprise a slot portion 2239, and the staple cartridge 2200 can comprise a slot portion 2203 which can be aligned, or at least substantially aligned, with one another when the anvil 2240 is in a closed, or at least substantially closed, position. In various embodiments, the cutting member can be moved from the proximal end of the end effector toward the distal end of the end effector after the anvil 2240 has been closed and the staples 2220a, 2220b have been deformed. In at least one embodiment, the cutting member can be moved independently of the staple deformation process. In certain embodiments, the cutting member can be advanced at the same time that the staples are being deformed. In any event, in at least one embodiment, the cutting member can be configured to incise the tissue along a path positioned intermediate the inner rows of staples 2220b.


In various embodiments, as illustrated in FIG. 47, the inner staples 2220b can be formed to a shorter height than the outer staples 2220a wherein the inner staples 2220b can apply a larger clamping pressure or force to the tissue adjacent to the cut line created by the cutting member. In at least one such embodiment, the larger clamping pressure or force created by the inner staples 2220b can provide various therapeutic benefits such as reducing bleeding from the incised tissue T while the smaller clamping pressure created by the outer staples 2220a can provide flexibility within the stapled tissue. In various embodiments, referring again to FIGS. 46 and 47, the anvil 2240 can further comprise at least one piece of buttress material, such as buttress material 2260, for example, attached thereto. In at least one such embodiment, the legs of the staples 2220a, 2220b can be configured to incise the buttress material 2260 and/or pass through apertures in the buttress material 2260 when the staple cartridge 2200 is compressed by the anvil 2240 and thereafter contact the staple forming pockets 2242 in the anvil 2240. As the legs of the staples 2220a, 2220b are being deformed, the legs can contact and/or incise the buttress material 2260 once again. In various embodiments, the buttress material 2260 can improve the hemostasis of and/or provide strength to the tissue being stapled.


In various embodiments, referring again to FIGS. 46 and 47, the bottom surface of the cartridge body 2210 can comprise a stepped contour which matches, or at least substantially matches, the stepped contour of the cartridge support surface 2231. In certain embodiments, the bottom surface of the cartridge body 2210 can deform to match, or at least substantially match, the contour of the cartridge support surface 2231. In various embodiments, referring now to FIG. 48, an end effector, similar to the end effector depicted in FIG. 46, for example, can comprise a staple cartridge 2300 positioned therein. The staple cartridge 2300 can comprise a compressible, implantable body 2310 comprising an inner layer 2312 and an outer layer 2311 wherein, further to the above, the outer layer 2311 can be comprised of a water impermeable material in at least one embodiment. In various embodiments, the outer layer 2311 can extend around the staples 2220a, 2220b and can be positioned intermediate the staples 2220a, 2220b and the support slots 2232a, 2232b, respectively. In various embodiments, referring now to FIG. 49, an end effector, similar to the end effector depicted in FIG. 46, for example, can comprise a staple cartridge 2400 positioned therein Similar to the staple cartridge 2300, the compressible, implantable cartridge body 2410 of staple cartridge 2400 can comprise an inner layer 2412 and an outer layer 2411; however; in at least one embodiment, the cartridge body 2410 may not comprise a cutting member slot therein. In at least one such embodiment, the cutting member may be required to incise the inner layer 2412 and/or the outer layer 2411, for example, as it is advanced through the staple cartridge.


In various embodiments, referring now to FIG. 50, an end effector of a surgical stapler can comprise an anvil 2540, a staple cartridge channel 2530, and a staple cartridge 2500 positioned in the staple cartridge channel 2530. Similar to the above, the staple cartridge 2500 can comprise a compressible, implantable cartridge body 2510, outer rows of staples 2220a, and inner rows of staples 2220b. The staple cartridge channel 2530 can comprise a flat, or an at least substantially flat, cartridge support surface 2531 and staple support slots 2532 defined therein. The anvil 2540 can comprise a stepped surface 2541 and a plurality of staple forming pockets, such as forming pockets 2542a and 2542b, for example, defined therein Similar to the above, the forming pockets 2542a and the support slots 2532 can define a distance therebetween which is greater than the distance between the forming pockets 2452b and the support slots 2532. In various embodiments, the anvil 2540 can further comprise a piece of buttress material 2560 attached to the stepped surface 2541 of the anvil 2540. In at least one such embodiment, the buttress material 2560 can conform, or at least substantially conform, to the stepped surface 2541. In various embodiments, the buttress material 2560 can be removably attached to the surface 2541 by at least one adhesive, such as fibrin and/or protein hydrogel, for example. In certain embodiments, the cartridge body 2510 can also comprise a stepped profile which, in at least one embodiment, parallels, or at least substantially parallels, the stepped surface 2541 of the anvil 2540. More particularly, in at least one embodiment, the anvil 2540 can comprise steps 2548 extending toward the staple cartridge 2500 wherein the steps 2548 can comprise a step height which equals, or at least substantially equals, the step height of the steps 2508 extending from the cartridge body 2510. In at least one such embodiment, as a result of the above, the amount of the compressible cartridge body 2510 that can be captured in the first staples 2220a can be different than the amount of the compressible cartridge body 2510 that can be captured in the second staples 2220b, for example.


In various embodiments, referring now to FIG. 51, an end effector can comprise an anvil 2640, a staple cartridge channel 2530, and a staple cartridge 2600 positioned therebetween. The staple cartridge 2600 can comprise a compressible, implantable cartridge body 2610 including an inner layer 2612, an outer layer 2611, and a plurality of staples, such as staples 2220a and 2200b, for example, positioned therein. In various embodiments, the anvil 2640 can comprise a plurality of staple forming pockets 2642 in surface 2641 and the staple cartridge channel 2530 can comprise a plurality of staple forming slots 2532 defined in the support surface 2531. As illustrated in FIG. 51, the anvil surface 2641 can be parallel, or at least substantially parallel, to the cartridge support surface 2531 wherein each forming pocket 2642 can be positioned an equal, or at least substantially equal, distance away from an opposing and corresponding staple support slot 2532. In various embodiments, the staple cartridge 2600 can comprise staples having the same, or at least substantially the same, initial, unformed staple height and, in addition, the same, or at least substantially the same, formed staple height. In certain other embodiments, the outer rows of staples can comprise staples 2220a and the inner rows of staples can comprise staples 2220b wherein, as discussed above, the staples 2220a and 2220b can have different unformed staple heights. When the anvil 2640 is moved toward the staple cartridge 2600 into a closed position, the staples 2220a and 2220b can be formed such that they have the same, or at least substantially the same, formed staple height. In at least one such embodiment, as a result of the above, the formed outer staples 2220a and the inner staples 2220b may have the same, or at least substantially the same, amount of compressible cartridge body 2610 contained therein; however, as the outer staples 2220a have a taller unformed staple height than the inner staples 2220b and may have the same formed staple height nonetheless, a greater clamping pressure can be generated in the outer staples 2220a than the inner staples 2220b, for example.


In various embodiments, referring now to FIG. 52, an end effector of a surgical stapler can comprise an anvil 2740, a staple cartridge channel 2530, and a staple cartridge 2700 positioned within the staple cartridge channel 2530. Similar to the above, the staple cartridge 2700 can comprise a compressible, implantable cartridge body 2710 comprising an inner layer 2712, an outer layer 2711, and a plurality of staples, such as staples 2220a and 2220b, for example, positioned therein. In at least one embodiment, the thickness of the cartridge body 2710 can vary across its width. In at least one such embodiment, the cartridge body 2710 can comprise a center portion 2708 and side portions 2709, wherein the center portion 2708 can comprise a thickness which is greater than the thickness of the side portions 2709. In various embodiments, the thickest portion of the cartridge body 2710 can be located at the center portion 2708 while the thinnest portion of the cartridge body 2710 can be located at the side portions 2709. In at least one such embodiment, the thickness of the cartridge body 2710 can decrease gradually between the center portion 2708 and the side portions 2709. In certain embodiments, the thickness of the cartridge body 2710 can decrease linearly and/or geometrically between the center portion 2708 and the side portions 2709. In at least one such embodiment, the tissue-contacting surface 2719 of cartridge body 2710 can comprise two inclined, or angled, surfaces which slope downwardly from the center portion 2708 toward the side portions 2709. In various embodiments, the anvil 2740 can comprise two inclined, or angled, surfaces which parallel, or at least substantially parallel, the inclined tissue-contacting surfaces 2719. In at least one embodiment, the anvil 2740 can further comprise at least one piece of buttress material 2760 attached to the inclined surfaces of the anvil 2740.


In various embodiments, further to the above, the inner rows of staples in the staple cartridge 2700 can comprise the taller staples 2220a and the outer rows of staples can comprise the shorter staples 2220b. In at least one embodiment, the taller staples 2220a can be positioned within and/or adjacent to the thicker center portion 2708 while the staples 2220b can be positioned within and/or adjacent to the side portions 2709. In at least one such embodiment, as a result of the above, the taller staples 2220a can capture more material of the implantable cartridge body 2710 than the shorter staples 2220b. Such circumstances could result in the staples 2220a applying a greater clamping pressure to the tissue T than the staples 2220b. In certain embodiments, even though the taller staples 2220a may capture more material of the cartridge body 2710 therein than the shorter staples 2220b, the taller staples 2220a may have a taller formed staple height than the shorter staples 2220b owing to the inclined arrangement of the staple forming pockets 2742a and 2742b. Such considerations can be utilized to achieve a desired clamping pressure within the tissue captured by the staples 2220a and 2220b wherein, as a result, the clamping pressure in the staples 2220a can be greater than, less than, or equal to the clamping pressure applied to the tissue by the staples 2220b, for example. In various alternative embodiments to the end effector illustrated in FIG. 52, the shorter staples 2220b can be positioned within and/or adjacent to the thicker center portion 2708 of the cartridge body 2710 and the taller staples 2220a can be positioned within and/or adjacent to the thinner side portions 2709. Furthermore, although the staple cartridge 2700 is depicted as comprising inner and outer rows of staples, the staple cartridge 2700 may comprise additional rows of staples, such as staple rows positioned intermediate the inner and outer rows of staples, for example. In at least one such embodiment, the intermediate staple rows can comprise staples having an unformed staple height which is intermediate the unformed staple heights of the staples 2220a and 2220b and a formed staple height which is intermediate the formed staple heights of the staples 2220a and 2220b, for example.


In various embodiments, referring now to FIG. 53, an end effector of a surgical stapler can comprise an anvil 2840, a staple cartridge channel 2530, and a staple cartridge 2800 positioned within the staple cartridge channel 2530. Similar to the above, the staple cartridge 2800 can comprise a compressible, implantable cartridge body 2810 comprising an inner layer 2812, an outer layer 2811, and a plurality of staples, such as staples 2220a and 2220b, for example, positioned therein. In at least one embodiment, the thickness of the cartridge body 2810 can vary across its width. In at least one such embodiment, the cartridge body 2810 can comprise a center portion 2808 and side portions 2809, wherein the center portion 2808 can comprise a thickness which is less than the thickness of the side portions 2809. In various embodiments, the thinnest portion of the cartridge body 2810 can be located at the center portion 2808 while the thickest portion of the cartridge body 2810 can be located at the side portions 2809. In at least one such embodiment, the thickness of the cartridge body 2810 can increase gradually between the center portion 2808 and the side portions 2809. In certain embodiments, the thickness of the cartridge body 2810 can increase linearly and/or geometrically between the center portion 2808 and the side portions 2809. In at least one such embodiment, the tissue-contacting surface 2819 of cartridge body 2810 can comprise two inclined, or angled, surfaces which slope upwardly from the center portion 2808 toward the side portions 2809. In various embodiments, the anvil 2840 can comprise two inclined, or angled, surfaces which parallel, or at least substantially parallel, the inclined tissue-contacting surfaces 2819. In at least one embodiment, the anvil 2840 can further comprise at least one piece of buttress material 2860 attached to the inclined surfaces of the anvil 2840. In various embodiments, further to the above, the outer rows of staples in the staple cartridge 2800 can comprise the taller staples 2220a and the inner rows of staples can comprise the shorter staples 2220b. In at least one embodiment, the taller staples 2220a can be positioned within and/or adjacent to the thicker side portions 2809 while the staples 2220b can be positioned within and/or adjacent to the center portion 2808. In at least one such embodiment, as a result of the above, the taller staples 2220a can capture more material of the implantable cartridge body 2810 than the shorter staples 2220b.


As described above with regard to the embodiment of FIG. 46, for example, the staple cartridge channel 2230 can comprise a stepped support surface 2231 which can be configured to support the staples 2220a and 2220b at different heights with respect the anvil 2240. In various embodiments, the staple cartridge channel 2230 can be comprised of metal and the steps in the support surface 2231 may be formed in the support surface 2231 by a grinding operation, for example. In various embodiments, referring now to FIG. 54, an end effector of a surgical instrument can comprise a staple cartridge channel 2930 comprising a support insert 2935 positioned therein. More particularly, in at least one embodiment, the staple cartridge channel 2930 can be formed such that it has a flat, or at least substantially flat, support surface 2931, for example, which can be configured to support the insert 2935 which comprises the stepped surfaces for supporting the staples 2220a and 2220b of the staple cartridge 2200 at different heights. In at least one such embodiment, the insert 2935 can comprise a flat, or at least substantially flat, bottom surface which can be positioned against the support surface 2931. The insert 2935 can further comprise support slots, grooves, or troughs 2932a and 2932b which can be configured to support the staples 2220a and 2220b, respectively, at different heights Similar to the above, the insert 2935 can comprise a knife slot 2939 defined therein which can be configured to permit a cutting member to pass therethrough. In various embodiments, the staple cartridge channel 2930 can be comprised of the same material as or a different material than the support insert 2935. In at least one embodiment, the staple cartridge channel 2930 and the support insert 2935 can both be comprised of metal, for example, while, in other embodiments, the staple cartridge channel 2930 can be comprised of metal, for example, and the support insert 2935 can be comprised of plastic, for example. In various embodiments, the support insert 2935 can be fastened and/or welded into the staple cartridge channel 2930. In certain embodiments, the support insert 2935 can be snap-fit and/or press-fit into the staple cartridge channel 2930. In at least one embodiment the support insert 2935 can be secured in the staple cartridge channel 2930 using an adhesive.


In various embodiments, referring now to FIG. 55, an end effector of a surgical stapler can comprise an anvil 3040, a staple cartridge channel 3030, and a compressible, implantable staple cartridge 3000 positioned in the staple cartridge channel 3030. Similar to the above, the anvil 3040 can comprise a plurality of staple-forming pockets 3042 defined therein and a knife slot 3049 which can be configured to slidably receive a cutting member therein. Also similar to the above, the staple cartridge channel 3030 can comprise a plurality of staple support slots 3032 defined therein and a knife slot 3039 which can also be configured to slidably receive a cutting member therein. In various embodiments, the staple cartridge 3000 can comprise a first layer 3011, a second layer 3012, and a plurality of staples, such as staples 3020a and 3020b, for example, positioned therein. In at least one embodiment, the staples 3020a can comprise an unformed staple height which is taller than the unformed staple height of the staples 3020b. In various embodiments, the first layer 3011 can be comprised of a first compressible material and the second layer 3012 can be comprised of a second compressible material. In certain embodiments, the first compressible material can be compressed at a rate which is higher than the second compressible material while, in certain other embodiments, the first compressible material can be compressed at a rate which is lower than the second compressible material. In at least one embodiment, the first compressible material can be comprised of a resilient material which can comprise a first spring rate and the second compressible material can be comprised of a resilient material which can comprise a second spring rate which is different than the first spring rate. In various embodiments, the first compressible material can comprise a spring rate which is greater than the spring rate of the second compressible material. In certain other embodiments, the first compressible material can comprise a spring rate which is less than the spring rate of the second compressible material. In various embodiments, the first compressible layer can comprise a first stiffness and the second compressible layer can comprise a second stiffness, wherein the first stiffness is different than the second stiffness. In various embodiments, the first compressible layer can comprise a stiffness which is greater than the stiffness of the second compressible layer. In certain other embodiments, the first compressible layer can comprise a stiffness which is less than the stiffness of the second compressible layer.


In various embodiments, referring again to FIG. 55, the second layer 3012 of the staple cartridge 3000 can comprise a constant, or at least substantially constant, thickness across the width thereof. In at least one embodiment, the first layer 3011 can comprise a thickness which varies across the width thereof. In at least one such embodiment, the first layer 3011 can comprise one or more steps 3008 which can increase the thickness of the cartridge body 3010 in certain portions of the cartridge body 3010, such as the center portion, for example. Referring again to FIG. 55, the shorter staples 3020b can be positioned in or aligned with the steps 3008, i.e., the thicker portions of the cartridge body 3010, and the taller staples 3020a can be positioned in or aligned with the thinner portions of the cartridge body 3010. In various embodiments, as a result of the thicker and thinner portions of the cartridge body 3010, the stiffness of the cartridge body 3010 can be greater along the inner rows of staples 3020b than the outer rows of staples 3020a. In various embodiments, the first layer 3011 can be connected to the second layer 3012. In at least one such embodiment, the first layer 3011 and the second layer 3012 can comprise interlocking features which can retain the layers 3011 and 3012 together. In certain embodiments, the first layer 3011 can comprise a first laminate and the second layer 3012 can comprise a second laminate, wherein the first laminate can be adhered to the second laminate by one or more adhesives. In various embodiments, the staple cartridge 3000 can comprise a knife slot 3003 which can be configured to slidably receive a cutting member therein.


In various embodiments, referring now to FIG. 56, a staple cartridge 3100 can comprise a compressible, implantable cartridge body 3110 comprising a single layer of compressible material and, in addition, a plurality of staples, such as staples 3020b, for example, positioned therein. In at least one embodiment, the thickness of the cartridge body 3110 can vary across the width thereof. In at least one such embodiment, the cartridge body 3110 can comprise steps 3108 extending along the side portions thereof. In various embodiments, referring now to FIG. 57, a staple cartridge 3200 can comprise a compressible, implantable cartridge body 3210 comprising a single layer of compressible material and, in addition, a plurality of staples, such as staples 3020b, for example, positioned therein. In at least one embodiment, the thickness of the cartridge body 3210 can vary across the width thereof. In at least one such embodiment, the cartridge body 3210 can comprise steps 3208 extending along the center portion thereof. In various embodiments, referring now to FIG. 58, a staple cartridge 3300 can comprise a compressible, implantable cartridge body 3310 wherein, similar to the above, the thickness of the cartridge body 3310 can vary across the width thereof. In at least one embodiment, the thickness of the cartridge body 3310 can increase geometrically between the side portions and the center portion of the cartridge body 3310. In at least one such embodiment, the thickness of the cartridge body 3310 can be defined by an arcuate or curved profile and can comprise an arcuate or curved tissue-contacting surface 3319. In certain embodiments, the thickness of the cartridge body 3310, and the contour of the tissue-contacting surface 3319, can be defined by one radius of curvature or, alternatively, by several radiuses of curvature, for example. In various embodiments, referring now to FIG. 59, a staple cartridge 3400 can comprise a compressible, implantable cartridge body 3410 wherein the thickness of the cartridge body 3410 can increase linearly, or at least substantially linearly, between the side portions and the center portion of the cartridge body 3410.


In various embodiments, referring now to FIG. 60, a staple cartridge 3500 can comprise a compressible, implantable cartridge body 3510 and a plurality of staples 3520 positioned therein. The implantable cartridge body 3510 can comprise a first inner layer 3512, a second inner layer 3513, and an outer layer 3511. In at least one embodiment, the first inner layer 3512 can comprise a first thickness and the second inner layer 3513 can comprise a second thickness wherein the second inner layer 3513 can be thicker than the first inner layer 3512. In at least one alternative embodiment, the first inner layer 3512 can be thicker than the second inner layer 3513. In another alternative embodiment, the first inner layer 3512 can have the same, or at least substantially the same, thickness as the second inner layer 3513. In certain embodiments, each staple 3520 can comprise a base 3522 and one or more deformable legs 3521 extending from the base 3522. In various embodiments, each leg 3521 can comprise a tip 3523 which is embedded in the first inner layer 3511 and, in addition, each base 3522 of the staples 3520 can be embedded in the second inner layer 3512. In at least one embodiment, the first inner layer 3512 and/or the second inner layer 3513 can comprise at least one medicament stored therein and, in various embodiments, the outer layer 3511 can encapsulate and seal the first inner layer 3512 and the second inner layer 3513 such that the medicament does not flow out of the staple cartridge body 3510 until after the outer layer 3511 has been punctured by the staples 3520. More particularly, further to the above, an anvil can be pushed downwardly against tissue positioned against the tissue-contacting surface 3519 of staple cartridge 3500 such that the cartridge body 3510 is compressed and the surface 3519 is moved downwardly toward, and at least partially below, the staple tips 3523 such that the tips 3523 rupture or puncture the outer layer 3511. After the outer layer 3511 has been breached by the staple legs 3521, the at least one medicament M can flow out of the cartridge body 3510 around the staple legs 3521. In various circumstances, additional compression of the cartridge body 3510 can squeeze additional medicament M out of the cartridge body 3510 as illustrated in FIG. 61.


In various embodiments, referring again to FIG. 60, the outer layer 3511 can comprise a water impermeable, or at least substantially impermeable, wrap which can configured to, one, keep the medicament from prematurely flowing out of the staple cartridge 3500 and, two, prevent fluids within a surgical site, for example, from prematurely entering into the staple cartridge 3500. In certain embodiments, the first inner layer 3512 can comprise a first medicament stored, or absorbed, therein and the second inner layer 3513 can comprise a second medicament stored, or absorbed, therein, wherein the second medicament can be different than the first medicament. In at least one embodiment, an initial compression of the cartridge body 3510, which causes the rupture of the outer layer 3511, can generally express the first medicament out of the first inner layer 3512 and a subsequent compression of the cartridge body 3510 can generally express the second medicament out of the second inner layer 3513. In such embodiments, however, portions of the first medicament and the second medicament may be expressed simultaneously although a majority of the medicament that is initially expressed can be comprised of the first medicament and a majority of the medicament subsequently expressed thereafter can be comprised of the second medicament. In certain embodiments, further to the above, the first inner layer 3512 can be comprised of a more compressible material than the second inner layer 3513 such that the initial compression forces or pressure, which can be lower than the subsequent compression forces or pressure, can cause a larger initial deflection within the first inner layer 3512 than the second inner layer 3513. This larger initial deflection within the first inner layer 3512 can cause a larger portion of the first medicament to be expressed from the first inner layer 3512 than the second medicament from the second inner layer 3513. In at least one embodiment, the first inner layer 3512 can be more porous and/or more flexible than the second inner layer 3513. In at least one such embodiment, the first inner layer 3512 can comprise a plurality of pores, or voids, 3508 defined therein and the second inner layer 3513 can comprise a plurality of pores, or voids, 3509 defined therein wherein, in various embodiments, the pores 3508 can be configured to store the first medicament in the first inner layer 3512 and the pores 3509 can be configured to store the second medicament in the second inner layer 3513. In certain embodiments, the size and density of the pores 3508 within the first inner layer 3512 and the pores 3509 within the second inner layer 3513 can be selected so as to provide a desired result described herein.


In various embodiments, referring again to FIGS. 60 and 61, the outer layer 3511, the first inner layer 3512, and/or the second inner layer 3513 can be comprised of a bioabsorbable material. In at least one embodiment, the first inner layer 3512 can be comprised of a first bioabsorbable material, the second inner layer 3513 can be comprised of a second bioabsorbable material, and the outer layer 3511 can be comprised of a third bioabsothable material, wherein the first bioabsorbable material, the second bioabsorbable material, and/or the third bioabsorbable material can be comprised of different materials. In certain embodiments, the first bioabsothable material can be bioabsorbed at a first rate, the second bioabsorbable material can be bioabsorbed at a second rate, and the third bioabsorbable material can be bioabsorbed at a third rate, wherein the first rate, the second rate, and/or the third rate can be different. In at least one such embodiment, when a material is bioabsorbed at a particular rate, such a rate can be defined as the amount of material mass that is absorbed by a patient's body over a unit of time. As it is known, the bodies of different patients may absorb different materials at different rates and, thus, such rates may be expressed as average rates in order to account for such variability. In any event, a faster rate may be a rate in which more mass is bioabsorbed for a unit of time than a slower rate. In various embodiments, referring again to FIGS. 60 and 61, the first inner layer 3512 and/or the second inner layer 3513 can be comprised of a material which bioabsorbs faster than the material comprising the outer layer 3511. In at least one such embodiment, the first inner layer 3512 and/or the second inner layer 3513 can be comprised of a bioabsorbable foam, tissue sealant, and/or hemostatic material, such as oxidized regenerated cellulose (ORC), for example, and the outer layer 3511 can be comprised of a buttress material and/or plastic material, such as polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In such embodiments, the first inner layer 3512 and/or the second inner layer 3513 can immediately treat the tissue and can reduce bleeding from the tissue, for example, wherein the outer layer 3514 can provide longer-term structural support and can be bioabsorbed at a slower rate.


Owing to the slower rate of bioabsorbability of the outer layer 3511, further to the above, the outer layer 3511 can buttress or structurally reinforce the tissue within the staple line as it heals. In certain embodiments, one of the first inner layer 3512 and the second inner layer 3513 can be comprised of a material which can be bioabsorbed faster than the other such that, in at least one embodiment, one of the layers can provide an initial release of a therapeutic material and the other layer can provide a sustained release of the same therapeutic material and/or a different therapeutic material. In at least one such embodiment, the rate in which a therapeutic material can be released from a layer 3512, 3513 can be a function of the bioabsorbability of the substrate layer in which the medicament is absorbed or dispersed. For example, in at least one embodiment, the substrate comprising the first inner layer 3512 can be bioabsorbed faster than the substrate comprising the second inner layer 3513 and, as a result, a medicament can be release from the first inner layer 3512 faster than the second inner layer 3513, for example. In various embodiments, as described herein, one or more of the layers 3511, 3512, and 3513 of the cartridge body 3510 can be adhered to one another by at least one adhesive, such as fibrin and/or protein hydrogel, for example. In certain embodiments, the adhesive can be water soluble and can be configured to release the connection between the layers as the staple cartridge 3500 is being implanted and/or some time thereafter. In at least one such embodiment, the adhesive can be configured to bioabsorb faster than the outer layer 3511, the first inner layer 3512, and/or the second inner layer 3513.


In various embodiments, referring now to FIGS. 62 and 63, a staple cartridge, such as staple cartridge 3600, for example, can comprise a cartridge body 3610 including a compressible first layer 3611, a second layer 3612 attached to the first layer 3611, and a removable compressible layer 3613 attached to the second layer 3612. In at least one such embodiment, the first layer 3611 can be comprised of a compressible foam material, the second layer 3612 can comprise a laminate material adhered to the first layer 3611 utilizing one or more adhesives, and the third layer 3613 can comprise a compressible foam material removably adhered to the second layer 3612 utilizing one or more adhesives, for example. In various embodiments, the staple cartridge 3600 can further comprise a plurality of staples, such as staples 3620, for example, positioned in the cartridge body 3610. In at least one such embodiment, each staple 3620 can comprise a base 3622 positioned in the third layer 3613 and one or more deformable legs 3621 extending upwardly from the base 3622 through the second layer 3612 and into the first layer 3611, for example. In use, further to the above, the top surface 3619 of the staple cartridge body 3610 can be pushed downwardly by an anvil until the staple legs 3621 penetrate through the top surface 3619 and the targeted tissue and contact the anvil. After the staple legs 3621 have been sufficiently deformed, the anvil can be moved away from the staple cartridge 3600 such that the compressible layers thereof can at least partially re-expand. In various circumstances, the insertion of the staples through the tissue can cause the tissue to bleed. In at least one embodiment, the third layer 3613 can be comprised of an absorbent material, such as protein hydrogel, for example, which can draw blood away from the stapled tissue. In addition to or in lieu of the above, the third layer 3613 can be comprised of a hemostatic material and/or tissue sealant, such as freeze-dried thrombin and/or fibrin, for example, which can be configured to reduce the bleeding from the tissue. In certain embodiments, the third layer 3613 may provide a structural support to the first layer 3611 and the second layer 3612 wherein the third layer 3613 may be comprised of a bioabsorbable material and/or a non-bioabsorbable material. In any event, in various embodiments, the third layer 3613 can be detached from the second layer 3612 after the staple cartridge 3610 has been implanted. In embodiments where the third layer 3613 comprises an implantable-quality material, the surgeon can elect whether to remove the third layer 3613 of the cartridge body 3610. In at least one embodiment, the third layer 3613 can be configured to be removed from the second layer 3612 in one piece.


In various embodiments, the first layer 3611 can be comprised of a first foam material and the third layer 3613 can be comprised of a second foam material which can be different than the first foam material. In at least one embodiment, the first foam material can have a first density and the second foam material can have a second density wherein the first density can be different than the second density. In at least one such embodiment, the second density can be higher than the first density wherein, as a result, the third layer 3613 may be less compressible, or have a lower compression rate, than the first layer 3611. In at least one alternative embodiment, the first density can be higher than the second density wherein, as a result, the first layer 3611 may be less compressible, or have a lower compression rate, than the third layer 3613. In various embodiments, referring now to FIGS. 64 and 65, a staple cartridge 3700, similar to the staple cartridge 3600, can comprise a cartridge body 3710 comprising a first compressible foam layer 3711, a second layer 3712 attached to the first layer 3711, and a detachable third compressible foam layer 3713 removably attached to the second layer 3712. In at least one such embodiment, the third layer 3713 can comprise a plurality of staple receiving slots, or cut-outs, 3709 which can each be configured to receive at least a portion of a staple 3620, such as a staple base 3622, for example, therein. In certain embodiments, the staples 3620 can be configured to slide within the staple receiving slots 3709 or, stated another way, the third layer 3713 can be configured to slide relative to the staples 3620 when the staple cartridge 3700 is positioned against the targeted tissue and compressed by an anvil, for example. In at least one embodiment, the receiving slots 3709 can be configured such that there is clearance between the staples 3620 and the side walls of the receiving slots 3709. In at least one such embodiment, as a result of the above, the staples 3620 may not capture a portion of the third layer 3713 therein when the staples 3620 are deformed, as illustrated in FIGS. 64 and 65. In certain other embodiments, the ends of the staple receiving slots 3709 adjacent to the second layer 3712 can be closed by a portion of the third layer 3713 and, as a result, at least a portion of the third layer 3713 can be captured within the staples 3620 when they are deformed. In any event, the third layer 3713 can comprise one or more perforations and/or score marks 3708, for example, which can be configured to permit the third layer 3713 to be removed from the second layer 3712 in two or more pieces as illustrated in FIG. 64. In FIG. 64, one of the pieces of the third layer 3713 is illustrated as being removed by a tool 3755. In various embodiments, the perforations 3708 can be arranged along a line positioned intermediate a first row of staples and a second row of staples.


In various embodiments, referring again to FIGS. 64 and 65, the bases 3622 of the staples 3620 can be positioned within the receiving slots 3709 wherein, in at least one embodiment, the side walls of the receiving slots 3709 can be configured to contact and releasable retain the staple legs 3621 in position. In certain embodiments, although not illustrated, the third layer 3713 can comprise an elongated slot surrounding all of the staples within a staple line. In at least one such embodiment, a staple cartridge comprising four staple rows, for example, can comprise an elongate slot aligned with each staple row in the bottom layer of the staple cartridge. Further to the above, at least a portion of the staple cartridge 3600 and/or the staple cartridge 3700 can be implanted within a patient and at least a portion of the staple cartridge can be removable from the patient. In at least one embodiment, referring again to FIGS. 64 and 65, the first layer 3711 and the second layer 3712 can be captured within the staples 3620 and can be implanted with the staples 3620, whereas the third layer 3713 can be optionally removed or detached from the staple cartridge 3700. In various circumstances, the removal of a portion of the implanted staple cartridge can reduce the amount of material that the patient's body has to reabsorb which can provide various therapeutic benefits. In the event that a portion of a staple cartridge is detached and removed, such as by a laparoscopic tool 3755, for example, the detached staple cartridge portion can be removed from the surgical site through a trocar, such as a trocar having a 5 mm aperture, for example. In certain embodiments, a cartridge body can comprise more than one layer that can be removed. For example, the cartridge body 3710 can comprise a fourth layer wherein the third layer of 3713 of the cartridge body 3710 can be comprised of a hemostatic material and the fourth layer can be comprised of a support layer. In at least one such embodiment, a surgeon can remove the support layer and then elect whether to remove the hemostatic layer, for example.


In various embodiments, referring now to FIG. 66, a staple cartridge, such as staple cartridge 3800, for example, can comprise a cartridge body 3810 including an outer layer 3811 and an inner layer 3812. The inner layer 3812 can be comprised of a compressible foam material and the outer layer 3811 can be at leas partially wrapped around the inner layer 3812. In at least one embodiment, the outer layer 3811 can comprise a first portion 3811a configured to be positioned on a first side of the inner layer 3812 and a second portion 3811b configured to be positioned on a second side of the inner layer 3812 wherein the first portion 3811a and the second portion 3811b can be connected by a flexible hinge, such as hinge 3809, for example. In at least one such embodiment, at least one adhesive, such as fibrin and/or protein hydrogel, for example, can be applied to the first side and/or the second side of the inner layer 3812 in order to secure the portions of the outer layer 3811 thereto. In various embodiments, the outer layer 3811 can comprise one or more fastening members extending therefrom. In at least one such embodiment, the outer layer 3811 can comprise a plurality of deformable legs 3821 extending from one side of the outer layer 3811 which can be seated in the compressible inner layer 3812. In at least one such embodiment, the legs 3821 may not protrude from the second side of the inner layer 3812 while, in at least one alternative embodiment, the legs 3821 may at least partially protrude from the inner layer 3812. When the compressible cartridge body 3810 is compressed, in use, the legs 3821 can be configured to pierce the inner layer 3812 and the second portion 3811b of the outer layer 3811. In certain embodiments, the second portion 3811b of the outer layer 3811 can comprise apertures, such as apertures 3808, for example defined therein which can be configured to receive the staple legs 3821. In certain embodiments, at least portions of the staple cartridge 3800 can comprise a knife slot 3803 which can be configured to slidably receive a cutting member therein. In at least one such embodiment, the knife slot 3803 may not extend entirely through the thickness of the cartridge body 3810 and, as a result, the cutting member may incise the cartridge body 3810 as it is moved relative thereto.


In various embodiments, referring now to FIG. 67, a staple cartridge 3900 can comprise, similar to staple cartridge 3800, a cartridge body 3910 including an inner layer 3812 and an outer layer 3811, wherein the outer layer 3811 can comprise a first portion 3811a positioned adjacent to the first side of the inner layer 3812 and a second portion 3811b positioned adjacent to the second side of the inner layer 3812. In at least one embodiment, similar to the above, the outer layer 3811 can comprise one or more fastening members extending therefrom. In at least one such embodiment, the outer layer 3811 can comprise a plurality of deformable legs 3921 extending from one side of the outer layer 3811 which can be seated in the compressible inner layer 3812. In certain embodiments, each deformable leg 3921 can comprise at least one hook or bath 3923 protruding therefrom which can be configured to engage the second portion 3811b of the outer layer 3811 and, as a result, retain the outer layer 3811 to the inner layer 3812. In at least one such embodiment, the barbs 3923 can be configured to protrude from the second side of the inner layer 3812 and extend through the apertures 3808 in the second portion 3811b of the outer layer 3811 such that the barbs 3923 can engage the outside surface of the outer layer 3811 and lock the outer layer 3811 to the inner layer 3812. In order to construct the staple cartridge 3900, the inner layer 3812 may be at least partially compressed in order to cause the barbs to protrude therefrom and enter into the apertures 3808. In at least one such embodiment, the staple cartridge 3900 can be at least partially pre-compressed when it is inserted into a staple cartridge, for example. In certain embodiments, further to the above, at least a portion of the legs 3921 can be embedded within the first portion 3811a of the outer layer 3811 wherein, in at least one embodiment, the outer layer 3811 can be comprised of a plastic material, such as polydioxanone (PDS) and/or polyglycolic acid (PGA), for example, and the plastic material can be overmolded around at least a portion of the legs 3921.


In various embodiments, referring now to FIGS. 68-72, a staple cartridge, such as staple cartridge 4000, for example, can comprise a cartridge body 4010 including a compressible first layer 4011 and a second layer 4012 and, in addition, a plurality of staples 4020 positioned within the cartridge body 4010. In certain embodiments, referring to FIG. 70, each staple 4020 can comprise a base 4022 and at least one deformable leg 4023 extending from the base 4022. In at least one embodiment, referring to FIG. 68, the staple cartridge 4000 can be positioned between a staple cartridge channel 4030 and an anvil 4040 of an end effector of a surgical stapler wherein the second layer 4012 of the cartridge body 4010 and/or the bases 4022 of the staples 4020 can be positioned against the staple cartridge channel 4030. In various embodiments, referring now to FIG. 69, the second layer 4012 can comprise a layer of pledgets 4060 interconnected to one another by a pledget support frame 4061. In at least one such embodiment, the pledgets 4060 and the pledget support frame 4061 can be comprised of a molded plastic material, such as polyglycolic acid (PGA), for example. Each pledget 4060 can comprise one or more apertures or slots 4062 which can be configured to receive a staple leg 4021 extending therethrough as illustrated in FIGS. 70 and 71. Each pledget 4060 can further comprise a receiving slot 4063 defined therein which can be configured to receive a base 4022 of a staple 4020. In various embodiments, referring again to FIG. 69, the pledgets 4060 and/or pledget support fame 4061 can comprise a plurality of score marks, perforations, or the like which can be configured to allow the pledgets 4060 to become detached from the pledget support frame 4061 at a desired location. Similarly, referring to FIG. 71, one or more pledgets 4060 can be connected to one another along a line comprising perforations and/or score marks 4064, for example. In use, the compressible foam layer 4011 can be positioned against the targeted tissue T and the cartridge body 4010 can be compressed by the anvil 4040 such that the anvil 4040 can deform the staples 4020. When the staples 4020 are deformed, the staple legs 4021 of each staple 4020 can capture the tissue T, a portion of the first layer 4011, and a pledget 4060 within the deformed staple. When the staple cartridge channel 4030 is moved away from the implanted staple cartridge 4060, for example, the pledget support frame 4061 can be detached from the pledgets 4060 and/or the pledgets 4060 can be detached from one another. In certain circumstances, the pledgets 4060 can be detached from the frame 4061 and/or each other when the staples 4020 are being deformed by the anvil 4040 as described above.


In various embodiments described herein, the staples of a staple cartridge can be fully formed by an anvil when the anvil is moved into a closed position. In various other embodiments, referring now to FIGS. 73-76, the staples of a staple cartridge, such as staple cartridge 4100, for example, can be deformed by an anvil when the anvil is moved into a closed position and, in addition, by a staple driver system which moves the staples toward the closed anvil. The staple cartridge 4100 can comprise a compressible cartridge body 4110 which can be comprised of a foam material, for example, and a plurality of staples 4120 at least partially positioned within the compressible cartridge body 4110. In various embodiments, the staple driver system can comprise a driver holder 4160, a plurality of staple drivers 4162 positioned within the driver holder 4160, and a staple cartridge pan 4180 which can be configured to retain the staple drivers 4162 in the driver holder 4160. In at least one such embodiment, the staple drivers 4162 can be positioned within one or more slots 4163 in the driver holder 4160 wherein the sidewalls of the slots 4163 can assist in guiding the staple drivers 4162 upwardly toward the anvil. In various embodiments, the staples 4120 can be supported within the slots 4163 by the staple drivers 4162 wherein, in at least one embodiment, the staples 4120 can be entirely positioned in the slots 4163 when the staples 4120 and the staple drivers 4162 are in their unfired positions. In certain other embodiments, at least a portion of the staples 4120 can extend upwardly through the open ends 4161 of slots 4163 when the staples 4120 and staple drivers 4162 are in their unfired positions. In at least one such embodiment, referring primarily now to FIG. 74, the bases of the staples 4120 can be positioned within the driver holder 4160 and the tips of the staples 4120 can be embedded within the compressible cartridge body 4110. In certain embodiments, approximately one-third of the height of the staples 4120 can be positioned within the driver holder 4160 and approximately two-thirds of the height of the staples 4120 can be positioned within the cartridge body 4110. In at least one embodiment, referring to FIG. 73A, the staple cartridge 4100 can further comprise a water impermeable wrap or membrane 4111 surrounding the cartridge body 4110 and the driver holder 4160, for example.


In use, the staple cartridge 4100 can be positioned within a staple cartridge channel, for example, and the anvil can be moved toward the staple cartridge 4100 into a closed position. In various embodiments, the anvil can contact and compress the compressible cartridge body 4110 when the anvil is moved into its closed position. In certain embodiments, the anvil may not contact the staples 4120 when the anvil is in its closed position. In certain other embodiments, the anvil may contact the legs of the staples 4120 and at least partially deform the staples 4120 when the anvil is moved into its closed position. In either event, the staple cartridge 4100 can further comprise one or more sleds 4170 which can be advanced longitudinally within the staple cartridge 4100 such that the sleds 4170 can sequentially engage the staple drivers 4162 and move the staple drivers 4162 and the staples 4120 toward the anvil. In various embodiments, the sleds 4170 can slide between the staple cartridge pan 4180 and the staple drivers 4162. In embodiments where the closure of the anvil has started the forming process of the staples 4120, the upward movement of the staples 4120 toward the anvil can complete the forming process and deform the staples 4120 to their fully formed, or at least desired, height. In embodiments where the closure of the anvil has not deformed the staples 4120, the upward movement of the staples 4120 toward the anvil can initiate and complete the forming process and deform the staples 4120 to their fully formed, or at least desired, height. In various embodiments, the sleds 4170 can be advanced from a proximal end of the staple cartridge 4100 to a distal end of the staple cartridge 4100 such that the staples 4120 positioned in the proximal end of the staple cartridge 4100 are fully formed before the staples 4120 positioned in the distal end of the staple cartridge 4100 are fully formed. In at least one embodiment, referring to FIG. 75, the sleds 4170 can each comprise at least one angled or inclined surface 4711 which can be configured to slide underneath the staple drivers 4162 and lift the staple drivers 4162 as illustrated in FIG. 76.


In various embodiments, further to the above, the staples 4120 can be formed in order to capture at least a portion of the tissue T and at least a portion of the compressible cartridge body 4110 of the staple cartridge 4100 therein. After the staples 4120 have been formed, the anvil and the staple cartridge channel 4130 of the surgical stapler can be moved away from the implanted staple cartridge 4100. In various circumstances, the cartridge pan 4180 can be fixedly engaged with the staple cartridge channel 4130 wherein, as a result, the cartridge pan 4180 can become detached from the compressible cartridge body 4110 as the staple cartridge channel 4130 is pulled away from the implanted cartridge body 4110. In various embodiments, referring again to FIG. 73, the cartridge pan 4180 can comprise opposing side walls 4181 between which the cartridge body 4110 can be removably positioned. In at least one such embodiment, the compressible cartridge body 4110 can be compressed between the side walls 4181 such that the cartridge body 4110 can be removably retained therebetween during use and releasably disengaged from the cartridge pan 4180 as the cartridge pan 4180 is pulled away. In at least one such embodiment, the driver holder 4160 can be connected to the cartridge pan 4180 such that the driver holder 4160, the drivers 4162, and/or the sleds 4170 can remain in the cartridge pan 4180 when the cartridge pan 4180 is removed from the surgical site. In certain other embodiments, the drivers 4162 can be ejected from the driver holder 4160 and left within the surgical site. In at least one such embodiment, the drivers 4162 can be comprised of a bioabsorbable material, such as polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In various embodiments, the drivers 4162 can be attached to the staples 4120 such that the drivers 4162 are deployed with the staples 4120. In at least one such embodiment, each driver 4162 can comprise a trough configured to receive the bases of the staples 4120, for example, wherein, in at least one embodiment, the troughs can be configured to receive the staple bases in a press-fit and/or snap-fit manner.


In certain embodiments, further to the above, the driver holder 4160 and/or the sleds 4170 can be ejected from the cartridge pan 4180. In at least one such embodiment, the sleds 4170 can slide between the cartridge pan 4180 and the driver holder 4160 such that, as the sleds 4170 are advanced in order to drive the staple drivers 4162 and staples 4120 upwardly, the sleds 4170 can move the driver holder 4160 upwardly out of the cartridge pan 4180 as well. In at least one such embodiment, the driver holder 4160 and/or the sleds 4170 can be comprised of a bioabsorbable material, such as polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In various embodiments, the sleds 4170 can be integrally formed and/or attached to a drive bar, or cutting member, which pushes the sleds 4170 through the staple cartridge 4100. In such embodiments, the sleds 4170 may not be ejected from the cartridge pan 4180 and may remain with the surgical stapler while, in other embodiments in which the sleds 4170 are not attached to the drive bar, the sleds 4170 may be left in the surgical site. In any event, further to the above, the compressibility of the cartridge body 4110 can allow thicker staple cartridges to be used within an end effector of a surgical stapler as the cartridge body 4110 can compress, or shrink, when the anvil of the stapler is closed. In certain embodiments, as a result of the staples being at least partially deformed upon the closure of the anvil, taller staples, such as staples having an approximately 0.18″ staple height, for example, could be used, wherein approximately 0.12″ of the staple height can be positioned within the compressible layer 4110 and wherein the compressible layer 4110 can have an uncompressed height of approximately 0.14″, for example.


In various embodiments, referring now to FIGS. 77-80, a staple cartridge, such as staple cartridge 4200, for example, can comprise a compressible cartridge body 4210, a plurality of staples 4220 positioned therein, and a plurality of flexible lateral support members 4234. In various embodiments, referring now to FIG. 78, the staple cartridge 4200 can be positioned intermediate an anvil 4240 and a staple cartridge channel 4230 wherein, in at least one embodiment, the lateral support members 4234 can be attached to the staple cartridge channel 4230. When the anvil 4240 is moved downwardly to compress the cartridge body 4210 and at least partially deform the staples 4220, as illustrated in FIG. 79, the side portions of the cartridge body 4210 can bulge laterally and push the lateral support members 4234 outwardly. In at least one such embodiment, the lateral support members 4234 can be attached to the cartridge body 4210 and, when the cartridge body 4210 bulges laterally as described above, the lateral support members 4234 can detach from the cartridge body 4210 as illustrated in FIG. 79. In at least one embodiment, the lateral support members 4234 can be adhered to the cartridge body 4210 utilizing at least one adhesive, such as fibrin and/or protein hydrogel, for example Similar to the above, the closing of the anvil 4240 may only partially deform the staples 4220, wherein the formation of the staples 4220 can be completed by the advancement of one or more sleds 4270 through the staple cartridge 4200 as illustrated in FIG. 80. In various embodiments, referring now to FIGS. 82 and 83, the sleds 4270 can be advanced from a proximal end of the staple cartridge 4200 to a distal end of the staple cartridge 4200 by a cutting member 4280. In at least one such embodiment, the cutting member 4280 can comprise a cutting element, or knife, 4283, which can be advanced through the tissue T and/or the compressible cartridge body 4210. In certain embodiments, the cutting member 4280 can comprise camming members 4282 which can travel along the outside surfaces of the jaws 4230 and 4240 and move or hold the jaws in position. In various embodiments, as a result of the above, the staples 4220 can be formed into their final shapes at the same time, or at least substantially the same time, as the tissue T is incised. In at least one such embodiment, the sleds 4270 can be positioned distally with respect to the knife 4283 such that the tissue T is only incised when the proceeding portion of the tissue has been fully stapled, for example.


In various embodiments, referring again to FIGS. 82 and 83, the sleds 4270 can comprise separate slidable members which are advanced together by the cutting member 4280. In at least one such embodiment, the sleds 4270 can be contained within the staple cartridge 4200 and the cutting member 4280 can be advanced into the staple cartridge 4200 by a firing bar 4281 such that the cutting member 4280 engages the sleds 4270 and advances the sleds 4270 distally. In certain embodiments, the sleds 4270 can be connected to one another. In either event, each sled 4270 can comprise an angled surface, or cam, 4271 which can be configured to lift the staples 4220 aligned within a staple row. In certain embodiments, the angled surfaces 4271 can be integrally formed with the cutting member 4280. In at least one embodiment, referring again to FIGS. 82 and 83, each staple 4200 can comprise a base, at least one deformable member extending from the base, and a crown 4229 overmolded onto and/or positioned around at least a portion of the base and/or the deformable members of the staple 4200. In various embodiments, such crowns 4229 can be configured to be driven directly by a sled 4270, for example. More particularly, in at least one embodiment, the crowns 4229 of staples 4220 can be configured such that the angled surfaces 4271 of the sleds 4270 can slide underneath and directly contact the crowns 4229 without a staple driver positioned therebetween. In such embodiments, each crown 4229 can comprise at least one co-operating angled or inclined surface which can be engaged by an angled surface 4271 of the sleds 4270 such that the co-operating angled surfaces can drive the staples 4220 upwardly when the sleds 4270 are slid underneath the staples 4220.


In various embodiments, referring now to FIG. 81, a staple cartridge, such as staple cartridge 4300, for example, can comprise a compressible body 4310 and a plurality of staples 4320 positioned within the compressible body 4310. Similar to the above, the staple cartridge 4300 can comprise flexible lateral supports 4334 which can be attached to a staple cartridge channel and/or adhered to the compressible body 4310. In addition to the above, the flexible lateral supports 4334 can be connected together by one or more struts, or connection members, 4335 which can be configured to hold the lateral supports 4334 together. In use, the connection members 4335 can be configured to prevent, or at least inhibit, the lateral supports 4334 from becoming prematurely detached from the cartridge body 4310. In certain embodiments, the connection members 4335 can be configured to hold the lateral supports 4334 together after the staple cartridge 4300 has been compressed by an anvil. In such embodiments, the lateral supports 4334 can resist the lateral bulging, or displacement, of the lateral portions of the cartridge body 4310. In certain embodiments, a cutting member, such as cutting member 4280, for example, can be configured to transect the connection members 4335 as the cutting member 4280 is moved distally within the cartridge body 4310. In at least one such embodiment, the cutting member 4280 can be configured to push one or more sleds, such as sleds 4270, for example, distally in order to form the staples 4320 against an anvil. The sleds 4270 can lead the cutting edge 4283 such that the cutting member 4280 does not transect a connection member 4335 until the staples 4320 adjacent to that connection member 4335 have been fully formed, or at least formed to a desired height. In various circumstances, the connection members 4335, in co-operation with the lateral supports 4334, can prevent, or at least reduce, the lateral movement of the compressible cartridge body 4310 and, concurrently, prevent, or at least reduce, the lateral movement of the staples 4320 positioned within the cartridge body 4310. In such circumstances, the connection members 4335 can hold the staples 4320 in position until after they are deformed and the connection members 4335 can be thereafter cut to release the lateral portions of the cartridge body 4310. As mentioned above, the lateral supports 4334 can be connected to the staple cartridge channel and, as a result, can be removed from the surgical site with the staple cartridge channel after the staple cartridge 4300 has been implanted. In certain embodiments, the lateral supports 4334 can be comprised of an implantable material and can be left within a surgical site. In at least one embodiment, the connection members 4335 can be positioned intermediate the cartridge body 4310 and the tissue T and, after the connection members 4335 have been detached from the lateral supports 4334, the connections members 4335 can remain implanted in the patient. In at least one such embodiment, the connection members 4335 can be comprised of an implantable material and, in certain embodiments, the connection members 4335 can be comprised of the same material as the lateral supports 4334, for example. In various embodiments, the connection members 4335 and/or lateral supports 4334 can be comprised of a flexible bioabsorbable material such as polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In various embodiments, a connection member can comprise a sheet of material connecting the lateral supports 4334. In certain embodiments, a staple cartridge can comprise connection members extending across the top surface of the cartridge body 4310 and, in addition, connection members extending around the bottom surface of the cartridge body 4310.


In various embodiments, referring now to FIG. 84, a staple cartridge can comprise staples, such as staples 4420, for example, which can comprise a wire portion inserted into a crown portion. In at least one embodiment, the wire portion can be comprised of metal, such as titanium and/or stainless steel, for example, and/or plastic, such as polydioxanone (PDS) and/or polyglycolic acid (PGA), for example. In at least one embodiment, the crown portion can be comprised of metal, such as titanium and/or stainless steel, for example, and/or plastic, such as polydioxanone (PDS) and/or polyglycolic acid (PGA), for example. In certain embodiments, the wire portion of each staple 4420 can comprise a base 4422 and deformable legs 4421 extending from the base 4422 wherein the crown portion of each staple 4420 can comprise a crown 4429 which can be configured to receive at least a portion of a base 4422 therein. In order to assemble the portions of each staple 4420, referring now to FIGS. 85A-85C, the legs 4421 of the wire portion can be inserted into an opening 4426 in a crown 4429 wherein the opening 4426 can be configured to guide the legs 4421 into a base chamber 4427. The wire portion can be further inserted into the crown 4429 such that the legs 4421 exit the base chamber 4427 and the base 4422 of the wire portion enters into the base chamber 4427. In at least one such embodiment, the base chamber 4427 can be configured such that the wire portion is rotated within the crown 4429 as the base 4422 enters into the base chamber 4427 such that the staple legs 4421 are pointed in an upward, or at least substantially upward, direction. In various embodiments, referring again to FIG. 84, the crown 4429 can comprise exit holes 4425 which can be configured to receive the staple legs 4421 therein.


In various embodiments, further to the above, a surgical stapler can comprise a sled 4470 configured to transverse the staple cartridge 4400 and staple cartridge channel 4430 and move the staples 4420 contained within the cartridge body 4410 toward an anvil. In various circumstances, the sled 4470 can be moved from a proximal end of the staple cartridge channel 4430 to a distal end of the cartridge channel 4430 in order to implant the cartridge body 4410 and the staples 4420. In certain circumstances, the sled 4470 can be retracted or returned to the proximal end of the cartridge channel 4430 and another staple cartridge 4400 can be inserted into the cartridge channel 4430. Once the new staple cartridge 4400 has been positioned within the cartridge channel 4430, the sled 4470 can be advanced distally once again. In various embodiments, the surgical stapler may comprise one or more lock-out features which can prevent the sled 4470 from being advanced distally once again without a new staple cartridge 4400 being positioned within the cartridge channel 4430. In at least one such embodiment, referring again to FIG. 84, the staple cartridge channel 4430 can comprise a lock-out shoulder 4439 which can be configured to prevent, or at least limit, the distal movement of the sled 4470. More particularly, the sled 4470 can be configured to abut the shoulder 4439 unless the sled 4470 is at least partially lifted upwardly over the shoulder 4439 by a lift feature 4428, for example, extending between the proximal-most staples 4420 within a staple cartridge 4400. Stated another way, absent the presence of the proximal-most staples 4420 in a new staple cartridge 4400, the sled 4470 cannot be advanced. Thus, when an expended staple cartridge 4400 is present within the cartridge channel 4430, or no staple cartridge 4400 is present in the cartridge channel 4430 at all, the sled 4470 cannot be advanced within the cartridge channel 4430.


Further to the above, referring now to FIG. 86, a staple cartridge, such as staple cartridge 4500, for example, can be positioned within a staple cartridge channel 4530 and can comprise a compressible cartridge body 4510, a plurality of staples 4520 positioned within the cartridge body 4510, and a cartridge pan, or retainer, 4580. In various embodiments, the compressible cartridge body 4510 can comprise an outer layer 4511 and an inner layer 4512 wherein, in at least one embodiment, the outer layer 4511 can sealingly enclose the inner layer 4512. In at least one such embodiment, the outer layer 4511 can extend between the inner layer 4512 and the cartridge pan 4580. In certain other embodiments, the outer layer 4511 may only partially surround the inner layer 4512 and, in at least one such embodiment, the outer layer 4511 and the cartridge pan 4580 can co-operate to encompass, or at least substantially encompass, the inner layer 4512. In various embodiments, further to the above, the staples 4520 can be supported by the cartridge pan 4580 wherein the cartridge pan 4580 can comprise one or more staple support channels configured to support the staples 4520. In certain embodiments, the cartridge pan 4580 can be attached to the cartridge body 4510 wherein, in at least one such embodiment, the cartridge body 4510 can be compressed laterally between opposing side walls of the cartridge pan 4580. In various embodiments, the side walls of the cartridge pan 4580 can support the cartridge body 4510 laterally and, in at least one such embodiment, the cartridge pan 4580 can comprise one or more walls, or fins, 4582 extending upwardly from the bottom support 4583 into the cartridge body 4510. In at least one such embodiment, the cartridge body 4510 can comprise one or more slots, or channels, therein which can be configured to receive and/or interlock with the walls 4582. In various embodiments, the walls 4582 can extend partially, or almost entirely, through the cartridge body 4510. In at least one such embodiment, the walls 4582 can extend longitudinally through the staple cartridge 4500 between a first row of staples 4520 and a second row of staples 4520.


In various embodiments, the cartridge body 4510 and/or the cartridge pan 4580 can comprise co-operating retention features which can provide a snap-fit between the cartridge pan 4580 and the cartridge body 4510. In certain embodiments, the staple cartridge 4500 can be positioned within the cartridge channel 4530 such that the cartridge pan 4580 is positioned against and/or attached to the cartridge channel 4530. In at least one embodiment, the cartridge pan 4580 can be detachably coupled to the cartridge channel 4530 such that, after the staple cartridge 4500 has been compressed by the anvil 4540 and the staples 4520 have been deformed, the cartridge pan 4580 can detach from the cartridge channel 4530 and can be implanted with the cartridge body 4510. In at least one such embodiment, the cartridge pan 4580 can be comprised of a bioabsorbable material such as polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In certain embodiments, a surgical stapler can further comprise a firing mechanism and/or driver which can be slid intermediate the staple cartridge channel 4530 and a bottom drive surface on the cartridge pan 4580 which can be configured to lift or eject the cartridge pan 4580 from the cartridge channel 4530. In certain embodiments, the cartridge body 4510 can be detachably coupled to the cartridge pan 4580 such that, after the staple cartridge 4500 has been compressed by the anvil 4540 and the staples 4520 have been deformed, the cartridge body 4510 can detach from the cartridge pan 4580. In at least one such embodiment, the cartridge pan 4580 can remain fixedly engaged with the cartridge channel 4530 such that the cartridge pan 4580 is removed from the surgical site with the cartridge channel 4530. In certain embodiments, a surgical stapler can further comprise a firing mechanism and/or driver which can be slid intermediate the staple cartridge pan 4580 and a bottom drive surface on the cartridge body 4510 which can be configured to lift or eject the cartridge body 4510 from the cartridge pan 4580. In at least one such embodiment, the staple cartridge 4500 can further comprise staple drivers positioned intermediate the cartridge pan 4580 and the staples 4520 such that, as the firing mechanism is slid distally, the staple drivers and the staples 4520 can be driven upwardly toward the anvil. In at least one such embodiment, the staple drivers can be at least partially embedded within the compressible cartridge body 4510.


In various embodiments, similar to the above, the staple cartridge 4500 can comprise a lock-out feature which can be configured to prevent, or at least limit, the distal movement of a cutting member unless a unfired staple cartridge 4500 has been positioned within the staple cartridge channel 4530. In certain embodiments, the staple cartridge pan 4580 can comprise a surface which lifts the cutting member upwardly and over a locking surface within the staple cartridge channel 4530, for example. In the event that a staple cartridge 4500 comprising a cartridge pan 4580 is not present in the cartridge channel 4530, the cutting member cannot be advanced. In at least one embodiment, the proximal-most staples, and/or any other suitable staples, within a staple cartridge 4500 can comprise a lifting surface which can sufficiently lift the cutting member over the locking surface. In addition to or in lieu of the above, various portions of the staple cartridge 4500 can be comprised of materials having different colors. In such embodiments, a surgeon may be able to visually identify when an unfired and/or fired staple cartridge is present in the staple cartridge channel 4530. In at least one such embodiment, the outer layer 4511 of the cartridge body 4510 may have a first color, the cartridge pan 4580 may have a second color, and the staple cartridge channel 4530 may have a third color. In the event that the surgeon sees the first color, the surgeon may know that an unfired cartridge 4500 is present in the staple cartridge channel 4530; in the event that the surgeon sees the second color, the surgeon may know that a fired cartridge 4500 is present in the staple cartridge channel 4530 and that the remaining cartridge pan 4580 needs to be removed; and in the event that the surgeon sees the third color, the surgeon may know that no portion of a staple cartridge 4500 remains within the cartridge channel 4530.


In various embodiments, referring now to FIG. 87, a staple cartridge, such as staple cartridge 4600, for example, can comprise a compressible, implantable cartridge body 4610 and a plurality of staples 4620 positioned therein. The cartridge body 4610 can comprise an outer layer 4611 and an inner layer 4612. In certain embodiments, the inner layer 4612 can comprise a plurality of pockets, such as pockets, or cavities, 4615, for example, defined therein which can facilitate the collapse of the cartridge body 4610. In at least one such embodiment, the inner layer 4612 can comprise a corrugated, or honeycomb-configured, lattice which can be configured to withstand a compressive force, or pressure, as long as the compressive force, or pressure, does not exceed a certain threshold value. When the threshold value has not been exceeded, the inner layer 4612 can deform at a linear, or at least substantially linear, rate with respect to the compressive force, or pressure, being applied. After the compressive force, or pressure, has exceeded the threshold value, the inner layer 4612 can suddenly succumb to large deflections and collapse, or buckle, as a result of the compressive load. In various embodiments, the lattice of the inner layer 4612 can be comprised of a plurality of sub-layers 4612a which can be connected together. In at least one embodiment, each sub-layer 4612a can comprise a plurality of alternating furrows and ridges, or waves, which can be aligned with the alternating furrows and ridges of an adjacent sub-layer 4612a. In at least one such embodiment, the furrows of a first sub-layer 4612a can be positioned adjacent to the ridges of a second sub-layer 4612a and, similarly, the ridges of the first sub-layer 4612a can be positioned adjacent to the furrows of the second sub-layer 4612a. In various embodiments, the adjacent sub-layers 4612a can be adhered to one another and/or the outer layer 4611 by at least one adhesive, such as fibrin and/or protein hydrogel, for example. FIG. 88 illustrates the staple cartridge 4600 after the cartridge body 4610 has been collapsed and the staples 4620 have been deformed in order to capture and hold tissue T against the cartridge body 4610.


In various embodiments, referring now to FIGS. 89-91, a staple cartridge, such as staple cartridge 4700, for example, can comprise a compressible, implantable cartridge body 4710 and a plurality of staples 4720 positioned within the cartridge body 4710. Similar to the above, the cartridge body 4710 can comprise an outer layer 4711 and an inner layer 4712, wherein the inner layer 4712 can comprise a plurality of sub-layers 4712a. Also similar to the above, each sub-layer 4712a can comprise alternating furrows 4717 and ridges 4718 which can be aligned with one another to define pockets, or cavities, 4715 therebetween. In at least one such embodiment, the furrows 4717 and/or the ridges 4718 can extend along axes which are parallel to one another and/or parallel to a longitudinal axis 4709. In various embodiments, the staples 4720 can be aligned in a plurality of staple rows which can extend along axes which are parallel to one another and/or parallel to the longitudinal axis 4709. In various alternative embodiments, referring again to FIGS. 87 and 88, the staples 4620 contained in the cartridge body 4600 can extend along axes which are traverse or perpendicular with respect to the axes defined by the furrows and ridges of the sub-layers 4612a. Referring again to FIGS. 89-91, the staples 4720 can extend through the furrows 4717 and the ridges 4718 wherein friction forces between the staples 4720 and the sub-layers 4712a can hold the staples 4720 within the cartridge body 4710. In certain embodiments, the plurality of sub-layers 4712a can be comprised of a buttress material and/or plastic material, such as polydioxanone (PDS) and/or polyglycolic acid (PGA), for example, which can be configured to hold the staples 4720 in an upright orientation, for example, and/or hold the staples 4720 in alignment with respect to each other as illustrated in FIGS. 89 and 90. FIG. 91 illustrates the staple cartridge 4700 after the cartridge body 4710 has been collapsed and the staples 4720 have been deformed in order to capture and hold tissue T against the cartridge body 4710.


In various embodiments, referring again to FIGS. 89-91, the cartridge body 4710 can resiliently or elastically collapse when it is compressed. In at least one such embodiment, the waves formed within each sub-layer 4712a by the furrows 4717 and the ridges 4718 can be flattened, or at least substantially flattened, when the cartridge body 4710 is compressed which can collapse, or at least substantially collapse, the cavities 4715 defined therebetween. In various circumstances, the cartridge body 4710, or at least portions of the cartridge body 4710, can resiliently or elastically re-expand after the compressive force, or pressure, has been removed from the cartridge body 4710. In at least one such embodiment, the connections between the furrows 4717 and the ridges 4718 of adjacent sub-layers 4712a can remain intact, or at least substantially intact, when the cartridge body 4710 is compressed such that, after the compression force has been removed from the cartridge body 4710, the sub-layers 4712a can bias themselves away from each other and, as a result, at least partially re-expand the cartridge body 4710. In certain embodiments, the cartridge body 4710 can be plastically deformed, or crushed, when it is compressed and, as a result, the cartridge body 4710 may not re-expand after the compressive force, or pressure, has been removed from the cartridge body 4710. In certain embodiments, referring now to FIG. 92, a staple cartridge, such as staple cartridge 4800, for example, can comprise a crushable cartridge body 4810 comprising an outer layer 4811 and an inner layer 4812, wherein the inner layer 4812 can comprise a corrugated, honeycomb-configured, lattice having a plurality of pockets, or cavities, 4815 defined therein. In various embodiments, the walls defining the lattice of inner layer 4812 can comprise one or more weakened, or thin, cross-sections 4819 which can be configured to allow the walls defining the lattice to break when the cartridge body 4810 is compressed. In such circumstances, the cartridge body 4810 can be crushed when the staple cartridge 4800 is implanted.


In various embodiments, referring now to FIGS. 93-95, a staple cartridge, such as staple cartridge 4900, for example, can comprise a cartridge body 4910 comprising an outer layer 4911 and a plurality of collapsible elements 4912 positioned intermediate top and bottom portions of the outer layer 4911, for example. Referring primarily to FIGS. 93 and 94, the staple cartridge 4900 can further comprise a plurality of staples 4920, wherein each staple 4920 can be positioned in a collapsible element 4912. More particularly, each collapsible element 4912 can comprise a first portion 4912a, a second portion 4012b, and a third portion 4012c which can co-operate to define a cavity 4915 therein which is configured to receive a staple 4920. In use, further to the above, the staple cartridge 4900 can be positioned within a staple cartridge channel and a compressive force can be applied to the tissue contacting surface 4919 in order to compress the cartridge body 4910. As the tissue contacting surface 4919 is moved downwardly, the collapsible elements 4912 can collapse. In such circumstances, the second portion 4912b of each collapsible element 4912 can collapse into a corresponding first portion 4912a and, similarly, the third portion 4912c of each collapsible element 4912 can collapse into a corresponding second portion 4912b. As the cartridge body 4910 is compressed and the collapsible elements 4912 are collapsed, the staples 4920 positioned within the collapsible elements 4912 can be deformed, as illustrated in FIG. 95. In various embodiments, the second portion 4912b of each collapsible element 4912 can be frictionally engaged and/or press-fit within a corresponding first portion 4912a such that, once the compressive force applied to the collapsible element 4912 exceeds the retention force retaining the first portion 4912a and the second portion 4912b in their extended position (FIG. 94), the first portion 4912a and the second portion 4912b can begin to slide relative to one another. Similarly, the third portion 4912c of each collapsible element 4912 can be frictionally engaged and/or press-fit within a corresponding second portion 4912b such that, once the compressive force applied to the collapsible element 4912 exceeds the retention force retaining the second portion 4912b and the third portion 4912c in their extended position (FIG. 94), the second portion 4912b and the third portion 4912c can begin to slide relative to one another.


In many embodiments described herein, a staple cartridge can comprise a plurality of staples therein. In various embodiments, such staples can be comprised of a metal wire deformed into a substantially U-shaped configuration having two staple legs. Other embodiments are envisioned in which staples can comprise different configurations such as two or more wires that have been joined together having three or more staple legs. In various embodiments, the wire, or wires, used to form the staples can comprise a round, or at least substantially round, cross-section. In at least one embodiment, the staple wires can comprise any other suitable cross-section, such as square and/or rectangular cross-sections, for example. In certain embodiments, the staples can be comprised of plastic wires. In at least one embodiment, the staples can be comprised of plastic-coated metal wires. In various embodiments, a cartridge can comprise any suitable type of fastener in addition to or in lieu of staples. In at least one such embodiment, such a fastener can comprise pivotable arms which are folded when engaged by an anvil. In certain embodiments, two-part fasteners could be utilized. In at least one such embodiment, a staple cartridge can comprise a plurality of first fastener portions and an anvil can comprise a plurality of second fastener portions which are connected to the first fastener portions when the anvil is compressed against the staple cartridge. In certain embodiments, as described above, a sled or driver can be advanced within a staple cartridge in order to complete the forming process of the staples. In certain embodiments, a sled or driver can be advanced within an anvil in order to move one or more forming members downwardly into engagement with the opposing staple cartridge and the staples, or fasteners, positioned therein.


In various embodiments described herein, a staple cartridge can comprise four rows of staples stored therein. In at least one embodiment, the four staple rows can be arranged in two inner staple rows and two outer staple rows. In at least one such embodiment, an inner staple row and an outer staple row can be positioned on a first side of a cutting member, or knife, slot within the staple cartridge and, similarly, an inner staple row and an outer staple row can be positioned on a second side of the cutting member, or knife, slot. In certain embodiments, a staple cartridge may not comprise a cutting member slot; however, such a staple cartridge may comprise a designated portion configured to be incised by a cutting member in lieu of a staple cartridge slot. In various embodiments, the inner staple rows can be arranged within the staple cartridge such that they are equally, or at least substantially equally, spaced from the cutting member slot. Similarly, the outer staple rows can be arranged within the staple cartridge such that they are equally, or at least substantially equally, spaced from the cutting member slot. In various embodiments, a staple cartridge can comprise more than or less than four rows of staples stored within a staple cartridge. In at least one embodiment, a staple cartridge can comprise six rows of staples. In at least one such embodiment, the staple cartridge can comprise three rows of staples on a first side of a cutting member slot and three rows of staples on a second side of the cutting member slot. In certain embodiments, a staple cartridge may comprise an odd number of staple rows. For example, a staple cartridge may comprise two rows of staples on a first side of a cutting member slot and three rows of staples on a second side of the cutting member slot. In various embodiments, the staple rows can comprise staples having the same, or at least substantially the same, unformed staple height. In certain other embodiments, one or more of the staple rows can comprise staples having a different unformed staple height than the other staples. In at least one such embodiment, the staples on a first side of a cutting member slot may have a first unformed height and the staples on a second side of a cutting member slot may have a second unformed height which is different than the first height, for example.


In various embodiments, referring now to FIGS. 96A-96D, an end effector of a surgical stapler can comprise a cartridge attachment portion, such as staple cartridge channel 5030, for example, a fastener cartridge removably positioned in the staple cartridge channel 5030, such as staple cartridge 5000, for example, and a jaw 5040 positioned opposite the staple cartridge 5000 and the staple cartridge channel 5030. The staple cartridge 5000 can comprise a compressible body 5010 and a plurality of staples 5020, and/or any other suitable fasteners, at least partially positioned in the compressible body 5010. In at least one such embodiment, each staple 5020 can comprise a base 5022 and, in addition, legs 5021 extending upwardly from the base 5022, wherein at least a portion of the legs 5021 can be embedded in the cartridge body 5010. In various embodiments, the compressible body 5010 can comprise a top, or tissue-contacting, surface 5019 and a bottom surface 5018, wherein the bottom surface 5018 can be positioned against and supported by a support surface 5031 of the staple cartridge channel 5030. Similar to the above, the support surface 5031 can comprise a plurality of support slots 5032 (FIG. 96D), for example, defined therein which can be configured to receive and support the bases 5022 of the staples 5020. In various embodiments, the end effector of the surgical stapler can further comprise a retention matrix, such as retention matrix 5050, for example, which can be configured to engage the staples 5020 and capture tissue therebetween. In at least one such embodiment, the retention matrix 5050 can be removably mounted to the jaw 5040. In use, once the staple cartridge 5000 has been positioned within the staple cartridge channel 5030, the jaw 5040, and the retention matrix 5050 attached thereto, can be moved toward the staple cartridge 5000 and the staple cartridge channel 5030. In at least one embodiment, the jaw 5040 can be moved downwardly along an axis 5099 such that the jaw 5040 and the staple cartridge channel 5030 remain parallel, or at least substantially parallel, to one another as the jaw 5040 is closed. More particularly, in at least one such embodiment, the jaw 5040 can be closed in a manner such that a tissue-contacting surface 5051 of the retention matrix 5050 is parallel, or at least substantially parallel, to the tissue-contacting surface 5019 of the staple cartridge 5000 as the jaw 5040 is moved toward the staple cartridge 5000.


In various embodiments, referring now to FIG. 96A, the retention matrix 5050 can be detachably secured to the jaw 5040 such that there is little, if any, relative movement between the retention matrix 5050 and the jaw 5040 when the retention matrix 5050 is attached to the jaw 5040. In at least one embodiment, the jaw 5040 can comprise one or more retention features which can be configured to hold the retention matrix 5050 in position. In at least one such embodiment, the retention matrix 5050 can be snap-fit and/or press-fit into the jaw 5040. In certain embodiments, the retention matrix 5050 can be adhered to the jaw 5040 utilizing at least one adhesive. In any event, the jaw 5040 can be moved into a position in which the retention matrix 5050 is in contact with the tissue T and the tissue T is positioned against the tissue-contacting surface 5019 of the staple cartridge 5000. When the tissue T is positioned against the staple cartridge 5000 by the jaw 5040, the compressible body 5010 of the staple cartridge 5000 may or may not be compressed by the jaw 5040. In either circumstance, in various embodiments, the legs 5021 of the staples 5200 may not protrude through the tissue-contacting surface 5019 of the staple cartridge 5000 as illustrated in FIG. 96A. Furthermore, as also illustrated in FIG. 96A, the jaw 5040 can hold the tissue T against the compressible body 5010 without engaging the retention matrix 5050 with the staples 5020. Such embodiments can permit a surgeon to open and close the jaw 5040 multiple times in order to obtain a desired positioning of the end effector within a surgical site, for example, without damaging the tissue T. Other embodiments are envisioned, however, where the staple tips 5023 can protrude from the tissue-contacting surface 5019 prior to the cartridge body 5010 being compressed by the anvil 5040. Once the end effector has been suitably positioned, referring now to FIG. 96B, the jaw 5040 can be moved downwardly toward the staple cartridge channel 5030 such that the compressible body 5010 is compressed by the anvil 5040 and such that the tissue-contacting surface 5019 is pushed downwardly relative to the staples 5020. As the tissue-contacting surface 5019 is pushed downwardly, the tips 5023 of the staple legs 5021 can pierce the tissue-contacting surface 5019 and pierce at least a portion of the tissue T. In such circumstances, the retention matrix 5050 may be positioned above the staples 5020 such that the retention apertures 5052 of retention matrix 5050 are aligned, or at least substantially aligned, with the tips 5023 of the staple legs 5021.


As the retention matrix 5050 is pushed downwardly along the axis 5099, referring now to FIG. 96C, the staple legs 5021 of staples 5020 can enter into the retention apertures 5052. In various embodiments, the staple legs 5021 can engage the side walls of the retention apertures 5052. In certain embodiments, as described in greater detail below, the retention matrix 5050 can comprise one or more retention members extending into and/or around the retention apertures 5052 which can engage the staple legs 5021. In either event, the staple legs 5021 can be retained in the retention apertures 5052. In various circumstances, the tips 5023 of the staple legs 5021 can enter into the retention apertures 5052 and can frictionally engage the retention members and/or the side walls of the apertures 5052. As the retention matrix 5050 is pushed toward the bases 5022 of the staples 5020, the staple legs 5021 can slide relative to the side walls and/or the retention members. As a result of the above, sliding friction forces can be created between the staple legs 5021 and the retention matrix 5050 wherein such sliding friction forces can resist the insertion of the retention matrix 5050 onto the staples 5020. In various embodiments, the sliding friction forces between the retention matrix 5050 and the staples 5020 can be constant, or at least substantially constant, as the retention matrix 5050 is slid downwardly along the staple legs 5021 of the staples 5020. In certain embodiments, the sliding friction forces may increase and/or decrease as the retention matrix 5050 is slid downwardly along the staple legs 5021 owing to variations in geometry of the staple legs 5021, the retention apertures 5052, and/or the retention members extending into and/or around the retention apertures 5052, for example. In various embodiments, the insertion of the retention matrix 5050 onto the staples 5020 can also be resisted by the compressible body 5010 of the staple cartridge 5000. More particularly, the compressible body 5010 can be comprised of an elastic material, for example, which can apply a resistive force to the retention matrix 5050 which increases as the distance in which the compressible body 5010 is compressed increases. In at least one such embodiment, the increase in the resistive force generated by the cartridge body 5010 can be linearly proportional, or at least substantially linearly proportional, with respect to the distance in which the cartridge body 5010 is compressed. In certain embodiments, the increase in the resistive force generated by the cartridge body 5010 can be geometrically proportional with respect to the distance in which the cartridge body 5010 is compressed.


In various embodiments, further to the above, a sufficient firing force can be applied to the jaw 5040 and the retention matrix 5050 in order to overcome the resistive and friction forces described above. In use, the retention matrix 5050 can be seated to any suitable depth with respect to the staples 5020. In at least one embodiment, the retention matrix 5050 can be seated to a depth with respect to the bases 5022 of the staples 5020 in order to secure two or more layers of tissue together and generate compressive forces, or pressure, within the tissue. In various circumstances, the system comprising the retention matrix 5050 and the staples 5020 can allow a surgeon to select the amount of compressive forces, or pressure, that is applied the tissue by selecting the depth in which the retention matrix 5050 is seated. For example, the retention matrix 5050 can be pushed downwardly toward the staple bases 5022 of the staples 5020 until the retention matrix 5050 is seated a certain depth 5011 away from the bottom of the support slots 5032, wherein a shorter depth 5011 can result in higher compressive forces, or pressure, being applied to the tissue T than a taller depth 5011 which can result in lower compressive forces, or pressure, being applied to the tissue T. In various embodiments, the compressive forces, or pressures, applied to the tissue T can be linearly proportional, or at least substantially linearly proportional, to the depth 5011 in which the retention matrix 5050 is seated. In various circumstances, the compressive forces, or pressure, applied to the tissue T can depend on the thickness of the tissue T positioned between the retention matrix 5050 and the staple cartridge 5020. More particularly, for a given distance 5011, the presence of thicker tissue T can result in higher compression forces, or pressure, than the presence of thinner tissue T.


In various circumstances, further to the above, a surgeon can adjust the depth in which the retention matrix 5050 is seated in order to account for thicker and/or thinner tissue positioned within the end effector and to apply a certain or predetermined pressure to the tissue T regardless of the tissue thickness. For example, the surgeon can seat the retention matrix 5050 to a shorter depth 5011 when fastening thinner tissue T or a taller depth 5011 when fastening thicker tissue T in order to arrive at the same, or at least substantially the same, compression pressure within the tissue. In certain embodiments, further to the above, a surgeon can selectively determine the amount of compressive pressure to apply to the tissue T positioned between the retention matrix 5050 and the staple cartridge 5010. In various circumstances, a surgeon can engage the retention matrix 5050 with the staples 5020 and position the retention matrix 5050 a first distance away from the bases 5022 of the staples 5020 in order to apply a first compressive pressure to the tissue. The surgeon can alternatively position the retention matrix 5050 a second distance away from the bases 5022, which is shorter than the first distance, in order to apply a second compressive pressure to the tissue which is greater than the first pressure. The surgeon can alternatively position the retention matrix 5050 a third distance away from the bases 5022, which is shorter than the second distance, in order to apply a third compressive pressure to the tissue which is greater than the second pressure. In various embodiments, the fastening system comprising the retention matrix 5050 and the staples 5020 can be configured to permit a surgeon to apply a wide range of compressive pressures to the targeted tissue.


In various embodiments, referring now to FIG. 96D, the staple legs 5021 can be inserted through the retention matrix 5050 such that the staple leg tips 5023 extend above the top surface of the retention matrix 5050. In at least one embodiment, referring again to FIG. 96C, the jaw 5040 can further comprise clearance apertures 5042 defined therein which can be configured to receive the staple leg tips 5023 as they pass through the retention apertures 5052 in the retention matrix 5050. In at least one such embodiment, the clearance apertures 5042 can be aligned with the retention apertures 5052 such that the legs 5021 do not contact the jaw 5040. In various embodiments, the clearance apertures 5042 can have a sufficient depth such that the staple legs 5021 do not contact the jaw 5040 regardless of the distance in which the retention matrix 5050 is seated. After the retention matrix 5050 has been engaged with the staples 5020 and seated to a desired position, referring now to FIG. 96D, the staple cartridge channel 5030 and the jaw 5040 can be moved away from the tissue T. More particularly, the staple cartridge channel 5030 can be detached from the implanted staple cartridge 5000 and the anvil 5040 can be detached from the implanted retention matrix 5050. As the jaw 5040 is moved away from the retention matrix 5050 and the staple supports 5032 are moved away from the staple bases 5022, the distance 5011 between the retention matrix 5050 and the bottom of the bases 5022 can be maintained even though the jaw 5040 and the staple cartridge channel 5030 are no longer providing support thereto. In various embodiments, the static friction forces between the staple legs 5021 and the retention matrix 5050 can be sufficient to maintain the retention matrix 5050 in position despite a biasing force being applied to the retention matrix 5050 by the compressed cartridge body 5010 and/or the compressed tissue T. In at least one such embodiment, the cartridge body 5010 can be comprised of a resilient material which, when compressed, can apply an elastic biasing force to the retention matrix 5050 and the staples 5020 in a manner which tends to push the retention matrix 5050 and the staples 5020 apart, although such movement is opposed by the frictional engagement between the staple legs 5021 and the retention matrix 5050.


In various embodiments, as described above, a retention matrix can comprise a plurality of retention apertures, wherein each retention aperture can be configured to receive a leg of a fastener therein. In at least one embodiment, referring now to FIG. 97, a portion of a retention matrix 5150 is illustrated therein which can comprise a retention aperture 5152 defined by a perimeter 5156. In various embodiments, the perimeter 5156 of the aperture 5152 can comprise a circular, or at least substantially circular, profile and/or any other suitable profile. In certain embodiments, the retention matrix 5150 can comprise one or more retention members, such as retention members 5153, for example, which extend into the aperture 5152 and can be configured to engage a fastener leg when the fastener leg is inserted therethrough. In at least one such embodiment, each retention member 5153 can comprise a cantilever which extends inwardly toward a center axis 5159, i.e., toward the center of the aperture 5152. In various embodiments, each cantilever can comprise a first end which is attached to the retention matrix body 5158 and a second end which forms the perimeter 5156 of the retention aperture 5152. In certain embodiments, the perimeter 5156 of a retention aperture 5152 can be defined by a first diameter, or width, and a fastener leg can be defined by a second diameter, or width, wherein the second diameter can be larger than the first diameter. In at least one such embodiment, the fastener leg can be configured to contact and deflect one or more of the retention members 5153 in order to increase the diameter of the retention aperture 5152 as the fastener leg is being inserted therethrough. In certain embodiments, further to the above, the fastener leg can define a perimeter which is larger than the perimeter 5156 of the retention aperture 5152 such that the fastener leg can expand the perimeter 5156 when the fastener leg is inserted therein.


In various embodiments, referring again to FIG. 97, the aperture 5152 can be defined by the deformable members 5153, wherein each deformable member 5153 can be configured to deflect relative to, or independently of, the other deformable members 5153. In at least one such embodiment, adjacent deformable members 5153 can be separated by slots 5154 which can be configured to permit each deformable member 5153 to flex relative to the others. In certain embodiments, each slot 5154 can comprise a first end 5155 in the retention matrix body 5158, a second end opening into the retention aperture 5152, and a constant, or at least substantially constant, width extending between the first end 5155 and the second end. In various other embodiments, the width of each slot 5154 may not be constant and each slot 5154 may increase and/or decrease in width between the first and second ends thereof. In certain embodiments, the first ends 5155 of the slots 5154 can comprise an enlarged portion, such as a circular portion, which can provide, one, strain relief to the bases of the deformable members 5153 attached to the retention matrix body 5158 and, two, means for increasing the flexibility of the deformable members 5153. In various embodiments, the geometry of the deformable members 5153, and/or slots 5154, can be selected so as to provide the deformable members 5153 with a desired flexibility. In certain embodiments, for example, the slots 5154 can be lengthened in order to create longer deformable members 5153 which can be more flexible than deformable members 5153 having a shorter length. In at least one embodiment, the width of each deformable member 5153 can be selected so as to provide a desired flexibility thereof. More particularly, deformable members having a thinner width can be more flexible than deformable members having a thicker width. In certain embodiments, referring again to FIG. 97, the first ends of the cantilevers of deformable members 5153 attached to the retention matrix body 5158 can be wider than the second ends of the cantilevers. In at least one such embodiment, the cantilevers can be tapered in a linear, or at least substantially linear, manner between the first and second ends thereof.


In various embodiments, referring again to FIG. 97, the retention matrix body 5158 can comprise a flat, or at least substantially flat, sheet of material having a tissue-contacting surface 5151 and a top surface 5157. In at least one such embodiment, the tissue-contacting surface 5151 and the top surface 5157 can be parallel, or at least substantially parallel, to one another. In various embodiments, each deformable member 5153 can comprise a first portion 5153a and a second portion 5153b, wherein the first portion 5153a can extend in a first direction and the second portion 5153b can extend in a different, or second, direction. In at least one such embodiment, the retention matrix body 5158 can define a plane and the first portions 5153a of the deformable members 5153 can lie within such a plane. In various embodiments, the second portions 5153b of the deformable members 5153 can extend at an angle relative to the first portions 5153a. In at least one such embodiment, the second portions 5153b can extend in directions which are pointed away from the top surface 5157 of the retention matrix body 5158 and, in certain embodiments, the second portions 5153b can converge toward the central axis 5159 of the retention aperture 5152. In any event, in various embodiments, the second portions 5153b can be configured to deflect away from the central axis 5159 when the fastener leg is inserted therethrough. In embodiments where a staple leg 5021 of a staple 5020 is inserted into a retention aperture 5152, the deformable members 5153 can deform in a direction which is generally away from the bases 5122 of the staples 5120. In certain embodiments, as a result, the deformable members 5153 can deflect in a general direction which is the same as, or at least substantially the same as, the direction in which the staple legs 5021 are being inserted.


In various embodiments, referring again to FIG. 97, the second portions 5153b of the deformable members 5153 can each comprise a sharp tip, for example, which can be configured to slide against a staple leg 5021 as the staple leg 5021 is inserted therein. The sharp tips of the second portions 5153b can also be configured to bite into the staple leg 5021 in the event that the staple leg 5021 were to be pulled in the opposite direction, i.e., in a direction which would remove the staple leg 5021 from the retention aperture 5052. In certain circumstances, the second portions 5153b can be inclined at an angle relative to the side of the staple leg 5021 which is greater than 90 degrees and, as a result, the second portions 5153b may dig, or burrow, into the side of the staple leg 5021 when the staple leg 5021 experiences a force which tends to withdraw the staple leg 5021 from the retention aperture 5052. In certain embodiments, the staple legs 5021 can comprise indentations and/or concavities, such as microindentations, for example, in the surfaces thereof which can be configured to receive the tips of the deformable members 5053, for example, therein. In at least one such embodiment, the tips of the deformable members 5053 can catch in and burrow into the indentations in the staple legs 5021 when a withdrawing force is applied to the staple legs 5021. In various embodiments, as a result of the burrowing of the second portions 5153b into the staple legs 5021, forces acting to remove the staple legs 5021 from the retention apertures 5022 may only seat the second portions 5153b deeper into the staple legs 5021 and increase the force required to remove the staple legs 5021. Furthermore, owing to the upward inclination of the second portions 5153b, in at least one embodiment, the second portions 5153b can be more permissive to the insertion of a staple leg 5021 within a retention aperture 5152 and more resistive to withdrawal of the staple leg 5021. In at least one embodiment, as a result, the force required to insert a staple leg 5021 into a retention aperture 5022 may be less than the force required to remove the staple leg 5021 from the retention aperture 5022. In various embodiments, the force needed to remove the staple leg 5021 from the retention aperture 5022 can be approximately 50 percent greater than the force needed to insert the staple leg 5021 into the retention aperture 5022, for example. In various other embodiments, the force needed to remove the staple leg 5021 may between approximately 10 percent and approximately 100 percent greater than the force needed to insert the staple leg 5021, for example. In certain embodiments, the force needed to remove the staple leg 5021 may be approximately 100 percent, approximately 150 percent, approximately 200 percent, and/or greater than approximately 200 percent larger than the force needed to insert the staple leg 5021, for example.


In certain embodiments, referring again to FIG. 97, the second portions 5153b can be arranged circumferentially around the aperture 5152 and can define a pocket therebetween. More particularly, the second portions 5153b can define a pocket 5160 which can be configured to receive the tip of the fastener leg when it is inserted into the retention aperture 5152. In various embodiments, the second portions 5153b of the deformable members 5153 can comprise an annular, or an at least substantially annular, contour which can co-operatively define an annular, or at least substantially annular, profile of the pocket 1560, for example. In at least one such embodiment, the second portions 5153b can define a conical or frustoconical pocket. In various embodiments, the pocket can be defined by a suitable number of deformable members, such as four deformable members 5153 (FIG. 97), six deformable members 5153 (FIG. 98), or eight deformable members 5153 (FIG. 99), for example. In certain embodiments, referring now to FIG. 100, the deformable members of a retention matrix, such as retention matrix 5250, for example, can form a pyramidal shape, or an at least substantially pyramidal shape, for example. In various embodiments, a retention matrix 5250 can comprise a plurality of retention apertures, such as retention aperture 5252, for example, which can be defined by a perimeter 5256. In various embodiments, the perimeter 5256 can comprise a polygonal, or at least substantially polygonal, profile and/or any other suitable profile. In certain embodiments, the retention matrix 5250 can comprise one or more retention members, such as retention members 5253, for example, which extend into the aperture 5252 and can be configured to engage a fastener leg when the fastener leg is inserted therethrough. In at least one such embodiment, each retention member 5253 can comprise a cantilever which extends inwardly toward a center axis 5259, i.e., toward the center of the aperture 5252. In various embodiments, each cantilever can comprise a first end which is attached to the retention matrix body 5258 and a second end which forms the perimeter 5256 of the retention aperture 5252. In certain embodiments, the perimeter 5256 of a retention aperture 5252 can be defined by a first diameter, or width, and a fastener leg can be defined by a second diameter, or width, wherein the second diameter can be larger than the first diameter. In at least one such embodiment, the fastener leg can be configured to contact and deflect one or more of the retention members 5253 in order to increase the diameter of the retention aperture 5252 as the fastener leg is being inserted therethrough. In certain embodiments, further to the above, the fastener leg can define a perimeter which is larger than the perimeter 5256 of the retention aperture 5252 such that the fastener leg can expand the perimeter 5256 when the fastener leg is inserted therein.


In various embodiments, referring again to FIG. 100, the aperture 5252 can be defined by the deformable members 5253, wherein each deformable member 5253 can be configured to deflect relative to, or independently of, the other deformable members 5253. In at least one such embodiment, adjacent deformable members 5253 can be separated by slots 5254 which can be configured to permit each deformable member 5253 to flex relative to the others. In various embodiments, the retention matrix body 5258 can comprise a flat, or at least substantially flat, sheet of material having a tissue-contacting surface 5251 and a top surface 5257. In at least one such embodiment, the tissue-contacting surface 5251 and the top surface 5257 can be parallel, or at least substantially parallel, to one another. In various embodiments, each deformable member 5253 can comprise a first portion 5253a and a second portion 5253b, wherein the first portion 5253a can extend in a first direction and the second portion 5253b can extend in a different, or second, direction. In at least one such embodiment, the retention matrix body 5258 can define a plane and the first portions 5253a of the deformable members 5253 can lie within such a plane. In various embodiments, the second portions 5253b of the deformable members 5253 can extend at an angle relative to the first portions 5253a. In at least one such embodiment, the second portions 5253b can extend in directions which are pointed away from the top surface 5257 of the retention matrix body 5258 and, in certain embodiments, the second portions 5253b can converge toward the central axis 5259 of the retention aperture 5252. In any event, in various embodiments, the second portions 5253b can be configured to deflect away from the central axis 5259 when the fastener leg is inserted therethrough. In certain embodiments, referring again to FIG. 100, the second portions 5253b can be arranged circumferentially around the aperture 5252 and can define a pocket therebetween. More particularly, the second portions 5253b can define a pocket which can be configured to receive the tip of the fastener leg when it is inserted into the retention aperture 5252. In various embodiments, the second portions 5253b of the deformable members 5253 can define a polygonal, or an at least substantially polygonal, pocket, for example. In various embodiments, the pocket can be defined by a suitable number of deformable members, such as four deformable members 5253 (FIG. 100) which can define a square, six deformable members 5253 (FIG. 101) which can define a hexagon, or eight deformable members 5253 (FIG. 102) which can define an octagon, for example.


In various embodiments, referring now to FIG. 103, a retention matrix, such as retention matrix 5350, for example, can be formed from a flat, or an at least substantially flat, sheet of material such as titanium and/or stainless steel, for example. In at least one such embodiment, a plurality of apertures 5352 can be formed in the body 5358 of the retention matrix 5350 by one or more stamping processes. The sheet of material can be positioned in a stamping die which, when actuated, can punch out certain portions of the material in order to form slots 5354, apertures 5355 of slots 5354, and/or the perimeter 5356 of the retention aperture 5352, for example. The stamping die can also be configured to bend the deformable members 5353 in a suitable configuration. In at least one such embodiment, the stamping die can deform the second portions 5353b upwardly relative to the first portions 5353a along a crease line 5353c. In various embodiments, referring now to FIG. 104, a retention matrix, such as retention matrix 5450, for example, can comprise a plurality of retention apertures 5452. Similar to the above, the perimeter 5456 of each retention aperture 5452 can be defined by a plurality of deformable members 5453 separated by slots, or slits, 5454. In at least one such embodiment, the entirety of each deformable member 5453 can be bent upwardly wherein the free ends of the cantilevers comprising the deformable members 5453 can define the perimeter 5456. In various embodiments, the retention matrix 5450 can comprise a plurality of apertures 5455 surrounding, or at least substantially surrounding, the retention aperture 5452. In at least one such embodiment, the apertures 5455 can be arranged in a circular array surrounding or enclosing a perimeter defined by the fixed ends of the cantilevers of the deformable members 5453. In certain embodiments, each aperture 5455 can comprise a circular, or at least substantially circular, perimeter and/or any other suitable perimeter. In use, the apertures 5455 can provide, one, strain relief to the bases of the deformable members 5453 attached to the retention matrix body 5458 and, two, means for increasing the flexibility of the deformable members 5453. In various embodiments, larger apertures 5455 can provide more flexibility to the deformable members 5453 as compared to smaller apertures 5455. Furthermore, apertures 5455 which are closer to the deformable members 5453 can provide more flexibility as compared to apertures 5455 which are further away.


In various embodiments, referring now to FIG. 105, a retention matrix, such as retention matrix 5550, for example, can comprise a plurality of retention apertures 5552. Each retention aperture 5552 can comprise an elongate slot 5554 having enlarged circular, or at least substantially circular, ends 5555. In at least one such embodiment, the ends 5555 can be defined by a diameter which is wider than the slot 5554. In certain embodiments, the elongate slot 5554 and the ends 5555 can positioned along, and/or centered along, a longitudinal axis 5559. In various embodiments, the slot 5554 and the ends 5555 can define two opposing tabs 5553 which can be configured to engage a leg of a fastener and deflect as the fastener leg is inserted therethrough. In at least one embodiment, ends 5555 having a larger perimeter, or diameter, can define longer tabs 5553 which can be more flexible than tabs 5553 defined by ends 5555 having a smaller perimeter, or diameter. In various embodiments, the ends 5555 can have the same perimeter and diameter and, in at least one such embodiment, each tab 5553 can be symmetrical about an axis which is perpendicular, or at least substantially perpendicular, to the longitudinal axis 5559. Alternatively, the ends 5555 can have different perimeters and/or diameters wherein, in at least one embodiment, each tab 5553 may not be symmetrical about its axis. In at least one such alternative embodiment, the tabs 5553 may twist about their axes as the fastener leg is inserted through the retention aperture 5552. In various embodiments, referring now to FIG. 106, a retention matrix, such as retention matrix 5650, for example, can comprise a plurality of retention apertures 5652. Each retention aperture 5652 can comprise an elongate slot 5654 comprising circular, or at least substantially circular, ends 5655. In at least one such embodiment, the elongate slot 5654 and the ends 5655 can be positioned along, and/or centered along, a longitudinal axis 5659. In various embodiments, each end 5655 can be defined by a diameter which is the same as, or at least substantially the same as, the width of the slot 5654.


In various embodiments, referring now to FIG. 107, a retention matrix, such as retention matrix 5750, for example, can comprise a plurality of retention apertures 5752. Each retention aperture 5752 can comprise a plurality of slots, such as slots 5754, for example, having enlarged ends 5755. In at least one such embodiment, the slots 5754 and the ends 5755 can be positioned along and/or centered along longitudinal axes 5759. In various embodiments, the axes 5759 can extend in directions which are perpendicular or transverse to one another. In certain embodiments, the slots 5754 and the ends 5755 can define four tabs 5753, for example, which can be configured to engage a fastener leg and deflect when the fastener leg is inserted through the retention aperture 5752. In at least one embodiment, each tab 5753 can comprise a triangular, or at least substantially triangular, configuration, such as an equilateral triangle, for example. In various other embodiments, referring now to FIG. 108, a retention matrix, such as retention matrix 5850, for example, can comprise a plurality of retention apertures 5852. Each retention aperture 5852 can comprise a plurality of slots, such as slots 5854, for example, having ends 5855, wherein the slots 5854 and the ends 5855 can be positioned along and/or centered along longitudinal axes 5859. In various embodiments, the axes 5859 can extend in directions which are perpendicular or transverse to one another. In certain embodiments, the slots 5854 and the ends 5855 can define tabs 5853 which can be configured to engage a fastener leg and deflect when the fastener leg is inserted through the retention aperture 5852. In at least one embodiment, each tab 5853 can comprise an arcuate profile. More particularly, each tab 5853 can comprise a curved end, as opposed to a pointed end depicted in FIG. 105, which can be configured to contact the fastener leg.


In various embodiments, referring now to FIG. 109, a retention matrix, such as retention matrix 5950, for example, can comprise a plurality of retention apertures 5952. Each retention aperture 5952 can comprise a plurality of slots, such as slots 5954, for example, wherein each slot 5954 can extend along, and/or can be centered along, an axis 5959. In various embodiments, the axes 5959 can be transverse to each other and, in at least one such embodiment, the axes 5959 can be arranged such that all of the axes 5959 extend through a center of the retention aperture 5952 and are spaced equidistantly, or at least substantially equidistantly, from each other. In at least one embodiment, each slot 5954 can comprise an open end facing the center of the retention aperture 5952 and a second, or closed, end 5955 at the opposite end of the slot 5954. Similar to the above, the slots 5954 and the ends 5955 can define three tabs 5953, for example, which can be configured to engage a fastener leg and deflect when the fastener leg is inserted into the retention aperture 5952. In various embodiments, each tab 5953 can comprise an arcuate configuration extending between adjacent ends 5955 of the slots 5954. In various embodiments, referring now to FIG. 110, a retention matrix, such as retention matrix 6050, for example, can comprise a plurality of retention apertures 6052. Each retention aperture 6052 can comprise a tab 6053 which can be configured to engage a fastener leg and to deflect when the fastener leg is inserted into the retention aperture 6052. In at least one such embodiment, the tab 6053 can comprise a base fixed to the retention matrix body 6058 and a free end comprising an arcuate or curved profile 6056 which can be configured to contact the fastener leg. In certain embodiments, the fastener leg can be a staple leg comprised of a round wire wherein the curved profile 6056 can be configured to match, or at least substantially match, a curved outer surface of the round wire.


In various embodiments, referring again to FIG. 110, the retention matrix body 6058 can comprise a plurality of slots 6054 and apertures 6055 which can be configured to define the tab 6053 and various portions of the retention aperture 6052. In at least one embodiment, the tab 6053 can comprise a rectangular configuration comprising parallel, or at least substantially parallel, sides. In certain embodiments, referring now to FIG. 111, a retention matrix, such as retention matrix 6150, for example, can comprise a plurality of retention apertures 6152. Each retention aperture 6152 can comprise a tab 6153 which can be configured to engage a fastener leg and to deflect when the fastener leg is inserted into the retention aperture 6152. In at least one such embodiment, the tab 6153 can comprise a base fixed to the retention matrix body 6158 and a free end comprising an arcuate or curved profile 6156 which can be configured to contact the fastener leg. In various embodiments, the retention matrix body 6158 can comprise a plurality of slots 6154 and apertures 6155 which can be configured to define the tab 6153 and various portions of the retention aperture 6152. In at least one embodiment, the tab 6153 can comprise a tapered configuration comprising arcuate sides. In at least one such embodiment, the tab 6153 can taper geometrically with the base being wider than the free end, for example.


In various embodiments, as described above, a fastening system can comprise a plurality of staples comprising staple legs which are inserted through a plurality of retention apertures in a retention matrix. In certain embodiments, as described in greater detail below, the staples can be held in a first jaw and the retention matrix can be held in a second jaw, wherein at least one of the first jaw and the second jaw can be moved toward the other. In various circumstances, the staples positioned within the first jaw can be secured therein such that the staple legs are aligned with the retention apertures when the retention matrix is engaged with the staple legs. In certain embodiments, referring to FIGS. 112 and 113, a fastener system can comprise a staple cartridge 6200, for example, positioned in a first jaw of a surgical stapler and a retention matrix 6250, for example, positioned in a second jaw of the surgical stapler. Referring now to FIGS. 119 and 120, further to the above, the retention matrix 6250 can comprise a plurality of retention apertures 6252, wherein each retention aperture 6252 can comprise a perimeter 6256 defined by one or more deflectable members 6253. In at least one such embodiment, further to the above, the deflectable members 6253 defining each aperture 6252 can define a pocket 6201. In various embodiments, each pocket 6201 can comprise a curved and/or concave surface, for example, which can be configured to guide a tip of a staple leg into the aperture 6252 in the event that the staple leg is misaligned with the retention aperture 6252 and initially contacts the deflectable members 6253 and/or the tissue-contacting surface 6251, for example.


In various embodiments, further to the above, the fastening system can further comprise a plurality of staples 6220 comprising staple legs 6221 which can be inserted through the retention apertures 6252 in the retention matrix 6250. In at least one such embodiment, each staple 6220 can comprise a substantially U-shaped configuration, for example, comprising a base 6222 from which the staple legs 6221 can extend upwardly. In various embodiments, referring now to FIGS. 115 and 116, the retention apertures 6252 in the retention matrix 6250 can be arranged in two parallel, or at least substantially parallel, longitudinal rows, for example, which can extend along, or parallel to, a longitudinal axis of the retention matrix. In certain embodiments, the retention apertures 6252 in a first row can be offset, or staggered, with respect to the retention apertures 6252 in a second row. In at least one such embodiment, each staple 6220 can comprise a first staple leg 6221 positioned in a retention aperture 6252 in the first row of and a second staple leg 6221 positioned in a retention aperture 6252 in the second row wherein, as a result, the bases 6222 can extend in a direction which is transverse to the longitudinal axis of the retention matrix 6250. In at least one such embodiment, the staples 6220 can be parallel, or at least substantially parallel, to one another. More particularly, a base 6222a of a staple 6220a be parallel to, or at least substantially parallel to, a base 6222b of a staple 6220b which can be parallel to, or at least substantially parallel to, a base 6222c of a staple 6220c, for example. In at least one embodiment, the staple legs 6221a of staple 6220a can define a plane which is parallel to, or at least substantially parallel to, a plane defined by the staple legs 6221b of staple 6220b which can be parallel to, or at least substantially parallel to, a plane defined by the staple legs 6221 of staple 6220c, for example.


In various embodiments, referring now to FIGS. 112 and 114, the staple cartridge 6200 can comprise a plurality of staples 6220 and, in addition, an alignment matrix 6260 comprising a plurality of alignment guides, such as slots, grooves, and/or apertures, for example, which can be configured to align the staples 6220. In various circumstances, the alignment matrix 6260 can be configured such that the staple legs 6221 of the staples 6220 are aligned with the retention apertures 6252 in the retention matrix 6250 before the retention matrix 6250 is engaged with the staple legs 6221. In various embodiments, referring now to FIGS. 117 and 118, the alignment matrix 6260 can comprise a plurality of alignment apertures 6262 which can be configured to closely receive the staple legs 6221 of the staples 6220. In at least one such embodiment, each staple 6220 can comprise a base 6222 and two staple legs 6221 extending from the base 6222 wherein the bases 6222 of the staples 6220 can extend around a bottom surface 6264 of the retention matrix 6260 and the staple legs 6221 can extend upwardly through the alignment apertures 6262. In certain embodiments, each alignment aperture 6262 can be circular, or at least substantially circular, and can be defined by a diameter which is equal to or slightly larger than the diameter of the staple leg 6221 extending therethrough. In various embodiments, the alignment matrix 6260 can further comprise a plurality of raised members 6263 which can extend upwardly from the top surface 6261 of the alignment matrix 6260 and surround, or at least partially surround, the alignment apertures 6262. In certain embodiments, the raised members 6263 can provide for longer alignment apertures 6262 wherein, in various circumstances, longer apertures 6262 can provide more control over the alignment of the staple legs 6221 than shorter apertures 6262.


In use, in various embodiments, a first jaw supporting the staple cartridge 6200 can be positioned on one side of the tissue that is to be stapled and a second jaw supporting the retention matrix 6250 can be positioned on the other side of the tissue. Once the jaws have been suitably positioned relative to the tissue, in certain embodiments, the second jaw and the retention matrix 6250 can be moved toward the staple cartridge 6200. As the staple legs 6221 are being inserted through the retention apertures 6252 of the retention matrix 6250, in various embodiments, a tissue-contacting, or bottom, surface 6251 of the retention matrix 6250 can contact the tissue and press the tissue against the tissue-contacting, or top, surface 6261 of the alignment matrix 6260. In various other embodiments, as described in greater detail further below, the staple cartridge 6200 can further comprise a compressible cartridge body positioned above the top surface 6261 of the alignment matrix 6260, for example, which can contact the tissue. In certain embodiments, referring again to FIGS. 114 and 118, the alignment matrix 6260 can further comprise one or more apertures 6203 defined therein which, when the alignment matrix 6260 is positioned against tissue, can be configured to receive a portion of the tissue therein. In embodiments where a compressible cartridge body is positioned above and/or against the alignment matrix 6260, a portion of the compressible cartridge body can enter into the apertures 6203 when the cartridge body is compressed. Similarly, the retention matrix 6250 can comprise a plurality of apertures 6202 which can be configured to receive at least a portion of the tissue therein when the retention matrix 6250 is positioned against the tissue.


As the staple legs 6221 of the staples 6220 are inserted through the retention apertures 6252 of the retention matrix 6250, further to the above, the tips of the staple legs 6221 may protrude upwardly from the top surface 6257 of the retention matrix 6250. In various circumstances, as described above, the tips of the staple legs 6221 may remain unbent after they have been inserted through the retention apertures 6252. In certain embodiments, referring now to FIGS. 121-124, a fastening system comprising the staple cartridge 6200 and the retention matrix 6250 may further comprise a plurality of protective caps or covers, such as caps 6270, for example, which can be assembled to the staple legs 6221 protruding above the retention matrix 6250. In various embodiments, each cap 6270 can entirely, or at least partially, cover the sharp end of a staple leg 6221 such that the sharp end does not contact tissue positioned adjacent thereto. In at least one embodiment, referring now to FIG. 124, each cap 6270 can comprise an aperture 6271 defined therein which can be configured to closely receive a tip of a staple leg 6221 therein. In various embodiments, the caps 6270 can be comprised of an elastomeric material, such as silicone, polyisoprene, sanoprene, and/or natural rubber, for example. In at least one embodiment, the aperture 6271 can comprise a perimeter or diameter which is smaller than the perimeter or diameter of the staple leg 6221 inserted therein. In at least one such embodiment, the aperture 6271 in the protective cap 6270 can expand in order to receive the staple leg 6221 therein. In various alternative embodiments, the caps 6270 may not comprise apertures and the tips of the staple legs 6221 can be configured to incise the caps 6270 as the legs 6221 are inserted therein. In any event, in various embodiments, each cap 6270 can be seated onto a staple leg 6221 until the base 6272 of the cap 6270 abuts, or is positioned adjacent to, the top surface 6257 of the retention matrix 6250. In various circumstances, the caps 6270 can be configured such that they are seated snugly onto the tips of the staple legs 6221 such that they are not easily removed therefrom. In certain embodiments, each cap 6270 can comprise a conical, or at least substantially conical, outer surface, for example. In various embodiments, the caps 6270 can comprise any suitable shape, such as shapes comprising a parabolic, or at least substantially parabolic, outer surface, for example.


In various embodiments, the fastener system described above, for example, could be deployed using the surgical stapler depicted in FIGS. 125-127, for example. In various embodiments, the end effector can comprise a first jaw, or staple cartridge channel, 6230 which can be configured to support the staple cartridge 6200 therein and a second jaw 6240 which can be configured to support the retention matrix 6250 and the plurality of protective caps 6270. Referring primarily to FIG. 125, which illustrates the second jaw 6240 in an open configuration, the jaws 6230 and 6240 can be positioned relative to tissue T such that the tissue T is positioned intermediate the retention matrix 6250 and the staple cartridge 6200. In various embodiments, as discussed above, the staple cartridge 6200 can further comprise a compressible cartridge body, such as cartridge body 6210, for example, in which the staples 6220 and the alignment matrix 6260 can be positioned. In at least one such embodiment, the tissue T can be positioned against a top surface of the cartridge body 6210. In certain embodiments, the second jaw 6240 can comprise a plurality of recesses, or apertures, 6245 configured to receive the plurality of protective caps 6270 and, in addition, one or more retention features, or retainers, which can be configured to hold the retention matrix 6250 in position over the caps 6270. In at least one such embodiment, the retention matrix 6250 can be configured to retain the caps 6270 in the apertures 6245. In various embodiments, referring now to FIG. 137, each aperture 6245 can be configured to receive a portion of, or the entirety of, a cap 6270 therein. In certain embodiments, the apertures 6245 can be sufficiently sized and configured such that the caps 6270 can be secured therein by at least one of a press-fit and/or snap fit arrangement, for example. In some embodiments, at least one adhesive could be utilized to secure the caps 6270 in the apertures 6245. In at least one such embodiment, such an adhesive could be selected such that caps 6270 can detach from the second jaw 6240 after the caps 6270 have been engaged with the staple legs 6221 and the second jaw 6240 is moved away from the implanted fastener assembly. In certain embodiments, referring now to FIG. 138, the second jaw 6240 can further comprise at least one cover sheet 6246 which can be assembled to the second jaw 6240 and can extend over and retain the caps 6270 in the apertures 6245. In at least one such embodiment, at least a portion of the cover sheet 6246 can be secured to the jaw 6240 utilizing at least one adhesive, for example. In use, in at least one embodiment, the cover sheet 6246 can be at least partially detached from the jaw 6240 before the end effector is inserted into a surgical site. In certain embodiments, the cover sheet 6246 can be comprised of an implantable material, such as PDS and/or PGA, for example, which can be incised by the staple legs 6221 as the staple legs 6221 emerge from the retention matrix 6250. In at least one such embodiment, the cover sheet 6246 can be secured in the fastening system intermediate the covers 6270 and the retention matrix 6250.


Further to the above, referring now to FIG. 126, the jaw 6240 can be moved from an open position to a closed position in which the tissue T is positioned against the retention matrix 6250 and the cartridge body 6210. In such a position, the retention matrix 6250 may not yet be engaged with the staples 6220. In various embodiments, the jaw 6240 can be moved between its open position and its closed position by an actuator 6235. In at least one such embodiment, the jaw 6240 can comprise a distal pin 6243 and a proximal pin 6244 extending therefrom, wherein the distal pin 6243 can slide vertically, or at least substantially vertically, within a distal slot 6233 defined in the cartridge channel 6230, and wherein the proximal pin 6244 can slide vertically, or at least substantially vertically, within a proximal slot 6234 which is also defined in the staple cartridge channel 6230. In use, the actuator 6235 can be retracted proximally in order to drive the pins 6243 and 6244 into the upper ends of their respective slots 6233 and 6234 as illustrated in FIG. 126. In at least one such embodiment, the actuator 6235 can comprise a distal drive slot 6236 and a proximal drive slot 6237, wherein the sidewalls of the drive slots 6236 and 6237 can be configured to contact the distal pin 6243 and the proximal pin 6244, respectively, and drive the pins 6243 and 6244 upwardly as the actuator 6235 is moved proximally. More particularly, as the actuator 6235 is moved proximally, the distal pin 6243 can slide up an inclined first portion 6236a of the distal drive slot 6236 into an intermediate, or second, portion 6236b and, similarly, the proximal pin 6244 can slide up an inclined first portion 6237a of the distal drive slot 6237 into an intermediate, or second, portion 6237b. As the pins 6243 and 6244 are both moved upwardly, the jaw 6240 can be rotated downwardly toward the tissue T into a closed position.


Further to the above, referring now to FIG. 127, the actuator 6235 can be pulled further proximally in order to push the second jaw 6240 downwardly toward the first jaw 6230, compress the cartridge body 6210, and engage the retention matrix 6250 and the plurality of protective caps 6270 with the staple legs of the staples 6220. In at least one such embodiment, the additional proximal movement of the actuator 6235 can cause the sidewalls of the drive slots 6236 and 6237 to contact the pins 6243 and 6244, respectively, and drive the pins 6243 and 6244 downwardly toward the bottom ends of the slots 6233 and 6234, respectively. In such circumstances, the actuator 6235 can be pulled proximally such that, one, the distal pin 6243 exits the second portion 6236b of the drive slot 6236 and enters into an inclined third portion 6236c and, similarly, the proximal pin 6244 exits the second portion 6237b of the drive slot 6237 and enters into an inclined third portion 6237c. As the pins 6243 and 6244 are both moved downwardly, the second jaw 6240 can move downwardly toward the first jaw 6230 into a fired position. In at least one such embodiment, the second jaw 6240 can be moved downwardly such that the retention matrix 6250 remains parallel, or at least substantially parallel, to the top surface of the cartridge body 6210 and/or parallel, or at least substantially parallel, to the alignment matrix 6260. In any event, once the retention matrix 6250 and the protective caps 6270 have been engaged with the staple legs 6221 of the staples 6220, as illustrated in FIG. 129, the second jaw 6240 can be returned to an open, or an at least substantially open, position. In at least one such embodiment, the actuator 6235 can be pushed distally in order to drive the pins 6243 and 6244 to the top ends of the slots 6233 and 6234, respectively, and then driven downwardly toward the bottom ends of the slots 6233 and 6234 once the pins have passed through the intermediate portions 6236b and 6237b of the respective drive slots 6236 and 6237. Once the second jaw 6240 has been opened, the first jaw 6230 can be detached from the implanted staple cartridge 6200 and the first and second jaws 6230, 6240 can be removed away from the implanted fastener assembly, as illustrated in FIG. 128.


Referring to FIG. 127 once again, the reader will note that the pins 6243 and 6244 are not illustrated as being seated in the very bottoms of their respective slots 6233 and 6234 even though the retention matrix 6250 and the caps 6270 have been engaged with the staple legs 6221. Such circumstances can arise when thick tissue T is positioned between the retention matrix 6250 and the cartridge body 6210. In circumstances where thinner tissue T is positioned between the retention matrix 6250 and the cartridge body 6210, referring now to FIG. 130, the pins 6243 and 6244 can be drive further downwardly into their respective slots 6233 and 6234 as illustrated in FIG. 132. In general, in at least one such embodiment, the actuator 6235 can be pulled proximally in order to drive the pins 6243 and 6244 upwardly and downwardly through the progressions described above and illustrated in FIGS. 130-132 and, owing to the thinner tissue T, the retention matrix 6250 and the protective caps 6270 can be driven further onto the staple legs 6221 of the staples 6220, as illustrated in FIGS. 133 and 134. In various embodiments, as a result of the adjustability afforded by the retention matrix 6250, the same, or at least substantially the same, compressive pressure can be obtained in the fastened tissue regardless of whether the tissue captured within the end effector is thick or thin. In certain embodiments, the adjustability afforded by the retention matrix 6250 can allow a surgeon can select whether to apply a larger compressive pressure or a smaller compressive pressure to the tissue by selecting the depth to which the retention matrix 6250 is seated. In at least one such embodiment, the range in which the retention matrix 6250 can be seated onto the staple legs 6221 can be determined by the lengths, or ranges, of the slots 6233 and 6234, for example.


In various embodiments, as described above, the protective caps 6270 can be comprised of a soft or flexible material, for example, which can be configured to grip the ends of the staple legs 6221. In certain embodiments, the protective caps 6270 can be comprised of a bioabsorbable plastic, polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example, and/or a biocompatible metal, such as titanium and/or stainless steel, for example. As illustrated in FIG. 124, in at least one embodiment, each cap 6270 can be unconnected to the other caps 6270. In certain other embodiments, one or more caps 6270 can be mounted to the retention matrix 6250. In at least one such embodiment, the caps 6270 can be connected to the retention matrix 6250 by at least one adhesive, for example, wherein the apertures 6271 in the caps 6270 can be aligned, or at least substantially aligned, with the retention apertures 6252 in the retention matrix 6270. In various embodiments, referring now to FIG. 135, a protective cap, such as a cap 6370, for example, can define an inner cavity, or dome, 6374 which can be configured to receive a tip of a staple leg 6221, for example, therein. In at least one such embodiment, the cap 6370 can comprise a bottom 6372 and an aperture 6371 extending through the bottom 6372. In various embodiments, the aperture 6371 can be defined by one or more deflectable members 6373 which can be configured to deflect when the staple leg 6221 is inserted therethrough. In certain embodiments, two or more caps 6370, for example, can be connected together to form an array of caps 6370. In at least one such embodiment, referring now to FIG. 136, a plurality of caps 6370 can be connected together by a sheet of material 6375. In certain embodiments, the sheet 6375 can be sufficiently rigid in order to maintain a desired arrangement and/or alignment of the caps 6370. In at least one embodiment, the caps 6370 can be comprised of a biocompatible or bioimplantible metal, such as titanium and/or stainless steel, for example, and the sheet 6375 can be comprised of a bioabsorbable plastic, polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. In various embodiments, a sheet 6375 can be comprised of a bioabsorbable material including an anti-microbial agent, such as colloidal silver and/or triclosan, for example, stored and/or dispersed therein which can be released as the sheet 6375 is bioabsorbed, for example.


In various embodiments, further to the above, the sheet 6375 can be injection molded around the caps 6370 utilizing an injection molding process, for example, such that the caps 6370 are embedded in the sheet 6375. In certain other embodiments, the sheet 6375 can be molded utilizing an injection molding process, for example, wherein apertures 6376 can be formed in the sheet 6375 during the injection molding process and/or after the injection molding process utilizing a stamping process, for example. In either event, the caps 6370 can be inserted into and secured in the apertures 6376 utilizing a press-fit and/or snap-fit interconnection and/or at least one adhesive. In certain embodiments, each cap 6370 can comprise an annular groove surrounding, or at least partially surrounding, the perimeter of the cap 6370 which can be configured to receive the perimeter of an aperture 6376 therein. In certain embodiments, the sheet 6375 can be comprised of a flexible and/or pliable material which can permit relative movement between the caps 6370. In at least one such embodiment, the flexible sheet 6375 can be comprised of a rubber, plastic, and/or silicone material, for example, and the caps 6370 can be comprised of a rigid material, such as metal, for example. In at least one such embodiment, similar to the above, the flexible material can be molded around the caps 6370. In certain embodiments, the caps 6370 can be pressed into a pre-molded sheet 6375, for example. In various embodiments, the durometer of the flexible material can be selected to provide a desired stiffness of the sheet 6375. In certain embodiments, the sheet 6375 can be configured such that it comprises a flexible band. In any event, the sheet 6375 can facilitate the assembly of the caps 6370 into an end effector as a plurality of the caps 6370 can be positioned and/or aligned simultaneously within the end effector. Furthermore, the sheet 6375 connecting the caps 6370, once implanted, can strengthen or bolster the tissue along the staple line, for example. In addition to or in lieu of a sheet connecting the caps 6370, the caps 6370 can be connected together by a plurality of links. In at least one such embodiment, such links can be flexible and can permit relative movement between the caps 6370.


In various embodiments, referring now to FIGS. 139 and 140, a protective cap, such as cap 6470, for example, can comprise a forming surface which can be configured to deform a tip of a staple leg. In at least one such embodiment, the cap 6470 can comprise a base 6472 which can include an aperture 6471 extending therethrough. In various embodiments, the aperture 6471 can be configured to closely receive a staple leg, such as a staple leg 6221, for example, therein. In at least one embodiment, the aperture 6471 can be defined by a diameter or perimeter which can be equal to or larger than the diameter or perimeter of the staple leg 6221. In various embodiments, the cap 6470 can further comprise a cavity, or dome, 6474 which can be configured to receive the tip of the staple leg 6221 as it is inserted into the cap 6470. Referring primarily to FIG. 140, the cap 6470 can further comprise an anvil, or forming surface, 6473 which can be configured to deflect and deform the staple leg 6221. In various circumstances, the forming surface 6473 can be curved and/or concave, for example, and can be configured to curl the staple leg 6221 as it is inserted into the cap 6470. In certain embodiments, the staple leg 6221 can be sufficiently deformed such that it cannot be withdrawn through the aperture 6471 and, as a result, the cap 6470 can become locked to the staple leg 6221. In at least one such embodiment, the base 6472 of the cap 6470 can define a lip extending around the aperture 6471 which can prevent the deformed staple leg 6221 from being removed from the cavity 6474. In various circumstances, as a result of the above, one or more caps 6470 can prevent, or inhibit, a retention matrix, such as retention matrix 6250, for example, from backing up or being disengaged from the staples 6220. In various embodiments, although not illustrated, the cap 6470 can be symmetrically, or at least substantially symmetrically, formed, and the aperture 6471 can be located along a central axis 6479 extending through the cap 6470. In various alternative embodiments, referring again to FIG. 139, the aperture 6471 can be offset with respect to the central axis 6479. In at least one such embodiment, the offset aperture 6471 can allow the staple leg 6221 to contact a side of the forming surface 6473 and curl over to the other side of the forming surface 6473 instead of contacting the center of the forming surface 6473, as may occur in embodiments comprising a centered aperture 6471 mentioned above.


In various embodiments, as discussed above, a retention matrix, such as retention matrix 6250, for example, can be comprised of a sheet of material and a plurality of retention apertures 6252 extending therethrough. In at least some embodiments, the sheet of material comprising the retention matrix 6250 can be rigid or substantially inflexible. In certain other embodiments, a retention matrix can be comprised of an array of retention matrix elements and a plurality of flexible connectors, or links, connecting the retention matrix elements. In various embodiments, referring now to FIG. 141, a retention matrix, or a portion of retention matrix, 6550 can comprise a plurality of element bodies 6505 which can be connected together by one or more connecting links 6507. In at least one embodiment, each element body 6505 can comprise a plurality of deformable members 6553 which define a retention aperture 6552 therein. In certain embodiments, the element bodies 6505 and the connecting links 6507 of a retention matrix 6550 can be integrally formed and can comprise a unitary piece of material. In various embodiments, the retention matrix 6550 can be stamped or cast, for example, from a metal material, such as titanium and/or stainless steel, for example. In at least one embodiment, the retention matrix 6550 can be comprised of plastic, such as polyetheretherketone (PEEK), polypropylene which is marketed under the trade name Prolene, polyester, polyethylene terephthalate which is marketed under the trade names Ethibond and Mersilene, polyvinylidene fluoride, polyvinylidene fluoride-co-hexafluoropropylene, poly hexafluoropropylene-VDF which is marketed under the trade name Pronova, and/or long-chain aliphatic polymers Nylon 6 and Nylon 6,6 which are marketed under the trade names Ethilon & Nurolon, for example, and can be formed by an injection molding process, for example. In certain embodiments, the element bodies 6505 may not be integrally formed with the connecting links 6507. In various embodiments, a plurality of singular element bodies 6505 can be produced which are subsequently connected together and embedded in a retention matrix. In at least one such embodiment, the element bodies 6505 can be stamped from a metal material, such as titanium and/or stainless steel, for example, and placed in a plastic injection mold wherein a plastic material can be injected into the mold to form, one, a rim 6506 of material surrounding, or at least partially surrounding, the element bodies 6505 and, two, connecting links 6507 extending from the rims 6506. In certain other embodiments, one or more connector lattices can be formed comprising apertures defined within a plurality of rims 6506 wherein each such aperture can be configured to receive an element body 6505 therein. In at least one embodiment, each element body 6505 can comprise a circular, or at least substantially circular, outer perimeter and, similarly, each rim 6506 can define a circular, or at least substantially circular, aperture therein, wherein the diameter of the aperture can be equal to or smaller than the diameter of the element body 6505. In at least one such embodiment, the element bodies 6505 can be press-fit or embedded into the apertures in the rims 6505. In certain embodiments, the element bodies 6505 can be secured in the apertures utilizing at least one adhesive.


In various embodiments, further to the above, a retention matrix can comprise a plurality of element bodies 6505 and a plurality of connecting links 6507 which can connect the element bodies 6505 in any suitable array, such as those illustrated in FIGS. 142-145, for example. Regardless of the pattern of the array, in various embodiments, the connecting links 6507 can be configured to allow the element bodies 6505 and the retention apertures 6552 to move relative to one another. In at least one such embodiment, the lattice of element bodies 6505 and connecting links 6507 comprising the retention matrix 6550, once engaged with tissue, can be configured to stretch, twist, contract, and/or otherwise flex in order to permit at least some movement within the tissue yet, at the same time, resist larger movements thereof. In various embodiments, each connecting link 6507 can comprise a flexible member configured to stretch, twist, and/or contract in order to permit the retention matrix 6550 to flex intermediate the matrix retention elements 6505, for example. Referring again to FIG. 141, each link 6507 extending from a rim 6506 can be defined by a width which is narrower than the width of the element body 6505 and/or the rim 6506. In certain embodiments, referring to FIGS. 142-145, one or more links 6507 can comprise straight portions which extend along a line between adjacent element bodies 6506, for example. In at least one such embodiment, each link 6507 can comprise a first end attached to a first rim 6506 and a second end attached to a second rim 6506. In certain embodiments, referring once again to FIG. 141, two or more links 6507 can be connected to one another. In at least one such embodiment, two or more links 6507 can be connected at an intermediate hinge 6509, for example. In various embodiments, the hinge 6509 can comprise a reduction in cross-sectional thickness in one or more directions as compared to the cross-sectional thickness of the links 6507 which can permit the connected links 6507 to move relative to each other, for example. In certain embodiments, the retention matrix 6550 can further comprise hinges 6508 which can connect the links 6507 to the rims 6506 and permit relative movement between the links 6507 and the rims 6506. Similar to hinges 6509, hinges 6508 can comprise a reduction in cross-sectional thickness in one or more directions as compared to the cross-sectional thickness of the links 6507, for example.


In various embodiments, further to the above, the connected links 6507 can extend in different directions. In at least one such embodiment, a first link 6507 can extend in a first direction and a second link 6507 can extend in a second direction, wherein the first direction can be different than the second direction. In certain embodiments, the first link 6507 can extend along a first line and the second link 6507 can extend along a second line, wherein the first line and the second line can intersect each other at an angle, such as approximately 30 degrees, approximately 45 degrees, approximately 60 degrees, and/or approximately 90 degrees, for example. In various embodiments, the hinges 6508 and/or hinges 6509 can comprise living hinges which can permit the links 6507 to move relative to each other a number of times without breaking. In certain embodiments, the hinges 6508 and/or hinges 6509 can comprise frangible, or easily-breakable, portions which can break when flexed too far and/or flexed too many times. In at least one such embodiment, such frangible portions can permit one or more portions of the retention matrix 6550 to break away from another portion of the retention matrix 6550. In various embodiments, the hinges 6508 and/or hinges 6509, for example, can comprise sections of the retention matrix 6550 which are easier to incise than the other portions of the retention matrix 6550. More particularly, an implanted retention matrix, and the tissue fastened by the implanted retention matrix, may oftentimes by incised by a cutting member for various reasons and, in order to facilitate such cross-cutting, the hinges 6508 and/or hinges 6509 can provide avenues, or thin sections, through which a cutting member can more easily pass through the retention matrix 6550, for example. In various embodiments, further to the above, the connecting links 6507 can comprise one or more coined features or material upsets, for example, defined therein which can facilitate the bending, breakage, and/or incision of the connecting links 6507.


In various embodiments, a retention matrix can comprise a plurality of retention matrix elements, such as matrix element bodies 6505, for example, which can be embedded in a flexible sheet, or band, of material. In at least one embodiment, a flexible sheet of material can be formed from a bioabsorbable, elastomeric material, such as silicone, for example, wherein the flexible sheet can be produced with a plurality of apertures defined therein. In at least one such embodiment, a solid flexible sheet can be molded and a plurality of apertures can be punched out of the flexible sheet. In various alternative embodiments, the flexible sheet can be molded and the apertures defined therein can be formed during the molding process. In either event, the retention matrix elements 6505, for example, can be inserted into and retained within the flexible sheet. In certain other embodiments, similar to the above, the flexible sheet can be formed around the matrix elements 6505. In at least one embodiment, the flexible sheet can be comprised of a woven mesh, for example, and/or any other suitable material. Such a woven mesh, further to the above, may be easy to cross-cut.


In various embodiments, referring now to FIGS. 146 and 147, a fastener system comprising a retention matrix, such as retention matrix 6250, for example, can further comprise a cover, such as cover 6670, for example, which can cover the tips of the staple legs 6221 when they extend above the top surface 6257 of the retention matrix 6250. In various embodiments, the cover 6670 can be attached to the retention matrix 6250. In certain embodiments, the cover 6670 and/or the retention matrix 6250 can comprise retention features which can be configured to retain the cover 6670 to the retention matrix 6250. In at least one embodiment, at least one adhesive can be utilized to adhere the cover 6670 to the retention matrix 6250. In at least one embodiment, the cover 6670 can be comprised of a single layer, although the cover 6670 is illustrated as comprising two layers as described in greater detail further below. In various embodiments, referring primarily to FIG. 147, the tips of the staple legs 6221 can extend through a bottom surface 6673 of the cover 6670; however, the cover 6670 can comprise a sufficient thickness such that the staple tips do not extend through the top surface 6675 of the cover 6670. In at least one such embodiment, as a result, the tips of the staple legs 6221 may not protrude from the cover 6670. In various embodiments, the cover 6670 can comprise a plurality of layers. In at least one such embodiment, the cover 6670 can comprise a first layer 6671 and a second layer 6672. In at least one embodiment, the first layer 6671 and the second layer 6672 can be attached to one another wherein, in at least one embodiment, the second layer 6672 can comprise a bottom surface 6676 which is adhered to the first layer 6671. In various embodiments, the first layer 6671 and the second layer 6672 can comprise different thicknesses while, in certain embodiments, they can comprise the same thickness. In at least one embodiment, the first layer 6671 and the second layer 6672 can comprise substantially the same width and/or length. In alternative embodiments, the layers 6671 and 6672 can comprise different widths and/or lengths.


In various embodiments, further to the above, the first layer 6671 can be comprised of a compressible foam, mesh material, and/or hydrogel, for example, which can be incised by the staple legs 6211. In at least one embodiment, the second layer 6672 can be comprise of a tougher material, or skin, such as PGA and/or PDS, for example, and/or any suitable buttress material. In at least one such embodiment, the staple legs 6221 can be configured to penetrate the first layer 6671; however, in various embodiments, the staple legs 6221 may be unable to penetrate the second layer 6672. In certain embodiments, the second layer 6672 can be comprised of a material having a sufficient resiliency and/or toughness which can permit the second layer 6672 to be contacted and displaced by the staple leg 6221 but not be incised, or only marginally incised, by the staple tip of the staple leg 6221. Although not illustrated, a cover can comprise more than two layers wherein one or more of such layers may be penetration-resistant. In use, in at least one such embodiment, the retention matrix 6250 can be positioned against the tissue to be fastened and pushed downwardly such that the staple legs 6221 of the staples 6220 are pushed through the tissue T and the retention apertures 6252 in the retention matrix 6250 and enter into the first layer 6271 of the cover 6270. In various embodiments, the tips of the staple legs 6221 may not enter, or at least substantially enter, into the second layer 6272 of the cover 6270. After the retention matrix 6250 has been suitably positioned, the jaw 6240 can be opened and the cover 6670 and the retention matrix 6250 can detach from the jaw 6240 as illustrated in FIG. 146. As illustrated in FIG. 146, a jaw 6640 can be configured to hold more than one retention matrix 6250 and cover 6670. In at least one such embodiment, the jaw 6640 can comprise two channels 6679 which each can be configured to receive a cover 6670 therein and a retention matrix 6250 positioned thereover such that the tissue-contacting surface 6251 of each retention matrix 6250 depends downwardly from the bottom of the jaw 6240. In at least one such embodiment, a retention matrix 6250 and a cover 6270 can be housed in the jaw 6640 on each side of a knife slot 6678. In use, both retention matrices 6250 and covers 6670 can be deployed simultaneously and/or to the same depth with respect to opposing staple cartridges, such as cartridges 6200, for example, positioned thereacross. Thereafter, in various embodiments, the fastened tissue can be incised along a cutting line by a cutting member that traverses the knife slot 6678 wherein the jaw 6640 can then be re-opened. In certain embodiments, the covers 6670 may not be attached to the retention matrix 6250. In at least one such embodiment, the covers 6670 can be positioned in the channels 6679 and can be retained in the channels 6679 by the retention matrices 6250 which can be secured to the jaw 6640. In various embodiments, the each retention matrix 6250 can be wider and/or longer than their respective covers 6670 such that the retention matrices 6250 can retain the entirety of their covers 6670 in position. In certain embodiments, each retention matrix 6250 can comprise the same width and/or length as their respective cover 6670, for example.


In various embodiments, as described above, a fastener system can comprise a layer of material which can be attached to a retention matrix, such as retention matrix 6250, for example. In at least one embodiment, referring now to FIG. 150, a layer of material 6870 can be attached to the bottom surface 6251 of the retention matrix 6250. In certain embodiments, the layer 6870 and/or the retention matrix 6250 can comprise retention features which can be configured to retain the layer 6870 to the retention matrix 6250. In at least one embodiment, at least one adhesive can be utilized to adhere the layer 6870 to the retention matrix 6250. In any event, the layer 6870 can comprise a bottom, or tissue-contacting, surface 6873 which can be configured to contact the tissue T when the retention matrix 6250 is moved downwardly toward the staples 6220 to engage the retention apertures 6252 with the staple legs 6221. In at least one such embodiment, the layer 6870 can be comprised of a compressible material, such as a bioabsorbable foam, for example, which can be compressed between the bottom surface 6251 of the retention matrix 6250 and the tissue T. In various embodiments, the layer 6870 can further comprise at least one medicament stored and/or absorbed therein which can be expressed from the layer 6870 as the layer 6870 is compressed. In at least one embodiment, the medicament can comprise at least one tissue sealant, hemostatic agent, and/or anti-microbial material, such as ionized silver and/or triclosan, for example. In various embodiments, the compression of the layer 6870 can squeeze the medicament from the layer 6870 such that the entirety of, or at least a significant portion of, the surface of the tissue T is covered with the medicament. Furthermore, as the layer 6870 is compressed and the staple legs 6221 penetrate the tissue T and the layer 6870, the medicament can flow down the staple legs 6221 and treat the tissue that has just been incised by the staple legs 6221, for example. In various embodiments, the body of the retention matrix 6250 can comprise a first layer which is comprised of a biocompatible material, such as titanium and/or stainless steel, for example, and the bottom layer 6870 can comprise a second layer comprised of a bioabsorbable material, such as oxidized regenerated cellulose (ORC), biologically active agents like fibrin and/or thrombin (either in their liquid state or freeze dried), glycerin, absorbable porcine gelatin in either flue or foam configurations, and/or anti-microbials, such as ionized silver and/or triclosan, for example. Additional bioabsorbable materials can comprise Surgicel Nu-Knit, Surgicel Fibrillar, collagen/ORC which is a hybrid with a built in collagen matrix and is marketed under the trade name Promogran, polyglycolic acid (PGA) which is marketed under the trade name Vicryl, polylactic acid (PLA or PLLA), polydioxanone (PDS), polyhydroxyalkanoate (PHA), poliglecaprone 25 (PGCL) which is marketed under the trade name Monocryl, polycaprolactone (PCL), and/or a composite of PGA, PLA, PDS, PHA, PGCL and/or PCL, for example. Although only one layer 6870 is illustrated in FIG. 150, any suitable number of layers could be used. In at least one embodiment, a first layer comprising a first medicament could be attached to the retention matrix 6250 and a second layer comprising a second, or different, medicament could be attached to the first layer. In at least one such embodiment, a plurality of layers could be used wherein each layer can comprise a different medicament and/or a different combination of medicaments contained therein.


In various embodiments, referring now to FIG. 148, a fastener system can comprise a layer of material 6770 attached to the bottom surface 6251 of the retention matrix 6250. In certain embodiments, the layer 6770 and/or the retention matrix 6250 can comprise retention features which can be configured to retain the layer 6770 to the retention matrix 6250. In at least one embodiment, at least one adhesive can be utilized to adhere the layer 6770 to the retention matrix 6250. In any event, the layer 6770 can comprise a bottom, or tissue-contacting, surface 6773 which can be configured to contact the tissue T when the retention matrix 6250 is moved downwardly toward the staples 6220 to engage the retention apertures 6252 with the staple legs 6221. In at least one such embodiment, the layer 6770 can be comprised of a compressible material, such as a bioabsorbable foam, for example, which can be compressed between the surface 6251 of the retention matrix 6250 and the tissue T. In various embodiments, the layer 6770 can further comprise one or more encapsulations, or cells, 6774 which can be configured to store at least one medicament therein. In certain embodiments, referring to FIG. 149, the encapsulations 6774 can be aligned, or at least substantially aligned, with the retention apertures 6252 such that, when the staple legs 6221 are pushed through the tissue T and the layer 6770, the staple legs 6221 can puncture and/or otherwise rupture the encapsulations 6774. After the encapsulations 6774 have been ruptured, the at least one medicament M stored in the encapsulations 6774 can flow out onto the tissue T. In at least one such embodiment, the medicament M can comprise a fluid which can flow or wick down the staple legs 6221 and treat the tissue T that was just incised by the staple legs. As a result of the above, the medicament stored within the encapsulations 6774 can provide a localized treatment to the tissue. In certain embodiments, the encapsulations 6774 in the sheet 6770 can comprise different medicaments stored therein. For example, a first group of encapsulations 6774 can comprise a first medicament, or a first combination of medicaments, stored therein and a second group of encapsulations can comprise a different medicament, or a different combination of medicaments, stored therein. In various embodiments, the layer 6770 can be comprised of a flexible silicone sheet and the encapsulations 6774 can represent voids in the silicone sheet. In at least one such embodiment, the silicone sheet can comprise two layers that can be attached to one another wherein the encapsulations 6774 can be defined between the two layers. In various embodiments, the layer 6770 can comprise one or more thin sections or weakened portions, such as partial perforations, for example, which can facilitate the incision of the layer 6770 and the rupture of the encapsulations 6774 by the legs 6221. In certain embodiments, at least a portion of the encapsulations 6774 can be positioned within domes 6777, wherein the domes 6777 can extend upwardly from the sheet 6770. In at least one such embodiment, the domes 6777 and/or at least a portion of the encapsulations 6774 can be positioned within the pockets 6201 formed within the retention matrix 6250. In certain embodiments, the encapsulations 6774 may comprise discrete cells which are unconnected to each other. In certain other embodiments, one or more of the encapsulations 6774 can be in fluid communication with each other via one or more passageways, conduits, and/or channels, for example, extending through the layer 6770. The disclosure of U.S. Pat. No. 7,780,685, entitled ADHESIVE AND MECHANICAL FASTENER, which issued on Aug. 24, 2010, is hereby incorporated by reference in its entirety.


In various embodiments, further to the above, a staple cartridge comprising a cartridge body, staples, and/or an alignment matrix therein can be loaded into a first jaw of an end effector and, similarly, a retention matrix and/or one or more covers can be loaded into a second jaw of the end effector. In certain embodiments, referring now to FIG. 151, an instrument, such as cartridge loader 6990, for example, can be used to insert two or more fastener cartridges into an end effector at the same. In at least one embodiment, the cartridge loader 6990 can comprise a handle 6991 and a cartridge carrier 6992, wherein the cartridge carrier 6992 can comprise a first retention portion configured to retain the cartridge body 6210 of the staple cartridge 6200 thereto and, in addition, a second retention portion configured to retain a cartridge body 6980 which supports, one, a plurality of protective caps 6270 therein and, two, a retention matrix 6250 along the bottom surface thereof, for example. In various embodiments, the first and second retention portions can each comprise one or more retention members configured to releasably engage the cartridge bodies 6210 and 6980. In use, referring now to FIGS. 152 and 153, an end effector can comprise a first, or bottom, jaw 6230 and a second, or top, jaw 6940, wherein the staple cartridge 6200 can be loaded into the first jaw 6230 and the cartridge body 6980 can be loaded into the second jaw 6940. In various circumstances, the top jaw 6940 can be rotated from an open position (FIG. 152) to a closed position (FIG. 153) by an actuator 6235, wherein the operation of the actuator 6235 is described above and is not repeated herein for the sake of brevity. Once the top jaw 6940 is in its closed position, referring now to FIG. 153, the distal end 6993 of the cartridge carrier 6992 can be inserted into the end effector such that the staple cartridge 6200 is slid through the distal end 6938 of the first jaw 6930 and into a first attachment portion, or channel, 6939 in the first jaw 6230. Similarly, the distal end 6993 of the cartridge carrier 6992 can be inserted into the end effector such that the cartridge body 6980 is slid through the distal end 6948 of the second jaw 6940 and into a second attachment portion, or channel, 6949 in the second jaw 6940. A surgeon, or other clinician, holding the handle 6991 of the cartridge loader 6990 can push the staple cartridge 6200 and the cartridge body 6980 through the channels 6939 and 6949, respectively, until the staple cartridge 6200 and the cartridge body 6980 are fully seated therein.


As the staple cartridge 6200 and the cartridge body 6980 are being seated, the staple cartridge 6200 and the cartridge body 6980 can each engage one or more retention portions in their respective jaws 6230 and 6940, as described in greater detail further below. In any event, once the staple cartridge 6200 and the cartridge body 6980 have been seated, referring now to FIG. 154, the cartridge loader 6990 can be detached from the staple cartridge 6200 and the cartridge body 6980 and removed from the end effector. In at least one such embodiment, the retention force holding the staple cartridge 6200 in the first jaw 6230 can be greater than the retention force holding the staple cartridge 6200 to the cartridge carrier 6992 such that, as the cartridge carrier 6992 is pulled distally out of the end effector, the staple cartridge 6200 can remain behind in the first jaw 6230. Similarly, the retention force holding the cartridge body 6980 in the second jaw 6940 can be greater than the retention force holding the cartridge body 6940 to the cartridge carrier 6992 such that, as the cartridge carrier 6992 is pulled distally out of the end effector, the cartridge body 6940 can remain behind in the second jaw 6940. Once the cartridge loader 6990 has been removed from the end effector, the loaded first jaw 6230 and the loaded second jaw 6940 can be positioned relative to the tissue T that is to be stapled. Referring now to FIG. 155, the second jaw 6940 can be moved from an open position (FIG. 154) to a fired position (FIG. 155) in order to engage the retention matrix 6250 and the plurality of protective caps 6270 carried by the cartridge body 6980 with the staples 6220 positioned within the staple cartridge 6200.


Referring now to FIGS. 156 and 157, the second jaw 6940 can be re-opened and the plurality of protective caps 6270 and the retention matrix 6250 can detach from the cartridge body 6980 such that the caps 6270 and the retention matrix 6250 can remain engaged with the tissue T and the staple cartridge 6200. In at least one embodiment, the cartridge body 6980 can comprise a plurality of pockets in which the plurality of caps 6270 can be removably positioned and one or more retention slots configured to removably retain the retention matrix 6250 thereto. In various embodiments, the retention members of the second jaw 6940 engaged with the cartridge body 6980 can retain the cartridge body 6980 in the second jaw 6940 after the second jaw 6940 has been opened. In certain embodiments, the cartridge body 6980 can be configured to tear as the second jaw 6940 is opened such that a portion of the cartridge body 6980 is implanted with the caps 6270 and the retention matrix 6250 and a portion of the cartridge body 6980 remains in the second jaw 6940. Similarly, referring again to FIGS. 156 and 157, the retention members of the first jaw 6230 engaged with the cartridge body 6210 can retain the cartridge body 6210 in the first jaw 6230 after the second jaw 6940 has been opened. In certain embodiments, the cartridge body 6210 can be configured to tear as the first jaw 6230 is pulled away from the implanted cartridge 6200 such that a portion of the cartridge body 6210 is implanted with the staples 6220 and alignment matrix 6260 and a portion of the cartridge body 6210 remains in the first jaw 6230. In various embodiments, referring now to FIGS. 158-160, a staple cartridge, such as staple cartridge 6900, for example, can comprise one or more longitudinal retention slots 6913 extending along the length of the cartridge body 6910 which, when the staple cartridge 6900 is inserted into a jaw 6930, for example, can be configured to receive one or more longitudinal retention rails 6916 extending from the jaw 6930 therein. In use, in at least one embodiment, an end of the retention slots 6913 can be aligned with the distal ends of the retention rails 6916 before the staple cartridge 6900 is slid through the distal end 6938 of the retention channel 6939, for example.


In various embodiments, referring again to FIG. 160, the jaw 6940 can comprise two retention channels 6949, wherein each retention channel 6949 can be configured to receive a cartridge body 6980 comprising a plurality of caps 6270 and a retention matrix 6250 therein. In certain embodiments, each cartridge body 6980 can comprise one or more longitudinal retention shoulders 6917 which can be configured to be slid along one or more longitudinal retention rails 6918 of the second jaw 6940 as the cartridge bodies 6980 are inserted into their respective retention channels 6949 in jaw 6940. In various embodiments, the retention rails 6918 and the retention shoulders 6917 can co-operate to retain the cartridge body 6980 in the second jaw 6940 as the cartridge bodies 6980 are detached from the caps 6270 and the retention matrix 6250 stored therein. In various embodiments, referring now to FIG. 159, the second jaw 6940 can further comprise one or more distal bumps, or retention members, 6915 extending therefrom which can be configured to removably lock the cartridge bodies 6980 in their respective retention channels. In at least one such embodiment, the second jaw 6940 can comprise a distal bump 6915 configured and positioned relative to each retention channel 6949 such that each cartridge body 6980 can flex around the bumps 6915 as the cartridge bodies 6980 are being inserted into the channels 6949 wherein, just as the cartridge bodies 6915 are being fully seated in the channels 6949, the distal ends of the cartridge bodies 6980 can clear and snap over the bumps 6915. In order to remove the cartridge bodies 6980 after they have been expended, as described above, the cartridge bodies 6980 can be pulled back over the bumps 6915 and removed from the retention channels 6949. Similar to the above, the first jaw 6930 can comprise one or more distal retention bumps 6914 extending therefrom which can be configured to be received in one or more retention grooves, or slots, 6912 (FIG. 158) in the cartridge body 6910 when the staple cartridge 6900 has been fully seated.


In various embodiments, further to the above, a first fastener cartridge comprising a plurality of first fasteners positioned therein can be positioned in a first jaw of a surgical fastening device and a second fastener cartridge comprising a plurality of second fasteners positioned therein can be positioned in a second jaw of the surgical fastening device. In use, the first jaw and/or the second jaw can be moved toward the other in order to engage the first fasteners with the second fasteners and secure tissue therebetween. In certain embodiments, the first fastener cartridge and the second fastener cartridge can be engaged with each other as the first fasteners are engaged with the second fasteners. In at least one embodiment, the body of the first fastener cartridge can be comprised of a first compressible material and the body of the second fastener cartridge can be comprised of a second compressible material, wherein the first body and/or the second body can be compressed against the tissue being fastened. After the tissue has been fastened, the first jaw can be moved away from the implanted first fastener cartridge and the second jaw can be moved away from the implanted second fastener cartridge. Thereafter, the first jaw can be reloaded with another first fastener cartridge, or the like, and the second jaw can be reloaded with another second fastener cartridge, or the like, and the surgical fastening instrument can be reused. While staples can be used in some embodiments, other embodiments are envisioned comprising other types of fasteners, such as two-part fasteners which are locked together when they are engaged with one another, for example. In at least one such embodiment, the first fastener cartridge can comprise a first storage portion for storing the first fastener portions and the second fastener cartridge can comprise a second storage portion for storing the second fastener portions. In various embodiments, the fastening systems described herein can utilize fasteners comprising any suitable type of material and/or form. In certain embodiments, the fasteners can comprise penetrating members. Such penetrating members could be comprised of a polymer, a composite, and/or a multi-layered substrate, for example. An example of a multi-layered substrate could be a wire or a sheet substrate with an elastomeric or polymeric coating. It could be a thin sheet formed such that penetrating members are oriented perpendicular, or at least substantially perpendicular, to the connecting member. The penetrating members could comprise a rectangular profile, semi-circular profile, and/or any beam profile. In various embodiments, the fasteners described herein can be manufactured utilizing any suitable process, such as a wire extruding process, for example. Another possibility is the use of microfabrication to create hollow penetrating members. These penetrating members could be fabricated from a process which is different than a wire extruded process and could use a combination of materials.


As described above, the tips of staple legs protruding through a retention matrix can be covered by one or more caps and/or covers. In certain embodiments, the tips of the staple legs can be deformed after they have been inserted through the retention matrix. In at least one embodiment, a jaw holding the retention matrix can further comprise anvil pockets positioned above and/or aligned with the retention apertures which can be configured to deform the staple legs as they protrude above the retention matrix. In various embodiments, the staple legs of each staple can be curled inwardly toward each other and/or toward the center of the staple, for example. In certain other embodiments, one or more of the staple legs of a staple can be curled outwardly away from the other staple legs and/or away from the center of the staple. In various embodiments, regardless of the direction in which the staple legs are curled, the tips of the staple legs can contact the body of the retention matrix and may not re-enter the tissue that has been fastened by the staples. In at least one embodiment, the deformation of the staple legs after they have passed through the retention matrix can lock the retention matrix in position.


In various embodiments, referring now to FIGS. 161 and 162, a surgical stapling instrument, such as surgical stapler 7000, for example, can comprise a first jaw 7030 and a second jaw 7040, wherein the second jaw 7040 can be moved toward and away from the first jaw 7030 by the movement of actuator 6235. The operation of actuator 6235 is described above and is not repeated herein for the sake of brevity. In various embodiments, the first jaw 7030 can comprise a distal end 7031 and a proximal end 7032, wherein the first jaw 7030 can define a channel extending between the distal end 7031 and the proximal end 7032 which is configured to receive a staple cartridge. For the purposes of illustration, the cartridge body of such a staple cartridge is not depicted in FIG. 161, although such a staple cartridge can comprise a cartridge body, staples 6220 positioned within the cartridge body, and staple drivers 7012 positioned underneath the staples 6220. In certain embodiments, although not illustrated in FIG. 161 for the sake of clarity, the second jaw 7040 can be configured to hold a retention matrix, such as retention matrix 6250, for example, over the staples 6220 and/or move the retention matrix into engagement with the legs of the staples 6220 as described above. In at least one embodiment, the surgical stapler 7000 can further comprise a sled 7010 positioned in the first jaw 7030 which can be slid from the distal end 7031 of the first jaw 7030 toward the proximal end 7032, for example, and lift the staple drivers 7012, and the staple 6220 supported thereon, toward the retention matrix and the second jaw 7040. In various other embodiments, the sled 7010 can be moved from the proximal end 7032 toward the distal end 7031 in order to deploy the staples 6020, for example. In at least one embodiment, the sled 7010 can comprise one or more inclined ramps, or cams, 7011 which can be configured to slide underneath the staple drivers 7012 and lift the staple drivers 7012 upwardly. In various embodiments, the surgical stapler 7000 can further comprise a pull, or push, rod operably coupled to the sled 7010 which can be moved proximally and/or distally by an actuator located on a handle and/or shaft of the surgical stapler 7000, for example.


In various embodiments, referring again to FIG. 161, the second jaw 7040 of the surgical stapler 7000 can comprise a frame 7041, a distal end 7048, and a proximal end 7049 positioned opposite the distal end 7048. In certain embodiments, the second jaw 7040 can further comprise a guide system comprising one or more guide rails, such as guide rails 7045 and 7046, for example, extending along the longitudinal axis of the frame 7041 which, as described in greater detail further below, can be configured to guide one or more anvils, or cams, which can engage and deform the staple legs of the staples 6220 after the staple legs 6221 of the staples 6220 have passed through the retention matrix. In at least one such embodiment, the guide rails 7045 and 7046 can comprise a guide wire or cable which extends along a top portion or surface of the frame 7041, around a distal post 7047, and back along the top portion or surface of the frame 7041, for example. In various embodiments, as mentioned above and referring primarily now to FIGS. 163 and 165, the second jaw 7040 can further comprise one or more anvils, or cams, such as first anvil 7050 and second anvil 7060, for example, which can be moved longitudinally along the second jaw 7040 in order to deform the legs of the staples 6220 after they have passed through the retention matrix. In at least one embodiment, the surgical stapler 7000 can further comprise a first anvil driver, or actuator, 7051 connected to and/or operably coupled to the first anvil 7050 which can be configured to pull the first anvil 7050 proximally and/or push the first anvil 7050 distally. Similarly, in at least one embodiment, the surgical stapler 7000 can further comprise a second anvil driver, or actuator, connected to and/or operably coupled to the second anvil 7060 which can be configured to push the second anvil 7060 distally and/or pull the second anvil 7060 proximally. In various embodiments, the first anvil 7050 can comprise guide slots 7052 and the second anvil 7060 can comprise guide slots 7062 which can each be configured to slidably receive guide rail 7045 or guide rail 7046 therein. In at least one such embodiment, the guide rails 7045 and 7046 can be closely received within the guide slots 7052 and 7062 such that relative lateral, or side-to-side, movement therebetween can be prevented, or at least limited.


In certain embodiments, further to the above, the first anvil 7050 can be pulled proximally and the second anvil 7060 can be pulled distally. In at least one embodiment, referring to FIG. 161, the guide rails 7045 and 7046 and the distal post 7047 can comprise a pulley system configured to pull the second anvil 7060 distally and/or pull the second anvil 7060 proximally. In at least one such embodiment, the guide rail 7045 and the guide rail 7046 can comprise a continuous wire or cable extending around the distal post 7047, wherein a portion of the continuous wire can be pulled in order to cycle the wire around the distal post 7047. In various embodiments, the guide rail 7046, for example, can be mounted to the second anvil 7060 such that, when the continuous cable is cycled in a first direction, the second anvil 7060 can be pulled distally toward the distal end 7048 of the jaw 7040 and, when the continuous cable is cycled in a second, or opposite, direction, the second anvil 7060 can be pulled proximally toward the proximal end 7049. In at least one embodiment, referring now to FIG. 163, the guide rail 7046 can be secured within a guide slot 7062 such that a pulling force can be transmitted therebetween. In at least one such embodiment, the guide rail 7045 can be configured to slide within the other guide slot 7062. In various embodiments, the first anvil 7050 may operate independently of the second anvil 7060 and the pulley system and the guide slots 7052 defined in the first anvil 7050 may be configured to slidably receive the guide rails 7045 and 7046 such that relative movement is permitted therebetween. In various embodiments, the continuous cable comprising guide rails 7045 and 7046 can be sufficiently flexible in order to accommodate the opening and closing of the top jaw 7040. The continuous cable can also be sufficiently flexible in order to accommodate the vertical movement of the second anvil 7060 toward and away from the bottom jaw 7030, which is described in greater detail further below.


In various embodiments, referring again to FIGS. 163 and 165, the first anvil 7050 can comprise cam followers 7055 extending therefrom which can be configured to ride in one or more cam slots, or guide slots, such as cam slot 7070 (FIG. 166), for example, defined in the frame 7041 of the second jaw 7040. More particularly, in at least one embodiment, the frame 7041 can comprise a first cam slot 7070 extending longitudinally along a first side of the frame 7041 and a second cam 7070 extending longitudinally along a second, or opposite, side of the frame 7041, wherein the cam followers 7055 extending from a first side of the first anvil 7050 can ride in the first cam slot 7070 and the cam followers 7055 extending from a second side of the first anvil 7050 can ride in the second cam slot 7070. In at least one such embodiment, the contours of each cam slot 7070 can be identical, or at least substantially identical, and can be aligned, or at least substantially aligned, with one another. Similarly, in various embodiments, the second anvil 7060 can comprise cam followers 7065 extending therefrom which can be configured to ride in the cam slots 7070 (FIG. 166) defined in the frame 7041 of the second jaw 7040. More particularly, in at least one embodiment, the cam followers 7065 extending from a first side of the second anvil 7060 can ride in the first cam slot 7070 and the cam followers 7065 extending from a second side of the second anvil 7060 can ride in the second cam slot 7070.


In use, the cam followers 7055 of the first anvil 7050 and the cam followers 7065 of the second anvil 7060 can slide within the cam slots 7070 such that first anvil 7050 and the second anvil 7060 follow the contours of the cam slots 7070 as the first anvil 7050 and the second anvil 7060 are pulled proximally and/or pushed distally. In various embodiments, each cam slot 7070 can comprise a plurality of dwell, or upper, portions 7071 and a plurality of driver, or lower, portions 7072 which can be configured to move the anvils 7050 and 7060 vertically, i.e., toward and away from the bottom jaw 7030, at the same time that the anvils 7050 and 7060 are being moved longitudinally, i.e., between the distal end 7048 and the proximal end 7049 of the frame 7041, as described in greater detail further below.


When the surgical stapler 7000 is in an unfired condition, referring to FIG. 166, the first anvil 7050 can be positioned at the distal end 7048 of the frame 7041 and the second anvil 7060 can be positioned at the proximal end 7049 of the frame 7041; furthermore, referring now to FIG. 167, the staples 6220 positioned in the first jaw 7030 may not yet be inserted into the tissue T and/or the retention matrix positioned thereabove when the surgical stapler 7000 is in an unfired condition. In use, referring now to FIG. 168, the staples 6220 can be driven upwardly within the staple cavities 7033 of a staple cartridge by the staple drivers 7012 and, in addition, the first anvil 7050 can be moved proximally from the distal end 7048 of the frame 7041 toward the distal end 7049 in order to engage the staple legs 6221 of the staples 6220. In at least one embodiment, the staples 6220 can be driven upwardly before the first anvil 7050 is engaged with the staple legs 6221 thereof. In various embodiments, all of the staples 6220 may be deployed upwardly by the sled 7010 before the first anvil 7050 is advanced into contact with the staple legs 6221 or, alternatively, the sled 7010 may be moved proximally at the same time that the first anvil 7050 is moved proximally, although the sled 7010 may sufficiently lead the first anvil 7050 in order to deploy the staples 6220 ahead of the first anvil 7050. In various embodiments, as illustrated in FIG. 168, the cam slots 7070 can be configured and arranged such that the forming surfaces, such as forming, or camming, surfaces 7053 and 7054, for example, of the first cam 7050 can contact at least some of the staple legs 6221 when the first cam 7050 is passing through a dwell, or upper, position. In various circumstances, the cam followers 7055 of the first anvil 7050 can each be positioned in a dwell portion 7071 of the cam slots 7070 such that the forming surfaces 7053 and 7054 are in a raised position and such that the staple legs 6221 are only partially deformed when the anvil 7050 passes thereby in the dwell position. As the first cam 7050 is moved further along the cam slots 7070, as illustrated in FIG. 169, the cam followers 7055 of the first anvil 7050 can be driven into driven, or lower, portions 7072 of the cam slots 7070 such that the forming surfaces 7053 and 7054 are moved vertically downwardly toward the staple legs 6021 in order to drive the staple legs 6021 into their finally formed configurations. Thereafter, as the first anvil 7050 is progressed further along the cam slots 7070, the first anvil 7050 can be driven vertically upwardly into another set of dwell portions 7071 of the cam slots 7070. As illustrated in FIGS. 168 and 169, the reader will note that the first anvil 7050 may only engage some of the staple legs and not others. In at least one such embodiment, the first anvil 7050 can be configured to only deform a group of staple legs comprising the distal staple legs 6221 of the staples 6220, for example. In at least one such embodiment, the first anvil 7050 can be configured to deform the distal staple legs 6221 toward the center of the staples 6220. In various embodiments, each proximal staple leg 6221 can be contacted twice by the first anvil 7050, i.e., by a first forming surface 7053 and by a second forming surface 7054 aligned with the first forming surface 7053. In at least one such embodiment, the first forming surfaces 7053 can deform the distal staple legs 6221 into a partially-deformed configuration when the first anvil 7050 is in a dwell, or upper, position and the second forming surfaces 7054 can deform the distal staple legs 6221 into a fully-formed configuration when the first anvil 7050 is moved into a driven, or lower, position. In various embodiments, referring now to FIGS. 163 and 164, the first anvil 7050 can comprise a plurality of first forming surfaces 7053 and a plurality of second forming surfaces 7054 in order to deform the distal staple legs 6221 of staples 6220 when the staple legs 6221 are arranged in more than one row or line. In various embodiments, as described in greater detail further below, the proximal staple legs 6221 of the staples 6020 can be deformed by the second anvil 7060, for example.


In various embodiments, further to the above, the first anvil 7050 can be moved from the distal end 7048 of the frame 7041 to the proximal end 7049 in order to deform all of the distal staple legs 6221 of the staples 6220. As the reader will note, the first anvil 7050 can be moved up and down relative to the undeformed proximal staple legs 6221 and, in order to accommodate such relative movement, in various embodiments, the first anvil 7050 can comprise one or more clearance slots 7057 (FIG. 165) which can be configured to receive the unbent proximal staple legs 6221 as the first anvil 7050 bends the distal staple legs 6221. Similarly, referring again to FIG. 163, the second anvil 7060 can comprise a clearance slot 7067 which can be configured to accommodate the vertical movement of the first cam actuator 7051 which moves up and down as the first anvil 7050 is moved between its dwell and driven positions as described above. After all of the distal staple legs 6221 have been bent, in at least one embodiment, the second anvil 7060 can be moved from the proximal end 7049 of the frame 7041 to the distal end 7048 by the anvil actuator 7061. Similar to the above, referring now to FIG. 170, the cam followers 7065 of the second anvil 7060 can slide within the cam slots 7070 such that the second anvil 7060 is moved between dwell, or upper, positions and driven, or lower, positions in order to deform the proximal staple legs 6221 inwardly toward the centers of the staples 6220, for example Similar to the above, the second anvil 7060 can comprise a plurality of first forming, or camming, surfaces 7063 and a plurality of second forming, or camming, surfaces 7064 which can each be configured to at least partially deform and/or completely deform one or more of the proximal staple legs 6021. Referring again to FIG. 164, the second anvil 7060 can comprise a plurality of first forming surface 7063 and a plurality of second forming surfaces 7064 which can be configured to deform the proximal staple legs 6221 of staples 6220 arranged in a plurality of rows, or lines, for example. As also illustrated in FIG. 164, the first forming surfaces 7063 and the second forming surfaces 7064 of the second anvil 7060 may not be aligned with the first forming surfaces 7053 and the second forming surfaces 7054 of the first anvil 7050 wherein, as a result, the proximal legs 6221 of the staples 6220 may be positioned in different rows, or lines, than the distal legs 6221 of the staples 6220. As the reader will also note, the second anvil 7060 can push the first anvil 7050 as the second anvil 7060 is moved distally. In at least one such embodiment, the second anvil 7060 can push the first anvil 7050 back into the distal end 7048 of the frame 7041 such that the first anvil 7050 can be returned to its initial, or unfired, position. After all of the proximal staple legs 6221 of the staples 6220 have been deformed, the second anvil 7060 can be retracted proximally and returned to its initial, or unfired, position. In this way, the surgical stapler 7000 can be reset such that a new staple cartridge can be positioned in the first jaw 7030 and a new retention matrix can be positioned in the second jaw 7040 in order to use the surgical stapler 7000 once again.


In various embodiments, as described above, a surgical stapler can comprise two or more anvils which can travel longitudinally in order to engage the legs of a plurality of staples in a transverse direction. In certain embodiments, a surgical stapler can comprise an anvil which is moved proximally, for example, in order to deform a first group of staple legs and distally, for example, in order to deform a second group of staple legs. In at least one such embodiment, such an anvil can comprise forming surfaces facing proximally and forming surfaces facing distally, for example.


In various embodiments, referring now to FIG. 171, an anvil, such as anvil 7140, for example, can comprise a bottom, or tissue-contacting, surface 7141 and a plurality of forming pockets 7142 defined therein. In at least one embodiment, the anvil 7140 can comprise more than one plate, such as pocket plates 7143, for example, which can be welded into a frame 7144. In at least one such embodiment, each pocket plate 7143 can be positioned in a plate channel 7145 in the frame 7144 and welded to the frame 7144 through a weld slot 7146 extending through the frame 7144 in order to form a longitudinal weld 7147. In various circumstances, the longitudinal weld 7147 can comprise a continuous weld extending along the entire length of the weld slot 7146 or a series of spaced-apart spot welds extending along the length thereof, for example. In various embodiments, each pocket plate 7143 can comprise two or more plate portions that have been welded together. In at least one such embodiment, each pocket plate 7143 can comprise a first plate portion 7143a and a second plate portion 7143b which can be welded together along a seam 7148. In various embodiments, the first plate portion 7143a and the second plate portion 7143b of each plate 7143 can be welded together before the plates 7143 are welded into the plate channels 7145 in the frame 7144. In at least one such embodiment, the first plate portion 7143a and the second plate portion 7143b can comprise co-operating profiles, such as the toothed profiles illustrated in FIG. 171, for example, which can be fitted together to form a tight seam 7148. In at least one embodiment, each plate 7143 can comprise a height of approximately 0.02″, for example, which can be taller than the depth of the plate channels 7145 such that the tissue-contacting surfaces 7141 thereof extend from the frame 7044 of the anvil 7040. In certain embodiments, referring now to FIG. 172, the plates 7143 can be connected together by at least one weld 7149 at the distal ends of the plates 7143, for example.


As illustrated in FIGS. 171 and 172, each pocket plate 7143 can comprise a plurality of forming pockets 7142 defined therein. In various embodiments, the forming pockets 7142 can be formed in the plates 7143 by any suitable manufacturing process, such as a grinding process and/or electrode-burning process, for example. In at least one such embodiment, referring now to FIGS. 173 and 174, each forming pocket 7142 can be manufactured by first forming a deep well 7150, then forming an arcuate or curved surface 7151 surrounding the deep well 7150, and then forming a staple leg guide groove 7152 in the curved surface 7151, for example. In various other embodiments, these steps can be performed in any suitable order. In various embodiments, referring now to FIG. 175, the staple forming pockets 7142 can be formed such that the inner edges 7153 of the forming pockets are separated by a consistent, or at least substantially consistent, gap 7154. In at least one such embodiment, the gap 7154 can be approximately 0.008″, for example. Furthermore, in at least one such embodiment, the forming pockets 7142 can be positioned along two or more rows, or lines, the centerlines of which can be separated by a consistent, or at least substantially consistent, spacing 7155. In at least one such embodiment, the spacing 7155 between the centerlines can be approximately 0.035″, for example. In various embodiments, referring again to FIG. 175, each forming pocket 7142 can taper between a narrow width 7156 and a wide width 7157. In at least one such embodiment, the narrow width 7156 can be approximately 0.045″ and the wide width 7157 can be approximately 0.075″, for example. In various embodiments, the plates 7143 can be comprised of the same material as the frame 7144. In at least one such embodiment, the plates 7143 and the frame 7144 can both be comprised of stainless steel, such as a 300 series or a 400 series stainless steel, for example, and/or titanium, for example. In various other embodiments, the plates 7143 and the frame 7144 can be comprised of different materials. In at least one such embodiment, the plates 7143 can be comprised of a ceramic material, for example, and the frame 7144 can be comprised of a stainless steel and/or titanium, for example. In various circumstances, depending on the materials used, at least one brazing process could be used to secure the plates 7143 in the frame 7144 in addition to or in lieu of the welding processes described above, for example.


In various embodiments, referring now to FIGS. 176-178, an anvil 7240 can comprise a frame 7244 and a plurality of pocket plates 7243 which can be inserted into the frame 7244. Similar to the above, each pocket plate 7243 can comprise a plurality of forming pockets 7242 defined therein. In at least one embodiment, the anvil frame 7244 can comprise retention slots 7246 defined therein which can each be configured to receive a retention rail 7247 extending from a pocket plate 7243. In order to assemble the pocket plates 7243 to the anvil frame 7244, the side walls 7245 of the anvil frame 7244 can be flexed or splayed outwardly, as illustrated in FIG. 177, in order to widen the retention slots 7246 such that each retention slot 7246 can receive a retention rail 7247 of a pocket plate 7243 therein. Once the retention rails 7247 have been positioned in the retention slots 7246, the side walls 7245 can be released, as illustrated in FIG. 178, thereby allowing the frame 7244 to resiliently contract and/or return to its unflexed state. In such circumstances, the retention slots 7246 can contract and thereby capture the retention rails 7247 therein. In certain embodiments, the retention rails 7247 and/or the retention slots 7246 can comprise one or more co-operating tapered surfaces which, after the flexed retention slots 7246 have been released, can form a taper-lock engagement which can retain the retention rails 7247 in the retention slots 7246. Similar to the above, the pocket plates 7243 can be comprised of the same material as or a different material than the frame 7244. In at least one such embodiment, the plates 7243 can be comprised of a ceramic material, for example, and the frame 7244 can be comprised of a stainless steel and/or titanium, for example. In various circumstances, depending on the materials used, at least one brazing process and/or at least one welding process, for example, could be used to secure the plates 7243 in the frame 7244.


In FIGS. 179 and 180, a surgical stapling and severing instrument 8010 can comprise an anvil 8014 which may be repeatably opened and closed about its pivotal attachment to an elongate staple channel 8016. A staple applying assembly 8012 can comprise the anvil 8014 and the channel 8016, wherein the assembly 8012 can be proximally attached to the elongate shaft 8018 forming an implement portion 8022. When the staple applying assembly 8012 is closed, or at least substantially closed, the implement portion 8022 can present a sufficiently small cross-section suitable for inserting the staple applying assembly 8012 through a trocar. In various embodiments, the assembly 8012 can be manipulated by a handle 8020 connected to the shaft 8018. The handle 8020 can comprise user controls such as a rotation knob 8030 that rotates the elongate shaft 8018 and staple applying assembly 8012 about a longitudinal axis of the shaft 8018. A closure trigger 8026, which can pivot in front of a pistol grip 8036 about a closure trigger pin 8152 (FIG. 181) engaged laterally across the handle housing 8154, can be depressed to close the staple applying assembly 8012. In various embodiments, a closure release button 8038 can be outwardly presented on the handle 8020 when the closure trigger 8026 is clamped such that the release button 8038 can be depressed to unclamp the closure trigger 8026 and open the staple applying assembly 8012, as described in greater detail below. A firing trigger 8034, which can pivot in front of the closure trigger 8026, can cause the staple applying assembly 8012 to simultaneously sever and staple tissue clamped therein. In various circumstances, as described in greater detail below, multiple firing strokes can be employed using the firing trigger 8034 to reduce the amount of force required to be applied by the surgeon's hand per stroke. In certain embodiments, the handle 8020 can comprise rotatable right and/or left indicator wheels 8040, 8041 (FIG. 181) which can indicate the firing progress. For instance, full firing travel may require three full firing strokes of firing trigger 8034 and thus the indicator wheels 8040, 8041 can rotate up to one-third of a revolution each per stroke of firing trigger 8034. As described in greater detail below, a manual firing release lever 8042 can allow the firing system to be retracted before full firing travel has been completed, if desired, and, in addition, the firing release lever 8042 can allow a surgeon, or other clinician, to retract the firing system in the event that the firing system binds and/or fails.


With reference to FIGS. 179 and 181, the elongate shaft 8018 can comprise an outer structure including a longitudinally reciprocating closure tube 8024 that pivots the anvil 8014 toward its close position in response to the proximal depression of the closure trigger 8026 of handle 8020. The elongate channel 8018 can be connected to the handle 8020 by a frame 8028 (FIG. 181) that is internal to the closure tube 8024. The frame 8028 can be rotatably engaged to the handle 8020 so that the rotation of the rotation knob 8030 (FIG. 179) can rotate the implement portion 8022. With particular reference to FIG. 181, the rotation knob 8030 can be comprised of two half-shells which can include one or more inward projections 8031 that can extend through one or more elongate side openings 8070 in the closure tube 8024 and engage the frame 8028. As a result of the above, the rotation knob 8030 and the frame 8028 can be rotated together, or synchronously, such that the rotated position of knob 8030 determines the rotated position of the implement portion 8022. In various embodiments, the longitudinal length of the longer opening 8070 is sufficiently long to allow the longitudinal closure motion, and opening motion, of the closure tube 8024. With regard to generating the closure motion of closure tube 8024, referring primarily to FIGS. 181 and 183, an upper portion 8160 of the closure trigger 8026 can push forward a closure yoke 8162 via a closure link 8164. The closure link 8164 is pivotally attached at its distal end by a closure yoke pin 8166 to the closure yoke 8162 and is pivotally attached at its proximal end by a closure link pin 8168. In various embodiments, the closure trigger 8026 can be urged to an open position by a closure trigger tension spring 8246 that is connected proximally to the upper portion 8160 of the closure trigger 8026 and a handle housing 8154 formed by right and left half shells 8156, 8158. The tension force applied by the tension spring 8246 can be overcome by a closing force applied to the closure trigger 8026 in order to advance the yoke 8162, closure link 8164, and the closure tube 8024 distally.


As the closure trigger 8026 is actuated, or depressed, as described above, the closure release button 8038 can be positioned such that the surgeon, or other clinician, can push the closure release button 8038, if desired, and allow the closure trigger 8026, and the rest of the surgical instrument, to return to an unactuated state. In various embodiments, the closure release button 8038 can be connected to a pivoting locking arm 8172 by a central lateral pivot 8173 such that motion can be transferred between the release button 8038 and the locking arm 8172. Referring again to FIG. 181, a compression spring 8174 can bias the closure release button 8038 proximally, i.e., clockwise about the central lateral pivot 8173 as viewed from the right and the upper portion 8160 of the closure trigger 8026 can include a proximal crest 8170 with an aft notch 8171. As the closure trigger 8026 is depressed, the pivoting locking arm 8172 can ride upon the proximal crest 8170 and when the closure trigger 8026 reaches its fully depressed position, it should be appreciated that the aft notch 8171 is presented below the pivoting locking arm 8172 which drops into and locks against the aft notch 8171 under the urging of the compression spring 8174. At such point, manual depression of the closure release button 8038 rotates the pivoting locking arm 8172 upward and out of aft notch 8171 thereby unlocking the closure trigger 8026 and allowing the closure trigger 8026 to be returned to its unclamped position.


Once the closure trigger 8026 is proximally clamped, as discussed above, the firing trigger 8034 can be drawn toward the pistol grip 8036 in order to advance a firing rod 8032 distally from the handle 8020. In various embodiments, the firing trigger 8034 can pivot about a firing trigger pin 8202 that laterally traverses and is engaged with the right and left half shells 8156, 8158 of the handle 8020. The firing trigger 8034, when actuated, can advance a linked transmission firing mechanism 8150. The linked transmission firing mechanism 8150 can be urged into a retracted, unfired, position by a spring 8184 that is, one, attached to the pistol grip 8036 of the handle 8020 and, two, attached to one of the links, for example, of the linked transmission firing mechanism 8150 as described in greater detail below. The spring 8184 can comprise a nonmoving end 8186 connected to the housing 8154 and a moving end 8188 connected to a proximal end 8190 of a steel band 8192. A distally-disposed end 8194 of the steel band 8192 can be attached to an attachment feature 8195 on a front link 8196a of a plurality of links 8196a-8196d that form a linked rack 8200. Linked rack 8200 can be flexible such that it can readily retract into the pistol grip 8036 and minimize the length of the handle 8020 and yet form a straight rigid rack assembly that may transfer a significant firing force to and/or through the firing rod 8032. As described in greater detail below, the firing trigger 8034 can be engaged with a first link 8196a during a first actuation of the firing trigger 8034, engaged with a second link 8196b during a second actuation of the firing trigger 8034, engaged with a third link 8196c during a third actuation of the firing trigger 8034, and engaged with a fourth link 8196d during a fourth actuation of the firing trigger 8034, wherein each actuation of the firing trigger 8034 can advance the linked rack 8200 distally an incremental amount. In various embodiments, further to the above, the multiple strokes of firing trigger 1034 can rotate the right and left indicator gauge wheels 1040, 1041 to indicate the distance in which the linked rack 8200 has been advanced.


Referring now to FIGS. 181 and 183, an anti-backup mechanism 8250 can prevent the combination tension/compression spring 8184 from retracting the linked rack 8200 between firing strokes. In various embodiments, a coupling slide tube 8131 abuts the first link 8196a and connects to the firing rod 8032 to communicate the firing motion. The firing rod 8032 extends proximally out of a proximal end of the frame 8028 and through a through hole 8408 of an anti-backup plate 8266. The through hole 8408 is sized to slidingly receive the firing rod 8032 when perpendicularly aligned but to bind when tipped. A lower tab attachment 8271 extends proximally from a lower lip of the proximal end of the frame 8028, extending through an aperture 8269 on a lower edge of the anti-backup plate 8266. This lower tab attachment 8271 draws the lower portion of the anti-backup plate 8266 proximate to the frame 8028 so that the anti-backup plate 8266 is perpendicular when the firing rod 8032 is distally advanced and allowed to tip top aft into a binding state when the firing rod 8032 attempts to retract. An anti-backup compression spring 8264 is distally constrained by the proximal end of the frame 8028 and proximally abuts a top portion of the anti-backup plate 8266, biasing the anti-backup plate 8266 to a locking state. Opposing the spring bias, an anti-backup cam tube 8268 slidingly encompasses the coupling slide tube 8131 and abuts the anti-backup plate 8266. A proximally projecting anti-backup yoke 8256 attached to the anti-backup cam tube 8268 extends overtop of the closure yoke 8162.


Referring to FIG. 181, a link triggered automatic retraction mechanism 8289 is incorporated into the surgical stapling and severing instrument 8010 to cause knife retraction at the end of full firing travel. To that end, the distal link 8196d includes a tang 8290 that projects upwardly when the distal link 8196d is advanced into rack channel 8291 (FIG. 181) formed in the closure yoke 8162. This tang 8290 is aligned to activate a bottom proximal cam 8292 on an anti-backup release lever 8248 (FIG. 186). With particular reference to FIGS. 186 and 187, structures formed in the right and left half shells 8156, 8158 constrain movement of the anti-backup release lever 8248. A pin receptacle 8296 and circular pin 8293 formed respectively between right and left half shells 8156, 8158 is received through a longitudinally elongate aperture 8294 formed in the anti-backup release lever 8248 distal to the bottom proximal cam 8292, thus allowing longitudinal translation as well as rotation about the circular pin 8293. In the right half shell 8156, a proximally open channel 8295 includes a proximal horizontal portion 8295a that communicates with an upwardly and distally angled portion 8295b that receives a rightward aft pin 8297 (FIG. 187) near the proximal end of the anti-backup release lever 8248, thus imparting an upward rotation as the anti-backup release lever 8248 reaches the distal most portion of its translation. A blocking structure formed in the right half shell 8156 proximal to the anti-backup release lever 8248 prevents proximal movement thereof once assembled to maintain rightward aft pin 8297 in the proximally open channel 8295.


Further to the above, as depicted in FIGS. 187 and 188, a distal end 8254 of the anti-backup release lever 8248 thus is urged distally and downwardly, causing a rightward front pin 8298 to drop into distally open step structure 8299 formed in the right half shell 8156, which is urged into this engagement by a compression spring 8300 (FIG. 188) hooked to a leftward hook 8301 on the anti-backup release lever 8248 between the rightward front pin 8298 and the longitudinally elongate aperture 8294. The other end of the compression spring 8300 is attached to a hook 8302 (FIGS. 186, 188, 189) formed in the right half shell 8156 in a more proximal and lower position just above the closure yoke 8266. The compression spring 8300 thus pulls the distal end 8254 of the anti-backup release lever 8248 down and aft, which results in the rightward front pin 8298 locking into the distally open step structure 8299 when distally advanced. Thus, once tripped, referring to FIG. 189, the anti-backup release lever 8248 remains forward holding the anti-backup plate 8266 perpendicularly and thus allowing the linked rack 8200 to be retracted. When the closure yoke 8266 is subsequently retracted when unclamping the end effector 8012, an upwardly projecting reset tang 8303 on the closure yoke 8266 contacts a bottom distal cam 8305 of the anti-backup release lever 8248, lifting the right-ward front pin 8298 out of the distally open step structure 8299 so that the anti-backup compression spring 8264 can proximally push the anti-backup cam tube 8268 and the anti-backup release lever 8248 to their retracted positions (FIG. 186).


In various embodiments, referring to FIGS. 179 and 189, the firing trigger 8034 can be operably engaged to the linked rack 8200 in any suitable manner. With particular reference to FIGS. 180 and 185, the firing trigger 8034 pivots about a firing trigger pin 8202 that is connected to the housing 8154. An upper portion 8204 of the firing trigger 8034 moves distally about the firing trigger pin 8202 as the firing trigger 8034 is depressed towards pistol grip 8036, stretching a proximally placed firing trigger tension spring 8206 (FIG. 181) proximally connected between the upper portion 8204 of the firing trigger 8034 and the housing 8154. The upper portion 8204 of the firing trigger 8034 engages the linked rack 8200 during each firing trigger depression via a spring biased side pawl mechanism 8210. When the firing trigger is released, the side pawl mechanism is disengaged from the linked rack 8200 and the firing trigger can be returned to an undepressed, or unfired, position. In use, a ramped right-side track formed by a proximally and rightwardly facing beveled surface 8284 in each of the links 8196a-8196d is engaged by a side pawl assembly 8285. In particular, a pawl slide 8270 (FIGS. 181 and 183) has right and left lower guides 8272 that slide respectively in a left track 8274 (FIG. 181) formed in the closure yoke 8266 below the rack channel 8291 and a right track 8275 in a closure yoke rail 8276 that parallels rack channel 8291 and is attached to a rack channel cover 8277 that closes a rightwardly open portion of the rack channel 8291 in the closure yoke 8266 that is distal to the travel of the pawl slide 8270. In FIGS. 181, 182, and 185, a compression spring 8278 is attached between a hook 8279 on a top proximal position on the closure yoke rail 8276 and a hook 8280 on a distal right-side of the pawl slide 8270, which keeps the pawl slide 8270 drawn proximally into contact with the upper portion 8204 of the firing trigger 8034.


With particular reference to FIG. 181, a pawl block 8318 sits on the pawl slide 8270 pivoting about a vertical aft pin 8320 that passes through a left proximal corner of pawl block 8318 and pawl slide 8270. A kick-out block recess 8322 is formed on a distal portion of a top surface of the block 8318 to receive a kick-out block 8324 pivotally pinned therein by a vertical pin 8326 whose bottom tip extends into a pawl spring recess 8328 on a top surface of the pawl slide 8270. A pawl spring 8330 in the pawl spring recess 8328 extends to the right of the vertical front pin 8326 urging the pawl block 8318 to rotate counterclockwise when viewed from above into engagement with the ramped right-side track 8282. A small coil spring 8332 in the kick-out block recess 8322 urges the kick-out block 8324 to rotate clockwise when viewed from above, its proximal end urged into contact with a contoured lip 8334 formed in the closure yoke 8266 above the rack channel 8291. As shown in FIG. 184, the stronger mechanical advantage of the pawl spring 8330 over the small coil spring 8332 means that the pawl block 8318 tends toward engagement with the kick-out block 8324 rotated clockwise. In FIG. 185, as the firing trigger 8034 is fully depressed and begins to be release, the kick-out block 8324 encounters a ridge 8336 in the contoured lip 8334 as the pawl slide 8270 retracts, forcing the kick-out block 8324 to rotate clockwise when viewed from above and thereby kicking out the pawl block 8318 from engagement with the linked rack 8200. The shape of the kick-out block recess 8322 stops the clockwise rotation of the kick-out block 8324 to a perpendicular orientation to the contoured lip 8334 maintaining this disengagement during the full retraction and thereby eliminating a ratcheting noise.


In FIGS. 181, 183, 190, and 195, the surgical stapling and severing instrument 8010 can include a manual retraction mechanism 8500 that provides for a manual release of the firing mechanism, manual retraction, and in one version (FIGS. 196-202) further performs automatic retraction at the end of full firing travel. Referring now to FIGS. 181, 190, and 191, in particular, a front idler gear 8220 is engaged with a toothed upper, left surface 8222 of the linked rack 8200 wherein the front idler gear 8220 also engages an aft idler gear 8230 having a smaller right-side ratchet gear 8231. Both the front idler gear 8220 and aft idler gear 8230 are rotatably connected to the handle housing 8154 respectively on front idler axle 8232 and aft idler axle 8234. Each end of the aft axle 8232 extend through the respective right and left housing half shells 8156, 8158 and are attached to the left and right indicator gauge wheels 8040, 8041 and, since the aft axle 8234 is free spinning in the handle housing 8154 and has a keyed engagement to the aft gear 8230, the indicator gauge wheels 8040, 8041 rotate with the aft gear 8230. The gear relationship between the linked rack 8200, idler gear 8220 and aft gear 8230 may be advantageously selected so that the toothed upper surface 8222 has tooth dimensions that are suitably strong and that the aft gear 8230 makes no more than one revolution during the full firing travel of the linked transmission firing mechanism 8150. In addition to gear mechanism 8502 visually indicating the firing travel, or progress, the gear mechanism 8502 can also be used to manual retract the knife. In various embodiments, the smaller right-side ratchet gear 8231 of the aft idler gear 8230 extends into a hub 8506 of the manual retraction lever 8042, specifically aligned with a vertical longitudinally-aligned slot 8508 (FIG. 190) bisecting the hub 8506. A lateral through hole 8510 of the hub 8506 communicates with an upper recess 8512. A front portion 8514 is shaped to receive a proximally directed locking pawl 8516 that pivots about a rightward lateral pin 8518 formed in a distal end of the upper recess 8512. An aft portion 8520 is shaped to receive an L-shaped spring tab 8522 that urges the locking pawl 8516 downward into engagement with the right-side smaller ratchet gear 8231. A hold-up structure 8524 (FIGS. 186 and 193) projects from the right half shell 8156 into the upper recess 8512 holding up the locking pawl 8516 from engaging the smaller right-side ratchet gear 8231 when the manual retraction lever 8042 is down (FIG. 193). A coil spring 8525 (FIG. 181) urges the manual retraction lever 8042 down.


In use, as depicted in FIGS. 192 and 193, the combination tension/compression spring 8184 may become disconnected with the linked rack distally positioned. In FIGS. 194 and 195, as the manual retraction lever 8042 is raised, the locking pawl 8516 rotates clockwise and no longer is held up by the hold-up structure 8524 and engages the smaller right-side ratcheting gear 8231, rotating the aft idler gear 8230 clockwise when viewed from the left. Thus, the forward idler gear 8220 responds counterclockwise retracting the linked rack 8200. In addition, a rightward curved ridge 8510 projects out from the hub 8506, sized to contact and distally move the anti-backup release lever 8248 to release the anti-backup mechanism 8250 as the manual retraction lever 8042 is rotated.


In FIGS. 196-202, an automatic retraction mechanism 8600 for a surgical stapling and severing instrument 8010a can incorporate automatic retraction at the end of full firing travel into a front idler gear 8220a having a tooth 8602 that moves within a circular groove 8604 in a cam wheel 8606 until encountering a blockage 8608 after nearly a full rotation corresponding to three firing strokes. In such circumstances, rightward ridge 8610 is rotated upward into contact a bottom cam recess 8612 to distally move an anti-backup release lever 8248a. With particular reference to FIG. 197, the anti-backup release lever 8248a includes the distal end 8254 that operates as previously described. The circular pin 8293 and pin receptacle 8296 formed between right and left half shells 8156, 8158 is received through a generally rectangular aperture 8294a formed in the anti-backup release lever 8248a aft of the bottom cam 8192, thus allowing longitudinal translation as well as downward locking motion of the distal end 8254 of the anti-backup release lever 8248a. In the right half shell 8156, a horizontal proximally open channel 8295a receives the rightward aft pin 8297 near the proximal end of the anti-backup release lever 8248a.


In operation, before firing in FIGS. 198, 198A, the linked rack 8200 and the anti-backup cam tube 8268 are in a retracted position, locking the anti-backup mechanism 8250 as the anti-backup compression spring 8264 proximally tips the anti-backup plate 8266. The automatic retraction mechanism 8600 is at an initial state with the anti-backup release lever 8248a retracted with link 8196a in contact with the forward idler gear 8220a. The tooth 8602 is at a six o'clock position with full travel of the circular groove 8604 progressing counterclockwise thereof with the rightward ridge 8610 just proximal to the tooth 8602. In FIGS. 199, 199A, one firing stroke has occurred moving up one distal link 8196b into contact with the forward idler gear 8220a. The tooth 8602 has progressed one third of a turn through the circular groove 8604 of the immobile cam wheel 8606. In FIGS. 200, 200A, a second firing stroke has occurred moving up one more link 8196c into contact with the forward idler gear 8220a. The tooth 8602 has progressed two thirds of a turn through the circular groove 8604 of the immobile cam wheel 8606. In FIGS. 201, 201A, a third firing stroke has occurred moving up one distal link 8196d into contact with the forward idler gear 8220a. The tooth 8602 has progressed fully around the circular groove 8604 into contact with the blockage 8608 initiating counterclockwise rotation (when viewed from the right) of the cam wheel 8606 bringing the rightward ridge 8608 into contact with the anti-backup release lever 8248a. In FIG. 202, the anti-backup release lever 8248a has moved distally in response thereto, locking the rightward front pin 8298 into the distally open step structure 8299 and releasing the anti-backup mechanism 8250. Similar surgical stapling instruments are disclosed in U.S. Pat. No. 7,083,075, which issued on Aug. 1, 2006, the entire disclosure of which is incorporated by reference herein.


Referring to FIG. 203, the staple applying assembly 9012 of a surgical stapling instrument 9010 accomplishes the functions of clamping onto tissue, driving staples and severing tissue by two distinct motions transferred longitudinally down the shaft 9016 relative to a shaft frame 9070. This shaft frame 9070 is proximally attached to a handle of a surgical stapling instrument and is coupled thereto for rotation about a longitudinal axis. An illustrative multi-stroke handle for the surgical stapling and severing instrument is described in greater detail in the commonly-owned U.S. patent application entitled SURGICAL STAPLING INSTRUMENT INCORPORATING A MULTISTROKE FIRING POSITION INDICATOR AND RETRACTION MECHANISM, Ser. No. 10/674,026, now U.S. Pat. No. 7,364,061, the disclosure of which is hereby incorporated by reference in its entirety. Other applications consistent with the present invention may incorporate a single firing stroke, such as described in commonly-owned U.S. patent application SURGICAL STAPLING INSTRUMENT HAVING SEPARATE DISTINCT CLOSING AND FIRING SYSTEMS, Ser. No. 10/441,632, now U.S. Pat. No. 7,000,818, the disclosure of which is hereby incorporated by reference in its entirety.


With particular reference to FIG. 204, the distal end of the shaft frame 9070 is attached to the staple channel 9018. The anvil 9022 has a proximal pivoting end 9072 that is pivotally received within a proximal end 9074 of the staple channel 9018, just distal to its engagement to the shaft frame 9070. When the anvil 9022 is pivoted downwardly, the anvil 9022 moves a tissue contacting surface 9028 and forming pockets 9026 toward an opposing staple cartridge, described in greater detail further below. The pivoting end 9072 of the anvil 9022 includes a closure feature 9076 proximate but distal to its pivotal attachment with the staple channel 9018. Thus, a closure tube 9078, whose distal end includes a horseshoe aperture 9080 that engages this closure feature 9076, selectively imparts an opening motion to the anvil 9022 during proximal longitudinal motion and a closing motion to the anvil 9022 during distal longitudinal motion of the closure tube 9078 sliding over the shaft frame 9070 in response to a closure trigger, similar to the above. The shaft frame 9070 encompasses and guides a firing motion from the handle through a longitudinally reciprocating, two-piece knife and firing bar 9090. In particular, the shaft frame 9070 includes a longitudinal firing bar slot 9092 that receives a proximal portion of the two-piece knife and firing bar 9090, specifically a laminate tapered firing bar 9094. It should be appreciated that the laminated tapered firing bar 9094 may be substituted with a solid firing bar and/or any other suitable materials.


An E-beam 9102 is the distal portion of the two-piece knife and firing bar 9090, which facilitates separate closure and firing as well as spacing of the anvil 9022 from the elongate staple channel 9018 during firing. With particular reference to FIGS. 204 and 205, in addition to any attachment treatment such as brazing or an adhesive, the knife and firing bar 9090 are formed of a female vertical attachment aperture 9104 proximally formed in the E-beam 9102 that receives a corresponding male attachment member 9106 distally presented by the laminated tapered firing bar 9094, allowing each portion to be formed of a selected material and process suitable for their disparate functions (e.g., strength, flexibility, friction). The E-beam 9102 may be advantageously formed of a material having suitable material properties for forming a pair of top pins 9110, a pair of middle pins 9112 and a bottom pin or foot 9114, as well as being able to acquire a sharp cutting edge 9116. In addition, integrally formed and proximally projecting top guide 9118 and middle guide 9120 bracketing each vertical end of the cutting edge 9116 further define a tissue staging area 9122 assisting in guiding tissue to the sharp cutting edge 9116 prior to being severed. The middle guide 9120 also serves to engage and fire the staple applying apparatus 9012 by abutting a stepped central member 9124 of a wedge sled 9126 (FIG. 206) that effects staple formation by the staple applying assembly 9012, as described in greater detail below. Forming these features (e.g., top pins 9110, middle pins 9112, and bottom foot 9114) integrally with the E-beam 9102 facilitates manufacturing at tighter tolerances relative to one another as compared to being assembled from a plurality of parts, ensuring desired operation during firing and/or effective interaction with various lockout features of the staple applying assembly 9012.


In FIGS. 207 and 208, the staple applying assembly 9012 is shown open, with the E-beam 9102 fully retracted. During assembly, the lower foot 9114 of the E-beam 9102 is dropped through a widened hole 9130 in the staple channel 9018 and the E-beam 9102 is then advanced such that the E-beam 9102 slides distally along a lower track 9132 formed in the staple channel 9018. In particular, the lower track 9132 includes a narrow slot 9133 that opens up as a widened slot 9134 on an undersurface of the staple channel 9018 to form an inverted T-shape in lateral cross section, as depicted particularly in FIGS. 208 and 209, which communicates with the widened hole 9130. Once assembled, the components proximally coupled to the laminate tapered firing bar 9094 do not allow the lower foot 9114 to proximally travel again to the widened hole 9130 to permit disengagement. Referring to FIG. 210, the laminate tapered firing bar 9094 facilitates insertion of the staple applying assembly 9012 through a trocar. In particular, a more distal, downward projection 9136 raises the E-beam 9102 when fully retracted. This is accomplished by placement of the downward projection 9136 at a point where it cams upwardly on a proximal edge of the widened hole 9130 in the staple channel 9018. Referring now to FIG. 211, the laminate tapered firing bar 9094 also enhances operation of certain lockout features that may be incorporated into the staple channel 9018 by including a more proximal upward projection 9138 that is urged downwardly by the shaft frame 9070 during an initial portion of the firing travel. In particular, a lateral bar 9140 is defined between a pair of square apertures 9142 in the shaft frame 9070 (FIG. 204). A clip spring 9144 that encompasses the lateral bar 9140 downwardly urges a portion of the laminate tapered firing bar 9094 projecting distally out of the longitudinal firing bar slot 9092, which ensures certain advantageous lockout features are engaged when appropriate. This urging is more pronounced or confined solely to that portion of the firing travel when the upward projection 9138 contacts the clip spring 9144.


In FIGS. 207 and 208, the E-beam 9102 is retracted with the top pins 9110 thereof residing within an anvil pocket 9150 near the pivoting proximal end of the anvil 9022. A downwardly open vertical anvil slot 9152 (FIG. 203) laterally widens in the anvil 9022 into an anvil internal track 9154 that captures the top pins 9110 of the E-beam 9102 as they distally advance during firing, as depicted in FIGS. 210 and 211, affirmatively spacing the anvil 9022 from the staple channel 9018. Thus, with the E-beam 9102 retracted, the surgeon is able to repeatably open and close the staple applying assembly 9012 until satisfied with the placement and orientation of tissue captured therein for stapling and severing, yet the E-beam 9102 assists in proper positioning of tissue even for a staple applying assembly 9012 of reduced diameter and correspondingly reduced rigidity. In FIGS. 203, 204, 206, 207, 209, and 215, the staple applying assembly 9012 is shown with the replaceable staple cartridge 9020 that includes the wedge sled 9126. Longitudinally aligned and parallel plurality of downwardly open wedge slots 9202 (FIG. 209) receive respective wedges 9204 integral to the wedge sled 9126. In FIGS. 209-211, the wedge sled 9126 thus cams upwardly a plurality of staple drivers 9206 that are vertically slidable within staple driver recesses 9208. In this illustrative version, each staple driver 9206 includes two vertical prongs, each translating upwardly into a respective staple hole 9210, or cavity 9024, to upwardly force out and deform a staple 9023 resting thereupon against a staple forming surface 9214 (FIG. 211) of the anvil 9022. A central firing recess 9216 (FIG. 204) defined within the staple cartridge 9020 proximate to the staple channel 9018 allows the passage of the bottom, horizontal portion 9218 (FIG. 206) of the wedge sled 9126 as well as the middle pins 9112 of the E-beam 9102. Specifically, a staple cartridge tray 9220 (FIGS. 204, 209) attaches to and underlies a polymer staple cartridge body 9222 that has the staple driver recesses 9208, staple holes 9210, and central firing recess 9216 formed therein. As staples 9023 are thus formed to either side, the sharp cutting edge 9116 enters a vertical through slot 9230 passing through the longitudinal axis of the staple cartridge 9020, excepting only a most distal end thereof.


Firing the staple applying assembly 9012 begins as depicted in FIG. 211 with the two-piece knife and firing bar 9090 proximally drawn until the downward projection 9136 cams the middle guide 9120 on the E-beam 9102 upward and aft, allowing a new staple cartridge 9020 to be inserted into the staple channel 9018 when the anvil 9022 is open as depicted in FIGS. 203 and 207. In FIG. 212, the two-piece knife and firing bar 9090 has been distally advanced a small distance, allowing the downward projection 9136 to drop into the widened hole 9130 of the lower track 9132 under the urging of the clip spring 9144 against the upward projection 9138 of the laminate tapered firing bar 9094. The middle guide 9120 prevents further downward rotation by resting upon the stepped central member 9124 of the wedge sled 9126, thus maintaining the middle pin 9112 of the E-beam within the central firing recess 9216. In FIG. 213, the two-piece knife and firing bar 9090 has been distally fired, advancing the wedge sled 9126 to cause formation of staples 9023 while severing tissue 9242 clamped between the anvil 9022 and staple cartridge 9020 with the sharp cutting edge 9116. Thereafter, in FIG. 214, the two-piece knife and firing bar 9090 is retracted, leaving the wedge sled 9126 distally positioned. In FIG. 215, the middle pin 9112 is allowed to translate down into a lockout recess 9240 formed in the staple channel 9018 (also see FIGS. 208, 211). Thus, the operator would receive a tactile indication as the middle pin 9112 encounters the distal edge of the lockout recess 9240 when the wedge sled 9126 (not shown in FIG. 215) is not proximally positioned (i.e., missing staple cartridge 9020 or spent staple cartridge 9020) Similar surgical stapling instruments are disclosed in U.S. Pat. No. 7,380,696, which issued on Jun. 3, 2008, the entire disclosure of which is incorporated by reference herein.


In various embodiments, as described above, a staple cartridge can comprise a cartridge body including a plurality of staple cavities defined therein. The cartridge body can comprise a deck and a top deck surface wherein each staple cavity can define an opening in the deck surface. As also described above, a staple can be positioned within each staple cavity such that the staples are stored within the cartridge body until they are ejected therefrom. Prior to being ejected from the cartridge body, in various embodiments, the staples can be contained with the cartridge body such that the staples do not protrude above the deck surface. As the staples are positioned below the deck surface, in such embodiments, the possibility of the staples becoming damaged and/or prematurely contacting the targeted tissue can be reduced. In various circumstances, the staples can be moved between an unfired position in which they do not protrude from the cartridge body and a fired position in which they have emerged from the cartridge body and can contact an anvil positioned opposite the staple cartridge. In various embodiments, the anvil, and/or the forming pockets defined within the anvil, can be positioned a predetermined distance above the deck surface such that, as the staples are being deployed from the cartridge body, the staples are deformed to a predetermined formed height. In some circumstances, the thickness of the tissue captured between the anvil and the staple cartridge may vary and, as a result, thicker tissue may be captured within certain staples while thinner tissue may be captured within certain other staples. In either event, the clamping pressure, or force, applied to the tissue by the staples may vary from staple to staple or vary between a staple on one end of a staple row and a staple on the other end of the staple row, for example. In certain circumstances, the gap between the anvil and the staple cartridge deck can be controlled such that the staples apply a certain minimum clamping pressure within each staple. In some such circumstances, however, significant variation of the clamping pressure within different staples may still exist.


In various embodiments described herein, a staple cartridge can comprise means for compensating for the thickness of the tissue captured within the staples deployed from the staple cartridge. In various embodiments, referring to FIG. 216, a staple cartridge, such as staple cartridge 10000, for example, can include a rigid first portion, such as support portion 10010, for example, and a compressible second portion, such as tissue thickness compensator 10020, for example. In at least one embodiment, referring primarily to FIG. 218, the support portion 10010 can comprise a cartridge body, a top deck surface 10011, and a plurality of staple cavities 10012 wherein, similar to the above, each staple cavity 10012 can define an opening in the deck surface 10011. A staple 10030, for example, can be removably positioned in each staple cavity 10012. In at least one such embodiment, referring primarily to FIG. 245 and as described in greater detail below, each staple 10030 can comprise a base 10031 and one or more legs 10032 extending from the base 10031. Prior to the staples 10030 being deployed, as also described in greater detail below, the bases 10031 of the staples 10030 can be supported by staple drivers positioned within the support portion 10010 and, concurrently, the legs 10032 of the staples 10030 can be at least partially contained within the staple cavities 10012. In various embodiments, the staples 10030 can be deployed between an unfired position and a fired position such that the legs 10032 move through the tissue thickness compensator 10020, penetrate through a top surface of the tissue thickness compensator 10020, penetrate the tissue T, and contact an anvil positioned opposite the staple cartridge 10000. As the legs 10032 are deformed against the anvil, the legs 10032 of each staple 10030 can capture a portion of the tissue thickness compensator 10020 and a portion of the tissue T within each staple 10030 and apply a compressive force to the tissue. Further to the above, the legs 10032 of each staple 10030 can be deformed downwardly toward the base 10031 of the staple to form a staple entrapment area 10039 in which the tissue T and the tissue thickness compensator 10020 can be captured. In various circumstances, the staple entrapment area 10039 can be defined between the inner surfaces of the deformed legs 10032 and the inner surface of the base 10031. The size of the entrapment area for a staple can depend on several factors such as the length of the legs, the diameter of the legs, the width of the base, and/or the extent in which the legs are deformed, for example.


In previous embodiments, a surgeon was often required to select the appropriate staples having the appropriate staple height for the tissue being stapled. For example, a surgeon could select tall staples for use with thick tissue and short staples for use with thin tissue. In some circumstances, however, the tissue being stapled did not have a consistent thickness and, thus, some staples were unable to achieve the desired fired configuration. For example, FIG. 250 illustrates a tall staple used in thin tissue. Referring now to FIG. 251, when a tissue thickness compensator, such as tissue thickness compensator 10020, for example, is used with thin tissue, for example, the larger staple may be formed to a desired fired configuration.


Owing to the compressibility of the tissue thickness compensator, the tissue thickness compensator can compensate for the thickness of the tissue captured within each staple. More particularly, referring now to FIGS. 245 and 246, a tissue thickness compensator, such as tissue thickness compensator 10020, for example, can consume larger and/or smaller portions of the staple entrapment area 10039 of each staple 10030 depending on the thickness and/or type of tissue contained within the staple entrapment area 10039. For example, if thinner tissue T is captured within a staple 10030, the tissue thickness compensator 10020 can consume a larger portion of the staple entrapment area 10039 as compared to circumstances where thicker tissue T is captured within the staple 10030. Correspondingly, if thicker tissue T is captured within a staple 10030, the tissue thickness compensator 10020 can consume a smaller portion of the staple entrapment area 10039 as compared to the circumstances where thinner tissue T is captured within the staple 10030. In this way, the tissue thickness compensator can compensate for thinner tissue and/or thicker tissue and assure that a compressive pressure is applied to the tissue irrespective, or at least substantially irrespective, of the tissue thickness captured within the staples. In addition to the above, the tissue thickness compensator 10020 can compensate for different types, or compressibilities, of tissues captured within different staples 10030. Referring now to FIG. 246, the tissue thickness compensator 10020 can apply a compressive force to vascular tissue T which can include vessels V and, as a result, restrict the flow of blood through the less compressible vessels V while still applying a desired compressive pressure to the surrounding tissue T. In various circumstances, further to the above, the tissue thickness compensator 10020 can also compensate for malformed staples. Referring to FIG. 247, the malformation of various staples 10030 can result in larger staple entrapment areas 10039 being defined within such staples. Owing to the resiliency of the tissue thickness compensator 10020, referring now to FIG. 248, the tissue thickness compensator 10020 positioned within malformed staples 10030 may still apply a sufficient compressive pressure to the tissue T even though the staple entrapment areas 10039 defined within such malformed staples 10030 may be enlarged. In various circumstances, the tissue thickness compensator 10020 located intermediate adjacent staples 10030 can be biased against the tissue T by properly-formed staples 10030 surrounding a malformed staple 10030 and, as a result, apply a compressive pressure to the tissue surrounding and/or captured within the malformed staple 10030, for example. In various circumstances, a tissue thickness compensator can compensate for different tissue densities which can arise due to calcifications, fibrous areas, and/or tissue that has been previously stapled or treated, for example.


In various embodiments, a fixed, or unchangeable, tissue gap can be defined between the support portion and the anvil and, as a result, the staples may be deformed to a predetermined height regardless of the thickness of the tissue captured within the staples. When a tissue thickness compensator is used with these embodiments, the tissue thickness compensator can adapt to the tissue captured between the anvil and the support portion staple cartridge and, owing to the resiliency of the tissue thickness compensator, the tissue thickness compensator can apply an additional compressive pressure to the tissue. Referring now to FIGS. 252-257, a staple 10030 has been formed to a predefined height H. With regard to FIG. 252, a tissue thickness compensator has not been utilized and the tissue T consumes the entirety of the staple entrapment area 10039. With regard to FIG. 259, a portion of a tissue thickness compensator 10020 has been captured within the staple 10030, compressed the tissue T, and consumed at least a portion of the staple entrapment area 10039. Referring now to FIG. 254, thin tissue T has been captured within the staple 10030. In this embodiment, the compressed tissue T has a height of approximately 2/9H and the compressed tissue thickness compensator 10020 has a height of approximately 7/9H, for example. Referring now to FIG. 255, tissue T having an intermediate thickness has been captured within the staple 10030. In this embodiment, the compressed tissue T has a height of approximately 4/9H and the compressed tissue thickness compensator 10020 has a height of approximately 5/9H, for example. Referring now to FIG. 256, tissue T having an intermediate thickness has been captured within the staple 10030. In this embodiment, the compressed tissue T has a height of approximately ⅔H and the compressed tissue thickness compensator 10020 has a height of approximately ⅓H, for example. Referring now to FIG. 255, thick tissue T has been captured within the staple 10030. In this embodiment, the compressed tissue T has a height of approximately 8/9H and the compressed tissue thickness compensator 10020 has a height of approximately 1/9H, for example. In various circumstances, the tissue thickness compensator can comprise a compressed height which comprises approximately 10% of the staple entrapment height, approximately 20% of the staple entrapment height, approximately 30% of the staple entrapment height, approximately 40% of the staple entrapment height, approximately 50% of the staple entrapment height, approximately 60% of the staple entrapment height, approximately 70% of the staple entrapment height, approximately 80% of the staple entrapment height, and/or approximately 90% of the staple entrapment height, for example.


In various embodiments, the staples 10030 can comprise any suitable unformed height. In certain embodiments, the staples 10030 can comprise an unformed height between approximately 2 mm and approximately 4.8 mm, for example. The staples 10030 can comprise an unformed height of approximately 2.0 mm, approximately 2.5 mm, approximately 3.0 mm, approximately 3.4 mm, approximately 3.5 mm, approximately 3.8 mm, approximately 4.0 mm, approximately 4.1 mm, and/or approximately 4.8 mm, for example. In various embodiments, the height H to which the staples can be deformed can be dictated by the distance between the deck surface 10011 of the support portion 10010 and the opposing anvil. In at least one embodiment, the distance between the deck surface 10011 and the tissue-contacting surface of the anvil can be approximately 0.097″, for example. The height H can also be dictated by the depth of the forming pockets defined within the anvil. In at least one embodiment, the forming pockets can have a depth measured from the tissue-contacting surface, for example. In various embodiments, as described in greater detail below, the staple cartridge 10000 can further comprise staple drivers which can lift the staples 10030 toward the anvil and, in at least one embodiment, lift, or “overdrive”, the staples above the deck surface 10011. In such embodiments, the height H to which the staples 10030 are formed can also be dictated by the distance in which the staples 10030 are overdriven. In at least one such embodiment, the staples 10030 can be overdriven by approximately 0.028″, for example, and can result in the staples 10030 being formed to a height of approximately 0.189″, for example. In various embodiments, the staples 10030 can be formed to a height of approximately 0.8 mm, approximately 1.0 mm, approximately 1.5 mm, approximately 1.8 mm, approximately 2.0 mm, and/or approximately 2.25 mm, for example. In certain embodiments, the staples can be formed to a height between approximately 2.25 mm and approximately 3.0 mm, for example. Further to the above, the height of the staple entrapment area of a staple can be determined by the formed height of the staple and the width, or diameter, of the wire comprising the staple. In various embodiments, the height of the staple entrapment area 10039 of a staple 10030 can comprise the formed height H of the staple less two diameter widths of the wire. In certain embodiments, the staple wire can comprise a diameter of approximately 0.0089″, for example. In various embodiments, the staple wire can comprise a diameter between approximately 0.0069″ and approximately 0.0119″, for example. In at least one exemplary embodiment, the formed height H of a staple 10030 can be approximately 0.189″ and the staple wire diameter can be approximately 0.0089″ resulting in a staple entrapment height of approximately 0.171″, for example.


In various embodiments, further to the above, the tissue thickness compensator can comprise an uncompressed, or pre-deployed, height and can be configured to deform to one of a plurality of compressed heights. In certain embodiments, the tissue thickness compensator can comprise an uncompressed height of approximately 0.125″, for example. In various embodiments, the tissue thickness compensator can comprise an uncompressed height of greater than or equal to approximately 0.080″, for example. In at least one embodiment, the tissue thickness compensator can comprise an uncompressed, or pre-deployed, height which is greater than the unfired height of the staples. In at least one embodiment, the uncompressed, or pre-deployed, height of the tissue thickness compensator can be approximately 10% taller, approximately 20% taller, approximately 30% taller, approximately 40% taller, approximately 50% taller, approximately 60% taller, approximately 70% taller, approximately 80% taller, approximately 90% taller, and/or approximately 100% taller than the unfired height of the staples, for example. In at least one embodiment, the uncompressed, or pre-deployed, height of the tissue thickness compensator can be up to approximately 100% taller than the unfired height of the staples, for example. In certain embodiments, the uncompressed, or pre-deployed, height of the tissue thickness compensator can be over 100% taller than the unfired height of the staples, for example. In at least one embodiment, the tissue thickness compensator can comprise an uncompressed height which is equal to the unfired height of the staples. In at least one embodiment, the tissue thickness compensator can comprise an uncompressed height which is less than the unfired height of the staples. In at least one embodiment, the uncompressed, or pre-deployed, height of the thickness compensator can be approximately 10% shorter, approximately 20% shorter, approximately 30% shorter, approximately 40% shorter, approximately 50% shorter, approximately 60% shorter, approximately 70% shorter, approximately 80% shorter, and/or approximately 90% shorter than the unfired height of the staples, for example. In various embodiments, the compressible second portion can comprise an uncompressed height which is taller than an uncompressed height of the tissue T being stapled. In certain embodiments, the tissue thickness compensator can comprise an uncompressed height which is equal to an uncompressed height of the tissue T being stapled. In various embodiments, the tissue thickness compensator can comprise an uncompressed height which is shorter than an uncompressed height of the tissue T being stapled.


As described above, a tissue thickness compensator can be compressed within a plurality of formed staples regardless of whether thick tissue or thin tissue is captured within the staples. In at least one exemplary embodiment, the staples within a staple line, or row, can be deformed such that the staple entrapment area of each staple comprises a height of approximately 2.0 mm, for example, wherein the tissue T and the tissue thickness compensator can be compressed within this height. In certain circumstances, the tissue T can comprise a compressed height of approximately 1.75 mm within the staple entrapment area while the tissue thickness compensator can comprise a compressed height of approximately 0.25 mm within the staple entrapment area, thereby totaling the approximately 2.0 mm staple entrapment area height, for example. In certain circumstances, the tissue T can comprise a compressed height of approximately 1.50 mm within the staple entrapment area while the tissue thickness compensator can comprise a compressed height of approximately 0.50 mm within the staple entrapment area, thereby totaling the approximately 2.0 mm staple entrapment area height, for example. In certain circumstances, the tissue T can comprise a compressed height of approximately 1.25 mm within the staple entrapment area while the tissue thickness compensator can comprise a compressed height of approximately 0.75 mm within the staple entrapment area, thereby totaling the approximately 2.0 mm staple entrapment area height, for example. In certain circumstances, the tissue T can comprise a compressed height of approximately 1.0 mm within the staple entrapment area while the tissue thickness compensator can comprise a compressed height of approximately 1.0 mm within the staple entrapment area, thereby totaling the approximately 2.0 mm staple entrapment area height, for example. In certain circumstances, the tissue T can comprise a compressed height of approximately 0.75 mm within the staple entrapment area while the tissue thickness compensator can comprise a compressed height of approximately 1.25 mm within the staple entrapment area, thereby totaling the approximately 2.0 mm staple entrapment area height, for example. In certain circumstances, the tissue T can comprise a compressed height of approximately 1.50 mm within the staple entrapment area while the tissue thickness compensator can comprise a compressed height of approximately 0.50 mm within the staple entrapment area, thereby totaling the approximately 2.0 mm staple entrapment area height, for example. In certain circumstances, the tissue T can comprise a compressed height of approximately 0.25 mm within the staple entrapment area while the tissue thickness compensator can comprise a compressed height of approximately 1.75 mm within the staple entrapment area, thereby totaling the approximately 2.0 mm staple entrapment area height, for example.


In various embodiments, further to the above, the tissue thickness compensator can comprise an uncompressed height which is less than the fired height of the staples. In certain embodiments, the tissue thickness compensator can comprise an uncompressed height which is equal to the fired height of the staples. In certain other embodiments, the tissue thickness compensator can comprise an uncompressed height which is taller than the fired height of the staples. In at least one such embodiment, the uncompressed height of a tissue thickness compensator can comprise a thickness which is approximately 110% of the formed staple height, approximately 120% of the formed staple height, approximately 130% of the formed staple height, approximately 140% of the formed staple height, approximately 150% of the formed staple height, approximately 160% of the formed staple height, approximately 170% of the formed staple height, approximately 180% of the formed staple height, approximately 190% of the formed staple height, and/or approximately 200% of the formed staple height, for example. In certain embodiments, the tissue thickness compensator can comprise an uncompressed height which is more than twice the fired height of the staples. In various embodiments, the tissue thickness compensator can comprise a compressed height which is from approximately 85% to approximately 150% of the formed staple height, for example. In various embodiments, as described above, the tissue thickness compensator can be compressed between an uncompressed thickness and a compressed thickness. In certain embodiments, the compressed thickness of a tissue thickness compensator can be approximately 10% of its uncompressed thickness, approximately 20% of its uncompressed thickness, approximately 30% of its uncompressed thickness, approximately 40% of its uncompressed thickness, approximately 50% of its uncompressed thickness, approximately 60% of its uncompressed thickness, approximately 70% of its uncompressed thickness, approximately 80% of its uncompressed thickness, and/or approximately 90% of its uncompressed thickness, for example. In various embodiments, the uncompressed thickness of the tissue thickness compensator can be approximately two times, approximately ten times, approximately fifty times, and/or approximately one hundred times thicker than its compressed thickness, for example. In at least one embodiment, the compressed thickness of the tissue thickness compensator can be between approximately 60% and approximately 99% of its uncompressed thickness. In at least one embodiment, the uncompressed thickness of the tissue thickness compensator can be at least 50% thicker than its compressed thickness. In at least one embodiment, the uncompressed thickness of the tissue thickness compensator can be up to one hundred times thicker than its compressed thickness. In various embodiments, the compressible second portion can be elastic, or at least partially elastic, and can bias the tissue T against the deformed legs of the staples. In at least one such embodiment, the compressible second portion can resiliently expand between the tissue T and the base of the staple in order to push the tissue T against the legs of the staple. In certain embodiments, discussed in further detail below, the tissue thickness compensator can be positioned intermediate the tissue T and the deformed staple legs. In various circumstances, as a result of the above, the tissue thickness compensator can be configured to consume any gaps within the staple entrapment area.


In various embodiments, the tissue thickness compensator may comprise a polymeric composition. The polymeric composition may comprise one or more synthetic polymer and/or one or more non-synthetic polymer. The synthetic polymer may comprise a synthetic absorbable polymer and/or a synthetic non-absorbable polymer. In various embodiments, the polymeric composition may comprise a biocompatible foam, for example. The biocompatible foam may comprise a porous, open cell foam and/or a porous, closed cell foam, for example. The biocompatible foam can have a uniform pore morphology or may have a gradient pore morphology (i.e. small pores gradually increasing in size to large pores across the thickness of the foam in one direction). In various embodiments, the polymeric composition may comprise one or more of a porous scaffold, a porous matrix, a gel matrix, a hydrogel matrix, a solution matrix, a filamentous matrix, a tubular matrix, a composite matrix, a membranous matrix, a biostable polymer, and a biodegradable polymer, and combinations thereof. For example, the tissue thickness compensator may comprise a foam reinforced by a filamentous matrix or may comprise a foam having an additional hydrogel layer that expands in the presence of bodily fluids to further provide the compression on the tissue. In various embodiments, a tissue thickness compensator could also be comprised of a coating on a material and/or a second or third layer that expands in the presence of bodily fluids to further provide the compression on the tissue. Such a layer could be a hydrogel that could be a synthetic and/or naturally derived material and could be either biodurable and/or biodegradable, for example. In certain embodiments, a tissue thickness compensator could be reinforced with fibrous non-woven materials or fibrous mesh type elements, for example, that can provide additional flexibility, stiffness, and/or strength. In various embodiments, a tissue thickness compensator that has a porous morphology which exhibits a gradient structure such as, for example, small pores on one surface and larger pores on the other surface. Such morphology could be more optimal for tissue in-growth or hemostatic behavior. Further, the gradient could be also compositional with a varying bio-absorption profile. A short term absorption profile may be preferred to address hemostasis while a long term absorption profile may address better tissue healing without leakages.


Examples of non-synthetic polymers include, but are not limited to, lyophilized polysaccharide, glycoprotein, elastin, proteoglycan, gelatin, collagen, and oxidized regenerated cellulose (ORC). Examples of synthetic absorbable polymers include, but are not limited to, poly(lactic acid) (PLA), poly(L-lactic acid) (PLLA), polycaprolactone (PCL), polyglycolic acid (PGA), poly(trimethylene carbonate) (TMC), polyethylene terephthalate (PET), polyhydroxyalkanoate (PHA), a copolymer of glycolide and ε-caprolactone (PGCL), a copolymer of glycolide and -trimethylene carbonate, poly(glycerol sebacate) (PGS), polydioxanone, poly(orthoesters), polyanhydrides, polysaccharides, poly(ester-amides), tyrosine-based polyarylates, tyrosine-based polyiminocarbonates, tyrosine-based polycarbonates, poly(D,L-lactide-urethane), poly(B-hydroxybutyrate), poly(E-caprolactone), polyethyleneglycol (PEG), poly [bis(carboxylatophenoxy) phosphazene], poly(amino acids), pseudo-poly(amino acids), absorbable polyurethanes, and combinations thereof. In various embodiments, the polymeric composition may comprise from approximately 50% to approximately 90% by weight of the polymeric composition of PLLA and approximately 50% to approximately 10% by weight of the polymeric composition of PCL, for example. In at least one embodiment, the polymeric composition may comprise approximately 70% by weight of PLLA and approximately 30% by weight of PCL, for example. In various embodiments, the polymeric composition may comprise from approximately 55% to approximately 85% by weight of the polymeric composition of PGA and 15% to 45% by weight of the polymeric composition of PCL, for example. In at least one embodiment, the polymeric composition may comprise approximately 65% by weight of PGA and approximately 35% by weight of PCL, for example. In various embodiments, the polymeric composition may comprise from approximately 90% to approximately 95% by weight of the polymeric composition of PGA and approximately 5% to approximately 10% by weight of the polymeric composition of PLA, for example.


In various embodiments, the synthetic absorbable polymer may comprise a bioabsorbable, biocompatible, bioimplantible, elastomeric copolymer. Suitable bioabsorbable, biocompatible elastomeric copolymers include but are not limited to copolymers of epsilon-caprolactone and glycolide (preferably having a mole ratio of epsilon-caprolactone to glycolide of from about 30:70 to about 70:30, preferably 35:65 to about 65:35, and more preferably 45:55 to 35:65); elastomeric copolymers of epsilon-caprolactone and lactide, including L-lactide, D-lactide blends thereof or lactic acid copolymers (preferably having a mole ratio of epsilon-caprolactone to lactide of from about 35:65 to about 65:35 and more preferably 45:55 to 30:70) elastomeric copolymers of p-dioxanone (1,4-dioxan-2-one) and lactide including L-lactide, D-lactide and lactic acid (preferably having a mole ratio of p-dioxanone to lactide of from about 40:60 to about 60:40); elastomeric copolymers of epsilon-caprolactone and p-dioxanone (preferably having a mole ratio of epsilon-caprolactone to p-dioxanone of from about 30:70 to about 70:30); elastomeric copolymers of p-dioxanone and trimethylene carbonate (preferably having a mole ratio of p-dioxanone to trimethylene carbonate of from about 30:70 to about 70:30); elastomeric copolymers of trimethylene carbonate and glycolide (preferably having a mole ratio of trimethylene carbonate to glycolide of from about 30:70 to about 70:30); elastomeric copolymer of trimethylene carbonate and lactide including L-lactide, D-lactide, blends thereof or lactic acid copolymers (preferably having a mole ratio of trimethylene carbonate to lactide of from about 30:70 to about 70:30) and blends thereof. In one embodiment, the elastomeric copolymer is a copolymer of glycolide and epsilon-caprolactone. In another embodiment, the elastomeric copolymer is a copolymer of lactide and epsilon-caprolactone.


The disclosures of U.S. Pat. No. 5,468,253, entitled ELASTOMERIC MEDICAL DEVICE, which issued on Nov. 21, 1995, and U.S. Pat. No. 6,325,810, entitled FOAM BUTTRESS FOR STAPLING APPARATUS, which issued on Dec. 4, 2001, are hereby incorporated by reference in their respective entireties.


In various embodiments, the synthetic absorbable polymer may comprise one or more of 90/10 poly(glycolide-L-lactide) copolymer, commercially available from Ethicon, Inc. under the trade designation VICRYL (polyglactic 910), polyglycolide, commercially available from American Cyanamid Co. under the trade designation DEXON, polydioxanone, commercially available from Ethicon, Inc. under the trade designation PDS, poly(glycolide-trimethylene carbonate) random block copolymer, commercially available from American Cyanamid Co. under the trade designation MAXON, 75/25 poly(glycolide-E-caprolactone-poliglecaprolactone 25) copolymer, commercially available from Ethicon under the trade designation MONOCRYL, for example.


Examples of synthetic non-absorbable polymers include, but are not limited to, foamed polyurethane, polypropylene (PP), polyethylene (PE), polycarbonate, polyamides, such as nylon, polyvinylchloride (PVC), polymethylmetacrylate (PMMA), polystyrene (PS), polyester, polyetheretherketone (PEEK), polytetrafluoroethylene (PTFE), polytrifluorochloroethylene (PTFCE), polyvinylfluoride (PVF), fluorinated ethylene propylene (FEP), polyacetal, polysulfone, and combinations thereof. The synthetic non-absorbable polymers may include, but are not limited to, foamed elastomers and porous elastomers, such as, for example, silicone, polyisoprene, and rubber. In various embodiments, the synthetic polymers may comprise expanded polytetrafluoroethylene (ePTFE), commercially available from W. L. Gore & Associates, Inc. under the trade designation GORE-TEX Soft Tissue Patch and co-polyetherester urethane foam commercially available from Polyganics under the trade designation NASOPORE.


The polymeric composition of a tissue thickness compensator may be characterized by percent porosity, pore size, and/or hardness, for example. In various embodiments, the polymeric composition may have a percent porosity from approximately 30% by volume to approximately 99% by volume, for example. In certain embodiments, the polymeric composition may have a percent porosity from approximately 60% by volume to approximately 98% by volume, for example. In various embodiments, the polymeric composition may have a percent porosity from approximately 85% by volume to approximately 97% by volume, for example. In at least one embodiment, the polymeric composition may comprise approximately 70% by weight of PLLA and approximately 30% by weight of PCL, for example, and can comprise approximately 90% porosity by volume, for example. In at least one such embodiment, as a result, the polymeric composition would comprise approximately 10% copolymer by volume. In at least one embodiment, the polymeric composition may comprise approximately 65% by weight of PGA and approximately 35% by weight of PCL, for example, and can have a percent porosity from approximately 93% by volume to approximately 95% by volume, for example. In various embodiments, the polymeric composition may comprise a greater than 85% porosity by volume. The polymeric composition may have a pore size from approximately 5 micrometers to approximately 2000 micrometers, for example. In various embodiments, the polymeric composition may have a pore size between approximately 10 micrometers to approximately 100 micrometers, for example. In at least one such embodiment, the polymeric composition can comprise a copolymer of PGA and PCL, for example. In certain embodiments, the polymeric composition may have a pore size between approximately 100 micrometers to approximately 1000 micrometers, for example. In at least one such embodiment, the polymeric composition can comprise a copolymer of PLLA and PCL, for example. According to certain aspects, the hardness of a polymeric composition may be expressed in terms of the Shore Hardness, which can defined as the resistance to permanent indentation of a material as determined with a durometer, such as a Shore Durometer. In order to assess the durometer value for a given material, a pressure is applied to the material with a durometer indenter foot in accordance with ASTM procedure D2240-00, entitled, “Standard Test Method for Rubber Property-Durometer Hardness”, the entirety of which is incorporated herein by reference. The durometer indenter foot may be applied to the material for a sufficient period of time, such as 15 seconds, for example, wherein a reading is then taken from the appropriate scale. Depending on the type of scale being used, a reading of 0 can be obtained when the indenter foot completely penetrates the material, and a reading of 100 can be obtained when no penetration into the material occurs. This reading is dimensionless. In various embodiments, the durometer may be determined in accordance with any suitable scale, such as Type A and/or Type OO scales, for example, in accordance with ASTM D2240-00. In various embodiments, the polymeric composition of a tissue thickness compensator may have a Shore A hardness value from approximately 4 A to approximately 16 A, for example, which is approximately 45 OO to approximately 65 OO on the Shore OO range. In at least one such embodiment, the polymeric composition can comprise a PLLA/PCL copolymer or a PGA/PCL copolymer, for example. In various embodiments, the polymeric composition of a tissue thickness compensator may have a Shore A Hardness value of less than 15 A. In various embodiments, the polymeric composition of a tissue thickness compensator may have a Shore A Hardness value of less than 10 A. In various embodiments, the polymeric composition of a tissue thickness compensator may have a Shore A Hardness value of less than 5 A. In certain embodiments, the polymeric material may have a Shore OO composition value from approximately 35 OO to approximately 75 OO, for example.


In various embodiments, the polymeric composition may have at least two of the above-identified properties. In various embodiments, the polymeric composition may have at least three of the above-identified properties. The polymeric composition may have a porosity from 85% to 97% by volume, a pore size from 5 micrometers to 2000 micrometers, and a Shore A hardness value from 4 A to 16 A and Shore OO hardness value from 45 OO to 65 OO, for example. In at least one embodiment, the polymeric composition may comprise 70% by weight of the polymeric composition of PLLA and 30% by weight of the polymeric composition of PCL having a porosity of 90% by volume, a pore size from 100 micrometers to 1000 micrometers, and a Shore A hardness value from 4 A to 16 A and Shore OO hardness value from 45 OO to 65 OO, for example. In at least one embodiment, the polymeric composition may comprise 65% by weight of the polymeric composition of PGA and 35% by weight of the polymeric composition of PCL having a porosity from 93% to 95% by volume, a pore size from 10 micrometers to 100 micrometers, and a Shore A hardness value from 4 A to 16 A and Shore OO hardness value from 45 OO to 65 OO, for example.


In various embodiments, the polymeric composition may comprise a pharmaceutically active agent. The polymeric composition may release a therapeutically effective amount of the pharmaceutically active agent. In various embodiments, the pharmaceutically active agent may be released as the polymeric composition is desorbed/absorbed. In various embodiments, the pharmaceutically active agent may be released into fluid, such as, for example, blood, passing over or through the polymeric composition. Examples of pharmaceutically active agents may include, but are not limited to, hemostatic agents and drugs, such as, for example, fibrin, thrombin, and oxidized regenerated cellulose (ORC); anti-inflammatory drugs, such as, for example, diclofenac, aspirin, naproxen, sulindac, and hydrocortisone; antibiotic and antimicrobial drug or agents, such as, for example, triclosan, ionic silver, ampicillin, gentamicin, polymyxin B, chloramphenicol; and anticancer agents, such as, for example, cisplatin, mitomycin, adriamycin.


In various embodiments, referring now to FIG. 216, a staple cartridge, such as staple cartridge 10000, for example, can comprise a support portion 10010 and a compressible tissue thickness compensator 10020. Referring now to FIGS. 218-220, the support portion 10010 can comprise a deck surface 10011 and a plurality of staple cavities 10012 defined within the support portion 10010. Each staple cavity 10012 can be sized and configured to removably store a staple, such as a staple 10030, for example, therein. The staple cartridge 10000 can further comprise a plurality of staple drivers 10040 which can each be configured to support one or more staples 10030 within the staple cavities 10012 when the staples 10030 and the staple drivers 10040 are in their unfired positions. In at least one such embodiment, referring primarily to FIGS. 224 and 225, each staple driver 10040 can comprise one or more cradles, or troughs, 10041, for example, which can be configured to support the staples and limit relative movement between the staples 10030 and the staple drivers 10040. In various embodiments, referring again to FIG. 218, the staple cartridge 10000 can further comprise a staple-firing sled 10050 which can be moved from a proximal end 10001 to a distal end 10002 of the staple cartridge in order to sequentially lift the staple drivers 10040 and the staples 10030 from their unfired positions toward an anvil positioned opposite the staple cartridge 10000. In certain embodiments, referring primarily to FIGS. 218 and 220, each staple 10030 can comprise a base 10031 and one or more legs 10032 extending from the base 10031 wherein each staple can be at least one of substantially U-shaped and substantially V-shaped, for example. In at least one embodiment, the staples 10030 can be configured such that the tips of the staple legs 10032 are recessed with respect to the deck surface 10011 of the support portion 10010 when the staples 10030 are in their unfired positions. In at least one embodiment, the staples 10030 can be configured such that the tips of the staple legs 10032 are flush with respect to the deck surface 10011 of the support portion 10010 when the staples 10030 are in their unfired positions. In at least one embodiment, the staples 10030 can be configured such that the tips of the staple legs 10032, or at least some portion of the staple legs 10032, extend above the deck surface 10011 of the support portion 10010 when the staples 10030 are in their unfired positions. In such embodiments, the staple legs 10032 can extend into and can be embedded within the tissue thickness compensator 10020 when the staples 10030 are in their unfired positions. In at least one such embodiment, the staple legs 10032 can extend above the deck surface 10011 by approximately 0.075″, for example. In various embodiments, the staple legs 10032 can extend above the deck surface 10011 by a distance between approximately 0.025″ and approximately 0.125″, for example. In certain embodiments, further to the above, the tissue thickness compensator 10020 can comprise an uncompressed thickness between approximately 0.08″ and approximately 0.125″, for example.


In use, further to the above and referring primarily to FIG. 233, an anvil, such as anvil, 10060, for example, can be moved into a closed position opposite the staple cartridge 10000. As described in greater detail below, the anvil 10060 can position tissue against the tissue thickness compensator 10020 and, in various embodiments, compress the tissue thickness compensator 10020 against the deck surface 10011 of the support portion 10010, for example. Once the anvil 10060 has been suitably positioned, the staples 10030 can be deployed, as also illustrated in FIG. 233. In various embodiments, as mentioned above, the staple-firing sled 10050 can be moved from the proximal end 10001 of the staple cartridge 10000 toward the distal end 10002, as illustrated in FIG. 234. As the sled 10050 is advanced, the sled 10050 can contact the staple drivers 10040 and lift the staple drivers 10040 upwardly within the staple cavities 10012. In at least one embodiment, the sled 10050 and the staple drivers 10040 can each comprise one or more ramps, or inclined surfaces, which can co-operate to move the staple drivers 10040 upwardly from their unfired positions. In at least one such embodiment, referring to FIGS. 221-225, each staple driver 10040 can comprise at least one inclined surface 10042 and the sled 10050 can comprise one or more inclined surfaces 10052 which can be configured such that the inclined surfaces 10052 can slide under the inclined surface 10042 as the sled 10050 is advanced distally within the staple cartridge. As the staple drivers 10040 are lifted upwardly within their respective staple cavities 10012, the staple drivers 10040 can lift the staples 10030 upwardly such that the staples 10030 can emerge from their staple cavities 10012 through openings in the staple deck 10011. During an exemplary firing sequence, referring primarily to FIGS. 227-229, the sled 10050 can first contact staple 10030a and begin to lift the staple 10030a upwardly. As the sled 10050 is advanced further distally, the sled 10050 can begin to lift staples 10030b, 10030c, 10030d, 10030e, and 10030f, and any other subsequent staples, in a sequential order. As illustrated in FIG. 229, the sled 10050 can drive the staples 10030 upwardly such that the legs 10032 of the staples contact the opposing anvil, are deformed to a desired shape, and ejected therefrom the support portion 10010. In various circumstances, the sled 10030 can move several staples upwardly at the same time as part of a firing sequence. With regard to the firing sequence illustrated in FIG. 229, the staples 10030a and 10030b have been moved into their fully fired positions and ejected from the support portion 10010, the staples 10030c and 10030d are in the process of being fired and are at least partially contained within the support portion 10010, and the staples 10030e and 10030f are still in their unfired positions.


As discussed above, and referring to FIG. 235, the staple legs 10032 of the staples 10030 can extend above the deck surface 10011 of the support portion 10010 when the staples 10030 are in their unfired positions. With further regard to this firing sequence illustrated in FIG. 229, the staples 10030e and 10030f are illustrated in their unfired position and their staple legs 10032 extend above the deck surface 10011 and into the tissue thickness compensator 10020. In various embodiments, the tips of the staple legs 10032, or any other portion of the staple legs 10032, may not protrude through a top tissue-contacting surface 10021 of the tissue thickness compensator 10020 when the staples 10030 are in their unfired positions. As the staples 10030 are moved from their unfired positions to their fired positions, as illustrated in FIG. 229, the tips of the staple legs can protrude through the tissue-contacting surface 10032. In various embodiments, the tips of the staple legs 10032 can comprise sharp tips which can incise and penetrate the tissue thickness compensator 10020. In certain embodiments, the tissue thickness compensator 10020 can comprise a plurality of apertures which can be configured to receive the staple legs 10032 and allow the staple legs 10032 to slide relative to the tissue thickness compensator 10020. In certain embodiments, the support portion 10010 can further comprise a plurality of guides 10013 extending from the deck surface 10011. The guides 10013 can be positioned adjacent to the staple cavity openings in the deck surface 10011 such that the staple legs 10032 can be at least partially supported by the guides 10013. In certain embodiments, a guide 10013 can be positioned at a proximal end and/or a distal end of a staple cavity opening. In various embodiments, a first guide 10013 can be positioned at a first end of each staple cavity opening and a second guide 10013 can be positioned at a second end of each staple cavity opening such that each first guide 10013 can support a first staple leg 10032 of a staple 10030 and each second guide 10013 can support a second staple leg 10032 of the staple. In at least one embodiment, referring to FIG. 235, each guide 10013 can comprise a groove or slot, such as groove 10016, for example, within which a staple leg 10032 can be slidably received. In various embodiments, each guide 10013 can comprise a cleat, protrusion, and/or spike that can extend from the deck surface 10011 and can extend into the tissue thickness compensator 10020. In at least one embodiment, as discussed in greater detail below, the cleats, protrusions, and/or spikes can reduce relative movement between the tissue thickness compensator 10020 and the support portion 10010. In certain embodiments, the tips of the staple legs 10032 may be positioned within the guides 10013 and may not extend above the top surfaces of the guides 10013 when the staples 10030 are in their unfired position. In at least such embodiment, the guides 10013 can define a guide height and the staples 10030 may not extend above this guide height when they are in their unfired position.


In various embodiments, a tissue thickness compensator, such as tissue thickness compensator 10020, for example, can be comprised of a single sheet of material. In at least one embodiment, a tissue thickness compensator can comprise a continuous sheet of material which can cover the entire top deck surface 10011 of the support portion 10010 or, alternatively, cover less than the entire deck surface 10011. In certain embodiments, the sheet of material can cover the staple cavity openings in the support portion 10010 while, in other embodiments, the sheet of material can comprise openings which can be aligned, or at least partially aligned, with the staple cavity openings. In various embodiments, a tissue thickness compensator can be comprised of multiple layers of material. In some embodiments, referring now to FIG. 217, a tissue thickness compensator can comprise a compressible core and a wrap surrounding the compressible core. In certain embodiments, a wrap 10022 can be configured to releasably hold the compressible core to the support portion 10010. In at least one such embodiment, the support portion 10010 can comprise one or more projections, such as projections 10014 (FIG. 220), for example, extending therefrom which can be received within one or more apertures and/or slots, such as apertures 10024, for example, defined in the wrap 10022. The projections 10014 and the apertures 10024 can be configured such that the projections 10014 can retain the wrap 10022 to the support portion 10010. In at least one embodiment, the ends of the projections 10014 can be deformed, such as by a heat-stake process, for example, in order to enlarge the ends of the projections 10014 and, as a result, limit the relative movement between the wrap 10022 and the support portion 10010. In at least one embodiment, the wrap 10022 can comprise one or more perforations 10025 which can facilitate the release of the wrap 10022 from the support portion 10010, as illustrated in FIG. 217. Referring now to FIG. 226, a tissue thickness compensator can comprise a wrap 10222 including a plurality of apertures 10223, wherein the apertures 10223 can be aligned, or at least partially aligned, with the staple cavity openings in the support portion 10010. In certain embodiments, the core of the tissue thickness compensator can also comprise apertures which are aligned, or at least partially aligned, with the apertures 10223 in the wrap 10222. In other embodiments, the core of the tissue thickness compensator can comprise a continuous body and can extend underneath the apertures 10223 such that the continuous body covers the staple cavity openings in the deck surface 10011.


In various embodiments, as described above, a tissue thickness compensator can comprise a wrap for releasably holding a compressible core to the support portion 10010. In at least one such embodiment, referring to FIG. 218, a staple cartridge can further comprise retainer clips 10026 which can be configured to inhibit the wrap, and the compressible core, from prematurely detaching from the support portion 10010. In various embodiments, each retainer clip 10026 can comprise apertures 10028 which can be configured to receive the projections 10014 extending from the support portion 10010 such that the retainer clips 10026 can be retained to the support portion 10010. In certain embodiments, the retainer clips 10026 can each comprise at least one pan portion 10027 which can extend underneath the support portion 10010 and can support and retain the staple drivers 10040 within the support portion 10010. In certain embodiments, as described above, a tissue thickness compensator can be removably attached to the support portion 10010 by the staples 10030. More particularly, as also described above, the legs of the staples 10030 can extend into the tissue thickness compensator 10020 when the staples 10030 are in their unfired position and, as a result, releasably hold the tissue thickness compensator 10020 to the support portion 10010. In at least one embodiment, the legs of the staples 10030 can be in contact with the sidewalls of their respective staple cavities 10012 wherein, owing to friction between the staple legs 10032 and the sidewalls, the staples 10030 and the tissue thickness compensator 10020 can be retained in position until the staples 10030 are deployed from the staple cartridge 10000. When the staples 10030 are deployed, the tissue thickness compensator 10020 can be captured within the staples 10030 and held against the stapled tissue T. When the anvil is thereafter moved into an open position to release the tissue T, the support portion 10010 can be moved away from the tissue thickness compensator 10020 which has been fastened to the tissue. In certain embodiments, an adhesive can be utilized to removably hold the tissue thickness compensator 10020 to the support portion 10010. In at least one embodiment, a two-part adhesive can be utilized wherein, in at least one embodiment, a first part of the adhesive can be placed on the deck surface 10011 and a second part of the adhesive can be placed on the tissue thickness compensator 10020 such that, when the tissue thickness compensator 10020 is placed against the deck surface 10011, the first part can contact the second part to active the adhesive and detachably bond the tissue thickness compensator 10020 to the support portion 10010. In various embodiments, any other suitable means could be used to detachably retain the tissue thickness compensator to the support portion of a staple cartridge.


In various embodiments, further to the above, the sled 10050 can be advanced from the proximal end 10001 to the distal end 10002 to fully deploy all of the staples 10030 contained within the staple cartridge 10000. In at least one embodiment, referring now to FIGS. 258-262, the sled 10050 can be advanced distally within a longitudinal cavity 10016 within the support portion 10010 by a firing member, or knife bar, 10052 of a surgical stapler. In use, the staple cartridge 10000 can be inserted into a staple cartridge channel in a jaw of the surgical stapler, such as staple cartridge channel 10070, for example, and the firing member 10052 can be advanced into contact with the sled 10050, as illustrated in FIG. 258. As the sled 10050 is advanced distally by the firing member 10052, the sled 10050 can contact the proximal-most staple driver, or drivers, 10040 and fire, or eject, the staples 10030 from the cartridge body 10010, as described above. As illustrated in FIG. 258, the firing member 10052 can further comprise a cutting edge 10053 which can be advanced distally through a knife slot in the support portion 10010 as the staples 10030 are being fired. In various embodiments, a corresponding knife slot can extend through the anvil positioned opposite the staple cartridge 10000 such that, in at least one embodiment, the cutting edge 10053 can extend between the anvil and the support portion 10010 and incise the tissue and the tissue thickness compensator positioned therebetween. In various circumstances, the sled 10050 can be advanced distally by the firing member 10052 until the sled 10050 reaches the distal end 10002 of the staple cartridge 10000, as illustrated in FIG. 260. At such point, the firing member 10052 can be retracted proximally. In some embodiments, the sled 10050 can be retracted proximally with the firing member 10052 but, in various embodiments, referring now to FIG. 261, the sled 10050 can be left behind in the distal end 10002 of the staple cartridge 10000 when the firing member 10052 is retracted. Once the firing member 10052 has been sufficiently retracted, the anvil can be re-opened, the tissue thickness compensator 10020 can be detached from the support portion 10010, and the remaining non-implanted portion of the expended staple cartridge 10000, including the support portion 10010, can be removed from the staple cartridge channel 10070.


After the expended staple cartridge 10000 has been removed from the staple cartridge channel, further to the above, a new staple cartridge 10000, or any other suitable staple cartridge, can be inserted into the staple cartridge channel 10070. In various embodiments, further to the above, the staple cartridge channel 10070, the firing member 10052, and/or the staple cartridge 10000 can comprise co-operating features which can prevent the firing member 10052 from being advanced distally a second, or subsequent, time without a new, or unfired, staple cartridge 10000 positioned in the staple cartridge channel 10070. More particularly, referring again to FIG. 258, as the firing member 10052 is advanced into contact with the sled 10050 and, when the sled 10050 is in its proximal unfired position, a support nose 10055 of the firing member 10052 can be positioned on and/or over a support ledge 10056 on the sled 10050 such that the firing member 10052 is held in a sufficient upward position to prevent a lock, or beam, 10054 extending from the firing member 10052 from dropping into a lock recess defined within the staple cartridge channel. As the lock 10054 will not drop into the lock recess, in such circumstances, the lock 10054 may not abut a distal sidewall 10057 of the lock recess as the firing member 10052 is advanced. As the firing member 10052 pushes the sled 10050 distally, the firing member 10052 can be supported in its upward firing position owing to the support nose 10055 resting on the support ledge 10056. When the firing member 10052 is retracted relative to the sled 10050, as discussed above and illustrated in FIG. 261, the firing member 10052 can drop downwardly from its upward position as the support nose 10055 is no longer resting on the support ledge 10056 of the sled 10050. In at least one such embodiment, the surgical staple can comprise a spring 10058, and/or any other suitable biasing element, which can be configured to bias the firing member 10052 into its downward position. Once the firing member 10052 has been completely retracted, as illustrated in FIG. 262, the firing member 10052 cannot be advanced distally through the spent staple cartridge 10000 once again. More particularly, the firing member 10052 can't be held in its upper position by the sled 10050 as the sled 10050, at this point in the operating sequence, has been left behind at the distal end 10002 of the staple cartridge 10000. Thus, as mentioned above, in the event that the firing member 10052 is advanced once again without replacing the staple cartridge, the lock beam 10054 will contact the sidewall 10057 of the lock recess which will prevent the firing member 10052 from being advanced distally into the staple cartridge 10000 once again. Stated another way, once the spent staple cartridge 10000 has been replaced with a new staple cartridge, the new staple cartridge will have a proximally-positioned sled 10050 which can hold the firing member 10052 in its upper position and allow the firing member 10052 to be advanced distally once again.


As described above, the sled 10050 can be configured to move the staple drivers 10040 between a first, unfired position and a second, fired position in order to eject staples 10030 from the support portion 10010. In various embodiments, the staple drivers 10040 can be contained within the staple cavities 10012 after the staples 10030 have been ejected from the support portion 10010. In certain embodiments, the support portion 10010 can comprise one or more retention features which can be configured to block the staple drivers 10040 from being ejected from, or falling out of, the staple cavities 10012. In various other embodiments, the sled 10050 can be configured to eject the staple drivers 10040 from the support portion 10010 with the staples 10030. In at least one such embodiment, the staple drivers 10040 can be comprised of a bioabsorbable and/or material, such as Ultem, for example. In certain embodiments, the staple drivers can be attached to the staples 10030. In at least one such embodiment, a staple driver can be molded over and/or around the base of each staple 10030 such that the driver is integrally formed with the staple. U.S. patent application Ser. No. 11/541,123, entitled SURGICAL STAPLES HAVING COMPRESSIBLE OR CRUSHABLE MEMBERS FOR SECURING TISSUE THEREIN AND STAPLING INSTRUMENTS FOR DEPLOYING THE SAME, filed on Sep. 29, 2006, now U.S. Pat. No. 7,794,475, is hereby incorporated by reference in its entirety.


In various circumstances, further to the above, a compressible tissue thickness compensator can move, twist, and/or deflect relative to the underlying rigid support portion of a staple cartridge. In various embodiments, the support portion, and/or any other suitable portion of the staple cartridge, can comprise one or more features configured to limit relative movement between the tissue thickness compensator and the support portion. As described above, at least a portion of the staples 10030 can extend above the deck surface 10011 of the support portion 10010 wherein, in certain circumstances, referring now to FIGS. 263 and 264, lateral forces applied to a tissue thickness compensator 10120, for example, can be resisted by the staples 10030 and/or the cleats 10013 extending from the support portion 10010, for example. In various circumstances, the staples 10030 may tilt and/or bend within the staple cavities 10012 while resisting the lateral movement of the tissue thickness compensator 10120 wherein, in various embodiments, the staple cavities 10012 and the staples 10030 can be sized and configured to maintain the relative alignment between the legs 10032 of the staples 10030 and the forming pockets 10062 in the opposing anvil 10060 such that the staples 10000 are properly formed during the staple forming process. In various embodiments, the staples 10030 and/or the cleats 10013 can be configured to prevent or at least limit lateral distortion within the tissue thickness compensator 10020, as illustrated in FIG. 264. In at least one such embodiment, the staples 10030 and/or cleats 10013, for example, can be configured to stiffen, or limit the lateral and/or longitudinal movement of, a first, or tissue-contacting, surface 10021 of the tissue thickness compensator relative to a second, or bottom, surface 10029. In various embodiments, a staple cartridge, and/or a staple cartridge channel in which the staple cartridge is positioned, can comprise at least one distortion minimizing member which can extend upwardly to limit the lateral and/or longitudinal movement, or distortion, of a tissue thickness compensator. A wrap at least partially surrounding a tissue thickness compensator, as discussed above, may also prevent, or at least limit, the lateral and/or longitudinal movement, or distortion, of the tissue thickness compensator.


In various embodiments, referring again to FIGS. 263 and 264, a tissue thickness compensator, such as tissue thickness compensator 10120, for example, can comprise a core 10128 and a skin 10122. The skin 10122 and the compressible core 10128 can be comprised of different materials or, alternatively, of the same material. In either event, the skin 10122 can have a higher density than the core 10128. In circumstances where the skin 10122 comprises the top of the tissue thickness compensator 10120, the tips of the staple legs 10032 can be embedded in the skin 10122. In embodiments wherein a skin comprises the bottom of the tissue thickness compensator 10120, the staple legs 10032 can extend through the skin and into the core. In either event, the skin of the tissue thickness compensator can assist in holding the staple legs 10032 in alignment with the forming pockets 10062 of the anvil 10060. In various embodiments, the skin 10122 can comprise a density which is approximately 10% greater than the density of the core 10128, approximately 20% greater than the density of the core 10128, approximately 30% greater than the density of the core 10128, approximately 40% greater than the density of the core 10128, approximately 50% greater than the density of the core 10128, approximately 60% greater than the density of the core 10128, approximately 70% greater than the density of the core 10128, approximately 80% greater than the density of the core 10128, approximately 90% greater than the density of the core 10128, and/or approximately 100% greater than the density of the core 10128, for example. In various embodiments, the skin 10122 can comprise a density which is more than the density of the core 10128 and less than twice the density of the core 10128, for example. In various embodiments, the skin 10122 can comprise a density which is over twice the density of the core 10128, for example. In various embodiments, further to the above, the skin 10122 and the core 10128 can be formed, or manufactured, simultaneously. In at least one such embodiment, a fluid comprising any suitable material disclosed herein can be poured into a dish or mold and, while the fluid solidifies, the fluid can form a skin, or layer, which has a higher density than the remainder of the material. In various embodiments, multiple layers within a material can be formed by utilizing a process in which one or more subsequent layers of material are poured onto a previously cured layer. In certain embodiments, two or more layers can be bonded to each other with an adhesive, for example. In some embodiments, two or more layers can be attached to each other by one or more fasteners and/or one or more mechanical interlocking features, for example. In at least one such embodiment, adjacent layers can be connected together by one or more dovetail joints, for example. In certain embodiments, the skin can comprise a sealed surface which can prevent, or at least limit, the flow of fluid therethrough. In certain other embodiments, the skin can comprise an open cell porous structure, for example.


In various embodiments, further to the above, the skin can be cut off of the tissue thickness compensator. In at least one embodiment, the tissue thickness compensator can be cut from a larger block of material such that the tissue thickness compensator does not comprise a skin. In at least one such embodiment, the tissue thickness compensator can be comprised of a homogenous, or at least substantially homogeneous, material, comprising large pores, for example.


In various embodiments, a staple cartridge can comprise a plurality of staple cavities each containing a staple positioned therein wherein the staple cavities can be arranged in a plurality of rows, and wherein an anvil positioned opposite the staple cartridge can comprise a plurality of forming pockets which correspond to the staple cavities in the staple cartridge. Stated another way, the anvil can comprise a plurality of forming pocket rows wherein each forming pocket can be positioned opposite a staple cavity in the staple cartridge. In various embodiments, each forming pocket can comprise two forming cups configured to receive the staple legs 10032 of a staple 10030 wherein each forming cup is configured to receive a staple leg 10032 and form or curl the staple leg 10032 toward the other staple leg 10032, for example. In various circumstances, the legs 10032 may miss or not properly enter into the forming cups and, as a result, the staple legs 10032 may become malformed during the firing sequence. In various embodiments described herein, an anvil can comprise an array, or grid, of forming pockets which are each configured to receive and form a staple leg. In at least one such embodiment, the array of forming pockets can comprise a quantity of forming pockets that exceeds the quantity of staples contained within the staple cartridge. In at least one embodiment, a staple cartridge can comprise six longitudinal rows of staple cavities, for example, wherein the anvil can comprise six rows of forming pockets aligned with the six rows of staple cavities and, in addition, forming pockets positioned intermediate the rows of forming pockets. For example, on one side of the anvil, the anvil can comprise a first row of forming pockets which can be positioned over a first row of staple cavities, a second row of forming pockets which can be positioned over a second row of staple cavities that is adjacent to the first row of staple cavities, and, in addition, a row of forming pockets positioned intermediate the first row of forming pockets and the second row of forming pockets. In various embodiments, referring now to FIGS. 276-279, an anvil 10260 can comprise six rows of forming pockets 10261 which can be configured to be placed over six corresponding rows of staple cavities in the staple cartridge 10200. In at least one such embodiment, rows of intermediate forming pockets 10262 can be positioned intermediate and/or adjacent to the rows of forming pockets 10261. In certain embodiments, referring now to FIGS. 277, 278, and 280, each forming pocket 10261 and 10262 can comprise two forming cups, wherein each forming cup can comprise a distal portion 10263 which can be configured to form or curl a staple leg 10032 proximally and a proximal portion 10264 which can be configured to form or curl a staple leg 10032 distally. In various other circumstances, the staples 10030 can be formed in a variety of other ways. For example, a staple 10030 can be formed such that one leg 10032 is formed outwardly and the other leg 10032 is formed inwardly (FIG. 281), or such that both legs 10032 are formed outwardly (FIG. 282) depending on, one, which forming cups that the staple legs 10032 enter into and/or, two, whether the legs 10032 enter into the proximal portion 10263 or the distal portion 10064 of each forming cup, for example.


In various embodiments, further to the above, each forming pocket 10261 and/or forming pocket 10262 can comprise a triangular or diamond-like shape, for example. In at least one embodiment, each distal portion 10263 and/or each proximal portion 10264 of the forming pockets can comprise a triangular shape wherein, in at least one such embodiment, the triangular shapes of the distal portions 10263 and the proximal portions 10264 can be arranged such that they have vertices pointing in opposite directions. In certain embodiments, an anvil can comprise an array of substantially square forming pockets, for example. In at least one such embodiment, the forming surface of each square forming pocket can comprise an arcuate surface that extends between the sides of the square. In some embodiments, an anvil can comprise an array of circular or spherical dimples, for example. In various embodiments, further to the above, the forming pockets 10261 can be positioned along one or more lines and, similarly, the forming pockets 10262 can also be positioned along one or more lines. In various other embodiments, the forming pockets 10261 and/or the forming pockets 10262 can be arranged in one or more circular rows. In at least one such embodiment, the forming pockets 10261 can be arranged along a primary circumference and the forming pockets 10262 can be arranged along a different circumference. In various embodiments, the primary circumference and the different circumference can be concentric, or at least substantially concentric. In certain embodiments, the forming pockets 10262 can be arranged along an inner circumference positioned radially inwardly with respect to the primary circumference and/or an outer circumference positioned radially outwardly with respect to the primary circumference, for example. In various embodiments, the primary circumference can be defined by a primary diameter, the inner circumference can be defined by an inner diameter, and the outer circumference can be defined by an outer diameter. In at least one such embodiment, the inner diameter can be shorter than the primary diameter and the outer diameter can be longer than the primary diameter.


In various embodiments, as described above, an anvil can be moved from an open position to a closed position in order to compress tissue against the tissue thickness compensator of a staple cartridge, such as tissue thickness compensator 10020, for example. In various circumstances, the tissue thickness compensator can be positioned adjacent to the support portion of the staple cartridge prior to the tissue thickness compensator being positioned relative to the tissue. In certain embodiments, the tissue thickness compensator 10020 can be in a position in which it abuts the support portion 10018 prior to the anvil being moved into its closed position. In certain other embodiments, the tissue thickness compensator 10020 can be in a position in which a gap is present between the tissue thickness compensator 10020 and the support portion 10018. In at least one such embodiment, the anvil can displace the tissue and the tissue thickness compensator 10020 downwardly until the tissue thickness compensator 10020 abuts the support portion 10018 wherein, at such point, the anvil can be moved into is closed position and generate compression within the tissue. In the event that a surgeon is not satisfied with the positioning of the tissue between the anvil and the staple cartridge, the surgeon can open the anvil, adjust the position of the anvil and the staple cartridge, and close the anvil once again. Owing to such positioning and re-positioning of the staple cartridge relative to the tissue, in various circumstances, the distal end of the tissue thickness compensator 10020 may become dislodged from the support portion 10010, for example. In some such circumstances, the distal end of the tissue thickness compensator 10020 can contact the tissue and peel away from, or roll relative to, the support portion 10010. In various embodiments, as described in greater detail below, a staple cartridge can comprise one or more features configured to releasably retain a tissue thickness compensator to an underlying support portion of the staple cartridge


In various embodiments, referring now to FIG. 265, a staple cartridge 10300 can comprise a support portion 10310, a tissue thickness compensator 10320 supported by the support portion 10310, and a distal end 10302 which includes a nose 10303 configured to releasably hold a distal end 10325 of the tissue thickness compensator 10320 in position. In at least one embodiment, the nose 10303 can comprise a slot 10305 configured to receive the distal end 10325 of the tissue thickness compensator 10320. In various embodiments, the distal end 10325 can be compressed, or wedged, within the slot 10305 such that the distal end 10325 can be held in place as the staple cartridge 10300 is positioned relative to the tissue. In at least one such embodiment, the slot 10305 can be oriented in a direction which is parallel, or at least substantially parallel, to the deck surface 10311 of the support portion 10310. In various embodiments, the slot 10305 can be horizontal with respect to the deck surface 10311. In various other embodiments, referring now to FIG. 266, a staple cartridge 10400 can comprise a support portion, a tissue thickness compensator 10420 supported by support portion, and a distal end 10402 which includes a nose 10403 configured to releasably hold the distal end 10425 of the tissue thickness compensator 10420 in position. In at least one embodiment, the distal end 10425 can comprise a projection extending therefrom and the nose 10403 can comprise a vertical slot 10405 configured to receive the projection of the distal end 10425. In various embodiments, the distal end 10425, and/or the projection extending therefrom, can be compressed, or wedged, within the slot 10405 such that the distal end 10425 can be held in place as the staple cartridge 10400 is positioned relative to the tissue. In certain embodiments, the tissue thickness compensator 10420 can comprise a slot, such as slot 10429, for example, which can be configured to receive at least a portion of the nose 10403 therein. In at least one embodiment, the slot 10405 can be oriented in a direction which is perpendicular, or at least substantially perpendicular, to the deck surface 10411 of the support portion. In various embodiments, referring now to FIG. 267, a staple cartridge 10500 can comprise a support portion, a tissue thickness compensator 10520 supported by the support portion, and a distal end 10502 which includes a nose configured to releasably hold the distal end 10525 of the tissue thickness compensator 10520 in position. In at least one embodiment, the nose can comprise a vertical slot 10505 configured to receive the distal end 10525 of the tissue thickness compensator 10520. In various embodiments, the distal end 10525 can be compressed, or wedged, within the slot 10505 such that the distal end 10525 can be held in place as the staple cartridge 10500 is positioned relative to the tissue.


In various embodiments, referring again to FIG. 265, the tissue thickness compensator 10320 can comprise a top surface 10324 which can be positioned above the top surface 10304 of the nose 10303. Another exemplary embodiment in which the top surface of a tissue thickness compensator is positioned above the nose of the staple cartridge is illustrated in FIG. 238, wherein the top surface 10721 of the tissue thickness compensator 10720 is positioned above the top surface 10004 of the nose 10003, for example. In use, referring once again to FIG. 265, tissue can slide over the top surface 10304 of the nose 10303 and, in some circumstance, the tissue can contact the distal end 10325 of the tissue thickness compensator 10320 and can apply a force to the tissue thickness compensator 10320 tending to peel the tissue thickness compensator 10320 away from the support portion 10310. In the embodiments described herein, this peel force can be resisted by the portion of the distal end 10325 wedged within the nose 10303. In any event, once the tissue has been suitably positioned relative to the staple cartridge 13000, an anvil can be rotated into a closed position to compress the tissue and the tissue thickness compensator 10320 against the support portion 10310. In at least one such embodiment, the anvil can be rotated into a position in which the anvil contacts the top surface 10304 of the nose 10303 and, as a result, the anvil can be prevented from rotating further. In various circumstances, owing to the top surface 10324 of the tissue thickness compensator 10320 being positioned above the top surface 10304 of the nose 10303, the top surface 10324 can be pushed downwardly toward the support portion 10310 as the anvil is being closed and, in some circumstances, the top surface 10324 can be pushed below the top surface 10304 of the nose 10303, for example. After the staples contained within the staple cartridge 10300 have been deployed and the tissue thickness compensator 10320 has been incised, as described herein, the support portion 10310 and the nose 10303 can be moved away from the tissue thickness compensator 10320 such that the distal end 10325 of the tissue thickness compensator 10320 can slide out of the slot 10305.


As described above, an anvil, such as anvil 10060, for example, can be rotated into a closed position in which the anvil 10060 contacts the top nose surface 10004 of a staple cartridge, such as staple cartridge 10000, for example. Once the anvil has reached its closed position, the amount in which a tissue thickness compensator, such as tissue thickness compensator 10020, for example, is compressed will depend on, among other things, the uncompressed thickness, or height, of the tissue thickness compensator and the thickness of the tissue. Referring now to FIGS. 236 and 237, a tissue thickness compensator 10920 can comprise a top surface which is flush, or at least substantially flush, with the top surface 10004 of the nose 10003. In such embodiments, the top surface of the tissue thickness compensator 10920 can be pushed below the top surface 10004 of the nose 10003. Referring now to FIGS. 241 and 242, a tissue thickness compensator, such as tissue thickness compensator 10820, for example, can comprise a top surface 10821 which is positioned below the top nose surface 10004 prior to the tissue thickness compensator 10820 being compressed by the tissue T and anvil 10060. In the circumstances where the tissue T is relatively thin, as illustrated in FIGS. 239 and 240, the tissue thickness compensator 10920 may undergo relatively little compression. Referring now to FIGS. 241 and 242, the tissue thickness compensator 10820 may undergo a larger compression when the tissue T is relatively thicker. In the circumstances where the tissue T has both thin sections and thicker sections, as illustrated in FIGS. 243 and 244, the tissue thickness compensator 10820 may be compressed a larger amount when it is positioned under the thicker tissue T and a lesser amount when it is positioned under the thinner tissue T, for example. In this way, as described above, the tissue thickness compensator can compensate for different tissue thicknesses.


In various embodiments, referring now to FIGS. 268-270, a surgical stapling instrument can comprise, one, a cartridge channel 16670 configured to receive a staple cartridge 16600 and, two, an anvil 16660 pivotably coupled to the cartridge channel 16670. The staple cartridge 16600 can comprise a support portion 16610 and a tissue thickness compensator 16620 wherein a distal end 16625 of the tissue thickness compensator 16620 can be releasably held to the support portion 16610 by a nose 16603 at the distal end 16602 of the staple cartridge 16600. In at least one embodiment, the nose 16603 can comprise a slot 16605 and can be comprised of a flexible material. In use, referring primarily to FIG. 269, the nose 16603 can be flexed downwardly in order to expand the opening of slot 16605. In certain embodiments, the nose 16603 can comprise notches or cut-outs 16606 which can be configured to permit the nose 16603 to flex downwardly. In any event, in various circumstances, the expanded opening of the slot 16605 can facilitate the insertion of the distal end 16625 of the tissue thickness compensator 16620 into the slot 16605. Once the tissue thickness compensator 16620 has been suitably positioned, the nose 16603 can be released and, owing to the resiliency of the material comprising the nose 16603, the nose 16603 can return, or at least substantially return, to its unflexed condition and trap the distal end 16625 of the tissue thickness compensator 16620 against the deck surface 16611, as illustrated in FIG. 270. In use, similar to the above, the distal end 16625 can be pulled out of the slot 16605 when the support portion 16610 is moved away from the stapled tissue. In various circumstances, the flexible nose 16603 can be configured to deflect as the tissue thickness compensator 16620 is detached from the support portion 16610. In various embodiments, referring again to FIG. 270, the tissue thickness compensator 16620 can comprise a top surface 16621 which is aligned, or at least substantially aligned, with a top surface 16604 of the nose 16603.


In various embodiments, referring to FIG. 271, a surgical stapling instrument can comprise, one, a channel 10770 configured to receive a staple cartridge 10700 and, two, an anvil 10760 rotatably coupled to the channel 10770. The staple cartridge 10700 can comprise a support portion 10710 and a tissue thickness compensator 10720. In various embodiments, the tissue thickness compensator 10720 can be held in position by a nose sock 10703 which can be slid over the support portion 10710. In at least one embodiment, referring primarily to FIG. 272, the nose sock 10703 can comprise one or more side slots 10707 which can be configured to removably receive one or more attachment rails extending along the support portion 10710, for example. In various embodiments, the tissue thickness compensator 10720 can be positioned intermediate the side slots 10707. In certain embodiments, the nose sock 10703 can further comprise a distal end 10702 and a cavity 10706 defined in the distal end 10702 wherein the cavity 10706 can also be configured to receive at least a portion of the support portion 10710, for example, therein. In use, the nose sock 10703 can be slid onto the support portion 10710 in a distal to proximal direction. In various embodiments, the tissue thickness compensator 10720 can be removably mounted to the nose sock 10703 such that, after staples have been fired through the tissue thickness compensator 10720, the tissue thickness compensator 10720 can detach from the nose sock 10703 as the support portion 10710 and the nose sock 10703 are moved away from the tissue thickness compensator 10720. In various embodiments, the top surface 10721 of the tissue thickness compensator 10720 can be positioned below the top surface 10704 of the nose 10703.


In various embodiments, referring now to FIGS. 273 and 274, a surgical stapling instrument can comprise, one, a staple cartridge channel 11070 configured to receive a staple cartridge 11000 and, two, an anvil 11060 rotatably coupled to the channel 11070. The staple cartridge 11000 can comprise a support portion 11010 and a tissue thickness compensator 11020. In various embodiments, the tissue thickness compensator 11020 can be held in position by a one or more longitudinal rails 11019 extending from the deck 11011 of the support portion 11010. In at least one embodiment, the longitudinal rails 11019 can be embedded within the tissue thickness compensator 11020. In certain embodiments, referring primarily to FIG. 274, the tissue thickness compensator 11020 can comprise a longitudinal recess 11029 which can be configured to receive the longitudinal rails 11019. In at least one such embodiment, the recess 11029 can be sized and configured to receive the rails 11019 in a press-fit arrangement, for example. Such features, further to the above, can be configured to prevent, or at least limit, relative lateral movement between the tissue thickness compensator 11020 and the support portion 11010 and, in addition, limit the pre-mature release of the tissue thickness compensator 11020 from the support portion 11010, for example. In various embodiments, referring now to FIG. 275, a surgical stapling instrument can comprise, one, a staple cartridge channel 11170 configured to receive a staple cartridge 11100 and, two, an anvil 11160 rotatably coupled to the channel 11170. The staple cartridge 11100 can comprise a support portion 11110 and a tissue thickness compensator 11120. In various embodiments, the tissue thickness compensator 11120 can be held in position by one or more longitudinal rows of spikes, or teeth, 11119 extending from the deck 11111 of the support portion 11110. In at least one embodiment, the longitudinal rows of spikes 11119 can be embedded within the tissue thickness compensator 11120.


With regard to the embodiment illustrated in FIG. 273, further to the above, the tissue thickness compensator 11020 of the staple cartridge 11000 can be progressively released from the support portion 11010 as the staples are ejected from the staple cavities 10012 defined therein. More particularly, further to the above, the staples positioned in the staple cavities 10012 can be ejected sequentially between the proximal end 11001 of the staple cartridge 11000 and the distal end 11002 of the staple cartridge 11000 such that, as the staples are being ejected, the staples can apply an upward biasing force to the tissue thickness compensator 11020 which acts to push the tissue thickness compensator 11020 off of the rails 11019. In such circumstances, the proximal end 11006 of the tissue thickness compensator 11020 can be released from the support portion 11010 as the staples are ejected from the proximal-most staple cavities 10012. The tissue thickness compensator 11020 can then be progressively released from the support portion 11010 as the staples are progressively ejected from the support portion 11010 between the proximal end 11001 and the distal end 11002 of the staple cartridge 11000. When the staples positioned within the distal-most staple cavities 10012 are ejected from the support portion 11010, the distal end 11007 of the tissue thickness compensator 11020 can be released from the support portion 11010. With regard to the embodiment illustrated in FIG. 275, the tissue thickness compensator 11120 can be progressively released from the spikes 1119 extending from the support portion 11110 as the staples are progressively ejected from the staple cartridge between the proximal end 11101 and the distal end 11102.


As discussed above, a tissue thickness compensator can be progressively released from the support portion of a staple cartridge as the staples are progressively ejected from the support portion and contact the tissue thickness compensator. In various embodiments, the legs of the staple, such as staple legs 10032, for example, may be able to pass through the tissue thickness compensator without releasing the tissue thickness compensator from the support portion. In such embodiments, the tissue thickness compensator may remain engaged with the support portion until the bases of the staples, such as bases 10031, contact the tissue thickness compensator and push it upwardly. In various embodiments, however, cleats and/or other retention features extending from the support portion, for example, may oppose the release of the tissue thickness compensator from the support portion. In certain embodiments, as described in greater detail below, a support portion can comprise retention features which can be configured to progressively release a tissue thickness compensator from the support portion as the staples are progressively fired from the staple cartridge. Referring now to FIG. 283, a staple cartridge, such as staple cartridge 11200, for example, can comprise a support portion 11210 including retention features 11213 which can be configured to releasably hold a tissue thickness compensator 11220 (FIG. 284) to the support portion 11210. In various embodiments, the retention features 11213 can be positioned at the ends of each staple cavity 11212, for example, wherein each retention feature 11213 can comprise a guide groove 11216 defined therein which is configured to slidably receive a staple leg 10032 of a staple 10030. In such embodiments, both the staple legs 10032 and the retention features 11213 can be configured to releasably retain the tissue thickness compensator 11220 to the support portion 11210. In use, referring now to FIG. 284, staple drivers 10040 contained within the support portion 11210 can be driven upwardly by a sled 10050, as described above, wherein the staple drivers 10040 can be configured to contact the retention features 11213, at least partially detach the retention features 11213 from the support portion 11210, and displace the retention features 11213 outwardly and away from the staples 10030 and the staple cavities 11212. When the retention features 11213 are detached from the support portion 11210 and/or displaced outwardly, as illustrated in FIG. 284, the retention features 11213 may no longer be able to retain the tissue thickness compensator 11220 to the support portion 11210 and, as a result, the tissue thickness compensator 11220 can be released from the support portion 11210. Similar to the above, the tissue thickness compensator 11220 can be progressively released from the support portion 11210 as the staples 10030 are progressively ejected from the staple cartridge toward an anvil, such as anvil 11260, for example. In various embodiments, the staple drivers 10040 may contact the retention features 11213 when the top surfaces of the staple drivers 10040 become co-planar, or at least substantially co-planar, with the deck surface 11211 of the support portion 11210, for example. In such embodiments, the tissue thickness compensator 11220 may be released from the support portion 11210 at the same time as and/or just before the staples 10030 are formed to their fully-formed, or fully-fired, configuration. In at least one such embodiment, referring primarily to FIG. 285, the drivers 10040 can be overdriven such that they are pushed above the deck surface 11211 to fully form the staples 10030 and, during the process of being overdriven, break the retention features 11213 away from the support portion 11210. In various embodiments, referring again to FIG. 284, the retention features 11213 may extend over, or overhang, into the staple cavities 11212 prior to being detached or displaced outwardly such that the drivers 10040 can contact the retention features 11213 just as the drivers 10040 reach the deck surface 11211. In any event, once the tissue thickness compensator 11220 has been released from the support portion 11210, referring now to FIG. 285, the support portion 11210 can be moved away from the implanted tissue thickness compensator 11220.


As described above, a compressible tissue thickness compensator of a staple cartridge can be progressively released from a support portion, or cartridge body, of the staple cartridge as the staples are fired, or deployed, from the staple cartridge. In various circumstances, such a release can comprise a progressive loosening of the tissue thickness compensator from the support portion wherein, in some circumstances, a complete detachment of the tissue thickness compensator from the support portion may not occur until the anvil is opened and the support portion is moved away from the implanted tissue thickness compensator. In various embodiments, referring now to FIG. 289, a staple cartridge, such as staple cartridge 11300, for example, can comprise a tissue thickness compensator 11320 which is releasably retained to a support portion 11310. In at least one embodiment, the support portion 11310 can comprise a plurality of retention members 11313 extending therefrom which are configured to releasably compress and hold the longitudinal sides of the tissue thickness compensator 11320 to the support portion 11310. In at least one such embodiment, each retention member 11313 can comprise an inwardly-facing channel or slot 11316 which can be configured to receive the longitudinal sides of the tissue thickness compensator 11320 therein. In various circumstances, a plurality of retention members 11313 can extend along a first longitudinal side of the support portion 11310 and a plurality of retention members 11313 can extend along a second longitudinal side of the support portion 11310 wherein, in certain circumstances, the retention members 11313 can be configured to prevent, or at least limit, relative lateral movement between the tissue thickness compensator 11320 and the support portion 11310 and, in addition, prevent, or at least limit, the premature release of the tissue thickness compensator 11320 from the support portion 11310. In various embodiments, the retention members 11313 can be integrally formed with the support portion 11310 and, in at least one embodiment, referring to FIG. 290, the retention members 11313 can be configured to detach, or at least partially detach, from the support portion 11310 in order to allow the tissue thickness compensator 11320 to detach from the support portion 11310, as illustrated in FIG. 291, for example. In certain embodiments, an anvil, such as anvil 11360, for example, can be configured to compress the tissue thickness compensator 11320 and, in response to pressure generated within the tissue thickness compensator 11320, the tissue thickness compensator 11320 can expand laterally to at least partially detach, or disengage, the retention members 11313 from the tissue thickness compensator 11320. In various embodiments, the advancement of a knife member, discussed above, through the anvil 11360 and the staple cartridge 11300 can deploy the staples contained therein and, simultaneously, squeeze the anvil 11360 and the staple cartridge 11300 closer to one another which can apply an added compressive pressure to the tissue thickness compensator 11320 and thereby cause the retention members 11313 to sequentially detach as the knife member passes through the staple cartridge 11300.


In various embodiments, referring now to FIGS. 292-294, a staple cartridge, such as staple cartridge 11400, for example, can comprise a tissue thickness compensator 11420 removably attached to a support portion 11410. In at least one embodiment, the staple cartridge 11400 can comprise one or more retainer bars 11413 which can be configured to hold the longitudinal sides of the tissue thickness compensator 11420 to the deck surface 11411. In at least one such embodiment, each retainer bar 11413 can comprise opposing arms 11418 which can define a channel 11416 therebetween. In such embodiments, one of the arms 11418 can be configured to extend over the tissue thickness compensator 11420 and the other arm 11418 can be configured to extend under a lip 11419 extending from the support portion 11410. Referring primarily to FIG. 292, the channel 11416 of each retainer bar 11413 can be sized and configured to apply a compressive force to the longitudinal sides of the tissue thickness compensator 11420 prior to the staple cartridge 11400 being used. During use, referring primarily to FIG. 293, the staple cartridge 11400 can be positioned within a staple cartridge channel and, once the staple cartridge 11400 has been suitably positioned, an anvil, such as anvil 11460, for example, can be moved into a position in which it can compress the tissue thickness compensator 11420. Similar to the above, the thickness tissue compensator 11420, when compressed, can expand laterally, or outwardly, and, as a result, detach the retainer bars 11413 from the staple cartridge 11400. In certain other embodiments, the closing of the anvil 11460 may not detach, or may not completely detach, the retainer bars 11413 from the staple cartridge. In at least one such embodiment, the advancement of a firing bar, described above, through the staple cartridge 11400 can deploy the staples 10030 from the support portion 11410 and, simultaneously, squeeze the anvil 11460 and the staple cartridge 11400 closer together to apply a compressive force to the tissue thickness compensator 11420 that is sufficient to cause the tissue thickness compensator 11420 to expand laterally and detach the retainer bars 11413 from the staple cartridge 11400. Once the retainer bars 11413 have been detached from the staple cartridge 11400, referring to FIG. 294, the support portion 11410 can be moved away from the implanted tissue thickness compensator 11420 and removed from the surgical site. In certain alternative embodiments, referring now to FIG. 295, a staple cartridge 11400′ can comprise retainer bars 11413′ which, similar to the above, can comprise arms 11418′ extending therefrom. In at least one such embodiment, each of the arms 11418′ can comprise a wedge-lock bevel 11417′ which can be configured to releasably latch the retainer bars 11413′ to the staple cartridge 11400′. More particularly, in at least one embodiment, the support portion 11410′ of the staple cartridge 11400′ can comprise undercuts 11419′ which, in co-operation with the wedge-lock bevels 11417′, can be configured to releasably retain the retainer bars 11413′ to the staple cartridge 11400 and inhibit the tissue thickness compensator 11420 from being prematurely detached from the support portion 11410′. During use, similar to the above, the retainer bars 11413′ can be detached from the staple cartridge 11400′ when a sufficient compressive force is applied to the tissue thickness compensator 11420, for example.


In various circumstances, as described above and referring again to FIGS. 259 and 260, the sled 10050 of the staple cartridge 10000 and the firing member 10052 of a surgical stapling instrument can be moved from the proximal end 10001 of the staple cartridge 10000 to the distal end 10002 (FIG. 219) of the staple cartridge 10000 in order to deploy the staples 10030 from the support portion 10010. In at least one such circumstance, each staple 10030 can be moved from an unfired position to a fired position and ejected from the support portion 10010 to capture the entirety of the tissue thickness compensator 10020 against the tissue positioned between the anvil 10060 and the staple cartridge 10000. In certain circumstances, a surgeon may not need to fire all of the staples 10030 from the staple cartridge 10000 and the surgeon may stop the progression of the sled 10050 and the firing bar 10052 at a point located intermediate the proximal end 10001 and the distal end 10002 of the staple cartridge 10000. In such circumstances, the tissue thickness compensator 10020 may only be partially implanted to the tissue T and, in order to detach the unimplanted portion of the tissue thickness compensator 10020 from the support portion 10010, the surgeon can pull the support portion 10010 away from the partially implanted tissue thickness compensator 10020 such that the unimplanted portion peels or pulls off of the support portion 10010. While such embodiments are suitable in various circumstances, an improvement is illustrated in FIGS. 300-302 wherein a tissue thickness compensator, such as tissue thickness compensator 11520 of staple cartridge 11500, for example, can comprise a plurality of connected segments which can be configured to detach from one another. In at least one such embodiment, the tissue thickness compensator 11520 can comprise a first, or proximal-most, segment 11520a, a second segment 11520b removably connected to the first segment 11520a, a third segment 11520c removably connected to the second segment 11520b, a fourth segment 11520d removably connected to the third segment 11520c, and a fifth segment 11520e removably connected to the fourth segment 11520d, for example. In various embodiments, the tissue thickness compensator 11520 can comprise at least one thin section 11529 positioned intermediate any two adjacent segments 11520a-11520e which can be configured to define a pre-determined rupture or separation point in which the tissue thickness compensator segments can separate from one another. In certain embodiments, a tissue thickness compensator can include any suitable arrangement of perforations, thin sections, and/or any other means for creating a separation point within the tissue thickness compensator. Referring primarily to FIG. 301, an anvil 11560 is illustrated in a closed position and the firing member 10052 is illustrated as having been partially advanced through the staple cartridge 11500 such that the staples 10030 underlying the first segment 11520a, the second segment 11520b, and the third segment 11520c have been fired to capture the tissue thickness compensator 11520 against the tissue T. In such a position, the firing member 10052 has not yet been advanced to deploy the staples 10030 underlying the fourth segment 11520d and the fifth segment 11520e, for example. Referring now to FIG. 302, the anvil 11560 has been moved into an open position and the support portion 11510 of the staple cartridge 11500 has been moved away from the portion of the tissue thickness compensator 11520 that has been implanted. As illustrated in FIG. 302, the thin section 11529 (FIG. 300) located intermediate the third segment 11520c and the fourth segment 11520d has allowed the unimplanted portion of the tissue thickness compensator 11520 to separate from the implanted portion.


In various embodiments, further to the above, a staple cartridge can comprise a plurality of fasteners configured to releasably hold a tissue thickness compensator to a support portion of the staple cartridge. In certain embodiments, the support portion can comprise a plurality of apertures defined in the deck surface, for example, wherein the fasteners can extend through the tissue thickness compensator and can be releasably retained in the support portion apertures. In use, the fasteners can be progressively released from the support portion as the staples are progressively ejected from the support portion. In at least one such embodiment, the fasteners can be implanted with the tissue thickness compensator and, in at least one embodiment, the fasteners can be comprised of at least one bioabsorbable material, for example. In certain embodiments, the fasteners can detach from the support portion after the tissue thickness compensator has been at least partially implanted and as the support portion is moved away from the implanted tissue thickness compensator. In various embodiments, referring now to FIGS. 323-325, a staple cartridge, such as staple cartridge 11600, for example, can comprise a tissue thickness compensator 11620 releasably mounted to a support portion 11610 by a plurality of fasteners 11613. Each fastener 11613 can comprise a first end 11618 embedded within and/or otherwise engaged with the tissue thickness compensator 11620, a second end 11618 engaged with the support portion 11610, and a connector 11616 which connects the first end 11618 to the second end 11618. In various embodiments, the fasteners 11613 can extend through a knife slot 11615 defined in the support portion 11610. In use, the firing member 10052, described above, can move a knife edge through the knife slot 11615 in the support portion 11610 and incise the fasteners 11613 in order to release the tissue thickness compensator 11620 from the support portion 11610. In at least one such embodiment, the firing bar 10052 can be advanced from a proximal end 11601 of the staple cartridge 11600 to a distal end 11602 of the staple cartridge 11600 in order to, one, advance the sled 10050 distally and progressively fire the staples 10030, as discussed above, and, two, progressively incise and/or break the fasteners 11613 to progressively release the tissue thickness compensator 11620 from the support portion 11610. In certain embodiments, similar to the above, the tissue thickness compensator 11620 can comprise a plurality of detachable segments 11620a-11620e which can each be held to support portion 11610 by one or more fasteners 11613, for example. In the event that the firing member 10052 is stopped intermediate the proximal end 11601 and the distal end 11602 of the staple cartridge 11600, as illustrated in FIG. 324, the fasteners 11613 can assist in holding the unimplanted portion of the tissue thickness compensator 11620 to the support portion 11610 after the anvil 11660 is opened and the support portion 11610 is moved away from the tissue T, as illustrated in FIG. 325. In various embodiments, further to the above, the cutting edge 10053 of the firing member 10052 can be configured to incise and/or break the fasteners 11613. In certain alternative embodiments, referring now to FIGS. 327 and 328, a staple-deploying sled, such as sled 11650, for example, can comprise a knife edge 11653 which can be configured to incise the connectors 11616 of the fasteners 11613 as the sled 11650 traverses the staple cartridge 11600. In at least one such embodiment, each connector 11616 can comprise a cylindrical member extending between the T-shaped ends 11618 of the fasteners 11613 wherein the knife edge 11653 can comprise a concave profile 11653 which can be configured to receive the cylindrical connector 11616, for example.


As discussed above, a staple cartridge can be loaded into a staple cartridge channel of a surgical stapling instrument. In various circumstances, a surgeon, or other clinician, may insert the staple cartridge into the staple cartridge channel by placing a downward force onto the staple cartridge to lock the staple cartridge in place. In some such circumstances, the clinician may place their thumb, for example, on the top surface of the staple cartridge to apply such a downward force. In various embodiments, the top surface of the staple cartridge may comprise the top surface of a tissue thickness compensator wherein, as described above, the tissue thickness compensator can be compressible and, in certain embodiments, the downward force applied to tissue thickness compensator can cause the tissue thickness compensator to compress to the point in which the clinician's thumb comes into contact with the tips of the staples stored within the support portion. In various embodiments, a staple cartridge applicator can be utilized to insert a staple cartridge into a staple cartridge channel which can be configured to prevent, or at least limit, the possibility of the clinician touching the staples in the staple cartridge. After the staple cartridge has been suitably positioned within the staple cartridge channel, as described in greater detail below, the applicator can be detached from the staple cartridge.


In certain embodiments, referring now to FIGS. 305 and 306, a staple cartridge applicator can comprise a rigid cover, such as cover 10080, for example, which can be attached to a staple cartridge 10000. Further to the above, the cover 10080 can be configured to prevent, or at least inhibit, a clinician's thumb, for example, from contacting the tips of the staples 10030 positioned within the staple cartridge 10000 when the staple cartridge 10000 is inserted into a staple cartridge channel. Referring now to FIGS. 307 and 308, the cover 10080 can extend over the top surface 10021, or at least a portion of the top surface 10021, of the tissue thickness compensator 10020 and can include, one, a bottom surface 10081 which can extend over and/or abut the tissue thickness compensator 10020 and, two, a top surface 10082 which can provide a pushing surface for the clinician to apply a downward force thereto, for example. In use, the clinician can grab a handle portion 10084 of the cover 10080, align the support portion 10010 of the staple cartridge 10000 with the staple cartridge channel, and at least partially insert the staple cartridge 10000 within the staple cartridge channel. Thereafter, the clinician can completely seat the staple cartridge 10000 in the staple cartridge channel by applying the downward force to the top surface 10082 of the cover 10880 which can, in various embodiments, transmit the downward force directly to the support portion 10010. In at least one such embodiment, the cover 10080 can comprise proximal supports 10087 which can extend downwardly and contact the deck surface 10011 of the support portion. In certain embodiments, the cover 10080 can further comprise a distal support portion 10083 which can be configured to abut the nose 10003. When a downward force is applied the cover 10080, the downward force can be transmitted through the proximal supports 10087 and/or the distal support portion 10083 without transmitting, or at least without substantially transmitting, the downward force to the support portion 10010 through the tissue thickness compensator 10020. In various circumstances, as a result of the above, the clinician may not directly contact the tissue thickness compensator 10020. Also as a result of the above, the cover 10080 may not compress, or at least substantially compress, the tissue thickness compensator 10020 as the staple cartridge 10000 is being inserted into the staple cartridge channel. In various embodiments, a cover can comprise any suitable number of supports which are configured to transmit a downward force to the support portion without transmitting, or at least substantially transmitting, the downward force through the tissue thickness compensator. In certain embodiments, the supports can extend around the distal end, the proximal end, and/or the longitudinal sides of the tissue thickness compensator. In some embodiments, the supports can extend through the tissue thickness compensator. In at least one such embodiment, the supports can extend through apertures within the tissue thickness compensator and abut the deck of the support portion. In certain embodiments, at least some of the supports may not be in contact with the deck before the downward force is applied to the cover; however, in various embodiments, the cover can be configured to flex, or move, downwardly until the supports contact the deck of the support portion. At such point, the downward flexure, or movement, of the cover can be impeded, or at least substantially impeded, from flexing further.


As described above, the cover 10080 can be attached to the staple cartridge 10000 and can be used to manipulate the position of the staple cartridge 10000. In various embodiments, the cover 10080 can comprise any suitable number of gripping members which can be configured to releasably hold the cover 10080 to the support portion 10010 of the staple cartridge 10000, for example. In at least one such embodiment, the cover 10080 can further comprise one or more retention members, such as latch arms 10088 and/or 10089, for example. In various embodiments, the latch arms 10089 can be configured to extend around the sides of the nose 10003 and engage the bottom surface 10009 (FIG. 306) of the nose 10003. Similarly, the latch arms 10088 can extend around the sides of lock projections 10008 extending from the support portion 10010 and engage the bottom surfaces of the lock projections 10008. These latch arms, in various embodiments, can be configured to position the cover 10080 over the zone or region in which the staples are stored within the support portion 10010. In any event, once the staple cartridge 10000 has been suitably positioned, the cover 10080 can be detached from the staple cartridge 10000. In at least one embodiment, the clinician can apply an upward lifting force to the handle 10084 in order to detach the distal end of the cover 10080 from the distal end 10002 of the staple cartridge 10000. In at least one such embodiment, the latch arms 10088 and 10089 can flex outwardly as the handle 10084 is lifted upwardly such that the latch arms 10088 and 10089 can flex around the lock projections 10008 and the nose 10003, respectively. Thereafter, the proximal end of the cover 10080 can be lifted away from the proximal end 10001 of the staple cartridge and the cover 10080 can be moved away from the staple cartridge 10000.


In certain embodiments, referring now to FIGS. 309 and 310, a staple cartridge applicator, such as staple cartridge applicator 10680, for example, can be configured to position an upper tissue thickness compensator, such as tissue thickness compensator 10690, for example, relative to an anvil in addition to positioning a staple cartridge, such as staple cartridge 10600, for example, within a staple cartridge channel Similar to the above, the applicator 10680 can comprise latch arms 10688 which can be releasably engaged with lock projections 10608 extending from a support portion 10610 of the staple cartridge 10600 such that the applicator 10680 can be maintained in position over a tissue thickness compensator 10620 of the staple cartridge 10600. In various embodiments, the upper tissue thickness compensator 10690 can be removably attached to the staple cartridge applicator 10680 such that the anvil of a surgical instrument, such as anvil 10060, for example, can be closed onto the applicator 10680, engage the tissue thickness compensator 10690, and detach the tissue thickness compensator 10690 from the applicator 10680. In various embodiments, the tissue thickness compensator 10690 and/or the anvil 10060 can comprise one or more retention features which can be configured to releasably hold the tissue thickness compensator 10690 to the anvil 10060. In at least one such embodiment, the tissue thickness compensator 10690 can comprise a longitudinal rail 10695, for example, extending from the top surface 10691 of the tissue thickness compensator 10690 which can be received within a longitudinal knife slot 10065 defined within the anvil 10060. In various embodiments, the tissue thickness compensator 10690 and the longitudinal rail 10695 can be comprised of any suitable compressible material, such as those described in the this patent application, for example, wherein the longitudinal rail 10695 can be compressed and/or wedged within the knife slot 10065, for example. Once the anvil 10060 has been engaged with the tissue thickness compensator 10690, the anvil 10060 can be returned to an open position and, in such circumstances, the tissue thickness compensator 10690 can detach from the applicator 10680. Thereafter, the applicator 10680 can be detached from the staple cartridge 10600 such that the anvil 10060 and the staple cartridge 10600 can be positioned relative to the tissue that is to be stapled and/or incised. In use, a staple-deploying sled, such as sled 10050 (FIG. 236), for example, can be advanced distally through the staple cartridge 10600 by a firing member 10052 (FIG. 236), for example, in order to eject the staples from the staple cartridge 10060, as outlined above. As the staples are deformed, each staple can capture a portion of the tissue thickness compensator 10690 against the top surface of the tissue and a portion of the tissue thickness compensator 10620 against the bottom surface of the tissue. At the same time, the firing member 10052 can advance a knife edge 10053 (FIG. 236) through the tissue thickness compensator 10620 and/or the tissue thickness compensator 10690 wherein, in at least one embodiment, the knife edge 10053 can be advanced through the longitudinal rail 10695 in order to incise the rail 10695 and progressively detach the tissue thickness compensator 10690 from the anvil 10060. After the staples have been deployed, the anvil 10060 can be re-opened and moved away from the implanted tissue thickness compensator 10690 and, similarly, the support portion 10610 of the staple cartridge 10600 can be moved away from the implanted tissue thickness compensator 10620. In various embodiments, further to the above, the tissue thickness compensator 10620 and/or the tissue thickness compensator 10690 can comprise a plurality of detachable segments which can be configured to separate from one another in the event that only portions of the tissue thickness compensators 10620 and 10690 are implanted by the staples.


In various embodiments, further to the above, the applicator 10680 can comprise one or more retention features which can be configured to releasably hold the tissue thickness compensator 10690 to the applicator 10680. In at least one such embodiment, referring primarily to FIG. 310, the applicator 10680 can comprise a longitudinal retention rail 10685 which can be configured to be received in a longitudinal retention slot 10694 defined in the bottom surface 10692 of the tissue thickness compensator 10690 in a press-fit manner, for example. In various circumstances, the retention rail 10685 and the retention slot 10694 can be configured to retain the tissue thickness compensator 10690 to the applicator 10680 until a sufficient upward lifting force is applied to the tissue thickness compensator 10690 by the anvil 10060, as described above. In at least one such embodiment, the retention rail 10685 extending from the applicator 10680 can further comprise end stops 10686 positioned at the proximal and distal ends of the retention rail 10685 which can be configured to prevent, or at least limit, relative longitudinal movement between the tissue thickness compensator 10690 and the applicator 10680. In certain embodiments, referring again to FIG. 310, one or more adhesives, such as longitudinal adhesive strips 10693, for example, can be placed on the contact surface 10691 of the tissue thickness compensator 10690 such that, when the anvil 10060 contacts the tissue thickness compensator 10690, as described above, the adhesive can releasably attach the tissue thickness compensator 10690 to the anvil 10060. In various embodiments, one or more adhesives can be utilized in addition to or in lieu of the compressible retention features described above, for example. In certain embodiments, one or more adhesives can be utilized to releasably hold a tissue thickness compensator to a staple cartridge applicator. In at least one embodiment, referring now to FIG. 310A, the cover 10080, for example, can include one or more adhesive pads 12185 which can be configured to releasably retain an upper tissue thickness compensator, such as tissue thickness compensator 12190, for example, to the top surface 10082 of the cover 10080. In at least one such embodiment, similar to the embodiments described above, an anvil can be closed onto to the tissue thickness compensator 12190 to engage the longitudinal retention rail 12195 of the tissue thickness compensator 12190. In certain embodiments, a release mechanism can be positioned intermediate the tissue thickness compensator 12190 and the cover 10080 which can be utilized to break the adhesive bonds holding the tissue thickness compensator 12190 to the cover 10080 and detach the tissue thickness compensator 12190 from the cover 10080. In at least one embodiment, the release mechanism can comprise a pull tab 12196 and a loop 12197 wherein the loop 12197 can comprise first and second ends which are attached to the pull tab 12196. The loop 12197 can comprise a suture, for example, which can define a perimeter which circumscribes the adhesive pads 12185 such that, when the pull tab 12196 is pulled distally, the suture can slide between the tissue thickness compensator 12190 and the cover 10080 and contact the tissue pads 12185. In such circumstances, the suture can at least one of separate the adhesive pads 12185 from the tissue thickness compensator 12190, separate the adhesive pads 12185 from the cover 10080, and/or sever the adhesive pads 12185, for example.


In various embodiments, referring now to FIG. 311, a staple cartridge can comprise a support portion 10710, for example, which, similar to the above, can comprise a longitudinal knife slot 10715 extending therethrough. In at least one such embodiment, a staple cartridge applicator, such as applicator 10780, for example, can comprise a longitudinal retention and alignment member 10786 which can extend into the knife slot 10715 in the support portion 10710. In certain embodiments, the retention member 10786 can be configured to engage the sidewalls of the knife slot 10715 in a press-fit manner, for example, such that the applicator 10780 can be releasably retained to the support portion 10710. In various embodiments, although not illustrated, a first portion of a tissue thickness compensator can be positioned on a first side of the retention member 10786 and a second portion of the tissue thickness compensator can be positioned on an opposite, or second, side of the retention member 10786. Similar to the above, the first and second portions of the tissue thickness compensator can be mounted to the support portion 10710 of the staple cartridge via retention members 10013, for example. Also similar to the above, an upper tissue thickness compensator 10790 can be removably mounted to the applicator 10780 via a longitudinal retention member 10785 extending from the loading surface 10782 of the applicator 10780 wherein the retention member 10785 can be releasably press-fit into a longitudinal slot 10794 defined in the bottom surface 10792 of the tissue thickness compensator 10790, for example. In various embodiments, also similar to the above, the tissue thickness compensator 10790 can further comprise a longitudinal retention member 10795 extending from the top surface 10791 of the tissue thickness compensator 10790 which can be releasably retained in the longitudinal knife slot 10065 defined in the anvil 10060, for example. In at least one such embodiment, the longitudinal retention member 10795 can comprise a wedge-shaped cross-section comprising a top portion which is larger than a bottom portion, wherein the bottom portion can attach the retention member 10795 to the tissue thickness compensator 10790, for example.


In various embodiments, referring now to FIGS. 312 and 313, a staple cartridge 10800 comprising a support portion 10810 and a tissue thickness compensator 10820 can be loaded into a staple cartridge channel with a staple cartridge applicator 10880, for example Similar to the above, the staple cartridge applicator 10880 can also be configured to position an upper tissue thickness compensator 10890, for example, relative to an anvil, such as anvil 10060, for example, such that, when the anvil 10060 is closed, the anvil 10060 can contact and engage the tissue thickness compensator 10890. In at least one embodiment, the tissue thickness compensator 10890 can comprise a plurality of retention legs 10895 extending from the top surface 10891 of the tissue thickness compensator 10890 which can be configured to be engage the anvil 10060 and releasably retain the tissue thickness compensator 10890 to the anvil 10060. In at least one such embodiment, the legs 10895 can be arranged in a longitudinal row wherein each leg 10895 can comprise at least one foot configured to enter into and engage the knife slot 10065 defined in the anvil 10060. In certain embodiments, some of the feet of legs 10895 can extend in one direction while other feet can extend in another direction. In at least one embodiment, some of the feet can extend in opposite directions. In any event, once the anvil 10060 has been engaged with the tissue thickness compensator 10890, referring now to FIGS. 313 and 314, the anvil 10060 can be reopened and the clinician can move the staple cartridge applicator 10880 away from the tissue thickness compensators 10820 and 10890. Thereafter, referring to FIG. 314A, the upper tissue thickness compensator 10890 can be positioned on a first side of the targeted tissue and the tissue thickness compensator 10820, which can comprise a lower tissue thickness compensator, can be positioned on a second side of the tissue. After the tissue thickness compensators 10820 and 10890 have been suitably positioned, referring now to FIG. 314B, a knife edge of a firing member, such as knife edge 10053, for example, can be advanced through the tissue and the tissue thickness compensators. In various embodiments, referring now to FIG. 318, a staple cartridge applicator, such as applicator 12280, for example, can comprise a tissue thickness compensator 12290 detachably mounted thereto which can be, similar to the above, inserted into a staple cartridge channel, as illustrated in FIG. 319, and engaged by the anvil 10060 when the anvil 10060 is moved into a closed position. In at least one such embodiment, the tissue thickness compensator 12290 can comprise a plurality of retention members 12295 extending upwardly from the top surface 12291 of the tissue thickness compensator 12290 wherein each retention member 12295 can comprise a plurality of flexible legs 12296 which can be configured to be inserted into the knife slot 10065 in the anvil 10060. Referring primarily to FIGS. 321 and 322, the flexible legs 12296 of each retention member 12295 can be separated by a gap 12298 such that, as the legs 12296 are inserted into the knife slot 10065, the legs 12296 can flex inwardly and then resiliently return outwardly once the enlarged feet of the flexible legs 12296 have passed through the knife slot 10065. In various embodiments, the enlarged feet of the flexible legs 12296 can flex behind opposing retention lips 12297 defined in the anvil 10060 and, as a result of the interaction of the legs 12296 and the lips 12297, the tissue thickness compensator 12290 can be retained to the anvil 10060. Thereafter, the staple cartridge applicator 12280 can be moved away from the tissue thickness compensator 12290, as illustrated in FIG. 320. In use, once the tissue thickness compensator 12290 has been implanted against the tissue by staples deployed from staple cartridge 10000, for example, the anvil 10060 can be re-opened and, as the anvil 10060 is moved away from the implanted tissue thickness compensator 12290, the legs 12296 of the retention members 12995 can flex inwardly such that they can be pulled out of the knife slot 10065.


In various embodiments, referring now to FIGS. 315 and 316, a tissue thickness compensator, such as tissue thickness compensator 11990, for example, can be loaded longitudinally into an anvil, such as anvil 11960, for example. More particularly, in at least one embodiment, the tissue thickness compensator 11990 can comprise one or more longitudinal rails 11995 which can be inserted into a distal opening in a knife slot 11965 of the anvil 11960 and then pushed proximally until the tissue thickness compensator 11990 has been properly seated in the anvil 11960. In at least one such embodiment, each rail 11995 can comprise a longitudinal retention foot 11996 which can be positioned behind a longitudinal retention lip 11997 which at least partially defines the knife slot 11965, for example. As illustrated in FIG. 316, the feet 11996 can extend in opposite directions in order to be positioned behind retention lips 11997 positioned on the opposite sides of the knife slot 11965. In various embodiments, a longitudinal gap 11998 can be defined between the rails 11995 which can be configured to permit the rails 11995 to flex inwardly toward one another when the tissue thickness compensator 11990 is detached from the anvil 11960. In certain embodiments, referring now to FIG. 317, a tissue thickness compensator, such as tissue thickness compensator 12090, for example, can comprise one or more lock arms 12098 which can extend around the sides of an anvil, such as anvil 12060, for example. In use, the lock arms 12098 can engage the anvil 12060 and releasably retain the tissue thickness compensator 12090 to the anvil 12060. In at least one such embodiment, the anvil 12060 can comprise one or more notches, or lock shoulders, 12097, for example, which can each be configured to receive a foot extending from a lock arm 12098. In use, the arms 12098 can flex outwardly and detach from the anvil 12060 when the anvil 12060 is moved away from the tissue thickness compensator 12090 after the tissue thickness compensator 12090 has been at least partially implanted.


As described above, a surgical stapling instrument can comprise a staple cartridge channel configured to receive a staple cartridge, an anvil rotatably coupled to the staple cartridge channel, and a firing member comprising a knife edge which is movable relative to the anvil and the staple cartridge channel. In use, a staple cartridge can be positioned within the staple cartridge channel and, after the staple cartridge has been at least partially expended, the staple cartridge can be removed from the staple cartridge channel and replaced with a new staple cartridge. In some such embodiments, the staple cartridge channel, the anvil, and/or the firing member of the surgical stapling instrument may be re-used with the replacement staple cartridge. In certain other embodiments, a staple cartridge may comprise a part of a disposable loading unit assembly which can include a staple cartridge channel, an anvil, and/or a firing member, for example, which can be replaced along with the staple cartridge as part of replacing the disposable loading unit assembly. Certain disposable loading unit assemblies are disclosed in U.S. patent application Ser. No. 12/031,817, entitled END EFFECTOR COUPLING ARRANGEMENTS FOR A SURGICAL CUTTING AND STAPLING INSTRUMENT, now U.S. Patent Application Publication No. 2009/0206131, which was filed on Feb. 15, 2008, the entire disclosure of which is incorporated by reference herein. Referring now to FIG. 370, a disposable loading unit, such as disposable loading unit 12500, for example, can comprise a support portion 12510, an anvil 12560 rotatably coupled to the support portion 12510, and an elongate shaft 12570 extending from the support portion 12510. Similar to the staple cartridges described herein, the support portion 12510 can comprise a plurality of staple cavities 10012 and a staple, such as a staple 10030, for example, positioned in each staple cavity 10012, for example. The disposable loading unit 12500 can further comprise a firing member 12552 which can be advanced distally in order to move the anvil 12560 from an open position, as illustrated in FIG. 370, to a closed position. In various embodiments, the disposable loading unit 12500 can further comprise a tissue thickness compensator 12520 positioned on and/or attached to the support portion 12510 wherein, when the anvil 12560 is in its closed position, the anvil 12560 can be positioned opposite the tissue thickness compensator 12520 and, in some embodiments, the anvil 12560 can at least partially compress the tissue thickness compensator 12520 when the anvil 12560 is in its closed position. In either event, the firing member 12552 can be advanced further in order to eject the staples from the support portion 12510. As the staples are ejected, the staples can be deformed by the anvil 12560 and trap at least a portion of the tissue thickness compensator 12520 therein. Thereafter, the firing member 12552 can be retracted proximally, the anvil 12560 can be re-opened, and the support portion 12510 can be moved away from the implanted tissue thickness compensator 12520.


In various embodiments, further to the above, the tissue thickness compensator 12520 can be detachably mounted to the support portion 12510. In at least one such embodiment, the support portion 12510 can comprise a longitudinal retention rail 12526 mounted to each side thereof wherein each rail 12526 can comprise one or more apertures 12528 which can be configured to receive at least a portion of the tissue thickness compensator 12520 therein. Once the tissue thickness compensator 12520 has been at least partially implanted, the tissue thickness compensator 12520 can pull out of the apertures 12528 as the support portion 12510 is moved away. In various embodiments, referring now to FIGS. 371-373, a disposable loading unit 12600 can comprise a support portion 12610, a tissue thickness compensator 12620 detachably mounted to the support portion 12610, and one or more retention rails 12626 which can be configured to extend under the tissue thickness compensator 12620 and mount the tissue thickness compensator 12620 to the support portion 12610. Each retention rail 12626 can comprise a plurality of retention hooks 12628, for example, which can be engaged to the support portion 12610 via retention slots 12614, for example, defined in the support portion 12610. In use, in at least one such embodiment, the tissue thickness compensator 12620 can be configured to detach from the retention rails 12626 after the tissue thickness compensator 12620 has been at least partially implanted and the support portion 12610 is moved away from the tissue thickness compensator 12620. In various embodiments, referring now to FIGS. 374-376, a disposable loading unit 12700 can comprise one or more retention rails 12726 which can each comprise a bottom bar 12725 which can extend under the tissue thickness compensator 12720 and a top bar 12727 which can extend over the top surface 12621 of the tissue thickness compensator 12620. In certain embodiments, the tissue thickness compensator 12620 can be at least partially compressed between the top bars 12727 and the bottom bars 12725 such that the retention rails 12726 can releasably hold the tissue thickness compensator 12620 relative to the support portion 12610. In at least one such embodiment, each retention rail 12726 can comprise one or more retention hooks 12728 which can be engaged with the support portion 12610 to retain the retention rails 12726 to the support portion 12610.


In various embodiments, referring now to FIGS. 377 and 378, a disposable loading unit 12800 can comprise a retention member 12822 which can be configured to mount a tissue thickness compensator 12620 to the support portion 12610. In at least one such embodiment, the retention member 12822 can comprise a sheet of material positioned against the deck surface 12611 of the support portion wherein the tissue thickness compensator 12620 can be attached to the sheet of material by at least one adhesive, for example. The retention member 12822 can further comprise a longitudinal retention rail 12825 configured to extend downwardly into a knife slot 12615 defined in the support portion 12610. In at least one such embodiment, the retention rail 12825 can be sized and configured such that it is compressed between the sidewalls of the knife slot 12615. In use, the firing member 12552 can comprise a knife edge which can pass through the knife slot 12615 as the firing member 12552 is advanced distally and transect the tissue thickness compensator 12620 and the retention rail 12825 longitudinally. Also, in use, the staples ejected from the support portion 12610 can penetrate the retention member 12822, the tissue thickness compensator 12820, and the tissue positioned between the tissue thickness compensator 12820 and the anvil 12560. In various embodiments, the retention member 12822 can be comprised of a biocompatible and/or bioabsorbable material. In certain embodiments, the retention member 12822 can be comprised of a sufficiently compressible material to comprise a tissue thickness compensator underlying the tissue thickness compensator 12620. In various embodiments, referring now to FIGS. 379-381, a disposable loading unit 12900 can comprise a loading assembly including a bottom portion 12922 which can be removably attached to the support portion 12610, a top portion 12990 which can be removably attached to the anvil 12560, and a flexible joint 12991 connecting the bottom portion 12922 and the top portion 12990. Similar to the above, a longitudinal retention rail 12825 can extend downwardly from the bottom portion 12922 and into the knife slot 12615 defined in the support portion 12610 such that the bottom portion 12922 can be releasably retained to the support portion 12610. Similarly, a longitudinal retention rail 12995 can extend upwardly from the top portion 12990 into a knife slot defined in the anvil 12560 such that the top portion 12990 can be releasably retained to the anvil 12560. As illustrated in FIGS. 380 and 381, a tissue thickness compensator 12620 can be mounted to the bottom portion 12922 of the loading assembly wherein, in order to position the tissue thickness compensator 12620 relative to the support portion 12610, a clinician could flex the top portion 12990 and the bottom portion 12922 toward one another, position the loading assembly between the anvil 12560 and the support portion 12610, and release the flexed loading assembly such that it can resiliently expand and bias the top portion 12990 against the anvil 12560 and the bottom portion 12922 against the support portion 12610. In at least one embodiment, referring now to FIGS. 382-384, the loading assembly can further comprise one or more latch hooks, such as latch hooks 12994, for example, extending therefrom which can be configured to releasably connect the top portion 12990 to the anvil 12560 and/or releasably connect the bottom portion 12922 to the support portion 12610.


In various embodiments, referring now to FIG. 385, a disposable loading unit 15900, for example, can comprise an anvil 15960 and a staple cartridge channel 15970 wherein the staple cartridge channel 15970 can rotate relative to the anvil 15960. In at least one such embodiment, the anvil 15960 may not be able to rotate. In certain embodiments, tissue can be positioned between the anvil 15960 and the staple cartridge channel 15970 and, thereafter, the staple cartridge channel 15970 can be rotated toward the tissue to clamp the tissue against the anvil. In at least one such embodiment, the disposable loading unit 15900 can further comprise a tissue thickness compensator 15920 which can be configured to contact the tissue.


As discussed above and referring to FIG. 332, a staple cartridge, such as staple cartridge 10000, for example, can comprise a support portion 10010 and a tissue thickness compensator 10020 wherein a plurality of staples 10030 can be at least partially stored in the support portion 10010 and can extend into the tissue thickness compensator 10020 when the staples 10030 are in their unfired position. In various embodiments, the tips of the staples 10030 do not protrude from the tissue thickness compensator 10020 when the staples 10030 are in their unfired positions. As the staples 10030 are moved from their unfired positions to their fired positions by the staple drivers 10040, as discussed above, the tips of the staples 10030 can penetrate through the tissue thickness compensator 10020 and/or penetrate through the upper layer, or skin, 10022. In certain alternative embodiments, the tips of the staples 10030 can protrude through the top surface of the tissue thickness compensator 10020 and/or skin 10022 when the staples 10030 are in their unfired position. In either event, the staples 10030, as they extend upwardly out of the support portion 10010 prior to being deployed, may tilt and/or deflect relative to the support portion, as also discussed above. In various embodiments, referring now to FIG. 329, a staple cartridge, such as staple cartridge 13000, for example, can comprise a plurality of guide members, or retainers, which can be configured to limit relative movement between the support portion 13010 of the staple cartridge 13000 and the tips of the staples positioned therein. Referring primarily to FIG. 330, the staple cartridge 13000 can comprise a tissue thickness compensator 13020 mounted to a support portion 13010 and, in addition, a plurality of pledgets 13022 attached to the top surface 13021 of the tissue thickness compensator 13020. In various embodiments, each pledget 13022 can comprise a plurality of apertures 13029 defined therein which can be configured to slidably receive and/or guide the legs 13022 of a staple 13030 therein. In addition to or in lieu of the apertures, a pledget can comprise any suitable opening such as a slot, guide, and/or groove, for example, which can be configured to slidably receive and/or guide the legs 13022. In certain embodiments, as illustrated in FIG. 330, the tips of the staple legs 13032 can be positioned within the apertures 13029 when the staples 13030 are in their unfired positions. In at least one such embodiment, the tips of the staple legs 13032 can protrude above the pledgets 13022 when the staples are in their unfired position. In certain other embodiments, the tips of the staple legs 13032 may be positioned just below the pledgets 13022 when the staples 13030 are in their unfired positions such that, when the staples 13030 are moved upwardly through the tissue thickness compensator 13020, the staple legs 13032 can enter into the apertures 13029 of the pledgets 13022 and slide therethrough. In any event, when the legs 13032 of the staples 13030 are positioned within the pledgets, the lateral and/or longitudinal movement of the staple legs 13032 can be limited without preventing the upward movement of the staple legs 13032 when the staples 13030 are deployed. When the staples 13030 are deployed, referring now to FIG. 331, the staple legs 13032 can slide upwardly through the pledgets 13022 to penetrate the tissue T, contact an anvil positioned opposite the staple cartridge 13030, and deform downwardly to capture the tissue T and the tissue thickness compensator 13030 therein.


In various embodiments, further to the above, the pledgets 13022 can be attached to the tissue thickness compensator 13020 utilizing at least one biocompatible and/or bioabsorbable adhesive, for example. In certain embodiments, the pledgets 13022, and/or a retention member extending from each pledget, can be at least partially embedded within the tissue thickness compensator 13020. In at least one such embodiment, the tissue thickness compensator 13020 can comprise pockets defined therein which are configured to at least partially receive a pledget 13022. In certain embodiments, the tissue thickness compensator 13020 can be integrally molded, or formed around, the pledgets 13022 during a molding manufacturing process. In various embodiments, the pledgets 13022 may comprise discrete retainers that can move independently of one another. In at least one embodiment, referring primarily to FIG. 330, each pledget 13022 can comprise interlocking and/or keyed features which can be configured to permit and, to a certain extent, limit relative lateral and longitudinal movement between the pledgets 13022. In at least one such embodiment, each pledget 13022 can comprise a projection 13026 and one or more recesses 13027, for example, wherein the projection 13026 of a first pledget 13022 can be positioned within and/or aligned with respect to the recesses of 13027 of adjacent second and third pledgets 13022. In various embodiments, gaps can be present between adjacent pledgets 13022 which can permit the pledgets 13022 to move or slide relative to one another until they contact an adjacent pledget 13022. In certain embodiments, the pledgets 13022 can be loosely interconnected. In various embodiments, the pledgets 13022 can be detachably connected to one another. In at least one such embodiment, the pledgets 13022 can be manufactured as a sheet of interconnected pledgets wherein, when a sufficient force is applied to the sheet, one or more of the pledgets 13022 can break away from the others. In certain embodiments, referring again to FIG. 329, a first sheet 13024 of pledgets 13022 can be positioned on a first side of a longitudinal slot 13025 and a second sheet 13024 of pledgets 13022 can be positioned on a second side of slot 13025. In at least one embodiment, further to the above, the longitudinal slot 13025 extending through the tissue thickness compensator 13020 can be configured to facilitate the passage of a knife edge of a firing member through the tissue thickness compensator 13020 and, as the firing member passes thereby, the firing member can apply a compressive force to the sheets 13024 and separate or singulate at least some of the pledgets 13022.


In various embodiments, the pledgets 13022 can be comprised of a biocompatible and/or bioabsorbable plastic, for example. In certain embodiments, the pledgets 13022 can be comprised of a solid material, a semi-solid material, and/or a flexible material, for example. In certain embodiments, the pledgets 13022 can be embedded within a tissue thickness compensator such that the pledgets 13022 move with the tissue thickness compensator. In at least one such embodiment, the pledgets 13022 can be sufficiently flexible such that they can flex with the top surface of the tissue thickness compensator. In certain embodiments, the pledgets 13022 can be configured to remain embedded in the tissue thickness compensator while, in certain other embodiments, the pledgets 13022 can be configured to pop out of, or detach from, the tissue thickness compensator. In various embodiments, the pledges 13022 can comprise a top surface which is flush with the top surface of the tissue thickness compensator. In certain embodiments, the top surfaces of the pledgets 13022 can be positioned above and/or below the top surface of the tissue thickness compensator. In various embodiments, the top surfaces of the pledgets 13022 can be disposed such that they are visible when viewing the top surface of the tissue thickness compensator while, in other embodiments, the top surfaces of the pledgets 13022 can be positioned below a layer of the tissue thickness compensator, for example. In certain embodiments, guide features can be molded into the top surface of a tissue thickness compensator, for example. In at least one such embodiment, the tissue thickness compensator may not comprise a composite material and may comprise a unitary piece of material, for example.


In various embodiments, referring now to FIG. 338, a staple cartridge can comprise a tissue thickness compensator 13620 and a skin, or top layer, 13621, for example. In at least one such embodiment, one or more pledgets, or retainers, 13622, for example, can be embedded in the skin 13621. In certain embodiments, each retainer 13622 can comprise one or more apertures 13629 defined therein which can be configured to receive the staple legs 13032 of staples 13030 therein when the staples 13030 are in their unfired position, as illustrated in FIG. 338. In use, further to the above, the staple legs 10032 can slide through the apertures 13629 when the staples 13030 are moved from their unfired position to their fired position until the bases 13031 of the staples 13030 contact the tissue thickness compensator 13620 and compress at least a portion of the tissue thickness compensator 13620 against the bottom surfaces of the pledgets 13622, for example. In various embodiments, referring now to FIG. 333, a staple cartridge can comprise a tissue thickness compensator 13120 and a skin, or top layer, 13122, for example. In at least one such embodiment, the tissue thickness compensator 13120 can comprise conical bumps, projections, and/or protrusions 13128, for example, which can extend upwardly from the top surface 13121 of the tissue thickness compensator 13120. The projections 13128 can be configured to receive and envelop the tips of the staple legs 13032 of the staples 13030 when the staples 13030 are in their unfired position, as illustrated in FIG. 333. The top layer 13122 can also comprise conical bumps, projections, and/or protrusions 13129 which can be aligned, or at least substantially aligned, with the projections 13128. In use, the staple legs 10032 can penetrate the projections 13128 and 13129 and emerge from the tissue thickness compensator 13120. In various embodiments, referring now to FIG. 337, a staple cartridge can comprise a tissue thickness compensator 13520 and a skin, or top layer, 13522, for example. In at least one such embodiment, the skin 13522 can comprise conical bumps, projections, and/or protrusions 13529, for example, which can extend upwardly from the top surface 13521 of the tissue thickness compensator 13520. Similar to the above, the projections 13529 can be configured to receive and envelop the tips of the staple legs 13032 of the staples 13030 when the staples 13030 are in their unfired position, as illustrated in FIG. 337. In use, the staple legs 10032 can penetrate the projections 13529 and emerge from the skin 13522.


In various embodiments, referring now to FIG. 334, a staple cartridge can comprise a tissue thickness compensator 13220 and a skin, or top layer, 13222, for example. In at least one such embodiment, the tissue thickness compensator 13220 can comprise conical dimples and/or recesses 13128, for example, which can extend downwardly into the top surface 13221 of the tissue thickness compensator 13220. In various embodiments, the tips of the staple legs 13032 can extend through the recesses 13128 when the staples 13030 are in their unfired position, as illustrated in FIG. 334. In at least one embodiment, the top layer 13222 can also comprise conical dimples and/or recesses 13229 which can be aligned, or at least substantially aligned, with the recesses 13228. In various embodiments, referring now to FIG. 335, a staple cartridge can comprise a tissue thickness compensator 13320 and a skin, or top layer, 13322, for example. In at least one such embodiment, the skin 13320 can comprise thick portions 13329 which can extend downwardly into the top surface 13321 of the tissue thickness compensator 13320. In various circumstances, the thick portions 13329 can be configured to receive at least a portion of the staple legs 13032 of the staples 13030 therein when the staples 13030 are in their unfired position, as illustrated in FIG. 335. In such embodiments, the thick portions 13329 can hold the staple legs 13032 in position such that the legs 13032 are aligned, or at least substantially aligned, with the staple-forming pockets of an anvil positioned opposite the tissue thickness compensator 13320. In various embodiments, referring now to FIG. 336, a staple cartridge can comprise a tissue thickness compensator 13420 and a skin, or top layer, 13422, for example. In at least one such embodiment, the skin 13422 can comprise thick portions 13429 which can extend upwardly from the top surface 13421 of the tissue thickness compensator 13420. In various circumstances, the thick portions 13429 can be configured to receive at least a portion of the staple legs 13032 of the staples 13030 therein when the staples 13030 are in their unfired position, as illustrated in FIG. 336. In such embodiments, the thick portions 13429 can hold the staple legs 13032 in position such that the legs 13032 are aligned, or at least substantially aligned, with the staple-forming pockets of an anvil positioned opposite the tissue thickness compensator 13420.


In various embodiments, referring now to FIGS. 339 and 340, a staple cartridge can comprise a tissue thickness compensator 13720 and a skin, or top layer, 13721, for example. In at least one such embodiment, the tissue thickness compensator 13720 can comprise pyramidal and/or stepped bumps, projections, and/or protrusions 13728, for example, which can extend upwardly from the top surface 13721 of the tissue thickness compensator 13720. The projections 13728 can be configured to receive and envelop the tips of the staple legs 13032 of the staples 13030 when the staples 13030 are in their unfired position, as illustrated in FIG. 340. Similarly, the top layer 13721 can comprise pyramidal and/or stepped bumps, projections, and/or protrusions 13729 which can be aligned, or at least substantially aligned, with the projections 13728. In various embodiments, the skin 13721 can further comprise one or more teeth 13727 extending upwardly from the projections 13729 which can be configured to engage tissue positioned against the top layer 13721 and prevent, or at least limit, relative lateral and/or longitudinal movement between the tissue, the top layer 13721, and/or the tips of the staple legs 13032. In use, the staple legs 13032 can penetrate the projections 13728 and 13729 and emerge from the tissue thickness compensator 13720 when the staples 13030 are moved from their unfired positions to their fired positions. In various embodiments, referring now to FIGS. 341 and 342, a staple cartridge can comprise a tissue thickness compensator 13820 and a skin, or top layer, 13821, for example. In at least one such embodiment, the tissue thickness compensator 13820 can comprise pyramidal and/or stepped bumps, projections, and/or protrusions 13828, for example, which can extend upwardly from the top surface 13821 of the tissue thickness compensator 13820. The projections 13828 can be configured to receive and envelop the tips of the staple legs 13032 of the staples 13030 when the staples 13030 are in their unfired position, as illustrated in FIG. 342. Similarly, the top layer 13821 can comprise pyramidal and/or stepped bumps, projections, and/or protrusions 13829 which can be aligned, or at least substantially aligned, with the projections 13828. In various embodiments, the top layer 13821 can further comprise one or more teeth 13827 extending downwardly into the tissue thickness compensator 13820 which can be configured to prevent, or at least limit, relative lateral and/or longitudinal movement between the top layer 13821 and the tissue thickness compensator 13820, for example. In use, the staple legs 10032 can penetrate the projections 13828 and 13829 and emerge from the tissue thickness compensator 13820 when the staples 13030 are moved from their unfired positions and their fired positions.


In various embodiments, referring now to FIG. 343, a staple cartridge can comprise a tissue thickness compensator, such as tissue thickness compensator 13920, for example, which can include ridges 13923 and valleys 13924 defined therein wherein, in at least one embodiment, the valleys 13924 can be defined between the ridges 13923. In various embodiments, each ridge 13923 can comprise the same height, substantially the same height, or different heights. Similarly, each valley 13924 can comprise the same depth, substantially the same depth, or different depths. In various embodiments, a plurality of staples 13030 can be at least partially stored within the tissue thickness compensator 13920 such that the tips of the staples 13030 can be positioned within the ridges 13923. In at least one such embodiment, the staple legs 13032 of the staples 13030 may not protrude from the tissue thickness compensator 13920 and/or a skin, or top layer, 13921 attached to the tissue thickness compensator 13920, for example, when the staples 13030 are stored in their unfired position. In various embodiments, the ridges 13923 and/or the valleys 13924 can extend laterally across the staple cartridge. In at least one such embodiment, the staple cartridge can comprise a longitudinal knife slot wherein the ridges 13923 and the valleys 13924 can extend in a direction which is transverse and/or perpendicular to the knife slot. In various circumstances, the ridges 13923 can be configured to hold the tips of the staple legs 13032 in position until the staples 13030 are moved from their unfired position into their fired position. In various embodiments, referring now to FIG. 344, a tissue thickness compensator, and/or a skin covering a tissue thickness compensator, can comprise longitudinal ridges and/or valleys. In at least one such embodiment, a tissue thickness compensator can comprise a top surface defined by ridges 14023 and valleys 14024, wherein the valleys 14024 can be defined between the ridges 14023, for example. In various embodiments, the tissue thickness compensator can comprise a skin 14021 which can include a plurality of apertures 14029 defined therein which can each be configured to receive a staple leg 13032. In certain embodiments, the apertures 14029 can be defined in the ridges 14023 wherein the tips of the staple legs 13032 may be positioned below the peaks 14028 of the ridges 14029, positioned flush with the peaks 14028, and/or positioned above the peaks 14028. In certain embodiments, in addition to or in lieu of the above, the apertures 14029 can be defined in the valleys 14024, for example. In certain embodiments, each aperture can be surrounded, or at least partially surrounded, by an embossment, for example, which can strengthen the skin and/or tissue thickness compensator surrounding the apertures. In any event, further to the above, the skin 14021 can be attached to a tissue thickness compensator in any suitable manner, including using at least one adhesive, for example.


As described above and referring again to FIG. 233, a surgical stapling instrument can comprise an anvil, such as anvil 10060, for example, which can be moved between an open position and a closed position in order to compress tissue T against the tissue thickness compensator 10020 of a staple cartridge 10000, for example. In various circumstances, the anvil 10060 can be rotated toward the staple cartridge 10000 until its downward movement is stopped by some portion of the staple cartridge 10000 and/or some portion of the channel in which the staple cartridge 10000 is positioned. In at least one such circumstance, the anvil 10060 can be rotated downwardly until its downward movement is resisted by the nose 10003 of the staple cartridge 10000 and/or the tissue T positioned intermediate the nose 10003 and the staple cartridge 10000. In some circumstances, the anvil 10060 may sufficiently compress the tissue thickness compensator 10020 to permit the tissue T to contact the tips of the staples 10030. In certain circumstances, depending on the thickness of the tissue T, the anvil 10060 may sufficiently compress the tissue thickness compensator 10020 such that the anvil 10060 comes into contact with the staples 10030 by the time the anvil 10060 has reached its fully closed position. Stated another way, in such circumstances, the anvil 10060 may deform the staples 10030 prior to the firing member 10052 being advanced into the staple cartridge 10000 to fire the staples 10030. Such circumstances may be acceptable in certain embodiments; however, referring now to FIGS. 358 and 359, other embodiments are envisioned in which a distal gap-setting element, such as element 10059, for example, can be utilized to limit the distance in which the anvil 10060 can be closed prior to the firing bar 10052 being advanced into the staple cartridge 10000. In various embodiments, the element 10059 can extend upwardly from the top surface 10021 of the tissue thickness compensator 10020 such that the downward movement of the anvil 10060 can be arrested as the tissue T is compressed against the element 10059 and a resistive force is generated therebetween. In use, as described above, the firing member 10052 can be advanced distally into the staple cartridge 10000 toward the distal end 10002 of the staple cartridge 10000 in order to eject the staples 10030 from the support portion 10010. Simultaneously, the firing member 10052 can engage the anvil 10060 and position the anvil 10060 a desired distance from the deck surface 10011 (FIG. 218) of the support portion 10010 over the staples 10030 being formed. In this way, the firing member 10052 can control the distance, or gap, between the tissue-contacting surface of the anvil 10060 and the deck surface 10011 at a particular location, wherein this particular location can be advanced distally as the firing member 10052 is advanced distally. In various circumstances, this gap distance may be shorter than the gap between the anvil 10060 and the deck surface 10011 being controlled or dictated by the distal gap-setting element 10059 at the distal end of the tissue thickness compensator 10020. In various embodiments, referring now to FIG. 359, the knife edge 10053 of the firing member 10052 can be configured to transect the distal gap-setting element 10059 when the firing member 10052 reaches the distal end of the tissue thickness compensator 10020 such that, after the element 10059 has been transected, the firing member 10052 can pull the anvil 10060 downwardly toward the support portion 10010 and close the gap to the desired gap height when firing the staples 10030 at the distal end of the staple cartridge 10000. In certain alternative embodiments, a distal gap-setting element can be configured to collapse as the firing member approaches the distal end of the staple cartridge. In at least one such embodiment, the distal gap-setting element can comprise a column which can provide resistance to the anvil as described above and then suddenly buckle once the buckling strength of the gap-setting element has been reached when the firing member approaches the distal end of the staple cartridge. In at least one embodiment, this buckling force can be approximately 10 lbf, for example. In certain embodiments, a gap setting element can be configured to drop downwardly into the deck of the support portion when a force exceeding a predetermined amount is applied to the gap setting element, for example. In certain other embodiments, the distal gap can be controlled by the nose of the staple cartridge. In at least one such embodiment, the downward movement of the anvil 10060 can be limited by the nose until the firing member has reached the distal end of the cartridge wherein, at such point, the compressive force applied to the nose can cause the nose to collapse. In certain embodiments, the nose can comprise a cavity defined by cavity walls which can allow the cavity to collapse once the compressive force applied thereto has exceed a predetermined force. In at least one such embodiment, the cavity can be defined by collapsible walls.


In various embodiments, as described above, an anvil, such as anvil 10060, for example, can be moved between an open position and a closed position in order to compress a tissue thickness compensator between the anvil and the support portion of a staple cartridge. In certain circumstances, referring now to FIGS. 360 and 361, the tissue thickness compensator of a staple cartridge, such as tissue thickness compensator 14120 of staple cartridge 14100, for example, may expand laterally and/or longitudinally when the tissue thickness compensator 14120 is compressed against a support portion 14110 of the staple cartridge 14100. In certain embodiments, the ends and/or sides of the tissue thickness compensator 14120 may not be constrained by the support portion 14110 and/or the anvil 10060 and, as a result, the tissue thickness compensator 14120 can expand in those directions without generating a compressive pressure, or at least an undesirable compressive pressure, within the tissue thickness compensator 14120. In such embodiments, a firing member, such as firing member 10052 (FIG. 236), for example, passing through the tissue thickness compensator 14120 may not be unduly impeded by an undesirable compressive pressure within the tissue thickness compensator 14120, for example. In certain other embodiments, referring again to FIG. 360, the distal end 14125 of the tissue thickness compensator 14120 may be constrained by the nose 14103 of the staple cartridge 14100, for example. In this particular embodiment, similar to the above, the distal end 14125 of the tissue thickness compensator 14120 may be constrained by the nose 14103 in order to reduce the possibility of the tissue thickness compensator 14120 from becoming prematurely detached from the support portion 14110. In any event, as a result of the above, a large internal pressure can be generated within the distal end 14125 which can impede the advancement of the firing member 10052, especially when the firing member 10052 reaches the distal end 14125. More particularly, in certain circumstances, the firing member 10052 can push, plow, and/or displace the tissue thickness compensator 14120 distally as it transects the tissue thickness compensator 14120 and, as a result, an even larger internal pressure can be created within the distal end 14125 of the tissue thickness compensator 14120. In order to at least partially dissipate this pressure within the tissue thickness compensator 14120, the nose 14103 can be comprised of a flexible material which can allow the nose 14103 to flex distally, for example, and create additional space for the tissue thickness compensator 14120. In certain embodiments, referring now to FIGS. 362 and 363, the nose of a staple cartridge can comprise a portion which can slide distally. More particularly, the nose 14203 of the staple cartridge 14200 can comprise a slidable portion 14204 which can be slidably connected to the nose 14203 such that, when the anvil 10060 is closed and/or the firing member 10052 is advanced into the distal end of the staple cartridge 14200, the slidable portion 14204 can slide distally and create additional room for the tissue thickness compensator 14200 and at least partially alleviate the internal pressure therein. In at least one embodiment, one of the nose 14203 and the slidable portion 14204 can comprise one or more rails and the other of the nose 14203 and the slidable portion 14204 can comprise one or more channels configured to slidably receive the rails therein. In at least one such embodiment, the channels and rails can be configured to co-operatively limit the movement of the slidable portion 14204 to a longitudinal distal path, for example.


In various circumstances, further to the above, certain staples, such as the distal-most staples within a staple cartridge, for example, can capture a larger portion of a tissue thickness compensator than the proximal staples within the staple cartridge. In such circumstances, as a result, a large clamping pressure can be applied to the tissue captured within the distal staples as compared to the proximal staples. These circumstances can arise when at least a portion of the tissue thickness compensator is shifted to and/or gathered at the distal end of the staple cartridge during use, as described above, even though the tissue thickness compensator may be comprised of a substantially homogenous material having a substantially constant thickness. In various circumstances, it may be desirable for certain staples to apply a higher clamping pressure to the tissue than other staples wherein, in various embodiments, a support portion and/or a tissue thickness compensator can be constructed and arranged to control which staples may apply the higher clamping pressure to the tissue and which staples may apply a lower clamping pressure to the tissue. Referring now to FIG. 364, a staple cartridge 14300 can comprise a support portion 14310 and, in addition, a tissue thickness compensator 14320 positioned on the deck surface 14311 of the support portion 14310. As compared to other embodiments disclosed in this application which comprise a support portion 14310 having a flat, or at least substantially flat, deck surface, the deck surface 14311 can be inclined and/or declined between the distal end 14305 and the proximal end 14306 of the support portion 14310. In at least one embodiment, the deck surface 14311 of the support portion 14310 can comprise a deck height at its distal end 14305 which is shorter than the deck height at its proximal end 14306. In at least one such embodiment, the staples 10030 at the distal end of the staple cartridge 14300 can extend above the deck surface 14311 a larger distance than the staples 10030 at the proximal end. In various alternative embodiments, the deck surface of a support portion can comprise a height at its distal end which is taller than its height at its proximal end. Referring again to FIG. 364, the tissue thickness compensator 14320 may comprise a thickness which is different along the longitudinal length thereof. In various embodiments, the tissue thickness compensator 14320 can comprise a thickness at its distal end 14325 which is thicker than its proximal end 14326, for example. In at least one such embodiment, the tissue thickness compensator 14322 can comprise a bottom surface 14322 which can be inclined or declined to match, or at least substantially match, the inclined or declined deck surface 14311 of the support portion 14310. As a result, the top, or tissue-contacting, surface 14321 of the tissue thickness compensator 14320 can comprise a flat, or at least substantially flat, surface upon which the tissue T can be positioned. In any event, as the tissue thickness compensator 14320 is thicker at its distal end 14325, the distal staples 10030 can capture a larger portion of the tissue thickness compensator 14320 therein than the proximal staples 10030 and, as a result, the distal staples 10030 can apply a larger compressive force to the tissue T, especially when the gap distance between the anvil 10060 and the deck surface 14311 is constant, or at least substantially constant, at the proximal and distal ends of the staple cartridge. In certain circumstances, however, the anvil 10060 may not reach a fully closed position and, as a result, the gap distance between the anvil 10060 and the deck surface 14311 may be larger at the distal end of the staple cartridge 14300 than the proximal end. In various circumstances, the distal staples 10030 may not be fully formed and, as a result, the distal staples 10030 may not apply the desired clamping pressure to the tissue T. In the embodiments where the tissue thickness compensator is thicker at the distal end of the staple cartridge, the tissue thickness compensator may compensate for the underforming of the staples and apply a sufficient pressure to the tissue T.


In various embodiments, referring now to FIG. 365, a staple cartridge, such as staple cartridge 14400, for example, can comprise a support portion 14410 and, in addition, a tissue thickness compensator 14420 positioned on the deck surface 14411 of the support portion 14410. Similar to the above, the deck surface 14411 can be inclined and/or declined such that, in at least one embodiment, the distal end 14405 of the support portion 14410 can have a deck height which is shorter than the deck height at the proximal end 14406, for example. In certain embodiments, the tissue thickness compensator 14420 can comprise a constant, or at least substantially constant, thickness along the length thereof and, as a result, the top, or tissue-contacting, surface 14421 of the tissue thickness compensator 14420 may parallel, or at least substantially parallel, the contour of the deck surface 14411. In various embodiments, the staples 10030 of the staple cartridge 14400 can be completely embedded within the tissue thickness compensator 14420 and the support portion 14410 when the staples 10030 are in their unfired position. In certain embodiments, the staples 10030 positioned at the proximal end of the staple cartridge 14400 may be completely embedded within the tissue thickness compensator 14420 and the support portion 14410 when the staples 10030 are in their unfired position whereas, due to the declined slope of the deck 14411 and top surface 14421, the tips of certain staples 10030, including the staples 10030 positioned at the distal end of the staple cartridge 14400, can protrude through the top surface 14421 of the tissue thickness compensator 14420 when the staples 10030 are in their unfired position.


In various embodiments, as described above, a tissue thickness compensator can be comprised of a single material wherein the entirety of the tissue thickness compensator can have the same, or at least substantially the same, material properties, such as density, stiffness, spring rate, durometer, and/or elasticity, for example, throughout. In various other embodiments, referring now to FIG. 368, a tissue thickness compensator, such as tissue thickness compensator 14520, for example, can comprise a plurality of materials or layers of materials. In at least one embodiment, the tissue thickness compensator 14520 can comprise a first, or central, layer 14520a, second, or intermediate, layers 14520b attached to the first layer 14520a on opposite sides thereof, and a third, or outer layer 14520c attached to each of the second layers 14520b. In certain embodiments, the intermediate layers 14520b can be attached to the central layer 14520a utilizing at least one adhesive and, similarly, the outer layers 14520c can be attached the second layers 14520 utilizing at least one adhesive. In addition to or in lieu of an adhesive, the layers 14520a-14520c can be held together by one or more interlocking features and/or fasteners, for example. In any event, the inner layer 14520a can be comprised of a first material having a first set of material properties, the intermediate layers 14520b can be comprised of a second material having a second set of material properties, and the outer layers 14520c can be comprised of a third material having a third set of material properties, for example. These sets of material properties can include density, stiffness, spring rate, durometer, and/or elasticity, for example. In certain embodiments, a staple cartridge can comprise six rows of staples 10030, for example, wherein a row of staples 10030 can be at least partially positioned in each of the outer layers 14520c and each of the inner layers 14520b, for example, and wherein two rows of staples 10030 can be at least partially positioned with the inner layer 14520a. In use, similar to the above, the staples 10030 can be ejected from the staple cartridge such that the staple legs 10032 of the staples 10030 penetrate the top surface 14521 of the tissue thickness compensator 14520, penetrate tissue positioned against the top surface 14521 by an anvil, and then contact the anvil such that the legs 10032 are deformed to capture the tissue thickness compensator 14520 and the tissue within the staples 10030. Also similar to the above, the tissue thickness compensator 14520 can be transected by a firing member as the firing member is advanced through the staple cartridge. In at least one such embodiment, the firing member can transect the inner layer 14520a, and the tissue, along a path defined by axis 14529, for example.


In various embodiments, further to the above, the rows of staples 10030 positioned within the inner layer 14520a can comprise the staple rows which are closest to the edges of the transected tissue. Correspondingly, the rows of staples 10030 positioned within the outer layers 14520c can comprise the staple rows which are furthest away from the edges of the transected tissue. In certain embodiments, the first material comprising the inner layer 14520a may comprise a density which is higher than the density of the second material comprising the intermediate layers 14520b and, similarly, the density of the second material may be higher than the density of the third material comprising the outer layers 14520c, for example. In various circumstances, as a result, larger compressive forces can be created within the staples 10030 positioned within the inner layer 14520a as compared to the compressive forces generated within the staples 10030 positioned within the intermediate layers 14520b and the outer layers 14520c. Similarly, larger compressive forces can be created within the staples 10030 positioned within the intermediate layers 14520b as compared to compressive forces created within the staples 10030 positioned within the outer layers 14520c, for example. In various alternative embodiments, the first material comprising the inner layer 14520a may comprise a density which is lower than the density of the second material comprising the intermediate layers 14520b and, similarly, the density of the second material may be lower than the density of the third material comprising the outer layers 14520c, for example. In various circumstances, as a result, larger compressive forces can be created within the staples 10030 positioned within the outer layers 14520c as compared to the compressive forces created within the staples 10030 positioned within the intermediate layers 14520b and the inner layer 14520a. Similarly, larger compressive forces can be created within the staples 10030 positioned within the intermediate layers 14520b as compared to the compressive forces created within the staples 10030 positioned within the inner layer 14520a, for example. In various other embodiments, any other suitable arrangement of layers, materials, and/or material properties could be utilized. In any event, in various embodiments, the layers 14520a-14520c of the tissue thickness compensator 14520 can be configured to remain attached to one another after they have been implanted. In certain other embodiments, the layers 14520a-14520c of the tissue thickness compensator 14520 can be configured to detach from one another after they have been implanted. In at least one such embodiment, the layers 14520a-14520c can be bonded together utilizing one or more bioabsorbable adhesives which can initially hold the layers together and then allow the layers to release from one another over time.


As described above, a tissue thickness compensator of a staple cartridge, such as tissue thickness compensator 14520, for example, can comprise a plurality of longitudinal layers. In various other embodiments, referring now to FIG. 369, a staple cartridge can comprise a tissue thickness compensator, such as tissue thickness compensator 14620, for example, which can comprise a plurality of horizontal layers. In at least one such embodiment, the tissue thickness compensator 14620 can comprise a first, or bottom, layer 14620a, a second, or intermediate, layer 14620b attached to the bottom layer 14620a, and a third, or top, layer 14620c attached to the intermediate layer 14620b. In various embodiments, the first layer 14620a can comprise a flat, or substantially flat, bottom surface 14626a and a triangular, or pyramidal, top surface 14625a, for example. In at least one such embodiment, the second layer 14620b can comprise a triangular, or pyramidal, bottom surface 14626b which can be configured to parallel and abut the top surface 14625a of the first layer 14620a Similar to the above, the second layer 14620b can comprise a triangular, or pyramidal, top surface 14625b which can parallel and abut a bottom triangular, or pyramidal, bottom surface 14626c of the third layer 14620c, for example. In various embodiments, the top surface of the third layer 14626c can comprise a flat, or at least substantially flat, tissue-contacting surface 14621. Also similar to the above, the tissue thickness compensator 14620 can be configured to at least partially store six rows of staples, such as staples 10030, for example, therein wherein a firing member can transect the tissue thickness compensator 14620 between the two innermost staple rows along a path extending through axis 14629, for example Similar to the above, each layer 14620a, 14620b, and 14620c can be comprised of a different material which can comprise different material properties and, as a result of the triangular, or pyramidal, configuration of the layers 14620a-14620c, the tissue thickness compensator 14620 can have different overall properties at various locations therewithin. For example, the outermost rows of staples 10030 may capture more of the third layer 14620c than the first layer 14620a therein whereas the innermost rows of staples 10030 may capture less of the third layer 14620c than the first layer 14620a and, as a result, the tissue thickness compensator 14620 may compress the tissue captured within the outermost staples 10030 differently than the tissue captured within the innermost staples 10030, for example, even though the tissue thickness compensator 14620 may have the same, or at least substantially the same, overall thickness thereacross.


In various embodiments, referring now to FIG. 286, a tissue thickness compensator of a staple cartridge, such as tissue thickness compensator 14720 of staple cartridge 14700, for example, can comprise voids, pockets, channels, and/or grooves, for example, defined therein which can vary the thickness of the tissue thickness compensator 14720. In at least one such embodiment, the tissue thickness compensator 14720 can be positioned against the deck surface 14711 of a support portion 14710 of the staple cartridge 14700 such that voids 14723 defined in the bottom surface 14722 of the tissue thickness compensator 14720 can overlie certain staple cavities 10012, but not others. In various embodiments, the voids 14723 can extend transversely to the knife slot 14715 of the support portion 14710, perpendicular to the knife slot 14715, and/or parallel to the knife slot 14715, for example. In certain embodiments, the voids 14723 can define a tread pattern in the bottom surface 14722 of the tissue thickness compensator 14720. In any event, when staples, such as staples 10030, for example, are deployed from the support portion 14710, referring now to FIGS. 287 and 288, certain staples 10030 can capture the tissue thickness compensator 14720 within a region containing a void 14723 while other staples 10030 can capture the tissue thickness compensator 14720 within a region positioned intermediate the voids 14723. In addition to or in lieu of the above, the tissue thickness compensator 14720 can comprise voids, pockets, channels, and/or grooves, for example, defined in the top, or tissue-contacting, surface 14721. In certain embodiments, referring now to FIGS. 366 and 367, a staple cartridge 14800 can comprise a tissue thickness compensator 14820 which can include a plurality of treads 14823 extending at least one of upwardly from a top surface 14821 of the tissue thickness compensator 14820, inwardly toward a central groove 14825, and/or distally toward the distal end of the staple cartridge 14800, for example. In at least one such embodiment, the treads 14823 can be separated by channels, slots, and/or grooves, such as channels 14824, for example. In various circumstances, as a result of the above, the overall thickness of the tissue thickness compensator can vary between staple rows and/or vary between the staples within a staple row. In certain circumstances, the treads, or thick portions, can be constructed and arranged such that they can flow in a desire direction, such as inwardly, for example, when the tissue thickness compensator is compressed.


In various embodiments, referring now to FIG. 303, a staple cartridge, such as staple cartridge 14900, for example, can comprise a support portion 14910 and, in addition, a tissue thickness compensator 14920 positioned against the support portion 14910. Similar to the above, the support portion 14910 can comprise staple drivers which can be lifted upwardly by a staple-deploying sled in order to lift staples, such as staples 10030, for example, at least partially positioned within the support portion 14910 toward an anvil, such as anvil 10060, for example, positioned opposite the staple cartridge 14900. In certain embodiments, the support portion 14910 can comprise six rows of staple cavities, such as two outer rows of staple cavities, two inner rows of staple cavities, and two intermediate rows of staple cavities positioned intermediate the inner rows and the outer rows, for example, wherein the anvil 10060 can comprise six rows of forming pockets 10062 aligned, or at least substantially aligned, with the staple cavities. In various embodiments, the inner rows of staple cavities can include staple drivers 14940a positioned therein, the intermediate rows of staple cavities can include staple drivers 14940b positioned therein, and the outer rows of staple cavities can include staple drivers 14940c positioned therein, wherein each of the staple drivers 14940a can include a cradle 14949a configured to support a staple 10030, wherein each of the staple drivers 14940b can include a cradle 14949b configured to support a staple 10030, and wherein each of the staple drivers 14940c can include a cradle 14949c configured to support a staple 10030. In their unfired positions, i.e., when the staple drivers 14940a-14940c are sitting on driver supports 14926 which extend underneath the support portion 14910, the cradles 14949a of the staple drivers 14940a can be positioned closer to the anvil 10060 than the cradles 14949b of the staple drivers 14940b and the cradles 14949c of the staple drivers 14940c. In such a position, a first forming distance can be defined between the cradles 14949a and the forming pockets 10062 positioned over the cradles 14949a, a second forming distance can be defined between the cradles 14949b and the forming pockets 10062 positioned over the cradles 14949b, and a third forming distance can be defined between the cradles 14949c and the forming pockets 10062 positioned over the cradles 14949c, wherein, in various embodiments, the first forming distance can be shorter than the second forming distance and the second forming distance can be shorter than the third forming distance, for example. When the staple drivers 14940a-14940c are moved from their unfired positions (FIG. 303) to their fired positions, each staple driver 14940a-14940c can be moved upwardly an equal, or an at least substantially equal, distance toward the anvil 10060 by the staple-deploying sled such that the first drivers 14940a drive their respective staples 10030 to a first formed height, the second drivers 14940b drive their respective staples 10030 to a second formed height, and the third drivers 14940c drive their respective staples 10030 to a third formed height, wherein the first formed height can be shorter than the second formed height and the second formed height can be shorter than the third formed height, for example. Various other embodiments are envisioned in which the first staple drivers 14940a are displaced upwardly a first distance, the second staple drivers 14940b are displaced upwardly a second distance, and the third staple drivers 14940c are displaced upwardly a third distance, wherein one or more of the first distance, the second distance, and the third distance can be different.


In various embodiments, referring again to FIG. 303, the deck surface 14911 of the support portion 14910 can vary in height with respect to the tissue-contacting surface 10061 of the anvil 10060. In certain embodiments, this height variation can occur laterally and, in at least one embodiment, the height of the deck surface 14911 surrounding the inner rows of staple cavities can be higher than the deck surface 14911 surrounding the outer rows of staple cavities, for example. In various embodiments, the bottom surface 14922 of the tissue thickness compensator 14920 can be configured to parallel, or at least substantially parallel, the deck surface 14911 of the support portion 14910. Further to the above, the tissue thickness compensator 14920 can also vary in thickness wherein, in at least one embodiment, the top, or tissue-contacting, surface 14921 of the tissue thickness compensator 14920 can slope inwardly from the outside or lateral edges thereof. In at least one such embodiment, as a result of the above, the tissue thickness compensator 14920 can be thinner in a region positioned over the inner rows of staple cavities and thicker in a region positioned over the outer rows of staple cavities, for example. In various embodiments, referring now to FIG. 304, the deck surface of a support portion 15010 can comprise a stepped deck surface, for example, wherein the highest steps of the stepped surface can surround the inner rows of staple cavities and the lowest steps of the stepped surface can surround the outer rows of staple cavities, for example. In at least one such embodiment, steps having an intermediate height can surround the intermediate rows of staple cavities. In certain embodiments, a tissue thickness compensator, such as tissue thickness compensator 15020, for example, can comprise a bottom surface which can parallel and abut the deck surface of the support portion 15010. In at least one embodiment, the top, or tissue-contacting, surface 15021 of the tissue thickness compensator can comprise an arcuate, parabolic, and/or curved surface, for example, which, in at least one such embodiment, can extend from a first lateral side of the tissue thickness compensator 15020 to a second lateral side of the tissue thickness compensator 15020 with an apex aligned, or at least substantially aligned, with the center of the staple cartridge 15000, for example. In various embodiments, referring now to FIG. 299, a staple cartridge 15300, for example, can comprise a support portion 15310, a plurality of staple drivers 15340 movably positioned within staple cavities defined in the support portion 15310, and a tissue thickness compensator 15320 positioned above the deck surface 15311 of the support portion 15310. The staple cartridge 15300 can further comprise one or more bottom pan portions 15326 which can be attached to the support portion 15310 and extend around the bottom of the support portion 15310 and support the drivers 15340, and staples 15330, in their unfired positions. As a staple-deploying sled is advanced through the staple cartridge, the sled can also be supported by the bottom pan portions 15326 as the sled lifts the staple drivers 15340 and the staples 15330 upwardly through the tissue thickness compensator 15320. In at least one embodiment, the tissue thickness compensator 15320 can comprise a first, or inner, portion 15322a positioned over an inner row of staple cavities, a second, or intermediate portion 15322b positioned over an intermediate row of staple cavities, and a third, or outer, portion 15322c positioned over a row of staple cavities, wherein the inner portion 15322a can be thicker than the intermediate portion 15322b and the intermediate portion 15322b can be thicker than the outer portion 15322c, for example. In at least one embodiment, the tissue thickness compensator 15320 can comprise longitudinal channels, for example, defined therein which can create the thinner portions 15322b and 15322c of the tissue thickness compensator 15320. In various alternative embodiments, the longitudinal channels can be defined in the top surface and/or the bottom surface of a tissue thickness compensator. In at least one embodiment, the top surface 15321 of the tissue thickness compensator 15320 can comprise a flat, or at least substantially flat, surface, for example.


In various embodiments, referring now to FIG. 296, a staple cartridge can comprise a tissue thickness compensator, such as tissue thickness compensator 15120, for example, which can comprise a plurality of portions having different thicknesses. In at least one embodiment, the tissue thickness compensator 15120 can comprise a first, or inner, portion 15122a which can have a first thickness, second, or intermediate, portions 15122b extending from the first portion 15122b which can each have a second thickness, and third, or outer, portions 15122c extending from the second portions 15122b which can each have a third thickness. In at least one such embodiment, the third thickness can be thicker than the second thickness and the second thickness can be thicker than the first thickness, for example, although any suitable thicknesses could be utilized in various other embodiments. In various embodiments, the portions 15122a-15122c of the tissue thickness compensator 15120 can comprise steps having different thickness. In at least one embodiment, similar to the above, a staple cartridge can comprise several rows of staples 10030 and a plurality of staple drivers having different heights which can deform the staples 10030 to different formed heights. Also similar to the above, the staple cartridge can comprise first staple drivers 15140a which can drive the staples 10030 supported thereon to a first formed height, second staple drivers 15140b which can drive the staples 10030 supported thereon to a second formed height, and third staple drivers which can drive the staples 10030 supported thereon to a third formed height, wherein the first formed height can be shorter than the second formed height and the second formed height can be shorter than the third formed height, for example. In various embodiments, as illustrated in FIG. 296, each staple 10030 can comprise the same, or substantially the same, unformed, or unfired, height. In certain other embodiments, referring now to FIG. 296A, the first drivers 15140a, the second drivers 15140b, and/or the third drivers 15140c can support staples having different unformed heights. In at least one such embodiment, the first staple drivers 15140a can support staples 15130a having a first unformed height, the second staple drivers 15140b can support staples 15130b having a second unformed height, and the third staple drivers 15140c can support staples 15130c having a third unformed height, wherein the first unformed height can be shorter than the second unformed height and the second unformed height can be shorter than the third unformed height, for example. In various embodiments, referring again to FIG. 296A, the tips of the staples 15130a, 15130b, and/or 15130c can lie, or at least substantially lie, in the same plane while, in other embodiments, the tips of the staples 15130a, 15130b, and/or 15130c may not lie in same plane. In certain embodiments, referring now to FIG. 297, a staple cartridge can include a tissue thickness compensator 15220 having a plurality of portions having different thickness which can be implanted against the tissue T by the staples 15130a, 15130b, and 15130c, as described above. In at least one embodiment, referring now to FIG. 298, the staples 15130a, 15130b, and/or 15130c can be deformed to different formed heights wherein the first staples 15130a can be formed to a first formed height, the second staples 15130b can be formed to a second formed height, and the third staples 15130c can be formed to a third formed height, and wherein the first formed height can be shorter than the second formed height and the second formed height can be shorter than the third formed height, for example. Other embodiments are envisioned in which the staples 15130a, 15130b, and 15130c can be formed to any suitable formed heights and/or any relative formed heights.


In various embodiments, as described above, the anvil of a surgical stapling instrument can be moved between an open position and a closed position. In such circumstances, the tissue-contacting surface of the anvil can be moved into its final, or forming, position as the anvil is moved into its closed position. Once the anvil is in its closed position, in certain embodiments, the tissue-contacting surface may no longer be adjustable. In certain other embodiments, referring now to FIG. 351, a surgical stapler, such as surgical stapler 15500, for example, can comprise an anvil channel 15560 and an adjustable tissue-contacting anvil adjustment plate 15561 positioned within the anvil channel 15560. In such embodiments, the anvil plate 15561 can be raised and/or lowered within the anvil channel 15560 in order to adjust the position of the tissue-contacting surface of the anvil plate 15561 relative to a staple cartridge positioned opposite the anvil plate 15561. In various embodiments, the surgical stapler 15500 can comprise an adjustment slide 15564 which, referring to FIGS. 356 and 357, can be slid intermediate the anvil channel 15560 and the anvil plate 15561 in order to control the distance between the anvil plate 15561 and the staple cartridge. In certain embodiments, referring again to FIGS. 351 and 352, the surgical stapler 15500 can further comprise an actuator 15562 coupled to the adjustment slide 15564 which can be slid proximally in order to slide the adjustment slide 15564 proximally and/or slid distally in order to slide the adjustment slide 15564 distally. In various embodiments, referring again to FIGS. 356 and 357, the actuator 15562 can be slid between two or more pre-defined positions in order to adjust the anvil plate 15561 between two or more positions, respectively. In at least one embodiment, such pre-defined positions can be demarcated on the surgical stapler 15500 as demarcations 15563 (FIG. 351), for example. In certain embodiments, referring to FIG. 357, the adjustment slide 15564 can comprise a plurality of support surfaces, such as first support surface 15565a, second support surface 15565b, and third support surface 15565c, for example, which can be aligned with a plurality of plate positioning surfaces, such as first positioning surface 15569a, second positioning surface 15569b, and third positioning surface 15569c, respectively, on the backside of the anvil plate 15561 in order to position the anvil plate 15561 in a first position. In order to position the anvil plate 15561 in a second position, the actuator 15562 and the slide 15564 can be slid proximally, for example, in order to realign the support surfaces 15565a-15565c of the slide 15564 relative to the positioning surfaces 15569a-15569c of the anvil plate 15561. More particularly, referring to FIG. 356, the slide 15564 can be slid distally such that the first support surface 15565a of the slide 15564 can be positioned behind the second positioning surface 15569b of the anvil plate 15561 and such that the second support surface 15565b of the slide 15564 can be positioned behind the third positioning surface 15569c of the anvil plate 15561 in order to move the anvil plate 15561 closer to the staple cartridge. When the anvil plate 15561 is moved from its first position to its second position, in such circumstances, the adjustable anvil plate 15561 can further compress the tissue T positioned between the anvil plate 15561 and the staple cartridge. In addition to the above, the formed height of the staples can be controlled by the position of the anvil plate 15561 relative to the staple cartridge as the forming pockets defined in the anvil plate 15561 will move closer to and/or further away from the staple cartridge when the anvil plate 15561 is adjusted. Although only two positions are discussed above, the slide 15564 can be slid into a suitable number of positions to move the anvil plate 15561 closer to and/or away from the staple cartridge. In any event, once the anvil plate 15561 has been suitably positioned, a staple-deploying sled 15550 can be slid distally within the staple cartridge in order to lift staple drivers 15540 and staples 15530 toward the anvil plate 15561 and staple the tissue T, as illustrated in FIG. 354. Similar surgical staplers are disclosed in U.S. patent application Ser. No. 13/036,647, entitled SURGICAL STAPLING INSTRUMENT, which was filed on Feb. 28, 2011, now U.S. Pat. No. 8,561,870, the entire disclosure of which is incorporated by reference herein.


In various embodiments, referring now to FIG. 353, a staple cartridge can be positioned within a staple cartridge channel 15570 of the surgical stapler 15500 which can comprise a tissue thickness compensator, such as tissue thickness compensator 15520, for example. When the anvil plate 15561 is moved toward the staple cartridge, as described above, the anvil plate 15561 can compress the tissue thickness compensator 15520 and/or the tissue T positioned intermediate the anvil plate 15561 and the tissue thickness compensator 15520. As the staples 15530 are deployed from the staple cartridge, referring to FIG. 355, the staples 15530 can compress and implant the tissue thickness compensator 15520 against the tissue T. In various embodiments, when the anvil plate 15561 is positioned against the slide 15564 and tissue has not yet been placed between the anvil plate 15561 and the tissue thickness compensator 15520, a gap can be defined between the anvil plate 15561 and the top surface 15521 of the tissue thickness compensator 15520 when the anvil plate 15561 is in a first position. When the anvil plate 15561 is moved into a second position, the anvil plate 15561 can contact the tissue thickness compensator 15520. In various alternative embodiments, when the anvil plate 15561 is positioned against the slide 15564 and tissue has not yet been placed between the anvil plate 15561 and the tissue thickness compensator 15520, a gap can be defined between the anvil plate 15561 and the top surface 15521 of the tissue thickness compensator 15520 when the anvil plate 15561 is in a first position and/or a second position. In at least one such embodiment, the anvil plate 15561 may not come into contact with the tissue thickness compensator 15520. In further alternative embodiments, when the anvil plate 15561 is positioned against the slide 15564 and tissue has not yet been placed between the anvil plate 15561 and the tissue thickness compensator 15520, the anvil plate 15561 can be in contact with the top surface 15521 of the tissue thickness compensator 15520 regardless of whether the anvil plate 15561 is in a first position and/or a second position, for example. Although only two positions for the anvil plate 15611 are described herein, the anvil plate 15611 may be positioned, or indexed, into any suitable number of positions.


In various embodiments, as a result of the above, a surgical stapling instrument can comprise means for adjusting the formed height of the staples which can, in various circumstance, compensate for different tissue thicknesses. In addition, the surgical stapling instrument can comprise other means for compensating for different tissue thicknesses and/or thickness variations within the tissue, for example. In at least one such embodiment, the anvil plate 15561 can be adjusted upwardly, or away, from the opposing staple cartridge to increase the formed, or fired, height of the staples. Correspondingly, the anvil plate 15561 can be adjusted downwardly, or toward, the opposing staple cartridge to decrease the formed, or fired, height of the staples. In various embodiments, the adjustment of the anvil plate 15561, for example, can adjust the gap between the forming pockets defined in the anvil plate 15561 and the fired height of the staple drivers or, more specifically, the fired height of the staple driver cradles, for example. Even with such a capacity to adjust the formed height of the staples to account for thicker and/or thinner tissue, for example, a tissue thickness compensator can also compensate for thicker and/or thinner tissue and/or compensate for thickness variations within the tissue, as described above. In such embodiments, a surgeon can be afforded with several compensation means within the same surgical stapling instrument.


As described above and illustrated in several embodiments, a surgical stapling instrument can utilize a staple cartridge having a linear arrangement of staple cavities and staples wherein a firing member can be advanced distally through the staple cartridge to deploy the staples from the staple cavities. In certain embodiments, a staple cartridge can comprise rows of staple cavities and staples which are curved. In at least one embodiment, referring now to FIGS. 345 and 346, a surgical stapling instrument, such as stapler 15600, for example, can comprise one or more circular or annular rows of staple cavities defined in a circular or annular support portion 15610. Such circular staple rows can comprise a circular row of inner staple cavities 15612 and a circular row of outer staple cavities 15613, for example. In at least one such embodiment, the circular rows of staple cavities can surround a circular or annular aperture 15615 defined in the stapler 15600 which can house a circular or annular knife movably positioned therein. In use, tissue can be positioned against the deck surface 15611 of the support portion 15610 and an anvil (not illustrated) can be assembled to the surgical stapler 15600 via an actuator extending through and/or positioned within the aperture 15615 such that, when the actuator is actuated, the anvil can be clamped toward the support portion 15610 and compress the tissue against the deck surface 15611. Once the tissue has been sufficiently compressed, the staples positioned within the staple cavities 15612 and 15613 can be ejected from the support portion 15610 and through the tissue such that the staples can contact the anvil and be sufficiently deformed to capture the tissue therein. As the staples are being fired and/or after the staples have been fired, the circular knife can be advanced to transect the tissue. Thereafter, the anvil can be moved away from the support portion 15610 and/or detached from the surgical stapler 15600 such that the anvil and the surgical stapler 15600 can be removed from the surgical site. Such surgical staplers 15600 and such surgical techniques, in various embodiments, can be utilized to join two portions of a large intestine, for example. In various circumstances, the circular staple lines may be configured to hold the portions of the large intestine together while the tissue heals and, at the same time, permit the portions of the large intestine to resiliently expand Similar surgical stapling instruments and surgical techniques are disclosed in U.S. Pat. No. 5,285,945, entitled SURGICAL ANASTOMOSIS STAPLING INSTRUMENT, which issued on Feb. 15, 1994, the entire disclosure of which is incorporated by reference herein.


In various embodiments, further to the above, a tissue thickness compensator may be positioned against and/or attached to the support portion 15610 of the surgical stapler 15600, for example. In at least one embodiment, the tissue thickness compensator can be comprised of a circular or annular ring of material comprising an inner radius and an outer radius, for example. In certain circumstances, tissue can be positioned against this ring of material and, when the anvil is used to move the tissue toward the support portion 15610, the tissue thickness compensator can be compressed between the tissue and the deck surface 15611. During use, the staples can be fired through the tissue thickness compensator and the tissue such that the staples can contact the anvil and deform to their fired position to capture portions of the tissue and the tissue thickness compensator within the staples. In various circumstances, further to the above, the ring of material comprising the tissue thickness compensator must be sufficiently resilient to permit the portions of the large intestine surrounding the staple lines to expand. In various embodiments, referring again to FIGS. 345 and 346, a flexible tissue thickness compensator 15620 can comprise a circular or annular flexible inner ring 15624, for example, which, in at least one embodiment, can define a circular or annular aperture 15625. In certain embodiments, the inner ring 15624 may be configured such that it is not captured within staples deployed from the surgical stapler 15600; rather, in at least one embodiment, the inner ring 15624 may be positioned radially inwardly with respect to the inner row of staple cavities 15612. In at least one such embodiment, the tissue thickness compensator 15620 can comprise a plurality of tags, such as inner tags 15622 and outer tags 15623, for example, extending therefrom such that the tags can be at least partially captured within the staples as they are being deformed. More particularly, referring primarily to FIG. 345, each inner tag 15622 can comprise a head which is positioned over a staple cavity 15612 defined in the surgical stapler 15600 wherein the head can be attached to the inner ring 15624 by a neck 15626, for example, and, similarly, each outer tag 15623 can comprise a head which is positioned over a staple cavity 15613 defined in the surgical stapler 15600 wherein the head can be attached to the inner ring 15624 by a neck 15627, for example. In various embodiments, the heads of the inner tags 15622 and the outer tags 15623 can comprise any suitable shape, such as round, oval, and/or elliptical, for example. The necks 15626 and/or 15627 can also comprise any suitable shape wherein, in at least one embodiment, the necks 15627 connecting the heads of the outer tags 15623 to the inner ring 15624 can be configured to extend between adjacent inner staple cavities 15612 in the support portion 15610 such that the necks 15627 are not captured within the staples deployed from the inner staple cavities 15612.


In various embodiments, referring now to FIGS. 347 and 348, a flexible tissue thickness compensator 15720 can comprise a circular or annular flexible outer ring 15724, for example. In certain embodiments, the outer ring 15724 may be configured such that it is not captured within staples deployed from the surgical stapler 15600; rather, in at least one embodiment, the outer ring 15724 may be positioned radially outwardly with respect to the outer row of staple cavities 15613. In at least one such embodiment, the tissue thickness compensator 15720 can comprise a plurality of tags, such as inner tags 15622 and outer tags 15623, for example, extending therefrom such that the tags can be at least partially captured within the staples as they are being deformed. More particularly, referring primarily to FIG. 347, each inner tag 15622 can comprise a head which is positioned over a staple cavity 15612 defined in the surgical stapler 15600 wherein the head can be attached to the outer ring 15724 by a neck 15726, for example, and, similarly, each outer tag 15623 can comprise a head which is positioned over a staple cavity 15613 defined in the surgical stapler 15600 wherein the head can be attached to the outer ring 15724 by a neck 15727, for example. In various embodiments, the heads of the inner tags 15622 and the outer tags 15623 can comprise any suitable shape, such as round, oval, and/or elliptical, for example. The necks 15726 and/or 15727 can also comprise any suitable shape wherein, in at least one embodiment, the necks 15726 connecting the heads of the inner tags 15622 to the outer ring 15724 can be configured to extend between adjacent outer staple cavities 15613 such that the necks 15726 are not captured within the staples deployed from the outer staple cavities 15613. In certain alternative embodiments, a tissue thickness compensator can comprise a circular or annular flexible inner ring, a circular or annular flexible outer ring, and, in addition, a plurality of tags which can be connected to the inner ring and/or the outer ring. In at least one embodiment, certain tags can be connected to the inner ring and certain other tags can be connected to the outer ring. In certain embodiments, at least some of the tags can be connected to both the inner ring and the outer ring. In any event, further to the above, the inner ring 15624 of the tissue thickness compensator 15620, the outer ring 15724 of the tissue thickness compensator 15720, and/or any other suitable tissue thickness compensator, can be configured to resiliently expand and/or contract in order to accommodate the expansion and/or contraction of the tissue that it has been implanted against. Furthermore, although various embodiments are described herein as comprising circular or annular support rings, a tissue thickness compensator can comprise any suitably-shaped support structure for connecting the tags thereto. In various embodiments, further to the above, the circular knife advanced by the surgical stapler to cut the tissue captured between the anvil and the support portion can also cut the buttress material. In at least one such embodiment, the knife can separate the inner support ring from the tags by cutting the necks thereof, for example.


In various embodiments, further to the above, a tissue thickness compensator can comprise detachable and/or relatively movable positions which can be configured to allow the tissue thickness compensator to expand and/or contract in order to accommodate the movement of the tissue that it has been implanted against. Referring now to FIGS. 349 and 350, a circular or annular tissue thickness compensator 15820 can be positioned against and/or supported by the deck surface 15611 of the surgical stapler 15600 which can be held in an unexpanded position (FIG. 349) as it is being implanted against the tissue and, after the tissue thickness compensator 15820 has been implanted, the tissue thickness compensator 15820 can be configured to expand outwardly, as illustrated in FIG. 350. In various embodiments, the tissue thickness compensator 15820 can comprise a plurality of arcuate portions 15822 which can be connected together by an inner ring 15824, for example. In at least one embodiment, the arcuate portions 15822 can be separated from one another by seams 15828. In at least one other embodiment, the arcuate portions 15822 may be connected to one another wherein, in at least one such embodiment, an arrangement of perforations may permit the arcuate portions 15822 to separate from one another. In either event, in various embodiments, the arcuate portions 15822 can each comprise interlocking features, such as projections 15826 and notches 15823, for example, which can co-operate to limit relative movement between the arcuate portions 15822 prior to the tissue thickness compensator 15820 being implanted. Further to the above, each arcuate portion 15822 can be connected to the inner ring 15824 by one or more connectors 15827, for example, which can be configured to releasably hold the arcuate portions 15822 in position. After the staples, such as staples 10030, for example, stored within the support portion 15610 have been utilized to implant the tissue thickness compensator 15620 against the tissue, referring primarily to FIG. 350, the connectors 15827 can detach from the inner ring 15824 and allow the tissue thickness compensator 15820 to at least partially expand to accommodate movement within the underlying tissue. In various circumstances, all of the arcuate portions 15822 may detach from the inner ring 15824 while, in other circumstances, only some of the arcuate portions 15822 may detach from the inner ring 15824. In certain alternative embodiments, the arcuate portions 15822 can be connected by flexible sections which can permit the arcuate portions 15822 to move relative to each other but not detach from one another. In at least one such embodiment, the flexible sections may not receive staples therein and can be configured to stretch and/or contract to accommodate the relative movement of the arcuate portions 15822. In the embodiment illustrated in FIGS. 349 and 350, the tissue thickness compensator 15820 can comprise eight arcuate portions 15822, for example. In certain other embodiments, a tissue thickness compensator can comprise any suitable number of arcuate portions, such as two or more arcuate portions, for example.


Further to the above, a tissue thickness compensator 15620, 15720, and/or 15820, for example, can be configured to compensate for thicker and/or thinner tissue captured between the anvil and the support portion 15610 of the surgical instrument 15600. In various embodiments, similar to the above, the formed, or fired, height of the staples can be adjusted by moving the anvil toward and/or away from the support portion 15610. More particularly, the anvil can be moved closer to the support portion 15610 to decrease the formed height of the staples while, correspondingly, the anvil can be moved further away from the support portion 15610 to increase the formed height of the staples. In such embodiments, as a result, a surgeon can adjust the anvil away from the support portion 15610 to account for thick tissue and toward the support portion 15610 to account for thin tissue. In various other circumstances, the surgeon may decide not to adjust the anvil at all and rely on the tissue thickness compensator to account for the thinner and/or thicker tissue. In various embodiments, as a result, the surgical instrument 15600 can comprise at least two means for compensating for different tissue thicknesses and/or variations in the tissue thickness.


In various embodiments, as described above, a tissue thickness compensator can be attached to a support portion of a staple cartridge. In certain embodiments, the bottom surface of the tissue thickness compensator can comprise one of a layer of hooks or a layer of loops while a deck surface on the support portion can comprise the other one of the layer of hooks and the layer of loops. In at least one such embodiment, the hooks and the loops can be configured to engage one another and releasably retain the tissue thickness compensator to the support portion. In various embodiments, each hook can comprise an enlarged head extending from a neck, for example. In certain embodiments, a plurality of pads comprising the loops, for example, can be bonded to the bottom surface of the tissue thickness compensator while a plurality of pads comprising the hooks can be bonded to the deck surface of the support portion. In at least one embodiment, the support portion can comprise one or more apertures and/or recesses, for example, which can be configured to receive an insert therein comprising hooks and/or loops. In addition to or in lieu of the above, a tissue thickness compensator can be removably mounted to an anvil utilizing such hook and loop arrangements, for example. In various embodiments, the hooks and loops can comprise fibrous surfaces, for example.


In various embodiments, as described above, a staple cartridge can comprise a support portion and a tissue thickness compensator attached to the support portion. In certain embodiments, as also described above, the support portion can comprise a longitudinal slot configured to receive a cutting member therein and the tissue thickness compensator can comprise a retention member that can be retained in the longitudinal slot. In at least one embodiment, referring now to FIG. 386, a staple cartridge 16000 can comprise a support portion 16010 including a deck surface 16011 and a longitudinal slot 16015. The staple cartridge 16000 can further comprise a tissue thickness compensator 16020 positioned above the deck surface 16011. In various embodiments, the tissue thickness compensator 16020 can include a longitudinal retention member 16025 which extends downwardly into the longitudinal slot 16015. In at least one such embodiment, the retention member 16025 can be pressed into the slot 16015 such that the interaction between the retention member 16025 and the slot 16015 can resist relative movement between the support portion 16010 and the tissue thickness compensator 16020. In various embodiments, the body of the tissue thickness compensator 16020 can be comprised of a first material and the retention member 16025 can be comprised of a second, or different, material. In certain embodiments, the body of the tissue thickness compensator 16020 can be comprised of a material having a first durometer and the retention member 16025 can be comprised of a material having a second durometer, wherein the second durometer can be higher than the first durometer, for example. In use, in at least one embodiment, the staples 10030 can be pushed upwardly by staple drivers 10040 such that the tips of the staples 10030 can push through the body of the tissue thickness compensator 16020 and emerge from the tissue contacting surface 16021 and capture at least a portion of the tissue thickness compensator 16020 against the targeted tissue. In various embodiments, a cutting member passing through the slot 16015 can transect the retention member 16025 as the staples 10030 are being deployed. Once the tissue thickness compensator 16020 has been implanted, in various embodiments, the retention member 16025 can be pulled out of the slot 16015. In certain other embodiments, the body of the tissue thickness compensator 16020 can be configured to detach from the retention member 16025.


Referring now to FIGS. 387 and 389, a staple cartridge 17000 can comprise a support portion 17010 including a deck surface 17011 and a longitudinal slot 17015. The staple cartridge 17000 can further comprise a tissue thickness compensator 17020 positioned above the deck surface 17011. In various embodiments, the tissue thickness compensator 17020 can include a longitudinal retention member 17025 which extends downwardly into the longitudinal slot 17015. In at least one such embodiment, the retention member 17025 can be pressed into the slot 17015 such that the interaction between the retention member 17025 and the slot 17015 can resist relative movement between the support portion 17010 and the tissue thickness compensator 17020. In various embodiments, the retention member 17025 can extend through the entirety of the tissue thickness compensator 17020 to the top surface 17021 thereof wherein body portions 17024 of the tissue thickness compensator 17020 can be attached to opposite sides of the retention member 17025. In at least one such embodiment, the retention member 17025 can also be configured to resist the lateral deflection, for example, of the tissue thickness compensator 17020. In various embodiments, the body portions 17024 can be comprised of a first material and the retention member 17025 can be comprised of a second, or different, material. In certain embodiments, the body portions 17024 can be comprised of a material having a first durometer and the retention member 17025 can be comprised of a material having a second durometer, wherein the second durometer can be higher than the first durometer, for example. In various embodiments, further to the above, a cutting member passing through the slot 17015 can transect the retention member 17025 as the staples 10030 are being deployed. Once the tissue thickness compensator 17020 has been implanted, in various embodiments, the retention member 17025 can be pulled out of the slot 17015. In certain other embodiments, the body portions 17024 can be configured to detach from the retention member 17025.


Referring now to FIG. 388, a staple cartridge 18000 can comprise a support portion 18010 including a deck surface 18011 and a longitudinal slot 18015. The staple cartridge 18000 can further comprise a tissue thickness compensator 18020 positioned above the deck surface 18011. In various embodiments, the tissue thickness compensator 18020 can include a longitudinal retention member 18025 which extends downwardly into the longitudinal slot 18015. In at least one such embodiment, the retention member 18025 can be pressed into the slot 18015 such that the interaction between the retention member 18025 and the slot 18015 can resist relative movement between the support portion 18010 and the tissue thickness compensator 18020. In various embodiments, the retention member 18025 can extend through the entirety of the tissue thickness compensator 18020 to the top surface 18021 thereof wherein body portions 18024 of the tissue thickness compensator 18020 can be attached to opposite sides of the retention member 18025. In at least one embodiment, the retention member 18025 can comprise an enlarged portion 18026 which can be received in a cavity 18016 defined in the slot 18015. In at least one such embodiment, the enlarged portion 18026 can resist the withdrawal of the retention member 18025 from the slot 18015.



FIGS. 391-392 illustrate a tissue thickness compensator or buttress 19100 that is configured for use with a surgical circular stapler 19000 of the type, for example, shown in FIG. 390. The construction and operation of circular staplers are generally known in the art. Thus, the specific components and features of circular staplers will not be discussed in detail herein beyond what may be necessary to understand the construction and operation of the various embodiments of the present invention.


In general, as can be seen in FIG. 390, a circular stapler 19000 includes a handle portion 19012 that has an elongated shaft 19014 protruding therefrom. A stapling head 19016 is coupled to a distal end 19015 of the elongated shaft 19014 and is configured to operably support a staple cartridge 19017 therein. As can be seen in FIGS. 391 and 392, an axially displaceable driver 19020 is movably supported in the stapling head 19016 for driving surgical staples 19022 supported within the surgical staple cartridge 19017. A circular tissue cutting member 19030 that has a tissue cutting end 19032 formed thereon is supported by the driver 19020. When the driver 19020 is displaced in the distal “DD” direction, the driver 19020 drives the surgical staples 19022 and the tissue cutting member 19030 in the distal direction.


The circular stapler 19000 further includes an anvil 19040 that has an anvil body 19042. The anvil 19040 further has an anvil shaft 19044 that is configured to be removably attached to a trocar shaft 19050 that is movably supported within the elongated shaft 19014 of the circular stapler 19000. Movement of the trocar shaft 19050 is achieved by rotating an adjustment knob 19018 that is located at the proximal end of the handle portion 19012. An indicator panel 19019 may be provided on the handle portion 19012 to provide the user with an indication of the position of the body 19042 of the anvil 19040 relative to the staple cartridge 19017. Thus, when the anvil shaft 19044 is attached to the movable trocar shaft 19050, the position of the anvil body 19042 relative to the staple cartridge 19017 in the stapler head 19016 may be adjusted by rotating the adjustment knob 19018. The driver 19020 is controlled by a trigger assembly 19060 on the handle portion 19012. Further details concerning the operation and assembly of the circular stapler 19000, for example, may be gleaned from reference to U.S. Pat. No. 8,066,167, entitled CIRCULAR SURGICAL STAPLING INSTRUMENT WITH ANVIL LOCKING SYSTEM, the disclosure of which is herein incorporated by reference in its entirety.


When performing a lower colon procedure using a circular stapler 19000, a portion of the intestine may be laproscopically stapled using a conventional surgical stapler (not shown) that is inserted through a trocar (not shown). The conventional surgical stapler serves to place multiple rows of staples 19043, 19045 on either side of the diseased portion of colon to be removed. See FIG. 391. The target or diseased section is simultaneously cut as the adjoining end of the colon is stapled. After removing the diseased portion, the surgeon typically inserts the anvil 19040 of the circular stapling instrument 19000 into the distal end of the colon “DC”. This may be done by inserting the anvil 19040 into an entry port cut into the distal colon DC by the surgeon. The lower staple line 19043 is utilized to hold the tissue of the proximal colon end “PC” over the stapling head 19016. This method seals both ends PC, DC of the colon only to have the sealed portions cut through and removed. These intermediate step staple lines are only temporary and facilitate the next step in the procedure.


On occasion, the anvil 19040 can be placed transanally, by placing the anvil 19040 on the distal end of the stapler 19000 and inserting the instrument through the rectum. Once the anvil 1900 has been installed in the distal portion of the intestine, the intestine is secured around the anvil shaft 19044 by what is known as a “purse string” suture 19047. Once the stapler head 19016 has been inserted into position in the proximal end PC of the colon, the surgeon may then advance the trocar shaft 19050 through the stapled portion 19043. The proximal portion PC of intestine is similarly secured around the distally protruding trocar shaft 19050 by a purse string suture 19049 as shown in FIG. 391.


Once the ends of the intestine have been secured around their respective components, the surgeon, through an appropriate trocar sleeve (not shown), may employ a grasping device to grasp the anvil shaft 19044 and attach it to the portion of the trocar shaft 19050 protruding out of the proximal end PC of the colon. The surgeon then closes the gap between the anvil 19040 and cartridge 19017, thereby clamping the proximal and distal ends PC, DC of the intestine in the gap. The surgeon next actuates the stapler 19000 causing several rows of staples 19022 to be driven through both ends of the intestine PC, DC and formed, thereby joining the ends PC, DC and forming a tubular pathway. Simultaneously, as the staples 19022 are driven and formed, the concentric annular knife blade 19030 is driven through the intestinal tissue ends, cutting the ends adjacent to the inner row of staples. The surgeon then withdraws the stapler from the intestine and the procedure is complete.


The embodiment depicted in FIGS. 391-393 includes a tissue thickness compensator or buttress 19100 that comprises a bioabsothable compressible body 19102 that may comprise various tissue thickness compensator materials described in detail herein. Other tissue thickness compensators fabricated from materials and processes disclosed in U.S. Pat. No. 6,333,039, entitled POROUS TISSUE SCAFFOLDINGS FOR THE REPAIR OF REGENERATION OF TISSUE, issued Dec. 25, 2001, the entire disclosure of which is hereby incorporated by reference may also be employed. In at least one form, the compressible body 19102 is affixed to an attachment member 19110. For example, the compressible body 19102 is attached to the attachment member by adhesive, such as, for example 50/50 PGA/PCL, absorbable polyurethane, 36/64 PGA/PCL (the exact opposite ratio of the copolymer than the foam; the foam may be 64/36), glycerin gel, etc. In other embodiments, however, the body member 19102 is overmolded to the attachment member 19110. In still other arrangements, the body member 19102 is attached to the attachment member 19110 by a lockwasher and/or retainer tabs, etc.


In the embodiment depicted in FIGS. 391-393, the attachment member 19110 comprises an annular washer 19112 that is supported within the anvil body 19042. In at least one form, the annular washer 19112 also referred to herein as a “cut washer” is fabricated from material that may be cut through by the circular tissue cutting member 19030. For example, the cut washer 19112 may be fabricated from polypropylene, polyethylene, nylon, etc. As can be seen in FIG. 392, in at least one form, the cut washer 19112 has an outer annular wall 19114 that has a latch feature 19116 formed thereon to snappingly engage a corresponding portion of the anvil body 19042. In addition, the cut washer 19112 has an annular inner wall 19118 that is spaced from the outer wall 19114 by a frangible washer base 19120. As shown in FIG. 393, when the stapler 19000 is fired, the driver 19106 drives the staples 19022 through the portions of the colon to be stapled between the anvil 19040 and the cartridge 19017 while simultaneously driving the circular cutting member 19030 through the portions of captured colon. The tissue cutting edge 19032 is driven through the colon tissues, the tissue thickness compensator 19100 and through the washer base 19120 into the space between the outer wall 19114 and the inner wall 19118.


The tissue thickness compensator 19100 serve to enable the stapling device 19000 to adjust to variations in tissue thickness. The tissue thickness compensator 19100 is affixed to the anvil 19040 until the stapler 19000 is fired at which time it detaches from the anvil 19040. Such arrangement serves to protect the tissue thickness compensator 19100 from being dislodged or displaced from its position during insertion and/or tissue manipulation. The tissue thickness compensator 19100 is detached from the anvil 19040 by the tissue cutting member 19030 as it is driven therethrough. Thus, in at least one embodiment wherein adhesive is employed to affix the compressible body 19102 to the cut washer 19112, the compressible body 19102 may be affixed to the portion of the washer base 19120 that is inboard of where the tissue cutting member 19030 cuts through the washer base 19120. See FIG. 393. In an alternative embodiment, an annular attachment tab 19103 may be formed on the compressible body 19102 and be configured to be removably and retainingly received within an annular groove 19045 in the anvil face 19043. See FIG. 394. In alternative embodiments, a plurality of attachment tabs or tab segments and grooves may be employed to removably attach the compressible body 19102 to the anvil face 19043.


Various embodiments serve to deploy the compressible medium on the leg side of the staple line which may be beneficial when compared to other arrangements wherein the compressible material is attached to the crown side. For example, the side containing the staple legs 19023 has twice the number of staple puncture sites and the formed staple legs 19023 create non-uniform compressive loading on the tissue “T”. See FIG. 395.


The above-described arrangement comprises a means for affixing the compressible body 19102 to the anvil 19040 out of the box. Such arrangement further provides the user with the option for sterilizing and packaging the compressible body member separate from the circular stapler. Use of the tissue thickness compensator in this manner further avoids tissue pinching during device compression and enables the compressible body to be delivered on both sides of the staple line. That is, when employed with a compressible body supported on the cartridge as well as supported on the anvil, the tissue may be sandwiched therebetween. Such arrangement may improve compression, hemostasis and leak characteristics.



FIGS. 396 and 397 illustrate another tissue thickness compensator or buttress arrangement wherein a compressible bead 19130 is attached around the outer perimeter of the compressible body portion 19102 of the tissue thickness compensator 19100. In at least one embodiment, the compressible bead 19130 is fabricated from a compressible material that has a higher durometer that the material comprising the compressible body portion 19102. For example, in an embodiment wherein the compressible body portion 19102 is fabricated from compressible bioabsorbable material that has an approximate Durometer of, for example, less than 15 Shore A or 65 Shore OO. In at least one embodiment for example, the compressible body portion comprises foam to be in the 3-7 Shore A or 30-50 Shore OO range. Such material may experience, for example, forty percent (40%) compression under 3 lbs, sixty percent (60%) compression under 6 lbs, and eighty percent (80%) compression under 20 lbs. The compressible bead 19130 may be fabricated from a bioabsorbable compressible material that may be less than fifty to seventy five percent (50-75%) of the stiffness of the compressible body portion 19102. In this embodiment, for example, the compressible bead 19130 is attached to the compressible body portion 19102 by an appropriate adhesive material or is otherwise overmolded thereto. In other various embodiments, the compressible bead 19130 is fabricated from a burstable bioabsorbable material have characteristics similar to those of commercial bubble wrap material. The bead 19130 may be inflated with a gas (e.g., nitrogen, air, oxygen, carbon dioxide, etc.) or in alternative arrangements, the bead 19130 is inflated with a saline fluid to aid with removal of the anvil 19040. In still other embodiments, the bead 19130 is inflated with a healing or anti-microbial agent. Because circular staplers can fire a range of formed staple heights depending upon the knob/anvil tightness, such devices are therefore susceptible to over compressing or under compressing the body portion 19102 thereby minimizing its effect. In an effort to avoid that problem, in at least one embodiment, the burstable bead 19130 is calibrated with tissue compression to offer a visible indicator for optimal tissue compression. For example, the compressible body portion 19102 and tissue may be compressed above the “fully closed” state (e.g., eighty percent (80%) of fully closed or clamped) and then the pressure is adjusted in the bead 19130 to “relieve” the load allowing the tissue to re-expand. This can insure that mostly the compressible body portion 19102 (with a very slight load from the bead 19130) properly compresses the tissue when the staples are fired to thereby define the staple height to the thickness ratio of the body portion 19102.


In use, the compressible bead 19130 remains with the anvil 19040 during the operation of the device 19000. During placement of the anvil 19040, the compressible bead will remain in its neutral form (see e.g., FIG. 396) and be substantially rigid or uncompressed. The compressible bead 19130 will remain in its neutral form until tissue compression begins. As the tissue is compressed, the bead 19130 deforms and allows for compliance of the compressible body portion 19102 of the tissue thickness compensator 19100. See, e.g., FIG. 397. Such arrangement provides side buttressing for the anvil and delivers the buttressing capabilities on the staple leg side. This arrangement also protects the tissue thickness compensating material from being dislodged/displaced from the anvil surface during anvil insertion, tissue manipulation, etc. These embodiments further prevent the pinching of tissue during device compression and also provides a means for providing lubrication or healing agent delivery.



FIGS. 398 and 399 illustrate another anvil embodiment 19040′ that may be employed with the surgical stapling instrument 19000. The anvil 19040′ is substantially the same as 19040 described above, except in this embodiment, anvil 19040′ employs a movable anvil hood 19070 for protecting the outer perimeter 19101 of the tissue thickness compensator 19100 until the time to tissue compression. In various embodiments, the anvil hood 19070 is fabricated from substantially rigid material such as, for example, an elastomer (e.g., polyisoprene, sanoprene, silicone, etc.) or soft plastic (polypropylene, polyethylene, nylon, etc.) and is movably journaled on the anvil 19040′ to move from a “neutral” first position wherein the anvil hood 19070 extends around the outer perimeter 19101 of the tissue thickness compensator 19100 to a second “clamping” position wherein the perimeter 19101 of the tissue thickness compensator 19100 is uncovered. As can be seen in FIGS. 398 and 399, in at least one embodiment, a hood mounting platform 19072 is non-movably journaled on the anvil shaft 19044. The hood 19070 has an annular interior wall 19074 that is configured to axially slide between the hood mounting platform 19072 and the anvil body 19042. A retainer lip 19076 is formed on the end of the annular wall 19074 to retain the hood 19070 on the anvil 19040′. In addition, a tension member 19080 is provided between the distal end portion 19078 of the hood and the mounting platform 19072 to bias the hood 19070 into the neutral position.



FIG. 398 illustrates the anvil 19040′ with the hood 19070 in the neutral position. As can be seen in that Figure, when the hood 19070 is in the neutral position, the hood 19070 extends around and covers the perimeter 19101 of the tissue thickness compensator 19100. FIG. 399 illustrates the anvil hood 19070 in the clamping or second position. As can be seen in that Figure, the anvil shaft 19044 has been advanced in the proximal direction to clamp the tissue between the tissue thickness compensator 19100 and the staple cartridge 19017 and in doing so the tension member 19180 has pulled the anvil hood 19070 into the second position wherein the perimeter 19101 of the tissue thickness compensator 19100 has been uncovered. In at least one embodiment, the hood 19070 is in the neutral position until the anvil shaft 19044 is attached to the trocar shaft 19050. Once the anvil shaft 19044 has been attached to the trocar 19050, the hood 19070 is substantially free to float up and down. Pressure from the tissue during compression moves the hood 19070 distally away from the tissue thickness compression member 19100 and the tissue so that the tissue is not pinched. Such arrangement protects the tissue thickness compensator 19100 from being dislodged from the anvil surface 19043 during anvil insertion, tissue manipulation, etc. and prevents pinching of tissue during compression.



FIGS. 400 and 401 illustrate another tissue thickness compensator or buttress 19200 that may be effectively employed in connection with a circular surgical stapler 19000. As can be seen in FIG. 400, the staple cartridge 19017 supported within the stapler head 19016 has two annular rows 19019 of staple cavities 19021 that each support a surgical staple (not shown) therein. In this embodiment, the tissue thickness compensator 19200 has two annular rows 19202 of staple leg openings 19204 therein that correspond to the staple cavities 19021 in the surgical staple cartridge 19017. The tissue thickness compensator 19200 has a central opening 19206 therethrough that is sized and shaped to be received on the anvil shaft 19044 of the anvil 19040. The opening 19206 includes notch portions 19208 that are adapted to receive alignment features (e.g., keys or formations) on the anvil shaft 19044 to non-rotatably align the tissue thickness compensator 19200 thereon such that when the anvil shaft 19044 is attached to the trocar shaft 19050, the staple leg openings 19204 are in registration with the staple cavities 19021 in the staple cartridge 19017. The tissue thickness compensator 19200 may be fabricated from the various bioabsorbable materials described herein. For example, the tissue thickness compensator may be fabricated from foam, film, fibrous woven, fibrous non-woven PGA, PGA/PCL, PLA/PCL, PLLA/PCL, PGA/TMC, PDS, PEPBO or other absorbable Polyurethane, Polyester, Polycarbonate, polyorthoesters, Polyanhydrides, Polyesteramides, Polyoxaesters. Chemical names for various common copolymers are: PLA/PCL: Poly (Lactic Acid-Co-Polycaprolactone); PGA/PCL: Poly (Glycolic Acid-Co-Caprolactone): PGA/PLA: Poly (Glycolic Acid-Co-Lactic acid); PDS/PLA: Poly (P-Dioxanone-Co-Lactic Acid); PGA/TMC: Poly (Glycolic Acid-Co-Trimethylene Carbonate).


In use, once the anvil shaft 19044 has been inserted through the stapled distal colon portion DC, the tissue thickness compensator 19200 is then inserted over the anvil shaft 19044 (or the tissue thickness compensator 19200 may have been installed on the anvil shaft 19044 during insertion). The anvil shaft 19044 is attached to the trocar shaft 19050 and the stapler 1900 is used in the above-described manner. When the staples are fired through the clamped portions of colon, the legs of the staples not extend through both walls of the colon and the tissue thickness compensator 19200. The material in between the layers serves to prevent leaks through this area much like a gasket. The material could also likely control what parts of the surosal layers of the colon are allowed to remodel into one another since the healing/remodeling will be much faster than the absorption of the polymers. If saturated with drugs, it could limit rapid absorption since the surocal layers do not absorb drugs at the same rate that the inner mucosal layers do. The inner layer may be of any of the organic materials disclosed herein in addition to the absorbable polymers. For example, the organic materials may be Carboxymethyl Cellulose, Sodium Alginate, Cross-linked Hyaluronic Acid, Oxidized Regenerated Cellulose, etc.



FIGS. 402-407 illustrate another tissue thickness compensator or buttress 19300 that may be effectively employed in connection with a circular surgical stapler 19000. In this embodiment, the tissue thickness compensator 19300 has a central portion 19302 that has a central opening 19304 therein. The tissue thickness compensator 19300 has a series of radially extending spokes 19308 that extend radially outward from the central portion 19302 to be coupled to an outer annular portion 19310. An annular row 19312 of staple leg openings 19314 are provided through the outer annular portion 19310 that correspond to the staple cavities 19021 in the surgical staple cartridge 19017. The central opening 19304 includes notch portions 19306 that are adapted to receive alignment features on the anvil shaft 19044 to non-rotatably align the tissue thickness compensator 19300 thereon such that when the anvil shaft 19044 is attached to the trocar shaft 19050, the staple leg openings 19314 are in registration with the staple cavities 19021 in the staple cartridge 19017. The tissue thickness compensator 19300 may be fabricated from the various bioabsorbable materials described herein. For example, the tissue thickness compensator may be fabricated from various materials described above.


In use, the tissue thickness compensator 19300 is oriented such that the anvil shaft 19044 may be inserted through the central opening 19206 in a desired alignment orientation due to the notches 19308 registering with the alignment features on the anvil shaft 19044. See FIG. 403. The anvil 19040 is attached to the trocar shaft 19050 and the stapler 1900 is used in the above-described manner. See FIGS. 404-407. When the staples are fired through the clamped portions of colon, the legs of the staples extend through the staple leg openings 19314 in the tissue thickness compensator 19300.



FIGS. 408-410 illustrate the healing process that may take place when employing the tissue thickness compensator 19100 described above for joining the proximal colon portion PC to the distal colon portion DC. As can be seen in FIG. 408, two rows 19330A, 19330B of surgical staples 19022A, 19022b are stapled through the proximal colon portion PC, the tissue thickness compensator 19100 and the distal colon portion DC. As the healing process advances from inside of the colon, the inside row 19330A of staples 19022A slough off first and the mucosal layers of the distal and proximal colon portions bend toward each other as shown in FIG. 409. An outer scab 19340 starts to form between the exterior portions of the proximal and mucosal layers of the proximal and distal colon portions PC, DC and bridge over the tissue thickness compensator 19100. As the colon continues to heal, the second row 19330B of staples 19022B slough off leaving a continuous colon wall as shown in FIG. 410.



FIGS. 411 and 412 illustrate another tissue thickness compensator or buttress 19400 that comprises a first bioabsorbable layer 19402 of compressible material that is laminated or otherwise attached to a second bioabsorbable layer 19404 of compressible material. In one embodiment, the first and second layers may comprise various absorbable polymers or organic materials described above. In various embodiments, for example, layer 19402 may comprise material that differs from the material comprising layer 19404. In various embodiments, the layers 19402, 19404 may be attached together by, for example, applying heat. In other embodiments, adhesive such as, for example, 50/50 PGA/PCL, absorbable polyurethane, 36/64 PGA/PCL (the exact opposite ratio of the copolymer than the foam; the foam may be 64/36), glycerin gel, etc. may be employed. In other embodiments, a different type of polymer material may be inserted between the layers and then heat is applied thereto to melt the material. For example, PDS could be used to hold PGA/PCL to PLLA/PCL together. Such arrangements serve to form at least one pocket or annular line of discrete pockets therebetween. In the embodiment depicted in FIGS. 411 and 412, two annular pockets 19410, 19412 are formed between the layers 19402, 19404. As can be most particularly seen in FIG. 412, the tissue thickness compensator 19400 has an outer ring portion 19401 that has a first cross-sectional profile and a central web portion 19414 that has a second cross-sectional profile. In at least one embodiment, the second cross-sectional profile differs from the first cross-sectional profile. For example, the first cross-sectional profile may be thicker than the second cross-sectional profile. The pockets 19410, 19412 are formed in outer ring portion 14401. The central web portion 19414 has a central opening 19416 therethrough that is sized and shaped to be received on the trocar shaft 19050 of the stapler 19000. The opening 19416 includes notch portions 19418 that are adapted to receive keys 19051 on the trocar shaft 19050 in the above-described manner. In various embodiments, the pockets 19410, 19412 may contain a healing agent such as, for example Hyaluronic Acid, nutrients, fibrin, throbin, platelet rich plasma or any of the following materials for example: Sulfasalazine (Azulfidine—5ASA+Sulfapyridine Diazo Bond), Colonic Bacterial (Azoreductase), Mesalamine (5ASA with different prodrug configurations for delayed release), Asacol (5ASA+Eudragit-S Coated—PH>7 (coating dissolution)), Pentasa (5ASA+ethycellulose Coated—Time/PH dependent Slow release), Mesasal (5ASA+Eudragit-L Coated—PH>6), Olsalazine (5ASA+5ASA—Colonic Bacteria (Azoreductase)), Balsalazide (5ASA+4Aminobenzoyl-B-Alanince, Colonic Bacteria (Azoreductase)), Granulated Mesalamine, Lialda (delay and SR formulation of Mesalamine), HMPL-004 (Herbal Mixture that may inhibit TNF-Alpha, Interleukin-1Beta, and Nuclear-Kappa B Activation), CCX282-B (Orl Chemokine receptor Antagonist that interferes with Trafficking of T lymphocytes into the intestinal muscosa), Rifaximin (nonabsorbable broad spectrum antibiotic), Infliximab, Murine Chymieric Monoclonal Antibody directed against TNF-Alpha), Adalimumab, Total Human IgG1 Anti-TNF-Alpha Monoclonal Antibody, Certolizumab Pegoll, Humanized Anti-TNF FAB′ Monoclonal Antibody Fragment linked to Polyethylene Glycol, Natalizumab, First Non-TNF-Alpha Inhibitor, Humanized Monoclonal IgG4 Antibody directed against Alpha-4 Integrin, various Concomitant Immunomodulators that are potentially given with Infliximab such as for example: Azathioprine-prodrug 6-Mercaptopurine—purine synthesis inhibitor, Methotrexate—binds dihydrofolate reductase (DHFR) enzyme that participates in tetrahydrofolate synthesis, Allopurinol and Thioprine therapy, Upper GI (esophagus/gastric resections)—PPI,H2 for acid suppression to protect the healing line, C-Diff-Flagyl, Vancomycin, fecal translocation treatment, probiotics, repopulation of normal endoluminal flora and other healing materials.



FIGS. 413 and 414 illustrate another annular tissue thickness compensator or buttress 19500 that includes a central body portion 19502 that may be fabricated from, for example, PCL oxidized regenerated cellulose (“ORC”) or a bio-absorbable foam that is supported within layers 19504, 19506 of a biodegradable film that may, for example, comprise PGA (Polyglycolic acid, marketed under the trade mark Vicryl) or similar material. The layers 19504, 19506 have annular V-shaped grooves 19508, 19510 formed therein to form a somewhat corrugated outer ring portion 19510. In various embodiments, the bottom of each of the V-shaped grooves 19508. 19510 may be scored. In at least one embodiment, the film layers 19502, 19504 are welded together along their outer perimeter by the ORC material. The layers 19504, 19506 laminate together to form a central web portion 19530 in the tissue thickness compensator 19500. The inner portions of layers 19504, 19506 may be laminated together by, for example, applying heat. In other embodiments, adhesive such as, for example, 50/50 PGA/PCL, absorbable polyurethane, 36/64 PGA/PCL (the exact opposite ratio of the copolymer than the foam; the foam may be 64/36), glycerin gel, etc. may be employed. In other embodiments, a different type of polymer material may be inserted between the layers and heat is then applied thereto to melt the material. For example, PDS could be used to hold PGA/PCL to PLLA/PCL together. In at least one form, the outer ring portion 19510 has a first cross-sectional profile and the central web portion has a second cross-sectional profile that differs from the first cross-sectional profile. As can be most particularly seen in FIG. 413, the central web portion 19530 has a central opening 19532 therethrough that is sized and shaped to be received on the anvil shaft 19044 of the anvil 19040. The opening 19532 includes notch portions 19534 that are adapted to cooperate with alignment features on the anvil shaft 19044 in the above-described manner.



FIGS. 415-418 illustrate the healing process that may take place when employing the tissue thickness compensator 19500 described above for joining the proximal colon portion PC to the distal colon portion DC. As can be seen in FIG. 415, two rows 19330A, 19330B of surgical staples 19022A, 19022b are stapled through the proximal colon portion PC, the tissue thickness compensator 19500 and the distal colon portion DC. As can also be seen in FIG. 415, as the staples 19022A, 19022B are formed in the colon portions PC, DC, the cutting member 19030 serves to cut through the central portion 19530 of the tissue thickness compensator 19500. Blood and fluids enter the opened cell 19512 of the body portion 19502 which causes the ORC material therein to somewhat swell and fill in any gaps. As the healing process advances from inside of the colon, the inside adjoining mucosal end portions of the proximal colon portion PC and distal colon portion DC start to grow together as shown in FIG. 416 and the tissue thickness compensator begins to be absorbed. Eventually, the inside end portion EP as well as the first row 19330A of staples 19022A slough off into the colon as shown in FIG. 416. As the colon continues to heal, the second row 19330B of staples 19022B slough off leaving a continuous colon wall as shown in FIG. 418.



FIGS. 419-423 illustrate a multi-component tissue thickness compensator arrangement 19600 that may be effectively employed in connection with a circular surgical stapler 19000. In at least one form, the tissue thickness compensator arrangement comprises a first tissue thickness compensator 19601 that is attached to the anvil 19040. The tissue thickness compensator 19601 has an outer ring portion 19602 that corresponds to the lines of staple 19022 in the surgical staple cartridge 19017 in the surgical stapler 19000. The tissue thickness compensator 19601 further has central web portion 19604 that has a central opening 19606 therein that has notches 19608 that are configured to receive alignment features on the anvil shaft 19044 as was discussed above. The tissue thickness compensator 19600 may be fabricated, for example, from one of the following bioabsorbable material arrangements:

    • One of the a bioabsorbable foams described above such as, for example, oxidized regenerated cellulose (“ORC”) or a bio-absorbable foam fabricated from, for example, PGA (Polyglycolic acid, sold under the trademark Vicryl), PCL (polycaprolactone), PLA or PLLA (Polyactic acid), PDS, (Polydioxanone), PHA (polyhydroxyalkanoate), PGCL (poliglecaprone 25, sold under the trademark Monocryl) or a composite of PGA, PCL, PLA and PDS.
    • A non-woven bioabsorbable material comprising various monomers or co-polymers described above or comprising Carboxymethyl Cellulose, Cross-linked Hyaluronic Acid, Oxidized Regenerated Cellulose, etc.
    • A bioabsorbable tissue scaffolding material which may comprise, for example, a collagen matrix, A-cell material, Skeletonized Omentum, etc.


      In one embodiment, the outer ring portion 19602 has a first somewhat wed-shaped cross-sectional profile as shown in FIG. 421. As can be seen in that Figure, the thickness “T1” at the perimeter of the outer ring 19602 is less than the thickness “T2” of an inner portion of the outer ring 19602. The outer ring portion 19602 has a planar support surface 19603 and a tapered surface 19605 as shown. The central web portion 19604 has a second cross-sectional profile that differs from the first cross-sectional profile. For example, the shape and thickness of the second cross-sectional profile differs from the shape and thickness of the first cross-sectional profile.


As shown in FIG. 419, one of the tissue thickness compensators 19600 referred to as a “top tissue thickness compensator” is supported on the anvil 19040 with the tapered surface facing the surgical stapler head 19020. FIG. 421 illustrates the tissue thickness compensator 19600 supported on the staple cartridge 19017 of the stapler 19000. The planar surface 19603 may be attached to a portion of cut washer 19112 in the manner described above. The tapered surface 19605 faces the stapler 19000. A second tissue thickness compensator 19600, referred to as a “bottom tissue thickness compensator” is supported on the staple cartridge 19017 such that the tapered surface 19605 faces the anvil 19040. Such cross-sectional profile also enables the tissue thickness compensator 19601 to degrade at different rates. In alternative embodiments, the outer ring portion 19602 of the tissue thickness compensator 19601 may have annular rings of perforated cuts therein. The cuts may comprise annular cuts that do not extend completely through the outer ring 19602 on one or both surfaces 19605, 19603. The cuts may comprise a series of spaced cuts extending through a portion of the outer ring 19602. Such cuts may serve to form different sloughing layers to aid in the sloughing/healing process.


The multi-component tissue thickness compensator 19600 also comprises a central tissue thickness compensator or buttress 19700 that may be fabricated from any of the bioabsorbable materials described above with respect to the tissue thickness compensator 19601. As can be seen in FIGS. 422 and 423, one form of tissue thickness compensator 19700 has an outer ring portion 19702 and a central web portion 19704 that has a central opening 19706 therein that is configured to enable the tissue thickness compensator 19700 to be journaled on the anvil shaft 19044. In one embodiment, the outer ring portion 19702 has a first cross-sectional profile as shown in FIG. 423. As can be seen in that Figure, the cross-sectional thickness “T1” of the outer ring portion 19702 at its outer perimeter is greater that the cross-sectional thickness “TS” of the portion of the outer ring 19700 wherein it adjoins the central web portion 19704. The central web portion 19704 has a second cross-sectional profile that differs from the first cross-sectional profile. The outer ring portion 19702 has two opposed tapered surfaces 19710, 19720 that extend from the outer edge/perimeter of the outer ring portion 19702 to the central web portion 19704 as shown. When installed on the anvil shaft 19044, the tapered surface 19710 faces the tapered surface 19605 of the top tissue thickness compensator 19601 and the tapered surface 19720 faces the tapered surface 19605 of the bottom tissue thickness compensator 19601 on the staple cartridge 19017. The outer ring portion 19702 of the tissue thickness compensator 19700 may have annular rings of perforated cuts therein. The cuts may comprise annular cuts that do not extend completely through the outer ring 19702 on one or both surfaces 19710, 19720. The cuts may comprise a series of spaced cuts extending through a portion of the outer ring 19702. Such cuts may serve to form different sloughing layers to aid in the sloughing/healing process. For example, the multiple types/densities could provide variable spring rates, absorption rates or hydrophilic swelling. The variable thickness can vary tissue pressure by staple row or help to distribute tissue compression and strength.



FIGS. 424 and 425 illustrate another annular tissue thickness compensator 19700′ that is substantially similar in construction to the tissue thickness compensator 19700 described above. However, in this embodiment, the outer ring portion 19702 has two annular rows 19720 of staple leg openings 19722 that correspond to the rows of staple cavities in the surgical staple cartridge. The central opening 19706 has notches 19708 that are adapted to receive keys 19051 on the trocar shaft 19050 to non-rotatably align the tissue thickness compensator 19700′ thereon such that when received on the trocar shaft 19050, the staple leg openings 19722 are in registration with the staple cavities 19021 in the staple cartridge 19017. In use, the tapered cross-sectional profile of the tissue thickness compensator 19700′ with the staple leg openings 19722 serves to accommodate colon portions that have different thicknesses that extend across the staple lines. For example, the multiple types/densities could provide variable spring rates, absorption rates or hydrophilic swelling. The variable thickness can vary tissue pressure by staple row or help to distribute tissue compression and strength.



FIGS. 426 and 427 illustrate another annular tissue thickness compensator or buttress 19700″ that has substantially the same shape as the annular tissue thickness compensator 19700 described above. However, in this embodiment, the outer ring portion 19702 is formed from compressible materials of the types and construction described above that have different densities across the cross-sectional profile of the outer ring portion 19702. For example, as can be seen in FIG. 427, the outer ring portion 19702 may have three annular regions 19730, 19740, 19750 across its profile that have different densities and which degrade or are absorbed at different rates. The denser materials degrade or are absorbed at rates that are slower than the rates of the less denser materials. In the illustrated embodiment, the innermost region 19730 has a first density “D1”; the middle region 19740 has a second density “D2” and the outermost region 19750 has a third density “D3”. In the illustrated embodiment, D1<D2<D3. Thus, in one embodiment, the density D3 of the outermost annular region of the outer ring 19702 is great than densities D1 and D2. Other embodiments may only have two regions with different densities or they may have more than three regions with different densities. For example, FIGS. 428 and 429 illustrate an annular tissue thickness compensator or buttress 19700″ that has a fourth annular region 19760. In the illustrated embodiment, region 19760 is denser than region 19750 which is denser than region 19740 which is denser than region 19730. The tissue thickness compensators 19700″ may be fabricated from, for example, the various compressible bioabsorbable materials described herein. Such arrangement serves to provide stapling instrument with the ability to effectively staple colon tissues that vary in thickness across the staple lines.



FIGS. 430-433 illustrate the healing process that may take place when employing the tissue thickness compensator 19700″ described above for joining the proximal colon portion PC to the distal colon portion DC. As can be seen in FIG. 430, two rows 19330A, 19330B of surgical staples 19022A, 19022b are stapled through the proximal colon portion PC, the tissue thickness compensator 19700″ and the distal colon portion DC. As can also be seen in FIG. 430, as the line 19330A of staples 19022A are stapled through the first region 19730 and the line 19330B of staples 19022B are stapled through the second region 19740. As the healing process advances, a scab 19780 forms on the outside of the colon across the fourth region 19760 of the tissue thickness compensator 19700″. The mucosal ends of the proximal colon portion PC and distal colon portion DC grow together around the first region 19730 and eventually that portion of colon C1 sloughs off with the first line 19330A of staples 19022A into the interior of the colon as shown in FIG. 431. As the colon continues to heal, the colon continues to grow around the second region 19740 of the tissue thickness compensator 19700″ forming colon portion C2 which eventually sloughs off into the colon as illustrated in FIG. 432. Continued healing results in the colon growing around the third region 19750 of the tissue thickness compensator 19700″ forming colon portion C3 and eventually that colon portion C3 sloughs off with the second line 19330B of staples 19022B into the colon as shown in FIG. 433.



FIGS. 434 and 435 illustrate another annular tissue thickness compensator or buttress 19800 that may be effectively employed in connection with a circular surgical stapler 19000. In this embodiment, the bioabsorbable tissue thickness compensator 19800 has an annular outer ring portion 19802 that corresponds to the lines of staples 19022 in the surgical staple cartridge 19017 in the surgical stapler 19000. The tissue thickness compensator 19800 further has central web portion 19804 that has a central opening 19806 therein that is configured to enable the tissue thickness compensator 19800 to be journaled on the anvil shaft 19044. As can be seen in FIG. 435, a first portion 19820 of the outer ring portion 19802 is fabricated from anti-adhesion foam material such as, for example, Carboxymethyl Cellulose (Seprafilm), Hyaluronic Acid, etc. and a second portion 19822 that can elute or emit the drug as the colon heals. See FIG. 436. In one embodiment, the outer ring portion 19802 has a cross-sectional shape as shown in FIG. 435. As can be seen in that Figure, the cross-sectional thickness “T1” of the outer ring portion 19802 at its outer perimeter is greater that the cross-sectional thickness “T2” of the portion of the outer ring 19800 wherein it adjoins the central web portion 19804. The outer ring portion 19802 tapers on both sides from its outer edge/perimeter to the central web portion 19804 as shown. The outer ring portion 19802 has a first cross-sectional profile and the central web portion 19804 has a second cross-sectional profile that differs from the first cross-sectional profile. Such arrangement provides an annular drug elution zone that is bounded by the annular outside ring 19802 that serves to establish a seal between the colon portions PC, DC and can prevent adhesion.



FIGS. 437 and 438 illustrate another annular tissue thickness compensator or buttress 19900 that may be effectively employed in connection with a circular surgical stapler 19000. In this embodiment, the tissue thickness compensator 19900 has an outer ring portion 19902 that corresponds to the lines of staples 19022 in the surgical staple cartridge 19017 in the surgical stapler 19000. The tissue thickness compensator 19900 further has central web portion 19904 that has a central opening 19906 therein that is configured to enable the tissue thickness compensator 19900 to be journaled on the anvil shaft 19044. The tissue thickness compensator may be fabricated from the various materials described herein such as, for example, tissue scaffold material that may comprise: a collagen matrix, A-cell, or skeletonized Omentum. In one embodiment, the outer ring portion 19902 has a wedge-shaped cross-sectional profile as shown in FIG. 438. As can be seen in that Figure, the cross-sectional thickness “T1” of the outer ring portion 19902 at its outer perimeter is greater than the cross-sectional thickness “T2” of the portion of the outer ring 19900 wherein it adjoins the central web portion 19904. The outer ring portion 19902 tapers on both sides from its outer edge/perimeter to the central web portion 19904 as shown. The central web portion has a second cross-sectional profile that differs from the first cross-sectional profile. In addition, the outer ring portion 19902 of the tissue thickness compensator 19900 may be divided into a plurality of arcuate segments by slots 19920. In the depicted embodiment, for example, three slots 19920 serve to divide the tissue thickness compensator 19900 into three segments 19930, 19940, 19950. Such arrangement serves to prevent stricture.



FIGS. 439-440 illustrate another annular tissue thickness compensator or buttress 20000 that may be effectively employed in connection with a circular surgical stapler 19000. In this embodiment, the tissue thickness compensator 20000 has an annular outer ring portion 20002 that corresponds to the lines of staple 19022 in the surgical staple cartridge 19017 in the surgical stapler 19000. The tissue thickness compensator 20000 further has central web portion 20004 that has a central opening 20006 therein that is configured to enable the tissue thickness compensator 20000 to be journaled on the anvil shaft 19044. The tissue thickness compensator 20000 may be fabricated from, for example, various materials described in detail above. the outer ring portion 20002 has a first cross-sectional profile and the central web portion 20004 has a second cross-sectional profile that differs from the first cross-sectional profile. In one embodiment, the annular outer ring portion 20002 has a cross-sectional shape as shown in FIG. 440. As can be seen in that Figure, the thickness “T1” at the perimeter of the outer ring 20002 is greater than the thickness “T2” of an inner portion of the outer ring 20002. The outer ring portion 20002 has a planar support surface 20003 and a tapered surface 20005 as shown. Such arrangement enables the planar surface 20003 to be supported on the deck of the staple cartridge 19017 or on the anvil body 19042. In that embodiment, for example, the tissue thickness compensator 20000 may be attached to the cut washer 19112 with adhesive or be overmolded thereto.



FIGS. 441-442 illustrate another annular tissue thickness compensator or buttress 20100 that may be effectively employed in connection with a circular surgical stapler 19000. In this embodiment, the tissue thickness compensator 20100 has an outer ring portion 20102 that corresponds to the lines of staple 19022 in the surgical staple cartridge 19017 in the surgical stapler 19000. The tissue thickness compensator 20100 further has central web portion 20104 that has a central opening 20106 therein that is configured to enable the tissue thickness compensator 20100 to be journaled on the anvil shaft 19044. The tissue thickness compensator 20100 may be fabricated from, for example, various materials described in detail above. In one embodiment, the outer ring portion 20102 has a cross-sectional shape as shown in FIG. 442. As can be seen in that Figure, the outer ring portion 20102 has a constant cross-sectional thickness “T1” that is greater than the cross-sectional thickness “T2” of the central web portion 20104. Such arrangement enables the tissue thickness compensator 20100 to be supported on the deck of the staple cartridge 19017 or on the anvil body 19042. In that embodiment, for example, the tissue thickness compensator 20100 may be attached to the cut washer 19112 with adhesive or be overmolded thereto.



FIGS. 443-444 illustrate another annular tissue thickness compensator or buttress 20200 that may be effectively employed in connection with a circular surgical stapler 19000. In this embodiment, the tissue thickness compensator 20200 has an outer ring portion 20202 that corresponds to the lines of staple 19022 in the surgical staple cartridge 19017 in the surgical stapler 19000. The tissue thickness compensator 20200 further has central web portion 20204 that has a central opening 20206 therein that is configured to enable the tissue thickness compensator 20200 to be journaled on the anvil shaft 19044. The tissue thickness compensator 20200 may be fabricated from, for example, various materials described in detail above. In one embodiment, the outer ring portion 20202 has a first cross-sectional profile as shown in FIG. 444. As can be seen in that Figure, the outer edge of the outer ring portion 20202 has a cross-sectional thickness “T1” that is less than the cross-sectional thickness “T2” of the inner edge of the outer ring portion 10202 where it meets central web portion 20204. As can be seen in FIG. 444, in this embodiment, the outer ring portion 20202 tapers on both sides from its outer edge to its inner edge. The inner web 20204 has a cross-sectional thickness “T3” that is less than T2. The inner web 20204 has a second cross-sectional profile that differs form the first cross-sectional profile. The inner web serves to keep the disk centered on the anvil shank and minimize the cutting load due to its thinness.



FIGS. 445-448 illustrate another tissue thickness compensator 20300 that may be effectively employed in connection with a circular surgical stapler 19000. In at least one embodiment, the tissue thickness compensator 20300 has an outer ring portion 20302 that corresponds to the lines of staple 19022 in the surgical staple cartridge 19017 in the surgical stapler 19000. The tissue thickness compensator 20300 further has central web portion 20304 that has a central opening 20306 therein that is configured to enable the tissue thickness compensator 20300 to be journaled on the anvil shaft 19044. The tissue thickness compensator 20300 may be fabricated from, for example, various material described above. In one embodiment, the outer ring portion 20302 may have a cross-sectional shape as shown in FIG. 448. The tissue thickness compensator 20300 also has an annular array of openings 20330 that extend through the outer ring portion 20302. The outer ring portion 20302 serves to selectively only compensate the outer row of staples or compensate the two rows differently.



FIG. 449 depicts an enlarged portion of bioabsorbable material 20500 from which various tissue thickness compensator embodiments may be formed. The material comprises a woven web of fibers 20502 with additional fibers 20504 interspersed therein. The fibers 20502, 20504 may comprise, for example, any different absorbable polymer that is not dissolvable in the same foam manufacturing solvent (e.g., PGA in PLLA/PCL foam) or various organic materials described in detail above, for example. FIG. 450 depicts an enlarged portion of bioabsorbable material 20600 from which various tissue thickness compensator embodiments may be formed. The material comprises closed cell foam consisting of, for example, absorbable polyurethane FIG. 451 depicts an enlarged portion of bioabsorbable material 20700 from which various tissue thickness compensator embodiments may be formed. This material comprises closed cell foam of the type described above with fibers 20704 fabricated from the above-mentioned material interspersed and embedded into the foam body 20702.



FIGS. 452-457 illustrate another tissue thickness compensator 20800 that is substantially compressible as will be discussed in further detail below. In at least one embodiment, for example, the tissue thickness compensator 20800 comprises a pair of annular end discs 20802, 20804 that may be fabricated from, for example, various absorbable polymers or celluloses disclosed herein. The discs 20802, 20804 may be separated by an array of fins 20806. At least one of the fins 20806 has a medicine or healing agent 20810 applied thereto. In the illustrated embodiment, another medicine or healing agent 20812 is applied to some of the fins 20806. Each fin may have medicine or healing agent thereon or only some of the fins have healing agent/medicine thereon. The medicines or healing agents may comprise, for example, freeze dried fibrin, thrombin, glycerin, etc. FIG. 455 illustrates examples of alternative fin configurations 20806, 2080920806″. Each of the end discs 20802, 20804 have openings 20820 therethrough to enable the tissue thickness compensator 20800 to be received on the anvil shaft 19044.



FIG. 456 illustrates the tissue thickness compensator 20800 inserted onto the anvil shaft 19044 after it has been attached to the trocar shaft 19050 of the surgical instrument 19000. As shown in FIG. 457, when the stapler 19000 is fired, the driver 19106 drives the staples 19022 through the portions of the colon to be stapled between the anvil 19040 and the cartridge 19017 while simultaneously driving the circular cutting member 19030 through the portions of captured colon. The tissue cutting edge 19032 is driven through the colon tissues and the tissue thickness compensator 20800. The portion of the tissue thickness compensator 20800 that is compressed between the anvil 19040 and the staple cartridge 1907 collapses and the medicine/healing agents 20810, 20182 gets squeezed between the adjoining ends of the colon portions PC, DC which serves to facilitate healing between those portions of interconnected colon.



FIGS. 458-461 illustrate another tissue thickness compensator 20900 that is substantially compressible as will be discussed in further detail below. In at least one embodiment, for example, the tissue thickness compensator 20900 comprises a pair of annular end discs 20902, 20904 (shown in FIG. 460) that may be fabricated from, for example, various absorbable polymers or celluloses. The discs 20902, 20904 may be separated by an array of fins 20906. In this embodiment, an end wall 20910 extends around the circumference of the discs 20902, 20904. At least one of the fins has at least one medicine or healing agent 20920 of the types describe above applied thereto. Each fin may have medicine or healing agent thereon or only some of the fins have healing agent/medicine thereon. Each of the end discs 20902, 20904 have openings 20912 therethrough to enable the tissue thickness compensator 20900 to be received on the anvil shaft 19044.



FIG. 460 illustrates the tissue thickness compensator 20900 inserted onto the anvil shaft 19044 after it has been attached to the trocar shaft 19050 of the surgical instrument 19000. As shown in FIG. 461, when the stapler 19000 is fired, the driver 19106 drives the staples 19022 through the portions of the colon to be stapled between the anvil 19040 and the cartridge 19017 while simultaneously driving the circular cutting member 19030 through the portions of captured colon. The tissue cutting edge 19032 is driven through the colon tissues and the tissue thickness compensator 20900. The portion of the tissue thickness compensator 20900 that is compressed between the anvil 19040 and the staple cartridge 1907 collapses and the medicine/healing agents 20920 gets squeezed between the adjoining ends of the colon portions PC, DC which serves to facilitate healing between those portions of interconnected colon.



FIG. 462 illustrates a portion of another circular staple buttress ring 21000 that comprises a non-woven tissue scaffold material of the various types and constructions described above. The tissue scaffold material may be encapsulated with a layer 210001 of, for example, PGA, PLA, PLLA, etc. The buttress ring 21000 also includes a plurality of sharp spikes or barbs 21002 that may be fabricated from polydioxanon material sold under the trademark PDS®. Other embodiments may be manufactured from, for example, PCL, TMC, etc. In one embodiment, for example, the spikes 21002 may be 0.5 mm long. The spikes 21001 may extend out of both sides of the ring 21000. The buttress ring 21000 may be employed with a circular stapling instrument 19000 in the manner described above such that when installed, the buttress ring 21000 is stapled between the proximal and distal colon portions PC, DC as shown in FIG. 463. As can be seen in that Figure, the spikes 21002 puncture the serosa on the PC and DC colon portions. The spikes 21002 cause the serosa defects to aid vascular growth and stem cell migration. See FIGS. 465 and 466. Trauma causes tissue remodeling and potentially improved healing. The more the surosal layers are scored or punctured, the better the remodeled/healed tissue will be



FIG. 467 illustrates a portion of another circular staple buttress ring 21200 that comprises a central layer or bead 21202 of a healing agent which may comprise, for example, Hyaluronic Acid that is sandwiched between two outer layers 21204, 21206 of, for example, the various foam bioabsorbable materials described above. FIG. 467 illustrates the buttress ring 21200 after is has been stapled between the distal and proximal colon segments DC, PC by staples 19022.



FIG. 468 illustrates a portion of another circular staple buttress ring 21300 after is has been stapled between the distal and proximal colon segments DC, PC by staples 19022. In at least one embodiment, the buttress ring 21300 is fabricated from, for example, bioabsorbable tissue scaffold material 21302 of the type described above wherein the scaffold fibers 21304 are coated with, for example, a healing agent 21306 which may comprise Hyaluronic Acid. See FIG. 469.



FIGS. 470 and 471 depict an annular tissue thickness compensator or buttress 21400 that may be effectively employed with a circular stapling device 19000. In at least one form, the annular tissue thickness compensator 21400 comprises a compressible annular body portion 21402 that may consist of various absorbable polymer foams described herein. The body portion 21402 is attached to a retainer ring 21404 that has a central opening 21406 therein and a tapered inner wall 21408 that is sized to sealingly receive the stapling head 19016 of a circular stapler 19000. The retainer ring 21404 may be fabricated from, for example, various biocompatible or bioimplantible, nonabsorbable materials such as, for example, Nylon, Polycarbonate, Polyethylene, Polypropylene, etc. and the body portion 21402 may be attached to the retainer ring by adhesive or it may be molded or laminated thereto.


Various embodiments of the annular tissue thickness compensator 21400 may be introduced into the patient using a circular stapler introducer 21500 as shown in FIGS. 472-478. In one form, the introducer 21500 comprises a substantially rigid shaft portion 21502 that defines a first lumen 21504 that is sized to receive the stapler head 19016 and elongated shaft 19014 of a circular stapler 19000 therein. The shaft portion 21502 may be fabricated from, for example, Polyisoprene, Silicone, Polyurethane, etc. The sheath 21510 has an open proximal end 21506 through which the stapler head 19016 may be inserted. A handle formation 21407 may be provided on the proximal end 21506 as shown. A releasable cap 21510 is pivotally coupled to a distal end 21508 of the shaft by a hinge 21512. The hinge may comprise, for example, at least one “living” hinge that is integrally formed with the distal end 21508 of the shaft 21502. The cap 21510 has a rounded dome portion 21514 and a latch 21516 that is adapted to releasably engage a latch feature or latch groove 21509 formed on the distal end 21508 of the shaft 21502. The cap 21510 is selectively pivotable between an open position (FIG. 478) and closed or latched positions (FIGS. 472-476).


In use, the circular stapling instrument 19000 is inserted into the introducer 21500 through the open proximal end 21506 with the tissue thickness compensator 21400 seated on the stapler head 19016 as shown in FIG. 274. In an alternative arrangement, the tissue thickness compensator 21400 is seated in the distal end portion 21508 adjacent the cap 21510 as shown in FIG. 475. The stapler 19000 may then be inserted into the introducer 21500 so that the stapler head 19016 is seated into the retainer ring 21404 as shown in FIG. 476. Once the introducer 21500 and stapler 19000 have been inserted into a desired location within the colon, the surgeon may push the stapler 19000 in the distal direction while holding onto the handle 21407 so that the staple head 19016 and tissue thickness compensator 21400 causes the cap 21510 to unlatch and pivot open as shown in FIG. 478. The introducer 21500 may then be withdrawn out of the colon and the stapling procedure conducted as described above.


The introducer 21500 protects the tissue thickness compensator 21400 from being dislodged or becoming damaged during entry and manipulation through the body. The introducer 21500 may also function as a packaging medium for the tissue thickness compensator 21400. Thus, the introducer and tissue thickness compensator 21400 can be packaged, sterilized, and sold separately from the circular stapler. Alternative introducer arrangements such as some of the introducer arrangements disclosed in U.S. Pat. No. 8,353,438, entitled CIRCULAR STAPLER INTRODUCER WITH RIGID CAP ASSEMBLY CONFIGURED FOR EASY REMOVAL, U.S. patent application Ser. No. 12/621,679, the entire disclosure of which is herein incorporated by reference may be employed in connection with the tissue thickness compensator 21400.


In various embodiments, further to the above, a tissue thickness compensator can be comprised of a biocompatible material. The biocompatible material, such as, a foam, may comprise tackifiers, surfactants, fillers, cross-linkers, pigments, dyes, antioxidants and other stabilizers and/or combinations thereof to provide desired properties to the material. In certain embodiments, a biocompatible foam may comprise a surfactant. The surfactant may be applied to the surface of the material and/or dispersed within the material. Without wishing to be bound to any particular theory, the surfactant applied to the biocompatible material may reduce the surface tension of the fluids contacting the material. For example, the surfactant may reduce the surface tension of water contacting the material to accelerate the penetration of water into the material. In various embodiments, the water may act as a catalyst. The surfactant may increase the hydrophilicity of the material.


In various embodiments, the surfactant may comprise an anionic surfactant, a cationic surfactant, and/or a non-ionic surfactant Examples surfactants include, but are not limited to polyacrylic acid, methalose, methyl cellulose, ethyl cellulose, propyl cellulose, hydroxy ethyl cellulose, carboxy methyl cellulose, polyoxyethylene cetyl ether, polyoxyethylene lauryl ether, polyoxyethylene octyl ether, polyoxyethylene octylphenyl ether, polyoxyethylene oleyl ether, polyoxyethylene sorbitan monolaurate, polyoxyethylene stearyl ether, polyoxyethylene nonylphenyl ether, dialkylphenoxy poly(ethyleneoxy) ethanol, and polyoxamers, and combinations thereof. In at least one embodiment, the surfactant may comprise a copolymer of polyethylene glycol and polypropylene glycol. In at least one embodiment, the surfactant may comprise a phospholipid surfactant. The phospholipid surfactant may provide antibacterial stabilizing properties and/or disperse other materials in the biocompatible material.


In various embodiments, the tissue thickness compensator may comprise at least one medicament. The tissue thickness compensator may comprise one or more of the natural materials, non-synthetic materials, and/or synthetic materials described herein. In certain embodiments, the tissue thickness compensator may comprise a biocompatible foam comprising gelatin, collagen, hyaluronic acid, oxidized regenerated cellulose, polyglycolic acid, polycaprolactone, polyactic acid, polydioxanone, polyhydroxyalkanoate, poliglecaprone, and combinations thereof. In certain embodiments, the tissue thickness compensator may comprise a film comprising the at least one medicament. In certain embodiments, the tissue thickness compensator may comprise a biodegradable film comprising the at least one medicament. In certain embodiments, the medicament may comprise a liquid, gel, and/or powder. In various embodiments, the medicaments may comprise anticancer agents, such as, for example, cisplatin, mitomycin, and/or adriamycin.


In various embodiments, the tissue thickness compensator may comprise a biodegradable material to provide controlled elution of the at least one medicament as the biodegradable material degrades. In various embodiments, the biodegradable material may degrade may decompose, or loses structural integrity, when the biodegradable material contacts an activator, such as, for example an activator fluid. In various embodiments, the activator fluid may comprise saline or any other electrolyte solution, for example. The biodegradable material may contact the activator fluid by conventional techniques, including, but not limited to spraying, dipping, and/or brushing. In use, for example, a surgeon may dip an end effector and/or a staple cartridge comprising the tissue thickness compensator comprising the at least one medicament into an activator fluid comprising a salt solution, such as sodium chloride, calcium chloride, and/or potassium chloride. The tissue thickness compensator may release the medicament as the tissue thickness compensator degrades. In certain embodiments, the elution of the medicament from the tissue thickness compensator may be characterized by a rapid initial elution rate and a slower sustained elution rate.


In various embodiments, a tissue thickness compensator, for example, can be comprised of a biocompatible material which may comprise an oxidizing agent. In various embodiments, the oxidizing agent may be an organic peroxide and/or an inorganic peroxide. Examples of oxidizing agents may include, but are not limited to, hydrogen peroxide, urea peroxide, calcium peroxide, and magnesium peroxide, and sodium percarbonate. In various embodiments, the oxidizing agent may comprise peroxygen-based oxidizing agents and hypohalite-based oxidizing agents, such as, for example, hydrogen peroxide, hypochlorous acid, hypochlorites, hypocodites, and percarbonates. In various embodiments, the oxidizing agent may comprise alkali metal chlorites, hypochlorites and perborates, such as, for example, sodium chlorite, sodium hypochlorite and sodium perborate. In certain embodiments, the oxidizing agent may comprise vanadate. In certain embodiments, the oxidizing agent may comprise ascorbic acid. In certain embodiments, the oxidizing agent may comprise an active oxygen generator. In various embodiments, a tissue scaffold may comprise the biocompatible material comprising an oxidizing agent.


In various embodiments, the biocompatible material may comprise a liquid, gel, and/or powder. In certain embodiments, the oxidizing agent may comprise microparticles and/or nanoparticles, for example. For example, the oxidizing agent may be milled into microparticles and/or nanoparticles. In certain embodiments, the oxidizing agent may be incorporated into the biocompatible material by suspending the oxidizing agent in a polymer solution. In certain embodiments, the oxidizing agent may be incorporated into the biocompatible material during the lyophylization process. After lyophylization, the oxidizing agent may be attached to the cell walls of the biocompatible material to interact with the tissue upon contact. In various embodiments, the oxidizing agent may not be chemically bonded to the biocompatible material. In at least one embodiment, a percarbonate dry power may be embedded within a biocompatible foam to provide a prolonged biological effect by the slow release of oxygen. In at least one embodiment, a percarbonate dry power may be embedded within a polymeric fiber in a non-woven structure to provide a prolonged biological effect by the slow release of oxygen. In various embodiments, the biocompatible material may comprise an oxidizing agent and a medicament, such as, for example, doxycycline and ascorbic acid.


In various embodiments, the biocompatible material may comprise a rapid release oxidizing agent and/or a slower sustained release oxidizing agent. In certain embodiments, the elution of the oxidizing agent from the biocompatible material may be characterized by a rapid initial elution rate and a slower sustained elution rate. In various embodiments, the oxidizing agent may generate oxygen when the oxidizing agent contacts bodily fluid, such as, for example, water. Examples of bodily fluids may include, but are not limited to, blood, plasma, peritoneal fluid, cerebral spinal fluid, urine, lymph fluid, synovial fluid, vitreous fluid, saliva, gastrointestinal luminal contents, and/or bile. Without wishing to be bound to any particular theory, the oxidizing agent may reduce cell death, enhance tissue viability and/or maintain the mechanical strength of the tissue to tissue that may be damaged during cutting and/or stapling. In various embodiments, the biocompatible material may comprise at least one microparticle and/or nanoparticle. The biocompatible material may comprise one or more of the natural materials, non-synthetic materials, and synthetic materials described herein. In various embodiments, the biocompatible material may comprise particles having a mean diameter of about 10 nm to about 100 nm and/or about 10 μm to about 100 μm, such as, for example, 45-50 nm and/or 45-50 μm. In various embodiments, the biocompatible material may comprise biocompatible foam comprising at least one microparticle and/or nanoparticle embedded therein. The microparticle and/or nanoparticle may not be chemically bonded to the biocompatible material. The microparticle and/or nanoparticle may provide controlled release of the medicament. In certain embodiments, the microparticle and/or nanoparticle may comprise at least one medicament. In certain embodiments, the microparticle and/or nanoparticle may comprise a hemostatic agent, an anti-microbial agent, and/or an oxidizing agent, for example. In certain embodiments, the tissue thickness compensator may comprise a biocompatible foam comprising an hemostatic agent comprising oxidized regenerated cellulose, an anti-microbial agent comprising doxycline and/or Gentamicin, and/or an oxidizing agent comprising a percarbant. In various embodiments, the microparticle and/or nanoparticle may provide controlled release of the medicament up to three days, for example.


In various embodiments, the microparticle and/or nanoparticle may be embedded in the biocompatible material during a manufacturing process. For example, a biocompatible polymer, such as, for example, a PGA/PCL, may contact a solvent, such as, for example, dioxane to form a mixture. The biocompatible polymer may be ground to form particles. Dry particles, with or without ORC particles, may be contacted with the mixture to form a suspension. The suspension may be lyophilized to form a biocompatible foam comprising PGA/PCL having dry particles and/or ORC particles embedded therein.


In various embodiments, the tissue thickness compensators or layers disclosed herein can be comprised of an absorbable polymer, for example. In certain embodiments, a tissue thickness compensator can be comprised of foam, film, fibrous woven, fibrous non-woven PGA, PGA/PCL (Poly(glycolic acid-co-caprolactone)), PLA/PCL (Poly(lactic acid-co-polycaprolactone)), PLLA/PCL, PGA/TMC (Poly(glycolic acid-co-trimethylene carbonate)), PDS, PEPBO or other absorbable polyurethane, polyester, polycarbonate, Polyorthoesters, Polyanhydrides, Polyesteramides, and/or Polyoxaesters, for example. In various embodiments, a tissue thickness compensator can be comprised of PGA/PLA (Poly(glycolic acid-co-lactic acid)) and/or PDS/PLA (Poly(p-dioxanone-co-lactic acid)), for example. In various embodiments, a tissue thickness compensator can be comprised of an organic material, for example. In certain embodiments, a tissue thickness compensator can be comprised of Carboxymethyl Cellulose, Sodium Alginate, Cross-linked Hyaluronic Acid, and/or Oxidized regenerated cellulose, for example. In various embodiments, a tissue thickness compensator can comprise a durometer in the 3-7 Shore A (30-50 Shore OO) ranges with a maximum stiffness of 15 Shore A (65 Shore OO), for example. In certain embodiments, a tissue thickness compensator can undergo 40% compression under 3 lbf load, 60% compression under 6 lbf load, and/or 80% compression under 20 lbf load, for example. In certain embodiments, one or more gasses, such as air, nitrogen, carbon dioxide, and/or oxygen, for example, can be bubbled through and/or contained within the tissue thickness compensator. In at least one embodiment, a tissue thickness compensator can comprise beads therein which comprise between approximately 50% and approximately 75% of the material stiffness comprising the tissue thickness compensator.


In various embodiments, a tissue thickness compensator can comprise hyaluronic acid, nutrients, fibrin, thrombin, platelet rich plasma, Sulfasalazine (Azulfidine®—5ASA+Sulfapyridine diazo bond))—prodrug—colonic bacterial (Azoreductase), Mesalamine (5ASA with different prodrug configurations for delayed release), Asacol® (5ASA+Eudragit-S coated—pH>7 (coating dissolution)), Pentasa® (5ASA+ethylcellulose coated—time/pH dependent slow release), Mesasal® (5ASA+Eudragit-L coated—pH>6), Olsalazine (5ASA+5ASA—colonic bacterial (Azoreductase)), Balsalazide (5ASA+4Aminobenzoyl-B-alanine)—colonic bacterial (Azoreductase)), Granulated mesalamine, Lialda (delay and SR formulation of mesalamine), HMPL-004 (herbal mixture that may inhibit TNF-alpha, interleukin-1 beta, and nuclear-kappa B activation), CCX282-B (oral chemokine receptor antagonist that interferes with trafficking of T lymphocytes into the intestinal mucosa), Rifaximin (nonabsorbable broad-spectrum antibiotic), Infliximab, murine chymieric (monoclonal antibody directed against TNF-alpha-approved for reducing signs/symptoms and maintaining clinical remission in adult/pediatric patients with moderate/severe luminal and fistulizing Crohn's disease who have had inadequate response to conventional therapy), Adalimumab, Total Human IgG1 (anti-TNF-alpha monoclonal antibody-approved for reducing signs/symptoms of Crohn's disease, and for the induction and maintenance of clinical remission in adult patients with moderate/severe active Crohn's disease with inadequate response to conventional therapies, or who become intolerant to Infliximab), Certolizumab pegoll, humanized anti-TNF FAB′ (monoclonal antibody fragment linked to polyethylene glycol-approved for reducing signs/symptoms of Crohn's disease and for the induction and maintenance of response in adult patients w/moderate/severe disease with inadequate response to conventional therapies), Natalizumab, First non-TNF-alpha inhibitor (biologic compound approved for Crohn's disease), Humanized monoclonal IgG4 antibody (directed against alpha-4 integrin—FDA approved for inducing and maintaining clinical response and remission in patients with moderate/severe disease with evidence of inflammation and who have had inadequate response to or are unable to tolerate conventional Crohn's therapies and inhibitors of TNF-alpha), concomitant Immunomodulators potentially given with Infliximab, Azathioprine 6-Mercaptopurine (purine synthesis inhibitor—prodrug), Methotrexate (binds dihydrofolate reductase (DHFR) enzyme that participates in tetrahydrofolate synthesis, inhibits all purine synthesis), Allopurinol and Thioprine therapy, PPI, H2 for acid suppression to protect the healing line, C-Diff—Flagyl, Vancomycin (fecal translocation treatment; probiotics; repopulation of normal endoluminal flora), and/or Rifaximin (treatment of bacterial overgrowth (notably hepatic encephalopathy); not absorbed in GI tract with action on intraluminal bacteria), for example.


As described herein, a tissue thickness compensator can compensate for variations in the thickness of tissue that is captured within the staples ejected from a staple cartridge and/or contained within a staple line, for example. Stated another way, certain staples within a staple line can capture thick portions of the tissue while other staples within the staple line can capture thin portions of the tissue. In such circumstances, the tissue thickness compensator can assume different heights or thicknesses within the staples and apply a compressive force to the tissue captured within the staples regardless of whether the captured tissue is thick or thin. In various embodiments, a tissue thickness compensator can compensate for variations in the hardness of the tissue. For instance, certain staples within a staple line can capture highly compressible portions of the tissue while other staples within the staple line can capture portions of the tissue which are less compressible. In such circumstances, the tissue thickness compensator can be configured to assume a smaller height within the staples that have captured tissue having a lower compressibility, or higher hardness, and, correspondingly, a larger height within the staples that have captured tissue having a higher compressibility, or lower hardness, for example. In any event, a tissue thickness compensator, regardless of whether it compensates for variations in tissue thickness and/or variations in tissue hardness, for example, can be referred to as a ‘tissue compensator’ and/or as a ‘compensator’, for example.


The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.


Preferably, the invention described herein will be processed before surgery. First, a new or used instrument is obtained and if necessary cleaned. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and instrument are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation kills bacteria on the instrument and in the container. The sterilized instrument can then be stored in the sterile container. The sealed container keeps the instrument sterile until it is opened in the medical facility.


Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.


While this invention has been described as having exemplary designs, the present invention may be further modified within the spirit and scope of the disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains

Claims
  • 1. A circular surgical stapler, comprising: a stapler head, comprising: a staple cartridge comprising at least one annular row of staples;an anvil configured to be positioned opposite said staple cartridge;an anvil shaft removably attachable to said stapler head; anda tissue thickness compensator comprising an annular compressible biocompatible body configured to be supported on said anvil shaft between said staple cartridge and said anvil, wherein said annular compressible biocompatible body comprises at least one annular pocket, and wherein said at least one annular pocket comprises a healing agent released upon the firing of said staples.
  • 2. The circular surgical stapler of claim 1, wherein said annular compressible biocompatible body comprises a first compressible bioabsorbable layer laminated to a second compressible bioabsorbable layer with said at least one annular pocket formed therebetween.
  • 3. A circular surgical stapler, comprising: a stapler head, comprising: a staple cartridge comprising at least one annular row of staples;an anvil configured to be positioned opposite said staple cartridge;an anvil shaft removably attachable to said stapler head; anda tissue thickness compensator comprising an annular compressible biocompatible body configured to be supported on said anvil shaft between said staple cartridge and said anvil, wherein said annular compressible biocompatible body comprises at least one annular pocket, wherein said at least one annular pocket comprises a healing agent, wherein said at least one annular pocket comprises two coaxial annular pockets comprising said healing agent, and wherein each annular pocket corresponds to a said annular row of staples in said staple cartridge.
  • 4. A surgical stapler, comprising: a stapler head, comprising: a staple cartridge comprising at least one row of staples;an anvil configured to be positioned opposite said staple cartridge;a shaft removably attachable to said anvil;a tissue thickness compensator configured to be supported by at least one of said staple cartridge and said anvil; anda compressible biocompatible body attached to said tissue thickness compensator and said anvil, and wherein said compressible biocompatible body comprises at least one pocket configured for storage.
  • 5. The surgical stapler of claim 4, wherein said at least one pocket comprises a healing agent.
  • 6. A surgical stapler, comprising: a stapler head, comprising: a staple cartridge comprising at least one row of staples;an anvil configured to be positioned opposite said staple cartridge;a shaft removably attachable to said anvil;a tissue thickness compensator configured to be supported by at least one of said staple cartridge and said anvil; anda compressible biocompatible body attached to said tissue thickness compensator and said anvil, wherein said compressible biocompatible body comprises at least one pocket, wherein said at least one pocket comprises a healing agent, wherein said at least one pocket comprises two coaxial pockets comprising said healing agent, and wherein each said pocket corresponds to a row of staples in said staple cartridge.
  • 7. The surgical stapler of claim 6, wherein said compressible biocompatible body comprises a first compressible bioabsorbable layer laminated to a second compressible bioabsorbable layer with said at least one pocket formed therebetween.
  • 8. A circular surgical stapler, comprising: a stapler head, comprising: a staple cartridge comprising at least one annular row of staples; andan anvil configured to be positioned opposite said staple cartridge;an anvil shaft removably attachable to said stapler head;a tissue thickness compensator configured to be supported between said staple cartridge and said anvil; andan annular compressible biocompatible body attached to said tissue thickness compensator and said anvil, wherein said annular compressible biocompatible body comprises at least one annular pocket configured for storage.
  • 9. The circular surgical stapler of claim 8, wherein said at least one annular pocket comprises a medicament.
  • 10. A circular surgical stapler, comprising: a stapler head, comprising: a staple cartridge comprising at least one annular row of staples; andan anvil configured to be positioned opposite said staple cartridge;an anvil shaft removably attachable to said stapler head;a tissue thickness compensator configured to be supported between said staple cartridge and said anvil; andan annular compressible biocompatible body attached to said tissue thickness compensator and said anvil, wherein said annular compressible biocompatible body comprises at least one annular pocket, wherein said at least one annular pocket comprises a medicament, wherein said at least one annular pocket comprises two coaxial annular pockets comprising said medicament, and wherein each said annular pocket corresponds to a said annular row of staples in said staple cartridge.
  • 11. The circular surgical stapler of claim 10, wherein said annular compressible biocompatible body comprises a first compressible bioabsorbable layer laminated to a second compressible bioabsorbable layer with said at least one annular pocket formed therebetween.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation application claiming priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 13/433,179, entitled TISSUE THICKNESS COMPENSATORS FOR CIRCULAR SURGICAL STAPLERS, filed Mar. 28, 2012, which issued Jun. 14, 2016 as U.S. Pat. No. 9,364,233, which is a continuation-in-part application claiming priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 13/097,891, entitled TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER COMPRISING AN ADJUSTABLE ANVIL, filed on Apr. 29, 2011, which issued on Oct. 21, 2014 as U.S. Pat. No. 8,864,009, which is a continuation-in-part application claiming priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 12/894,377, entitled SELECTIVELY ORIENTABLE IMPLANTABLE FASTENER CARTRIDGE, filed on Sep. 30, 2010, which issued on Mar. 12, 2013 as U.S. Pat. No. 8,393,514, the entire disclosures of which are hereby incorporated by reference herein.

US Referenced Citations (5521)
Number Name Date Kind
66052 Smith Jun 1867 A
662587 Blake Nov 1900 A
670748 Weddeler Mar 1901 A
719487 Minor Feb 1903 A
804229 Hutchinson Nov 1905 A
951393 Hahn Mar 1910 A
1306107 Elliott Jun 1919 A
1314601 McCaskey Sep 1919 A
1677337 Grove Jul 1928 A
1794907 Kelly Mar 1931 A
1849427 Hook Mar 1932 A
1944116 Stratman Jan 1934 A
1954048 Jeffrey et al. Apr 1934 A
2037727 La Chapelle Apr 1936 A
2132295 Hawkins Oct 1938 A
2161632 Nattenheimer Jun 1939 A
2211117 Hess Aug 1940 A
2214870 West Sep 1940 A
2224882 Peck Dec 1940 A
2318379 Davis et al. May 1943 A
2329440 La Place Sep 1943 A
2377581 Shaffrey Jun 1945 A
2406389 Lee Aug 1946 A
2441096 Happe May 1948 A
2448741 Scott et al. Sep 1948 A
2450527 Smith Oct 1948 A
2526902 Rublee Oct 1950 A
2527256 Jackson Oct 1950 A
2578686 Fish Dec 1951 A
2638901 Sugarbaker May 1953 A
2674149 Benson Apr 1954 A
2711461 Happe Jun 1955 A
2742955 Dominguez Apr 1956 A
2804848 O'Farrell et al. Sep 1957 A
2808482 Zanichkowsky et al. Oct 1957 A
2853074 Olson Sep 1958 A
2887004 Stewart May 1959 A
2957353 Lewis Oct 1960 A
2959974 Emrick Nov 1960 A
3032769 Palmer May 1962 A
3060972 Sheldon Oct 1962 A
3075062 Iaccarino Jan 1963 A
3078465 Bobrov Feb 1963 A
3079606 Bobrov et al. Mar 1963 A
3080564 Strekopitov et al. Mar 1963 A
3166072 Sullivan, Jr. Jan 1965 A
3180236 Beckett Apr 1965 A
3196869 Scholl Jul 1965 A
3204731 Bent et al. Sep 1965 A
3266494 Brownrigg et al. Aug 1966 A
3269630 Fleischer Aug 1966 A
3269631 Takaro Aug 1966 A
3275211 Hirsch et al. Sep 1966 A
3317103 Cullen et al. May 1967 A
3317105 Astafjev et al. May 1967 A
3357296 Lefever Dec 1967 A
3359978 Smith, Jr. Dec 1967 A
3480193 Ralston Nov 1969 A
3490675 Green et al. Jan 1970 A
3494533 Green et al. Feb 1970 A
3499591 Green Mar 1970 A
3503396 Pierie et al. Mar 1970 A
3509629 Kidokoro May 1970 A
3551987 Wilkinson Jan 1971 A
3568675 Harvey Mar 1971 A
3572159 Tschanz Mar 1971 A
3583393 Takahashi Jun 1971 A
3589589 Akopov Jun 1971 A
3598943 Barrett Aug 1971 A
3608549 Merrill Sep 1971 A
3618842 Bryan Nov 1971 A
3638652 Kelley Feb 1972 A
3640317 Panfili Feb 1972 A
3643851 Green et al. Feb 1972 A
3650453 Smith, Jr. Mar 1972 A
3661666 Foster et al. May 1972 A
3662939 Bryan May 1972 A
3688966 Perkins et al. Sep 1972 A
3695646 Mommsen Oct 1972 A
3709221 Riely Jan 1973 A
3717294 Green Feb 1973 A
3727904 Gabbey Apr 1973 A
3734207 Fishbein May 1973 A
3740994 De Carlo, Jr. Jun 1973 A
3744495 Johnson Jul 1973 A
3746002 Haller Jul 1973 A
3747603 Adler Jul 1973 A
3747692 Davidson Jul 1973 A
3751902 Kingsbury et al. Aug 1973 A
3752161 Bent Aug 1973 A
3799151 Fukaumi et al. Mar 1974 A
3808452 Hutchinson Apr 1974 A
3815476 Green et al. Jun 1974 A
3819100 Noiles et al. Jun 1974 A
3821919 Knohl Jul 1974 A
3836171 Hayashi et al. Sep 1974 A
3837555 Green Sep 1974 A
3841474 Maier Oct 1974 A
3851196 Hinds Nov 1974 A
3863639 Kleaveland Feb 1975 A
3883624 McKenzie et al. May 1975 A
3885491 Curtis May 1975 A
3892228 Mitsui Jul 1975 A
3894174 Cartun Jul 1975 A
3902247 Fleer et al. Sep 1975 A
3940844 Colby et al. Mar 1976 A
3944163 Hayashi et al. Mar 1976 A
3950686 Randall Apr 1976 A
3952747 Kimmell, Jr. Apr 1976 A
3955581 Spasiano et al. May 1976 A
3959879 Sellers Jun 1976 A
RE28932 Noiles et al. Aug 1976 E
3972734 King Aug 1976 A
3981051 Brumlik Sep 1976 A
4025216 Hives May 1977 A
4027746 Kine Jun 1977 A
4034143 Sweet Jul 1977 A
4054108 Gill Oct 1977 A
4060089 Noiles Nov 1977 A
4066133 Voss Jan 1978 A
4085337 Moeller Apr 1978 A
4100820 Evett Jul 1978 A
4106446 Yamada et al. Aug 1978 A
4108211 Tanaka Aug 1978 A
4111206 Vishnevsky et al. Sep 1978 A
4127227 Green Nov 1978 A
4129059 Van Eck Dec 1978 A
4132146 Uhlig Jan 1979 A
4135517 Reale Jan 1979 A
4154122 Severin May 1979 A
4169990 Lerdman Oct 1979 A
4180285 Reneau Dec 1979 A
4185701 Boys Jan 1980 A
4190042 Sinnreich Feb 1980 A
4198734 Brumlik Apr 1980 A
4198982 Fortner et al. Apr 1980 A
4207898 Becht Jun 1980 A
4213562 Garrett et al. Jul 1980 A
4226242 Jarvik Oct 1980 A
4239431 Davini Dec 1980 A
4241861 Fleischer Dec 1980 A
4244372 Kapitanov et al. Jan 1981 A
4250436 Weissman Feb 1981 A
4261244 Becht et al. Apr 1981 A
4272002 Moshofsky Jun 1981 A
4272662 Simpson Jun 1981 A
4274304 Curtiss Jun 1981 A
4274398 Scott, Jr. Jun 1981 A
4275813 Noiles Jun 1981 A
4278091 Borzone Jul 1981 A
4289131 Mueller Sep 1981 A
4289133 Rothfuss Sep 1981 A
4290542 Fedotov et al. Sep 1981 A
D261356 Robinson Oct 1981 S
4296654 Mercer Oct 1981 A
4296881 Lee Oct 1981 A
4304236 Conta et al. Dec 1981 A
4305539 Korolkov et al. Dec 1981 A
4312363 Rothfuss et al. Jan 1982 A
4312685 Riedl Jan 1982 A
4317451 Cerwin et al. Mar 1982 A
4319576 Rothfuss Mar 1982 A
4321002 Froehlich Mar 1982 A
4321746 Grinage Mar 1982 A
4328839 Lyons et al. May 1982 A
4331277 Green May 1982 A
4340331 Savino Jul 1982 A
4347450 Colligan Aug 1982 A
4349028 Green Sep 1982 A
4350151 Scott Sep 1982 A
4353371 Cosman Oct 1982 A
4357940 Muller Nov 1982 A
4361057 Kochera Nov 1982 A
4366544 Shima et al. Dec 1982 A
4373147 Carlson, Jr. Feb 1983 A
4376380 Burgess Mar 1983 A
4379457 Gravener et al. Apr 1983 A
4380312 Landrus Apr 1983 A
4382326 Rabuse May 1983 A
4383634 Green May 1983 A
4393728 Larson et al. Jul 1983 A
4396139 Hall et al. Aug 1983 A
4397311 Kanshin et al. Aug 1983 A
4402445 Green Sep 1983 A
4406621 Bailey Sep 1983 A
4408692 Sigel et al. Oct 1983 A
4409057 Molenda et al. Oct 1983 A
4415112 Green Nov 1983 A
4416276 Newton et al. Nov 1983 A
4417890 Dennehey et al. Nov 1983 A
4423456 Zaidenweber Dec 1983 A
4428376 Mericle Jan 1984 A
4429695 Green Feb 1984 A
4430997 DiGiovanni et al. Feb 1984 A
4434796 Karapetian et al. Mar 1984 A
4438659 Desplats Mar 1984 A
4442964 Becht Apr 1984 A
4448194 DiGiovanni et al. May 1984 A
4451743 Suzuki et al. May 1984 A
4452376 Klieman et al. Jun 1984 A
4454887 Kruger Jun 1984 A
4461305 Cibley Jul 1984 A
4467805 Fukuda Aug 1984 A
4469481 Kobayashi Sep 1984 A
4470414 Imagawa et al. Sep 1984 A
4471780 Menges et al. Sep 1984 A
4471781 Di Giovanni et al. Sep 1984 A
4473077 Noiles et al. Sep 1984 A
4475679 Fleury, Jr. Oct 1984 A
4478220 Di Giovanni et al. Oct 1984 A
4480641 Failla et al. Nov 1984 A
4485816 Krumme Dec 1984 A
4485817 Swiggett Dec 1984 A
4486928 Tucker et al. Dec 1984 A
4488523 Shichman Dec 1984 A
4489875 Crawford et al. Dec 1984 A
4493983 Taggert Jan 1985 A
4499895 Takayama Feb 1985 A
4500024 DiGiovanni et al. Feb 1985 A
D278081 Green Mar 1985 S
4503842 Takayama Mar 1985 A
4505272 Utyamyshev et al. Mar 1985 A
4505273 Braun et al. Mar 1985 A
4505414 Filipi Mar 1985 A
4506671 Green Mar 1985 A
4512038 Alexander et al. Apr 1985 A
4520817 Green Jun 1985 A
4522327 Korthoff et al. Jun 1985 A
4526174 Froehlich Jul 1985 A
4527724 Chow et al. Jul 1985 A
4530357 Pawloski et al. Jul 1985 A
4530453 Green Jul 1985 A
4531522 Bedi et al. Jul 1985 A
4532927 Miksza, Jr. Aug 1985 A
4540202 Amphoux et al. Sep 1985 A
4548202 Duncan Oct 1985 A
4556058 Green Dec 1985 A
4560915 Soultanian Dec 1985 A
4565109 Tsay Jan 1986 A
4565189 Mabuchi Jan 1986 A
4566620 Green et al. Jan 1986 A
4569346 Poirier Feb 1986 A
4569469 Mongeon et al. Feb 1986 A
4571213 Ishimoto Feb 1986 A
4573468 Conta et al. Mar 1986 A
4573469 Golden et al. Mar 1986 A
4573622 Green et al. Mar 1986 A
4576165 Green et al. Mar 1986 A
4576167 Noiles Mar 1986 A
4580712 Green Apr 1986 A
4585153 Failla et al. Apr 1986 A
4586501 Claracq May 1986 A
4586502 Bedi et al. May 1986 A
4589416 Green May 1986 A
4589870 Citrin et al. May 1986 A
4591085 Di Giovanni May 1986 A
RE32214 Schramm Jul 1986 E
4597753 Turley Jul 1986 A
4600037 Hatten Jul 1986 A
4604786 Howie, Jr. Aug 1986 A
4605001 Rothfuss et al. Aug 1986 A
4605004 Di Giovanni et al. Aug 1986 A
4606343 Conta et al. Aug 1986 A
4607638 Crainich Aug 1986 A
4608981 Rothfuss et al. Sep 1986 A
4610250 Green Sep 1986 A
4610383 Rothfuss et al. Sep 1986 A
4612933 Brinkerhoff et al. Sep 1986 A
D286180 Korthoff Oct 1986 S
D286442 Korthoff et al. Oct 1986 S
4617914 Ueda Oct 1986 A
4619262 Taylor Oct 1986 A
4619391 Sharkany et al. Oct 1986 A
D287278 Spreckelmeier Dec 1986 S
4628459 Shinohara et al. Dec 1986 A
4629107 Fedotov et al. Dec 1986 A
4632290 Green et al. Dec 1986 A
4633861 Chow et al. Jan 1987 A
4633874 Chow et al. Jan 1987 A
4634419 Kreizman et al. Jan 1987 A
4635638 Weintraub et al. Jan 1987 A
4641076 Linden Feb 1987 A
4642618 Johnson et al. Feb 1987 A
4643173 Bell et al. Feb 1987 A
4643731 Eckenhoff Feb 1987 A
4646722 Silverstein et al. Mar 1987 A
4646745 Noiles Mar 1987 A
4652820 Maresca Mar 1987 A
4654028 Suma Mar 1987 A
4655222 Florez et al. Apr 1987 A
4662555 Thornton May 1987 A
4663874 Sano et al. May 1987 A
4664305 Blake, III et al. May 1987 A
4665916 Green May 1987 A
4667674 Korthoff et al. May 1987 A
4669647 Storace Jun 1987 A
4671278 Chin Jun 1987 A
4671280 Dorband et al. Jun 1987 A
4671445 Barker et al. Jun 1987 A
4672964 Dee et al. Jun 1987 A
4675944 Wells Jun 1987 A
4676245 Fukuda Jun 1987 A
4679460 Yoshigai Jul 1987 A
4679719 Kramer Jul 1987 A
4684051 Akopov et al. Aug 1987 A
4688555 Wardle Aug 1987 A
4691703 Auth et al. Sep 1987 A
4693248 Failla Sep 1987 A
4698579 Richter et al. Oct 1987 A
4700703 Resnick et al. Oct 1987 A
4705038 Sjostrom et al. Nov 1987 A
4708141 Inoue et al. Nov 1987 A
4709120 Pearson Nov 1987 A
4715520 Roehr, Jr. et al. Dec 1987 A
4719917 Barrows et al. Jan 1988 A
4721099 Chikama Jan 1988 A
4724840 McVay et al. Feb 1988 A
4727308 Huljak et al. Feb 1988 A
4728020 Green et al. Mar 1988 A
4728876 Mongeon et al. Mar 1988 A
4729260 Dudden Mar 1988 A
4730726 Holzwarth Mar 1988 A
4741336 Failla et al. May 1988 A
4743214 Tai-Cheng May 1988 A
4744363 Hasson May 1988 A
4747820 Hornlein et al. May 1988 A
4750902 Wuchinich et al. Jun 1988 A
4752024 Green et al. Jun 1988 A
4754909 Barker et al. Jul 1988 A
4761326 Barnes et al. Aug 1988 A
4763669 Jaeger Aug 1988 A
4767044 Green Aug 1988 A
D297764 Hunt et al. Sep 1988 S
4773420 Green Sep 1988 A
4777780 Holzwarth Oct 1988 A
4781186 Simpson et al. Nov 1988 A
4784137 Kulik et al. Nov 1988 A
4787387 Burbank, III et al. Nov 1988 A
D298967 Hunt Dec 1988 S
4790225 Moody et al. Dec 1988 A
4790314 Weaver Dec 1988 A
4805617 Bedi et al. Feb 1989 A
4805823 Rothfuss Feb 1989 A
4807628 Peters et al. Feb 1989 A
4809695 Gwathmey et al. Mar 1989 A
4815460 Porat et al. Mar 1989 A
4817643 Olson Apr 1989 A
4817847 Redtenbacher et al. Apr 1989 A
4819853 Green Apr 1989 A
4821939 Green Apr 1989 A
4827911 Broadwin et al. May 1989 A
4828542 Hermann May 1989 A
4828944 Yabe et al. May 1989 A
4830855 Stewart May 1989 A
4833937 Nagano May 1989 A
4834720 Blinkhorn May 1989 A
4838859 Strassmann Jun 1989 A
4844068 Arata et al. Jul 1989 A
4848637 Pruitt Jul 1989 A
4856078 Konopka Aug 1989 A
4860644 Kohl et al. Aug 1989 A
4862891 Smith Sep 1989 A
4863423 Wallace Sep 1989 A
4865030 Polyak Sep 1989 A
4868530 Ahs Sep 1989 A
4869414 Green et al. Sep 1989 A
4869415 Fox Sep 1989 A
4873977 Avant et al. Oct 1989 A
4875486 Rapoport et al. Oct 1989 A
4880015 Nierman Nov 1989 A
4890613 Golden et al. Jan 1990 A
4892244 Fox et al. Jan 1990 A
4893622 Green et al. Jan 1990 A
4894051 Shiber Jan 1990 A
4896584 Stoll et al. Jan 1990 A
4896678 Ogawa Jan 1990 A
4900303 Lemelson Feb 1990 A
4903697 Resnick et al. Feb 1990 A
4909789 Taguchi et al. Mar 1990 A
4915100 Green Apr 1990 A
4919679 Averill et al. Apr 1990 A
4921479 Grayzel May 1990 A
4925082 Kim May 1990 A
4928699 Sasai May 1990 A
4930503 Pruitt Jun 1990 A
4930674 Barak Jun 1990 A
4931047 Broadwin et al. Jun 1990 A
4931737 Hishiki Jun 1990 A
4932960 Green et al. Jun 1990 A
4933800 Yang Jun 1990 A
4933843 Scheller et al. Jun 1990 A
D309350 Sutherland et al. Jul 1990 S
4938408 Bedi et al. Jul 1990 A
4941623 Pruitt Jul 1990 A
4943182 Hoblingre Jul 1990 A
4944443 Oddsen et al. Jul 1990 A
4946067 Kelsall Aug 1990 A
4948327 Crupi, Jr. Aug 1990 A
4949707 LeVahn et al. Aug 1990 A
4951860 Peters et al. Aug 1990 A
4951861 Schulze et al. Aug 1990 A
4955959 Tompkins et al. Sep 1990 A
4957212 Duck et al. Sep 1990 A
4962877 Hervas Oct 1990 A
4964559 Deniega et al. Oct 1990 A
4964863 Kanshin et al. Oct 1990 A
4965709 Ngo Oct 1990 A
4973274 Hirukawa Nov 1990 A
4973302 Armour et al. Nov 1990 A
4978049 Green Dec 1990 A
4978333 Broadwin et al. Dec 1990 A
4979952 Kubota et al. Dec 1990 A
4984564 Yuen Jan 1991 A
4986808 Broadwin et al. Jan 1991 A
4987049 Komamura et al. Jan 1991 A
4988334 Hornlein et al. Jan 1991 A
4995877 Ams et al. Feb 1991 A
4995959 Metzner Feb 1991 A
4996975 Nakamura Mar 1991 A
5002543 Bradshaw et al. Mar 1991 A
5002553 Shiber Mar 1991 A
5005754 Van Overloop Apr 1991 A
5009661 Michelson Apr 1991 A
5012411 Policastro et al. Apr 1991 A
5014898 Heidrich May 1991 A
5014899 Presty et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5018515 Gilman May 1991 A
5018657 Pedlick et al. May 1991 A
5024652 Dumenek et al. Jun 1991 A
5024671 Tu et al. Jun 1991 A
5025559 McCullough Jun 1991 A
5027834 Pruitt Jul 1991 A
5030226 Green et al. Jul 1991 A
5031814 Tompkins et al. Jul 1991 A
5035040 Kerrigan et al. Jul 1991 A
5038109 Goble et al. Aug 1991 A
5038247 Kelley et al. Aug 1991 A
5040715 Green et al. Aug 1991 A
5042707 Taheri Aug 1991 A
5061269 Muller Oct 1991 A
5062491 Takeshima et al. Nov 1991 A
5062563 Green et al. Nov 1991 A
5065929 Schulze et al. Nov 1991 A
5071052 Rodak et al. Dec 1991 A
5071430 de Salis et al. Dec 1991 A
5074454 Peters Dec 1991 A
5077506 Krause Dec 1991 A
5079006 Urquhart Jan 1992 A
5080556 Carreno Jan 1992 A
5083695 Foslien et al. Jan 1992 A
5084057 Green et al. Jan 1992 A
5088979 Filipi et al. Feb 1992 A
5088997 Delahuerga et al. Feb 1992 A
5089606 Cole et al. Feb 1992 A
5094247 Hernandez et al. Mar 1992 A
5098004 Kerrigan Mar 1992 A
5098360 Hirota Mar 1992 A
5100042 Gravener et al. Mar 1992 A
5100420 Green et al. Mar 1992 A
5104025 Main et al. Apr 1992 A
5104397 Vasconcelos et al. Apr 1992 A
5104400 Berguer et al. Apr 1992 A
5106008 Tompkins et al. Apr 1992 A
5108368 Hammerslag et al. Apr 1992 A
5109722 Hufnagle et al. May 1992 A
5111987 Moeinzadeh et al. May 1992 A
5116349 Aranyi May 1992 A
D327323 Hunt Jun 1992 S
5119009 McCaleb et al. Jun 1992 A
5122156 Granger et al. Jun 1992 A
5124990 Williamson Jun 1992 A
5129570 Schulze et al. Jul 1992 A
5137198 Nobis et al. Aug 1992 A
5139513 Segato Aug 1992 A
5141144 Foslien et al. Aug 1992 A
5142932 Moya et al. Sep 1992 A
5155941 Takahashi et al. Oct 1992 A
5156315 Green et al. Oct 1992 A
5156609 Nakao et al. Oct 1992 A
5156614 Green et al. Oct 1992 A
5158567 Green Oct 1992 A
D330699 Gill Nov 1992 S
5163598 Peters et al. Nov 1992 A
5168605 Bartlett Dec 1992 A
5170925 Madden et al. Dec 1992 A
5171247 Hughett et al. Dec 1992 A
5171249 Stefanchik et al. Dec 1992 A
5171253 Klieman Dec 1992 A
5173053 Swanson et al. Dec 1992 A
5173133 Morin et al. Dec 1992 A
5176677 Wuchinich Jan 1993 A
5176688 Narayan et al. Jan 1993 A
5187422 Izenbaard et al. Feb 1993 A
5188102 Idemoto et al. Feb 1993 A
5188111 Yates et al. Feb 1993 A
5190517 Zieve et al. Mar 1993 A
5190544 Chapman et al. Mar 1993 A
5190560 Woods et al. Mar 1993 A
5192288 Thompson et al. Mar 1993 A
5195505 Josefsen Mar 1993 A
5195968 Lundquist et al. Mar 1993 A
5197648 Gingold Mar 1993 A
5197649 Bessler et al. Mar 1993 A
5197966 Sommerkamp Mar 1993 A
5197970 Green et al. Mar 1993 A
5200280 Karasa Apr 1993 A
5201750 Hocherl et al. Apr 1993 A
5205459 Brinkerhoff et al. Apr 1993 A
5207697 Carusillo et al. May 1993 A
5209747 Knoepfler May 1993 A
5209756 Seedhom et al. May 1993 A
5211649 Kohler et al. May 1993 A
5211655 Hasson May 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217478 Rexroth Jun 1993 A
5219111 Bilotti et al. Jun 1993 A
5220269 Chen et al. Jun 1993 A
5221036 Takase Jun 1993 A
5221281 Klicek Jun 1993 A
5222945 Basnight Jun 1993 A
5222963 Brinkerhoff et al. Jun 1993 A
5222975 Crainich Jun 1993 A
5222976 Yoon Jun 1993 A
5223675 Taft Jun 1993 A
D338729 Sprecklemeier et al. Aug 1993 S
5234447 Kaster et al. Aug 1993 A
5236424 Imran Aug 1993 A
5236440 Hlavacek Aug 1993 A
5239981 Anapliotis Aug 1993 A
5240163 Stein et al. Aug 1993 A
5242457 Akopov et al. Sep 1993 A
5244462 Delahuerga et al. Sep 1993 A
5246156 Rothfuss et al. Sep 1993 A
5246443 Mai Sep 1993 A
5253793 Green et al. Oct 1993 A
5258007 Spetzler et al. Nov 1993 A
5258008 Wilk Nov 1993 A
5258009 Conners Nov 1993 A
5258010 Green et al. Nov 1993 A
5258012 Luscombe et al. Nov 1993 A
5259366 Reydel et al. Nov 1993 A
5259835 Clark et al. Nov 1993 A
5260637 Pizzi Nov 1993 A
5261877 Fine et al. Nov 1993 A
5261922 Hood Nov 1993 A
5263629 Trumbull et al. Nov 1993 A
5263937 Shipp Nov 1993 A
5263973 Cook Nov 1993 A
5264218 Rogozinski Nov 1993 A
5268622 Philipp Dec 1993 A
5271543 Grant et al. Dec 1993 A
5271544 Fox et al. Dec 1993 A
RE34519 Fox et al. Jan 1994 E
5275322 Brinkerhoff et al. Jan 1994 A
5275323 Schulze et al. Jan 1994 A
5275608 Forman et al. Jan 1994 A
5279416 Malec et al. Jan 1994 A
5281216 Klicek Jan 1994 A
5282806 Haber et al. Feb 1994 A
5282829 Hermes Feb 1994 A
5284128 Hart Feb 1994 A
5285381 Iskarous et al. Feb 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5286253 Fucci Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290271 Jernberg Mar 1994 A
5290310 Makower et al. Mar 1994 A
5292053 Bilotti et al. Mar 1994 A
5293024 Sugahara et al. Mar 1994 A
5297714 Kramer Mar 1994 A
5304204 Bregen Apr 1994 A
D347474 Olson May 1994 S
5307976 Olson et al. May 1994 A
5308576 Green et al. May 1994 A
5309387 Mori et al. May 1994 A
5309927 Welch May 1994 A
5312023 Green et al. May 1994 A
5312024 Grant et al. May 1994 A
5312329 Beaty et al. May 1994 A
5313935 Kortenbach et al. May 1994 A
5313967 Lieber et al. May 1994 A
5314424 Nicholas May 1994 A
5314445 Heidmueller nee Degwitz et al. May 1994 A
5314466 Stern et al. May 1994 A
5318221 Green et al. Jun 1994 A
5320627 Sorensen et al. Jun 1994 A
D348930 Olson Jul 1994 S
5326013 Green et al. Jul 1994 A
5329923 Lundquist Jul 1994 A
5330487 Thornton et al. Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5331971 Bales et al. Jul 1994 A
5332142 Robinson et al. Jul 1994 A
5333422 Warren et al. Aug 1994 A
5333772 Rothfuss et al. Aug 1994 A
5333773 Main et al. Aug 1994 A
5334183 Wuchinich Aug 1994 A
5336130 Ray Aug 1994 A
5336229 Noda Aug 1994 A
5336232 Green et al. Aug 1994 A
5339799 Kami et al. Aug 1994 A
5341724 Vatel Aug 1994 A
5341807 Nardella Aug 1994 A
5341810 Dardel Aug 1994 A
5342380 Hood Aug 1994 A
5342381 Tidemand Aug 1994 A
5342385 Norelli et al. Aug 1994 A
5342395 Jarrett et al. Aug 1994 A
5342396 Cook Aug 1994 A
5343382 Hale et al. Aug 1994 A
5343391 Mushabac Aug 1994 A
5344059 Green et al. Sep 1994 A
5344060 Gravener et al. Sep 1994 A
5344454 Clarke et al. Sep 1994 A
5346504 Ortiz et al. Sep 1994 A
5348259 Blanco et al. Sep 1994 A
5350355 Sklar Sep 1994 A
5350388 Epstein Sep 1994 A
5350391 Iacovelli Sep 1994 A
5350400 Esposito et al. Sep 1994 A
5352229 Goble et al. Oct 1994 A
5352235 Koros et al. Oct 1994 A
5352238 Green et al. Oct 1994 A
5354250 Christensen Oct 1994 A
5354303 Spaeth et al. Oct 1994 A
5356006 Alpern et al. Oct 1994 A
5356064 Green et al. Oct 1994 A
5358506 Green et al. Oct 1994 A
5358510 Luscombe et al. Oct 1994 A
5359231 Flowers et al. Oct 1994 A
D352780 Glaeser et al. Nov 1994 S
5359993 Slater et al. Nov 1994 A
5360305 Kerrigan Nov 1994 A
5360428 Hutchinson, Jr. Nov 1994 A
5364001 Bryan Nov 1994 A
5364002 Green et al. Nov 1994 A
5364003 Williamson, IV Nov 1994 A
5366133 Geiste Nov 1994 A
5366134 Green et al. Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5368015 Wilk Nov 1994 A
5368592 Stern et al. Nov 1994 A
5369565 Chen et al. Nov 1994 A
5370645 Klicek et al. Dec 1994 A
5372124 Takayama et al. Dec 1994 A
5372596 Klicek et al. Dec 1994 A
5372602 Burke Dec 1994 A
5374277 Hassler Dec 1994 A
5375588 Yoon Dec 1994 A
5376095 Ortiz Dec 1994 A
5379933 Green et al. Jan 1995 A
5381649 Webb Jan 1995 A
5381782 DeLaRama et al. Jan 1995 A
5381943 Allen et al. Jan 1995 A
5382247 Cimino et al. Jan 1995 A
5383880 Hooven Jan 1995 A
5383881 Green et al. Jan 1995 A
5383882 Buess et al. Jan 1995 A
5383888 Zvenyatsky et al. Jan 1995 A
5383895 Holmes et al. Jan 1995 A
5388568 van der Heide Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5389102 Green et al. Feb 1995 A
5389104 Hahnen et al. Feb 1995 A
5391180 Tovey et al. Feb 1995 A
5392979 Green et al. Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5395033 Byrne et al. Mar 1995 A
5395034 Allen et al. Mar 1995 A
5395312 Desai Mar 1995 A
5395384 Duthoit et al. Mar 1995 A
5397046 Savage et al. Mar 1995 A
5397324 Carroll et al. Mar 1995 A
5400267 Denen et al. Mar 1995 A
5403276 Schechter et al. Apr 1995 A
5403312 Yates et al. Apr 1995 A
5404106 Matsuda Apr 1995 A
5404870 Brinkerhoff et al. Apr 1995 A
5404960 Wada et al. Apr 1995 A
5405072 Zlock et al. Apr 1995 A
5405073 Porter Apr 1995 A
5405344 Williamson et al. Apr 1995 A
5405360 Tovey Apr 1995 A
5407293 Crainich Apr 1995 A
5408409 Glassman et al. Apr 1995 A
5409498 Braddock et al. Apr 1995 A
5409703 McAnalley et al. Apr 1995 A
D357981 Green et al. May 1995 S
5411481 Allen et al. May 1995 A
5411508 Bessler et al. May 1995 A
5413107 Oakley et al. May 1995 A
5413267 Solyntjes et al. May 1995 A
5413268 Green et al. May 1995 A
5413272 Green et al. May 1995 A
5413573 Koivukangas May 1995 A
5415334 Williamson et al. May 1995 A
5415335 Knodell, Jr. May 1995 A
5417203 Tovey et al. May 1995 A
5417361 Williamson, IV May 1995 A
5419766 Chang et al. May 1995 A
5421829 Olichney et al. Jun 1995 A
5422567 Matsunaga Jun 1995 A
5423471 Mastri et al. Jun 1995 A
5423809 Klicek Jun 1995 A
5423835 Green et al. Jun 1995 A
5425745 Green et al. Jun 1995 A
5427298 Tegtmeier Jun 1995 A
5431322 Green et al. Jul 1995 A
5431323 Smith et al. Jul 1995 A
5431654 Nic Jul 1995 A
5431668 Burbank, III et al. Jul 1995 A
5433721 Hooven et al. Jul 1995 A
5437681 Meade et al. Aug 1995 A
5438302 Goble Aug 1995 A
5439155 Viola Aug 1995 A
5439156 Grant et al. Aug 1995 A
5439479 Shichman et al. Aug 1995 A
5441191 Linden Aug 1995 A
5441193 Gravener Aug 1995 A
5441483 Avitall Aug 1995 A
5441494 Ortiz Aug 1995 A
5443197 Malis et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5444113 Sinclair et al. Aug 1995 A
5445155 Sieben Aug 1995 A
5445304 Plyley et al. Aug 1995 A
5445604 Lang Aug 1995 A
5445644 Pietrafitta et al. Aug 1995 A
5447265 Vidal et al. Sep 1995 A
5447417 Kuhl et al. Sep 1995 A
5447513 Davison et al. Sep 1995 A
5449355 Rhum et al. Sep 1995 A
5449365 Green et al. Sep 1995 A
5449370 Vaitekunas Sep 1995 A
5452836 Huitema et al. Sep 1995 A
5452837 Williamson, IV et al. Sep 1995 A
5454378 Palmer et al. Oct 1995 A
5454822 Schob et al. Oct 1995 A
5454827 Aust et al. Oct 1995 A
5456401 Green et al. Oct 1995 A
5456917 Wise et al. Oct 1995 A
5458279 Plyley Oct 1995 A
5458579 Chodorow et al. Oct 1995 A
5462215 Viola et al. Oct 1995 A
5464013 Lemelson Nov 1995 A
5464144 Guy et al. Nov 1995 A
5464300 Crainich Nov 1995 A
5465819 Weilant et al. Nov 1995 A
5465894 Clark et al. Nov 1995 A
5465895 Knodel et al. Nov 1995 A
5465896 Allen et al. Nov 1995 A
5466020 Page et al. Nov 1995 A
5467911 Tsuruta et al. Nov 1995 A
5468253 Bezwada et al. Nov 1995 A
5470006 Rodak Nov 1995 A
5470007 Plyley et al. Nov 1995 A
5470008 Rodak Nov 1995 A
5470009 Rodak Nov 1995 A
5470010 Rothfuss et al. Nov 1995 A
5471129 Mann Nov 1995 A
5472132 Savage et al. Dec 1995 A
5472442 Klicek Dec 1995 A
5473204 Temple Dec 1995 A
5474057 Makower et al. Dec 1995 A
5474223 Viola et al. Dec 1995 A
5474566 Alesi et al. Dec 1995 A
5476206 Green et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5476481 Schondorf Dec 1995 A
5478003 Green et al. Dec 1995 A
5478354 Tovey et al. Dec 1995 A
5480089 Blewett Jan 1996 A
5480409 Riza Jan 1996 A
5482197 Green et al. Jan 1996 A
5483952 Aranyi Jan 1996 A
5484095 Green et al. Jan 1996 A
5484398 Stoddard Jan 1996 A
5484451 Akopov et al. Jan 1996 A
5485947 Olson et al. Jan 1996 A
5485952 Fontayne Jan 1996 A
5487499 Sorrentino et al. Jan 1996 A
5487500 Knodel et al. Jan 1996 A
5489058 Plyley et al. Feb 1996 A
5489256 Adair Feb 1996 A
5489290 Furnish Feb 1996 A
5490819 Nicholas et al. Feb 1996 A
5492671 Krafft Feb 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5497933 DeFonzo et al. Mar 1996 A
5498838 Furman Mar 1996 A
5501654 Failla et al. Mar 1996 A
5503320 Webster et al. Apr 1996 A
5503635 Sauer et al. Apr 1996 A
5503638 Cooper et al. Apr 1996 A
5505363 Green et al. Apr 1996 A
5507426 Young et al. Apr 1996 A
5509596 Green et al. Apr 1996 A
5509916 Taylor Apr 1996 A
5511564 Wilk Apr 1996 A
5514129 Smith May 1996 A
5514149 Green et al. May 1996 A
5514157 Nicholas et al. May 1996 A
5518163 Hooven May 1996 A
5518164 Hooven May 1996 A
5520609 Moll et al. May 1996 A
5520634 Fox et al. May 1996 A
5520678 Heckele et al. May 1996 A
5520700 Beyar et al. May 1996 A
5522817 Sander et al. Jun 1996 A
5522831 Sleister et al. Jun 1996 A
5527264 Moll et al. Jun 1996 A
5527320 Carruthers et al. Jun 1996 A
5529235 Boiarski et al. Jun 1996 A
D372086 Grasso et al. Jul 1996 S
5531305 Roberts et al. Jul 1996 A
5531744 Nardella et al. Jul 1996 A
5531856 Moll et al. Jul 1996 A
5533521 Granger Jul 1996 A
5533581 Barth et al. Jul 1996 A
5533661 Main et al. Jul 1996 A
5535934 Boiarski et al. Jul 1996 A
5535935 Vidal et al. Jul 1996 A
5535937 Boiarski et al. Jul 1996 A
5540375 Bolanos et al. Jul 1996 A
5540705 Meade et al. Jul 1996 A
5541376 Ladtkow et al. Jul 1996 A
5541489 Dunstan Jul 1996 A
5542594 McKean et al. Aug 1996 A
5542949 Yoon Aug 1996 A
5543119 Sutter et al. Aug 1996 A
5543695 Culp et al. Aug 1996 A
5544802 Crainich Aug 1996 A
5547117 Hamblin et al. Aug 1996 A
5549583 Sanford et al. Aug 1996 A
5549621 Bessler et al. Aug 1996 A
5549627 Kieturakis Aug 1996 A
5549628 Cooper et al. Aug 1996 A
5549637 Crainich Aug 1996 A
5551622 Yoon Sep 1996 A
5553624 Francese et al. Sep 1996 A
5553675 Pitzen et al. Sep 1996 A
5553765 Knodel et al. Sep 1996 A
5554148 Aebischer et al. Sep 1996 A
5554169 Green et al. Sep 1996 A
5556020 Hou Sep 1996 A
5556416 Clark et al. Sep 1996 A
5558533 Hashizawa et al. Sep 1996 A
5558665 Kieturakis Sep 1996 A
5558671 Yates Sep 1996 A
5560530 Bolanos et al. Oct 1996 A
5560532 DeFonzo et al. Oct 1996 A
5561881 Klinger et al. Oct 1996 A
5562239 Boiarski et al. Oct 1996 A
5562241 Knodel et al. Oct 1996 A
5562682 Oberlin et al. Oct 1996 A
5562690 Green et al. Oct 1996 A
5562701 Huitema et al. Oct 1996 A
5562702 Huitema et al. Oct 1996 A
5563481 Krause Oct 1996 A
5564615 Bishop et al. Oct 1996 A
5569161 Ebling et al. Oct 1996 A
5569270 Weng Oct 1996 A
5569284 Young et al. Oct 1996 A
5571090 Sherts Nov 1996 A
5571100 Goble et al. Nov 1996 A
5571116 Bolanos et al. Nov 1996 A
5571285 Chow et al. Nov 1996 A
5571488 Beerstecher et al. Nov 1996 A
5573169 Green et al. Nov 1996 A
5573543 Akopov et al. Nov 1996 A
5574431 McKeown et al. Nov 1996 A
5575054 Klinzing et al. Nov 1996 A
5575789 Bell et al. Nov 1996 A
5575799 Bolanos et al. Nov 1996 A
5575803 Cooper et al. Nov 1996 A
5575805 Li Nov 1996 A
5577654 Bishop Nov 1996 A
5578052 Koros et al. Nov 1996 A
5579978 Green et al. Dec 1996 A
5580067 Hamblin et al. Dec 1996 A
5582611 Tsuruta et al. Dec 1996 A
5582617 Klieman et al. Dec 1996 A
5582907 Pall Dec 1996 A
5583114 Barrows et al. Dec 1996 A
5584425 Savage et al. Dec 1996 A
5586711 Plyley et al. Dec 1996 A
5588579 Schnut et al. Dec 1996 A
5588580 Paul et al. Dec 1996 A
5588581 Conlon et al. Dec 1996 A
5591170 Spievack et al. Jan 1997 A
5591187 Dekel Jan 1997 A
5597107 Knodel et al. Jan 1997 A
5599151 Daum et al. Feb 1997 A
5599279 Slotman et al. Feb 1997 A
5599344 Paterson Feb 1997 A
5599350 Schulze et al. Feb 1997 A
5599852 Scopelianos et al. Feb 1997 A
5601224 Bishop et al. Feb 1997 A
5601573 Fogelberg et al. Feb 1997 A
5601604 Vincent Feb 1997 A
5602449 Krause et al. Feb 1997 A
5603443 Clark et al. Feb 1997 A
5605272 Witt et al. Feb 1997 A
5605273 Hamblin et al. Feb 1997 A
5607094 Clark et al. Mar 1997 A
5607095 Smith et al. Mar 1997 A
5607433 Polla et al. Mar 1997 A
5607450 Zvenyatsky et al. Mar 1997 A
5607474 Athanasiou et al. Mar 1997 A
5609285 Grant et al. Mar 1997 A
5609601 Kolesa et al. Mar 1997 A
5611709 McAnulty Mar 1997 A
5613499 Palmer et al. Mar 1997 A
5613937 Garrison et al. Mar 1997 A
5613966 Makower et al. Mar 1997 A
5614887 Buchbinder Mar 1997 A
5615820 Viola Apr 1997 A
5618294 Aust et al. Apr 1997 A
5618303 Marlow et al. Apr 1997 A
5618307 Donlon et al. Apr 1997 A
5619992 Guthrie et al. Apr 1997 A
5620289 Curry Apr 1997 A
5620326 Younker Apr 1997 A
5620452 Yoon Apr 1997 A
5624398 Smith et al. Apr 1997 A
5624452 Yates Apr 1997 A
5626587 Bishop et al. May 1997 A
5626595 Sklar et al. May 1997 A
5628446 Geiste et al. May 1997 A
5628743 Cimino May 1997 A
5628745 Bek May 1997 A
5630539 Plyley et al. May 1997 A
5630540 Blewett May 1997 A
5630541 Williamson, IV et al. May 1997 A
5630782 Adair May 1997 A
5632432 Schulze et al. May 1997 A
5632433 Grant et al. May 1997 A
5633374 Humphrey et al. May 1997 A
5634584 Okorocha et al. Jun 1997 A
5636779 Palmer Jun 1997 A
5636780 Green et al. Jun 1997 A
5639008 Gallagher et al. Jun 1997 A
D381077 Hunt Jul 1997 S
5643291 Pier et al. Jul 1997 A
5643294 Tovey et al. Jul 1997 A
5643319 Green et al. Jul 1997 A
5645209 Green et al. Jul 1997 A
5647526 Green et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5649937 Bito et al. Jul 1997 A
5649956 Jensen et al. Jul 1997 A
5651491 Heaton et al. Jul 1997 A
5651762 Bridges Jul 1997 A
5651821 Uchida Jul 1997 A
5653373 Green et al. Aug 1997 A
5653374 Young et al. Aug 1997 A
5653677 Okada et al. Aug 1997 A
5653721 Knodel et al. Aug 1997 A
5655698 Yoon Aug 1997 A
5657417 Di Troia Aug 1997 A
5657429 Wang et al. Aug 1997 A
5657921 Young et al. Aug 1997 A
5658238 Suzuki et al. Aug 1997 A
5658281 Heard Aug 1997 A
5658298 Vincent et al. Aug 1997 A
5658300 Bito et al. Aug 1997 A
5658307 Exconde Aug 1997 A
5662258 Knodel et al. Sep 1997 A
5662260 Yoon Sep 1997 A
5662662 Bishop et al. Sep 1997 A
5662667 Knodel Sep 1997 A
5665085 Nardella Sep 1997 A
5667517 Hooven Sep 1997 A
5667526 Levin Sep 1997 A
5667527 Cook Sep 1997 A
5669544 Schulze et al. Sep 1997 A
5669904 Platt, Jr. et al. Sep 1997 A
5669907 Platt, Jr. et al. Sep 1997 A
5669918 Balazs et al. Sep 1997 A
5673840 Schulze et al. Oct 1997 A
5673841 Schulze et al. Oct 1997 A
5673842 Bittner et al. Oct 1997 A
5674286 D'Alessio et al. Oct 1997 A
5678748 Plyley et al. Oct 1997 A
5680981 Mililli et al. Oct 1997 A
5680982 Schulze et al. Oct 1997 A
5680983 Plyley et al. Oct 1997 A
5681341 Lunsford et al. Oct 1997 A
5683349 Makower et al. Nov 1997 A
5685474 Seeber Nov 1997 A
5686090 Schilder et al. Nov 1997 A
5688270 Yates et al. Nov 1997 A
5690269 Bolanos et al. Nov 1997 A
5692668 Schulze et al. Dec 1997 A
5693020 Rauh Dec 1997 A
5693042 Boiarski et al. Dec 1997 A
5693051 Schulze et al. Dec 1997 A
5695494 Becker Dec 1997 A
5695502 Pier et al. Dec 1997 A
5695504 Gifford et al. Dec 1997 A
5695524 Kelley et al. Dec 1997 A
5697542 Knodel et al. Dec 1997 A
5697543 Burdorff Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5697943 Sauer et al. Dec 1997 A
5700270 Peyser et al. Dec 1997 A
5700276 Benecke Dec 1997 A
5702387 Arts et al. Dec 1997 A
5702408 Wales et al. Dec 1997 A
5702409 Rayburn et al. Dec 1997 A
5704087 Strub Jan 1998 A
5704534 Huitema et al. Jan 1998 A
5706997 Green et al. Jan 1998 A
5706998 Plyley et al. Jan 1998 A
5707392 Kortenbach Jan 1998 A
5709334 Sorrentino et al. Jan 1998 A
5709335 Heck Jan 1998 A
5709680 Yates et al. Jan 1998 A
5709706 Kienzle et al. Jan 1998 A
5711472 Bryan Jan 1998 A
5712460 Carr et al. Jan 1998 A
5713128 Schrenk et al. Feb 1998 A
5713505 Huitema Feb 1998 A
5713895 Lontine et al. Feb 1998 A
5713896 Nardella Feb 1998 A
5713920 Bezwada et al. Feb 1998 A
5715604 Lanzoni Feb 1998 A
5715987 Kelley et al. Feb 1998 A
5715988 Palmer Feb 1998 A
5716366 Yates Feb 1998 A
5718359 Palmer et al. Feb 1998 A
5718360 Green et al. Feb 1998 A
5718548 Cotellessa Feb 1998 A
5718714 Livneh Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
D393067 Geary et al. Mar 1998 S
5724025 Tavori Mar 1998 A
5725536 Oberlin et al. Mar 1998 A
5725554 Simon et al. Mar 1998 A
5728110 Vidal et al. Mar 1998 A
5728113 Sherts Mar 1998 A
5728121 Bimbo et al. Mar 1998 A
5730758 Allgeyer Mar 1998 A
5732821 Stone et al. Mar 1998 A
5732871 Clark et al. Mar 1998 A
5732872 Bolduc et al. Mar 1998 A
5733308 Daugherty et al. Mar 1998 A
5735445 Vidal et al. Apr 1998 A
5735848 Yates et al. Apr 1998 A
5735874 Measamer et al. Apr 1998 A
5738474 Blewett Apr 1998 A
5738629 Moll et al. Apr 1998 A
5738648 Lands et al. Apr 1998 A
5741271 Nakao et al. Apr 1998 A
5743456 Jones et al. Apr 1998 A
5747953 Philipp May 1998 A
5749889 Bacich et al. May 1998 A
5749893 Vidal et al. May 1998 A
5749968 Melanson et al. May 1998 A
5752644 Bolanos et al. May 1998 A
5752965 Francis et al. May 1998 A
5752970 Yoon May 1998 A
5755717 Yates et al. May 1998 A
5758814 Gallagher et al. Jun 1998 A
5762255 Chrisman et al. Jun 1998 A
5762256 Mastri et al. Jun 1998 A
5766188 Igaki Jun 1998 A
5766205 Zvenyatsky et al. Jun 1998 A
5769303 Knodel et al. Jun 1998 A
5769748 Eyerly et al. Jun 1998 A
5769791 Benaron et al. Jun 1998 A
5769892 Kingwell Jun 1998 A
5772379 Evensen Jun 1998 A
5772578 Heimberger et al. Jun 1998 A
5772659 Becker et al. Jun 1998 A
5776130 Buysse et al. Jul 1998 A
5778939 Hok-Yin Jul 1998 A
5779130 Alesi et al. Jul 1998 A
5779131 Knodel et al. Jul 1998 A
5779132 Knodel et al. Jul 1998 A
5782396 Mastri et al. Jul 1998 A
5782397 Koukline Jul 1998 A
5782748 Palmer et al. Jul 1998 A
5782749 Riza Jul 1998 A
5782859 Nicholas et al. Jul 1998 A
5784934 Izumisawa Jul 1998 A
5785232 Vidal et al. Jul 1998 A
5785647 Tompkins et al. Jul 1998 A
5787897 Kieturakis Aug 1998 A
5791231 Cohn et al. Aug 1998 A
5792135 Madhani et al. Aug 1998 A
5792162 Jolly et al. Aug 1998 A
5792165 Klieman et al. Aug 1998 A
5792573 Pitzen et al. Aug 1998 A
5794834 Hamblin et al. Aug 1998 A
5796188 Bays Aug 1998 A
5797536 Smith et al. Aug 1998 A
5797537 Oberlin et al. Aug 1998 A
5797538 Heaton et al. Aug 1998 A
5797637 Ervin Aug 1998 A
5797906 Rhum et al. Aug 1998 A
5797927 Yoon Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5797959 Castro et al. Aug 1998 A
5799857 Robertson et al. Sep 1998 A
5800379 Edwards Sep 1998 A
5800423 Jensen Sep 1998 A
5804726 Geib et al. Sep 1998 A
5804936 Brodsky et al. Sep 1998 A
5806676 Wasgien Sep 1998 A
5807376 Viola et al. Sep 1998 A
5807378 Jensen et al. Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5809441 McKee Sep 1998 A
5810721 Mueller et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5810846 Virnich et al. Sep 1998 A
5810855 Rayburn et al. Sep 1998 A
5813813 Daum et al. Sep 1998 A
5814055 Knodel et al. Sep 1998 A
5814057 Oi et al. Sep 1998 A
5816471 Plyley et al. Oct 1998 A
5817084 Jensen Oct 1998 A
5817091 Nardella et al. Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5817109 McGarry et al. Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5820009 Melling et al. Oct 1998 A
5823066 Huitema et al. Oct 1998 A
5824333 Scopelianos et al. Oct 1998 A
5826776 Schulze et al. Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5827298 Hart et al. Oct 1998 A
5829662 Allen et al. Nov 1998 A
5830598 Patterson Nov 1998 A
5833690 Yates et al. Nov 1998 A
5833695 Yoon Nov 1998 A
5833696 Whitfield et al. Nov 1998 A
5836503 Ehrenfels et al. Nov 1998 A
5836960 Kolesa et al. Nov 1998 A
5839369 Chatterjee et al. Nov 1998 A
5839639 Sauer et al. Nov 1998 A
5843021 Edwards et al. Dec 1998 A
5843096 Igaki et al. Dec 1998 A
5843097 Mayenberger et al. Dec 1998 A
5843122 Riza Dec 1998 A
5843132 Ilvento Dec 1998 A
5843169 Taheri Dec 1998 A
5846254 Schulze et al. Dec 1998 A
5847566 Marritt et al. Dec 1998 A
5849011 Jones et al. Dec 1998 A
5849020 Long et al. Dec 1998 A
5849023 Mericle Dec 1998 A
5851179 Ritson et al. Dec 1998 A
5853366 Dowlatshahi Dec 1998 A
5855311 Hamblin et al. Jan 1999 A
5855583 Wang et al. Jan 1999 A
5860581 Robertson et al. Jan 1999 A
5860975 Goble et al. Jan 1999 A
5865361 Milliman et al. Feb 1999 A
5865638 Trafton Feb 1999 A
5868361 Rinderer Feb 1999 A
5868760 McGuckin, Jr. Feb 1999 A
5868790 Vincent et al. Feb 1999 A
5871135 Williamson, IV et al. Feb 1999 A
5873885 Weidenbenner Feb 1999 A
5876401 Schulze et al. Mar 1999 A
5878193 Wang et al. Mar 1999 A
5878607 Nunes et al. Mar 1999 A
5878937 Green et al. Mar 1999 A
5878938 Bittner et al. Mar 1999 A
5881777 Bassi et al. Mar 1999 A
5891094 Masterson et al. Apr 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5891558 Bell et al. Apr 1999 A
5893506 Powell Apr 1999 A
5893835 Witt et al. Apr 1999 A
5893878 Pierce Apr 1999 A
5894979 Powell Apr 1999 A
5897552 Edwards et al. Apr 1999 A
5897562 Bolanos et al. Apr 1999 A
5899824 Kurtz et al. May 1999 A
5899914 Zirps et al. May 1999 A
5901895 Heaton et al. May 1999 A
5902312 Frater et al. May 1999 A
5903117 Gregory May 1999 A
5904647 Ouchi May 1999 A
5904693 Dicesare et al. May 1999 A
5904702 Ek et al. May 1999 A
5906577 Beane et al. May 1999 A
5906625 Bito et al. May 1999 A
5907211 Hall et al. May 1999 A
5908402 Blythe Jun 1999 A
5908427 McKean et al. Jun 1999 A
5909062 Krietzman Jun 1999 A
5911353 Bolanos et al. Jun 1999 A
5915616 Viola et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5918791 Sorrentino et al. Jul 1999 A
5919198 Graves, Jr. et al. Jul 1999 A
5921956 Grinberg et al. Jul 1999 A
5924864 Loge et al. Jul 1999 A
5928137 Green Jul 1999 A
5928256 Riza Jul 1999 A
5931847 Bittner et al. Aug 1999 A
5931853 McEwen et al. Aug 1999 A
5937951 Lzuchukwu et al. Aug 1999 A
5938667 Peyser et al. Aug 1999 A
5941442 Geiste et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5944172 Hannula Aug 1999 A
5944715 Goble et al. Aug 1999 A
5946978 Yamashita Sep 1999 A
5947984 Whipple Sep 1999 A
5947996 Logeman Sep 1999 A
5948030 Miller et al. Sep 1999 A
5948429 Bell et al. Sep 1999 A
5951301 Younker Sep 1999 A
5951516 Bunyan Sep 1999 A
5951552 Long et al. Sep 1999 A
5951574 Stefanchik et al. Sep 1999 A
5951581 Saadat et al. Sep 1999 A
5954259 Viola et al. Sep 1999 A
5964394 Robertson Oct 1999 A
5964774 McKean et al. Oct 1999 A
5966126 Szabo Oct 1999 A
5971916 Koren Oct 1999 A
5973221 Collyer et al. Oct 1999 A
D416089 Barton et al. Nov 1999 S
5976122 Madhani et al. Nov 1999 A
5977746 Hershberger et al. Nov 1999 A
5980248 Kusakabe et al. Nov 1999 A
5984949 Levin Nov 1999 A
5988479 Palmer Nov 1999 A
5990379 Gregory Nov 1999 A
5993466 Yoon Nov 1999 A
5997528 Bisch et al. Dec 1999 A
5997552 Person et al. Dec 1999 A
6001108 Wang et al. Dec 1999 A
6003517 Sheffield et al. Dec 1999 A
6004319 Goble et al. Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6007521 Bidwell et al. Dec 1999 A
6010054 Johnson et al. Jan 2000 A
6010513 Tormala et al. Jan 2000 A
6010520 Pattison Jan 2000 A
6012494 Balazs Jan 2000 A
6013076 Goble et al. Jan 2000 A
6015406 Goble et al. Jan 2000 A
6015417 Reynolds, Jr. Jan 2000 A
6017322 Snoke et al. Jan 2000 A
6017354 Culp et al. Jan 2000 A
6017356 Frederick et al. Jan 2000 A
6018227 Kumar et al. Jan 2000 A
6019745 Gray Feb 2000 A
6022352 Vandewalle Feb 2000 A
6023641 Thompson Feb 2000 A
6024708 Bales et al. Feb 2000 A
6024741 Williamson, IV et al. Feb 2000 A
6024748 Manzo et al. Feb 2000 A
6024750 Mastri et al. Feb 2000 A
6024764 Schroeppel Feb 2000 A
6027501 Goble et al. Feb 2000 A
6030384 Nezhat Feb 2000 A
6032849 Mastri et al. Mar 2000 A
6033105 Barker et al. Mar 2000 A
6033378 Lundquist et al. Mar 2000 A
6033399 Gines Mar 2000 A
6033427 Lee Mar 2000 A
6036667 Manna et al. Mar 2000 A
6037724 Buss et al. Mar 2000 A
6037927 Rosenberg Mar 2000 A
6039733 Buysse et al. Mar 2000 A
6039734 Goble Mar 2000 A
6042601 Smith Mar 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6043626 Snyder et al. Mar 2000 A
6045560 McKean et al. Apr 2000 A
6047861 Vidal et al. Apr 2000 A
6049145 Austin et al. Apr 2000 A
6050172 Corves et al. Apr 2000 A
6050472 Shibata Apr 2000 A
6050989 Fox et al. Apr 2000 A
6050990 Tankovich et al. Apr 2000 A
6050996 Schmaltz et al. Apr 2000 A
6053390 Green et al. Apr 2000 A
6053899 Slanda et al. Apr 2000 A
6053922 Krause et al. Apr 2000 A
6054142 Li et al. Apr 2000 A
RE36720 Green et al. May 2000 E
6056735 Okada et al. May 2000 A
6056746 Goble et al. May 2000 A
6059806 Hoegerle May 2000 A
6062360 Shields May 2000 A
6063025 Bridges et al. May 2000 A
6063050 Manna et al. May 2000 A
6063095 Wang et al. May 2000 A
6063097 Oi et al. May 2000 A
6063098 Houser et al. May 2000 A
6065679 Levie et al. May 2000 A
6065919 Peck May 2000 A
6066132 Chen et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6068627 Orszulak et al. May 2000 A
6071233 Ishikawa et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
6074401 Gardiner et al. Jun 2000 A
6077280 Fossum Jun 2000 A
6077286 Cuschieri et al. Jun 2000 A
6077290 Marini Jun 2000 A
6079606 Milliman et al. Jun 2000 A
6080181 Jensen et al. Jun 2000 A
6082577 Coates et al. Jul 2000 A
6083191 Rose Jul 2000 A
6083223 Baker Jul 2000 A
6083234 Nicholas et al. Jul 2000 A
6083242 Cook Jul 2000 A
6086544 Hibner et al. Jul 2000 A
6086600 Kortenbach Jul 2000 A
6090106 Goble et al. Jul 2000 A
6093186 Goble Jul 2000 A
6099537 Sugai et al. Aug 2000 A
6099551 Gabbay Aug 2000 A
6102271 Longo et al. Aug 2000 A
6104162 Sainsbury et al. Aug 2000 A
6104304 Clark et al. Aug 2000 A
6106511 Jensen Aug 2000 A
6109500 Alli et al. Aug 2000 A
6110187 Donlon Aug 2000 A
6113618 Nic Sep 2000 A
6117148 Ravo et al. Sep 2000 A
6117158 Measamer et al. Sep 2000 A
6119913 Adams et al. Sep 2000 A
6120433 Mizuno et al. Sep 2000 A
6120462 Hibner et al. Sep 2000 A
6123241 Walter et al. Sep 2000 A
6123701 Nezhat Sep 2000 A
H001904 Yates et al. Oct 2000 H
6126058 Adams et al. Oct 2000 A
6126359 Dittrich et al. Oct 2000 A
6126670 Walker et al. Oct 2000 A
6131789 Schulze et al. Oct 2000 A
6131790 Piraka Oct 2000 A
6132368 Cooper Oct 2000 A
6139546 Koenig et al. Oct 2000 A
6142149 Steen Nov 2000 A
6142933 Longo et al. Nov 2000 A
6147135 Yuan et al. Nov 2000 A
6149660 Laufer et al. Nov 2000 A
6151323 O'Connell et al. Nov 2000 A
6152935 Kammerer et al. Nov 2000 A
6155473 Tompkins et al. Dec 2000 A
6156056 Kearns et al. Dec 2000 A
6157169 Lee Dec 2000 A
6159146 El Gazayerli Dec 2000 A
6159200 Verdura et al. Dec 2000 A
6159224 Yoon Dec 2000 A
6162208 Hipps Dec 2000 A
6162220 Nezhat Dec 2000 A
6162537 Martin et al. Dec 2000 A
6165175 Wampler et al. Dec 2000 A
6165184 Verdura et al. Dec 2000 A
6165188 Saadat et al. Dec 2000 A
6167185 Smiley et al. Dec 2000 A
6168605 Measamer et al. Jan 2001 B1
6171305 Sherman Jan 2001 B1
6171316 Kovac et al. Jan 2001 B1
6171330 Benchetrit Jan 2001 B1
6173074 Russo Jan 2001 B1
6174308 Goble et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6174318 Bates et al. Jan 2001 B1
6175290 Forsythe et al. Jan 2001 B1
6179195 Adams et al. Jan 2001 B1
6179776 Adams et al. Jan 2001 B1
6181105 Cutolo et al. Jan 2001 B1
6182673 Kindermann et al. Feb 2001 B1
6185356 Parker et al. Feb 2001 B1
6186142 Schmidt et al. Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6190386 Rydell Feb 2001 B1
6193129 Bittner et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6202914 Geiste et al. Mar 2001 B1
6206894 Thompson et al. Mar 2001 B1
6206897 Jamiolkowski et al. Mar 2001 B1
6206904 Ouchi Mar 2001 B1
6209414 Uneme Apr 2001 B1
6210403 Klicek Apr 2001 B1
6213999 Platt, Jr. et al. Apr 2001 B1
6214028 Yoon et al. Apr 2001 B1
6220368 Ark et al. Apr 2001 B1
6221007 Green Apr 2001 B1
6221023 Matsuba et al. Apr 2001 B1
6223100 Green Apr 2001 B1
6223835 Habedank et al. May 2001 B1
6224617 Saadat et al. May 2001 B1
6228080 Gines May 2001 B1
6228081 Goble May 2001 B1
6228083 Lands et al. May 2001 B1
6228084 Kirwan, Jr. May 2001 B1
6228089 Wahrburg May 2001 B1
6228098 Kayan et al. May 2001 B1
6231565 Tovey et al. May 2001 B1
6234178 Goble et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238384 Peer May 2001 B1
6241139 Milliman et al. Jun 2001 B1
6241140 Adams et al. Jun 2001 B1
6241723 Heim et al. Jun 2001 B1
6245084 Mark et al. Jun 2001 B1
6248116 Chevillon et al. Jun 2001 B1
6248117 Blatter Jun 2001 B1
6249076 Madden et al. Jun 2001 B1
6249105 Andrews et al. Jun 2001 B1
6250532 Green et al. Jun 2001 B1
6251485 Harris et al. Jun 2001 B1
6254534 Butler et al. Jul 2001 B1
6254619 Garabet et al. Jul 2001 B1
6254642 Taylor Jul 2001 B1
6258107 Balazs et al. Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6261679 Chen et al. Jul 2001 B1
6264086 McGuckin, Jr. Jul 2001 B1
6264087 Whitman Jul 2001 B1
6264617 Bales et al. Jul 2001 B1
6270508 Klieman et al. Aug 2001 B1
6270916 Sink et al. Aug 2001 B1
6273876 Klima et al. Aug 2001 B1
6273897 Dalessandro et al. Aug 2001 B1
6277114 Bullivant et al. Aug 2001 B1
6280407 Manna et al. Aug 2001 B1
6293927 McGuckin, Jr. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6296640 Wampler et al. Oct 2001 B1
6302311 Adams et al. Oct 2001 B1
6302743 Chiu et al. Oct 2001 B1
6305891 Burlingame Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6306149 Meade Oct 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6309397 Julian et al. Oct 2001 B1
6309403 Minor et al. Oct 2001 B1
6312435 Wallace et al. Nov 2001 B1
6315184 Whitman Nov 2001 B1
6319510 Yates Nov 2001 B1
6320123 Reimers Nov 2001 B1
6322494 Bullivant et al. Nov 2001 B1
6324339 Hudson et al. Nov 2001 B1
6325799 Goble Dec 2001 B1
6325805 Ogilvie et al. Dec 2001 B1
6325810 Hamilton et al. Dec 2001 B1
6328498 Mersch Dec 2001 B1
6330965 Milliman et al. Dec 2001 B1
6331181 Tierney et al. Dec 2001 B1
6331761 Kumar et al. Dec 2001 B1
6333029 Vyakarnam et al. Dec 2001 B1
6334860 Dorn Jan 2002 B1
6334861 Chandler et al. Jan 2002 B1
6336926 Goble Jan 2002 B1
6338737 Toledano Jan 2002 B1
6343731 Adams et al. Feb 2002 B1
6346077 Taylor et al. Feb 2002 B1
6348061 Whitman Feb 2002 B1
D454951 Bon Mar 2002 S
6352503 Matsui et al. Mar 2002 B1
6352532 Kramer et al. Mar 2002 B1
6355699 Vyakarnam et al. Mar 2002 B1
6356072 Chass Mar 2002 B1
6358224 Tims et al. Mar 2002 B1
6358263 Mark et al. Mar 2002 B2
6358459 Ziegler et al. Mar 2002 B1
6364877 Goble et al. Apr 2002 B1
6364888 Niemeyer et al. Apr 2002 B1
6370981 Watarai Apr 2002 B2
6371114 Schmidt et al. Apr 2002 B1
6373152 Wang et al. Apr 2002 B1
6377011 Ben-Ur Apr 2002 B1
6383201 Dong May 2002 B1
6387092 Burnside et al. May 2002 B1
6387113 Hawkins et al. May 2002 B1
6387114 Adams May 2002 B2
6391038 Vargas et al. May 2002 B2
6392854 O'Gorman May 2002 B1
6394998 Wallace et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
6398797 Bombard et al. Jun 2002 B2
6402766 Bowman et al. Jun 2002 B2
6406440 Stefanchik Jun 2002 B1
6406472 Jensen Jun 2002 B1
6409724 Penny et al. Jun 2002 B1
H002037 Yates et al. Jul 2002 H
6412639 Hickey Jul 2002 B1
6413274 Pedros Jul 2002 B1
6416486 Wampler Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6419695 Gabbay Jul 2002 B1
6423079 Blake, III Jul 2002 B1
RE37814 Allgeyer Aug 2002 E
6428070 Takanashi et al. Aug 2002 B1
6428487 Burdorff et al. Aug 2002 B1
6429611 Li Aug 2002 B1
6430298 Kettl et al. Aug 2002 B1
6432065 Burdorff et al. Aug 2002 B1
6436097 Nardella Aug 2002 B1
6436107 Wang et al. Aug 2002 B1
6436110 Bowman et al. Aug 2002 B2
6436122 Frank et al. Aug 2002 B1
6439439 Rickard et al. Aug 2002 B1
6439446 Perry et al. Aug 2002 B1
6440146 Nicholas et al. Aug 2002 B2
6441577 Blumenkranz et al. Aug 2002 B2
D462758 Epstein et al. Sep 2002 S
6443973 Whitman Sep 2002 B1
6445530 Baker Sep 2002 B1
6447518 Krause et al. Sep 2002 B1
6447523 Middleman et al. Sep 2002 B1
6447799 Ullman Sep 2002 B1
6447864 Johnson et al. Sep 2002 B2
6450391 Kayan et al. Sep 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6454781 Witt et al. Sep 2002 B1
6458077 Boebel et al. Oct 2002 B1
6458147 Cruise et al. Oct 2002 B1
6460627 Below et al. Oct 2002 B1
6468275 Wampler et al. Oct 2002 B1
6468286 Mastri et al. Oct 2002 B2
6471106 Reining Oct 2002 B1
6471659 Eggers et al. Oct 2002 B2
6478210 Adams et al. Nov 2002 B2
6482200 Shippert Nov 2002 B2
6482217 Pintor et al. Nov 2002 B1
6485490 Wampler et al. Nov 2002 B2
6485503 Jacobs et al. Nov 2002 B2
6485667 Tan Nov 2002 B1
6486286 McGall et al. Nov 2002 B1
6488196 Fenton, Jr. Dec 2002 B1
6488197 Whitman Dec 2002 B1
6488659 Rosenman Dec 2002 B1
6491201 Whitman Dec 2002 B1
6491690 Goble et al. Dec 2002 B1
6491701 Tierney et al. Dec 2002 B2
6492785 Kasten et al. Dec 2002 B1
6494885 Dhindsa Dec 2002 B1
6494896 D'Alessio et al. Dec 2002 B1
6498480 Manara Dec 2002 B1
6500176 Truckai et al. Dec 2002 B1
6500194 Benderev et al. Dec 2002 B2
6503139 Coral Jan 2003 B2
6503257 Grant et al. Jan 2003 B2
6503259 Huxel et al. Jan 2003 B2
6505768 Whitman Jan 2003 B2
6506197 Rollero et al. Jan 2003 B1
6510854 Goble Jan 2003 B2
6511468 Cragg et al. Jan 2003 B1
6512360 Goto et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6516073 Schulz et al. Feb 2003 B1
6517528 Pantages et al. Feb 2003 B1
6517535 Edwards Feb 2003 B2
6517565 Whitman et al. Feb 2003 B1
6517566 Hovland et al. Feb 2003 B1
6520971 Perry et al. Feb 2003 B1
6520972 Peters Feb 2003 B2
6522101 Malackowski Feb 2003 B2
6524180 Simms et al. Feb 2003 B1
6527782 Hogg et al. Mar 2003 B2
6527785 Sancoff et al. Mar 2003 B2
6532958 Buan et al. Mar 2003 B1
6533157 Whitman Mar 2003 B1
6533723 Lockery et al. Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6535764 Imran et al. Mar 2003 B2
6539816 Kogiso et al. Apr 2003 B2
6543456 Freeman Apr 2003 B1
6545384 Pelrine et al. Apr 2003 B1
6547786 Goble Apr 2003 B1
6550546 Thurler et al. Apr 2003 B2
6551333 Kuhns et al. Apr 2003 B2
6554861 Knox et al. Apr 2003 B2
6555770 Kawase Apr 2003 B2
6558378 Sherman et al. May 2003 B2
6558379 Batchelor et al. May 2003 B1
6558429 Taylor May 2003 B2
6561187 Schmidt et al. May 2003 B2
6565560 Goble et al. May 2003 B1
6566619 Gillman et al. May 2003 B2
6569085 Kortenbach et al. May 2003 B2
6569171 DeGuillebon et al. May 2003 B2
6578751 Hartwick Jun 2003 B2
6582364 Butler et al. Jun 2003 B2
6582427 Goble et al. Jun 2003 B1
6582441 He et al. Jun 2003 B1
6583533 Pelrine et al. Jun 2003 B2
6585144 Adams et al. Jul 2003 B2
6585664 Burdorff et al. Jul 2003 B2
6587750 Gerbi et al. Jul 2003 B2
6588643 Bolduc et al. Jul 2003 B2
6588931 Betzner et al. Jul 2003 B2
6589118 Soma et al. Jul 2003 B1
6589164 Flaherty Jul 2003 B1
6592538 Hotchkiss et al. Jul 2003 B1
6592597 Grant et al. Jul 2003 B2
6594552 Nowlin et al. Jul 2003 B1
6596296 Nelson et al. Jul 2003 B1
6596304 Bayon et al. Jul 2003 B1
6596432 Kawakami et al. Jul 2003 B2
6599323 Melican et al. Jul 2003 B2
D478665 Isaacs et al. Aug 2003 S
D478986 Johnston et al. Aug 2003 S
6601749 Sullivan et al. Aug 2003 B2
6602252 Mollenauer Aug 2003 B2
6602262 Griego et al. Aug 2003 B2
6603050 Heaton Aug 2003 B2
6605078 Adams Aug 2003 B2
6605669 Awokola et al. Aug 2003 B2
6605911 Klesing Aug 2003 B1
6607475 Doyle et al. Aug 2003 B2
6611793 Burnside et al. Aug 2003 B1
6613069 Boyd et al. Sep 2003 B2
6616686 Coleman et al. Sep 2003 B2
6619529 Green et al. Sep 2003 B2
6620111 Stephens et al. Sep 2003 B2
6620166 Wenstrom, Jr. et al. Sep 2003 B1
6625517 Bogdanov et al. Sep 2003 B1
6626834 Dunne et al. Sep 2003 B2
6629630 Adams Oct 2003 B2
6629974 Penny et al. Oct 2003 B2
6629988 Weadock Oct 2003 B2
6635838 Kornelson Oct 2003 B1
6636412 Smith Oct 2003 B2
6638108 Tachi Oct 2003 B2
6638285 Gabbay Oct 2003 B2
6638297 Huitema Oct 2003 B1
RE38335 Aust et al. Nov 2003 E
6641528 Torii Nov 2003 B2
6644532 Green et al. Nov 2003 B2
6645201 Utley et al. Nov 2003 B1
6646307 Yu et al. Nov 2003 B1
6648816 Irion et al. Nov 2003 B2
6648901 Fleischman et al. Nov 2003 B2
6652595 Nicolo Nov 2003 B1
D484243 Ryan et al. Dec 2003 S
D484595 Ryan et al. Dec 2003 S
D484596 Ryan et al. Dec 2003 S
6656177 Truckai et al. Dec 2003 B2
6656193 Grant et al. Dec 2003 B2
6659940 Adler Dec 2003 B2
6663623 Oyama et al. Dec 2003 B1
6663641 Kovac et al. Dec 2003 B1
6666854 Lange Dec 2003 B1
6666875 Sakurai et al. Dec 2003 B1
6667825 Lu et al. Dec 2003 B2
6669073 Milliman et al. Dec 2003 B2
6670806 Wendt et al. Dec 2003 B2
6671185 Duval Dec 2003 B2
D484977 Ryan et al. Jan 2004 S
6676660 Wampler et al. Jan 2004 B2
6677687 Ho et al. Jan 2004 B2
6679269 Swanson Jan 2004 B2
6679410 Wursch et al. Jan 2004 B2
6681978 Geiste et al. Jan 2004 B2
6681979 Whitman Jan 2004 B2
6682527 Strul Jan 2004 B2
6682528 Frazier et al. Jan 2004 B2
6682544 Mastri et al. Jan 2004 B2
6685698 Morley et al. Feb 2004 B2
6685727 Fisher et al. Feb 2004 B2
6689153 Skiba Feb 2004 B1
6692507 Pugsley et al. Feb 2004 B2
6692692 Stetzel Feb 2004 B2
6695198 Adams et al. Feb 2004 B2
6695199 Whitman Feb 2004 B2
6695774 Hale et al. Feb 2004 B2
6696814 Henderson et al. Feb 2004 B2
6697048 Rosenberg et al. Feb 2004 B2
6698643 Whitman Mar 2004 B2
6699177 Wang et al. Mar 2004 B1
6699214 Gellman Mar 2004 B2
6699235 Wallace et al. Mar 2004 B2
6704210 Myers Mar 2004 B1
6705503 Pedicini et al. Mar 2004 B1
6709445 Boebel et al. Mar 2004 B2
6712773 Viola Mar 2004 B1
6716223 Leopold et al. Apr 2004 B2
6716232 Vidal et al. Apr 2004 B1
6716233 Whitman Apr 2004 B1
6720734 Norris Apr 2004 B2
6722550 Ricordi et al. Apr 2004 B1
6722552 Fenton, Jr. Apr 2004 B2
6723087 O'Neill et al. Apr 2004 B2
6723091 Goble et al. Apr 2004 B2
6723109 Solingen Apr 2004 B2
6726697 Nicholas et al. Apr 2004 B2
6726706 Dominguez Apr 2004 B2
6729119 Schnipke et al. May 2004 B2
6736825 Blatter et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6740030 Martone et al. May 2004 B2
6743230 Lutze et al. Jun 2004 B2
6744385 Kazuya et al. Jun 2004 B2
6747121 Gogolewski Jun 2004 B2
6747300 Nadd et al. Jun 2004 B2
6749560 Konstorum et al. Jun 2004 B1
6749600 Levy Jun 2004 B1
6752768 Burdorff et al. Jun 2004 B2
6752816 Culp et al. Jun 2004 B2
6754959 Guiette, III et al. Jun 2004 B1
6755195 Lemke et al. Jun 2004 B1
6755338 Hahnen et al. Jun 2004 B2
6755843 Chung et al. Jun 2004 B2
6756705 Pulford, Jr. Jun 2004 B2
6758846 Goble et al. Jul 2004 B2
6761685 Adams et al. Jul 2004 B2
6762339 Klun et al. Jul 2004 B1
6764445 Ramans et al. Jul 2004 B2
6766957 Matsuura et al. Jul 2004 B2
6767352 Field et al. Jul 2004 B2
6767356 Kanner et al. Jul 2004 B2
6769590 Vresh et al. Aug 2004 B2
6769594 Orban, III Aug 2004 B2
6770027 Banik et al. Aug 2004 B2
6770070 Balbierz Aug 2004 B1
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773438 Knodel et al. Aug 2004 B1
6775575 Bommannan et al. Aug 2004 B2
6777838 Miekka et al. Aug 2004 B2
6780151 Grabover et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6783524 Anderson et al. Aug 2004 B2
6786382 Hoffman Sep 2004 B1
6786864 Matsuura et al. Sep 2004 B2
6786896 Madhani et al. Sep 2004 B1
6788018 Blumenkranz Sep 2004 B1
6790173 Saadat et al. Sep 2004 B2
6793652 Whitman et al. Sep 2004 B1
6793661 Hamilton et al. Sep 2004 B2
6793663 Kneifel et al. Sep 2004 B2
6793669 Nakamura et al. Sep 2004 B2
6796921 Buck et al. Sep 2004 B1
6802822 Dodge Oct 2004 B1
6802843 Truckai et al. Oct 2004 B2
6802844 Ferree Oct 2004 B2
6805273 Bilotti et al. Oct 2004 B2
6806808 Watters et al. Oct 2004 B1
6808525 Latterell et al. Oct 2004 B2
6810359 Sakaguchi Oct 2004 B2
6814741 Bowman et al. Nov 2004 B2
6817508 Racenet et al. Nov 2004 B1
6817509 Geiste et al. Nov 2004 B2
6817974 Cooper et al. Nov 2004 B2
6818018 Sawhney Nov 2004 B1
6820791 Adams Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6821282 Perry et al. Nov 2004 B2
6821284 Sturtz et al. Nov 2004 B2
6827246 Sullivan et al. Dec 2004 B2
6827712 Tovey et al. Dec 2004 B2
6827725 Batchelor et al. Dec 2004 B2
6828902 Casden Dec 2004 B2
6830174 Hillstead et al. Dec 2004 B2
6831629 Nishino et al. Dec 2004 B2
6832998 Goble Dec 2004 B2
6834001 Myono Dec 2004 B2
6835173 Couvillon, Jr. Dec 2004 B2
6835199 McGuckin, Jr. et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6836611 Popovic et al. Dec 2004 B2
6837846 Jaffe et al. Jan 2005 B2
6837883 Moll et al. Jan 2005 B2
6838493 Williams et al. Jan 2005 B2
6840423 Adams et al. Jan 2005 B2
6841967 Kim et al. Jan 2005 B2
6843403 Whitman Jan 2005 B2
6843789 Goble Jan 2005 B2
6843793 Brock et al. Jan 2005 B2
6846307 Whitman et al. Jan 2005 B2
6846308 Whitman et al. Jan 2005 B2
6846309 Whitman et al. Jan 2005 B2
6847190 Schaefer et al. Jan 2005 B2
6849071 Whitman et al. Feb 2005 B2
6850817 Green Feb 2005 B1
6852122 Rush Feb 2005 B2
6852330 Bowman et al. Feb 2005 B2
6853879 Sunaoshi Feb 2005 B2
6858005 Ohline et al. Feb 2005 B2
6859882 Fung Feb 2005 B2
RE38708 Bolanos et al. Mar 2005 E
D502994 Blake, III Mar 2005 S
6861142 Wilkie et al. Mar 2005 B1
6861954 Levin Mar 2005 B2
6863668 Gillespie et al. Mar 2005 B2
6863694 Boyce et al. Mar 2005 B1
6866178 Adams et al. Mar 2005 B2
6866671 Tierney et al. Mar 2005 B2
6867248 Martin et al. Mar 2005 B1
6869430 Balbierz et al. Mar 2005 B2
6869435 Blake, III Mar 2005 B2
6872214 Sonnenschein et al. Mar 2005 B2
6874669 Adams et al. Apr 2005 B2
6877647 Green et al. Apr 2005 B2
6878106 Herrmann Apr 2005 B1
6884392 Malkin et al. Apr 2005 B2
6884428 Binette et al. Apr 2005 B2
6887710 Call et al. May 2005 B2
6889116 Jinno May 2005 B2
6893435 Goble May 2005 B2
6894140 Roby May 2005 B2
6899538 Matoba May 2005 B2
6899593 Moeller et al. May 2005 B1
6905057 Swayze et al. Jun 2005 B2
6905497 Truckai et al. Jun 2005 B2
6905498 Hooven Jun 2005 B2
6908472 Wiener et al. Jun 2005 B2
6911033 de Guillebon et al. Jun 2005 B2
6911916 Wang et al. Jun 2005 B1
6913579 Truckai et al. Jul 2005 B2
6913608 Liddicoat et al. Jul 2005 B2
6913613 Schwarz et al. Jul 2005 B2
6921397 Corcoran et al. Jul 2005 B2
6921412 Black et al. Jul 2005 B1
6923093 Ullah Aug 2005 B2
6923803 Goble Aug 2005 B2
6923819 Meade et al. Aug 2005 B2
6926716 Baker et al. Aug 2005 B2
6928902 Eyssallenne Aug 2005 B1
6929641 Goble et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6931830 Liao Aug 2005 B2
6932218 Kosann et al. Aug 2005 B2
6932810 Ryan Aug 2005 B2
6936042 Wallace et al. Aug 2005 B2
6936948 Bell et al. Aug 2005 B2
D509297 Wells Sep 2005 S
D509589 Wells Sep 2005 S
6938706 Ng Sep 2005 B2
6939358 Palacios et al. Sep 2005 B2
6942662 Goble et al. Sep 2005 B2
6942674 Belef et al. Sep 2005 B2
6945444 Gresham et al. Sep 2005 B2
6945981 Donofrio et al. Sep 2005 B2
6951562 Zwirnmann Oct 2005 B2
6953138 Dworak et al. Oct 2005 B1
6953139 Milliman et al. Oct 2005 B2
6953461 McClurken et al. Oct 2005 B2
6957758 Aranyi Oct 2005 B2
6958035 Friedman et al. Oct 2005 B2
6959851 Heinrich Nov 2005 B2
6959852 Shelton, IV et al. Nov 2005 B2
6960107 Schaub et al. Nov 2005 B1
6960163 Ewers et al. Nov 2005 B2
6960220 Marino et al. Nov 2005 B2
6962587 Johnson et al. Nov 2005 B2
6963792 Green Nov 2005 B1
6964363 Wales et al. Nov 2005 B2
6966907 Goble Nov 2005 B2
6966909 Marshall et al. Nov 2005 B2
6968908 Tokunaga et al. Nov 2005 B2
6969385 Moreyra Nov 2005 B2
6969395 Eskuri Nov 2005 B2
6971988 Orban, III Dec 2005 B2
6972199 Lebouitz et al. Dec 2005 B2
6974435 Daw et al. Dec 2005 B2
6974462 Sater Dec 2005 B2
6978921 Shelton, IV et al. Dec 2005 B2
6978922 Bilotti et al. Dec 2005 B2
6981628 Wales Jan 2006 B2
6981941 Whitman et al. Jan 2006 B2
6981978 Gannoe Jan 2006 B2
6984203 Tartaglia et al. Jan 2006 B2
6984231 Goble et al. Jan 2006 B2
6986451 Mastri et al. Jan 2006 B1
6988649 Shelton, IV et al. Jan 2006 B2
6988650 Schwemberger et al. Jan 2006 B2
6989034 Hammer et al. Jan 2006 B2
6990731 Haytayan Jan 2006 B2
6990796 Schnipke et al. Jan 2006 B2
6993200 Tastl et al. Jan 2006 B2
6993413 Sunaoshi Jan 2006 B2
6994708 Manzo Feb 2006 B2
6995729 Govari et al. Feb 2006 B2
6996433 Burbank et al. Feb 2006 B2
6997931 Sauer et al. Feb 2006 B2
6997935 Anderson et al. Feb 2006 B2
6998736 Lee et al. Feb 2006 B2
6998816 Wieck et al. Feb 2006 B2
7000818 Shelton, IV et al. Feb 2006 B2
7000819 Swayze et al. Feb 2006 B2
7000911 McCormick et al. Feb 2006 B2
7001380 Goble Feb 2006 B2
7001408 Knodel et al. Feb 2006 B2
7004174 Eggers et al. Feb 2006 B2
7007176 Goodfellow et al. Feb 2006 B2
7008433 Voellmicke et al. Mar 2006 B2
7008435 Cummins Mar 2006 B2
7009039 Yayon et al. Mar 2006 B2
7011657 Truckai et al. Mar 2006 B2
7014640 Kemppainen et al. Mar 2006 B2
7018357 Emmons Mar 2006 B2
7018390 Turovskiy et al. Mar 2006 B2
7021669 Lindermeir et al. Apr 2006 B1
7023159 Gorti et al. Apr 2006 B2
7025064 Wang et al. Apr 2006 B2
7025732 Thompson et al. Apr 2006 B2
7025743 Mann et al. Apr 2006 B2
7025775 Gadberry et al. Apr 2006 B2
7028570 Ohta et al. Apr 2006 B2
7029435 Nakao Apr 2006 B2
7029439 Roberts et al. Apr 2006 B2
7030904 Adair et al. Apr 2006 B2
7032798 Whitman et al. Apr 2006 B2
7032799 Viola et al. Apr 2006 B2
7033356 Latterell et al. Apr 2006 B2
7035716 Harris et al. Apr 2006 B2
7035762 Menard et al. Apr 2006 B2
7036680 Flannery May 2006 B1
7037314 Armstrong May 2006 B2
7037344 Kagan et al. May 2006 B2
7041088 Nawrocki et al. May 2006 B2
7041102 Truckai et al. May 2006 B2
7041868 Greene et al. May 2006 B2
7043852 Hayashida et al. May 2006 B2
7044350 Kameyama et al. May 2006 B2
7044352 Shelton, IV et al. May 2006 B2
7044353 Mastri et al. May 2006 B2
7046082 Komiya et al. May 2006 B2
7048687 Reuss et al. May 2006 B1
7048745 Tierney et al. May 2006 B2
7052454 Taylor May 2006 B2
7052494 Goble et al. May 2006 B2
7052499 Steger et al. May 2006 B2
7055730 Ehrenfels et al. Jun 2006 B2
7055731 Shelton, IV et al. Jun 2006 B2
7056284 Martone et al. Jun 2006 B2
7056330 Gayton Jun 2006 B2
7059331 Adams et al. Jun 2006 B2
7059508 Shelton, IV et al. Jun 2006 B2
7063671 Couvillon, Jr. Jun 2006 B2
7063712 Vargas et al. Jun 2006 B2
7064509 Fu et al. Jun 2006 B1
7066879 Fowler et al. Jun 2006 B2
7066944 Laufer et al. Jun 2006 B2
7067038 Trokhan et al. Jun 2006 B2
7070083 Jankowski Jul 2006 B2
7070559 Adams et al. Jul 2006 B2
7070597 Truckai et al. Jul 2006 B2
7071287 Rhine et al. Jul 2006 B2
7075770 Smith Jul 2006 B1
7077856 Whitman Jul 2006 B2
7080769 Vresh et al. Jul 2006 B2
7081114 Rashidi Jul 2006 B2
7083073 Yoshie et al. Aug 2006 B2
7083075 Swayze et al. Aug 2006 B2
7083571 Wang et al. Aug 2006 B2
7083615 Peterson et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7083620 Jahns et al. Aug 2006 B2
7083626 Hart et al. Aug 2006 B2
7087049 Nowlin et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7087071 Nicholas et al. Aug 2006 B2
7090637 Danitz et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7090683 Brock et al. Aug 2006 B2
7090684 McGuckin, Jr. et al. Aug 2006 B2
7091412 Wang et al. Aug 2006 B2
7094202 Nobis et al. Aug 2006 B2
7094247 Monassevitch et al. Aug 2006 B2
7094916 DeLuca et al. Aug 2006 B2
7096972 Orozco, Jr. Aug 2006 B2
7097089 Marczyk Aug 2006 B2
7097644 Long Aug 2006 B2
7097650 Weller et al. Aug 2006 B2
7098794 Lindsay et al. Aug 2006 B2
7100949 Williams et al. Sep 2006 B2
7101187 Deconinck et al. Sep 2006 B1
7101394 Hamm et al. Sep 2006 B2
7104741 Krohn Sep 2006 B2
7108695 Witt et al. Sep 2006 B2
7108701 Evens et al. Sep 2006 B2
7108709 Cummins Sep 2006 B2
7111768 Cummins et al. Sep 2006 B2
7111769 Wales et al. Sep 2006 B2
7112214 Peterson et al. Sep 2006 B2
RE39358 Goble Oct 2006 E
7114642 Whitman Oct 2006 B2
7116100 Mock et al. Oct 2006 B1
7118020 Lee et al. Oct 2006 B2
7118528 Piskun Oct 2006 B1
7118563 Weckwerth et al. Oct 2006 B2
7118582 Wang et al. Oct 2006 B1
7119534 Butzmann Oct 2006 B2
7121446 Arad et al. Oct 2006 B2
7121773 Mikiya et al. Oct 2006 B2
7122028 Looper et al. Oct 2006 B2
7125403 Julian et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7126303 Farritor et al. Oct 2006 B2
7126879 Snyder Oct 2006 B2
7128253 Mastri et al. Oct 2006 B2
7128254 Shelton, IV et al. Oct 2006 B2
7128748 Mooradian et al. Oct 2006 B2
7131445 Amoah Nov 2006 B2
7133601 Phillips et al. Nov 2006 B2
7134587 Schwemberger et al. Nov 2006 B2
7135027 Delmotte Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7137981 Long Nov 2006 B2
7139016 Squilla et al. Nov 2006 B2
7140527 Ehrenfels et al. Nov 2006 B2
7140528 Shelton, IV Nov 2006 B2
7141055 Abrams et al. Nov 2006 B2
7143923 Shelton, IV et al. Dec 2006 B2
7143924 Scirica et al. Dec 2006 B2
7143925 Shelton, IV et al. Dec 2006 B2
7143926 Shelton, IV et al. Dec 2006 B2
7146191 Kerner et al. Dec 2006 B2
7147138 Shelton, IV Dec 2006 B2
7147139 Schwemberger et al. Dec 2006 B2
7147140 Wukusick et al. Dec 2006 B2
7147637 Goble Dec 2006 B2
7147648 Lin Dec 2006 B2
7147650 Lee Dec 2006 B2
7150748 Ebbutt et al. Dec 2006 B2
7153300 Goble Dec 2006 B2
7155316 Sutherland et al. Dec 2006 B2
7156863 Sonnenschein et al. Jan 2007 B2
7159750 Racenet et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7161036 Oikawa et al. Jan 2007 B2
7161580 Bailey et al. Jan 2007 B2
7163563 Schwartz et al. Jan 2007 B2
7166133 Evans et al. Jan 2007 B2
7168604 Milliman et al. Jan 2007 B2
7170910 Chen et al. Jan 2007 B2
7171279 Buckingham et al. Jan 2007 B2
7172104 Scirica et al. Feb 2007 B2
7172593 Trieu et al. Feb 2007 B2
7172615 Morriss et al. Feb 2007 B2
7174636 Lowe Feb 2007 B2
7177533 McFarlin et al. Feb 2007 B2
7179223 Motoki et al. Feb 2007 B2
7179267 Nolan et al. Feb 2007 B2
7182239 Myers Feb 2007 B1
7182763 Nardella Feb 2007 B2
7183737 Kitagawa Feb 2007 B2
7187960 Abreu Mar 2007 B2
7188758 Viola et al. Mar 2007 B2
7189207 Viola Mar 2007 B2
7190147 Gileff et al. Mar 2007 B2
7195627 Amoah et al. Mar 2007 B2
7196911 Takano et al. Mar 2007 B2
D541418 Schechter et al. Apr 2007 S
7199537 Okamura et al. Apr 2007 B2
7202576 Dechene et al. Apr 2007 B1
7202653 Pai Apr 2007 B2
7204404 Nguyen et al. Apr 2007 B2
7204835 Latterell et al. Apr 2007 B2
7207233 Wadge Apr 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7207472 Wukusick et al. Apr 2007 B2
7207556 Saitoh et al. Apr 2007 B2
7208005 Frecker et al. Apr 2007 B2
7210609 Leiboff et al. May 2007 B2
7211081 Goble May 2007 B2
7211084 Goble et al. May 2007 B2
7211092 Hughett May 2007 B2
7211979 Khatib et al. May 2007 B2
7213736 Wales et al. May 2007 B2
7214224 Goble May 2007 B2
7215517 Takamatsu May 2007 B2
7217285 Vargas et al. May 2007 B2
7220260 Fleming et al. May 2007 B2
7220272 Weadock May 2007 B2
7225959 Patton et al. Jun 2007 B2
7225963 Scirica Jun 2007 B2
7225964 Mastri et al. Jun 2007 B2
7226450 Athanasiou et al. Jun 2007 B2
7229408 Douglas et al. Jun 2007 B2
7234624 Gresham et al. Jun 2007 B2
7235072 Sartor et al. Jun 2007 B2
7235089 McGuckin, Jr. Jun 2007 B1
7235302 Jing et al. Jun 2007 B2
7237708 Guy et al. Jul 2007 B1
7238195 Viola Jul 2007 B2
7238901 Kim et al. Jul 2007 B2
7239657 Gunnarsson Jul 2007 B1
7241288 Braun Jul 2007 B2
7241289 Braun Jul 2007 B2
7246734 Shelton, IV Jul 2007 B2
7247161 Johnston et al. Jul 2007 B2
7249267 Chapuis Jul 2007 B2
7252641 Thompson et al. Aug 2007 B2
7252660 Kunz Aug 2007 B2
7255012 Hedtke Aug 2007 B2
7255696 Goble et al. Aug 2007 B2
7256695 Hamel et al. Aug 2007 B2
7258262 Mastri et al. Aug 2007 B2
7258546 Beier et al. Aug 2007 B2
7260431 Libbus et al. Aug 2007 B2
7265374 Lee et al. Sep 2007 B2
7267677 Johnson et al. Sep 2007 B2
7267679 McGuckin, Jr. et al. Sep 2007 B2
7272002 Drapeau Sep 2007 B2
7273483 Wiener et al. Sep 2007 B2
7275674 Racenet et al. Oct 2007 B2
7276044 Ferry et al. Oct 2007 B2
7276068 Johnson et al. Oct 2007 B2
7278562 Mastri et al. Oct 2007 B2
7278563 Green Oct 2007 B1
7278949 Bader Oct 2007 B2
7278994 Goble Oct 2007 B2
7282048 Goble et al. Oct 2007 B2
7286850 Frielink et al. Oct 2007 B2
7287682 Ezzat et al. Oct 2007 B1
7289139 Amling et al. Oct 2007 B2
7293685 Ehrenfels et al. Nov 2007 B2
7295893 Sunaoshi Nov 2007 B2
7295907 Lu et al. Nov 2007 B2
7296722 Ivanko Nov 2007 B2
7296724 Green et al. Nov 2007 B2
7297149 Vitali et al. Nov 2007 B2
7300373 Jinno et al. Nov 2007 B2
7300450 Vleugels et al. Nov 2007 B2
7303106 Milliman et al. Dec 2007 B2
7303107 Milliman et al. Dec 2007 B2
7303108 Shelton, IV Dec 2007 B2
7303502 Thompson Dec 2007 B2
7303556 Metzger Dec 2007 B2
7306597 Manzo Dec 2007 B2
7308998 Mastri et al. Dec 2007 B2
7311238 Liu Dec 2007 B2
7313430 Urquhart et al. Dec 2007 B2
7314473 Jinno et al. Jan 2008 B2
7322859 Evans Jan 2008 B2
7322975 Goble et al. Jan 2008 B2
7322994 Nicholas et al. Jan 2008 B2
7324572 Chang Jan 2008 B2
7326203 Papineau et al. Feb 2008 B2
7326213 Benderev et al. Feb 2008 B2
7328828 Ortiz et al. Feb 2008 B2
7328829 Arad et al. Feb 2008 B2
7330004 DeJonge et al. Feb 2008 B2
7331340 Barney Feb 2008 B2
7331343 Schmidt et al. Feb 2008 B2
7331403 Berry et al. Feb 2008 B2
7331406 Wottreng, Jr. et al. Feb 2008 B2
7331969 Inganas et al. Feb 2008 B1
7334717 Rethy et al. Feb 2008 B2
7334718 McAlister et al. Feb 2008 B2
7335199 Goble et al. Feb 2008 B2
7336045 Clermonts Feb 2008 B2
7336048 Lohr Feb 2008 B2
7336184 Smith et al. Feb 2008 B2
7337774 Webb Mar 2008 B2
7338505 Belson Mar 2008 B2
7338513 Lee et al. Mar 2008 B2
7341555 Ootawara et al. Mar 2008 B2
7341591 Grinberg Mar 2008 B2
7343920 Toby et al. Mar 2008 B2
7344532 Goble et al. Mar 2008 B2
7344533 Pearson et al. Mar 2008 B2
7346344 Fontaine Mar 2008 B2
7346406 Brotto et al. Mar 2008 B2
7348763 Reinhart et al. Mar 2008 B1
7348875 Hughes et al. Mar 2008 B2
RE40237 Bilotti et al. Apr 2008 E
7351258 Ricotta et al. Apr 2008 B2
7354447 Shelton, IV et al. Apr 2008 B2
7354502 Polat et al. Apr 2008 B2
7357287 Shelton, IV et al. Apr 2008 B2
7357806 Rivera et al. Apr 2008 B2
7361168 Makower et al. Apr 2008 B2
7361195 Schwartz et al. Apr 2008 B2
7362062 Schneider et al. Apr 2008 B2
7364060 Milliman Apr 2008 B2
7364061 Swayze et al. Apr 2008 B2
7368124 Chun et al. May 2008 B2
7371210 Brock et al. May 2008 B2
7371403 McCarthy et al. May 2008 B2
7377918 Amoah May 2008 B2
7377928 Zubik et al. May 2008 B2
7380695 Doll et al. Jun 2008 B2
7380696 Shelton, IV et al. Jun 2008 B2
7384403 Sherman Jun 2008 B2
7384417 Cucin Jun 2008 B2
7386365 Nixon Jun 2008 B2
7386730 Uchikubo Jun 2008 B2
7388217 Buschbeck et al. Jun 2008 B2
7388484 Hsu Jun 2008 B2
7391173 Schena Jun 2008 B2
7394190 Huang Jul 2008 B2
7396356 Mollenauer Jul 2008 B2
7397364 Govari Jul 2008 B2
7398707 Morley et al. Jul 2008 B2
7398907 Racenet et al. Jul 2008 B2
7398908 Holsten et al. Jul 2008 B2
7400107 Schneider et al. Jul 2008 B2
7400752 Zacharias Jul 2008 B2
7401000 Nakamura Jul 2008 B2
7401721 Holsten et al. Jul 2008 B2
7404449 Bermingham et al. Jul 2008 B2
7404508 Smith et al. Jul 2008 B2
7404509 Ortiz et al. Jul 2008 B2
7404822 Viart et al. Jul 2008 B2
7407074 Ortiz et al. Aug 2008 B2
7407075 Holsten et al. Aug 2008 B2
7407076 Racenet et al. Aug 2008 B2
7407077 Ortiz et al. Aug 2008 B2
7407078 Shelton, IV et al. Aug 2008 B2
7408310 Hong et al. Aug 2008 B2
7410085 Wolf et al. Aug 2008 B2
7410086 Ortiz et al. Aug 2008 B2
7410483 Danitz et al. Aug 2008 B2
7413563 Corcoran et al. Aug 2008 B2
7416101 Shelton, IV et al. Aug 2008 B2
7418078 Blanz et al. Aug 2008 B2
RE40514 Mastri et al. Sep 2008 E
7419080 Smith et al. Sep 2008 B2
7419081 Ehrenfels et al. Sep 2008 B2
7419321 Tereschouk Sep 2008 B2
7419495 Menn et al. Sep 2008 B2
7422136 Marczyk Sep 2008 B1
7422138 Bilotti et al. Sep 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7424965 Racenet et al. Sep 2008 B2
7427607 Suzuki Sep 2008 B2
D578644 Shumer et al. Oct 2008 S
7431188 Marczyk Oct 2008 B1
7431189 Shelton, IV et al. Oct 2008 B2
7431230 McPherson et al. Oct 2008 B2
7431694 Stefanchik et al. Oct 2008 B2
7431730 Viola Oct 2008 B2
7434715 Shelton, IV et al. Oct 2008 B2
7434717 Shelton, IV et al. Oct 2008 B2
7435249 Buysse et al. Oct 2008 B2
7438209 Hess et al. Oct 2008 B1
7438718 Milliman et al. Oct 2008 B2
7439354 Lenges et al. Oct 2008 B2
7441684 Shelton, IV et al. Oct 2008 B2
7441685 Boudreaux Oct 2008 B1
7442201 Pugsley et al. Oct 2008 B2
7443547 Moreno et al. Oct 2008 B2
7448525 Shelton, IV et al. Nov 2008 B2
7451904 Shelton, IV Nov 2008 B2
7455208 Wales et al. Nov 2008 B2
7455676 Holsten et al. Nov 2008 B2
7455682 Viola Nov 2008 B2
7461767 Viola et al. Dec 2008 B2
7462187 Johnston et al. Dec 2008 B2
7464845 Chou Dec 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7464847 Viola et al. Dec 2008 B2
7464849 Shelton, IV et al. Dec 2008 B2
7467740 Shelton, IV et al. Dec 2008 B2
7467849 Silverbrook et al. Dec 2008 B2
7472814 Mastri et al. Jan 2009 B2
7472815 Shelton, IV et al. Jan 2009 B2
7472816 Holsten et al. Jan 2009 B2
7473221 Ewers et al. Jan 2009 B2
7473253 Dycus et al. Jan 2009 B2
7473263 Johnston et al. Jan 2009 B2
7476237 Taniguchi et al. Jan 2009 B2
7479608 Smith Jan 2009 B2
7481347 Roy Jan 2009 B2
7481348 Marczyk Jan 2009 B2
7481349 Holsten et al. Jan 2009 B2
7481824 Boudreaux et al. Jan 2009 B2
7485124 Kuhns et al. Feb 2009 B2
7485133 Cannon et al. Feb 2009 B2
7485142 Milo Feb 2009 B2
7487899 Shelton, IV et al. Feb 2009 B2
7489055 Jeong et al. Feb 2009 B2
7490749 Schall et al. Feb 2009 B2
7491232 Bolduc et al. Feb 2009 B2
7494039 Racenet et al. Feb 2009 B2
7494499 Nagase et al. Feb 2009 B2
7494501 Ahlberg et al. Feb 2009 B2
7500979 Hueil et al. Mar 2009 B2
7501198 Barley et al. Mar 2009 B2
7503474 Hillstead et al. Mar 2009 B2
7506790 Shelton, IV Mar 2009 B2
7506791 Omaits et al. Mar 2009 B2
7507202 Schoellhorn Mar 2009 B2
7510107 Timm et al. Mar 2009 B2
7510534 Burdorff et al. Mar 2009 B2
7510566 Jacobs et al. Mar 2009 B2
7513407 Chang Apr 2009 B1
7513408 Shelton, IV et al. Apr 2009 B2
7517356 Heinrich Apr 2009 B2
7524320 Tierney et al. Apr 2009 B2
7527632 Houghton et al. May 2009 B2
7530984 Sonnenschein et al. May 2009 B2
7530985 Takemoto et al. May 2009 B2
7533906 Luettgen et al. May 2009 B2
7534259 Lashinski et al. May 2009 B2
7540867 Jinno et al. Jun 2009 B2
7542807 Bertolero et al. Jun 2009 B2
7546939 Adams et al. Jun 2009 B2
7546940 Milliman et al. Jun 2009 B2
7549563 Mather et al. Jun 2009 B2
7549564 Boudreaux Jun 2009 B2
7549998 Braun Jun 2009 B2
7552854 Wixey et al. Jun 2009 B2
7553173 Kowalick Jun 2009 B2
7553275 Padget et al. Jun 2009 B2
7554343 Bromfield Jun 2009 B2
7556185 Viola Jul 2009 B2
7556186 Milliman Jul 2009 B2
7556647 Drews et al. Jul 2009 B2
7559449 Viola Jul 2009 B2
7559450 Wales et al. Jul 2009 B2
7559452 Wales et al. Jul 2009 B2
7559937 de la Torre et al. Jul 2009 B2
7561637 Jonsson et al. Jul 2009 B2
7562910 Kertesz et al. Jul 2009 B2
7563269 Hashiguchi Jul 2009 B2
7563862 Sieg et al. Jul 2009 B2
7565993 Milliman et al. Jul 2009 B2
7566300 Devierre et al. Jul 2009 B2
7567045 Fristedt Jul 2009 B2
7568603 Shelton, IV et al. Aug 2009 B2
7568604 Ehrenfels et al. Aug 2009 B2
7568619 Todd et al. Aug 2009 B2
7575144 Ortiz et al. Aug 2009 B2
7578825 Huebner Aug 2009 B2
7583063 Dooley Sep 2009 B2
7586289 Andruk et al. Sep 2009 B2
7588174 Holsten et al. Sep 2009 B2
7588175 Timm et al. Sep 2009 B2
7588176 Timm et al. Sep 2009 B2
7588177 Racenet Sep 2009 B2
7591783 Boulais et al. Sep 2009 B2
7591818 Bertolero et al. Sep 2009 B2
7593766 Faber et al. Sep 2009 B2
7597229 Boudreaux et al. Oct 2009 B2
7597230 Racenet et al. Oct 2009 B2
7597693 Garrison Oct 2009 B2
7597699 Rogers Oct 2009 B2
7598972 Tomita Oct 2009 B2
7600663 Green Oct 2009 B2
7604150 Boudreaux Oct 2009 B2
7604151 Hess et al. Oct 2009 B2
7604668 Farnsworth et al. Oct 2009 B2
7607557 Shelton, IV et al. Oct 2009 B2
7611038 Racenet et al. Nov 2009 B2
7611474 Hibner et al. Nov 2009 B2
7615003 Stefanchik et al. Nov 2009 B2
7615067 Lee et al. Nov 2009 B2
7617961 Viola Nov 2009 B2
7624902 Marczyk et al. Dec 2009 B2
7624903 Green et al. Dec 2009 B2
7625370 Hart et al. Dec 2009 B2
7630841 Comisky et al. Dec 2009 B2
7631793 Rethy et al. Dec 2009 B2
7631794 Rethy et al. Dec 2009 B2
7635074 Olson et al. Dec 2009 B2
7635922 Becker Dec 2009 B2
7637409 Marczyk Dec 2009 B2
7637410 Marczyk Dec 2009 B2
7638958 Philipp et al. Dec 2009 B2
7641091 Olson et al. Jan 2010 B2
7641092 Kruszynski et al. Jan 2010 B2
7641093 Doll et al. Jan 2010 B2
7641095 Viola Jan 2010 B2
7641671 Crainich Jan 2010 B2
7644783 Roberts et al. Jan 2010 B2
7644848 Swayze et al. Jan 2010 B2
7645230 Mikkaichi et al. Jan 2010 B2
7648457 Stefanchik et al. Jan 2010 B2
7648519 Lee et al. Jan 2010 B2
7650185 Maile et al. Jan 2010 B2
7651017 Ortiz et al. Jan 2010 B2
7651498 Shifrin et al. Jan 2010 B2
7654431 Hueil et al. Feb 2010 B2
7655004 Long Feb 2010 B2
7655288 Bauman et al. Feb 2010 B2
7655584 Biran et al. Feb 2010 B2
7656131 Embrey et al. Feb 2010 B2
7658311 Boudreaux Feb 2010 B2
7658312 Vidal et al. Feb 2010 B2
7658705 Melvin et al. Feb 2010 B2
7659219 Biran et al. Feb 2010 B2
7662161 Briganti et al. Feb 2010 B2
7665646 Prommersberger Feb 2010 B2
7665647 Shelton, IV et al. Feb 2010 B2
7669746 Shelton, IV Mar 2010 B2
7669747 Weisenburgh, II et al. Mar 2010 B2
7670334 Hueil et al. Mar 2010 B2
7673780 Shelton, IV et al. Mar 2010 B2
7673781 Swayze et al. Mar 2010 B2
7673782 Hess et al. Mar 2010 B2
7673783 Morgan et al. Mar 2010 B2
7674253 Fisher et al. Mar 2010 B2
7674255 Braun Mar 2010 B2
7674263 Ryan Mar 2010 B2
7674270 Layer Mar 2010 B2
7682307 Danitz et al. Mar 2010 B2
7682367 Shah et al. Mar 2010 B2
7682686 Curro et al. Mar 2010 B2
7686201 Csiky Mar 2010 B2
7686804 Johnson et al. Mar 2010 B2
7686826 Lee et al. Mar 2010 B2
7688028 Phillips et al. Mar 2010 B2
7691098 Wallace et al. Apr 2010 B2
7691103 Fernandez et al. Apr 2010 B2
7691106 Schenberger et al. Apr 2010 B2
7694864 Okada et al. Apr 2010 B2
7694865 Scirica Apr 2010 B2
7695485 Whitman et al. Apr 2010 B2
7699204 Viola Apr 2010 B2
7699835 Lee et al. Apr 2010 B2
7699844 Utley et al. Apr 2010 B2
7699846 Ryan Apr 2010 B2
7699856 Van Wyk et al. Apr 2010 B2
7699859 Bombard et al. Apr 2010 B2
7699860 Huitema et al. Apr 2010 B2
7703653 Shah et al. Apr 2010 B2
7705559 Powell et al. Apr 2010 B2
7708180 Murray et al. May 2010 B2
7708181 Cole et al. May 2010 B2
7708182 Viola May 2010 B2
7708758 Lee et al. May 2010 B2
7712182 Zeiler et al. May 2010 B2
7713190 Brock et al. May 2010 B2
7714239 Smith May 2010 B2
7714334 Lin May 2010 B2
7717312 Beetel May 2010 B2
7717313 Criscuolo et al. May 2010 B2
7717846 Zirps et al. May 2010 B2
7717873 Swick May 2010 B2
7717915 Miyazawa May 2010 B2
7718180 Karp May 2010 B2
7718556 Matsuda et al. May 2010 B2
7721930 McKenna et al. May 2010 B2
7721931 Shelton, IV et al. May 2010 B2
7721933 Ehrenfels et al. May 2010 B2
7721934 Shelton, IV et al. May 2010 B2
7721936 Shalton, IV et al. May 2010 B2
7722527 Bouchier et al. May 2010 B2
7722607 Dumbauld et al. May 2010 B2
7722610 Viola et al. May 2010 B2
7725214 Diolaiti May 2010 B2
7726171 Langlotz et al. Jun 2010 B2
7726537 Olson et al. Jun 2010 B2
7726538 Holsten et al. Jun 2010 B2
7726539 Holsten et al. Jun 2010 B2
7727954 McKay Jun 2010 B2
7728553 Carrier et al. Jun 2010 B2
7729742 Govari Jun 2010 B2
7731072 Timm et al. Jun 2010 B2
7731073 Wixey et al. Jun 2010 B2
7731724 Huitema et al. Jun 2010 B2
7735703 Morgan et al. Jun 2010 B2
7736254 Schena Jun 2010 B2
7736306 Brustad et al. Jun 2010 B2
7736374 Vaughan et al. Jun 2010 B2
7738971 Swayze et al. Jun 2010 B2
7740159 Shelton, IV et al. Jun 2010 B2
7742036 Grant et al. Jun 2010 B2
7743960 Whitman et al. Jun 2010 B2
7744624 Bettuchi Jun 2010 B2
7744628 Viola Jun 2010 B2
7747146 Milano et al. Jun 2010 B2
7748587 Haramiishi et al. Jul 2010 B2
7748632 Coleman et al. Jul 2010 B2
7749204 Dhanaraj et al. Jul 2010 B2
7751870 Whitman Jul 2010 B2
7753245 Boudreaux et al. Jul 2010 B2
7753246 Scirica Jul 2010 B2
7753904 Shelton, IV et al. Jul 2010 B2
7757924 Gerbi et al. Jul 2010 B2
7758612 Shipp Jul 2010 B2
7762462 Gelbman Jul 2010 B2
7762998 Birk et al. Jul 2010 B2
7766207 Mather et al. Aug 2010 B2
7766209 Baxter, III et al. Aug 2010 B2
7766210 Shelton, IV et al. Aug 2010 B2
7766821 Brunnen et al. Aug 2010 B2
7766894 Weitzner et al. Aug 2010 B2
7770658 Ito et al. Aug 2010 B2
7770773 Whitman et al. Aug 2010 B2
7770774 Mastri et al. Aug 2010 B2
7770775 Shelton, IV et al. Aug 2010 B2
7770776 Chen et al. Aug 2010 B2
7771396 Stefanchik et al. Aug 2010 B2
7772720 McGee et al. Aug 2010 B2
7772725 Siman-Tov Aug 2010 B2
7775972 Brock et al. Aug 2010 B2
7776037 Odom Aug 2010 B2
7776060 Mooradian et al. Aug 2010 B2
7776065 Griffiths et al. Aug 2010 B2
7778004 Nerheim et al. Aug 2010 B2
7779737 Newman, Jr. et al. Aug 2010 B2
7780054 Wales Aug 2010 B2
7780055 Scirica et al. Aug 2010 B2
7780309 McMillan et al. Aug 2010 B2
7780663 Yates et al. Aug 2010 B2
7780685 Hunt et al. Aug 2010 B2
7784662 Wales et al. Aug 2010 B2
7784663 Shelton, IV Aug 2010 B2
7787256 Chan et al. Aug 2010 B2
7789283 Shah Sep 2010 B2
7789875 Brock et al. Sep 2010 B2
7789883 Takashino et al. Sep 2010 B2
7789889 Zubik et al. Sep 2010 B2
7793812 Moore et al. Sep 2010 B2
7794475 Hess et al. Sep 2010 B2
7798386 Schall et al. Sep 2010 B2
7799039 Shelton, IV et al. Sep 2010 B2
7799044 Johnston et al. Sep 2010 B2
7799965 Patel et al. Sep 2010 B2
7803151 Whitman Sep 2010 B2
7806871 Li et al. Oct 2010 B2
7806891 Nowlin et al. Oct 2010 B2
7810690 Bilotti et al. Oct 2010 B2
7810691 Boyden et al. Oct 2010 B2
7810692 Hall et al. Oct 2010 B2
7810693 Broehl et al. Oct 2010 B2
7811275 Birk et al. Oct 2010 B2
7814816 Alberti et al. Oct 2010 B2
7815092 Whitman et al. Oct 2010 B2
7815565 Stefanchik et al. Oct 2010 B2
7815662 Spivey et al. Oct 2010 B2
7819296 Hueil et al. Oct 2010 B2
7819297 Doll et al. Oct 2010 B2
7819298 Hall et al. Oct 2010 B2
7819299 Shelton, IV et al. Oct 2010 B2
7819799 Merril et al. Oct 2010 B2
7819884 Lee et al. Oct 2010 B2
7819886 Whitfield et al. Oct 2010 B2
7823592 Bettuchi et al. Nov 2010 B2
7823760 Zemlok et al. Nov 2010 B2
7824401 Manzo et al. Nov 2010 B2
7824422 Benchetrit Nov 2010 B2
7824426 Racenet et al. Nov 2010 B2
7828189 Holsten et al. Nov 2010 B2
7828794 Sartor Nov 2010 B2
7828808 Hinman et al. Nov 2010 B2
7831292 Quaid et al. Nov 2010 B2
7832408 Shelton, IV et al. Nov 2010 B2
7832611 Boyden et al. Nov 2010 B2
7832612 Baxter, III et al. Nov 2010 B2
7833234 Bailly et al. Nov 2010 B2
7835823 Sillman et al. Nov 2010 B2
7836400 May et al. Nov 2010 B2
7837079 Holsten et al. Nov 2010 B2
7837080 Schwemberger Nov 2010 B2
7837081 Holsten et al. Nov 2010 B2
7837425 Saeki et al. Nov 2010 B2
7837685 Weinberg et al. Nov 2010 B2
7837694 Tethrake et al. Nov 2010 B2
7838789 Stoffers et al. Nov 2010 B2
7839109 Carmen, Jr. et al. Nov 2010 B2
7841503 Sonnenschein et al. Nov 2010 B2
7842025 Coleman et al. Nov 2010 B2
7842028 Lee Nov 2010 B2
7843158 Frisco Nov 2010 B2
7845533 Marczyk et al. Dec 2010 B2
7845534 Viola et al. Dec 2010 B2
7845535 Scircia Dec 2010 B2
7845536 Viola et al. Dec 2010 B2
7845537 Shelton, IV et al. Dec 2010 B2
7846085 Silverman et al. Dec 2010 B2
7846149 Jankowski Dec 2010 B2
7848066 Yanagishima Dec 2010 B2
7850623 Griffin et al. Dec 2010 B2
7850642 Moll et al. Dec 2010 B2
7850982 Stopek et al. Dec 2010 B2
7854735 Houser et al. Dec 2010 B2
7854736 Ryan Dec 2010 B2
7857183 Shelton, IV Dec 2010 B2
7857184 Viola Dec 2010 B2
7857185 Swayze et al. Dec 2010 B2
7857186 Baxter, III et al. Dec 2010 B2
7857813 Schmitz et al. Dec 2010 B2
7861906 Doll et al. Jan 2011 B2
7862502 Pool et al. Jan 2011 B2
7862546 Conlon et al. Jan 2011 B2
7862579 Ortiz et al. Jan 2011 B2
7866525 Scirica Jan 2011 B2
7866527 Hall et al. Jan 2011 B2
7866528 Olson et al. Jan 2011 B2
7870989 Viola et al. Jan 2011 B2
7871418 Thompson et al. Jan 2011 B2
7871440 Schwartz et al. Jan 2011 B2
7875055 Cichocki, Jr. Jan 2011 B2
7879063 Khosravi Feb 2011 B2
7879070 Ortiz et al. Feb 2011 B2
7883461 Albrecht et al. Feb 2011 B2
7883465 Donofrio et al. Feb 2011 B2
7886951 Hessler Feb 2011 B2
7886952 Scirica et al. Feb 2011 B2
7887530 Zemlok et al. Feb 2011 B2
7887535 Lands et al. Feb 2011 B2
7887536 Johnson et al. Feb 2011 B2
7887563 Cummins Feb 2011 B2
7891531 Ward Feb 2011 B1
7891532 Mastri et al. Feb 2011 B2
7892200 Birk et al. Feb 2011 B2
7892245 Liddicoat et al. Feb 2011 B2
7893586 West et al. Feb 2011 B2
7896214 Farascioni Mar 2011 B2
7896215 Adams et al. Mar 2011 B2
7896869 DiSilvestro et al. Mar 2011 B2
7896877 Hall et al. Mar 2011 B2
7896895 Boudreaux et al. Mar 2011 B2
7896897 Gresham et al. Mar 2011 B2
7898198 Murphree Mar 2011 B2
7900805 Shelton, IV et al. Mar 2011 B2
7900806 Chen et al. Mar 2011 B2
7901381 Birk et al. Mar 2011 B2
7905380 Shelton, IV et al. Mar 2011 B2
7905381 Baxter et al. Mar 2011 B2
7905881 Masuda et al. Mar 2011 B2
7905889 Catanese, III et al. Mar 2011 B2
7905890 Whitfield et al. Mar 2011 B2
7905902 Huitema et al. Mar 2011 B2
7909039 Hur Mar 2011 B2
7909191 Baker et al. Mar 2011 B2
7909220 Viola Mar 2011 B2
7909221 Viola et al. Mar 2011 B2
7909224 Prommersberger Mar 2011 B2
7913891 Doll et al. Mar 2011 B2
7913893 Mastri et al. Mar 2011 B2
7914543 Roth et al. Mar 2011 B2
7914551 Ortiz et al. Mar 2011 B2
7918230 Whitman et al. Apr 2011 B2
7918376 Knodel et al. Apr 2011 B1
7918377 Measamer et al. Apr 2011 B2
7918845 Saadat et al. Apr 2011 B2
7918848 Lau et al. Apr 2011 B2
7918861 Brock et al. Apr 2011 B2
7918867 Dana et al. Apr 2011 B2
7922061 Shelton, IV et al. Apr 2011 B2
7922063 Zemlok et al. Apr 2011 B2
7922743 Heinrich et al. Apr 2011 B2
7923144 Kohn et al. Apr 2011 B2
7926691 Viola et al. Apr 2011 B2
7927328 Orszulak et al. Apr 2011 B2
7928281 Augustine Apr 2011 B2
7930040 Kelsch et al. Apr 2011 B1
7930065 Larkin et al. Apr 2011 B2
7931660 Aranyi et al. Apr 2011 B2
7931695 Ringeisen Apr 2011 B2
7931877 Steffens et al. Apr 2011 B2
7934630 Shelton, IV et al. May 2011 B2
7934631 Balbierz et al. May 2011 B2
7934896 Schnier May 2011 B2
7935773 Hadba et al. May 2011 B2
7936142 Otsuka et al. May 2011 B2
7938307 Bettuchi May 2011 B2
7941865 Seman, Jr. et al. May 2011 B2
7942303 Shah May 2011 B2
7942890 D'Agostino et al. May 2011 B2
7944175 Mori et al. May 2011 B2
7945792 Cherpantier May 2011 B2
7945798 Carlson et al. May 2011 B2
7946453 Voegele et al. May 2011 B2
7947011 Birk et al. May 2011 B2
7950560 Zemlok et al. May 2011 B2
7950561 Aranyi May 2011 B2
7951071 Whitman et al. May 2011 B2
7951166 Orban, III et al. May 2011 B2
7954682 Giordano et al. Jun 2011 B2
7954684 Boudreaux Jun 2011 B2
7954685 Viola Jun 2011 B2
7954686 Baxter, III et al. Jun 2011 B2
7954687 Zemlok et al. Jun 2011 B2
7955253 Ewers et al. Jun 2011 B2
7955257 Frasier et al. Jun 2011 B2
7955322 Devengenzo et al. Jun 2011 B2
7955327 Sartor et al. Jun 2011 B2
7955380 Chu et al. Jun 2011 B2
7959050 Smith et al. Jun 2011 B2
7959051 Smith et al. Jun 2011 B2
7959052 Sonnenschein et al. Jun 2011 B2
7963432 Knodel et al. Jun 2011 B2
7963433 Whitman et al. Jun 2011 B2
7963913 Devengenzo et al. Jun 2011 B2
7963963 Francischelli et al. Jun 2011 B2
7963964 Santilli et al. Jun 2011 B2
7964206 Suokas et al. Jun 2011 B2
7966236 Noriega et al. Jun 2011 B2
7966799 Morgan et al. Jun 2011 B2
7967178 Scirica et al. Jun 2011 B2
7967179 Olson et al. Jun 2011 B2
7967180 Scirica Jun 2011 B2
7967181 Viola et al. Jun 2011 B2
7967791 Franer et al. Jun 2011 B2
7967839 Flock et al. Jun 2011 B2
7972298 Wallace et al. Jul 2011 B2
7972315 Birk et al. Jul 2011 B2
7976213 Bertolotti et al. Jul 2011 B2
7976563 Summerer Jul 2011 B2
7979137 Tracey et al. Jul 2011 B2
7980443 Scheib et al. Jul 2011 B2
7981132 Dubrul et al. Jul 2011 B2
7987405 Turner et al. Jul 2011 B2
7988015 Mason, II et al. Aug 2011 B2
7988026 Knodel et al. Aug 2011 B2
7988027 Olson et al. Aug 2011 B2
7988028 Farascioni et al. Aug 2011 B2
7988779 Disalvo et al. Aug 2011 B2
7992757 Wheeler et al. Aug 2011 B2
7993360 Hacker et al. Aug 2011 B2
7994670 Ji Aug 2011 B2
7997054 Bertsch et al. Aug 2011 B2
7997468 Farascioni Aug 2011 B2
7997469 Olson et al. Aug 2011 B2
8002696 Suzuki Aug 2011 B2
8002784 Jinno et al. Aug 2011 B2
8002785 Weiss et al. Aug 2011 B2
8002795 Beetel Aug 2011 B2
8006365 Levin et al. Aug 2011 B2
8006885 Marczyk Aug 2011 B2
8006889 Adams et al. Aug 2011 B2
8007370 Hirsch et al. Aug 2011 B2
8007465 Birk et al. Aug 2011 B2
8007479 Birk et al. Aug 2011 B2
8007511 Brock et al. Aug 2011 B2
8007513 Nalagatla et al. Aug 2011 B2
8011550 Aranyi et al. Sep 2011 B2
8011551 Marczyk et al. Sep 2011 B2
8011553 Mastri et al. Sep 2011 B2
8011555 Tarinelli et al. Sep 2011 B2
8012170 Whitman et al. Sep 2011 B2
8016176 Kasvikis et al. Sep 2011 B2
8016177 Bettuchi et al. Sep 2011 B2
8016178 Olson et al. Sep 2011 B2
8016849 Wenchell Sep 2011 B2
8016855 Whitman et al. Sep 2011 B2
8016858 Whitman Sep 2011 B2
8016881 Furst Sep 2011 B2
8020742 Marczyk Sep 2011 B2
8020743 Shelton, IV Sep 2011 B2
8021375 Aldrich et al. Sep 2011 B2
8025199 Whitman et al. Sep 2011 B2
8025896 Malaviya et al. Sep 2011 B2
8028882 Viola Oct 2011 B2
8028883 Stopek Oct 2011 B2
8028884 Sniffin et al. Oct 2011 B2
8028885 Smith et al. Oct 2011 B2
8029510 Hoegerle Oct 2011 B2
8031069 Cohn et al. Oct 2011 B2
8033438 Scirica Oct 2011 B2
8033439 Racenet et al. Oct 2011 B2
8033440 Wenchell et al. Oct 2011 B2
8034077 Smith et al. Oct 2011 B2
8034337 Simard Oct 2011 B2
8034363 Li et al. Oct 2011 B2
8035487 Malackowski Oct 2011 B2
8037591 Spivey et al. Oct 2011 B2
8038045 Bettuchi et al. Oct 2011 B2
8038046 Smith et al. Oct 2011 B2
8038686 Huitema et al. Oct 2011 B2
8043207 Adams Oct 2011 B2
8043328 Hahnen et al. Oct 2011 B2
8044536 Nguyen et al. Oct 2011 B2
8044604 Hagino et al. Oct 2011 B2
8047236 Perry Nov 2011 B2
8048503 Farnsworth et al. Nov 2011 B2
8052636 Moll et al. Nov 2011 B2
8056787 Boudreaux et al. Nov 2011 B2
8056788 Mastri et al. Nov 2011 B2
8056789 White et al. Nov 2011 B1
8057508 Shelton, IV Nov 2011 B2
8058771 Giordano et al. Nov 2011 B2
8060250 Reiland et al. Nov 2011 B2
8061014 Smith et al. Nov 2011 B2
8061576 Cappola Nov 2011 B2
8062236 Soltz Nov 2011 B2
8062330 Prommersberger et al. Nov 2011 B2
8063619 Zhu et al. Nov 2011 B2
8066158 Vogel et al. Nov 2011 B2
8066166 Demmy et al. Nov 2011 B2
8066167 Measamer et al. Nov 2011 B2
8066168 Vidal et al. Nov 2011 B2
8066720 Knodel et al. Nov 2011 B2
D650074 Hunt et al. Dec 2011 S
8070033 Milliman et al. Dec 2011 B2
8070034 Knodel Dec 2011 B1
8070035 Holsten et al. Dec 2011 B2
8070743 Kagan et al. Dec 2011 B2
8074858 Marczyk Dec 2011 B2
8074861 Ehrenfels et al. Dec 2011 B2
8075476 Vargas Dec 2011 B2
8075571 Vitali et al. Dec 2011 B2
8079950 Stern et al. Dec 2011 B2
8079989 Birk et al. Dec 2011 B2
8080004 Downey et al. Dec 2011 B2
8083118 Milliman et al. Dec 2011 B2
8083119 Prommersberger Dec 2011 B2
8083120 Shelton, IV et al. Dec 2011 B2
8084001 Burns et al. Dec 2011 B2
8084969 David et al. Dec 2011 B2
8085013 Wei et al. Dec 2011 B2
8087563 Milliman et al. Jan 2012 B2
8089509 Chatenever et al. Jan 2012 B2
8091753 Viola Jan 2012 B2
8091756 Viola Jan 2012 B2
8092443 Bischoff Jan 2012 B2
8092932 Phillips et al. Jan 2012 B2
8093572 Kuduvalli Jan 2012 B2
8096458 Hessler Jan 2012 B2
8097017 Viola Jan 2012 B2
8100310 Zemlok Jan 2012 B2
8100824 Hegeman et al. Jan 2012 B2
8100872 Patel Jan 2012 B2
8102278 Deck et al. Jan 2012 B2
8105350 Lee et al. Jan 2012 B2
8107925 Natsuno et al. Jan 2012 B2
8108033 Drew et al. Jan 2012 B2
8108072 Zhao et al. Jan 2012 B2
8109426 Milliman et al. Feb 2012 B2
8110208 Hen Feb 2012 B1
8113405 Milliman Feb 2012 B2
8113408 Wenchell et al. Feb 2012 B2
8113410 Hall et al. Feb 2012 B2
8114017 Bacher Feb 2012 B2
8114100 Smith et al. Feb 2012 B2
8118206 Zand et al. Feb 2012 B2
8118207 Racenet et al. Feb 2012 B2
8120301 Goldberg et al. Feb 2012 B2
8122128 Burke, II et al. Feb 2012 B2
8123103 Milliman Feb 2012 B2
8123523 Carron et al. Feb 2012 B2
8123766 Bauman et al. Feb 2012 B2
8123767 Bauman et al. Feb 2012 B2
8125168 Johnson et al. Feb 2012 B2
8127975 Olson et al. Mar 2012 B2
8127976 Scirica et al. Mar 2012 B2
8128624 Couture et al. Mar 2012 B2
8128643 Aranyi et al. Mar 2012 B2
8128645 Sonnenschein et al. Mar 2012 B2
8128662 Altarac et al. Mar 2012 B2
8132703 Milliman et al. Mar 2012 B2
8132705 Viola et al. Mar 2012 B2
8132706 Marczyk et al. Mar 2012 B2
8134306 Drader et al. Mar 2012 B2
8136711 Beardsley et al. Mar 2012 B2
8136712 Zingman Mar 2012 B2
8136713 Hathaway et al. Mar 2012 B2
8137339 Jinno et al. Mar 2012 B2
8140417 Shibata Mar 2012 B2
8141762 Bedi et al. Mar 2012 B2
8141763 Milliman Mar 2012 B2
8142200 Crunkilton et al. Mar 2012 B2
8142425 Eggers Mar 2012 B2
8142461 Houser et al. Mar 2012 B2
8142515 Therin et al. Mar 2012 B2
8143520 Cutler Mar 2012 B2
8146790 Milliman Apr 2012 B2
8147421 Farquhar et al. Apr 2012 B2
8147456 Fisher et al. Apr 2012 B2
8147485 Wham et al. Apr 2012 B2
8152041 Kostrzewski Apr 2012 B2
8152756 Webster et al. Apr 2012 B2
8154239 Katsuki et al. Apr 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8157148 Scirica Apr 2012 B2
8157151 Ingmanson et al. Apr 2012 B2
8157152 Holsten et al. Apr 2012 B2
8157153 Shelton, IV et al. Apr 2012 B2
8157793 Omori et al. Apr 2012 B2
8161977 Shelton, IV et al. Apr 2012 B2
8162138 Bettenhausen et al. Apr 2012 B2
8162197 Mastri et al. Apr 2012 B2
8162668 Toly Apr 2012 B2
8162933 Francischelli et al. Apr 2012 B2
8162965 Reschke et al. Apr 2012 B2
8167185 Shelton, IV et al. May 2012 B2
8167622 Zhou May 2012 B2
8167895 D'Agostino et al. May 2012 B2
8167898 Schaller et al. May 2012 B1
8170241 Roe et al. May 2012 B2
8172004 Ho May 2012 B2
8172120 Boyden et al. May 2012 B2
8172122 Kasvikis et al. May 2012 B2
8172124 Shelton, IV et al. May 2012 B2
8177776 Humayun et al. May 2012 B2
8177797 Shimoji et al. May 2012 B2
8179705 Chapuis May 2012 B2
8180458 Kane et al. May 2012 B2
8181839 Beetel May 2012 B2
8181840 Milliman May 2012 B2
8182422 Bayer et al. May 2012 B2
8182444 Uber, III et al. May 2012 B2
8183807 Tsai et al. May 2012 B2
8186555 Shelton, IV et al. May 2012 B2
8186556 Viola May 2012 B2
8186558 Sapienza May 2012 B2
8186560 Hess et al. May 2012 B2
8191752 Scirica Jun 2012 B2
8192460 Orban, III et al. Jun 2012 B2
8192651 Young et al. Jun 2012 B2
8196795 Moore et al. Jun 2012 B2
8196796 Shelton, IV et al. Jun 2012 B2
8197501 Shadeck et al. Jun 2012 B2
8197502 Smith et al. Jun 2012 B2
8197837 Jamiolkowski et al. Jun 2012 B2
8201720 Hessler Jun 2012 B2
8201721 Zemlok et al. Jun 2012 B2
8202549 Stucky et al. Jun 2012 B2
8205779 Ma et al. Jun 2012 B2
8205780 Sorrentino et al. Jun 2012 B2
8205781 Baxter, III et al. Jun 2012 B2
8210411 Yates et al. Jul 2012 B2
8210414 Bettuchi et al. Jul 2012 B2
8210415 Ward Jul 2012 B2
8210416 Milliman et al. Jul 2012 B2
8210721 Chen et al. Jul 2012 B2
8211125 Spivey Jul 2012 B2
8214019 Govari et al. Jul 2012 B2
8215531 Shelton, IV et al. Jul 2012 B2
8215532 Marczyk Jul 2012 B2
8215533 Viola et al. Jul 2012 B2
8220468 Cooper et al. Jul 2012 B2
8220688 Laurent et al. Jul 2012 B2
8220690 Hess et al. Jul 2012 B2
8221424 Cha Jul 2012 B2
8225799 Bettuchi Jul 2012 B2
8225979 Farascioni et al. Jul 2012 B2
8226553 Shelton, IV et al. Jul 2012 B2
8226635 Petrie et al. Jul 2012 B2
8226675 Houser et al. Jul 2012 B2
8226715 Hwang et al. Jul 2012 B2
8227946 Kim Jul 2012 B2
8228048 Spencer Jul 2012 B2
8229549 Whitman et al. Jul 2012 B2
8231040 Zemlok et al. Jul 2012 B2
8231042 Hessler et al. Jul 2012 B2
8231043 Tarinelli et al. Jul 2012 B2
8235272 Nicholas et al. Aug 2012 B2
8236010 Ortiz et al. Aug 2012 B2
8236020 Smith et al. Aug 2012 B2
8237388 Jinno et al. Aug 2012 B2
8240537 Marczyk Aug 2012 B2
8241271 Millman et al. Aug 2012 B2
8241284 Dycus et al. Aug 2012 B2
8241308 Kortenbach et al. Aug 2012 B2
8241322 Whitman et al. Aug 2012 B2
8245594 Rogers et al. Aug 2012 B2
8245898 Smith et al. Aug 2012 B2
8245899 Swensgard et al. Aug 2012 B2
8245900 Scirica Aug 2012 B2
8245901 Stopek Aug 2012 B2
8246608 Omori et al. Aug 2012 B2
8246637 Viola et al. Aug 2012 B2
8256654 Bettuchi et al. Sep 2012 B2
8256655 Sniffin et al. Sep 2012 B2
8256656 Milliman et al. Sep 2012 B2
8257251 Shelton, IV et al. Sep 2012 B2
8257356 Bleich et al. Sep 2012 B2
8257386 Lee et al. Sep 2012 B2
8257391 Orban, III et al. Sep 2012 B2
8257634 Scirica Sep 2012 B2
8258745 Smith et al. Sep 2012 B2
8262655 Ghabrial et al. Sep 2012 B2
8267300 Boudreaux Sep 2012 B2
8267924 Zemlok et al. Sep 2012 B2
8267946 Whitfield et al. Sep 2012 B2
8267951 Whayne et al. Sep 2012 B2
8269121 Smith Sep 2012 B2
8272553 Mastri et al. Sep 2012 B2
8272554 Whitman et al. Sep 2012 B2
8272918 Lam Sep 2012 B2
8273404 Dave et al. Sep 2012 B2
8276801 Zemlok et al. Oct 2012 B2
8276802 Kostrzewski Oct 2012 B2
8277473 Sunaoshi et al. Oct 2012 B2
8281446 Moskovich Oct 2012 B2
8281973 Wenchell et al. Oct 2012 B2
8281974 Hessler et al. Oct 2012 B2
8282654 Ferrari et al. Oct 2012 B2
8285367 Hyde et al. Oct 2012 B2
8286723 Puzio et al. Oct 2012 B2
8286845 Perry et al. Oct 2012 B2
8286846 Smith et al. Oct 2012 B2
8287487 Estes Oct 2012 B2
8287522 Moses et al. Oct 2012 B2
8287561 Nunez et al. Oct 2012 B2
8292147 Viola Oct 2012 B2
8292150 Bryant Oct 2012 B2
8292151 Viola Oct 2012 B2
8292152 Milliman et al. Oct 2012 B2
8292155 Shelton, IV et al. Oct 2012 B2
8292157 Smith et al. Oct 2012 B2
8292801 Dejima et al. Oct 2012 B2
8292888 Whitman Oct 2012 B2
8298161 Vargas Oct 2012 B2
8298189 Fisher et al. Oct 2012 B2
8298233 Mueller Oct 2012 B2
8298677 Wiesner et al. Oct 2012 B2
8302323 Fortier et al. Nov 2012 B2
8308040 Huang et al. Nov 2012 B2
8308041 Kostrzewski Nov 2012 B2
8308042 Aranyi Nov 2012 B2
8308043 Bindra et al. Nov 2012 B2
8308046 Prommersberger Nov 2012 B2
8308659 Scheibe et al. Nov 2012 B2
8308725 Bell et al. Nov 2012 B2
8310188 Nakai Nov 2012 B2
8313496 Sauer et al. Nov 2012 B2
8313509 Kostrzewski Nov 2012 B2
8317070 Hueil et al. Nov 2012 B2
8317071 Knodel Nov 2012 B1
8317074 Ortiz et al. Nov 2012 B2
8317437 Merkley et al. Nov 2012 B2
8317744 Kirschenman Nov 2012 B2
8317790 Bell et al. Nov 2012 B2
8319002 Daniels et al. Nov 2012 B2
8322455 Shelton, IV et al. Dec 2012 B2
8322589 Boudreaux Dec 2012 B2
8322590 Patel et al. Dec 2012 B2
8322901 Michelotti Dec 2012 B2
8323789 Rozhin et al. Dec 2012 B2
8328061 Kasvikis Dec 2012 B2
8328062 Viola Dec 2012 B2
8328063 Milliman et al. Dec 2012 B2
8328064 Racenet et al. Dec 2012 B2
8328802 Deville et al. Dec 2012 B2
8328823 Aranyi et al. Dec 2012 B2
8333313 Boudreaux et al. Dec 2012 B2
8333691 Schaaf Dec 2012 B2
8333764 Francischelli et al. Dec 2012 B2
8333779 Smith et al. Dec 2012 B2
8334468 Palmer et al. Dec 2012 B2
8336753 Olson et al. Dec 2012 B2
8336754 Cappola et al. Dec 2012 B2
8342377 Milliman et al. Jan 2013 B2
8342378 Marczyk et al. Jan 2013 B2
8342379 Whitman et al. Jan 2013 B2
8343150 Artale Jan 2013 B2
8347978 Forster et al. Jan 2013 B2
8348123 Scirica et al. Jan 2013 B2
8348124 Scirica Jan 2013 B2
8348125 Viola et al. Jan 2013 B2
8348126 Olson et al. Jan 2013 B2
8348127 Marczyk Jan 2013 B2
8348129 Bedi et al. Jan 2013 B2
8348130 Shah et al. Jan 2013 B2
8348131 Omaits et al. Jan 2013 B2
8348837 Wenchell Jan 2013 B2
8348959 Wolford et al. Jan 2013 B2
8348972 Soltz et al. Jan 2013 B2
8349987 Kapiamba et al. Jan 2013 B2
8352004 Mannheimer et al. Jan 2013 B2
8353437 Boudreaux Jan 2013 B2
8353438 Baxter, III et al. Jan 2013 B2
8353439 Baxter, III et al. Jan 2013 B2
8356740 Knodel Jan 2013 B1
8357144 Whitman et al. Jan 2013 B2
8357161 Mueller Jan 2013 B2
8360296 Zingman Jan 2013 B2
8360297 Shelton, IV et al. Jan 2013 B2
8360298 Farascioni et al. Jan 2013 B2
8360299 Zemlok et al. Jan 2013 B2
8361501 DiTizio et al. Jan 2013 B2
8365973 White et al. Feb 2013 B1
8365975 Manoux et al. Feb 2013 B1
8365976 Hess et al. Feb 2013 B2
8366559 Papenfuss et al. Feb 2013 B2
8366787 Brown et al. Feb 2013 B2
8371393 Higuchi et al. Feb 2013 B2
8371491 Huitema et al. Feb 2013 B2
8371492 Aranyi et al. Feb 2013 B2
8371493 Aranyi et al. Feb 2013 B2
8371494 Racenet et al. Feb 2013 B2
8372094 Bettuchi et al. Feb 2013 B2
8376865 Forster et al. Feb 2013 B2
8377029 Nagao et al. Feb 2013 B2
8377044 Coe et al. Feb 2013 B2
8382773 Whitfield et al. Feb 2013 B2
8382790 Uenohara et al. Feb 2013 B2
8387848 Johnson et al. Mar 2013 B2
8388633 Rousseau et al. Mar 2013 B2
8389588 Ringeisen et al. Mar 2013 B2
8393513 Jankowski Mar 2013 B2
8393514 Shelton, IV et al. Mar 2013 B2
8393516 Kostrzewski Mar 2013 B2
8397971 Yates et al. Mar 2013 B2
8397973 Hausen Mar 2013 B1
8398633 Mueller Mar 2013 B2
8398669 Kim Mar 2013 B2
8398673 Hinchliffe et al. Mar 2013 B2
8400851 Byun Mar 2013 B2
8403138 Weisshaupt et al. Mar 2013 B2
8403198 Sorrentino et al. Mar 2013 B2
8403832 Cunningham et al. Mar 2013 B2
8403945 Whitfield et al. Mar 2013 B2
8403946 Whitfield et al. Mar 2013 B2
8403950 Palmer et al. Mar 2013 B2
8408439 Huang et al. Apr 2013 B2
8408442 Racenet et al. Apr 2013 B2
8409079 Okamoto et al. Apr 2013 B2
8409174 Omori Apr 2013 B2
8409175 Lee et al. Apr 2013 B2
8409222 Whitfield et al. Apr 2013 B2
8409223 Sorrentino et al. Apr 2013 B2
8411500 Gapihan et al. Apr 2013 B2
8413661 Rousseau et al. Apr 2013 B2
8413870 Pastorelli et al. Apr 2013 B2
8413871 Racenet et al. Apr 2013 B2
8413872 Patel Apr 2013 B2
8414577 Boudreaux et al. Apr 2013 B2
8418073 Mohr et al. Apr 2013 B2
8418906 Farascioni et al. Apr 2013 B2
8418908 Beardsley Apr 2013 B1
8418909 Kostrzewski Apr 2013 B2
8419717 Diolaiti et al. Apr 2013 B2
8419747 Hinman et al. Apr 2013 B2
8419754 Laby et al. Apr 2013 B2
8423182 Robinson et al. Apr 2013 B2
8424737 Scirica Apr 2013 B2
8424739 Racenet et al. Apr 2013 B2
8424740 Shelton, IV et al. Apr 2013 B2
8424741 McGuckin, Jr. et al. Apr 2013 B2
8425600 Maxwell Apr 2013 B2
8427430 Lee et al. Apr 2013 B2
8430292 Patel et al. Apr 2013 B2
8430892 Bindra et al. Apr 2013 B2
8430898 Wiener et al. Apr 2013 B2
8435257 Smith et al. May 2013 B2
8439246 Knodel May 2013 B1
8444036 Shelton, IV May 2013 B2
8444037 Nicholas et al. May 2013 B2
8444549 Viola et al. May 2013 B2
8453904 Eskaros et al. Jun 2013 B2
8453906 Huang et al. Jun 2013 B2
8453907 Laurent et al. Jun 2013 B2
8453908 Bedi et al. Jun 2013 B2
8453912 Mastri et al. Jun 2013 B2
8453914 Laurent et al. Jun 2013 B2
8454495 Kawano et al. Jun 2013 B2
8454628 Smith et al. Jun 2013 B2
8454640 Johnston et al. Jun 2013 B2
8457757 Cauller et al. Jun 2013 B2
8459520 Giordano et al. Jun 2013 B2
8459521 Zemlok et al. Jun 2013 B2
8459524 Pribanic et al. Jun 2013 B2
8459525 Yates et al. Jun 2013 B2
8464922 Marczyk Jun 2013 B2
8464923 Shelton, IV Jun 2013 B2
8464924 Gresham et al. Jun 2013 B2
8464925 Hull et al. Jun 2013 B2
8465475 Isbell, Jr. Jun 2013 B2
8465502 Zergiebel Jun 2013 B2
8465515 Drew et al. Jun 2013 B2
8469946 Sugita Jun 2013 B2
8469973 Meade et al. Jun 2013 B2
8470355 Skalla et al. Jun 2013 B2
8474677 Woodard, Jr. et al. Jul 2013 B2
8475453 Marczyk et al. Jul 2013 B2
8475454 Alshemari Jul 2013 B1
8475474 Bombard et al. Jul 2013 B2
8479968 Hodgkinson et al. Jul 2013 B2
8479969 Shelton, IV Jul 2013 B2
8480703 Nicholas et al. Jul 2013 B2
8485412 Shelton, IV et al. Jul 2013 B2
8485413 Scheib et al. Jul 2013 B2
8485970 Widenhouse et al. Jul 2013 B2
8487199 Palmer et al. Jul 2013 B2
8490851 Blier et al. Jul 2013 B2
8490853 Criscuolo et al. Jul 2013 B2
8491581 Deville et al. Jul 2013 B2
8491603 Yeung et al. Jul 2013 B2
8496154 Marczyk et al. Jul 2013 B2
8496156 Sniffin et al. Jul 2013 B2
8496683 Prommersberger et al. Jul 2013 B2
8499992 Whitman et al. Aug 2013 B2
8499993 Shelton, IV et al. Aug 2013 B2
8500721 Jinno Aug 2013 B2
8500762 Sholev et al. Aug 2013 B2
8502091 Palmer et al. Aug 2013 B2
8505799 Viola et al. Aug 2013 B2
8505801 Ehrenfels et al. Aug 2013 B2
8506555 Ruiz Morales Aug 2013 B2
8506557 Zemlok et al. Aug 2013 B2
8506580 Zergiebel et al. Aug 2013 B2
8506581 Wingardner, III et al. Aug 2013 B2
8511308 Hecox et al. Aug 2013 B2
8512359 Whitman et al. Aug 2013 B2
8512402 Marczyk et al. Aug 2013 B2
8517239 Scheib et al. Aug 2013 B2
8517241 Nicholas et al. Aug 2013 B2
8517243 Giordano et al. Aug 2013 B2
8517244 Shelton, IV et al. Aug 2013 B2
8518024 Williams et al. Aug 2013 B2
8521273 Kliman Aug 2013 B2
8523043 Ullrich et al. Sep 2013 B2
8523881 Cabiri et al. Sep 2013 B2
8523900 Jinno et al. Sep 2013 B2
8529588 Ahlberg et al. Sep 2013 B2
8529600 Woodard, Jr. et al. Sep 2013 B2
8529819 Ostapoff et al. Sep 2013 B2
8532747 Nock et al. Sep 2013 B2
8534527 Brendel et al. Sep 2013 B2
8534528 Shelton, IV Sep 2013 B2
8535304 Sklar et al. Sep 2013 B2
8535340 Allen Sep 2013 B2
8540128 Shelton, IV et al. Sep 2013 B2
8540129 Baxter, III et al. Sep 2013 B2
8540130 Moore et al. Sep 2013 B2
8540131 Swayze Sep 2013 B2
8540133 Bedi et al. Sep 2013 B2
8540733 Whitman et al. Sep 2013 B2
8540735 Mitelberg et al. Sep 2013 B2
8550984 Takemoto Oct 2013 B2
8551076 Duval et al. Oct 2013 B2
8555660 Takenaka et al. Oct 2013 B2
8556151 Viola Oct 2013 B2
8556918 Bauman et al. Oct 2013 B2
8556935 Knodel et al. Oct 2013 B1
8560147 Taylor et al. Oct 2013 B2
8561617 Lindh et al. Oct 2013 B2
8561870 Baxter, III et al. Oct 2013 B2
8561871 Rajappa et al. Oct 2013 B2
8561873 Ingmanson et al. Oct 2013 B2
8562598 Falkenstein et al. Oct 2013 B2
8567656 Shelton, IV et al. Oct 2013 B2
8568416 Schmitz et al. Oct 2013 B2
8568425 Ross et al. Oct 2013 B2
8573459 Smith et al. Nov 2013 B2
8573461 Shelton, IV et al. Nov 2013 B2
8573462 Smith et al. Nov 2013 B2
8573465 Shelton, IV Nov 2013 B2
8574199 von Bulow et al. Nov 2013 B2
8574263 Mueller Nov 2013 B2
8575880 Grantz Nov 2013 B2
8579176 Smith et al. Nov 2013 B2
8579178 Holsten et al. Nov 2013 B2
8579897 Vakharia et al. Nov 2013 B2
8579937 Gresham Nov 2013 B2
8584919 Hueil et al. Nov 2013 B2
8584920 Hodgkinson Nov 2013 B2
8584921 Scirica Nov 2013 B2
8585583 Sakaguchi et al. Nov 2013 B2
8585721 Kirsch Nov 2013 B2
8590760 Cummins et al. Nov 2013 B2
8590762 Hess et al. Nov 2013 B2
8590764 Hartwick et al. Nov 2013 B2
8596515 Okoniewski Dec 2013 B2
8597745 Farnsworth et al. Dec 2013 B2
8599450 Kubo et al. Dec 2013 B2
8602287 Yates et al. Dec 2013 B2
8602288 Shelton, IV et al. Dec 2013 B2
8603077 Cooper et al. Dec 2013 B2
8603089 Viola Dec 2013 B2
8603110 Maruyama et al. Dec 2013 B2
8603135 Mueller Dec 2013 B2
8608043 Scirica Dec 2013 B2
8608044 Hueil et al. Dec 2013 B2
8608045 Smith et al. Dec 2013 B2
8608046 Laurent et al. Dec 2013 B2
8608745 Guzman et al. Dec 2013 B2
8613383 Beckman et al. Dec 2013 B2
8616427 Viola Dec 2013 B2
8616431 Timm et al. Dec 2013 B2
8622274 Yates et al. Jan 2014 B2
8622275 Baxter, III et al. Jan 2014 B2
8627993 Smith et al. Jan 2014 B2
8627995 Smith et al. Jan 2014 B2
8628518 Blumenkranz et al. Jan 2014 B2
8628545 Cabrera et al. Jan 2014 B2
8631987 Shelton, IV et al. Jan 2014 B2
8631992 Hausen et al. Jan 2014 B1
8631993 Kostrzewski Jan 2014 B2
8632462 Yoo et al. Jan 2014 B2
8632525 Kerr et al. Jan 2014 B2
8632535 Shelton, IV et al. Jan 2014 B2
8632563 Nagase et al. Jan 2014 B2
8636187 Hueil et al. Jan 2014 B2
8636190 Zemlok et al. Jan 2014 B2
8636191 Meagher Jan 2014 B2
8636193 Whitman et al. Jan 2014 B2
8636736 Yates et al. Jan 2014 B2
8636766 Milliman et al. Jan 2014 B2
8639936 Hu et al. Jan 2014 B2
8640788 Dachs, II et al. Feb 2014 B2
8646674 Schulte et al. Feb 2014 B2
8647258 Aranyi et al. Feb 2014 B2
8652120 Giordano et al. Feb 2014 B2
8652151 Lehman et al. Feb 2014 B2
8657174 Yates et al. Feb 2014 B2
8657175 Sonnenschein et al. Feb 2014 B2
8657176 Shelton, IV et al. Feb 2014 B2
8657177 Scirica et al. Feb 2014 B2
8657178 Hueil et al. Feb 2014 B2
8657482 Malackowski et al. Feb 2014 B2
8657808 McPherson et al. Feb 2014 B2
8657814 Werneth et al. Feb 2014 B2
8657821 Palermo Feb 2014 B2
8662370 Takei Mar 2014 B2
8663106 Stivoric et al. Mar 2014 B2
8663192 Hester et al. Mar 2014 B2
8663245 Francischelli et al. Mar 2014 B2
8663262 Smith et al. Mar 2014 B2
8663270 Donnigan et al. Mar 2014 B2
8664792 Rebsdorf Mar 2014 B2
8668129 Olson Mar 2014 B2
8668130 Hess et al. Mar 2014 B2
8672206 Aranyi et al. Mar 2014 B2
8672207 Shelton, IV et al. Mar 2014 B2
8672208 Hess et al. Mar 2014 B2
8672922 Loh et al. Mar 2014 B2
8672935 Okada et al. Mar 2014 B2
8672951 Smith et al. Mar 2014 B2
8673210 Deshays Mar 2014 B2
8675820 Baic et al. Mar 2014 B2
8678263 Viola Mar 2014 B2
8679093 Farra Mar 2014 B2
8679098 Hart Mar 2014 B2
8679137 Bauman et al. Mar 2014 B2
8679154 Smith et al. Mar 2014 B2
8679156 Smith et al. Mar 2014 B2
8679454 Guire et al. Mar 2014 B2
8684248 Milliman Apr 2014 B2
8684249 Racenet et al. Apr 2014 B2
8684250 Bettuchi et al. Apr 2014 B2
8684253 Giordano et al. Apr 2014 B2
8684962 Kirschenman et al. Apr 2014 B2
8685004 Zemlock et al. Apr 2014 B2
8685020 Weizman et al. Apr 2014 B2
8695866 Leimbach et al. Apr 2014 B2
8696665 Hunt et al. Apr 2014 B2
8701958 Shelton, IV et al. Apr 2014 B2
8701959 Shah Apr 2014 B2
8708210 Zemlok et al. Apr 2014 B2
8708211 Zemlok et al. Apr 2014 B2
8708213 Shelton, IV et al. Apr 2014 B2
8714352 Farascioni et al. May 2014 B2
8714429 Demmy May 2014 B2
8714430 Natarajan et al. May 2014 B2
8715256 Greener May 2014 B2
8715302 Ibrahim et al. May 2014 B2
8720766 Hess et al. May 2014 B2
8721630 Ortiz et al. May 2014 B2
8721666 Schroeder et al. May 2014 B2
8727197 Hess et al. May 2014 B2
8727199 Wenchell May 2014 B2
8727200 Roy May 2014 B2
8727961 Ziv May 2014 B2
8728099 Cohn et al. May 2014 B2
8728119 Cummins May 2014 B2
8733470 Matthias et al. May 2014 B2
8733612 Ma May 2014 B2
8733613 Huitema et al. May 2014 B2
8733614 Ross et al. May 2014 B2
8734336 Bonadio et al. May 2014 B2
8734359 Ibanez et al. May 2014 B2
8734478 Widenhouse et al. May 2014 B2
8739033 Rosenberg May 2014 B2
8739417 Tokunaga et al. Jun 2014 B2
8740034 Morgan et al. Jun 2014 B2
8740037 Shelton, IV et al. Jun 2014 B2
8740038 Shelton, IV et al. Jun 2014 B2
8740987 Geremakis et al. Jun 2014 B2
8746529 Shelton, IV et al. Jun 2014 B2
8746530 Giordano et al. Jun 2014 B2
8746533 Whitman et al. Jun 2014 B2
8746535 Shelton, IV et al. Jun 2014 B2
8747238 Shelton, IV et al. Jun 2014 B2
8747441 Konieczynski et al. Jun 2014 B2
8752264 Ackley et al. Jun 2014 B2
8752699 Morgan et al. Jun 2014 B2
8752747 Shelton, IV et al. Jun 2014 B2
8752748 Whitman et al. Jun 2014 B2
8752749 Moore et al. Jun 2014 B2
8757287 Mak et al. Jun 2014 B2
8757465 Woodard, Jr. et al. Jun 2014 B2
8758235 Jaworek Jun 2014 B2
8758366 McLean et al. Jun 2014 B2
8758391 Swayze et al. Jun 2014 B2
8758438 Boyce et al. Jun 2014 B2
8763875 Morgan et al. Jul 2014 B2
8763877 Schall et al. Jul 2014 B2
8763879 Shelton, IV et al. Jul 2014 B2
8764732 Hartwell Jul 2014 B2
8770458 Scirica Jul 2014 B2
8770459 Racenet et al. Jul 2014 B2
8770460 Belzer Jul 2014 B2
8771169 Whitman et al. Jul 2014 B2
8777004 Shelton, IV et al. Jul 2014 B2
8777082 Scirica Jul 2014 B2
8777083 Racenet et al. Jul 2014 B2
8777898 Suon et al. Jul 2014 B2
8783541 Shelton, IV et al. Jul 2014 B2
8783542 Riestenberg et al. Jul 2014 B2
8783543 Shelton, IV et al. Jul 2014 B2
8784304 Mikkaichi et al. Jul 2014 B2
8784404 Doyle et al. Jul 2014 B2
8784415 Malackowski et al. Jul 2014 B2
8789737 Hodgkinson et al. Jul 2014 B2
8789739 Swensgard Jul 2014 B2
8789740 Baxter, III et al. Jul 2014 B2
8789741 Baxter, III et al. Jul 2014 B2
8790658 Cigarini et al. Jul 2014 B2
8790684 Dave et al. Jul 2014 B2
8794496 Scirica Aug 2014 B2
8794497 Zingman Aug 2014 B2
8795276 Dietz et al. Aug 2014 B2
8795308 Valin Aug 2014 B2
8795324 Kawai et al. Aug 2014 B2
8800681 Rousson et al. Aug 2014 B2
8800837 Zemlok Aug 2014 B2
8800838 Shelton, IV Aug 2014 B2
8800839 Beetel Aug 2014 B2
8800840 Jankowski Aug 2014 B2
8800841 Ellerhorst et al. Aug 2014 B2
8801710 Ullrich et al. Aug 2014 B2
8801734 Shelton, IV et al. Aug 2014 B2
8801735 Shelton, IV et al. Aug 2014 B2
8801752 Fortier et al. Aug 2014 B2
8801801 Datta et al. Aug 2014 B2
8806973 Ross et al. Aug 2014 B2
8807414 Ross et al. Aug 2014 B2
8808161 Gregg et al. Aug 2014 B2
8808274 Hartwell Aug 2014 B2
8808294 Fox et al. Aug 2014 B2
8808308 Boukhny et al. Aug 2014 B2
8808311 Heinrich et al. Aug 2014 B2
8808325 Hess et al. Aug 2014 B2
8810197 Juergens Aug 2014 B2
8811017 Fujii et al. Aug 2014 B2
8813866 Suzuki Aug 2014 B2
8814024 Woodard, Jr. et al. Aug 2014 B2
8814025 Miller et al. Aug 2014 B2
8814836 Ignon et al. Aug 2014 B2
8820603 Shelton, IV et al. Sep 2014 B2
8820605 Shelton, IV Sep 2014 B2
8820606 Hodgkinson Sep 2014 B2
8820607 Marczyk Sep 2014 B2
8822934 Sayeh et al. Sep 2014 B2
8825164 Tweden et al. Sep 2014 B2
8827133 Shelton, IV et al. Sep 2014 B2
8827134 Viola et al. Sep 2014 B2
8827903 Shelton, IV et al. Sep 2014 B2
8833219 Pierce Sep 2014 B2
8833630 Milliman Sep 2014 B2
8833632 Swensgard Sep 2014 B2
8834498 Byrum et al. Sep 2014 B2
8840003 Morgan et al. Sep 2014 B2
8840603 Shelton, IV et al. Sep 2014 B2
8840609 Stuebe Sep 2014 B2
8844789 Shelton, IV et al. Sep 2014 B2
8851215 Goto Oct 2014 B2
8851354 Swensgard et al. Oct 2014 B2
8852185 Twomey Oct 2014 B2
8852199 Deslauriers et al. Oct 2014 B2
8857693 Schuckmann et al. Oct 2014 B2
8857694 Shelton, IV et al. Oct 2014 B2
8858538 Belson et al. Oct 2014 B2
8858571 Shelton, IV et al. Oct 2014 B2
8858590 Shelton, IV et al. Oct 2014 B2
8864007 Widenhouse et al. Oct 2014 B2
8864009 Shelton, IV et al. Oct 2014 B2
8864010 Williams Oct 2014 B2
8870050 Hodgkinson Oct 2014 B2
8870912 Brisson et al. Oct 2014 B2
8875971 Hall et al. Nov 2014 B2
8875972 Weisenburgh, II et al. Nov 2014 B2
8876857 Burbank Nov 2014 B2
8876858 Braun Nov 2014 B2
8887979 Mastri et al. Nov 2014 B2
8888688 Julian et al. Nov 2014 B2
8888695 Piskun et al. Nov 2014 B2
8888792 Harris et al. Nov 2014 B2
8888809 Davison et al. Nov 2014 B2
8893946 Boudreaux et al. Nov 2014 B2
8893949 Shelton, IV et al. Nov 2014 B2
8894647 Beardsley et al. Nov 2014 B2
8894654 Anderson Nov 2014 B2
8899460 Wojcicki Dec 2014 B2
8899461 Farascioni Dec 2014 B2
8899462 Kostrzewski et al. Dec 2014 B2
8899463 Schall et al. Dec 2014 B2
8899464 Hueil et al. Dec 2014 B2
8899465 Shelton, IV et al. Dec 2014 B2
8899466 Baxter, III et al. Dec 2014 B2
8905287 Racenet et al. Dec 2014 B2
8905977 Shelton et al. Dec 2014 B2
8910846 Viola Dec 2014 B2
8911426 Coppeta et al. Dec 2014 B2
8911448 Stein Dec 2014 B2
8911460 Neurohr et al. Dec 2014 B2
8911471 Spivey et al. Dec 2014 B2
8920433 Barrier et al. Dec 2014 B2
8920435 Smith et al. Dec 2014 B2
8920438 Aranyi et al. Dec 2014 B2
8920443 Hiles et al. Dec 2014 B2
8920444 Hiles et al. Dec 2014 B2
8922163 Macdonald Dec 2014 B2
8925782 Shelton, IV Jan 2015 B2
8925783 Zemlok et al. Jan 2015 B2
8925788 Hess et al. Jan 2015 B2
8926506 Widenhouse et al. Jan 2015 B2
8926598 Mollere et al. Jan 2015 B2
8931576 Iwata Jan 2015 B2
8931679 Kostrzewski Jan 2015 B2
8931680 Milliman Jan 2015 B2
8931682 Timm et al. Jan 2015 B2
8936614 Allen, IV Jan 2015 B2
8939343 Milliman et al. Jan 2015 B2
8939344 Olson et al. Jan 2015 B2
8945163 Voegele et al. Feb 2015 B2
8955732 Zemlok et al. Feb 2015 B2
8956342 Russo et al. Feb 2015 B1
8956390 Shah et al. Feb 2015 B2
8958860 Banerjee et al. Feb 2015 B2
8960519 Whitman et al. Feb 2015 B2
8960520 McCuen Feb 2015 B2
8960521 Kostrzewski Feb 2015 B2
8961191 Hanshew Feb 2015 B2
8961504 Hoarau et al. Feb 2015 B2
8963714 Medhal et al. Feb 2015 B2
D725674 Jung et al. Mar 2015 S
8967443 McCuen Mar 2015 B2
8967444 Beetel Mar 2015 B2
8967446 Beardsley et al. Mar 2015 B2
8967448 Carter et al. Mar 2015 B2
8968276 Zemlok et al. Mar 2015 B2
8968312 Marczyk et al. Mar 2015 B2
8968337 Whitfield et al. Mar 2015 B2
8968340 Chowaniec et al. Mar 2015 B2
8968355 Malkowski et al. Mar 2015 B2
8968358 Reschke Mar 2015 B2
8970507 Holbein et al. Mar 2015 B2
8973803 Hall et al. Mar 2015 B2
8973804 Hess et al. Mar 2015 B2
8973805 Scirica et al. Mar 2015 B2
8974440 Farritor et al. Mar 2015 B2
8974932 McGahan et al. Mar 2015 B2
8978954 Shelton, IV et al. Mar 2015 B2
8978955 Aronhalt et al. Mar 2015 B2
8978956 Schall et al. Mar 2015 B2
8979843 Timm et al. Mar 2015 B2
8979890 Boudreaux Mar 2015 B2
8982195 Claus et al. Mar 2015 B2
8991676 Hess et al. Mar 2015 B2
8991677 Moore et al. Mar 2015 B2
8991678 Wellman et al. Mar 2015 B2
8992042 Eichenholz Mar 2015 B2
8992422 Spivey et al. Mar 2015 B2
8992565 Brisson et al. Mar 2015 B2
8996165 Wang et al. Mar 2015 B2
8998058 Moore et al. Apr 2015 B2
8998059 Smith et al. Apr 2015 B2
8998060 Bruewer et al. Apr 2015 B2
8998061 Williams et al. Apr 2015 B2
8998939 Price et al. Apr 2015 B2
9002518 Manzo et al. Apr 2015 B2
9004339 Park Apr 2015 B1
9005230 Yates et al. Apr 2015 B2
9005238 DeSantis et al. Apr 2015 B2
9005243 Stopek et al. Apr 2015 B2
9010606 Aranyi et al. Apr 2015 B2
9010608 Casasanta, Jr. et al. Apr 2015 B2
9011439 Shalaby et al. Apr 2015 B2
9011471 Timm et al. Apr 2015 B2
9016539 Kostrzewski et al. Apr 2015 B2
9016540 Whitman et al. Apr 2015 B2
9016541 Viola et al. Apr 2015 B2
9016542 Shelton, IV et al. Apr 2015 B2
9016545 Aranyi et al. Apr 2015 B2
9017331 Fox Apr 2015 B2
9017355 Smith et al. Apr 2015 B2
9017369 Renger et al. Apr 2015 B2
9017371 Whitman et al. Apr 2015 B2
9021684 Lenker et al. May 2015 B2
9023014 Chowaniec et al. May 2015 B2
9023071 Miller et al. May 2015 B2
9027817 Milliman et al. May 2015 B2
9028494 Shelton, IV et al. May 2015 B2
9028495 Mueller et al. May 2015 B2
9028519 Yates et al. May 2015 B2
9030169 Christensen et al. May 2015 B2
9033203 Woodard, Jr. et al. May 2015 B2
9033204 Shelton, IV et al. May 2015 B2
9034505 Detry et al. May 2015 B2
9038881 Schaller et al. May 2015 B1
9039690 Kersten et al. May 2015 B2
9039694 Ross et al. May 2015 B2
9039720 Madan May 2015 B2
9043027 Durant et al. May 2015 B2
9044227 Shelton, IV et al. Jun 2015 B2
9044228 Woodard, Jr. et al. Jun 2015 B2
9044229 Scheib et al. Jun 2015 B2
9044230 Morgan et al. Jun 2015 B2
9044281 Pool et al. Jun 2015 B2
9050083 Yates et al. Jun 2015 B2
9050084 Schmid et al. Jun 2015 B2
9050100 Yates et al. Jun 2015 B2
9050120 Swarup et al. Jun 2015 B2
9050123 Krause et al. Jun 2015 B2
9050176 Datta et al. Jun 2015 B2
9055941 Schmid et al. Jun 2015 B2
9055942 Balbierz et al. Jun 2015 B2
9055943 Zemlok et al. Jun 2015 B2
9055944 Hodgkinson et al. Jun 2015 B2
9055961 Manzo et al. Jun 2015 B2
9060770 Shelton, IV et al. Jun 2015 B2
9060776 Yates et al. Jun 2015 B2
9060794 Kang et al. Jun 2015 B2
9060894 Wubbeling Jun 2015 B2
9061392 Forgues et al. Jun 2015 B2
9072515 Hall et al. Jul 2015 B2
9072523 Houser et al. Jul 2015 B2
9072535 Shelton, IV et al. Jul 2015 B2
9072536 Shelton, IV et al. Jul 2015 B2
9078653 Leimbach et al. Jul 2015 B2
9084601 Moore et al. Jul 2015 B2
9084602 Gleiman Jul 2015 B2
9086875 Harrat et al. Jul 2015 B2
9089326 Krumanaker et al. Jul 2015 B2
9089330 Widenhouse et al. Jul 2015 B2
9089352 Jeong Jul 2015 B2
9091588 Lefler Jul 2015 B2
D736792 Brinda et al. Aug 2015 S
9095339 Moore et al. Aug 2015 B2
9095346 Houser et al. Aug 2015 B2
9095362 Dachs, II et al. Aug 2015 B2
9095367 Olson et al. Aug 2015 B2
9096033 Holop et al. Aug 2015 B2
9099863 Smith et al. Aug 2015 B2
9101358 Kerr et al. Aug 2015 B2
9101385 Shelton, IV et al. Aug 2015 B2
9101475 Wei et al. Aug 2015 B2
9107663 Swensgard Aug 2015 B2
9107690 Bales, Jr. et al. Aug 2015 B2
9110587 Kim et al. Aug 2015 B2
9113862 Morgan et al. Aug 2015 B2
9113864 Morgan et al. Aug 2015 B2
9113865 Shelton, IV et al. Aug 2015 B2
9113873 Marczyk et al. Aug 2015 B2
9113874 Shelton, IV et al. Aug 2015 B2
9113876 Zemlok et al. Aug 2015 B2
9113880 Zemlok et al. Aug 2015 B2
9113881 Scirica Aug 2015 B2
9113883 Aronhalt et al. Aug 2015 B2
9113884 Shelton, IV et al. Aug 2015 B2
9113887 Behnke, II et al. Aug 2015 B2
9119657 Shelton, IV et al. Sep 2015 B2
9119898 Bayon et al. Sep 2015 B2
9119957 Gantz et al. Sep 2015 B2
9123286 Park Sep 2015 B2
9124097 Cruz Sep 2015 B2
9125654 Aronhalt et al. Sep 2015 B2
9125662 Shelton, IV Sep 2015 B2
9126317 Lawton et al. Sep 2015 B2
9131835 Widenhouse et al. Sep 2015 B2
9131940 Huitema et al. Sep 2015 B2
9131950 Matthew Sep 2015 B2
9131957 Skarbnik et al. Sep 2015 B2
9138225 Huang et al. Sep 2015 B2
9138226 Racenet et al. Sep 2015 B2
9144455 Kennedy et al. Sep 2015 B2
9149274 Spivey et al. Oct 2015 B2
9149324 Huang et al. Oct 2015 B2
9149325 Worrell et al. Oct 2015 B2
9153994 Wood et al. Oct 2015 B2
9161753 Prior Oct 2015 B2
9161803 Yates et al. Oct 2015 B2
9168038 Shelton, IV et al. Oct 2015 B2
9168039 Knodel Oct 2015 B1
9168054 Turner et al. Oct 2015 B2
9168144 Rivin et al. Oct 2015 B2
9179911 Morgan et al. Nov 2015 B2
9179912 Yates et al. Nov 2015 B2
9182244 Luke et al. Nov 2015 B2
9186046 Ramamurthy et al. Nov 2015 B2
9186137 Farascioni et al. Nov 2015 B2
9186140 Hiles et al. Nov 2015 B2
9186142 Fanelli et al. Nov 2015 B2
9186143 Timm et al. Nov 2015 B2
9186148 Felder et al. Nov 2015 B2
9186221 Burbank Nov 2015 B2
9192380 (Tarinelli) Racenet et al. Nov 2015 B2
9192384 Bettuchi Nov 2015 B2
9192430 Rachlin et al. Nov 2015 B2
9192434 Twomey et al. Nov 2015 B2
9193045 Saur et al. Nov 2015 B2
9198642 Storz Dec 2015 B2
9198644 Balek et al. Dec 2015 B2
9198661 Swensgard Dec 2015 B2
9198662 Barton et al. Dec 2015 B2
9198683 Friedman et al. Dec 2015 B2
9204830 Zand et al. Dec 2015 B2
9204877 Whitman et al. Dec 2015 B2
9204878 Hall et al. Dec 2015 B2
9204879 Shelton, IV Dec 2015 B2
9204880 Baxter, III et al. Dec 2015 B2
9204923 Manzo et al. Dec 2015 B2
9204924 Marczyk et al. Dec 2015 B2
9211120 Scheib et al. Dec 2015 B2
9211121 Hall et al. Dec 2015 B2
9211122 Hagerty et al. Dec 2015 B2
9216013 Scirica et al. Dec 2015 B2
9216019 Schmid et al. Dec 2015 B2
9216020 Zhang et al. Dec 2015 B2
9216030 Fan et al. Dec 2015 B2
9216062 Duque et al. Dec 2015 B2
9220500 Swayze et al. Dec 2015 B2
9220501 Baxter, III et al. Dec 2015 B2
9220502 Zemlok et al. Dec 2015 B2
9220508 Dannaher Dec 2015 B2
9220559 Worrell et al. Dec 2015 B2
9220570 Kim et al. Dec 2015 B2
D746854 Shardlow et al. Jan 2016 S
9226750 Weir et al. Jan 2016 B2
9226751 Shelton, IV et al. Jan 2016 B2
9226767 Stulen et al. Jan 2016 B2
9232941 Mandakolathur Vasudevan et al. Jan 2016 B2
9232945 Zingman Jan 2016 B2
9232979 Parihar et al. Jan 2016 B2
9233610 Kim et al. Jan 2016 B2
9237891 Shelton, IV Jan 2016 B2
9237892 Hodgkinson Jan 2016 B2
9237895 McCarthy et al. Jan 2016 B2
9237921 Messerly et al. Jan 2016 B2
9239064 Helbig et al. Jan 2016 B2
9240740 Zeng et al. Jan 2016 B2
9241712 Zemlok et al. Jan 2016 B2
9241714 Timm et al. Jan 2016 B2
9241716 Whitman Jan 2016 B2
9241731 Boudreaux et al. Jan 2016 B2
D750122 Shardlow et al. Feb 2016 S
9259274 Prisco Feb 2016 B2
9261172 Solomon et al. Feb 2016 B2
9265500 Sorrentino et al. Feb 2016 B2
9265516 Casey et al. Feb 2016 B2
9265585 Wingardner et al. Feb 2016 B2
9271718 Milad et al. Mar 2016 B2
9271727 McGuckin, Jr. et al. Mar 2016 B2
9271753 Butler et al. Mar 2016 B2
9271799 Shelton, IV et al. Mar 2016 B2
9272406 Aronhalt et al. Mar 2016 B2
9277919 Timmer et al. Mar 2016 B2
9277922 Carter et al. Mar 2016 B2
9282962 Schmid et al. Mar 2016 B2
9282963 Bryant Mar 2016 B2
9282966 Shelton, IV et al. Mar 2016 B2
9282974 Shelton, IV Mar 2016 B2
9283028 Johnson Mar 2016 B2
9283045 Rhee et al. Mar 2016 B2
9283054 Morgan et al. Mar 2016 B2
9289206 Hess et al. Mar 2016 B2
9289207 Shelton, IV Mar 2016 B2
9289210 Baxter, III et al. Mar 2016 B2
9289211 Williams et al. Mar 2016 B2
9289212 Shelton, IV et al. Mar 2016 B2
9289225 Shelton, IV et al. Mar 2016 B2
9289256 Shelton, IV et al. Mar 2016 B2
9293757 Toussaint et al. Mar 2016 B2
9295464 Shelton, IV et al. Mar 2016 B2
9295465 Farascioni Mar 2016 B2
9295466 Hodgkinson et al. Mar 2016 B2
9295468 Heinrich et al. Mar 2016 B2
9295514 Shelton, IV et al. Mar 2016 B2
9295522 Kostrzewski Mar 2016 B2
9295784 Eggert et al. Mar 2016 B2
9301691 Hufnagel et al. Apr 2016 B2
9301752 Mandakolathur Vasudevan et al. Apr 2016 B2
9301753 Aldridge et al. Apr 2016 B2
9301755 Shelton, IV et al. Apr 2016 B2
9301759 Spivey et al. Apr 2016 B2
9307965 Ming et al. Apr 2016 B2
9307986 Hall et al. Apr 2016 B2
9307987 Swensgard et al. Apr 2016 B2
9307988 Shelton, IV Apr 2016 B2
9307989 Shelton, IV et al. Apr 2016 B2
9307994 Gresham et al. Apr 2016 B2
9308009 Madan et al. Apr 2016 B2
9308011 Chao et al. Apr 2016 B2
9308646 Lim et al. Apr 2016 B2
9314246 Shelton, IV et al. Apr 2016 B2
9314247 Shelton, IV et al. Apr 2016 B2
9314261 Bales, Jr. et al. Apr 2016 B2
9314908 Tanimoto et al. Apr 2016 B2
9320518 Henderson et al. Apr 2016 B2
9320520 Shelton, IV et al. Apr 2016 B2
9320521 Shelton, IV et al. Apr 2016 B2
9320523 Shelton, IV et al. Apr 2016 B2
9326767 Koch, Jr. et al. May 2016 B2
9326768 Shelton, IV May 2016 B2
9326769 Shelton, IV et al. May 2016 B2
9326770 Shelton, IV et al. May 2016 B2
9326771 Baxter, III et al. May 2016 B2
9326788 Batross et al. May 2016 B2
9326812 Waaler et al. May 2016 B2
9332890 Ozawa May 2016 B2
9332974 Henderson et al. May 2016 B2
9332984 Weaner et al. May 2016 B2
9332987 Leimbach et al. May 2016 B2
9333040 Shellenberger et al. May 2016 B2
9333082 Wei et al. May 2016 B2
9339226 van der Walt et al. May 2016 B2
9345477 Anim et al. May 2016 B2
9345480 Hessler et al. May 2016 B2
9345481 Hall et al. May 2016 B2
9351726 Leimbach et al. May 2016 B2
9351727 Leimbach et al. May 2016 B2
9351728 Sniffin et al. May 2016 B2
9351730 Schmid et al. May 2016 B2
9351731 Carter et al. May 2016 B2
9351732 Hodgkinson May 2016 B2
D758433 Lee et al. Jun 2016 S
9358003 Hall et al. Jun 2016 B2
9358005 Shelton, IV et al. Jun 2016 B2
9358015 Sorrentino et al. Jun 2016 B2
9358031 Manzo Jun 2016 B2
9364217 Kostrzewski et al. Jun 2016 B2
9364219 Olson et al. Jun 2016 B2
9364220 Williams Jun 2016 B2
9364226 Zemlok et al. Jun 2016 B2
9364229 D'Agostino et al. Jun 2016 B2
9364230 Shelton, IV et al. Jun 2016 B2
9364231 Wenchell Jun 2016 B2
9364233 Alexander, III et al. Jun 2016 B2
9364279 Houser et al. Jun 2016 B2
9368991 Qahouq Jun 2016 B2
9370341 Ceniccola et al. Jun 2016 B2
9370358 Shelton, IV et al. Jun 2016 B2
9370364 Smith et al. Jun 2016 B2
9375206 Vidal et al. Jun 2016 B2
9375255 Houser et al. Jun 2016 B2
9381058 Houser et al. Jul 2016 B2
9386983 Swensgard et al. Jul 2016 B2
9386984 Aronhalt et al. Jul 2016 B2
9386985 Koch, Jr. et al. Jul 2016 B2
9386988 Baxter, III et al. Jul 2016 B2
9387003 Kaercher et al. Jul 2016 B2
9393015 Laurent et al. Jul 2016 B2
9393017 Flanagan et al. Jul 2016 B2
9393018 Wang et al. Jul 2016 B2
9398911 Auld Jul 2016 B2
9402604 Williams et al. Aug 2016 B2
9402626 Ortiz et al. Aug 2016 B2
9402627 Stevenson et al. Aug 2016 B2
9408604 Shelton, IV et al. Aug 2016 B2
9408606 Shelton, IV Aug 2016 B2
9408622 Stulen et al. Aug 2016 B2
9411370 Benni et al. Aug 2016 B2
9413128 Tien et al. Aug 2016 B2
9414838 Shelton, IV et al. Aug 2016 B2
9414849 Nagashimada Aug 2016 B2
9414880 Monson et al. Aug 2016 B2
9420967 Zand et al. Aug 2016 B2
9421003 Williams et al. Aug 2016 B2
9421014 Ingmanson et al. Aug 2016 B2
9421030 Cole et al. Aug 2016 B2
9421060 Monson et al. Aug 2016 B2
9427223 Park et al. Aug 2016 B2
9427231 Racenet et al. Aug 2016 B2
9433411 Racenet et al. Sep 2016 B2
9433419 Gonzalez et al. Sep 2016 B2
9433420 Hodgkinson Sep 2016 B2
9439649 Shelton, IV et al. Sep 2016 B2
9439650 McGuckin, Jr. et al. Sep 2016 B2
9439651 Smith et al. Sep 2016 B2
9439668 Timm et al. Sep 2016 B2
9445808 Woodard, Jr. et al. Sep 2016 B2
9445813 Shelton, IV et al. Sep 2016 B2
9451958 Shelton, IV et al. Sep 2016 B2
9461340 Li et al. Oct 2016 B2
9463040 Jeong et al. Oct 2016 B2
9463260 Stopek Oct 2016 B2
9468438 Baber et al. Oct 2016 B2
9468447 Aman et al. Oct 2016 B2
9470297 Aranyi et al. Oct 2016 B2
9471969 Zeng et al. Oct 2016 B2
9474506 Magnin et al. Oct 2016 B2
9474523 Meade et al. Oct 2016 B2
9474540 Stokes et al. Oct 2016 B2
9475180 Eshleman et al. Oct 2016 B2
9480476 Aldridge et al. Nov 2016 B2
9480492 Aranyi et al. Nov 2016 B2
9483095 Tran et al. Nov 2016 B2
9486186 Fiebig et al. Nov 2016 B2
9486213 Altman et al. Nov 2016 B2
9486214 Shelton, IV Nov 2016 B2
9486302 Boey et al. Nov 2016 B2
9488197 Wi Nov 2016 B2
9492146 Kostrzewski et al. Nov 2016 B2
9492167 Shelton, IV et al. Nov 2016 B2
9492170 Bear et al. Nov 2016 B2
9492189 Williams et al. Nov 2016 B2
9492192 To et al. Nov 2016 B2
9498213 Marczyk et al. Nov 2016 B2
9498219 Moore et al. Nov 2016 B2
9504521 Deutmeyer et al. Nov 2016 B2
D775336 Shelton, IV et al. Dec 2016 S
9510828 Yates et al. Dec 2016 B2
9510830 Shelton, IV et al. Dec 2016 B2
9510846 Sholev et al. Dec 2016 B2
9510895 Houser et al. Dec 2016 B2
9510925 Hotter et al. Dec 2016 B2
9517063 Swayze et al. Dec 2016 B2
9517068 Shelton, IV et al. Dec 2016 B2
9521996 Armstrong Dec 2016 B2
9522029 Yates et al. Dec 2016 B2
9526481 Storz et al. Dec 2016 B2
9526499 Kostrzewski et al. Dec 2016 B2
9526564 Rusin Dec 2016 B2
D777773 Shi Jan 2017 S
9532783 Swayze et al. Jan 2017 B2
9545258 Smith et al. Jan 2017 B2
9549732 Yates et al. Jan 2017 B2
9549735 Shelton, IV et al. Jan 2017 B2
9554794 Baber et al. Jan 2017 B2
9554796 Kostrzewski Jan 2017 B2
9554812 Inkpen et al. Jan 2017 B2
9559624 Philipp Jan 2017 B2
9561030 Zhang et al. Feb 2017 B2
9561031 Heinrich et al. Feb 2017 B2
9561032 Shelton, IV et al. Feb 2017 B2
9561038 Shelton, IV et al. Feb 2017 B2
9561045 Hinman et al. Feb 2017 B2
9566061 Aronhalt et al. Feb 2017 B2
9566067 Milliman et al. Feb 2017 B2
9572574 Shelton, IV et al. Feb 2017 B2
9572577 Lloyd et al. Feb 2017 B2
9572592 Price et al. Feb 2017 B2
9574644 Parihar Feb 2017 B2
D781879 Butcher et al. Mar 2017 S
9585550 Abel et al. Mar 2017 B2
9585657 Shelton, IV et al. Mar 2017 B2
9585658 Shelton, IV Mar 2017 B2
9585659 Viola et al. Mar 2017 B2
9585660 Laurent et al. Mar 2017 B2
9585662 Shelton, IV et al. Mar 2017 B2
9585663 Shelton, IV et al. Mar 2017 B2
9585672 Bastia Mar 2017 B2
9590433 Li Mar 2017 B2
9592050 Schmid et al. Mar 2017 B2
9592052 Shelton, IV Mar 2017 B2
9592053 Shelton, IV et al. Mar 2017 B2
9592054 Schmid et al. Mar 2017 B2
9597073 Sorrentino et al. Mar 2017 B2
9597075 Shelton, IV et al. Mar 2017 B2
9597080 Milliman et al. Mar 2017 B2
9597104 Nicholas et al. Mar 2017 B2
9597143 Madan et al. Mar 2017 B2
9603595 Shelton, IV et al. Mar 2017 B2
9603598 Shelton, IV et al. Mar 2017 B2
9603991 Shelton, IV et al. Mar 2017 B2
9610080 Whitfield et al. Apr 2017 B2
9614258 Takahashi et al. Apr 2017 B2
9615826 Shelton, IV et al. Apr 2017 B2
9629623 Lytle, IV et al. Apr 2017 B2
9629629 Leimbach et al. Apr 2017 B2
9629652 Mumaw et al. Apr 2017 B2
9629814 Widenhouse et al. Apr 2017 B2
D788140 Hemsley et al. May 2017 S
9636850 Stopek (nee Prommersberger) et al. May 2017 B2
9641122 Romanowich et al. May 2017 B2
9642620 Baxter, III et al. May 2017 B2
9649096 Sholev May 2017 B2
9649110 Parihar et al. May 2017 B2
9649111 Shelton, IV et al. May 2017 B2
9655613 Schaller May 2017 B2
9655614 Swensgard et al. May 2017 B2
9655615 Knodel et al. May 2017 B2
9655624 Shelton, IV et al. May 2017 B2
9662108 Williams May 2017 B2
9662110 Huang et al. May 2017 B2
9662116 Smith et al. May 2017 B2
9662131 Omori et al. May 2017 B2
D790570 Butcher et al. Jun 2017 S
9668728 Williams et al. Jun 2017 B2
9668729 Williams et al. Jun 2017 B2
9668732 Patel et al. Jun 2017 B2
9675344 Combrowski et al. Jun 2017 B2
9675351 Hodgkinson et al. Jun 2017 B2
9675355 Shelton, IV et al. Jun 2017 B2
9675372 Laurent et al. Jun 2017 B2
9675375 Houser et al. Jun 2017 B2
9675405 Trees et al. Jun 2017 B2
9681870 Baxter, III et al. Jun 2017 B2
9681873 Smith et al. Jun 2017 B2
9681884 Clem et al. Jun 2017 B2
9687230 Leimbach et al. Jun 2017 B2
9687231 Baxter, III et al. Jun 2017 B2
9687232 Shelton, IV et al. Jun 2017 B2
9687233 Fernandez et al. Jun 2017 B2
9687236 Leimbach et al. Jun 2017 B2
9687237 Schmid et al. Jun 2017 B2
9687253 Detry et al. Jun 2017 B2
9689466 Kanai et al. Jun 2017 B2
9690362 Leimbach et al. Jun 2017 B2
9693772 Ingmanson et al. Jul 2017 B2
9693774 Gettinger et al. Jul 2017 B2
9693777 Schellin et al. Jul 2017 B2
9700309 Jaworek et al. Jul 2017 B2
9700310 Morgan et al. Jul 2017 B2
9700312 Kostrzewski et al. Jul 2017 B2
9700317 Aronhalt et al. Jul 2017 B2
9700318 Scirica et al. Jul 2017 B2
9700319 Motooka et al. Jul 2017 B2
9700321 Shelton, IV et al. Jul 2017 B2
9706981 Nicholas et al. Jul 2017 B2
9706991 Hess et al. Jul 2017 B2
9706993 Hessler et al. Jul 2017 B2
9707026 Malackowski et al. Jul 2017 B2
9707043 Bozung Jul 2017 B2
9707684 Ruiz Morales et al. Jul 2017 B2
9713468 Harris et al. Jul 2017 B2
9713470 Scirica et al. Jul 2017 B2
9717497 Zerkle et al. Aug 2017 B2
9717498 Aranyi et al. Aug 2017 B2
9724091 Shelton, IV et al. Aug 2017 B2
9724092 Baxter, III et al. Aug 2017 B2
9724094 Baber et al. Aug 2017 B2
9724096 Thompson et al. Aug 2017 B2
9724098 Baxter, III et al. Aug 2017 B2
9724163 Orban Aug 2017 B2
9730692 Shelton, IV et al. Aug 2017 B2
9730695 Leimbach et al. Aug 2017 B2
9730697 Morgan et al. Aug 2017 B2
9730717 Katsuki et al. Aug 2017 B2
9731410 Hirabayashi et al. Aug 2017 B2
9733663 Leimbach et al. Aug 2017 B2
9737297 Racenet et al. Aug 2017 B2
9737301 Baber et al. Aug 2017 B2
9737302 Shelton, IV et al. Aug 2017 B2
9737303 Shelton, IV et al. Aug 2017 B2
9737365 Hegeman et al. Aug 2017 B2
9743927 Whitman Aug 2017 B2
9743928 Shelton, IV et al. Aug 2017 B2
9743929 Leimbach et al. Aug 2017 B2
9750498 Timm et al. Sep 2017 B2
9750499 Leimbach et al. Sep 2017 B2
9750501 Shelton, IV et al. Sep 2017 B2
9750502 Scirica et al. Sep 2017 B2
9750639 Barnes et al. Sep 2017 B2
9757123 Giordano et al. Sep 2017 B2
9757124 Schellin et al. Sep 2017 B2
9757126 Cappola Sep 2017 B2
9757128 Baber et al. Sep 2017 B2
9757129 Williams Sep 2017 B2
9757130 Shelton, IV Sep 2017 B2
9763662 Shelton, IV et al. Sep 2017 B2
9770245 Swayze et al. Sep 2017 B2
9770274 Pool et al. Sep 2017 B2
D800904 Leimbach et al. Oct 2017 S
9775608 Aronhalt et al. Oct 2017 B2
9775609 Shelton, IV et al. Oct 2017 B2
9775610 Nicholas et al. Oct 2017 B2
9775611 Kostrzewski Oct 2017 B2
9775613 Shelton, IV et al. Oct 2017 B2
9775614 Shelton, IV et al. Oct 2017 B2
9775635 Takei Oct 2017 B2
9782169 Kimsey et al. Oct 2017 B2
9782170 Zemlok et al. Oct 2017 B2
9782180 Smith et al. Oct 2017 B2
9782214 Houser et al. Oct 2017 B2
9788834 Schmid et al. Oct 2017 B2
9788835 Morgan et al. Oct 2017 B2
9788836 Overmyer et al. Oct 2017 B2
9788847 Jinno Oct 2017 B2
9788851 Dannaher et al. Oct 2017 B2
9795379 Leimbach et al. Oct 2017 B2
9795381 Shelton, IV Oct 2017 B2
9795382 Shelton, IV Oct 2017 B2
9795383 Aldridge et al. Oct 2017 B2
9795384 Weaner et al. Oct 2017 B2
9797486 Zergiebel et al. Oct 2017 B2
9801626 Parihar et al. Oct 2017 B2
9801627 Harris et al. Oct 2017 B2
9801628 Harris et al. Oct 2017 B2
9801634 Shelton, IV et al. Oct 2017 B2
9802033 Hibner et al. Oct 2017 B2
9804618 Leimbach et al. Oct 2017 B2
D803850 Chang et al. Nov 2017 S
9808244 Leimbach et al. Nov 2017 B2
9808246 Shelton, IV et al. Nov 2017 B2
9808247 Shelton, IV et al. Nov 2017 B2
9808249 Shelton, IV Nov 2017 B2
9814460 Kimsey et al. Nov 2017 B2
9814462 Woodard, Jr. et al. Nov 2017 B2
9820738 Lytle, IV et al. Nov 2017 B2
9820741 Kostrzewski Nov 2017 B2
9820768 Gee et al. Nov 2017 B2
9825455 Sandhu et al. Nov 2017 B2
9826976 Parihar et al. Nov 2017 B2
9826977 Leimbach et al. Nov 2017 B2
9826978 Shelton, IV et al. Nov 2017 B2
9829698 Haraguchi et al. Nov 2017 B2
9833236 Shelton, IV et al. Dec 2017 B2
9833238 Baxter, III et al. Dec 2017 B2
9833239 Yates et al. Dec 2017 B2
9833241 Huitema et al. Dec 2017 B2
9833242 Baxter, III et al. Dec 2017 B2
9839420 Shelton, IV et al. Dec 2017 B2
9839421 Zerkle et al. Dec 2017 B2
9839422 Schellin et al. Dec 2017 B2
9839423 Vendely et al. Dec 2017 B2
9839427 Swayze et al. Dec 2017 B2
9839428 Baxter, III et al. Dec 2017 B2
9839429 Weisenburgh, II et al. Dec 2017 B2
9839480 Pribanic et al. Dec 2017 B2
9844368 Boudreaux et al. Dec 2017 B2
9844369 Huitema et al. Dec 2017 B2
9844372 Shelton, IV et al. Dec 2017 B2
9844373 Swayze et al. Dec 2017 B2
9844374 Lytle, IV et al. Dec 2017 B2
9844375 Overmyer et al. Dec 2017 B2
9844376 Baxter, III et al. Dec 2017 B2
9844379 Shelton, IV et al. Dec 2017 B2
9848873 Shelton, IV Dec 2017 B2
9848875 Aronhalt et al. Dec 2017 B2
9848877 Shelton, IV et al. Dec 2017 B2
9855662 Ruiz Morales et al. Jan 2018 B2
9861261 Shahinian Jan 2018 B2
9861359 Shelton, IV et al. Jan 2018 B2
9861361 Aronhalt et al. Jan 2018 B2
9861382 Smith et al. Jan 2018 B2
9867612 Parihar et al. Jan 2018 B2
9867618 Hall et al. Jan 2018 B2
9868198 Nicholas et al. Jan 2018 B2
9872682 Hess et al. Jan 2018 B2
9872683 Hopkins et al. Jan 2018 B2
9872684 Hall et al. Jan 2018 B2
9877721 Schellin et al. Jan 2018 B2
9877723 Hall et al. Jan 2018 B2
9883843 Garlow Feb 2018 B2
9883860 Leimbach et al. Feb 2018 B2
9883861 Shelton, IV et al. Feb 2018 B2
9884456 Schellin et al. Feb 2018 B2
9888919 Leimbach et al. Feb 2018 B2
9888921 Williams et al. Feb 2018 B2
9889230 Bennett et al. Feb 2018 B2
9895147 Shelton, IV Feb 2018 B2
9895148 Shelton, IV et al. Feb 2018 B2
9895813 Blumenkranz et al. Feb 2018 B2
9901341 Kostrzewski Feb 2018 B2
9901342 Shelton, IV et al. Feb 2018 B2
9901344 Moore et al. Feb 2018 B2
9901345 Moore et al. Feb 2018 B2
9901346 Moore et al. Feb 2018 B2
9907456 Miyoshi Mar 2018 B2
9907553 Cole et al. Mar 2018 B2
9907620 Shelton, IV et al. Mar 2018 B2
9913642 Leimbach et al. Mar 2018 B2
9913644 McCuen Mar 2018 B2
9913646 Shelton, IV Mar 2018 B2
9913647 Weisenburgh, II et al. Mar 2018 B2
9913648 Shelton, IV et al. Mar 2018 B2
9913694 Brisson Mar 2018 B2
9918704 Shelton, IV et al. Mar 2018 B2
9918715 Menn Mar 2018 B2
9918716 Baxter, III et al. Mar 2018 B2
9924942 Swayze et al. Mar 2018 B2
9924944 Shelton, IV et al. Mar 2018 B2
9924945 Zheng et al. Mar 2018 B2
9924946 Vendely et al. Mar 2018 B2
9924947 Shelton, IV et al. Mar 2018 B2
9924961 Shelton, IV et al. Mar 2018 B2
9931116 Racenet et al. Apr 2018 B2
9931118 Shelton, IV et al. Apr 2018 B2
9936949 Measamer et al. Apr 2018 B2
9936950 Shelton, IV et al. Apr 2018 B2
9936951 Hufnagel et al. Apr 2018 B2
9936954 Shelton, IV et al. Apr 2018 B2
9943309 Shelton, IV et al. Apr 2018 B2
9943310 Harris et al. Apr 2018 B2
9943312 Posada et al. Apr 2018 B2
9955965 Chen et al. May 2018 B2
9955966 Zergiebel May 2018 B2
9962158 Hall et al. May 2018 B2
9962159 Heinrich et al. May 2018 B2
9962161 Scheib et al. May 2018 B2
9968354 Shelton, IV et al. May 2018 B2
9968355 Shelton, IV et al. May 2018 B2
9968356 Shelton, IV et al. May 2018 B2
9968397 Taylor et al. May 2018 B2
9974529 Shelton, IV et al. May 2018 B2
9974538 Baxter, III et al. May 2018 B2
9974539 Yates et al. May 2018 B2
9980713 Aronhalt et al. May 2018 B2
9980729 Moore et al. May 2018 B2
9980769 Trees et al. May 2018 B2
9987000 Shelton, IV et al. Jun 2018 B2
9987003 Timm et al. Jun 2018 B2
9987006 Morgan et al. Jun 2018 B2
9987099 Chen et al. Jun 2018 B2
9993248 Shelton, IV et al. Jun 2018 B2
9993258 Shelton, IV et al. Jun 2018 B2
9999408 Boudreaux et al. Jun 2018 B2
9999426 Moore et al. Jun 2018 B2
9999431 Shelton, IV et al. Jun 2018 B2
10004497 Overmyer et al. Jun 2018 B2
10004498 Morgan et al. Jun 2018 B2
10004500 Shelton, IV et al. Jun 2018 B2
10004501 Shelton, IV et al. Jun 2018 B2
10004505 Moore et al. Jun 2018 B2
10004506 Shelton, IV et al. Jun 2018 B2
10010322 Shelton, IV et al. Jul 2018 B2
10010324 Huitema et al. Jul 2018 B2
10013049 Leimbach et al. Jul 2018 B2
10016199 Baber et al. Jul 2018 B2
10022125 (Prommersberger) Stopek Jul 2018 B2
10024407 Aranyi et al. Jul 2018 B2
10028742 Shelton, IV et al. Jul 2018 B2
10028743 Shelton, IV et al. Jul 2018 B2
10028744 Shelton, IV et al. Jul 2018 B2
10028761 Leimbach et al. Jul 2018 B2
10029125 Shapiro et al. Jul 2018 B2
10034668 Ebner Jul 2018 B2
10039440 Fenech et al. Aug 2018 B2
10039529 Kerr et al. Aug 2018 B2
10039545 Sadowski et al. Aug 2018 B2
10041822 Zemlok Aug 2018 B2
10045769 Aronhalt et al. Aug 2018 B2
10045776 Shelton, IV et al. Aug 2018 B2
10045778 Yates et al. Aug 2018 B2
10045779 Savage et al. Aug 2018 B2
10045781 Cropper et al. Aug 2018 B2
10052044 Shelton, IV et al. Aug 2018 B2
10052099 Morgan et al. Aug 2018 B2
10052100 Morgan et al. Aug 2018 B2
10052102 Baxter, III et al. Aug 2018 B2
10052104 Shelton, IV et al. Aug 2018 B2
10052164 Overmyer Aug 2018 B2
10058317 Fan et al. Aug 2018 B2
10058327 Weisenburgh, II et al. Aug 2018 B2
10058963 Shelton, IV et al. Aug 2018 B2
10064620 Gettinger et al. Sep 2018 B2
10064621 Kerr et al. Sep 2018 B2
10064624 Shelton, IV et al. Sep 2018 B2
10064639 Ishida et al. Sep 2018 B2
10064649 Golebieski et al. Sep 2018 B2
10064688 Shelton, IV et al. Sep 2018 B2
10070861 Spivey et al. Sep 2018 B2
10070863 Swayze et al. Sep 2018 B2
10071452 Shelton, IV et al. Sep 2018 B2
10076325 Huang et al. Sep 2018 B2
10076326 Yates et al. Sep 2018 B2
D831209 Huitema et al. Oct 2018 S
10085624 Isoda et al. Oct 2018 B2
10085748 Morgan et al. Oct 2018 B2
10085751 Overmyer et al. Oct 2018 B2
10085806 Hagn et al. Oct 2018 B2
10092292 Boudreaux et al. Oct 2018 B2
10098636 Shelton, IV et al. Oct 2018 B2
10098642 Baxter, III et al. Oct 2018 B2
10099303 Yoshida et al. Oct 2018 B2
10105128 Cooper et al. Oct 2018 B2
10105136 Yates et al. Oct 2018 B2
10105139 Yates et al. Oct 2018 B2
10105140 Malinouskas et al. Oct 2018 B2
10111679 Baber et al. Oct 2018 B2
10117649 Baxter, III et al. Nov 2018 B2
10117652 Schmid et al. Nov 2018 B2
10117653 Leimbach et al. Nov 2018 B2
10117654 Ingmanson et al. Nov 2018 B2
10123798 Baxter, III et al. Nov 2018 B2
10130352 Widenhouse et al. Nov 2018 B2
10130359 Hess et al. Nov 2018 B2
10130361 Yates et al. Nov 2018 B2
10130363 Huitema et al. Nov 2018 B2
10130366 Shelton, IV et al. Nov 2018 B2
10133248 Fitzsimmons et al. Nov 2018 B2
10135242 Baber et al. Nov 2018 B2
10136887 Shelton, IV et al. Nov 2018 B2
10136889 Shelton, IV et al. Nov 2018 B2
10136890 Shelton, IV et al. Nov 2018 B2
10143474 Bucciaglia et al. Dec 2018 B2
10149679 Shelton, IV et al. Dec 2018 B2
10149680 Parihar et al. Dec 2018 B2
10149682 Shelton, IV et al. Dec 2018 B2
10149683 Smith et al. Dec 2018 B2
10149712 Manwaring et al. Dec 2018 B2
10154841 Weaner et al. Dec 2018 B2
20010000531 Casscells et al. Apr 2001 A1
20010025183 Shahidi Sep 2001 A1
20020014510 Richter et al. Feb 2002 A1
20020022810 Urich Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020022861 Jacobs et al. Feb 2002 A1
20020029032 Arkin Mar 2002 A1
20020029036 Goble et al. Mar 2002 A1
20020042620 Julian et al. Apr 2002 A1
20020091374 Cooper Jul 2002 A1
20020095175 Brock et al. Jul 2002 A1
20020103494 Pacey Aug 2002 A1
20020117534 Green et al. Aug 2002 A1
20020127265 Bowman et al. Sep 2002 A1
20020128633 Brock et al. Sep 2002 A1
20020134811 Napier et al. Sep 2002 A1
20020135474 Sylliassen Sep 2002 A1
20020143340 Kaneko Oct 2002 A1
20020158593 Henderson et al. Oct 2002 A1
20020165444 Whitman Nov 2002 A1
20020185514 Adams et al. Dec 2002 A1
20020188170 Santamore et al. Dec 2002 A1
20020188287 Zvuloni et al. Dec 2002 A1
20030009193 Corsaro Jan 2003 A1
20030011245 Fiebig Jan 2003 A1
20030066858 Holgersson Apr 2003 A1
20030078647 Vallana et al. Apr 2003 A1
20030083648 Wang et al. May 2003 A1
20030084983 Rangachari et al. May 2003 A1
20030093103 Malackowski et al. May 2003 A1
20030094356 Waldron May 2003 A1
20030096158 Takano et al. May 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030153908 Goble et al. Aug 2003 A1
20030153968 Geis et al. Aug 2003 A1
20030163085 Tanner et al. Aug 2003 A1
20030181900 Long Sep 2003 A1
20030190584 Heasley Oct 2003 A1
20030195387 Kortenbach et al. Oct 2003 A1
20030205029 Chapolini et al. Nov 2003 A1
20030212005 Petito et al. Nov 2003 A1
20030216732 Truckai et al. Nov 2003 A1
20030236505 Bonadio et al. Dec 2003 A1
20040006335 Garrison Jan 2004 A1
20040006340 Latterell et al. Jan 2004 A1
20040007608 Ehrenfels et al. Jan 2004 A1
20040024457 Boyce et al. Feb 2004 A1
20040028502 Cummins Feb 2004 A1
20040030333 Goble Feb 2004 A1
20040034357 Beane et al. Feb 2004 A1
20040044364 DeVries et al. Mar 2004 A1
20040049121 Yaron Mar 2004 A1
20040049172 Root et al. Mar 2004 A1
20040059362 Knodel et al. Mar 2004 A1
20040068161 Couvillon Apr 2004 A1
20040068224 Couvillon et al. Apr 2004 A1
20040068307 Goble Apr 2004 A1
20040070369 Sakakibara Apr 2004 A1
20040073222 Koseki Apr 2004 A1
20040078037 Batchelor et al. Apr 2004 A1
20040085180 Juang May 2004 A1
20040093024 Lousararian et al. May 2004 A1
20040098040 Taniguchi et al. May 2004 A1
20040101822 Wiesner et al. May 2004 A1
20040102783 Sutterlin et al. May 2004 A1
20040108357 Milliman et al. Jun 2004 A1
20040110439 Chaikof et al. Jun 2004 A1
20040115022 Albertson et al. Jun 2004 A1
20040116952 Sakurai et al. Jun 2004 A1
20040119185 Chen Jun 2004 A1
20040122423 Dycus et al. Jun 2004 A1
20040133095 Dunki-Jacobs et al. Jul 2004 A1
20040143297 Ramsey Jul 2004 A1
20040147909 Johnston et al. Jul 2004 A1
20040153100 Ahlberg et al. Aug 2004 A1
20040158261 Vu Aug 2004 A1
20040164123 Racenet et al. Aug 2004 A1
20040166169 Malaviya et al. Aug 2004 A1
20040167572 Roth et al. Aug 2004 A1
20040181219 Goble et al. Sep 2004 A1
20040193189 Kortenbach et al. Sep 2004 A1
20040197367 Rezania et al. Oct 2004 A1
20040199181 Knodel et al. Oct 2004 A1
20040204735 Shiroff et al. Oct 2004 A1
20040222268 Bilotti et al. Nov 2004 A1
20040225186 Horne et al. Nov 2004 A1
20040232201 Wenchell et al. Nov 2004 A1
20040236352 Wang et al. Nov 2004 A1
20040243147 Lipow Dec 2004 A1
20040243151 Demmy et al. Dec 2004 A1
20040243163 Casiano et al. Dec 2004 A1
20040247415 Mangone Dec 2004 A1
20040249366 Kunz Dec 2004 A1
20040254455 Iddan Dec 2004 A1
20040254566 Plicchi et al. Dec 2004 A1
20040254590 Hoffman et al. Dec 2004 A1
20040260315 Dell et al. Dec 2004 A1
20040267310 Racenet et al. Dec 2004 A1
20050010158 Brugger et al. Jan 2005 A1
20050010213 Stad et al. Jan 2005 A1
20050021078 Vleugels et al. Jan 2005 A1
20050032511 Malone et al. Feb 2005 A1
20050033352 Zepf et al. Feb 2005 A1
20050051163 Deem et al. Mar 2005 A1
20050054946 Krzyzanowski Mar 2005 A1
20050057225 Marquet Mar 2005 A1
20050058890 Brazell et al. Mar 2005 A1
20050059996 Bauman Mar 2005 A1
20050059997 Bauman Mar 2005 A1
20050070929 Dalessandro et al. Mar 2005 A1
20050075561 Golden Apr 2005 A1
20050080342 Gilreath et al. Apr 2005 A1
20050085693 Belson et al. Apr 2005 A1
20050090817 Phan Apr 2005 A1
20050096683 Ellins et al. May 2005 A1
20050116673 Carl et al. Jun 2005 A1
20050124855 Jaffe et al. Jun 2005 A1
20050125897 Wyslucha et al. Jun 2005 A1
20050130682 Takara et al. Jun 2005 A1
20050131173 McDaniel et al. Jun 2005 A1
20050131211 Bayley et al. Jun 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050131436 Johnston et al. Jun 2005 A1
20050131457 Douglas et al. Jun 2005 A1
20050137454 Saadat et al. Jun 2005 A1
20050137455 Ewers et al. Jun 2005 A1
20050139636 Schwemberger et al. Jun 2005 A1
20050143759 Kelly Jun 2005 A1
20050143769 White et al. Jun 2005 A1
20050145671 Viola Jul 2005 A1
20050150928 Kameyama et al. Jul 2005 A1
20050154258 Tartaglia et al. Jul 2005 A1
20050154406 Bombard et al. Jul 2005 A1
20050159778 Heinrich et al. Jul 2005 A1
20050165419 Sauer et al. Jul 2005 A1
20050169974 Tenerz et al. Aug 2005 A1
20050171522 Christopherson Aug 2005 A1
20050177181 Kagan et al. Aug 2005 A1
20050177249 Kladakis et al. Aug 2005 A1
20050182298 Ikeda et al. Aug 2005 A1
20050184121 Heinrich Aug 2005 A1
20050186240 Ringeisen et al. Aug 2005 A1
20050187545 Hooven et al. Aug 2005 A1
20050203550 Laufer et al. Sep 2005 A1
20050209614 Fenter et al. Sep 2005 A1
20050216055 Scirica et al. Sep 2005 A1
20050222587 Jinno et al. Oct 2005 A1
20050222611 Weitkamp Oct 2005 A1
20050222616 Rethy et al. Oct 2005 A1
20050222665 Aranyi Oct 2005 A1
20050228224 Okada et al. Oct 2005 A1
20050228446 Mooradian et al. Oct 2005 A1
20050230453 Viola Oct 2005 A1
20050240178 Morley et al. Oct 2005 A1
20050245965 Orban III Nov 2005 A1
20050246881 Kelly et al. Nov 2005 A1
20050251063 Basude Nov 2005 A1
20050256452 DeMarchi et al. Nov 2005 A1
20050261676 Hall et al. Nov 2005 A1
20050263563 Racenet et al. Dec 2005 A1
20050267455 Eggers et al. Dec 2005 A1
20050274034 Hayashida et al. Dec 2005 A1
20050283188 Loshakove et al. Dec 2005 A1
20060008787 Hayman et al. Jan 2006 A1
20060015009 Jaffe et al. Jan 2006 A1
20060020258 Strauss et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060025812 Shelton Feb 2006 A1
20060041188 Dirusso et al. Feb 2006 A1
20060047275 Goble Mar 2006 A1
20060049229 Milliman et al. Mar 2006 A1
20060052824 Ransick et al. Mar 2006 A1
20060052825 Ransick et al. Mar 2006 A1
20060064086 Odom Mar 2006 A1
20060079735 Martone et al. Apr 2006 A1
20060079879 Faller et al. Apr 2006 A1
20060086032 Valencic et al. Apr 2006 A1
20060087746 Lipow Apr 2006 A1
20060089535 Raz et al. Apr 2006 A1
20060100643 Laufer et al. May 2006 A1
20060100649 Hart May 2006 A1
20060111210 Hinman May 2006 A1
20060111711 Goble May 2006 A1
20060111723 Chapolini et al. May 2006 A1
20060116634 Shachar Jun 2006 A1
20060142772 Ralph et al. Jun 2006 A1
20060161050 Butler et al. Jul 2006 A1
20060161185 Saadat et al. Jul 2006 A1
20060167471 Phillips Jul 2006 A1
20060173470 Oray et al. Aug 2006 A1
20060176031 Forman et al. Aug 2006 A1
20060178556 Hasser et al. Aug 2006 A1
20060180633 Emmons Aug 2006 A1
20060180634 Shelton et al. Aug 2006 A1
20060185682 Marczyk Aug 2006 A1
20060199999 Ikeda et al. Sep 2006 A1
20060201989 Ojeda Sep 2006 A1
20060206100 Eskridge et al. Sep 2006 A1
20060217729 Eskridge et al. Sep 2006 A1
20060235368 Oz Oct 2006 A1
20060244460 Weaver Nov 2006 A1
20060252990 Kubach Nov 2006 A1
20060252993 Freed et al. Nov 2006 A1
20060258904 Stefanchik et al. Nov 2006 A1
20060259073 Miyamoto et al. Nov 2006 A1
20060261763 Iott et al. Nov 2006 A1
20060264831 Skwarek et al. Nov 2006 A1
20060264929 Goble et al. Nov 2006 A1
20060271042 Latterell et al. Nov 2006 A1
20060271102 Bosshard et al. Nov 2006 A1
20060282064 Shimizu et al. Dec 2006 A1
20060284730 Schmid et al. Dec 2006 A1
20060287576 Tsuji et al. Dec 2006 A1
20060289602 Wales et al. Dec 2006 A1
20060291981 Viola et al. Dec 2006 A1
20070010702 Wang et al. Jan 2007 A1
20070010838 Shelton et al. Jan 2007 A1
20070016235 Tanaka et al. Jan 2007 A1
20070026039 Drumheller et al. Feb 2007 A1
20070026040 Crawley et al. Feb 2007 A1
20070027468 Wales et al. Feb 2007 A1
20070027551 Farnsworth et al. Feb 2007 A1
20070043387 Vargas et al. Feb 2007 A1
20070049951 Menn Mar 2007 A1
20070049966 Bonadio et al. Mar 2007 A1
20070051375 Milliman Mar 2007 A1
20070055228 Berg et al. Mar 2007 A1
20070073341 Smith et al. Mar 2007 A1
20070073389 Bolduc et al. Mar 2007 A1
20070078328 Ozaki et al. Apr 2007 A1
20070078484 Talarico et al. Apr 2007 A1
20070084897 Shelton et al. Apr 2007 A1
20070090788 Hansford et al. Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070102472 Shelton May 2007 A1
20070106113 Ravo May 2007 A1
20070106317 Shelton et al. May 2007 A1
20070134251 Ashkenazi et al. Jun 2007 A1
20070135686 Pruitt et al. Jun 2007 A1
20070135803 Belson Jun 2007 A1
20070152612 Chen et al. Jul 2007 A1
20070155010 Farnsworth et al. Jul 2007 A1
20070170225 Shelton et al. Jul 2007 A1
20070173687 Shima et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070175950 Shelton et al. Aug 2007 A1
20070175951 Shelton et al. Aug 2007 A1
20070175955 Shelton et al. Aug 2007 A1
20070179477 Danger Aug 2007 A1
20070179528 Soltz Aug 2007 A1
20070185545 Duke Aug 2007 A1
20070190110 Pameijer et al. Aug 2007 A1
20070191868 Theroux et al. Aug 2007 A1
20070194079 Hueil et al. Aug 2007 A1
20070194082 Morgan et al. Aug 2007 A1
20070197954 Keenan Aug 2007 A1
20070198039 Jones et al. Aug 2007 A1
20070203510 Bettuchi Aug 2007 A1
20070207010 Caspi Sep 2007 A1
20070208359 Hoffman Sep 2007 A1
20070208375 Nishizawa et al. Sep 2007 A1
20070213750 Weadock Sep 2007 A1
20070225562 Spivey et al. Sep 2007 A1
20070233163 Bombard et al. Oct 2007 A1
20070243227 Gertner Oct 2007 A1
20070244471 Malackowski Oct 2007 A1
20070246505 Pace-Floridia et al. Oct 2007 A1
20070262592 Hwang et al. Nov 2007 A1
20070275035 Herman et al. Nov 2007 A1
20070276409 Ortiz et al. Nov 2007 A1
20070279011 Jones et al. Dec 2007 A1
20070286892 Herzberg et al. Dec 2007 A1
20070296286 Avenell Dec 2007 A1
20080003196 Jonn et al. Jan 2008 A1
20080015598 Prommersberger Jan 2008 A1
20080021486 Oyola et al. Jan 2008 A1
20080029570 Shelton et al. Feb 2008 A1
20080029573 Shelton et al. Feb 2008 A1
20080029574 Shelton et al. Feb 2008 A1
20080029575 Shelton et al. Feb 2008 A1
20080030170 Dacquay et al. Feb 2008 A1
20080042861 Dacquay et al. Feb 2008 A1
20080051833 Gramuglia et al. Feb 2008 A1
20080064921 Larkin et al. Mar 2008 A1
20080065153 Allard et al. Mar 2008 A1
20080071328 Haubrich et al. Mar 2008 A1
20080078802 Hess et al. Apr 2008 A1
20080082114 McKenna et al. Apr 2008 A1
20080082125 Murray et al. Apr 2008 A1
20080082126 Murray et al. Apr 2008 A1
20080083807 Beardsley et al. Apr 2008 A1
20080085296 Powell et al. Apr 2008 A1
20080086078 Powell et al. Apr 2008 A1
20080091072 Omori et al. Apr 2008 A1
20080108443 Jinno et al. May 2008 A1
20080114250 Urbano et al. May 2008 A1
20080125634 Ryan et al. May 2008 A1
20080125749 Olson May 2008 A1
20080128469 Dalessandro et al. Jun 2008 A1
20080129253 Shiue et al. Jun 2008 A1
20080135600 Hiranuma et al. Jun 2008 A1
20080140115 Stopek Jun 2008 A1
20080140159 Bornhoft et al. Jun 2008 A1
20080154299 Livneh Jun 2008 A1
20080154335 Thrope et al. Jun 2008 A1
20080169328 Shelton Jul 2008 A1
20080169332 Shelton et al. Jul 2008 A1
20080169333 Shelton et al. Jul 2008 A1
20080172087 Fuchs et al. Jul 2008 A1
20080183193 Omori et al. Jul 2008 A1
20080190989 Crews et al. Aug 2008 A1
20080196419 Dube Aug 2008 A1
20080197167 Viola et al. Aug 2008 A1
20080200755 Bakos Aug 2008 A1
20080200762 Stokes et al. Aug 2008 A1
20080200835 Monson et al. Aug 2008 A1
20080200911 Long Aug 2008 A1
20080200933 Bakos et al. Aug 2008 A1
20080200934 Fox Aug 2008 A1
20080234709 Houser Sep 2008 A1
20080242939 Johnston Oct 2008 A1
20080249536 Stahler et al. Oct 2008 A1
20080249608 Dave Oct 2008 A1
20080255413 Zemlok et al. Oct 2008 A1
20080262654 Omori et al. Oct 2008 A1
20080269596 Revie et al. Oct 2008 A1
20080281171 Fennell et al. Nov 2008 A1
20080287944 Pearson et al. Nov 2008 A1
20080293910 Kapiamba et al. Nov 2008 A1
20080294179 Balbierz et al. Nov 2008 A1
20080296346 Shelton, IV et al. Dec 2008 A1
20080297287 Shachar et al. Dec 2008 A1
20080308602 Timm et al. Dec 2008 A1
20080308603 Shelton et al. Dec 2008 A1
20080312687 Blier Dec 2008 A1
20080315829 Jones et al. Dec 2008 A1
20090001121 Hess et al. Jan 2009 A1
20090001130 Hess et al. Jan 2009 A1
20090004455 Gravagna et al. Jan 2009 A1
20090005809 Hess et al. Jan 2009 A1
20090012534 Madhani et al. Jan 2009 A1
20090015195 Loth-Krausser Jan 2009 A1
20090020958 Soul Jan 2009 A1
20090048583 Williams et al. Feb 2009 A1
20090048589 Takashino et al. Feb 2009 A1
20090076506 Baker Mar 2009 A1
20090078736 Van Lue Mar 2009 A1
20090081313 Aghion et al. Mar 2009 A1
20090088659 Graham et al. Apr 2009 A1
20090090763 Zemlok et al. Apr 2009 A1
20090092651 Shah et al. Apr 2009 A1
20090099579 Nentwick et al. Apr 2009 A1
20090099876 Whitman Apr 2009 A1
20090119011 Kondo et al. May 2009 A1
20090143855 Weber et al. Jun 2009 A1
20090149871 Kagan et al. Jun 2009 A9
20090171147 Lee et al. Jul 2009 A1
20090177226 Reinprecht et al. Jul 2009 A1
20090181290 Baldwin et al. Jul 2009 A1
20090188964 Orlov Jul 2009 A1
20090198272 Kerver et al. Aug 2009 A1
20090204108 Steffen Aug 2009 A1
20090204109 Grove et al. Aug 2009 A1
20090206125 Huitema et al. Aug 2009 A1
20090206126 Huitema et al. Aug 2009 A1
20090206131 Weisenburgh, II et al. Aug 2009 A1
20090206133 Morgan et al. Aug 2009 A1
20090206137 Hall et al. Aug 2009 A1
20090206139 Hall et al. Aug 2009 A1
20090206141 Huitema et al. Aug 2009 A1
20090206142 Huitema et al. Aug 2009 A1
20090221993 Sohi et al. Sep 2009 A1
20090234273 Intoccia et al. Sep 2009 A1
20090242610 Shelton, IV et al. Oct 2009 A1
20090247368 Chiang Oct 2009 A1
20090247901 Zimmer Oct 2009 A1
20090248041 Williams et al. Oct 2009 A1
20090253959 Yoshie et al. Oct 2009 A1
20090255974 Viola Oct 2009 A1
20090262078 Pizzi Oct 2009 A1
20090270895 Churchill et al. Oct 2009 A1
20090290016 Suda Nov 2009 A1
20090292283 Odom Nov 2009 A1
20090306639 Nevo et al. Dec 2009 A1
20090308907 Nalagatla et al. Dec 2009 A1
20100012703 Calabrese Jan 2010 A1
20100016888 Calabrese Jan 2010 A1
20100023024 Zeiner et al. Jan 2010 A1
20100030233 Whitman et al. Feb 2010 A1
20100036370 Mirel et al. Feb 2010 A1
20100065604 Weng Mar 2010 A1
20100069942 Shelton, IV Mar 2010 A1
20100076483 Imuta Mar 2010 A1
20100076489 Stopek et al. Mar 2010 A1
20100081883 Murray et al. Apr 2010 A1
20100087840 Ebersole Apr 2010 A1
20100094340 Stopek et al. Apr 2010 A1
20100100124 Calabrese et al. Apr 2010 A1
20100116519 Gareis May 2010 A1
20100122339 Boccacci May 2010 A1
20100133317 Shelton, IV et al. Jun 2010 A1
20100145146 Melder Jun 2010 A1
20100147921 Olson Jun 2010 A1
20100147922 Olson Jun 2010 A1
20100179022 Shirokoshi Jul 2010 A1
20100180711 Kilibarda et al. Jul 2010 A1
20100191262 Harris et al. Jul 2010 A1
20100191292 DeMeo et al. Jul 2010 A1
20100193566 Scheib et al. Aug 2010 A1
20100204717 Knodel Aug 2010 A1
20100222901 Swayze et al. Sep 2010 A1
20100241137 Doyle et al. Sep 2010 A1
20100249497 Peine et al. Sep 2010 A1
20100256675 Romans Oct 2010 A1
20100258327 Esenwein et al. Oct 2010 A1
20100267662 Fielder et al. Oct 2010 A1
20100274160 Yachi et al. Oct 2010 A1
20100292540 Hess et al. Nov 2010 A1
20100298636 Castro et al. Nov 2010 A1
20100312261 Suzuki et al. Dec 2010 A1
20100318085 Austin et al. Dec 2010 A1
20100331856 Carlson et al. Dec 2010 A1
20110006101 Hall et al. Jan 2011 A1
20110011916 Levine Jan 2011 A1
20110016960 Debrailly Jan 2011 A1
20110021871 Berkelaar Jan 2011 A1
20110022032 Zemlok et al. Jan 2011 A1
20110024477 Hall Feb 2011 A1
20110024478 Shelton, IV Feb 2011 A1
20110025311 Chauvin et al. Feb 2011 A1
20110034910 Ross et al. Feb 2011 A1
20110036891 Zemlok et al. Feb 2011 A1
20110046667 Culligan et al. Feb 2011 A1
20110060363 Hess et al. Mar 2011 A1
20110066156 McGahan et al. Mar 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087276 Bedi et al. Apr 2011 A1
20110087278 Viola et al. Apr 2011 A1
20110088921 Forgues et al. Apr 2011 A1
20110095064 Taylor et al. Apr 2011 A1
20110101069 Bombard et al. May 2011 A1
20110101794 Schroeder et al. May 2011 A1
20110112517 Peine et al. May 2011 A1
20110112530 Keller May 2011 A1
20110114697 Baxter, III et al. May 2011 A1
20110121049 Malinouskas et al. May 2011 A1
20110125176 Yates et al. May 2011 A1
20110127945 Yoneda Jun 2011 A1
20110129706 Takahashi et al. Jun 2011 A1
20110144764 Bagga et al. Jun 2011 A1
20110147433 Shelton, IV et al. Jun 2011 A1
20110163146 Ortiz et al. Jul 2011 A1
20110172495 Armstrong Jul 2011 A1
20110174861 Shelton, IV et al. Jul 2011 A1
20110192882 Hess et al. Aug 2011 A1
20110199225 Touchberry et al. Aug 2011 A1
20110218400 Ma et al. Sep 2011 A1
20110218550 Ma Sep 2011 A1
20110230713 Kleemann et al. Sep 2011 A1
20110238044 Main et al. Sep 2011 A1
20110241597 Zhu et al. Oct 2011 A1
20110275901 Shelton, IV Nov 2011 A1
20110276083 Shelton, IV et al. Nov 2011 A1
20110278343 Knodel et al. Nov 2011 A1
20110279268 Konishi et al. Nov 2011 A1
20110290856 Shelton, IV et al. Dec 2011 A1
20110293690 Griffin et al. Dec 2011 A1
20110295295 Shelton, IV et al. Dec 2011 A1
20110313894 Dye et al. Dec 2011 A1
20110315413 Fisher et al. Dec 2011 A1
20120004636 Lo Jan 2012 A1
20120016239 Barthe et al. Jan 2012 A1
20120016413 Timm et al. Jan 2012 A1
20120016467 Chen et al. Jan 2012 A1
20120029272 Shelton, IV et al. Feb 2012 A1
20120033360 Hsu Feb 2012 A1
20120059286 Hastings et al. Mar 2012 A1
20120064483 Lint et al. Mar 2012 A1
20120074200 Schmid et al. Mar 2012 A1
20120078071 Bohm et al. Mar 2012 A1
20120078139 Aldridge et al. Mar 2012 A1
20120078244 Worrell et al. Mar 2012 A1
20120080336 Shelton, IV et al. Apr 2012 A1
20120080344 Shelton, IV Apr 2012 A1
20120080478 Morgan et al. Apr 2012 A1
20120080498 Shelton, IV et al. Apr 2012 A1
20120086276 Sawyers Apr 2012 A1
20120095458 Cybulski et al. Apr 2012 A1
20120109186 Parrott et al. May 2012 A1
20120116261 Mumaw et al. May 2012 A1
20120116262 Houser et al. May 2012 A1
20120116265 Houser et al. May 2012 A1
20120116266 Houser et al. May 2012 A1
20120118595 Pellenc May 2012 A1
20120123203 Riva May 2012 A1
20120125792 Cassivi May 2012 A1
20120132286 Lim et al. May 2012 A1
20120171539 Rejman et al. Jul 2012 A1
20120175398 Sandborn et al. Jul 2012 A1
20120197272 Oray et al. Aug 2012 A1
20120211542 Racenet Aug 2012 A1
20120223121 Viola et al. Sep 2012 A1
20120234895 O'Connor et al. Sep 2012 A1
20120234897 Shelton, IV et al. Sep 2012 A1
20120239068 Morris et al. Sep 2012 A1
20120241505 Alexander, III Sep 2012 A1
20120248169 Widenhouse et al. Oct 2012 A1
20120251861 Liang et al. Oct 2012 A1
20120253328 Cunningham et al. Oct 2012 A1
20120283707 Giordano et al. Nov 2012 A1
20120289979 Eskaros et al. Nov 2012 A1
20120292367 Morgan et al. Nov 2012 A1
20120298722 Hess et al. Nov 2012 A1
20120303002 Chowaniec et al. Nov 2012 A1
20130006227 Takashino Jan 2013 A1
20130012983 Kleyman Jan 2013 A1
20130018400 Milton et al. Jan 2013 A1
20130020375 Shelton, IV et al. Jan 2013 A1
20130020376 Shelton, IV et al. Jan 2013 A1
20130023861 Shelton, IV et al. Jan 2013 A1
20130023910 Solomon et al. Jan 2013 A1
20130026208 Shelton, IV et al. Jan 2013 A1
20130026210 Shelton, IV et al. Jan 2013 A1
20130030462 Keating et al. Jan 2013 A1
20130057162 Pollischansky Mar 2013 A1
20130068816 Mandakolathur Vasudevan et al. Mar 2013 A1
20130087597 Shelton, IV et al. Apr 2013 A1
20130090534 Burns et al. Apr 2013 A1
20130096568 Justis Apr 2013 A1
20130098970 Racenet et al. Apr 2013 A1
20130105550 Zemlok et al. May 2013 A1
20130105552 Weir et al. May 2013 A1
20130116669 Shelton, IV et al. May 2013 A1
20130123816 Hodgkinson et al. May 2013 A1
20130126202 Oomori et al. May 2013 A1
20130131476 Siu et al. May 2013 A1
20130131651 Strobl et al. May 2013 A1
20130136969 Yasui et al. May 2013 A1
20130153636 Shelton, IV et al. Jun 2013 A1
20130153641 Shelton, IV et al. Jun 2013 A1
20130158390 Tan et al. Jun 2013 A1
20130162198 Yokota et al. Jun 2013 A1
20130172878 Smith Jul 2013 A1
20130175317 Yates et al. Jul 2013 A1
20130181033 Shelton, IV et al. Jul 2013 A1
20130181034 Shelton, IV et al. Jul 2013 A1
20130214025 Zemlok et al. Aug 2013 A1
20130214030 Aronhalt et al. Aug 2013 A1
20130233906 Hess et al. Sep 2013 A1
20130238021 Gross et al. Sep 2013 A1
20130248578 Arteaga Gonzalez Sep 2013 A1
20130253480 Kimball et al. Sep 2013 A1
20130256373 Schmid et al. Oct 2013 A1
20130256379 Schmid et al. Oct 2013 A1
20130256380 Schmid et al. Oct 2013 A1
20130270322 Scheib et al. Oct 2013 A1
20130277410 Fernandez et al. Oct 2013 A1
20130296908 Schulte et al. Nov 2013 A1
20130317753 Kamen et al. Nov 2013 A1
20130324981 Smith et al. Dec 2013 A1
20130324982 Smith et al. Dec 2013 A1
20130327552 Lovelass et al. Dec 2013 A1
20130333910 Tanimoto et al. Dec 2013 A1
20130334280 Krehel et al. Dec 2013 A1
20130334283 Swayze et al. Dec 2013 A1
20130334284 Swayze et al. Dec 2013 A1
20130334285 Swayze et al. Dec 2013 A1
20130341374 Shelton, IV et al. Dec 2013 A1
20140001231 Shelton, IV et al. Jan 2014 A1
20140001234 Shelton, IV et al. Jan 2014 A1
20140005640 Shelton, IV et al. Jan 2014 A1
20140005678 Shelton, IV et al. Jan 2014 A1
20140005702 Timm et al. Jan 2014 A1
20140005718 Shelton, IV et al. Jan 2014 A1
20140012289 Snow et al. Jan 2014 A1
20140012299 Stoddard et al. Jan 2014 A1
20140014705 Baxter, III Jan 2014 A1
20140018832 Shelton, IV Jan 2014 A1
20140039549 Belsky et al. Feb 2014 A1
20140048580 Merchant et al. Feb 2014 A1
20140081176 Hassan Mar 2014 A1
20140100558 Schmitz et al. Apr 2014 A1
20140107640 Yates et al. Apr 2014 A1
20140110456 Taylor Apr 2014 A1
20140114327 Boudreaux et al. Apr 2014 A1
20140115229 Kothamasu et al. Apr 2014 A1
20140131418 Kostrzewski May 2014 A1
20140151433 Shelton, IV et al. Jun 2014 A1
20140158747 Measamer et al. Jun 2014 A1
20140166724 Schellin et al. Jun 2014 A1
20140166725 Schellin et al. Jun 2014 A1
20140166726 Schellin et al. Jun 2014 A1
20140171966 Giordano et al. Jun 2014 A1
20140175147 Manoux et al. Jun 2014 A1
20140175150 Shelton, IV et al. Jun 2014 A1
20140175152 Hess et al. Jun 2014 A1
20140188159 Steege Jul 2014 A1
20140200561 Ingmanson et al. Jul 2014 A1
20140207124 Aldridge et al. Jul 2014 A1
20140207125 Applegate et al. Jul 2014 A1
20140224857 Schmid Aug 2014 A1
20140228867 Thomas et al. Aug 2014 A1
20140230595 Butt et al. Aug 2014 A1
20140243865 Swayze et al. Aug 2014 A1
20140246475 Hall et al. Sep 2014 A1
20140248167 Sugimoto et al. Sep 2014 A1
20140249557 Koch, Jr. et al. Sep 2014 A1
20140249573 Arav Sep 2014 A1
20140263541 Leimbach et al. Sep 2014 A1
20140263552 Hall et al. Sep 2014 A1
20140263554 Leimbach et al. Sep 2014 A1
20140263558 Hausen et al. Sep 2014 A1
20140276730 Boudreaux et al. Sep 2014 A1
20140284371 Morgan et al. Sep 2014 A1
20140288460 Ouyang et al. Sep 2014 A1
20140291378 Shelton, IV et al. Oct 2014 A1
20140291379 Schellin et al. Oct 2014 A1
20140291383 Spivey et al. Oct 2014 A1
20140299648 Shelton, IV et al. Oct 2014 A1
20140303645 Morgan et al. Oct 2014 A1
20140303660 Boyden et al. Oct 2014 A1
20140309666 Shelton, IV et al. Oct 2014 A1
20140330161 Swayze et al. Nov 2014 A1
20140367445 Ingmanson et al. Dec 2014 A1
20140374130 Nakamura et al. Dec 2014 A1
20140378950 Chiu Dec 2014 A1
20150002089 Rejman et al. Jan 2015 A1
20150008248 Giordano et al. Jan 2015 A1
20150053737 Leimbach et al. Feb 2015 A1
20150053742 Shelton, IV et al. Feb 2015 A1
20150053743 Yates et al. Feb 2015 A1
20150053746 Shelton, IV et al. Feb 2015 A1
20150053748 Yates et al. Feb 2015 A1
20150060518 Shelton, IV et al. Mar 2015 A1
20150060519 Shelton, IV et al. Mar 2015 A1
20150060520 Shelton, IV et al. Mar 2015 A1
20150060521 Weisenburgh, II et al. Mar 2015 A1
20150066000 An et al. Mar 2015 A1
20150073357 Bagwell et al. Mar 2015 A1
20150076207 Boudreaux et al. Mar 2015 A1
20150076208 Shelton, IV Mar 2015 A1
20150076209 Shelton, IV et al. Mar 2015 A1
20150076210 Shelton, IV et al. Mar 2015 A1
20150076212 Shelton, IV Mar 2015 A1
20150080868 Kerr Mar 2015 A1
20150083781 Giordano et al. Mar 2015 A1
20150083782 Scheib et al. Mar 2015 A1
20150090760 Giordano et al. Apr 2015 A1
20150090761 Giordano et al. Apr 2015 A1
20150090762 Giordano et al. Apr 2015 A1
20150090763 Murray et al. Apr 2015 A1
20150108199 Shelton, IV et al. Apr 2015 A1
20150122870 Zemlok et al. May 2015 A1
20150134077 Shelton, IV et al. May 2015 A1
20150148830 Stulen et al. May 2015 A1
20150150554 Soltz Jun 2015 A1
20150150620 Miyamoto et al. Jun 2015 A1
20150173744 Shelton, IV et al. Jun 2015 A1
20150173749 Shelton, IV et al. Jun 2015 A1
20150173756 Baxter, III et al. Jun 2015 A1
20150173789 Baxter, III et al. Jun 2015 A1
20150182220 Yates et al. Jul 2015 A1
20150196295 Shelton, IV et al. Jul 2015 A1
20150196296 Swayze et al. Jul 2015 A1
20150196299 Swayze et al. Jul 2015 A1
20150196347 Yates et al. Jul 2015 A1
20150196348 Yates et al. Jul 2015 A1
20150201932 Swayze et al. Jul 2015 A1
20150201936 Swayze et al. Jul 2015 A1
20150201937 Swayze et al. Jul 2015 A1
20150201938 Swayze et al. Jul 2015 A1
20150201939 Swayze et al. Jul 2015 A1
20150201940 Swayze et al. Jul 2015 A1
20150201941 Swayze et al. Jul 2015 A1
20150222212 Iwata Aug 2015 A1
20150231409 Racenet et al. Aug 2015 A1
20150238118 Legassey et al. Aug 2015 A1
20150245835 Racenet et al. Sep 2015 A1
20150272557 Overmyer et al. Oct 2015 A1
20150272571 Leimbach et al. Oct 2015 A1
20150272580 Leimbach et al. Oct 2015 A1
20150272582 Leimbach et al. Oct 2015 A1
20150272604 Chowaniec et al. Oct 2015 A1
20150280384 Leimbach et al. Oct 2015 A1
20150282810 Shelton, IV et al. Oct 2015 A1
20150289873 Shelton, IV et al. Oct 2015 A1
20150289874 Leimbach et al. Oct 2015 A1
20150297200 Fitzsimmons et al. Oct 2015 A1
20150297222 Huitema et al. Oct 2015 A1
20150297223 Huitema et al. Oct 2015 A1
20150297225 Huitema et al. Oct 2015 A1
20150297228 Huitema et al. Oct 2015 A1
20150297229 Schellin et al. Oct 2015 A1
20150297232 Huitema et al. Oct 2015 A1
20150297233 Huitema et al. Oct 2015 A1
20150297234 Schellin et al. Oct 2015 A1
20150297235 Harris et al. Oct 2015 A1
20150297236 Harris et al. Oct 2015 A1
20150303417 Koeder et al. Oct 2015 A1
20150313594 Shelton, IV et al. Nov 2015 A1
20150316431 Collins et al. Nov 2015 A1
20150324317 Collins et al. Nov 2015 A1
20150327864 Hodgkinson et al. Nov 2015 A1
20150335328 Shelton, IV et al. Nov 2015 A1
20150336249 Iwata et al. Nov 2015 A1
20150342607 Shelton, IV et al. Dec 2015 A1
20150351758 Shelton, IV et al. Dec 2015 A1
20150351762 Vendely et al. Dec 2015 A1
20150351765 Valentine et al. Dec 2015 A1
20150352699 Sakai et al. Dec 2015 A1
20150366220 Zhang et al. Dec 2015 A1
20150372265 Morisaku et al. Dec 2015 A1
20150374360 Scheib et al. Dec 2015 A1
20150374361 Gettinger et al. Dec 2015 A1
20150374363 Laurent, IV et al. Dec 2015 A1
20150374368 Swayze et al. Dec 2015 A1
20150374369 Yates et al. Dec 2015 A1
20150374371 Richard et al. Dec 2015 A1
20150374372 Zergiebel et al. Dec 2015 A1
20150374374 Shelton, IV et al. Dec 2015 A1
20150374375 Shelton, IV et al. Dec 2015 A1
20150374376 Shelton, IV Dec 2015 A1
20150374377 Shelton, IV Dec 2015 A1
20150374378 Giordano et al. Dec 2015 A1
20150374379 Shelton, IV Dec 2015 A1
20150380187 Zergiebel et al. Dec 2015 A1
20160000430 Ming et al. Jan 2016 A1
20160000431 Giordano et al. Jan 2016 A1
20160000437 Giordano et al. Jan 2016 A1
20160000438 Swayze et al. Jan 2016 A1
20160000442 Shelton, IV Jan 2016 A1
20160000452 Yates et al. Jan 2016 A1
20160000453 Yates et al. Jan 2016 A1
20160000513 Shelton, IV et al. Jan 2016 A1
20160007992 Yates et al. Jan 2016 A1
20160008023 Yates et al. Jan 2016 A1
20160015391 Shelton, IV et al. Jan 2016 A1
20160023342 Koenig et al. Jan 2016 A1
20160030042 Heinrich et al. Feb 2016 A1
20160051257 Shelton, IV et al. Feb 2016 A1
20160058443 Yates et al. Mar 2016 A1
20160066913 Swayze et al. Mar 2016 A1
20160069449 Kanai et al. Mar 2016 A1
20160073909 Zand et al. Mar 2016 A1
20160074040 Widenhouse et al. Mar 2016 A1
20160082161 Zilberman et al. Mar 2016 A1
20160089137 Hess et al. Mar 2016 A1
20160089142 Harris et al. Mar 2016 A1
20160089146 Harris et al. Mar 2016 A1
20160089147 Harris et al. Mar 2016 A1
20160089149 Harris et al. Mar 2016 A1
20160089198 Arya et al. Mar 2016 A1
20160095585 Zergiebel et al. Apr 2016 A1
20160106431 Shelton, IV et al. Apr 2016 A1
20160113653 Zingman Apr 2016 A1
20160120544 Shelton, IV et al. May 2016 A1
20160120545 Shelton, IV et al. May 2016 A1
20160166248 Deville et al. Jun 2016 A1
20160166256 Baxter, III et al. Jun 2016 A1
20160166308 Manwaring et al. Jun 2016 A1
20160174969 Kerr et al. Jun 2016 A1
20160174972 Shelton, IV et al. Jun 2016 A1
20160174974 Schmid et al. Jun 2016 A1
20160174985 Baxter, III et al. Jun 2016 A1
20160183939 Shelton, IV et al. Jun 2016 A1
20160183943 Shelton, IV Jun 2016 A1
20160183944 Swensgard et al. Jun 2016 A1
20160183945 Shelton, IV et al. Jun 2016 A1
20160192916 Shelton, IV et al. Jul 2016 A1
20160192917 Shelton, IV et al. Jul 2016 A1
20160192918 Shelton, IV et al. Jul 2016 A1
20160192933 Shelton, IV Jul 2016 A1
20160192936 Leimbach et al. Jul 2016 A1
20160192977 Manwaring et al. Jul 2016 A1
20160192996 Spivey et al. Jul 2016 A1
20160199059 Shelton, IV et al. Jul 2016 A1
20160199061 Shelton, IV et al. Jul 2016 A1
20160199063 Mandakolathur Vasudevan et al. Jul 2016 A1
20160199064 Shelton, IV et al. Jul 2016 A1
20160199089 Hess et al. Jul 2016 A1
20160199956 Shelton, IV et al. Jul 2016 A1
20160206310 Shelton, IV Jul 2016 A1
20160206314 Scheib et al. Jul 2016 A1
20160220248 Timm et al. Aug 2016 A1
20160220249 Shelton, IV et al. Aug 2016 A1
20160220266 Shelton, IV et al. Aug 2016 A1
20160220268 Shelton, IV et al. Aug 2016 A1
20160235403 Shelton, IV et al. Aug 2016 A1
20160235404 Shelton, IV Aug 2016 A1
20160235405 Shelton, IV et al. Aug 2016 A1
20160235406 Shelton, IV et al. Aug 2016 A1
20160235408 Shelton, IV et al. Aug 2016 A1
20160235409 Shelton, IV et al. Aug 2016 A1
20160235494 Shelton, IV et al. Aug 2016 A1
20160242775 Shelton, IV et al. Aug 2016 A1
20160242776 Shelton, IV et al. Aug 2016 A1
20160242777 Shelton, IV et al. Aug 2016 A1
20160242781 Shelton, IV et al. Aug 2016 A1
20160242782 Shelton, IV et al. Aug 2016 A1
20160242783 Shelton, IV et al. Aug 2016 A1
20160249909 Shelton, IV et al. Sep 2016 A1
20160249910 Shelton, IV et al. Sep 2016 A1
20160249911 Timm et al. Sep 2016 A1
20160249915 Beckman et al. Sep 2016 A1
20160249916 Shelton, IV et al. Sep 2016 A1
20160249917 Beckman et al. Sep 2016 A1
20160249918 Shelton, IV et al. Sep 2016 A1
20160249922 Morgan et al. Sep 2016 A1
20160249927 Beckman et al. Sep 2016 A1
20160256071 Shelton, IV et al. Sep 2016 A1
20160256154 Shelton, IV et al. Sep 2016 A1
20160256156 Shelton, IV et al. Sep 2016 A1
20160256159 Pinjala et al. Sep 2016 A1
20160256160 Shelton, IV et al. Sep 2016 A1
20160256161 Overmyer et al. Sep 2016 A1
20160256185 Shelton, IV et al. Sep 2016 A1
20160256229 Morgan et al. Sep 2016 A1
20160262745 Morgan et al. Sep 2016 A1
20160262746 Shelton, IV et al. Sep 2016 A1
20160270780 Hall et al. Sep 2016 A1
20160278765 Shelton, IV et al. Sep 2016 A1
20160278775 Shelton, IV et al. Sep 2016 A1
20160287250 Shelton, IV et al. Oct 2016 A1
20160287251 Shelton, IV et al. Oct 2016 A1
20160287253 Shelton, IV et al. Oct 2016 A1
20160310143 Bettuchi Oct 2016 A1
20160331375 Shelton, IV et al. Nov 2016 A1
20160345976 Gonzalez et al. Dec 2016 A1
20160346034 Arya et al. Dec 2016 A1
20160354085 Shelton, IV et al. Dec 2016 A1
20160367122 Ichimura et al. Dec 2016 A1
20160367245 Wise et al. Dec 2016 A1
20160367246 Baxter, III et al. Dec 2016 A1
20160367254 Baxter, III et al. Dec 2016 A1
20160367255 Wise et al. Dec 2016 A1
20160367256 Hensel et al. Dec 2016 A1
20160374672 Bear et al. Dec 2016 A1
20160374675 Shelton, IV et al. Dec 2016 A1
20170000485 Shelton, IV et al. Jan 2017 A1
20170007236 Shelton, IV et al. Jan 2017 A1
20170007237 Yates et al. Jan 2017 A1
20170007238 Yates et al. Jan 2017 A1
20170007239 Shelton, IV Jan 2017 A1
20170007241 Shelton, IV et al. Jan 2017 A1
20170007242 Shelton, IV et al. Jan 2017 A1
20170007243 Shelton, IV et al. Jan 2017 A1
20170007244 Shelton, IV et al. Jan 2017 A1
20170007245 Shelton, IV et al. Jan 2017 A1
20170007246 Shelton, IV et al. Jan 2017 A1
20170007247 Shelton, IV et al. Jan 2017 A1
20170007248 Shelton, IV et al. Jan 2017 A1
20170007249 Shelton, IV et al. Jan 2017 A1
20170007250 Shelton, IV et al. Jan 2017 A1
20170007251 Yates et al. Jan 2017 A1
20170007254 Jaworek et al. Jan 2017 A1
20170007255 Jaworek et al. Jan 2017 A1
20170007341 Swensgard et al. Jan 2017 A1
20170007347 Jaworek et al. Jan 2017 A1
20170014125 Shelton, IV et al. Jan 2017 A1
20170027571 Nalagatla et al. Feb 2017 A1
20170027572 Nalagatla et al. Feb 2017 A1
20170027573 Nalagatla et al. Feb 2017 A1
20170027574 Nalagatla et al. Feb 2017 A1
20170049444 Schellin et al. Feb 2017 A1
20170049447 Barton et al. Feb 2017 A1
20170049448 Widenhouse et al. Feb 2017 A1
20170055986 Harris et al. Mar 2017 A1
20170055989 Shelton, IV et al. Mar 2017 A1
20170055997 Swayze et al. Mar 2017 A1
20170055998 Baxter, III et al. Mar 2017 A1
20170055999 Baxter, III et al. Mar 2017 A1
20170056000 Nalagatla et al. Mar 2017 A1
20170056001 Shelton, IV et al. Mar 2017 A1
20170056002 Nalagatla et al. Mar 2017 A1
20170056004 Shelton, IV et al. Mar 2017 A1
20170056005 Shelton, IV et al. Mar 2017 A1
20170056006 Shelton, IV et al. Mar 2017 A1
20170056007 Eckert et al. Mar 2017 A1
20170079640 Overmyer et al. Mar 2017 A1
20170079642 Overmyer et al. Mar 2017 A1
20170079643 Yates et al. Mar 2017 A1
20170079644 Overmyer et al. Mar 2017 A1
20170086823 Leimbach et al. Mar 2017 A1
20170086827 Vendely et al. Mar 2017 A1
20170086829 Vendely et al. Mar 2017 A1
20170086830 Yates et al. Mar 2017 A1
20170086831 Shelton, IV et al. Mar 2017 A1
20170086832 Harris et al. Mar 2017 A1
20170086835 Harris et al. Mar 2017 A1
20170086836 Harris et al. Mar 2017 A1
20170086837 Vendely et al. Mar 2017 A1
20170086838 Harris et al. Mar 2017 A1
20170086839 Vendely et al. Mar 2017 A1
20170086840 Harris et al. Mar 2017 A1
20170086841 Vendely et al. Mar 2017 A1
20170086842 Shelton, IV et al. Mar 2017 A1
20170086843 Vendely et al. Mar 2017 A1
20170086844 Vendely et al. Mar 2017 A1
20170086845 Vendely et al. Mar 2017 A1
20170086936 Shelton, IV et al. Mar 2017 A1
20170095250 Kostrzewski et al. Apr 2017 A1
20170119386 Scheib et al. May 2017 A1
20170119387 Dalessandro et al. May 2017 A1
20170119389 Turner et al. May 2017 A1
20170119390 Schellin et al. May 2017 A1
20170119392 Shelton, IV et al. May 2017 A1
20170119397 Harris et al. May 2017 A1
20170128149 Heinrich et al. May 2017 A1
20170135695 Shelton, IV et al. May 2017 A1
20170135697 Mozdzierz et al. May 2017 A1
20170150983 Ingmanson et al. Jun 2017 A1
20170172672 Bailey et al. Jun 2017 A1
20170182211 Raxworthy et al. Jun 2017 A1
20170189018 Harris et al. Jul 2017 A1
20170189019 Harris et al. Jul 2017 A1
20170189020 Harris et al. Jul 2017 A1
20170196558 Morgan et al. Jul 2017 A1
20170196560 Leimbach et al. Jul 2017 A1
20170196561 Shelton, IV et al. Jul 2017 A1
20170196562 Shelton, IV et al. Jul 2017 A1
20170196637 Shelton, IV et al. Jul 2017 A1
20170196649 Yates et al. Jul 2017 A1
20170202596 Shelton, IV et al. Jul 2017 A1
20170209145 Swayze et al. Jul 2017 A1
20170209146 Yates et al. Jul 2017 A1
20170209226 Overmyer et al. Jul 2017 A1
20170215881 Shelton, IV et al. Aug 2017 A1
20170224330 Worthington et al. Aug 2017 A1
20170224331 Worthington et al. Aug 2017 A1
20170224332 Hunter et al. Aug 2017 A1
20170224333 Hunter et al. Aug 2017 A1
20170224334 Worthington et al. Aug 2017 A1
20170224335 Weaner et al. Aug 2017 A1
20170224336 Hunter et al. Aug 2017 A1
20170224339 Huang et al. Aug 2017 A1
20170224342 Worthington et al. Aug 2017 A1
20170224343 Baxter, III et al. Aug 2017 A1
20170231623 Shelton, IV et al. Aug 2017 A1
20170231626 Shelton, IV et al. Aug 2017 A1
20170231627 Shelton, IV et al. Aug 2017 A1
20170231628 Shelton, IV et al. Aug 2017 A1
20170238928 Morgan et al. Aug 2017 A1
20170238929 Yates et al. Aug 2017 A1
20170245952 Shelton, IV et al. Aug 2017 A1
20170245953 Shelton, IV et al. Aug 2017 A1
20170249431 Shelton, IV et al. Aug 2017 A1
20170258469 Shelton, IV et al. Sep 2017 A1
20170265856 Shelton, IV et al. Sep 2017 A1
20170281155 Shelton, IV et al. Oct 2017 A1
20170281161 Shelton, IV et al. Oct 2017 A1
20170281162 Shelton, IV et al. Oct 2017 A1
20170281163 Shelton, IV et al. Oct 2017 A1
20170281164 Harris et al. Oct 2017 A1
20170281165 Harris et al. Oct 2017 A1
20170281166 Morgan et al. Oct 2017 A1
20170281167 Shelton, IV et al. Oct 2017 A1
20170281168 Shelton, IV et al. Oct 2017 A1
20170281169 Harris et al. Oct 2017 A1
20170281170 Shelton, IV et al. Oct 2017 A1
20170281171 Shelton, IV et al. Oct 2017 A1
20170281172 Shelton, IV et al. Oct 2017 A1
20170281173 Shelton, IV et al. Oct 2017 A1
20170281174 Harris et al. Oct 2017 A1
20170281177 Harris et al. Oct 2017 A1
20170281178 Shelton, IV et al. Oct 2017 A1
20170281179 Shelton, IV et al. Oct 2017 A1
20170281180 Morgan et al. Oct 2017 A1
20170281183 Miller et al. Oct 2017 A1
20170281184 Shelton, IV et al. Oct 2017 A1
20170281185 Miller et al. Oct 2017 A1
20170281186 Shelton, IV et al. Oct 2017 A1
20170281187 Shelton, IV et al. Oct 2017 A1
20170281188 Shelton, IV et al. Oct 2017 A1
20170281189 Nalagatla et al. Oct 2017 A1
20170290585 Shelton, IV et al. Oct 2017 A1
20170296169 Yates et al. Oct 2017 A1
20170296170 Shelton, IV et al. Oct 2017 A1
20170296171 Shelton, IV et al. Oct 2017 A1
20170296172 Harris et al. Oct 2017 A1
20170296173 Shelton, IV et al. Oct 2017 A1
20170296177 Harris et al. Oct 2017 A1
20170296178 Miller et al. Oct 2017 A1
20170296179 Shelton, IV et al. Oct 2017 A1
20170296180 Harris et al. Oct 2017 A1
20170296183 Shelton, IV et al. Oct 2017 A1
20170296184 Harris et al. Oct 2017 A1
20170296185 Swensgard et al. Oct 2017 A1
20170296189 Vendely et al. Oct 2017 A1
20170296190 Aronhalt et al. Oct 2017 A1
20170296191 Shelton, IV et al. Oct 2017 A1
20170296213 Swensgard et al. Oct 2017 A1
20170311944 Morgan et al. Nov 2017 A1
20170311949 Shelton, IV Nov 2017 A1
20170311950 Shelton, IV et al. Nov 2017 A1
20170312040 Giordano et al. Nov 2017 A1
20170312041 Giordano et al. Nov 2017 A1
20170312042 Giordano et al. Nov 2017 A1
20170319201 Morgan et al. Nov 2017 A1
20170319207 Shelton, IV et al. Nov 2017 A1
20170319209 Morgan et al. Nov 2017 A1
20170319777 Shelton, IV et al. Nov 2017 A1
20170325813 Aranyi et al. Nov 2017 A1
20170333034 Morgan et al. Nov 2017 A1
20170333035 Morgan et al. Nov 2017 A1
20170333070 Laurent et al. Nov 2017 A1
20170348043 Wang et al. Dec 2017 A1
20170354415 Casasanta, Jr. et al. Dec 2017 A1
20170360441 Sgroi Dec 2017 A1
20170360442 Shelton, IV et al. Dec 2017 A1
20170367700 Leimbach et al. Dec 2017 A1
20170367991 Widenhouse et al. Dec 2017 A1
20180000483 Leimbach et al. Jan 2018 A1
20180000545 Giordano et al. Jan 2018 A1
20180008269 Moore et al. Jan 2018 A1
20180008270 Moore et al. Jan 2018 A1
20180008271 Moore et al. Jan 2018 A1
20180008356 Giordano et al. Jan 2018 A1
20180008357 Giordano et al. Jan 2018 A1
20180028184 Shelton, IV et al. Feb 2018 A1
20180028185 Shelton, IV et al. Feb 2018 A1
20180042611 Swayze et al. Feb 2018 A1
20180049824 Harris et al. Feb 2018 A1
20180049883 Moskowitz et al. Feb 2018 A1
20180055510 Schmid et al. Mar 2018 A1
20180055513 Shelton, IV et al. Mar 2018 A1
20180055524 Shelton, IV et al. Mar 2018 A1
20180055525 Shelton, IV et al. Mar 2018 A1
20180055526 Shelton, IV et al. Mar 2018 A1
20180064437 Yates et al. Mar 2018 A1
20180064440 Shelton, IV et al. Mar 2018 A1
20180064441 Shelton, IV et al. Mar 2018 A1
20180064442 Shelton, IV et al. Mar 2018 A1
20180064443 Shelton, IV et al. Mar 2018 A1
20180070939 Giordano et al. Mar 2018 A1
20180070942 Shelton, IV et al. Mar 2018 A1
20180070946 Shelton, IV et al. Mar 2018 A1
20180078248 Swayze et al. Mar 2018 A1
20180085116 Yates et al. Mar 2018 A1
20180085117 Shelton, IV et al. Mar 2018 A1
20180085123 Shelton, IV et al. Mar 2018 A1
20180103952 Aronhalt et al. Apr 2018 A1
20180103953 Shelton, IV et al. Apr 2018 A1
20180103955 Shelton, IV et al. Apr 2018 A1
20180110516 Baxter, III et al. Apr 2018 A1
20180110518 Overmyer et al. Apr 2018 A1
20180110519 Lytle, IV et al. Apr 2018 A1
20180110520 Shelton, IV et al. Apr 2018 A1
20180110521 Shelton, IV et al. Apr 2018 A1
20180110522 Shelton, IV et al. Apr 2018 A1
20180110523 Shelton, IV Apr 2018 A1
20180110574 Shelton, IV et al. Apr 2018 A1
20180110575 Shelton, IV et al. Apr 2018 A1
20180116658 Aronhalt, IV et al. May 2018 A1
20180116662 Shelton, IV et al. May 2018 A1
20180116665 Hall et al. May 2018 A1
20180125481 Yates et al. May 2018 A1
20180125488 Morgan et al. May 2018 A1
20180125489 Leimbach et al. May 2018 A1
20180125590 Giordano et al. May 2018 A1
20180126504 Shelton, IV et al. May 2018 A1
20180132845 Schmid et al. May 2018 A1
20180132850 Leimbach et al. May 2018 A1
20180132851 Hall et al. May 2018 A1
20180132952 Spivey et al. May 2018 A1
20180133856 Shelton, IV et al. May 2018 A1
20180140299 Weaner et al. May 2018 A1
20180140368 Shelton, IV et al. May 2018 A1
20180146960 Shelton, IV et al. May 2018 A1
20180153542 Shelton, IV et al. Jun 2018 A1
20180161034 Scheib et al. Jun 2018 A1
20180168575 Simms et al. Jun 2018 A1
20180168576 Hunter et al. Jun 2018 A1
20180168577 Aronhalt et al. Jun 2018 A1
20180168578 Aronhalt et al. Jun 2018 A1
20180168579 Aronhalt et al. Jun 2018 A1
20180168580 Hunter et al. Jun 2018 A1
20180168581 Hunter et al. Jun 2018 A1
20180168582 Swayze et al. Jun 2018 A1
20180168583 Hunter et al. Jun 2018 A1
20180168584 Harris et al. Jun 2018 A1
20180168589 Swayze et al. Jun 2018 A1
20180168590 Overmyer et al. Jun 2018 A1
20180168591 Swayze et al. Jun 2018 A1
20180168592 Overmyer et al. Jun 2018 A1
20180168593 Overmyer et al. Jun 2018 A1
20180168594 Shelton, IV et al. Jun 2018 A1
20180168595 Overmyer et al. Jun 2018 A1
20180168596 Beckman et al. Jun 2018 A1
20180168597 Fanelli et al. Jun 2018 A1
20180168598 Shelton, IV et al. Jun 2018 A1
20180168599 Bakos et al. Jun 2018 A1
20180168600 Shelton, IV et al. Jun 2018 A1
20180168601 Bakos et al. Jun 2018 A1
20180168602 Bakos et al. Jun 2018 A1
20180168603 Morgan et al. Jun 2018 A1
20180168604 Shelton, IV et al. Jun 2018 A1
20180168605 Baber et al. Jun 2018 A1
20180168606 Shelton, IV et al. Jun 2018 A1
20180168607 Shelton, IV et al. Jun 2018 A1
20180168608 Shelton, IV et al. Jun 2018 A1
20180168609 Fanelli et al. Jun 2018 A1
20180168610 Shelton, IV et al. Jun 2018 A1
20180168611 Shelton, IV et al. Jun 2018 A1
20180168612 Shelton, IV et al. Jun 2018 A1
20180168613 Shelton, IV et al. Jun 2018 A1
20180168614 Shelton, IV et al. Jun 2018 A1
20180168615 Shelton, IV et al. Jun 2018 A1
20180168618 Scott et al. Jun 2018 A1
20180168619 Scott et al. Jun 2018 A1
20180168620 Huang et al. Jun 2018 A1
20180168621 Shelton, IV et al. Jun 2018 A1
20180168622 Shelton, IV et al. Jun 2018 A1
20180168623 Simms et al. Jun 2018 A1
20180168624 Shelton, IV et al. Jun 2018 A1
20180168625 Posada et al. Jun 2018 A1
20180168626 Shelton, IV et al. Jun 2018 A1
20180168627 Weaner et al. Jun 2018 A1
20180168628 Hunter et al. Jun 2018 A1
20180168629 Shelton, IV et al. Jun 2018 A1
20180168630 Shelton, IV et al. Jun 2018 A1
20180168631 Harris et al. Jun 2018 A1
20180168632 Harris et al. Jun 2018 A1
20180168633 Shelton, IV et al. Jun 2018 A1
20180168634 Harris et al. Jun 2018 A1
20180168635 Shelton, IV et al. Jun 2018 A1
20180168636 Shelton, IV et al. Jun 2018 A1
20180168637 Harris et al. Jun 2018 A1
20180168638 Harris et al. Jun 2018 A1
20180168639 Shelton, IV et al. Jun 2018 A1
20180168640 Shelton, IV et al. Jun 2018 A1
20180168641 Harris et al. Jun 2018 A1
20180168642 Shelton, IV et al. Jun 2018 A1
20180168644 Shelton, IV et al. Jun 2018 A1
20180168645 Shelton, IV et al. Jun 2018 A1
20180168646 Shelton, IV et al. Jun 2018 A1
20180168649 Shelton, IV et al. Jun 2018 A1
20180168651 Shelton, IV et al. Jun 2018 A1
20180199940 Zergiebel et al. Jul 2018 A1
20180206843 Yates et al. Jul 2018 A1
20180206906 Moua et al. Jul 2018 A1
20180214147 Merchant et al. Aug 2018 A1
20180221046 Demmy et al. Aug 2018 A1
20180221050 Kostrzewski et al. Aug 2018 A1
20180228490 Richard et al. Aug 2018 A1
20180250001 Aronhalt et al. Sep 2018 A1
20180256184 Shelton, IV et al. Sep 2018 A1
20180256185 Shelton, IV et al. Sep 2018 A1
20180271520 Shelton, IV et al. Sep 2018 A1
20180280020 Hess et al. Oct 2018 A1
20180280021 Timm et al. Oct 2018 A1
20180280022 Timm et al. Oct 2018 A1
20180280023 Timm et al. Oct 2018 A1
20180286274 Kamiguchi et al. Oct 2018 A1
20180289369 Shelton, IV et al. Oct 2018 A1
20180296211 Timm et al. Oct 2018 A1
20180296215 Baxter, III et al. Oct 2018 A1
20180296216 Shelton, IV et al. Oct 2018 A1
20180296217 Moore et al. Oct 2018 A1
20180303478 Yates et al. Oct 2018 A1
20180303481 Shelton, IV et al. Oct 2018 A1
20180303482 Shelton, IV et al. Oct 2018 A1
20180310931 Hall et al. Nov 2018 A1
20180311002 Giordano et al. Nov 2018 A1
20180317917 Huang et al. Nov 2018 A1
20180317918 Shelton, IV Nov 2018 A1
20180317919 Shelton, IV et al. Nov 2018 A1
20180333155 Hall et al. Nov 2018 A1
20180333169 Leimbach et al. Nov 2018 A1
20180344319 Shelton, IV et al. Dec 2018 A1
20180353170 Overmyer et al. Dec 2018 A1
20180353176 Shelton, IV et al. Dec 2018 A1
20180353177 Shelton, IV et al. Dec 2018 A1
20180353178 Shelton, IV et al. Dec 2018 A1
20180353179 Shelton, IV et al. Dec 2018 A1
20180360443 Shelton, IV et al. Dec 2018 A1
20180360444 Harris et al. Dec 2018 A1
20180360445 Shelton, IV et al. Dec 2018 A1
20180360446 Shelton, IV et al. Dec 2018 A1
20180360447 Shelton, IV et al. Dec 2018 A1
20180360448 Harris et al. Dec 2018 A1
20180360449 Shelton, IV et al. Dec 2018 A1
20180360450 Shelton, IV et al. Dec 2018 A1
20180360451 Shelton, IV et al. Dec 2018 A1
20180360452 Shelton, IV et al. Dec 2018 A1
20180360454 Shelton, IV et al. Dec 2018 A1
20180360455 Shelton, IV et al. Dec 2018 A1
20180360456 Shelton, IV et al. Dec 2018 A1
20180360469 Shelton, IV et al. Dec 2018 A1
20180360470 Parfett et al. Dec 2018 A1
20180360471 Parfett et al. Dec 2018 A1
20180360472 Harris et al. Dec 2018 A1
20180360473 Shelton, IV et al. Dec 2018 A1
20180368833 Shelton, IV et al. Dec 2018 A1
20180368837 Morgan et al. Dec 2018 A1
20180368838 Shelton, IV et al. Dec 2018 A1
20180368839 Shelton, IV et al. Dec 2018 A1
20180368840 Shelton, IV et al. Dec 2018 A1
20180368841 Shelton, IV et al. Dec 2018 A1
20180368842 Shelton, IV et al. Dec 2018 A1
20180368843 Shelton, IV et al. Dec 2018 A1
20180368844 Bakos et al. Dec 2018 A1
20180368845 Bakos et al. Dec 2018 A1
20180368846 Shelton, IV et al. Dec 2018 A1
20180368847 Shelton, IV et al. Dec 2018 A1
20190000446 Shelton, IV et al. Jan 2019 A1
20190000447 Shelton, IV et al. Jan 2019 A1
20190000448 Shelton, IV et al. Jan 2019 A1
20190000450 Shelton, IV et al. Jan 2019 A1
20190000454 Swayze et al. Jan 2019 A1
20190000456 Shelton, IV et al. Jan 2019 A1
20190000457 Shelton, IV et al. Jan 2019 A1
20190000458 Shelton, IV et al. Jan 2019 A1
20190000459 Shelton, IV et al. Jan 2019 A1
20190000460 Shelton, IV et al. Jan 2019 A1
20190000461 Shelton, IV et al. Jan 2019 A1
20190000462 Shelton, IV et al. Jan 2019 A1
20190000463 Shelton, IV et al. Jan 2019 A1
20190000464 Shelton, IV et al. Jan 2019 A1
20190000465 Shelton, IV et al. Jan 2019 A1
20190000466 Shelton, IV et al. Jan 2019 A1
20190000467 Shelton, IV et al. Jan 2019 A1
20190000469 Shelton, IV et al. Jan 2019 A1
20190000470 Yates et al. Jan 2019 A1
20190000471 Shelton, IV et al. Jan 2019 A1
20190000472 Shelton, IV et al. Jan 2019 A1
20190000473 Shelton, IV et al. Jan 2019 A1
20190000474 Shelton, IV et al. Jan 2019 A1
20190000475 Shelton, IV et al. Jan 2019 A1
20190000476 Shelton, IV et al. Jan 2019 A1
20190000477 Shelton, IV et al. Jan 2019 A1
20190000528 Yates et al. Jan 2019 A1
20190000530 Yates et al. Jan 2019 A1
20190000565 Shelton, IV et al. Jan 2019 A1
20190000577 Shelton, IV et al. Jan 2019 A1
20190006806 Adams et al. Jan 2019 A1
20190008509 Shelton, IV et al. Jan 2019 A1
20190008511 Kerr et al. Jan 2019 A1
20190015096 Shelton, IV et al. Jan 2019 A1
20190015102 Baber et al. Jan 2019 A1
20190015165 Giordano et al. Jan 2019 A1
Foreign Referenced Citations (1357)
Number Date Country
2008207624 Mar 2009 AU
2010214687 Sep 2010 AU
2011218702 Jun 2013 AU
2012200178 Jul 2013 AU
1015829 Aug 1977 CA
1125615 Jun 1982 CA
2458946 Mar 2003 CA
2477181 Apr 2004 CA
2512960 Jan 2006 CA
2514274 Jan 2006 CA
2639177 Feb 2009 CA
2664874 Nov 2009 CA
2576347 Aug 2015 CA
2940510 Aug 2015 CA
86100996 Sep 1986 CN
1163558 Oct 1997 CN
2488482 May 2002 CN
1424891 Jun 2003 CN
1523725 Aug 2004 CN
1545154 Nov 2004 CN
1634601 Jul 2005 CN
1636525 Jul 2005 CN
1636526 Jul 2005 CN
2716900 Aug 2005 CN
2738962 Nov 2005 CN
1726874 Feb 2006 CN
1726878 Feb 2006 CN
1868411 Nov 2006 CN
1915180 Feb 2007 CN
2868212 Feb 2007 CN
1960679 May 2007 CN
101011286 Aug 2007 CN
200942099 Sep 2007 CN
200991269 Dec 2007 CN
101095621 Jan 2008 CN
101111196 Jan 2008 CN
201001747 Jan 2008 CN
101137402 Mar 2008 CN
101143105 Mar 2008 CN
201029899 Mar 2008 CN
101224122 Jul 2008 CN
101224124 Jul 2008 CN
101254126 Sep 2008 CN
101507620 Aug 2009 CN
101507622 Aug 2009 CN
101507623 Aug 2009 CN
101507625 Aug 2009 CN
101507628 Aug 2009 CN
101522120 Sep 2009 CN
101534724 Sep 2009 CN
101626731 Jan 2010 CN
101669833 Mar 2010 CN
101675898 Mar 2010 CN
101683280 Mar 2010 CN
101721236 Jun 2010 CN
101801284 Aug 2010 CN
101828940 Sep 2010 CN
101868203 Oct 2010 CN
101873834 Oct 2010 CN
101073509 Dec 2010 CN
101912285 Dec 2010 CN
101028205 Jan 2011 CN
101933824 Jan 2011 CN
101934098 Jan 2011 CN
201719298 Jan 2011 CN
102038531 May 2011 CN
102038532 May 2011 CN
101534722 Jun 2011 CN
201879759 Jun 2011 CN
101361666 Aug 2011 CN
201949071 Aug 2011 CN
101224119 Sep 2011 CN
101336835 Sep 2011 CN
102188270 Sep 2011 CN
101779977 Dec 2011 CN
101534723 Jan 2012 CN
101310680 Apr 2012 CN
101912284 Jul 2012 CN
202397539 Aug 2012 CN
202426586 Sep 2012 CN
101317782 Oct 2012 CN
202489990 Oct 2012 CN
101507639 Nov 2012 CN
101541251 Nov 2012 CN
102835977 Dec 2012 CN
101507633 Feb 2013 CN
101023879 Mar 2013 CN
101507624 Mar 2013 CN
101327137 Jun 2013 CN
101401736 Jun 2013 CN
101332110 Jul 2013 CN
101683281 Jan 2014 CN
103648408 Mar 2014 CN
203564285 Apr 2014 CN
203564287 Apr 2014 CN
203597997 May 2014 CN
103829983 Jun 2014 CN
103908313 Jul 2014 CN
203736251 Jul 2014 CN
103981635 Aug 2014 CN
102783741 Oct 2014 CN
102973300 Oct 2014 CN
102793571 Dec 2014 CN
104337556 Feb 2015 CN
102166129 Mar 2015 CN
102469995 Mar 2015 CN
102113902 Apr 2015 CN
102247177 Feb 2016 CN
103750872 May 2016 CN
273689 May 1914 DE
1775926 Jan 1972 DE
3036217 Apr 1982 DE
3212828 Nov 1982 DE
3210466 Sep 1983 DE
3709067 Sep 1988 DE
4228909 Mar 1994 DE
9412228 Sep 1994 DE
19509116 Sep 1996 DE
19534043 Mar 1997 DE
19707373 Feb 1998 DE
19851291 Jan 2000 DE
19924311 Nov 2000 DE
69328576 Jan 2001 DE
20016423 Feb 2001 DE
19941859 Mar 2001 DE
10052679 May 2001 DE
20112837 Oct 2001 DE
20121753 Apr 2003 DE
10314827 Apr 2004 DE
202004012389 Sep 2004 DE
10314072 Oct 2004 DE
202007003114 Jun 2007 DE
102010013150 Sep 2011 DE
0000756 Feb 1979 EP
0033633 Aug 1981 EP
0122046 Oct 1984 EP
0070230 Apr 1985 EP
0156774 Oct 1985 EP
0072754 Apr 1986 EP
0033548 May 1986 EP
0077262 Aug 1986 EP
0189807 Aug 1986 EP
0212278 Mar 1987 EP
0129442 Nov 1987 EP
0255631 Feb 1988 EP
0276104 Jul 1988 EP
0178940 Jan 1991 EP
0178941 Jan 1991 EP
0169044 Jun 1991 EP
0248844 Jan 1993 EP
0539762 May 1993 EP
0541950 May 1993 EP
0545029 Jun 1993 EP
0548998 Jun 1993 EP
0379721 Sep 1993 EP
0277959 Oct 1993 EP
0233940 Nov 1993 EP
0261230 Nov 1993 EP
0324636 Mar 1994 EP
0591946 Apr 1994 EP
0593920 Apr 1994 EP
0594148 Apr 1994 EP
0427949 Jun 1994 EP
0523174 Jun 1994 EP
0600182 Jun 1994 EP
0310431 Nov 1994 EP
0375302 Nov 1994 EP
0376562 Nov 1994 EP
0623311 Nov 1994 EP
0630612 Dec 1994 EP
0630614 Dec 1994 EP
0634144 Jan 1995 EP
0639349 Feb 1995 EP
0646356 Apr 1995 EP
0646357 Apr 1995 EP
0505036 May 1995 EP
0653189 May 1995 EP
0669104 Aug 1995 EP
0387980 Oct 1995 EP
0511470 Oct 1995 EP
0674876 Oct 1995 EP
0676173 Oct 1995 EP
0679367 Nov 1995 EP
0392547 Dec 1995 EP
0685204 Dec 1995 EP
0686374 Dec 1995 EP
0364216 Jan 1996 EP
0699418 Mar 1996 EP
0702937 Mar 1996 EP
0488768 Apr 1996 EP
0705571 Apr 1996 EP
0528478 May 1996 EP
0711611 May 1996 EP
0541987 Jul 1996 EP
0667119 Jul 1996 EP
0737446 Oct 1996 EP
0741996 Nov 1996 EP
0748614 Dec 1996 EP
0708618 Mar 1997 EP
0770355 May 1997 EP
0503662 Jun 1997 EP
0447121 Jul 1997 EP
0621009 Jul 1997 EP
0625077 Jul 1997 EP
0633749 Aug 1997 EP
0710090 Aug 1997 EP
0578425 Sep 1997 EP
0623312 Sep 1997 EP
0621006 Oct 1997 EP
0625335 Nov 1997 EP
0552423 Jan 1998 EP
0592244 Jan 1998 EP
0648476 Jan 1998 EP
0649290 Mar 1998 EP
0598618 Sep 1998 EP
0678007 Sep 1998 EP
0869104 Oct 1998 EP
0603472 Nov 1998 EP
0605351 Nov 1998 EP
0878169 Nov 1998 EP
0879742 Nov 1998 EP
0695144 Dec 1998 EP
0722296 Dec 1998 EP
0760230 Feb 1999 EP
0623316 Mar 1999 EP
0650701 Mar 1999 EP
0537572 Jun 1999 EP
0923907 Jun 1999 EP
0640317 Sep 1999 EP
0843906 Mar 2000 EP
0552050 May 2000 EP
0833592 May 2000 EP
0832605 Jun 2000 EP
0484677 Jul 2000 EP
0830094 Sep 2000 EP
1034747 Sep 2000 EP
1034748 Sep 2000 EP
0726632 Oct 2000 EP
0694290 Nov 2000 EP
1050278 Nov 2000 EP
1053719 Nov 2000 EP
1053720 Nov 2000 EP
1055399 Nov 2000 EP
1055400 Nov 2000 EP
1058177 Dec 2000 EP
1080694 Mar 2001 EP
1090592 Apr 2001 EP
1095627 May 2001 EP
0806914 Sep 2001 EP
0768840 Dec 2001 EP
0908152 Jan 2002 EP
0717959 Feb 2002 EP
0872213 May 2002 EP
0862386 Jun 2002 EP
1234587 Aug 2002 EP
0949886 Sep 2002 EP
1238634 Sep 2002 EP
0858295 Dec 2002 EP
0656188 Jan 2003 EP
0717960 Feb 2003 EP
1284120 Feb 2003 EP
1287788 Mar 2003 EP
0717966 Apr 2003 EP
0717967 May 2003 EP
0869742 May 2003 EP
0829235 Jun 2003 EP
0887046 Jul 2003 EP
1323384 Jul 2003 EP
0852480 Aug 2003 EP
0891154 Sep 2003 EP
0813843 Oct 2003 EP
0873089 Oct 2003 EP
0856326 Nov 2003 EP
1374788 Jan 2004 EP
0814712 Feb 2004 EP
1402837 Mar 2004 EP
0705570 Apr 2004 EP
0959784 Apr 2004 EP
1407719 Apr 2004 EP
1411626 Apr 2004 EP
1086713 May 2004 EP
0996378 Jun 2004 EP
1426012 Jun 2004 EP
0833593 Jul 2004 EP
1442694 Aug 2004 EP
0888749 Sep 2004 EP
0959786 Sep 2004 EP
1453432 Sep 2004 EP
1459695 Sep 2004 EP
1254636 Oct 2004 EP
1473819 Nov 2004 EP
1477119 Nov 2004 EP
1479345 Nov 2004 EP
1479347 Nov 2004 EP
1479348 Nov 2004 EP
0754437 Dec 2004 EP
1025807 Dec 2004 EP
1001710 Jan 2005 EP
1496805 Jan 2005 EP
1256318 Feb 2005 EP
1520521 Apr 2005 EP
1520522 Apr 2005 EP
1520523 Apr 2005 EP
1520525 Apr 2005 EP
1522264 Apr 2005 EP
1523942 Apr 2005 EP
1550408 Jul 2005 EP
1557129 Jul 2005 EP
1064883 Aug 2005 EP
1067876 Aug 2005 EP
0870473 Sep 2005 EP
1157666 Sep 2005 EP
0880338 Oct 2005 EP
1158917 Nov 2005 EP
1344498 Nov 2005 EP
0906764 Dec 2005 EP
1330989 Dec 2005 EP
0771176 Jan 2006 EP
1621138 Feb 2006 EP
1621139 Feb 2006 EP
1621141 Feb 2006 EP
1621143 Feb 2006 EP
1621145 Feb 2006 EP
1621151 Feb 2006 EP
1034746 Mar 2006 EP
1201196 Mar 2006 EP
1632191 Mar 2006 EP
1647231 Apr 2006 EP
1065981 May 2006 EP
1082944 May 2006 EP
1230899 May 2006 EP
1652481 May 2006 EP
1382303 Jun 2006 EP
1253866 Jul 2006 EP
1676539 Jul 2006 EP
1032318 Aug 2006 EP
1045672 Aug 2006 EP
1617768 Aug 2006 EP
1693015 Aug 2006 EP
1400214 Sep 2006 EP
1702567 Sep 2006 EP
1129665 Nov 2006 EP
1400206 Nov 2006 EP
1721568 Nov 2006 EP
1723914 Nov 2006 EP
1256317 Dec 2006 EP
1285633 Dec 2006 EP
1728473 Dec 2006 EP
1736105 Dec 2006 EP
1011494 Jan 2007 EP
1479346 Jan 2007 EP
1484024 Jan 2007 EP
1749485 Feb 2007 EP
1754445 Feb 2007 EP
1759812 Mar 2007 EP
1767157 Mar 2007 EP
1767163 Mar 2007 EP
1563792 Apr 2007 EP
1769756 Apr 2007 EP
1769758 Apr 2007 EP
1581128 May 2007 EP
1780825 May 2007 EP
1785097 May 2007 EP
1790293 May 2007 EP
1790294 May 2007 EP
1563793 Jun 2007 EP
1791473 Jun 2007 EP
1800610 Jun 2007 EP
1300117 Aug 2007 EP
1813199 Aug 2007 EP
1813200 Aug 2007 EP
1813201 Aug 2007 EP
1813202 Aug 2007 EP
1813203 Aug 2007 EP
1813207 Aug 2007 EP
1813209 Aug 2007 EP
1815950 Aug 2007 EP
1330991 Sep 2007 EP
1837041 Sep 2007 EP
0922435 Oct 2007 EP
1487359 Oct 2007 EP
1599146 Oct 2007 EP
1839596 Oct 2007 EP
1679096 Nov 2007 EP
1857057 Nov 2007 EP
1402821 Dec 2007 EP
1872727 Jan 2008 EP
1550410 Feb 2008 EP
1671593 Feb 2008 EP
1897502 Mar 2008 EP
1611856 Apr 2008 EP
1908417 Apr 2008 EP
1917929 May 2008 EP
1330201 Jun 2008 EP
1702568 Jul 2008 EP
1943955 Jul 2008 EP
1943957 Jul 2008 EP
1943959 Jul 2008 EP
1943962 Jul 2008 EP
1943964 Jul 2008 EP
1943976 Jul 2008 EP
1593337 Aug 2008 EP
1970014 Sep 2008 EP
1974678 Oct 2008 EP
1980213 Oct 2008 EP
1980214 Oct 2008 EP
1759645 Nov 2008 EP
1987780 Nov 2008 EP
1990014 Nov 2008 EP
1992296 Nov 2008 EP
1552795 Dec 2008 EP
1693008 Dec 2008 EP
1759640 Dec 2008 EP
1997439 Dec 2008 EP
2000101 Dec 2008 EP
2000102 Dec 2008 EP
2005894 Dec 2008 EP
2005897 Dec 2008 EP
2005901 Dec 2008 EP
2008595 Dec 2008 EP
2025293 Feb 2009 EP
1736104 Mar 2009 EP
1749486 Mar 2009 EP
1782743 Mar 2009 EP
2039302 Mar 2009 EP
2039308 Mar 2009 EP
2039316 Mar 2009 EP
1721576 Apr 2009 EP
1733686 Apr 2009 EP
2044890 Apr 2009 EP
2055243 May 2009 EP
1550409 Jun 2009 EP
1550413 Jun 2009 EP
1719461 Jun 2009 EP
1834594 Jun 2009 EP
1709911 Jul 2009 EP
2077093 Jul 2009 EP
1745748 Aug 2009 EP
2090231 Aug 2009 EP
2090237 Aug 2009 EP
2090241 Aug 2009 EP
2090245 Aug 2009 EP
2090254 Aug 2009 EP
2090256 Aug 2009 EP
2095777 Sep 2009 EP
2098170 Sep 2009 EP
2100562 Sep 2009 EP
2110082 Oct 2009 EP
2110083 Oct 2009 EP
2110084 Oct 2009 EP
2111803 Oct 2009 EP
1813208 Nov 2009 EP
1908426 Nov 2009 EP
2116195 Nov 2009 EP
2116196 Nov 2009 EP
2116197 Nov 2009 EP
1607050 Dec 2009 EP
1762190 Dec 2009 EP
1815804 Dec 2009 EP
1875870 Dec 2009 EP
1878395 Jan 2010 EP
2151204 Feb 2010 EP
1813211 Mar 2010 EP
2165654 Mar 2010 EP
2165656 Mar 2010 EP
2165660 Mar 2010 EP
2165663 Mar 2010 EP
2165664 Mar 2010 EP
1566150 Apr 2010 EP
1813206 Apr 2010 EP
2184014 May 2010 EP
1769754 Jun 2010 EP
1854416 Jun 2010 EP
1911408 Jun 2010 EP
2198787 Jun 2010 EP
2214610 Aug 2010 EP
2218409 Aug 2010 EP
1647286 Sep 2010 EP
1825821 Sep 2010 EP
1535565 Oct 2010 EP
1702570 Oct 2010 EP
1785098 Oct 2010 EP
2005896 Oct 2010 EP
2030578 Nov 2010 EP
2036505 Nov 2010 EP
2245993 Nov 2010 EP
2245994 Nov 2010 EP
2253280 Nov 2010 EP
1627605 Dec 2010 EP
2027811 Dec 2010 EP
2130498 Dec 2010 EP
2258282 Dec 2010 EP
2263568 Dec 2010 EP
1994890 Jan 2011 EP
2005900 Jan 2011 EP
2277667 Jan 2011 EP
2283780 Feb 2011 EP
2286738 Feb 2011 EP
1494595 Mar 2011 EP
1690502 Mar 2011 EP
1884201 Mar 2011 EP
2292153 Mar 2011 EP
1769755 Apr 2011 EP
2090240 Apr 2011 EP
2305135 Apr 2011 EP
2308388 Apr 2011 EP
2314254 Apr 2011 EP
2316345 May 2011 EP
2316366 May 2011 EP
2319443 May 2011 EP
2324776 May 2011 EP
1813205 Jun 2011 EP
2042107 Jun 2011 EP
2090243 Jun 2011 EP
2329773 Jun 2011 EP
2090239 Jul 2011 EP
2340771 Jul 2011 EP
1728475 Aug 2011 EP
2353545 Aug 2011 EP
2361562 Aug 2011 EP
2377472 Oct 2011 EP
1836986 Nov 2011 EP
1908414 Nov 2011 EP
2153781 Nov 2011 EP
2387943 Nov 2011 EP
2389928 Nov 2011 EP
1847225 Dec 2011 EP
2397079 Dec 2011 EP
2399538 Dec 2011 EP
1785102 Jan 2012 EP
1316290 Feb 2012 EP
1962711 Feb 2012 EP
2415416 Feb 2012 EP
2090253 Mar 2012 EP
2430986 Mar 2012 EP
1347638 May 2012 EP
1943956 May 2012 EP
2446834 May 2012 EP
2455007 May 2012 EP
2457519 May 2012 EP
2462878 Jun 2012 EP
2462880 Jun 2012 EP
1813204 Jul 2012 EP
2189121 Jul 2012 EP
2248475 Jul 2012 EP
2478845 Jul 2012 EP
2005895 Aug 2012 EP
2090248 Aug 2012 EP
2481359 Aug 2012 EP
2484304 Aug 2012 EP
2486860 Aug 2012 EP
2486862 Aug 2012 EP
2486868 Aug 2012 EP
1908412 Sep 2012 EP
1935351 Sep 2012 EP
2497431 Sep 2012 EP
1550412 Oct 2012 EP
1616549 Oct 2012 EP
2030579 Oct 2012 EP
2090252 Oct 2012 EP
2517637 Oct 2012 EP
2517638 Oct 2012 EP
2517642 Oct 2012 EP
2517645 Oct 2012 EP
2517649 Oct 2012 EP
2517651 Oct 2012 EP
2526877 Nov 2012 EP
2526883 Nov 2012 EP
1884206 Mar 2013 EP
2286735 Mar 2013 EP
2090238 Apr 2013 EP
1806103 May 2013 EP
2586380 May 2013 EP
2586383 May 2013 EP
2606812 Jun 2013 EP
2606834 Jun 2013 EP
1982657 Jul 2013 EP
2614782 Jul 2013 EP
2617369 Jul 2013 EP
2620117 Jul 2013 EP
2090234 Sep 2013 EP
2633830 Sep 2013 EP
2090244 Oct 2013 EP
2644124 Oct 2013 EP
2644209 Oct 2013 EP
2649948 Oct 2013 EP
2649949 Oct 2013 EP
1997438 Nov 2013 EP
2684529 Jan 2014 EP
2687164 Jan 2014 EP
2700367 Feb 2014 EP
2713902 Apr 2014 EP
1772105 May 2014 EP
2743042 Jun 2014 EP
2759267 Jul 2014 EP
2764826 Aug 2014 EP
2764827 Aug 2014 EP
2767243 Aug 2014 EP
2772206 Sep 2014 EP
2772209 Sep 2014 EP
2777520 Sep 2014 EP
2777524 Sep 2014 EP
2777528 Sep 2014 EP
2777537 Sep 2014 EP
2777538 Sep 2014 EP
2786714 Oct 2014 EP
2792313 Oct 2014 EP
2803324 Nov 2014 EP
2815704 Dec 2014 EP
2446835 Jan 2015 EP
2842500 Mar 2015 EP
2845545 Mar 2015 EP
1943960 Apr 2015 EP
2090255 Apr 2015 EP
2853220 Apr 2015 EP
2923647 Sep 2015 EP
2923653 Sep 2015 EP
2923660 Sep 2015 EP
2932913 Oct 2015 EP
2944270 Nov 2015 EP
1774914 Dec 2015 EP
2090235 Apr 2016 EP
2823773 Apr 2016 EP
2131750 May 2016 EP
2298220 Jun 2016 EP
2510891 Jun 2016 EP
1915957 Aug 2016 EP
2296559 Aug 2016 EP
2586379 Aug 2016 EP
2777533 Oct 2016 EP
2364651 Nov 2016 EP
2747235 Nov 2016 EP
2116192 Mar 2017 EP
2789299 May 2017 EP
2311386 Jun 2017 EP
2839787 Jun 2017 EP
2745782 Oct 2017 EP
3363378 Aug 2018 EP
2396594 Feb 2013 ES
459743 Nov 1913 FR
999646 Feb 1952 FR
1112936 Mar 1956 FR
2452275 Apr 1983 FR
2598905 Nov 1987 FR
2689749 Jul 1994 FR
2765794 Jan 1999 FR
2815842 May 2002 FR
939929 Oct 1963 GB
1210522 Oct 1970 GB
1217159 Dec 1970 GB
1339394 Dec 1973 GB
2024012 Jan 1980 GB
2109241 Jun 1983 GB
2090534 Jun 1984 GB
2272159 May 1994 GB
2284242 May 1995 GB
2286435 Aug 1995 GB
2336214 Oct 1999 GB
2425903 Nov 2006 GB
2426391 Nov 2006 GB
2423199 May 2009 GB
2509523 Jul 2014 GB
930100110 Nov 1993 GR
S4711908 May 1972 JP
S5033988 Apr 1975 JP
S56112235 Sep 1981 JP
S58500053 Jan 1983 JP
S58501360 Aug 1983 JP
S59174920 Oct 1984 JP
S60100955 Jun 1985 JP
S60212152 Oct 1985 JP
S6198249 May 1986 JP
S61502036 Sep 1986 JP
S62170011 Oct 1987 JP
S6359764 Mar 1988 JP
S63147449 Jun 1988 JP
S63203149 Aug 1988 JP
S63270040 Nov 1988 JP
H0129503 Jun 1989 JP
H02279149 Nov 1990 JP
H0312126 Jan 1991 JP
H0318354 Jan 1991 JP
H0378514 Aug 1991 JP
H0385009 Aug 1991 JP
H04215747 Aug 1992 JP
H04131860 Dec 1992 JP
H0584252 Apr 1993 JP
H05123325 May 1993 JP
H05212039 Aug 1993 JP
H 05226945 Sep 1993 JP
H067357 Jan 1994 JP
H0630945 Feb 1994 JP
H0654857 Mar 1994 JP
H0663054 Mar 1994 JP
H0626812 Apr 1994 JP
H06121798 May 1994 JP
H06125913 May 1994 JP
H06197901 Jul 1994 JP
H06237937 Aug 1994 JP
H06327684 Nov 1994 JP
H079622 Feb 1995 JP
H0731623 Feb 1995 JP
H0747070 Feb 1995 JP
H0751273 Feb 1995 JP
H07124166 May 1995 JP
H07163573 Jun 1995 JP
H07163574 Jun 1995 JP
H07171163 Jul 1995 JP
H07255735 Oct 1995 JP
H07285089 Oct 1995 JP
H07299074 Nov 1995 JP
H0833641 Feb 1996 JP
H0833642 Feb 1996 JP
H08164141 Jun 1996 JP
H08173437 Jul 1996 JP
H08182684 Jul 1996 JP
H08215201 Aug 1996 JP
H08507708 Aug 1996 JP
H08229050 Sep 1996 JP
H08289895 Nov 1996 JP
H08336540 Dec 1996 JP
H08336544 Dec 1996 JP
H09501081 Feb 1997 JP
H09501577 Feb 1997 JP
H09164144 Jun 1997 JP
H09-323068 Dec 1997 JP
H10113352 May 1998 JP
H10118090 May 1998 JP
H10-200699 Jul 1998 JP
H 10296660 Nov 1998 JP
H10512465 Dec 1998 JP
H10512469 Dec 1998 JP
2000014632 Jan 2000 JP
2000033071 Feb 2000 JP
2000112002 Apr 2000 JP
3056672 Jun 2000 JP
2000166932 Jun 2000 JP
2000171730 Jun 2000 JP
2000287987 Oct 2000 JP
2000325303 Nov 2000 JP
2001037763 Feb 2001 JP
2001046384 Feb 2001 JP
2001087272 Apr 2001 JP
2001514541 Sep 2001 JP
2001276091 Oct 2001 JP
2001286477 Oct 2001 JP
2001517473 Oct 2001 JP
2002051974 Feb 2002 JP
2002054903 Feb 2002 JP
2002085415 Mar 2002 JP
2002143078 May 2002 JP
2002204801 Jul 2002 JP
2002528161 Sep 2002 JP
2002314298 Oct 2002 JP
2002369820 Dec 2002 JP
2002542186 Dec 2002 JP
2003000603 Jan 2003 JP
2003500153 Jan 2003 JP
2003504104 Feb 2003 JP
2003135473 May 2003 JP
2003148903 May 2003 JP
2003164066 Jun 2003 JP
2003521301 Jul 2003 JP
2003521304 Jul 2003 JP
2003523251 Aug 2003 JP
2003523254 Aug 2003 JP
2003524431 Aug 2003 JP
3442423 Sep 2003 JP
2003300416 Oct 2003 JP
2004147701 May 2004 JP
2004162035 Jun 2004 JP
2004229976 Aug 2004 JP
2004524076 Aug 2004 JP
2004531280 Oct 2004 JP
2004532084 Oct 2004 JP
2004532676 Oct 2004 JP
2004-535217 Nov 2004 JP
2004329624 Nov 2004 JP
2004337617 Dec 2004 JP
2004344662 Dec 2004 JP
2004344663 Dec 2004 JP
2005013573 Jan 2005 JP
2005028147 Feb 2005 JP
2005028148 Feb 2005 JP
2005028149 Feb 2005 JP
2005505309 Feb 2005 JP
2005505322 Feb 2005 JP
2005505334 Feb 2005 JP
2005080702 Mar 2005 JP
2005103280 Apr 2005 JP
2005103281 Apr 2005 JP
2005103293 Apr 2005 JP
2005511131 Apr 2005 JP
2005511137 Apr 2005 JP
2005131163 May 2005 JP
2005131164 May 2005 JP
2005131173 May 2005 JP
2005131211 May 2005 JP
2005131212 May 2005 JP
2005137423 Jun 2005 JP
2005137919 Jun 2005 JP
2005144183 Jun 2005 JP
2005152416 Jun 2005 JP
2005516714 Jun 2005 JP
2005187954 Jul 2005 JP
2005521109 Jul 2005 JP
2005523105 Aug 2005 JP
2005524474 Aug 2005 JP
2005296412 Oct 2005 JP
2005529675 Oct 2005 JP
2005529677 Oct 2005 JP
2005328882 Dec 2005 JP
2005335432 Dec 2005 JP
2005342267 Dec 2005 JP
2006034975 Feb 2006 JP
2006034977 Feb 2006 JP
2006034978 Feb 2006 JP
2006034980 Feb 2006 JP
2006043451 Feb 2006 JP
2006506106 Feb 2006 JP
2006510879 Mar 2006 JP
3791856 Jun 2006 JP
2006187649 Jul 2006 JP
2006218228 Aug 2006 JP
2006218297 Aug 2006 JP
2006223872 Aug 2006 JP
2006281405 Oct 2006 JP
2006289064 Oct 2006 JP
2006334412 Dec 2006 JP
2006334417 Dec 2006 JP
2006346445 Dec 2006 JP
2007000634 Jan 2007 JP
2007050253 Mar 2007 JP
2007061628 Mar 2007 JP
3906843 Apr 2007 JP
2007083051 Apr 2007 JP
2007098130 Apr 2007 JP
2007105481 Apr 2007 JP
2007117725 May 2007 JP
2007130471 May 2007 JP
2007130479 May 2007 JP
3934161 Jun 2007 JP
2007203047 Aug 2007 JP
2007203049 Aug 2007 JP
2007203051 Aug 2007 JP
2007203055 Aug 2007 JP
2007203057 Aug 2007 JP
2007524435 Aug 2007 JP
2007222615 Sep 2007 JP
2007229448 Sep 2007 JP
2007526026 Sep 2007 JP
4001860 Oct 2007 JP
2007252916 Oct 2007 JP
2007307373 Nov 2007 JP
2007325922 Dec 2007 JP
2008068073 Mar 2008 JP
2008510515 Apr 2008 JP
2008516669 May 2008 JP
2008528203 Jul 2008 JP
2008-220032 Sep 2008 JP
2008206967 Sep 2008 JP
2008212637 Sep 2008 JP
2008212638 Sep 2008 JP
2008212640 Sep 2008 JP
2008220956 Sep 2008 JP
2008237881 Oct 2008 JP
2008259860 Oct 2008 JP
2008264535 Nov 2008 JP
2008283459 Nov 2008 JP
2008307393 Dec 2008 JP
2009000531 Jan 2009 JP
2009006137 Jan 2009 JP
2009502351 Jan 2009 JP
2009502352 Jan 2009 JP
2009022742 Feb 2009 JP
2009506799 Feb 2009 JP
2009507526 Feb 2009 JP
2009072595 Apr 2009 JP
2009072599 Apr 2009 JP
2009090113 Apr 2009 JP
2009106752 May 2009 JP
2009189821 Aug 2009 JP
2009189823 Aug 2009 JP
2009189836 Aug 2009 JP
2009189837 Aug 2009 JP
2009189838 Aug 2009 JP
2009189846 Aug 2009 JP
2009189847 Aug 2009 JP
2009201998 Sep 2009 JP
2009207260 Sep 2009 JP
2009226028 Oct 2009 JP
2009536082 Oct 2009 JP
2009261944 Nov 2009 JP
2009268908 Nov 2009 JP
2009538684 Nov 2009 JP
2009539420 Nov 2009 JP
2009291604 Dec 2009 JP
2010504808 Feb 2010 JP
2010504809 Feb 2010 JP
2010504813 Feb 2010 JP
2010504846 Feb 2010 JP
2010505524 Feb 2010 JP
2010069307 Apr 2010 JP
2010069310 Apr 2010 JP
2010075694 Apr 2010 JP
2010075695 Apr 2010 JP
2010088876 Apr 2010 JP
2010094514 Apr 2010 JP
2010098844 Apr 2010 JP
4461008 May 2010 JP
2010-520025 Jun 2010 JP
2010-148879 Jul 2010 JP
2010142636 Jul 2010 JP
4549018 Sep 2010 JP
2010214166 Sep 2010 JP
2010-240429 Oct 2010 JP
2010240411 Oct 2010 JP
2010246948 Nov 2010 JP
2010-540041 Dec 2010 JP
2010279690 Dec 2010 JP
2010540192 Dec 2010 JP
2011005260 Jan 2011 JP
2011504391 Feb 2011 JP
2011509786 Mar 2011 JP
2011072574 Apr 2011 JP
2011072797 Apr 2011 JP
2011078763 Apr 2011 JP
2011-115594 Jun 2011 JP
2011-520564 Jul 2011 JP
4722849 Jul 2011 JP
4783373 Sep 2011 JP
2011524199 Sep 2011 JP
2011251156 Dec 2011 JP
2012040398 Mar 2012 JP
2012507356 Mar 2012 JP
2012517289 Aug 2012 JP
5140421 Feb 2013 JP
5154710 Feb 2013 JP
5162595 Mar 2013 JP
2013517891 May 2013 JP
2013526342 Jun 2013 JP
2013128791 Jul 2013 JP
5333899 Nov 2013 JP
2014121599 Jul 2014 JP
2016-512057 Apr 2016 JP
20100110134 Oct 2010 KR
20110003229 Jan 2011 KR
1814161 May 1993 RU
2008830 Mar 1994 RU
2052979 Jan 1996 RU
2066128 Sep 1996 RU
2098025 Dec 1997 RU
2141279 Nov 1999 RU
2144791 Jan 2000 RU
2161450 Jan 2001 RU
2181566 Apr 2002 RU
2187249 Aug 2002 RU
2189091 Sep 2002 RU
32984 Oct 2003 RU
2225170 Mar 2004 RU
42750 Dec 2004 RU
61114 Feb 2007 RU
61122 Feb 2007 RU
2007103563 Aug 2008 RU
189517 Jan 1967 SU
297156 May 1971 SU
328636 Sep 1972 SU
511939 Apr 1976 SU
674747 Jul 1979 SU
728848 Apr 1980 SU
886900 Dec 1981 SU
1009439 Apr 1983 SU
1022703 Jun 1983 SU
1271497 Nov 1986 SU
1333319 Aug 1987 SU
1377052 Feb 1988 SU
1377053 Feb 1988 SU
1443874 Dec 1988 SU
1509051 Sep 1989 SU
1561964 May 1990 SU
1708312 Jan 1992 SU
1722476 Mar 1992 SU
1752361 Aug 1992 SU
1814161 May 1993 SU
WO-8202824 Sep 1982 WO
WO-8602254 Apr 1986 WO
WO-9115157 Oct 1991 WO
WO-9220295 Nov 1992 WO
WO-9221300 Dec 1992 WO
WO-9308755 May 1993 WO
WO-9313718 Jul 1993 WO
WO-9314690 Aug 1993 WO
WO-9315648 Aug 1993 WO
WO-9315850 Aug 1993 WO
WO-9319681 Oct 1993 WO
WO-9400060 Jan 1994 WO
WO-9411057 May 1994 WO
WO-9414129 Jun 1994 WO
WO-9412108 Jun 1994 WO
WO-9417737 Aug 1994 WO
WO-9418893 Sep 1994 WO
WO-9420030 Sep 1994 WO
WO-9422378 Oct 1994 WO
WO-9423659 Oct 1994 WO
WO-9424943 Nov 1994 WO
WO-9424947 Nov 1994 WO
WO-9502369 Jan 1995 WO
WO-9503743 Feb 1995 WO
WO-9506817 Mar 1995 WO
WO-9509576 Apr 1995 WO
WO-9509577 Apr 1995 WO
WO-9514436 Jun 1995 WO
WO-9517855 Jul 1995 WO
WO-9518383 Jul 1995 WO
WO-9518572 Jul 1995 WO
WO-9519739 Jul 1995 WO
WO-9520360 Aug 1995 WO
WO-9523557 Sep 1995 WO
WO-9524865 Sep 1995 WO
WO-9525471 Sep 1995 WO
WO-9526562 Oct 1995 WO
WO-9529639 Nov 1995 WO
WO-9604858 Feb 1996 WO
WO-9618344 Jun 1996 WO
WO-9619151 Jun 1996 WO
WO-9619152 Jun 1996 WO
WO-9620652 Jul 1996 WO
WO-9621119 Jul 1996 WO
WO-9622055 Jul 1996 WO
WO-9623448 Aug 1996 WO
WO-9624301 Aug 1996 WO
WO-9627337 Sep 1996 WO
WO-9631155 Oct 1996 WO
WO-9635464 Nov 1996 WO
WO-9639085 Dec 1996 WO
WO-9639086 Dec 1996 WO
WO-9639087 Dec 1996 WO
WO-9639088 Dec 1996 WO
WO-9639089 Dec 1996 WO
WO-9700646 Jan 1997 WO
WO-9700647 Jan 1997 WO
WO-9701989 Jan 1997 WO
WO-9706582 Feb 1997 WO
WO-9710763 Mar 1997 WO
WO-9710764 Mar 1997 WO
WO-9711648 Apr 1997 WO
WO-9711649 Apr 1997 WO
WO-9715237 May 1997 WO
WO-9724073 Jul 1997 WO
WO-9724993 Jul 1997 WO
WO-9730644 Aug 1997 WO
WO-9730659 Aug 1997 WO
WO-9734533 Sep 1997 WO
WO-9737598 Oct 1997 WO
WO-9739688 Oct 1997 WO
WO-9741767 Nov 1997 WO
WO-9801080 Jan 1998 WO
WO-9817180 Apr 1998 WO
WO-9822154 May 1998 WO
WO-9827880 Jul 1998 WO
WO-9830153 Jul 1998 WO
WO-9847436 Oct 1998 WO
WO-9858589 Dec 1998 WO
WO-9902090 Jan 1999 WO
WO-9903407 Jan 1999 WO
WO-9903408 Jan 1999 WO
WO-9903409 Jan 1999 WO
WO-9912483 Mar 1999 WO
WO-9912487 Mar 1999 WO
WO-9912488 Mar 1999 WO
WO-9915086 Apr 1999 WO
WO-9915091 Apr 1999 WO
WO-9923933 May 1999 WO
WO-9923959 May 1999 WO
WO-9925261 May 1999 WO
WO-9929244 Jun 1999 WO
WO-9934744 Jul 1999 WO
WO-9945849 Sep 1999 WO
WO-9948430 Sep 1999 WO
WO-9951158 Oct 1999 WO
WO-0024322 May 2000 WO
WO-0024330 May 2000 WO
WO-0033755 Jun 2000 WO
WO-0041638 Jul 2000 WO
WO-0048506 Aug 2000 WO
WO-0053112 Sep 2000 WO
WO-0054653 Sep 2000 WO
WO-0057796 Oct 2000 WO
WO-0064365 Nov 2000 WO
WO-0072762 Dec 2000 WO
WO-0072765 Dec 2000 WO
WO-0078222 Dec 2000 WO
WO-0103587 Jan 2001 WO
WO-0105702 Jan 2001 WO
WO-0110482 Feb 2001 WO
WO-0135845 May 2001 WO
WO-0154594 Aug 2001 WO
WO-0158371 Aug 2001 WO
WO-0162158 Aug 2001 WO
WO-0162161 Aug 2001 WO
WO-0162162 Aug 2001 WO
WO-0162163 Aug 2001 WO
WO-0162164 Aug 2001 WO
WO-0162169 Aug 2001 WO
WO-0178605 Oct 2001 WO
WO-0180757 Nov 2001 WO
WO-0191646 Dec 2001 WO
WO-0200121 Jan 2002 WO
WO-0207608 Jan 2002 WO
WO-0207618 Jan 2002 WO
WO-0217799 Mar 2002 WO
WO-0219920 Mar 2002 WO
WO-0219932 Mar 2002 WO
WO-0226143 Apr 2002 WO
WO-0230297 Apr 2002 WO
WO-0232322 Apr 2002 WO
WO-0236028 May 2002 WO
WO-0243571 Jun 2002 WO
WO-02058568 Aug 2002 WO
WO-02060328 Aug 2002 WO
WO-02065933 Aug 2002 WO
WO-02067785 Sep 2002 WO
WO-02080781 Oct 2002 WO
WO-02085218 Oct 2002 WO
WO-02087586 Nov 2002 WO
WO-02098302 Dec 2002 WO
WO-03000138 Jan 2003 WO
WO-03001329 Jan 2003 WO
WO-03001986 Jan 2003 WO
WO-03013363 Feb 2003 WO
WO-03013372 Feb 2003 WO
WO-03015604 Feb 2003 WO
WO-03020106 Mar 2003 WO
WO-03020139 Mar 2003 WO
WO-03024339 Mar 2003 WO
WO-03030743 Apr 2003 WO
WO-03037193 May 2003 WO
WO-03055402 Jul 2003 WO
WO-03057048 Jul 2003 WO
WO-03057058 Jul 2003 WO
WO-03063694 Aug 2003 WO
WO-03077769 Sep 2003 WO
WO-03079911 Oct 2003 WO
WO-03082126 Oct 2003 WO
WO-03086206 Oct 2003 WO
WO-03088845 Oct 2003 WO
WO-03047436 Nov 2003 WO
WO-03090630 Nov 2003 WO
WO-03094743 Nov 2003 WO
WO-03094745 Nov 2003 WO
WO-03094746 Nov 2003 WO
WO-03094747 Nov 2003 WO
WO-03101313 Dec 2003 WO
WO-03105698 Dec 2003 WO
WO-03105702 Dec 2003 WO
WO-2004004578 Jan 2004 WO
WO-2004006980 Jan 2004 WO
WO-2004011037 Feb 2004 WO
WO-2004014238 Feb 2004 WO
WO-03079909 Mar 2004 WO
WO-2004019769 Mar 2004 WO
WO-2004019803 Mar 2004 WO
WO-2004021868 Mar 2004 WO
WO-2004028585 Apr 2004 WO
WO-2004030554 Apr 2004 WO
WO-2004032754 Apr 2004 WO
WO-2004032760 Apr 2004 WO
WO-2004032762 Apr 2004 WO
WO-2004032763 Apr 2004 WO
WO-2004032783 Apr 2004 WO
WO-2004034875 Apr 2004 WO
WO-2004047626 Jun 2004 WO
WO-2004047653 Jun 2004 WO
WO-2004049956 Jun 2004 WO
WO-2004050971 Jun 2004 WO
WO-2004052426 Jun 2004 WO
WO-2004056276 Jul 2004 WO
WO-2004056277 Jul 2004 WO
WO-2004062516 Jul 2004 WO
WO-2004064600 Aug 2004 WO
WO-2004078050 Sep 2004 WO
WO-2004078051 Sep 2004 WO
WO-2004078236 Sep 2004 WO
WO-2004086987 Oct 2004 WO
WO-2004096015 Nov 2004 WO
WO-2004096057 Nov 2004 WO
WO-2004103157 Dec 2004 WO
WO-2004105593 Dec 2004 WO
WO-2004105621 Dec 2004 WO
WO-2004112618 Dec 2004 WO
WO-2004112652 Dec 2004 WO
WO-2005027983 Mar 2005 WO
WO-2005037329 Apr 2005 WO
WO-2005042041 May 2005 WO
WO-2005044078 May 2005 WO
WO-2005048809 Jun 2005 WO
WO-2005055846 Jun 2005 WO
WO-2005072634 Aug 2005 WO
WO-2005078892 Aug 2005 WO
WO-2005079675 Sep 2005 WO
WO-2005087128 Sep 2005 WO
WO-2005096954 Oct 2005 WO
WO-2005110243 Nov 2005 WO
WO-2005112806 Dec 2005 WO
WO-2005112808 Dec 2005 WO
WO-2005115251 Dec 2005 WO
WO-2005115253 Dec 2005 WO
WO-2005117735 Dec 2005 WO
WO-2005122936 Dec 2005 WO
WO-2006026520 Mar 2006 WO
WO-2006023486 Mar 2006 WO
WO-2006023578 Mar 2006 WO
WO-2006027014 Mar 2006 WO
WO-2006028314 Mar 2006 WO
WO-2006044490 Apr 2006 WO
WO-2006044581 Apr 2006 WO
WO-2006044810 Apr 2006 WO
WO-2006049852 May 2006 WO
WO-2006050360 May 2006 WO
WO-2006051252 May 2006 WO
WO-2006057702 Jun 2006 WO
WO-2006059067 Jun 2006 WO
WO-2006073581 Jul 2006 WO
WO-2006083748 Aug 2006 WO
WO-2006085389 Aug 2006 WO
WO-2006092563 Sep 2006 WO
WO-2006092565 Sep 2006 WO
WO-2006115958 Nov 2006 WO
WO-2006125940 Nov 2006 WO
WO-2006132992 Dec 2006 WO
WO-2007002180 Jan 2007 WO
WO-2007014355 Feb 2007 WO
WO-2007015971 Feb 2007 WO
WO-2007016290 Feb 2007 WO
WO-2007018898 Feb 2007 WO
WO-2007034161 Mar 2007 WO
WO-2007051000 May 2007 WO
WO-2007059233 May 2007 WO
WO-2007074430 Jul 2007 WO
WO-2007089603 Aug 2007 WO
WO-2007098220 Aug 2007 WO
WO-2007121579 Nov 2007 WO
WO-2007129121 Nov 2007 WO
WO-2007131110 Nov 2007 WO
WO-2007137304 Nov 2007 WO
WO-2007139734 Dec 2007 WO
WO-2007142625 Dec 2007 WO
WO-2007145825 Dec 2007 WO
WO-2007146987 Dec 2007 WO
WO-2007147439 Dec 2007 WO
WO-2008020964 Feb 2008 WO
WO-2008021687 Feb 2008 WO
WO-2008021969 Feb 2008 WO
WO-2008027972 Mar 2008 WO
WO-2008039237 Apr 2008 WO
WO-2008039249 Apr 2008 WO
WO-2008039270 Apr 2008 WO
WO-2008045383 Apr 2008 WO
WO-2008061566 May 2008 WO
WO-2008057281 May 2008 WO
WO-2008070763 Jun 2008 WO
WO-2008080148 Jul 2008 WO
WO-2008089404 Jul 2008 WO
WO-2008101080 Aug 2008 WO
WO-2008101228 Aug 2008 WO
WO-2008103797 Aug 2008 WO
WO-2008109123 Sep 2008 WO
WO-2008109125 Sep 2008 WO
WO-2008112912 Sep 2008 WO
WO-2008118728 Oct 2008 WO
WO-2008118928 Oct 2008 WO
WO-2008124748 Oct 2008 WO
WO-2008131357 Oct 2008 WO
WO-2009005969 Jan 2009 WO
WO-2009022614 Feb 2009 WO
WO-2009023851 Feb 2009 WO
WO-2009033057 Mar 2009 WO
WO-2009039506 Mar 2009 WO
WO-2009046394 Apr 2009 WO
WO-2009066105 May 2009 WO
WO-2009067649 May 2009 WO
WO-2009091497 Jul 2009 WO
WO-2009120944 Oct 2009 WO
WO-2009137761 Nov 2009 WO
WO-2009143092 Nov 2009 WO
WO-2009143331 Nov 2009 WO
WO-2009150650 Dec 2009 WO
WO-2009152307 Dec 2009 WO
WO-2010028332 Mar 2010 WO
WO-2010030434 Mar 2010 WO
WO-2010045425 Apr 2010 WO
WO-2010050771 May 2010 WO
WO-2010054404 May 2010 WO
WO-2010056714 May 2010 WO
WO-2010063795 Jun 2010 WO
WO-2010090940 Aug 2010 WO
WO-2010093333 Aug 2010 WO
WO-2010098871 Sep 2010 WO
WO-2010134913 Nov 2010 WO
WO-2011008672 Jan 2011 WO
WO-2011013103 Feb 2011 WO
WO-2011044343 Apr 2011 WO
WO-2011056458 May 2011 WO
WO-2011060311 May 2011 WO
WO-2011084969 Jul 2011 WO
WO-2011127137 Oct 2011 WO
WO-2012006306 Jan 2012 WO
WO-2012009431 Jan 2012 WO
WO-2012013577 Feb 2012 WO
WO-2012021671 Feb 2012 WO
WO-2012040438 Mar 2012 WO
WO-2012044551 Apr 2012 WO
WO-2012044554 Apr 2012 WO
WO-2012044597 Apr 2012 WO
WO-2012044606 Apr 2012 WO
WO-2012044820 Apr 2012 WO
WO-2012044844 Apr 2012 WO
WO-2012044853 Apr 2012 WO
WO-2012044854 Apr 2012 WO
WO-2012058213 May 2012 WO
WO-2012068156 May 2012 WO
WO-2012109760 Aug 2012 WO
WO-2012127462 Sep 2012 WO
WO-2012135705 Oct 2012 WO
WO-2012143913 Oct 2012 WO
WO-2012148667 Nov 2012 WO
WO-2012148668 Nov 2012 WO
WO-2012148703 Nov 2012 WO
WO-2012160163 Nov 2012 WO
WO-2012166503 Dec 2012 WO
WO-2013009252 Jan 2013 WO
WO-2013009699 Jan 2013 WO
WO-2013023114 Feb 2013 WO
WO-2013036409 Mar 2013 WO
WO-2013043707 Mar 2013 WO
WO-2013043717 Mar 2013 WO
WO-2013043721 Mar 2013 WO
WO-2013062978 May 2013 WO
WO-2013116869 Aug 2013 WO
WO-2013148762 Oct 2013 WO
WO-2013151888 Oct 2013 WO
WO-2013167427 Nov 2013 WO
WO-2013188130 Dec 2013 WO
WO-2014008289 Jan 2014 WO
WO-2014004199 Jan 2014 WO
WO-2014004209 Jan 2014 WO
WO-2014004294 Jan 2014 WO
WO-2014113438 Jul 2014 WO
WO-2014134034 Sep 2014 WO
WO-2014172213 Oct 2014 WO
WO-2014158882 Oct 2014 WO
WO-2015032797 Mar 2015 WO
WO-2015138760 Sep 2015 WO
WO-2015148136 Oct 2015 WO
WO-2015148141 Oct 2015 WO
WO-2015153642 Oct 2015 WO
WO-2015187107 Dec 2015 WO
Non-Patent Literature Citations (57)
Entry
Qiu Li Loh et al.: “Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size”, Tissue Engineering Part B—Reviews, vol. 19, No. 6, Dec. 1, 2013, pp. 485-502.
Texas Instruments: “Current Recirculation and Decay Modes,” Application Report SLVA321—Mar. 2009; Retrieved from the Internet: URL:http://www.ti.com/lit/an/slva321/slva321 [retrieved on Apr. 25, 2017], 7 pages.
Brar et al., “Investigation of the mechanical and degradation properties of Mg—Sr and Mg—Zn—Sr alloys for use as potential biodegradable implant materials,” J. Mech. Behavior of Biomed. Mater. 7 (2012) pp. 87-95.
Yan et al., “Comparison of the effects of Mg—6Zn and titanium on intestinal tract in vivo,” J Mater Sci: Mater Med (2013), 11 pages.
Pellicer et al. “On the biodegradability, mechanical behavior, and cytocompatibility of amorphous Mg72Zn23Ca5 and crystalline Mg70Zn23Ca5Pd2 alloys as temporary implant materials,” J Biomed Mater Res Part A ,2013:101A:502-517.
Yan et al, Comparison of the effects of Mg—6Zn and Ti—3Al—2.5V alloys on TGF-β/TNF-α/VEGF/b—FGF in the healing of the intestinal track in vivo, Biomed. Mater. 9 (2014), 11 pages.
Mouser Electronics, “LM317 3-Terminal Adjustable Regulator with Overcurrent/Overtemperature Self Protection”, Sep. 30, 2016 (Sep. 30, 2016), XP0555246104, Retrieved from the Internet: URL: http://www.mouser.com/ds/2/405/lm317m-440423.pdf, pp. 1-9.
Mouser Electronics, “LM317M 3-Terminal Adjustable Regulator with Overcurrent/Overtemperature Self Protection”, Mar. 1, 2014 (Mar. 31, 2014), XP0555246104, Retrieved from the Internet: URL: http://www.mouser.com/ds/2/405/lm317m-440423.pdf, pp. 1-8.
The Sodem Aseptic Battery Transfer Kit, Sodem Systems, 2000, 3 pages.
Anonymous, Analog Devices Wiki, Chapter 11: The Current Mirror, Aug. 20, 2017, 22 pages. https://wiki.analog.com/university/courses/electronics/text/chapter-11?rev=1503222341.
Cuper et al., “The Use of Near-Infrared Light for Safe and Effective Visualization of Subsurface Blood Vessels to Facilitate Blood Withdrawal in Children,” Medical Engineering & Physics, vol. 35, No. 4, pp. 433-440 (2013).
Anonymous: “Sense & Control Application Note Current Sensing Using Linear Hall Sensors,” Feb. 3, 2009, pp. 1-18. Retrieved from the Internet: URL: http://www.infineon.com/dgdl/Current_Sensing_Rev.1.1.pdf?fileId=db3a304332d040720132d939503e5f17 [retrieved on Oct. 18, 2016].
Lyon et al. “The Relationship Between Current Load and Temperature for Quasi-Steady State and Transient Conditions,” SPIE—International Society for Optical Engineering. Proceedings, vol. 4020, (pp. 62-70), Mar. 30, 2000.
Serial Communication Protocol; Michael Lemmon Feb. 1, 2009; http://www3.nd.edu/˜lemmon/courses/ee224/web-manual/web-manual/lab12/node2.html; Wayback Machine to Apr. 29, 2012.
Byrne et al., “Molecular Imprinting Within Hydrogels,” Advanced Drug Delivery Reviews, 54 (2002) pp. 149-161.
Fast, Versatile Blackfin Processors Handle Advanced RFID Reader Applications; Analog Dialogue: vol. 40—Sep. 2006; http://www.analog.com/library/analogDialogue/archives/40-09/rfid.pdf; Wayback Machine to Feb. 15, 2012.
C.C. Thompson et al., “Peroral Endoscopic Reduction of Dilated Gastrojejunal Anastomosis After Roux-en-Y Gastric Bypass: A Possible New Option for Patients with Weight Regain,” Surg Endosc (2006) vol. 20., pp. 1744-1748.
Covidien Brochure, “Endo GIA™ Black Reload with Tri-Staple™ Technology,” (2012), 2 pages.
Chen et al., “Elastomeric Biomaterials for Tissue Engineering,” Progress in Polymer Science 38 (2013), pp. 584-671.
Covidien Brochure, “Endo GIA™ Reloads with Tri-Staple™ Technology,” (2010), 2 pages.
Covidien Brochure, “Endo GIA™ Curved Tip Reload with Tri-Staple™ Technology,” (2012), 2 pages.
Covidien Brochure, “Endo GIA™ Reloads with Tri-Staple™ Technology and Endo GIA™ Ultra Universal Staplers,” (2010), 2 pages.
Covidien Brochure, “Endo GIA™ Reloads with Tri-Staple™ Technology,” (2010), 1 page.
Data Sheet of LM4F230H5QR, 2007.
Matsuda, “Thermodynamics of Formation of Porous Polymeric Membrane from Solutions,” Polymer Journal, vol. 23, No. 5, pp. 435-444 (1991).
Seils et al., Covidien Summary: Clinical Study “UCONN Biodynamics: Final Report on Results,” (2 pages).
“Indian Standard: Automotive Vehicles—Brakes and Braking Systems (IS 11852-1:2001)”, Mar. 1, 2001.
Pitt et al., “Attachment of Hyaluronan to Metallic Surfaces,” J. Biomed. Mater. Res. 68A: pp. 95-106, 2004.
Datasheet for Panasonic TK Relays Ultra Low Profile 2 A Polarized Relay, Copyright Matsushita Electric Works, Ltd. (Known of at least as early as Aug. 17, 2010), 5 pages.
D. Tuite, Ed., “Get the Lowdown on Ultracapacitors,” Nov. 15, 2007; [online] URL: http://electronicdesign.com/Articles/Print.cfm?ArticleID=17465, accessed Jan. 15, 2008 (5 pages).
B.R. Coolman, DVM, MS et al., “Comparison of Skin Staples With Sutures for Anastomosis of the Small Intestine in Dogs,” Abstract; http://www.blackwell-synergy.com/doi/abs/10.1053/jvet.2000.7539?cookieSet=1&journalCode=vsu which redirects to http://www3.interscience.wiley.com/journal/119040681/abstract?CRETRY=1&SRETRY=0; [online] accessed: Sep. 22, 2008 (2 pages).
Allegro MicroSystems, LLC, Automotive Full Bridge MOSFET Driver, A3941-DS, Rev. 5, 21 pages, http://www.allegromicro.com/˜media/Files/Datasheets/A3941-Datasheet.ashx?la=en.
http://ninpgan.net/publications/51-100/89.pdf; 2004, Ning Pan, on Uniqueness of Fibrous Materials, Design & Nature II. Eds: Colins, M. and Brebbia, C. WIT Press, Boston, 493-504.
Covidien Brochure “iDrive™ Ultra Powered Stapling System,” (6 pages).
Covidien “iDrive™ Ultra Powered Stapling System, Cleaning and Sterilization Guide,” (2 pages).
Covidien “iDrive™ Ultra Powered Stapling System, A Guide for Surgeons,” (6 pages).
Covidien iDrive™ Ultra Powered Stapling System ibrochure, “The Power of iDrive™ Ultra Powered Stapling System and Tri-Staple™ Technology,” (23 pages).
Covidien iDrive™ Ultra in Service Reference Card, “iDrive™ Ultra Powered Stapling Device,” (4 pages).
Solorio et al., “Gelatin Microspheres Crosslinked with Genipin for Local Delivery of Growth Factors,” J. Tissue Eng. Regen. Med. (2010), 4(7): pp. 514-523.
Schellhammer et al., “Poly-Lactic-Acid for Coating of Endovascular Stents: Preliminary Results in Canine Experimental Av-Fistulae,” Mat.-wiss. u. Werkstofftech., 32, pp. 193-199 (2001).
Young, “Microcellular foams via phase separation,” Journal of Vacuum Science & Technology A 4(3), (May/Jun. 1986).
Peppas, Editor “Hydrogels in Medicine and Pharmacy,” vol. I, Fundamentals, CRC Press, 1986.
Ebara, “Carbohydrate-Derived Hydrogels and Microgels,” Engineered Carbohydrate-Based Materials for Biomedical Applications: Polymers, Surfaes, Dendrimers, Nanoparticles, and Hydrogels, Edited by Ravin Narain, 2011, pp. 337-345.
Peppas, “Physiologically Responsive Hydrogels,” Journal of Bioactive and Compatible Polymers, vol. 6 (Jul. 1991) pp. 241-246.
Hoffman, “Hydrogels for Biomedical Applications,” Advanced Drug Delivery Reviews, 54 (2002) pp. 3-12.
Hoffman, “Hydrogels for Biomedical Applications,” Advanced Drug Delivery Reviews, 43 (2002) pp. 3-12.
Qiu et al., “Environment-Sensitive Hydrogels for Drug Delivery,” Advanced Drug Delivery Reviews, 53 (2001) pp. 321-339.
Jeong et al., “Thermosensitive Sol-Gel Reversible Hydrogels,” Advanced Drug Delivery Reviews, 54 (2002) pp. 37-51.
Miyata et al., “Biomolecule-Sensitive Hydrogels,” Advanced Drug Delivery Reviews, 54 (2002) pp. 79-98.
Covidien Brochure, “Endo GIA™ Ultra Universal Stapler,” (2010), 2 pages.
ASTM procedure D2240-05, “Standard Test Method for Rubber Property-Durometer Hardness,” (Published Apr. 2010).
ASTM procedure D2240-00, “Standard Test Method for Rubber Property-Durometer Hardness,” (Published Aug. 2000).
Breedveld et al., “A New, Easily Miniaturized Sterrable Endoscope,” IEEE Engineering in Medicine and Biology Magazine (Nov./Dec. 2005).
Van Meer et al., “A Disposable Plastic Compact Wrist for Smart Minimally Invasive Surgical Tools,” LAAS/CNRS (Aug. 2005).
“Biomedical Coatings,” Fort Wayne Metals, Research Products Corporation, obtained online at www.fwmetals.com on Jun. 21, 2010 (1 page).
Disclosed Anonymously, “Motor-Driven Surgical Stapler Improvements,” Research Disclosure Database No. 526041, Published: Feb. 2008.
Patrick J. Sweeney: “RFID for Dummies”, Mar. 11, 2010, pp. 365-365, XP055150775, ISBN: 978-1-11-805447-5, Retrieved from the Internet: URL: books.google.de/books?isbn=1118054474 [retrieved on Nov. 4, 2014]—book not attached.
Related Publications (1)
Number Date Country
20160287249 A1 Oct 2016 US
Continuations (1)
Number Date Country
Parent 13433179 Mar 2012 US
Child 15180905 US
Continuation in Parts (2)
Number Date Country
Parent 13097891 Apr 2011 US
Child 13433179 US
Parent 12894377 Sep 2010 US
Child 13097891 US